| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2006 |
Age |
13-17 Years |
1.0 |
0.6 to 1.8 |
1335 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
25.1 |
22.3 to 28.1 |
1441 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
37.6 |
25.7 to 51.2 |
90 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-17 Years |
38.2 |
28.1 to 49.5 |
105 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
27.1 |
19.5 to 36.3 |
183 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
21.0 |
15.5 to 27.8 |
262 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
20.3 |
15.2 to 26.6 |
281 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-17 Years |
22.9 |
15.5 to 32.7 |
156 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-17 Years |
22.9 |
14.6 to 34.0 |
81 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-17 Years |
20.3 |
11.6 to 33.1 |
54 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
29.0 |
20.5 to 39.2 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
32.8 |
25.5 to 41.1 |
185 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
38.8 |
30.6 to 47.8 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
50.5 |
40.3 to 60.7 |
120 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
22.4 |
16.2 to 30.2 |
185 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
46.6 |
36.1 to 57.5 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
33.5 |
25.6 to 42.6 |
181 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
45.0 |
35.6 to 54.8 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
46.8 |
37.9 to 56.0 |
164 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
38.7 |
30.0 to 48.3 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
36.7 |
26.8 to 48.0 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
18.5 |
13.0 to 25.6 |
167 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
40.2 |
32.3 to 48.6 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
28.4 |
20.5 to 38.0 |
131 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
27.0 |
20.8 to 34.2 |
373 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
28.6 |
20.8 to 37.9 |
173 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
26.6 |
19.2 to 35.6 |
200 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
26.1 |
19.8 to 33.6 |
173 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
41.9 |
32.6 to 51.9 |
127 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
30.1 |
21.8 to 40.0 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
26.3 |
18.8 to 35.4 |
133 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
36.6 |
28.3 to 45.6 |
179 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
40.3 |
32.2 to 49.0 |
169 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
41.1 |
32.4 to 50.5 |
198 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
53.3 |
43.8 to 62.6 |
152 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
32.3 |
23.8 to 42.1 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
33.6 |
26.4 to 41.6 |
167 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2008 |
Age |
13-17 Years |
15.8 |
10.6 to 23.0 |
187 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
31.6 |
23.8 to 40.7 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
17.8 |
12.0 to 25.5 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
29.5 |
23.0 to 37.0 |
186 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
30.0 |
21.2 to 40.5 |
117 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
54.4 |
44.3 to 64.1 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
43.0 |
34.3 to 52.1 |
187 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
48.3 |
38.4 to 58.4 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
50.2 |
43.1 to 57.3 |
270 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
48.3 |
38.0 to 58.7 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
51.5 |
41.9 to 61.0 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
34.4 |
26.3 to 43.6 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
28.7 |
21.9 to 36.7 |
177 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
29.1 |
21.6 to 37.9 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
35.5 |
27.3 to 44.7 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
34.8 |
25.6 to 45.3 |
106 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
46.1 |
38.7 to 53.7 |
346 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
51.8 |
43.3 to 60.3 |
178 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
45.2 |
36.8 to 53.9 |
168 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
37.2 |
35.1 to 39.3 |
8607 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
50.1 |
45.0 to 55.2 |
911 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
48.0 |
42.3 to 53.7 |
457 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
42.8 |
38.4 to 47.4 |
1176 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
28.9 |
25.3 to 32.8 |
1333 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
31.2 |
27.8 to 34.8 |
1123 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
32.8 |
26.8 to 39.4 |
1018 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
33.3 |
28.6 to 38.3 |
608 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
28.3 |
23.9 to 33.1 |
911 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
46.1 |
37.6 to 54.9 |
549 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
54.7 |
44.2 to 64.8 |
152 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
18.7 |
13.2 to 25.9 |
183 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
45.9 |
37.9 to 54.1 |
178 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
29.6 |
21.5 to 39.3 |
172 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
31.6 |
23.2 to 41.5 |
370 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
40.7 |
30.6 to 51.7 |
114 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
30.2 |
20.3 to 42.4 |
102 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
31.1 |
21.4 to 42.7 |
154 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
40.3 |
34.4 to 46.5 |
521 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2008 |
Age |
13-17 Years |
17.1 |
10.3 to 27.2 |
109 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
50.4 |
40.9 to 59.8 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
40.6 |
31.9 to 50.0 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
46.5 |
37.1 to 56.1 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
33.6 |
25.7 to 42.6 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
47.0 |
37.0 to 57.1 |
113 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
36.2 |
27.7 to 45.7 |
124 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
49.4 |
40.8 to 58.1 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
40.8 |
31.7 to 50.6 |
136 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
52.8 |
43.6 to 61.7 |
184 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
34.6 |
26.6 to 43.5 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
49.2 |
39.9 to 58.6 |
190 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
52.7 |
43.7 to 61.4 |
198 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
61.2 |
52.7 to 69.2 |
191 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
51.5 |
42.4 to 60.5 |
186 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
60.0 |
51.4 to 68.0 |
198 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
39.3 |
31.3 to 48.0 |
216 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
38.6 |
30.8 to 47.1 |
182 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
65.0 |
55.2 to 73.6 |
115 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
30.2 |
21.0 to 41.4 |
105 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
34.3 |
28.0 to 41.3 |
365 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
36.2 |
28.8 to 44.2 |
199 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
33.8 |
26.2 to 42.4 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
37.1 |
30.2 to 44.6 |
404 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
42.4 |
34.3 to 51.1 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
44.1 |
33.9 to 54.9 |
117 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
31.0 |
23.8 to 39.2 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
48.6 |
37.6 to 59.7 |
127 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
44.4 |
35.3 to 53.8 |
140 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
39.6 |
28.7 to 51.6 |
110 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
69.0 |
60.4 to 76.5 |
181 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
39.0 |
31.5 to 47.1 |
220 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
44.9 |
36.5 to 53.5 |
164 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
22.9 |
16.5 to 30.9 |
191 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
32.7 |
25.5 to 40.8 |
173 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
35.0 |
26.8 to 44.2 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
49.4 |
40.2 to 58.6 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
39.0 |
30.2 to 48.4 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
60.0 |
51.3 to 68.2 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
42.2 |
34.4 to 50.4 |
197 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
53.1 |
45.0 to 60.9 |
195 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
48.8 |
41.4 to 56.3 |
262 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
43.2 |
32.4 to 54.7 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
52.6 |
42.8 to 62.2 |
125 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
50.3 |
40.9 to 59.6 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
45.1 |
36.0 to 54.6 |
133 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
40.6 |
31.8 to 49.9 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
40.1 |
31.9 to 48.9 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
52.9 |
45.2 to 60.5 |
200 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
53.2 |
43.8 to 62.4 |
262 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
58.2 |
49.1 to 66.8 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
52.4 |
41.6 to 62.9 |
114 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
44.3 |
42.4 to 46.1 |
9621 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
63.6 |
59.0 to 67.8 |
1022 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
46.8 |
41.1 to 52.5 |
459 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
45.3 |
40.1 to 50.6 |
1049 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
39.8 |
36.4 to 43.4 |
1416 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
39.6 |
36.2 to 43.1 |
1507 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
39.7 |
35.1 to 44.6 |
1352 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
39.4 |
34.8 to 44.2 |
607 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
45.2 |
40.3 to 50.2 |
962 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
49.5 |
42.0 to 57.1 |
648 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
68.3 |
58.9 to 76.4 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
28.5 |
21.0 to 37.4 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
62.4 |
53.2 to 70.8 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
43.6 |
35.4 to 52.1 |
180 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
37.6 |
31.3 to 44.5 |
696 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
47.7 |
37.7 to 57.9 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
41.7 |
29.8 to 54.7 |
112 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
47.0 |
36.7 to 57.7 |
131 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
57.8 |
49.0 to 66.1 |
153 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
33.9 |
25.7 to 43.3 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-17 Years |
14.9 |
9.6 to 22.4 |
175 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
52.9 |
47.6 to 58.2 |
599 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
32.5 |
24.7 to 41.4 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
60.7 |
52.5 to 68.4 |
184 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
36.8 |
28.6 to 45.8 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
60.0 |
50.9 to 68.5 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
38.5 |
29.5 to 48.4 |
118 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
49.2 |
40.7 to 57.6 |
178 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
43.6 |
35.8 to 51.7 |
184 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
45.8 |
36.9 to 55.0 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
40.8 |
32.0 to 50.3 |
134 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
52.8 |
43.4 to 62.0 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
37.9 |
28.5 to 48.3 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
56.1 |
46.9 to 64.9 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
52.5 |
43.5 to 61.4 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
57.9 |
49.4 to 65.9 |
182 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
63.9 |
54.9 to 72.0 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
57.5 |
48.6 to 66.0 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
41.1 |
31.5 to 51.4 |
147 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
43.5 |
35.8 to 51.5 |
195 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
62.7 |
52.8 to 71.6 |
133 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
28.8 |
21.6 to 37.3 |
152 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
39.7 |
33.3 to 46.4 |
362 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
50.6 |
41.5 to 59.7 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
36.8 |
29.4 to 44.9 |
187 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
37.0 |
29.2 to 45.6 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
48.2 |
38.9 to 57.7 |
128 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
40.2 |
32.0 to 48.9 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
40.1 |
31.4 to 49.5 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
54.2 |
44.9 to 63.2 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
54.6 |
45.0 to 63.8 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
41.6 |
32.6 to 51.3 |
140 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
65.9 |
56.5 to 74.1 |
140 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
49.4 |
39.6 to 59.3 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
51.3 |
42.0 to 60.5 |
139 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
34.0 |
26.2 to 42.6 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
41.4 |
33.4 to 49.8 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
45.5 |
36.9 to 54.4 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
52.3 |
42.8 to 61.6 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
47.4 |
38.9 to 56.2 |
165 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
49.6 |
41.4 to 57.7 |
173 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
35.4 |
27.0 to 44.9 |
180 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
48.4 |
40.1 to 56.8 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
56.2 |
49.5 to 62.7 |
329 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
62.7 |
54.3 to 70.4 |
182 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
52.0 |
42.4 to 61.4 |
147 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
51.9 |
42.8 to 60.9 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
41.7 |
33.7 to 50.2 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
44.0 |
35.3 to 53.0 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
47.4 |
38.8 to 56.2 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
54.1 |
44.4 to 63.4 |
129 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
52.3 |
44.7 to 59.7 |
360 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
60.2 |
51.8 to 68.0 |
185 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
51.1 |
42.5 to 59.6 |
175 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
48.7 |
46.9 to 50.5 |
9220 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
61.1 |
56.2 to 65.7 |
953 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
49.6 |
44.1 to 55.1 |
509 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
50.4 |
45.8 to 55.1 |
1161 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
42.3 |
38.5 to 46.1 |
1272 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
45.0 |
41.3 to 48.7 |
1099 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
47.6 |
42.7 to 52.6 |
1438 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
44.1 |
39.4 to 48.8 |
616 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
48.7 |
43.9 to 53.6 |
970 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
55.4 |
48.0 to 62.5 |
612 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
73.0 |
64.6 to 80.0 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
41.5 |
32.6 to 51.0 |
164 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
68.8 |
60.5 to 76.1 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
33.1 |
25.7 to 41.4 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
47.5 |
40.5 to 54.6 |
824 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
44.2 |
36.4 to 52.2 |
203 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
55.1 |
46.2 to 63.8 |
197 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
34.4 |
24.6 to 45.7 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
67.4 |
58.8 to 74.9 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
47.7 |
38.3 to 57.2 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
22.5 |
14.5 to 33.1 |
116 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
57.8 |
52.7 to 62.8 |
590 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
39.2 |
31.0 to 48.0 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
49.6 |
40.4 to 58.8 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
54.0 |
44.3 to 63.5 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
69.3 |
61.5 to 76.2 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
42.4 |
34.3 to 51.0 |
164 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
54.4 |
44.5 to 63.9 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
53.2 |
44.1 to 62.0 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
49.5 |
40.4 to 58.7 |
180 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
59.5 |
49.7 to 68.5 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
55.3 |
44.9 to 65.2 |
191 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
36.1 |
24.9 to 49.0 |
152 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
65.0 |
57.9 to 71.5 |
270 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
45.9 |
35.8 to 56.3 |
220 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
60.5 |
51.8 to 68.6 |
223 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
60.2 |
51.3 to 68.5 |
203 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
55.0 |
45.5 to 64.1 |
210 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
50.0 |
41.3 to 58.7 |
240 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
48.4 |
39.5 to 57.4 |
215 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
73.1 |
64.4 to 80.4 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
45.5 |
35.3 to 56.1 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
51.6 |
44.1 to 59.0 |
404 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
47.0 |
37.8 to 56.5 |
181 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
52.7 |
43.7 to 61.5 |
223 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
40.8 |
32.0 to 50.2 |
199 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
53.5 |
43.5 to 63.3 |
169 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
37.2 |
29.0 to 46.3 |
198 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
46.0 |
36.5 to 55.8 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
63.0 |
53.9 to 71.4 |
214 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
56.1 |
47.8 to 64.1 |
211 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
45.7 |
37.6 to 54.0 |
255 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
61.1 |
52.0 to 69.6 |
178 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
55.6 |
45.6 to 65.1 |
185 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
55.5 |
45.5 to 65.1 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
31.9 |
22.6 to 43.0 |
167 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
49.5 |
40.0 to 59.1 |
191 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
52.9 |
41.0 to 64.4 |
204 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
59.0 |
48.8 to 68.4 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
55.3 |
44.0 to 66.1 |
189 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
65.8 |
57.7 to 73.0 |
191 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
55.5 |
47.3 to 63.4 |
219 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
58.1 |
49.3 to 66.4 |
209 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
46.6 |
40.8 to 52.5 |
399 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
56.8 |
48.8 to 64.4 |
209 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
40.3 |
32.6 to 48.6 |
190 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
54.4 |
44.6 to 63.9 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
51.2 |
38.8 to 63.5 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
45.5 |
37.2 to 54.1 |
181 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
49.8 |
40.0 to 59.6 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
68.6 |
59.6 to 76.5 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
51.9 |
44.0 to 59.8 |
435 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
75.9 |
67.1 to 83.0 |
188 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
48.8 |
40.0 to 57.6 |
247 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
53.0 |
51.4 to 54.7 |
11236 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
62.1 |
57.3 to 66.7 |
1211 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
49.5 |
44.7 to 54.3 |
618 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
49.5 |
44.9 to 54.1 |
1458 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
47.9 |
44.1 to 51.7 |
1505 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
51.5 |
47.8 to 55.3 |
1338 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
50.1 |
45.4 to 54.8 |
1807 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
49.0 |
43.7 to 54.3 |
732 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
50.6 |
44.7 to 56.4 |
1090 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
63.4 |
57.6 to 68.8 |
804 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
76.1 |
68.1 to 82.5 |
203 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
38.7 |
28.7 to 49.7 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
58.1 |
44.1 to 70.9 |
179 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
46.0 |
36.8 to 55.5 |
205 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
48.8 |
42.3 to 55.4 |
1057 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
51.5 |
42.7 to 60.2 |
213 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
49.7 |
40.7 to 58.6 |
250 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
41.2 |
32.2 to 50.8 |
196 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
75.0 |
66.2 to 82.1 |
169 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
48.2 |
39.4 to 57.0 |
229 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
26.4 |
20.3 to 33.5 |
232 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
63.8 |
58.2 to 69.1 |
673 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
53.3 |
42.8 to 63.5 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
63.0 |
54.6 to 70.6 |
205 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
46.9 |
37.6 to 56.4 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
66.5 |
57.1 to 74.7 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
50.6 |
41.4 to 59.6 |
179 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
65.7 |
56.8 to 73.6 |
210 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
60.9 |
50.1 to 70.8 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
46.6 |
36.5 to 57.0 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
56.1 |
46.7 to 65.1 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
54.3 |
44.7 to 63.5 |
178 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
41.2 |
31.0 to 52.2 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
65.0 |
56.4 to 72.8 |
202 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
61.4 |
50.2 to 71.5 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
57.6 |
47.1 to 67.4 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
67.2 |
56.8 to 76.1 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
57.8 |
47.5 to 67.5 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
39.4 |
29.8 to 49.8 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
52.3 |
41.6 to 62.8 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
64.6 |
54.7 to 73.4 |
152 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
51.3 |
41.9 to 60.7 |
173 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
41.2 |
33.1 to 49.8 |
308 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
61.4 |
50.6 to 71.2 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
36.2 |
26.8 to 46.7 |
165 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
48.4 |
38.7 to 58.2 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
57.5 |
47.7 to 66.7 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
42.7 |
32.7 to 53.4 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
51.2 |
40.8 to 61.6 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
62.1 |
53.2 to 70.3 |
186 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
61.7 |
52.0 to 70.6 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
42.7 |
32.4 to 53.8 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
69.3 |
60.9 to 76.7 |
165 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
48.1 |
38.6 to 57.7 |
171 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
59.4 |
48.8 to 69.2 |
164 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
39.7 |
29.8 to 50.6 |
160 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
51.6 |
41.1 to 61.8 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
55.1 |
45.2 to 64.6 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
67.5 |
56.8 to 76.6 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
62.5 |
52.7 to 71.5 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
52.2 |
41.7 to 62.5 |
121 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
54.6 |
44.9 to 64.0 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
51.1 |
41.1 to 61.0 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
56.0 |
48.8 to 62.9 |
303 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
53.6 |
44.7 to 62.2 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
57.5 |
47.2 to 67.2 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
53.3 |
43.6 to 62.8 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
60.3 |
50.2 to 69.5 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
56.4 |
45.8 to 66.4 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
55.1 |
45.5 to 64.3 |
167 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
58.5 |
49.0 to 67.5 |
160 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
57.4 |
49.3 to 65.2 |
337 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
76.2 |
67.0 to 83.5 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
55.0 |
45.9 to 63.8 |
171 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
53.8 |
52.0 to 55.7 |
9058 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
64.2 |
59.3 to 68.8 |
900 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
55.5 |
49.8 to 61.2 |
448 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
52.2 |
47.1 to 57.4 |
1089 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
47.0 |
42.7 to 51.3 |
1230 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
49.7 |
45.4 to 53.9 |
1089 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
52.1 |
47.8 to 56.3 |
1466 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
53.1 |
47.4 to 58.7 |
604 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
54.6 |
48.5 to 60.5 |
908 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
63.4 |
56.5 to 69.8 |
691 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
73.7 |
63.3 to 82.0 |
153 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
41.9 |
31.8 to 52.7 |
153 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
51.0 |
41.0 to 60.9 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
54.3 |
43.3 to 65.0 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
51.2 |
45.4 to 57.0 |
798 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
43.0 |
33.0 to 53.5 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
55.8 |
46.4 to 64.9 |
189 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
51.5 |
44.8 to 58.1 |
433 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
28.7 |
22.7 to 35.7 |
262 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
60.5 |
54.4 to 66.3 |
633 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
44.3 |
34.4 to 54.8 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
66.4 |
56.9 to 74.8 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
50.9 |
40.1 to 61.6 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
64.5 |
53.9 to 73.8 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
45.2 |
35.0 to 55.9 |
134 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
50.5 |
39.8 to 61.1 |
133 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
53.9 |
43.8 to 63.6 |
153 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
54.7 |
45.4 to 63.6 |
152 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
52.2 |
42.9 to 61.4 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
64.1 |
55.0 to 72.3 |
171 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
44.3 |
35.3 to 53.6 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
67.6 |
57.5 to 76.2 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
58.2 |
49.4 to 66.4 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
56.0 |
46.6 to 64.9 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
68.7 |
60.1 to 76.1 |
183 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
55.6 |
41.0 to 69.3 |
84 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
49.7 |
39.7 to 59.7 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
53.7 |
42.9 to 64.1 |
132 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
69.1 |
60.3 to 76.6 |
164 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
52.7 |
42.6 to 62.5 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
55.0 |
44.3 to 65.2 |
124 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
53.2 |
45.6 to 60.7 |
268 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
61.8 |
48.5 to 73.5 |
94 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
51.2 |
42.3 to 60.0 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
54.1 |
45.8 to 62.3 |
194 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
57.0 |
48.2 to 65.4 |
183 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
39.9 |
30.6 to 50.1 |
133 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
47.6 |
37.9 to 57.4 |
140 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
59.8 |
50.4 to 68.6 |
138 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
60.2 |
51.2 to 68.6 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
50.0 |
38.7 to 61.2 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
62.3 |
53.7 to 70.2 |
183 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
66.0 |
56.4 to 74.4 |
131 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
59.3 |
49.8 to 68.1 |
167 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
53.1 |
43.6 to 62.3 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
46.1 |
35.9 to 56.8 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
45.8 |
36.5 to 55.4 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
65.1 |
55.5 to 73.7 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
53.8 |
44.3 to 62.9 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
68.0 |
59.2 to 75.6 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
45.8 |
36.4 to 55.5 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
67.1 |
58.0 to 75.1 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
61.7 |
55.3 to 67.7 |
344 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
64.2 |
54.8 to 72.7 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
60.1 |
51.4 to 68.2 |
190 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
59.3 |
49.6 to 68.3 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
57.5 |
48.0 to 66.6 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
54.8 |
45.5 to 63.9 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
54.8 |
46.1 to 63.3 |
184 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
66.3 |
57.5 to 74.1 |
164 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
59.5 |
51.3 to 67.3 |
379 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
78.4 |
70.3 to 84.8 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
57.0 |
47.9 to 65.8 |
220 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
57.3 |
55.4 to 59.2 |
8710 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
61.9 |
57.2 to 66.4 |
978 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
56.5 |
51.1 to 61.7 |
501 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
55.1 |
49.6 to 60.5 |
1101 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
53.0 |
48.9 to 57.2 |
1165 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
57.4 |
53.6 to 61.1 |
1076 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
56.2 |
50.9 to 61.4 |
1159 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
49.7 |
44.2 to 55.3 |
592 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
52.6 |
47.6 to 57.6 |
919 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
66.0 |
58.1 to 73.0 |
610 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
76.6 |
67.6 to 83.7 |
147 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
60.4 |
50.4 to 69.6 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
56.0 |
46.3 to 65.4 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
48.9 |
39.6 to 58.4 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
56.2 |
48.7 to 63.4 |
514 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
54.8 |
45.6 to 63.6 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
62.0 |
50.9 to 72.1 |
119 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
55.9 |
47.2 to 64.2 |
240 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
33.2 |
25.3 to 42.2 |
156 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
61.0 |
55.1 to 66.7 |
609 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
44.3 |
35.0 to 54.0 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
60.2 |
51.0 to 68.8 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
51.9 |
39.3 to 64.3 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
60.7 |
50.6 to 69.9 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
49.7 |
40.5 to 59.0 |
152 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
59.4 |
50.1 to 68.0 |
160 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
54.3 |
44.8 to 63.5 |
147 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
54.7 |
45.3 to 63.7 |
172 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
48.7 |
40.1 to 57.4 |
200 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
58.2 |
48.7 to 67.2 |
194 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
54.6 |
45.5 to 63.4 |
183 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
69.2 |
59.1 to 77.8 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
62.5 |
53.9 to 70.3 |
189 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
63.5 |
54.7 to 71.5 |
185 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
67.6 |
57.7 to 76.1 |
180 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
75.2 |
64.7 to 83.4 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
57.2 |
46.7 to 67.2 |
173 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
65.4 |
55.9 to 73.9 |
187 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
60.4 |
51.6 to 68.6 |
186 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
59.4 |
49.0 to 69.0 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
64.4 |
57.7 to 70.6 |
349 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
78.1 |
69.0 to 85.2 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
61.2 |
53.3 to 68.6 |
208 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
61.4 |
52.6 to 69.5 |
184 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
59.5 |
49.3 to 68.9 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
38.3 |
29.3 to 48.1 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
52.1 |
42.7 to 61.4 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
53.2 |
43.7 to 62.4 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
66.8 |
58.2 to 74.4 |
165 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
57.9 |
47.8 to 67.4 |
192 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
69.0 |
60.0 to 76.8 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
58.0 |
48.7 to 66.7 |
172 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
67.0 |
57.1 to 75.7 |
134 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
45.8 |
36.5 to 55.4 |
160 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
47.5 |
38.5 to 56.7 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
57.2 |
47.8 to 66.0 |
197 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
59.6 |
50.2 to 68.3 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
54.2 |
45.6 to 62.6 |
184 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
71.0 |
63.4 to 77.7 |
181 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
48.0 |
38.3 to 57.8 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
59.0 |
49.9 to 67.5 |
202 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
58.8 |
51.3 to 65.9 |
283 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
58.0 |
47.6 to 67.8 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
59.3 |
48.9 to 69.0 |
139 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
71.1 |
62.4 to 78.4 |
173 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
60.9 |
51.2 to 69.8 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
61.0 |
52.3 to 69.1 |
202 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
65.3 |
56.3 to 73.3 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
64.6 |
55.5 to 72.8 |
193 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
66.8 |
59.1 to 73.8 |
380 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
80.3 |
71.0 to 87.2 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
65.1 |
56.3 to 72.9 |
223 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
76.1 |
64.3 to 84.9 |
107 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
60.0 |
58.1 to 61.8 |
10084 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
67.8 |
63.1 to 72.2 |
1070 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
55.3 |
49.3 to 61.1 |
428 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
62.5 |
57.7 to 67.2 |
1222 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
58.4 |
54.3 to 62.3 |
1386 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
61.9 |
58.3 to 65.4 |
1206 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
53.0 |
48.0 to 57.9 |
1516 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
49.8 |
44.7 to 54.9 |
645 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
60.3 |
55.6 to 64.8 |
1153 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
66.7 |
58.8 to 73.7 |
730 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
76.0 |
67.5 to 82.8 |
194 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
52.1 |
42.6 to 61.5 |
193 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
61.0 |
51.3 to 69.9 |
177 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
47.8 |
38.2 to 57.5 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
50.7 |
43.7 to 57.6 |
793 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
47.7 |
38.6 to 57.1 |
179 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
66.8 |
57.3 to 75.1 |
197 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
71.9 |
61.1 to 80.7 |
189 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
48.7 |
40.6 to 56.8 |
228 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
63.6 |
58.1 to 68.9 |
728 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
59.2 |
50.7 to 67.1 |
199 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
63.4 |
54.2 to 71.7 |
182 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
59.2 |
48.6 to 69.1 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
65.8 |
56.6 to 74.0 |
179 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
58.0 |
48.5 to 67.0 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
61.0 |
50.8 to 70.2 |
165 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
50.3 |
42.2 to 58.3 |
223 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
57.7 |
48.3 to 66.6 |
165 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
57.0 |
48.2 to 65.5 |
165 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
68.3 |
60.6 to 75.2 |
215 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
63.5 |
54.7 to 71.4 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
66.7 |
56.5 to 75.5 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
65.3 |
56.7 to 73.0 |
180 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
70.9 |
62.1 to 78.4 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
67.6 |
58.7 to 75.4 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
76.5 |
67.9 to 83.3 |
199 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
62.5 |
52.5 to 71.6 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
54.4 |
44.8 to 63.6 |
172 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
68.9 |
60.7 to 76.1 |
192 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
71.3 |
62.7 to 78.6 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
57.3 |
48.2 to 65.9 |
177 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
62.0 |
55.9 to 67.7 |
401 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
70.8 |
62.0 to 78.3 |
147 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
60.0 |
52.9 to 66.8 |
254 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
53.7 |
44.7 to 62.5 |
167 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
66.7 |
58.3 to 74.2 |
190 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
50.9 |
42.2 to 59.5 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
57.4 |
48.6 to 65.7 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
60.3 |
51.4 to 68.5 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
66.0 |
57.3 to 73.7 |
186 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
66.0 |
56.5 to 74.3 |
203 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
73.5 |
64.0 to 81.2 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
67.6 |
58.9 to 75.3 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
65.5 |
56.2 to 73.7 |
179 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
52.4 |
44.4 to 60.2 |
205 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
59.3 |
49.0 to 68.8 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
55.0 |
46.5 to 63.3 |
192 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
67.3 |
58.9 to 74.6 |
184 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
72.0 |
63.6 to 79.1 |
176 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
74.2 |
64.4 to 82.0 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
69.0 |
60.6 to 76.2 |
178 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
66.7 |
58.7 to 73.8 |
214 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
62.3 |
55.7 to 68.4 |
298 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
65.3 |
56.2 to 73.4 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
60.3 |
51.3 to 68.7 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
65.7 |
56.8 to 73.6 |
172 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
70.5 |
61.8 to 78.0 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
61.0 |
50.7 to 70.4 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
58.1 |
47.9 to 67.7 |
129 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
70.0 |
61.3 to 77.4 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
62.2 |
54.3 to 69.5 |
397 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
79.3 |
71.7 to 85.3 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
60.0 |
51.2 to 68.2 |
222 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
77.4 |
68.7 to 84.2 |
158 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
62.8 |
61.0 to 64.5 |
10508 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
73.0 |
68.1 to 77.4 |
1026 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
64.5 |
59.3 to 69.3 |
476 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
63.0 |
58.1 to 67.7 |
1295 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
59.4 |
55.5 to 63.2 |
1375 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
62.0 |
58.3 to 65.4 |
1232 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
60.5 |
56.6 to 64.2 |
1962 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
60.2 |
55.0 to 65.2 |
691 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
57.8 |
52.8 to 62.5 |
1026 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
67.3 |
59.4 to 74.4 |
727 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
87.9 |
82.1 to 92.1 |
201 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
53.7 |
44.7 to 62.4 |
172 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
53.2 |
44.1 to 62.1 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
59.7 |
50.8 to 68.1 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
60.1 |
54.9 to 65.1 |
1294 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
56.2 |
47.6 to 64.4 |
198 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
66.9 |
56.1 to 76.1 |
116 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
75.4 |
68.3 to 81.4 |
276 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
58.9 |
52.4 to 65.1 |
453 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
40.4 |
33.0 to 48.3 |
222 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
65.3 |
60.2 to 70.1 |
698 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
47.8 |
38.6 to 57.1 |
171 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
68.7 |
60.1 to 76.2 |
189 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
61.2 |
49.7 to 71.6 |
171 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
65.8 |
57.3 to 73.4 |
188 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
62.0 |
53.1 to 70.2 |
164 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
60.5 |
51.5 to 68.8 |
171 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
47.7 |
38.3 to 57.3 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
54.2 |
45.1 to 63.1 |
153 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
61.9 |
53.0 to 70.0 |
183 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
65.4 |
56.1 to 73.6 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
53.3 |
43.8 to 62.6 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
78.0 |
68.5 to 85.3 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
68.3 |
57.9 to 77.1 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
68.9 |
60.3 to 76.4 |
191 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
78.3 |
70.5 to 84.5 |
180 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
80.7 |
72.2 to 87.0 |
181 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
58.4 |
48.6 to 67.6 |
181 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
77.0 |
68.9 to 83.5 |
193 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
76.9 |
70.0 to 82.5 |
242 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
71.7 |
62.3 to 79.5 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
59.8 |
50.7 to 68.4 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
68.5 |
61.7 to 74.5 |
293 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
79.7 |
66.0 to 88.8 |
76 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
66.0 |
58.2 to 73.0 |
217 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
53.9 |
44.5 to 63.1 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
64.4 |
55.9 to 72.2 |
183 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
62.4 |
53.1 to 70.9 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
54.8 |
45.6 to 63.7 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
69.9 |
61.1 to 77.4 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
73.1 |
64.4 to 80.3 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
69.0 |
59.9 to 76.8 |
213 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
77.6 |
69.7 to 83.9 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
70.5 |
60.9 to 78.7 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
58.1 |
49.0 to 66.7 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
47.8 |
38.7 to 57.0 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
55.0 |
45.7 to 64.0 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
68.2 |
59.6 to 75.7 |
189 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
69.4 |
59.8 to 77.6 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
64.6 |
55.6 to 72.7 |
169 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
70.6 |
61.9 to 78.1 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
66.0 |
57.8 to 73.4 |
221 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
63.1 |
54.4 to 71.1 |
171 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
75.0 |
69.0 to 80.1 |
299 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
81.9 |
73.8 to 87.9 |
136 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
70.5 |
62.0 to 77.8 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
57.9 |
48.8 to 66.5 |
192 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
68.3 |
58.2 to 76.9 |
130 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
57.6 |
48.1 to 66.5 |
178 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
63.8 |
53.0 to 73.4 |
127 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
62.6 |
52.7 to 71.6 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
72.0 |
65.1 to 78.1 |
390 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
88.2 |
81.2 to 92.8 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
69.9 |
62.1 to 76.7 |
240 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
80.8 |
72.7 to 86.9 |
197 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
65.1 |
63.3 to 66.8 |
9661 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
74.9 |
70.7 to 78.7 |
1017 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
72.0 |
67.2 to 76.4 |
520 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
65.0 |
60.2 to 69.5 |
1320 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
59.6 |
55.7 to 63.3 |
1319 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
63.4 |
59.7 to 67.0 |
1096 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
57.3 |
53.2 to 61.2 |
1492 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
60.7 |
55.7 to 65.5 |
664 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
64.1 |
58.6 to 69.3 |
953 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
75.3 |
68.0 to 81.4 |
615 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
90.1 |
83.4 to 94.2 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
50.5 |
40.2 to 60.7 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
61.7 |
51.8 to 70.8 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
55.3 |
45.4 to 64.7 |
136 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
54.5 |
49.0 to 59.8 |
891 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
58.3 |
48.6 to 67.5 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
59.4 |
45.7 to 71.8 |
94 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
48.8 |
37.9 to 59.8 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
78.4 |
68.4 to 85.9 |
172 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
53.3 |
46.2 to 60.2 |
328 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
43.8 |
35.6 to 52.4 |
201 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
66.5 |
61.1 to 71.5 |
665 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
58.8 |
49.2 to 67.8 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
71.2 |
62.4 to 78.6 |
171 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
50.7 |
39.6 to 61.6 |
209 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
70.9 |
62.4 to 78.3 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
58.5 |
48.8 to 67.6 |
147 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
68.1 |
58.6 to 76.2 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
50.4 |
41.5 to 59.3 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
61.1 |
52.6 to 69.0 |
193 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
61.1 |
52.3 to 69.3 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
68.9 |
59.1 to 77.2 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
66.7 |
57.4 to 74.8 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
75.6 |
65.9 to 83.3 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
74.4 |
65.9 to 81.4 |
169 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
75.4 |
66.2 to 82.8 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
76.2 |
67.0 to 83.4 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
91.8 |
84.3 to 95.9 |
165 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
62.4 |
52.9 to 71.1 |
193 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
64.5 |
54.8 to 73.1 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
69.3 |
60.4 to 77.0 |
185 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
78.7 |
70.2 to 85.4 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
68.4 |
58.6 to 76.8 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
62.3 |
55.4 to 68.8 |
310 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
84.9 |
74.4 to 91.6 |
95 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
57.4 |
49.4 to 65.0 |
215 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
68.0 |
58.4 to 76.3 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
80.0 |
71.9 to 86.2 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
55.2 |
45.3 to 64.7 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
54.9 |
46.0 to 63.5 |
169 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
73.8 |
65.3 to 80.9 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
79.6 |
71.9 to 85.7 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
73.2 |
62.9 to 81.5 |
221 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
85.4 |
78.5 to 90.4 |
191 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
71.0 |
62.5 to 78.2 |
167 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
66.0 |
56.8 to 74.2 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
56.0 |
46.9 to 64.7 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
62.7 |
53.8 to 70.8 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
64.5 |
54.7 to 73.3 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
72.0 |
62.5 to 79.8 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
70.6 |
61.6 to 78.3 |
164 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
75.2 |
67.3 to 81.6 |
173 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
71.6 |
62.9 to 78.9 |
169 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
73.6 |
65.1 to 80.7 |
160 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
71.2 |
64.4 to 77.2 |
292 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
82.4 |
73.8 to 88.6 |
133 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
64.0 |
54.6 to 72.5 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
66.8 |
57.1 to 75.3 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
74.7 |
66.9 to 81.2 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
69.5 |
61.7 to 76.4 |
206 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
56.0 |
46.7 to 64.9 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
70.1 |
61.9 to 77.2 |
183 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
69.2 |
61.3 to 76.1 |
393 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
84.6 |
77.2 to 89.9 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
67.1 |
58.3 to 74.9 |
219 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
68.6 |
66.9 to 70.2 |
9845 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
81.6 |
77.7 to 84.9 |
989 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
71.4 |
66.1 to 76.1 |
461 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
74.2 |
69.5 to 78.3 |
1274 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
62.4 |
58.5 to 66.1 |
1357 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
67.9 |
64.5 to 71.1 |
1159 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
62.5 |
58.7 to 66.1 |
1686 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
66.2 |
61.3 to 70.7 |
624 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
68.6 |
63.8 to 73.0 |
982 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
74.5 |
66.9 to 80.8 |
615 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
88.5 |
80.5 to 93.5 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
59.8 |
50.0 to 68.9 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
67.9 |
58.4 to 76.1 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
62.8 |
53.4 to 71.3 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
60.4 |
55.4 to 65.3 |
1063 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
68.8 |
59.7 to 76.7 |
160 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
73.6 |
59.8 to 83.9 |
82 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
64.3 |
53.5 to 73.9 |
123 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
84.8 |
76.4 to 90.6 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
76.8 |
67.6 to 84.0 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
55.9 |
49.2 to 62.4 |
394 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
70.7 |
65.5 to 75.4 |
698 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
63.1 |
53.9 to 71.5 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
83.8 |
76.4 to 89.3 |
174 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
82.5 |
72.7 to 89.3 |
181 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
72.6 |
63.9 to 79.9 |
178 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
67.5 |
58.3 to 75.6 |
153 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
73.5 |
64.3 to 81.0 |
147 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
50.0 |
41.1 to 58.8 |
169 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
69.1 |
59.9 to 77.0 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
65.7 |
57.2 to 73.2 |
193 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
65.3 |
54.9 to 74.5 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
65.9 |
56.5 to 74.2 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
68.4 |
58.1 to 77.1 |
179 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
72.3 |
61.6 to 81.0 |
131 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
70.1 |
60.3 to 78.4 |
139 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
77.3 |
67.6 to 84.7 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
83.1 |
73.1 to 89.9 |
134 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
66.0 |
56.1 to 74.7 |
160 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
70.7 |
61.8 to 78.3 |
167 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
65.5 |
56.0 to 73.9 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
77.4 |
69.1 to 84.0 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
67.7 |
57.8 to 76.2 |
136 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
73.2 |
67.2 to 78.5 |
359 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
85.4 |
72.8 to 92.7 |
98 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
70.6 |
63.7 to 76.7 |
261 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
66.9 |
57.1 to 75.4 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
78.6 |
70.2 to 85.2 |
132 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
60.5 |
50.4 to 69.8 |
138 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
58.6 |
48.8 to 67.7 |
130 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
70.4 |
60.4 to 78.8 |
124 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
68.8 |
59.2 to 77.0 |
160 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
76.4 |
67.1 to 83.7 |
185 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
82.8 |
72.9 to 89.5 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
76.4 |
67.1 to 83.8 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
84.9 |
76.7 to 90.6 |
131 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
59.2 |
49.3 to 68.3 |
136 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
67.0 |
57.6 to 75.3 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
66.5 |
56.6 to 75.2 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
80.6 |
70.8 to 87.7 |
134 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
66.0 |
57.1 to 74.0 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
79.7 |
70.5 to 86.7 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
69.7 |
60.1 to 77.8 |
177 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
70.7 |
60.5 to 79.2 |
139 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
67.3 |
58.8 to 74.8 |
236 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
70.0 |
58.0 to 79.8 |
122 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
65.6 |
53.7 to 75.7 |
114 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
72.2 |
63.2 to 79.7 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
82.9 |
73.6 to 89.4 |
132 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
69.7 |
60.9 to 77.2 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
66.3 |
57.1 to 74.4 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
80.1 |
72.6 to 86.0 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
75.9 |
67.5 to 82.7 |
314 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
86.3 |
76.7 to 92.4 |
115 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
74.5 |
65.0 to 82.1 |
199 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
69.9 |
68.1 to 71.6 |
8928 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
78.3 |
73.3 to 82.6 |
895 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
68.1 |
61.7 to 73.9 |
413 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
74.3 |
69.0 to 78.9 |
1113 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
66.8 |
62.9 to 70.4 |
1205 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
73.4 |
70.0 to 76.5 |
1088 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
65.7 |
61.9 to 69.3 |
1544 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
70.1 |
65.1 to 74.7 |
548 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
73.2 |
67.8 to 78.0 |
845 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
68.0 |
60.0 to 75.1 |
644 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
87.0 |
79.8 to 91.9 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
66.7 |
57.1 to 75.0 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
66.5 |
57.7 to 74.3 |
169 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
60.9 |
50.6 to 70.3 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
64.6 |
59.5 to 69.3 |
969 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
71.1 |
61.4 to 79.2 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
77.1 |
64.9 to 85.9 |
85 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
69.4 |
57.4 to 79.2 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
63.8 |
54.6 to 72.2 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
62.7 |
56.2 to 68.8 |
419 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
74.7 |
69.2 to 79.5 |
633 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
76.7 |
68.3 to 83.4 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
82.9 |
75.4 to 88.5 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
70.6 |
57.4 to 81.1 |
167 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
74.6 |
64.9 to 82.4 |
153 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
69.3 |
60.8 to 76.7 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
72.8 |
64.1 to 80.0 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
67.2 |
56.4 to 76.4 |
117 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
69.6 |
60.0 to 77.8 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
69.0 |
60.8 to 76.1 |
208 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
70.6 |
61.6 to 78.3 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
71.0 |
61.5 to 78.9 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
79.7 |
67.9 to 88.0 |
126 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
85.1 |
75.2 to 91.5 |
109 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
69.1 |
58.1 to 78.2 |
128 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
75.6 |
66.2 to 83.1 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
84.0 |
72.0 to 91.4 |
121 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
71.5 |
59.7 to 81.0 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
68.5 |
58.4 to 77.1 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
60.5 |
50.3 to 69.9 |
139 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
76.3 |
66.2 to 84.1 |
147 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
67.8 |
57.4 to 76.6 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
72.1 |
64.7 to 78.4 |
274 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
80.7 |
65.1 to 90.3 |
74 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
70.2 |
61.8 to 77.5 |
200 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
67.4 |
56.9 to 76.4 |
126 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
74.2 |
65.2 to 81.6 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
61.7 |
51.9 to 70.6 |
182 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
79.8 |
71.0 to 86.4 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
76.6 |
66.0 to 84.6 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
64.9 |
54.8 to 73.9 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
78.3 |
69.3 to 85.2 |
261 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
89.8 |
82.5 to 94.2 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
72.2 |
62.4 to 80.2 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
75.8 |
64.4 to 84.4 |
129 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
56.3 |
45.3 to 66.6 |
126 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
74.2 |
64.1 to 82.2 |
140 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
70.0 |
60.4 to 78.0 |
138 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
74.0 |
63.2 to 82.5 |
132 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
68.3 |
58.1 to 77.0 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
80.0 |
71.6 to 86.3 |
154 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
71.6 |
62.3 to 79.3 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
64.5 |
55.4 to 72.7 |
200 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
73.5 |
65.3 to 80.4 |
239 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
72.3 |
61.7 to 80.9 |
123 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
74.3 |
62.1 to 83.6 |
116 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
73.7 |
63.8 to 81.7 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
88.1 |
82.1 to 92.3 |
152 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
73.7 |
64.4 to 81.3 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
70.8 |
62.0 to 78.3 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
73.8 |
63.2 to 82.2 |
134 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
78.9 |
71.7 to 84.7 |
351 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
91.2 |
84.3 to 95.3 |
108 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
77.3 |
69.2 to 83.8 |
243 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
71.4 |
54.8 to 83.8 |
107 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
73.2 |
71.3 to 75.0 |
8916 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
81.6 |
77.1 to 85.3 |
950 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
72.9 |
66.7 to 78.3 |
405 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
76.0 |
71.2 to 80.2 |
1176 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
71.2 |
66.9 to 75.1 |
1152 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
72.9 |
69.2 to 76.3 |
972 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
66.5 |
62.6 to 70.2 |
1577 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
71.5 |
66.3 to 76.2 |
608 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
79.0 |
73.9 to 83.3 |
840 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
77.7 |
68.8 to 84.5 |
592 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
93.4 |
84.9 to 97.3 |
140 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
75.7 |
66.6 to 82.9 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
71.8 |
61.9 to 79.9 |
124 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
69.9 |
59.5 to 78.6 |
126 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
64.2 |
59.0 to 69.1 |
897 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
65.7 |
55.4 to 74.6 |
138 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
84.2 |
71.2 to 92.0 |
87 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
68.5 |
57.7 to 77.6 |
128 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
85.4 |
78.0 to 90.7 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
60.7 |
54.0 to 67.1 |
402 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
52.0 |
39.8 to 63.9 |
111 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
73.3 |
67.4 to 78.5 |
644 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
75.0 |
65.0 to 82.9 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
85.9 |
79.7 to 90.4 |
228 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
71.3 |
59.3 to 80.9 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
75.2 |
65.3 to 82.9 |
147 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
67.5 |
57.3 to 76.3 |
123 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
78.2 |
69.2 to 85.1 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
63.2 |
53.8 to 71.8 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
70.4 |
60.8 to 78.6 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
73.0 |
63.3 to 81.0 |
145 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
69.9 |
60.2 to 78.1 |
160 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
72.8 |
62.8 to 81.0 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
83.2 |
73.8 to 89.8 |
184 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
81.2 |
73.1 to 87.4 |
167 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
82.3 |
73.8 to 88.5 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
76.6 |
67.9 to 83.6 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
85.4 |
76.6 to 91.3 |
189 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
68.6 |
58.0 to 77.5 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
78.1 |
68.4 to 85.5 |
134 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
76.3 |
66.9 to 83.7 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
83.2 |
74.6 to 89.3 |
131 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
75.7 |
67.6 to 82.3 |
197 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
76.9 |
69.3 to 83.1 |
332 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
85.9 |
76.2 to 92.1 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
75.0 |
66.0 to 82.3 |
190 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
80.8 |
71.7 to 87.4 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
80.1 |
70.6 to 87.1 |
129 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
66.4 |
56.6 to 74.9 |
163 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
83.1 |
74.6 to 89.2 |
128 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
77.1 |
68.1 to 84.2 |
171 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
72.7 |
63.9 to 80.0 |
165 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
87.7 |
83.1 to 91.2 |
386 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
85.1 |
77.9 to 90.3 |
201 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
78.1 |
69.6 to 84.7 |
179 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
81.9 |
72.0 to 88.8 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
50.9 |
41.3 to 60.3 |
140 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
71.0 |
61.5 to 79.0 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
79.0 |
69.9 to 86.0 |
155 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
82.3 |
74.1 to 88.3 |
184 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
74.6 |
65.1 to 82.3 |
186 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
83.2 |
76.1 to 88.5 |
183 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
75.2 |
66.6 to 82.1 |
171 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
80.1 |
72.5 to 85.9 |
166 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
81.1 |
74.8 to 86.1 |
342 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
82.3 |
73.7 to 88.6 |
180 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
80.4 |
71.2 to 87.1 |
162 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
82.3 |
74.3 to 88.2 |
158 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
82.8 |
74.9 to 88.6 |
198 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
73.2 |
64.3 to 80.6 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
63.2 |
54.4 to 71.3 |
165 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
80.0 |
70.8 to 86.9 |
129 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
77.0 |
69.0 to 83.4 |
394 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
86.8 |
78.5 to 92.2 |
125 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
75.7 |
66.8 to 82.9 |
269 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
63.6 |
46.4 to 78.0 |
67 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
77.1 |
75.4 to 78.7 |
9576 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
83.9 |
80.0 to 87.1 |
1015 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
79.1 |
74.2 to 83.3 |
513 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
78.3 |
74.3 to 81.9 |
1632 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
72.9 |
68.9 to 76.5 |
1171 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
77.9 |
74.5 to 81.0 |
1076 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
75.0 |
70.6 to 79.0 |
1227 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
73.7 |
68.7 to 78.1 |
651 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
77.5 |
72.9 to 81.5 |
957 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
80.8 |
73.7 to 86.3 |
661 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
94.9 |
87.8 to 98.0 |
112 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
69.3 |
59.8 to 77.4 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
81.9 |
73.8 to 87.9 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
69.4 |
60.6 to 77.1 |
170 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
76.1 |
69.9 to 81.4 |
563 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
77.2 |
68.7 to 83.9 |
153 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
87.6 |
77.0 to 93.8 |
111 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
75.2 |
68.0 to 81.2 |
299 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
77.3 |
71.9 to 82.0 |
673 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
71.7 |
62.0 to 79.8 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
86.8 |
79.5 to 91.7 |
195 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
76.2 |
68.0 to 82.9 |
353 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
76.8 |
67.5 to 84.1 |
202 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
63.6 |
54.1 to 72.1 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
81.5 |
72.4 to 88.1 |
122 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
65.5 |
55.4 to 74.4 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
76.8 |
67.1 to 84.3 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
69.8 |
58.8 to 79.0 |
121 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
83.2 |
74.7 to 89.2 |
127 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
76.2 |
67.7 to 83.0 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
80.5 |
68.9 to 88.5 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
82.1 |
72.2 to 89.0 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
76.3 |
66.3 to 84.1 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
82.2 |
73.3 to 88.6 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
88.4 |
81.5 to 93.0 |
197 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
65.3 |
52.4 to 76.3 |
127 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
82.5 |
73.8 to 88.8 |
118 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
75.3 |
64.2 to 83.9 |
94 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
83.5 |
75.3 to 89.4 |
126 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
81.8 |
73.0 to 88.2 |
153 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
76.5 |
69.4 to 82.4 |
282 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
86.8 |
70.0 to 94.9 |
72 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
74.2 |
66.0 to 81.0 |
210 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
75.3 |
64.9 to 83.4 |
122 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
81.3 |
67.7 to 90.0 |
92 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
83.2 |
74.4 to 89.5 |
140 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
66.8 |
54.5 to 77.1 |
111 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
79.6 |
69.9 to 86.8 |
129 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
80.2 |
70.7 to 87.2 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
87.9 |
83.3 to 91.4 |
389 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
90.4 |
79.1 to 95.9 |
115 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
80.8 |
71.7 to 87.5 |
179 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
84.8 |
74.4 to 91.4 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
58.3 |
47.9 to 68.0 |
146 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
78.8 |
70.4 to 85.3 |
156 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
71.3 |
61.3 to 79.5 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
85.9 |
77.6 to 91.4 |
147 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
75.8 |
65.9 to 83.5 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
86.9 |
79.0 to 92.1 |
133 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
66.3 |
54.5 to 76.4 |
122 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
82.0 |
73.2 to 88.3 |
168 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
79.9 |
72.5 to 85.6 |
278 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
85.9 |
78.1 to 91.3 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
75.8 |
64.8 to 84.3 |
128 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
87.5 |
76.4 to 93.8 |
122 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
80.1 |
68.0 to 88.3 |
87 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
82.2 |
70.8 to 89.8 |
129 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
75.6 |
65.6 to 83.5 |
114 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
77.3 |
67.1 to 85.1 |
129 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
77.4 |
70.8 to 82.8 |
434 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
90.9 |
84.9 to 94.7 |
157 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
75.6 |
68.3 to 81.6 |
277 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
89.4 |
83.4 to 93.5 |
175 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
78.5 |
76.6 to 80.4 |
8423 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
85.4 |
80.4 to 89.3 |
898 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
75.3 |
69.1 to 80.6 |
400 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
82.2 |
78.6 to 85.4 |
1546 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
75.1 |
70.4 to 79.3 |
1023 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
80.1 |
76.4 to 83.4 |
991 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
74.8 |
69.0 to 79.9 |
1022 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
81.3 |
76.5 to 85.3 |
535 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
81.4 |
76.6 to 85.4 |
840 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
80.7 |
71.9 to 87.2 |
574 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
90.9 |
78.2 to 96.5 |
138 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
77.8 |
68.2 to 85.2 |
123 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
92.0 |
86.4 to 95.4 |
202 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
81.6 |
72.9 to 87.9 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
73.4 |
65.2 to 80.3 |
462 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
82.5 |
74.1 to 88.5 |
150 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
74.4 |
59.8 to 85.1 |
73 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
72.6 |
63.1 to 80.4 |
239 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
74.3 |
61.1 to 84.2 |
113 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
79.5 |
74.4 to 83.8 |
594 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
82.8 |
74.7 to 88.8 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
84.8 |
77.9 to 89.8 |
216 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
84.8 |
76.0 to 90.8 |
259 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
80.9 |
72.7 to 87.1 |
191 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
81.8 |
73.1 to 88.2 |
123 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
83.9 |
75.5 to 89.8 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
68.0 |
56.9 to 77.3 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
77.2 |
68.3 to 84.2 |
139 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
78.3 |
66.6 to 86.6 |
99 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
74.0 |
63.6 to 82.3 |
129 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
78.8 |
70.3 to 85.3 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
70.1 |
59.4 to 79.0 |
140 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
81.1 |
72.9 to 87.3 |
160 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
83.3 |
74.0 to 89.7 |
125 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
82.6 |
72.8 to 89.3 |
127 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
88.0 |
79.3 to 93.3 |
113 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
77.3 |
67.4 to 85.0 |
149 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
76.8 |
67.3 to 84.2 |
159 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
63.5 |
50.5 to 74.8 |
120 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
88.6 |
80.2 to 93.8 |
109 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
84.9 |
75.9 to 90.9 |
121 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
81.5 |
74.4 to 87.0 |
294 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
81.2 |
69.0 to 89.4 |
119 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
81.6 |
73.2 to 87.8 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
77.5 |
66.9 to 85.4 |
116 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
88.6 |
78.5 to 94.3 |
88 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
73.5 |
63.6 to 81.6 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
70.6 |
60.3 to 79.2 |
139 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
81.6 |
72.5 to 88.2 |
169 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
81.3 |
71.1 to 88.5 |
126 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
85.5 |
74.8 to 92.2 |
161 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
86.7 |
76.7 to 92.9 |
136 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
82.5 |
72.8 to 89.2 |
127 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
85.8 |
78.3 to 91.0 |
152 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
60.6 |
48.7 to 71.3 |
116 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
80.3 |
71.8 to 86.7 |
144 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
80.0 |
70.8 to 86.9 |
142 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
76.2 |
65.9 to 84.1 |
134 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
78.2 |
68.0 to 85.8 |
117 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
85.8 |
76.1 to 92.0 |
109 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
73.4 |
62.9 to 81.7 |
133 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
83.3 |
73.9 to 89.7 |
148 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
81.6 |
75.4 to 86.5 |
263 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
82.7 |
72.7 to 89.5 |
112 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
80.9 |
72.4 to 87.2 |
151 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
70.9 |
60.9 to 79.3 |
175 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
81.3 |
71.0 to 88.5 |
128 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
81.9 |
70.6 to 89.5 |
123 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
70.4 |
59.2 to 79.6 |
109 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
82.2 |
72.4 to 89.1 |
116 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
76.1 |
68.8 to 82.1 |
339 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
90.3 |
79.6 to 95.7 |
116 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
74.2 |
66.1 to 80.9 |
223 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
86.4 |
80.7 to 90.7 |
323 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
77.8 |
75.8 to 79.6 |
7623 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
85.9 |
81.0 to 89.6 |
778 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
78.8 |
73.5 to 83.3 |
396 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
79.4 |
75.4 to 82.9 |
1131 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
74.5 |
70.6 to 78.1 |
1118 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
81.3 |
77.6 to 84.5 |
949 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
77.9 |
71.4 to 83.2 |
952 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
80.1 |
75.5 to 84.0 |
503 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
78.0 |
73.2 to 82.2 |
834 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
71.6 |
63.3 to 78.8 |
495 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
93.3 |
87.7 to 96.5 |
139 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
75.5 |
64.3 to 84.0 |
135 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
74.9 |
63.6 to 83.6 |
129 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
74.4 |
63.3 to 83.0 |
106 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
77.8 |
68.6 to 84.9 |
367 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
85.9 |
76.6 to 91.9 |
121 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
82.2 |
69.5 to 90.4 |
90 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
76.8 |
66.2 to 84.9 |
156 |
| HPV |
>=1 Dose, Females |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
85.6 |
80.8 to 89.3 |
467 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
75.2 |
64.3 to 83.6 |
141 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
89.4 |
80.9 to 94.4 |
143 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
80.4 |
73.8 to 85.7 |
281 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
88.3 |
80.4 to 93.3 |
131 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
71.9 |
61.5 to 80.4 |
110 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
77.9 |
67.6 to 85.6 |
137 |
| HPV |
>=1 Dose, Females |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
66.9 |
55.8 to 76.5 |
134 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
1.4 |
1.1 to 1.8 |
10037 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
1.1 |
0.6 to 1.9 |
1149 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
3.4 |
1.9 to 6.0 |
1563 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
8.4 |
5.0 to 14.0 |
225 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
13.0 |
8.7 to 19.1 |
313 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
13.6 |
7.8 to 22.7 |
211 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
17.3 |
11.9 to 24.5 |
230 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
11.6 |
7.4 to 17.9 |
239 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
7.3 |
4.3 to 12.1 |
210 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
11.7 |
7.3 to 18.3 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
6.2 |
3.8 to 9.9 |
444 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
15.8 |
10.4 to 23.3 |
259 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
14.0 |
8.8 to 21.4 |
261 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
14.2 |
7.8 to 24.3 |
194 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
11.3 |
7.2 to 17.1 |
222 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
6.4 |
4.1 to 9.7 |
441 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
10.1 |
6.6 to 15.1 |
226 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
8.9 |
5.1 to 15.1 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
8.5 |
5.5 to 12.9 |
445 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
19.0 |
13.2 to 26.6 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
7.2 |
4.1 to 12.3 |
246 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
8.3 |
7.4 to 9.3 |
12328 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
9.2 |
7.0 to 12.1 |
1256 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
6.0 |
4.2 to 8.5 |
654 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
9.2 |
7.1 to 11.8 |
1615 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
6.7 |
5.1 to 8.7 |
1666 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
5.8 |
4.2 to 8.0 |
1462 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
10.4 |
8.2 to 13.1 |
2031 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
6.2 |
4.3 to 8.9 |
796 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
8.9 |
5.9 to 13.2 |
1152 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
12.0 |
8.5 to 16.8 |
946 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
24.6 |
18.5 to 31.9 |
246 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
10.4 |
7.5 to 14.2 |
1167 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
12.1 |
7.4 to 19.3 |
235 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
14.5 |
9.4 to 21.6 |
240 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
12.9 |
8.1 to 20.0 |
245 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
27.6 |
20.2 to 36.5 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
8.7 |
5.2 to 14.2 |
261 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
8.0 |
5.4 to 11.5 |
750 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
8.9 |
5.1 to 15.2 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
6.9 |
4.2 to 11.2 |
224 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
17.8 |
10.3 to 29.1 |
171 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
14.1 |
9.4 to 20.7 |
195 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
19.7 |
13.6 to 27.7 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
12.7 |
7.5 to 20.9 |
166 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
29.4 |
22.5 to 37.3 |
228 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
31.3 |
20.2 to 45.0 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
20.3 |
14.4 to 27.8 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
26.2 |
19.4 to 34.4 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
33.8 |
24.9 to 44.1 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
21.4 |
13.5 to 32.1 |
175 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
19.5 |
12.3 to 29.4 |
172 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
43.1 |
33.8 to 52.9 |
190 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
16.2 |
10.0 to 25.2 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
24.3 |
17.3 to 32.8 |
324 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
40.2 |
30.3 to 50.9 |
144 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
20.5 |
12.6 to 31.4 |
180 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
17.2 |
10.9 to 25.9 |
187 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
19.4 |
12.7 to 28.4 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
13.5 |
8.0 to 22.0 |
183 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
20.6 |
13.6 to 29.9 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
25.3 |
18.3 to 34.0 |
157 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
20.2 |
13.7 to 28.7 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
25.5 |
18.4 to 34.1 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
13.1 |
7.6 to 21.6 |
197 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
15.2 |
9.1 to 24.5 |
158 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
20.9 |
13.2 to 31.6 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
21.7 |
13.4 to 33.2 |
142 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
16.8 |
10.9 to 25.0 |
175 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
19.6 |
13.6 to 27.3 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
11.6 |
7.1 to 18.3 |
170 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
20.5 |
14.2 to 28.7 |
157 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
19.8 |
13.1 to 28.9 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
20.2 |
13.3 to 29.6 |
172 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
17.9 |
13.4 to 23.6 |
324 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
27.3 |
18.9 to 37.7 |
154 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
12.1 |
7.6 to 18.7 |
170 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
18.8 |
12.7 to 26.8 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
18.6 |
12.3 to 27.2 |
173 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
15.2 |
9.7 to 23.2 |
168 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
24.4 |
17.6 to 32.8 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
14.5 |
9.5 to 21.4 |
221 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
21.9 |
16.5 to 28.4 |
404 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
46.7 |
37.1 to 56.6 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
18.8 |
13.1 to 26.2 |
222 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
20.8 |
19.4 to 22.4 |
10141 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
25.7 |
21.8 to 30.1 |
1016 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
18.6 |
14.6 to 23.3 |
509 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
18.9 |
15.8 to 22.6 |
1276 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
19.2 |
15.9 to 23.1 |
1382 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
17.7 |
14.8 to 21.1 |
1208 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
22.6 |
19.2 to 26.5 |
1473 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
19.1 |
14.7 to 24.6 |
681 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
21.3 |
15.6 to 28.3 |
1028 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
27.4 |
21.9 to 33.8 |
770 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
55.2 |
45.9 to 64.1 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
18.1 |
10.9 to 28.7 |
157 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
19.8 |
12.8 to 29.3 |
163 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
20.3 |
12.9 to 30.5 |
183 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
24.0 |
19.3 to 29.4 |
796 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
16.6 |
9.8 to 26.6 |
170 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
38.0 |
28.5 to 48.5 |
204 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
23.3 |
18.1 to 29.6 |
422 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
10.5 |
6.7 to 15.9 |
285 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
14.9 |
11.5 to 19.1 |
798 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
25.7 |
18.3 to 34.7 |
164 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
12.1 |
7.4 to 19.1 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
14.9 |
9.7 to 22.2 |
198 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
18.3 |
11.2 to 28.3 |
148 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
19.3 |
12.5 to 28.5 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
11.2 |
7.2 to 17.1 |
180 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
18.4 |
12.5 to 26.4 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
27.6 |
20.4 to 36.2 |
162 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
44.4 |
35.9 to 53.3 |
188 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
17.7 |
11.4 to 26.4 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
50.9 |
41.3 to 60.4 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
33.5 |
25.5 to 42.5 |
168 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
52.3 |
43.1 to 61.3 |
171 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
37.1 |
29.1 to 45.9 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
67.7 |
52.6 to 79.8 |
108 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
27.8 |
20.0 to 37.2 |
166 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
40.5 |
29.7 to 52.3 |
121 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
21.8 |
15.7 to 29.6 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
39.7 |
31.2 to 48.8 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
34.5 |
25.1 to 45.2 |
148 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
34.8 |
27.7 to 42.7 |
290 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
50.0 |
38.5 to 61.5 |
115 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
31.4 |
23.3 to 40.8 |
175 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
18.2 |
12.8 to 25.3 |
187 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
30.3 |
22.9 to 38.8 |
200 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
25.1 |
17.5 to 34.6 |
154 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
19.0 |
12.6 to 27.5 |
151 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
27.0 |
19.7 to 35.8 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
42.2 |
33.9 to 50.9 |
181 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
34.2 |
24.9 to 45.0 |
172 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
52.8 |
44.6 to 60.9 |
210 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
30.0 |
22.6 to 38.6 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
22.0 |
16.0 to 29.4 |
202 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
13.6 |
8.2 to 21.6 |
136 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
20.5 |
13.8 to 29.2 |
145 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
23.8 |
16.6 to 32.8 |
171 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
38.2 |
29.9 to 47.2 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
31.9 |
24.0 to 40.9 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
41.4 |
33.4 to 50.0 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
32.4 |
24.2 to 41.9 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
31.4 |
24.4 to 39.4 |
191 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
38.6 |
32.7 to 44.9 |
366 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
46.2 |
36.9 to 55.9 |
146 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
33.8 |
26.4 to 42.0 |
220 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
33.2 |
25.1 to 42.5 |
157 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
36.1 |
27.5 to 45.6 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
26.5 |
19.1 to 35.5 |
163 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
45.2 |
37.9 to 52.7 |
242 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
35.8 |
28.2 to 44.3 |
200 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
44.1 |
36.5 to 52.0 |
372 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
55.8 |
46.0 to 65.2 |
148 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
42.7 |
34.3 to 51.5 |
224 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
34.6 |
32.7 to 36.5 |
9554 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
51.4 |
46.8 to 55.9 |
1072 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
36.6 |
31.7 to 41.8 |
531 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
36.5 |
31.7 to 41.6 |
1140 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
28.4 |
24.8 to 32.4 |
1209 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
28.3 |
25.0 to 31.7 |
1188 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
33.1 |
28.7 to 37.8 |
1346 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
26.0 |
21.8 to 30.6 |
659 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
24.3 |
20.2 to 29.0 |
994 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
48.7 |
41.0 to 56.4 |
708 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
69.3 |
60.2 to 77.1 |
168 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
22.2 |
14.5 to 32.5 |
151 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
22.1 |
15.8 to 30.0 |
151 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
28.9 |
21.4 to 37.7 |
162 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
34.1 |
28.0 to 40.8 |
598 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
32.4 |
24.4 to 41.7 |
162 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
40.3 |
31.0 to 50.4 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
33.7 |
26.8 to 41.5 |
277 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
17.2 |
11.5 to 24.9 |
176 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
32.0 |
27.2 to 37.2 |
707 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
11.0 |
6.4 to 18.3 |
150 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
41.3 |
32.8 to 50.3 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
26.4 |
17.2 to 38.2 |
147 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
29.8 |
22.4 to 38.4 |
197 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
29.4 |
21.7 to 38.5 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
31.7 |
23.8 to 40.8 |
170 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
16.6 |
11.4 to 23.6 |
178 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
27.6 |
21.0 to 35.4 |
206 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
37.9 |
29.7 to 46.8 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
40.6 |
32.7 to 49.1 |
227 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
35.1 |
26.8 to 44.4 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
52.1 |
42.8 to 61.3 |
190 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
40.7 |
32.8 to 49.1 |
205 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
50.3 |
41.3 to 59.2 |
201 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
54.6 |
45.0 to 63.9 |
194 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
68.1 |
58.0 to 76.8 |
143 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
41.0 |
31.4 to 51.3 |
190 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
41.2 |
32.5 to 50.4 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
56.5 |
47.7 to 64.8 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
32.0 |
24.0 to 41.2 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
44.7 |
38.2 to 51.3 |
360 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
64.9 |
54.4 to 74.2 |
133 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
40.0 |
32.7 to 47.8 |
227 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
23.2 |
17.0 to 30.8 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
30.2 |
22.2 to 39.7 |
171 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
32.8 |
24.9 to 41.9 |
194 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
23.7 |
16.6 to 32.7 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
44.7 |
35.8 to 54.0 |
167 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
53.1 |
44.1 to 61.9 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
46.9 |
37.4 to 56.5 |
217 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
54.3 |
45.7 to 62.6 |
195 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
39.8 |
30.8 to 49.6 |
158 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
43.9 |
34.4 to 53.9 |
152 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
26.5 |
19.3 to 35.3 |
196 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
27.9 |
20.3 to 37.1 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
33.3 |
24.9 to 43.1 |
170 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
39.5 |
30.8 to 48.9 |
167 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
43.4 |
34.7 to 52.5 |
167 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
56.1 |
48.2 to 63.7 |
221 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
35.5 |
26.7 to 45.3 |
183 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
42.8 |
33.9 to 52.2 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
49.8 |
43.0 to 56.6 |
311 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
56.6 |
46.6 to 66.0 |
144 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
45.5 |
36.6 to 54.7 |
167 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
45.2 |
36.6 to 54.1 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
37.6 |
29.1 to 46.9 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
36.8 |
29.1 to 45.2 |
228 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
43.2 |
34.6 to 52.2 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
36.9 |
29.0 to 45.6 |
206 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
47.4 |
39.6 to 55.3 |
405 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
62.8 |
53.3 to 71.4 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
45.4 |
36.8 to 54.3 |
219 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
54.3 |
41.8 to 66.3 |
123 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
41.7 |
39.9 to 43.6 |
10743 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
54.1 |
49.4 to 58.8 |
1198 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
45.1 |
39.6 to 50.7 |
494 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
44.4 |
39.6 to 49.4 |
1331 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
36.7 |
32.9 to 40.7 |
1510 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
39.6 |
36.2 to 43.2 |
1259 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
38.2 |
33.7 to 43.0 |
1573 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
31.0 |
26.6 to 35.9 |
717 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
35.2 |
30.9 to 39.9 |
1137 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
50.2 |
42.8 to 57.5 |
761 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
69.0 |
61.1 to 75.9 |
220 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
29.4 |
21.6 to 38.5 |
187 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
34.4 |
25.9 to 44.0 |
181 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
30.5 |
22.7 to 39.5 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
36.6 |
30.4 to 43.2 |
859 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
35.6 |
27.4 to 44.9 |
206 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
53.7 |
43.8 to 63.4 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
54.2 |
43.9 to 64.2 |
208 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
34.4 |
27.3 to 42.3 |
263 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
45.0 |
39.7 to 50.5 |
763 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
28.6 |
21.3 to 37.2 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
50.5 |
41.3 to 59.7 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
36.3 |
26.6 to 47.3 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
53.8 |
44.9 to 62.4 |
195 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
42.7 |
34.1 to 51.7 |
188 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
49.3 |
40.0 to 58.6 |
175 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
29.3 |
22.5 to 37.2 |
223 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
39.4 |
31.2 to 48.3 |
196 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
41.6 |
33.4 to 50.3 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
51.3 |
43.1 to 59.4 |
229 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
44.2 |
36.3 to 52.4 |
200 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
58.5 |
48.5 to 67.9 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
63.2 |
54.5 to 71.1 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
65.3 |
57.1 to 72.7 |
203 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
62.9 |
55.0 to 70.2 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
73.0 |
64.5 to 80.0 |
219 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
45.3 |
35.7 to 55.2 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
51.0 |
42.5 to 59.4 |
202 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
52.2 |
44.4 to 59.9 |
227 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
62.5 |
54.2 to 70.2 |
178 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
44.2 |
35.5 to 53.2 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
44.3 |
38.1 to 50.7 |
378 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
68.1 |
58.5 to 76.3 |
136 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
39.1 |
32.0 to 46.7 |
242 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
43.2 |
34.6 to 52.4 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
48.0 |
39.5 to 56.7 |
193 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
36.0 |
28.3 to 44.4 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
34.8 |
27.0 to 43.4 |
168 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
49.5 |
41.7 to 57.4 |
219 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
65.8 |
57.5 to 73.2 |
188 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
55.0 |
45.5 to 64.1 |
200 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
63.0 |
53.8 to 71.3 |
180 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
52.3 |
43.9 to 60.4 |
205 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
57.1 |
48.3 to 65.4 |
187 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
38.9 |
30.4 to 48.0 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
44.7 |
35.2 to 54.5 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
46.0 |
38.2 to 54.1 |
214 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
54.3 |
46.4 to 62.0 |
209 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
44.5 |
36.0 to 53.4 |
196 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
69.8 |
61.4 to 77.1 |
158 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
50.9 |
42.1 to 59.6 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
54.3 |
45.7 to 62.5 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
60.3 |
54.1 to 66.2 |
367 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
72.3 |
64.3 to 79.1 |
171 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
52.6 |
44.1 to 60.9 |
196 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
48.0 |
39.5 to 56.7 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
62.3 |
53.1 to 70.7 |
164 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
43.7 |
35.0 to 52.8 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
52.9 |
44.0 to 61.6 |
162 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
58.6 |
49.9 to 66.7 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
55.9 |
48.7 to 62.9 |
435 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
79.5 |
71.5 to 85.7 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
52.8 |
44.8 to 60.6 |
270 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
68.1 |
59.0 to 76.0 |
181 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
49.8 |
48.0 to 51.6 |
11367 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
65.8 |
61.0 to 70.2 |
1162 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
57.2 |
52.1 to 62.2 |
553 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
51.1 |
46.4 to 55.8 |
1447 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
43.7 |
39.9 to 47.5 |
1418 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
47.1 |
43.7 to 50.6 |
1311 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
44.1 |
40.6 to 47.7 |
2086 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
44.8 |
39.9 to 49.9 |
760 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
52.0 |
47.2 to 56.8 |
1094 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
56.8 |
49.0 to 64.3 |
779 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
80.6 |
74.1 to 85.8 |
218 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
35.1 |
27.4 to 43.8 |
188 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
39.2 |
31.1 to 47.9 |
187 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
38.2 |
29.7 to 47.4 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
41.4 |
36.7 to 46.2 |
1323 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
40.3 |
31.7 to 49.5 |
170 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
58.6 |
48.8 to 67.8 |
143 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
60.7 |
53.3 to 67.7 |
282 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
38.7 |
33.1 to 44.6 |
493 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
35.5 |
28.8 to 42.8 |
236 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
49.5 |
44.5 to 54.5 |
757 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
40.9 |
32.4 to 49.9 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
66.1 |
58.1 to 73.3 |
215 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
40.1 |
30.1 to 51.0 |
214 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
46.8 |
38.9 to 54.8 |
208 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
45.3 |
37.1 to 53.8 |
180 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
46.4 |
38.4 to 54.5 |
194 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
37.1 |
28.8 to 46.2 |
169 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
49.2 |
40.5 to 58.1 |
180 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
60.3 |
51.7 to 68.4 |
209 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
60.9 |
51.6 to 69.5 |
175 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
55.4 |
47.3 to 63.3 |
203 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
67.3 |
58.4 to 75.2 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
58.8 |
49.2 to 67.8 |
168 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
55.8 |
46.6 to 64.6 |
166 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
63.3 |
54.7 to 71.1 |
195 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
77.7 |
69.5 to 84.3 |
196 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
53.5 |
44.4 to 62.5 |
195 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
58.0 |
48.5 to 67.0 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
58.5 |
51.4 to 65.3 |
293 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
58.3 |
49.2 to 66.8 |
168 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
54.7 |
46.0 to 63.1 |
192 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
58.7 |
51.8 to 65.3 |
312 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
66.8 |
52.0 to 79.0 |
81 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
56.9 |
49.2 to 64.4 |
231 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
36.9 |
29.0 to 45.5 |
193 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
57.2 |
48.9 to 65.1 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
41.7 |
32.9 to 51.0 |
166 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
41.6 |
33.2 to 50.5 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
51.5 |
43.1 to 59.9 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
67.1 |
58.4 to 74.8 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
60.2 |
51.0 to 68.7 |
238 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
65.5 |
57.1 to 72.9 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
52.5 |
42.6 to 62.2 |
139 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
60.1 |
51.6 to 68.0 |
201 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
43.6 |
35.1 to 52.4 |
209 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
48.3 |
39.1 to 57.5 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
43.0 |
34.5 to 51.9 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
58.3 |
49.3 to 66.8 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
65.1 |
55.9 to 73.3 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
69.3 |
60.1 to 77.1 |
152 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
51.2 |
42.7 to 59.7 |
201 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
57.9 |
49.3 to 66.1 |
203 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
68.2 |
62.1 to 73.8 |
356 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
71.9 |
62.9 to 79.5 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
65.9 |
57.6 to 73.3 |
201 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
57.1 |
47.8 to 66.0 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
66.9 |
57.9 to 74.7 |
163 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
55.0 |
45.2 to 64.3 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
50.3 |
40.3 to 60.2 |
154 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
60.9 |
52.1 to 69.0 |
170 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
57.2 |
49.9 to 64.1 |
485 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
73.7 |
65.7 to 80.3 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
54.9 |
46.8 to 62.8 |
286 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
71.1 |
62.9 to 78.1 |
208 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
56.0 |
54.3 to 57.7 |
10814 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
65.1 |
60.5 to 69.5 |
1080 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
62.7 |
57.6 to 67.4 |
557 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
57.6 |
53.0 to 62.0 |
1522 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
52.3 |
48.5 to 56.0 |
1438 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
53.7 |
49.9 to 57.4 |
1188 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
47.0 |
43.3 to 50.8 |
1778 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
50.2 |
45.3 to 55.1 |
730 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
50.9 |
45.7 to 56.1 |
1069 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
66.1 |
59.1 to 72.5 |
688 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
87.8 |
81.7 to 92.1 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
38.2 |
29.7 to 47.5 |
169 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
50.4 |
41.5 to 59.3 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
55.3 |
46.1 to 64.3 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
44.3 |
39.4 to 49.4 |
1036 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
48.5 |
39.7 to 57.4 |
178 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
65.9 |
54.2 to 75.9 |
131 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
42.7 |
33.4 to 52.5 |
153 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
81.1 |
73.0 to 87.2 |
173 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
40.6 |
34.2 to 47.2 |
401 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
40.1 |
32.5 to 48.1 |
227 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
58.9 |
53.5 to 64.1 |
764 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
40.9 |
32.4 to 50.1 |
163 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
69.5 |
61.8 to 76.3 |
209 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
56.4 |
46.2 to 66.0 |
242 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
58.9 |
49.9 to 67.3 |
193 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
50.0 |
40.9 to 59.2 |
166 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
56.0 |
47.3 to 64.4 |
183 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
36.9 |
29.2 to 45.3 |
205 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
55.1 |
46.4 to 63.5 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
67.6 |
59.4 to 74.9 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
61.4 |
52.1 to 69.9 |
173 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
55.7 |
47.2 to 64.0 |
206 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
68.2 |
59.3 to 76.0 |
171 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
69.8 |
61.4 to 77.1 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
67.3 |
58.3 to 75.2 |
187 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
74.5 |
66.1 to 81.5 |
189 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
92.1 |
86.4 to 95.5 |
153 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
57.2 |
47.8 to 66.1 |
222 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
64.2 |
54.4 to 72.9 |
173 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
65.7 |
57.3 to 73.2 |
197 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
60.6 |
51.5 to 69.0 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
56.7 |
47.6 to 65.3 |
191 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
69.6 |
63.6 to 75.0 |
373 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
78.8 |
66.1 to 87.6 |
109 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
67.7 |
60.9 to 73.9 |
264 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
51.0 |
42.3 to 59.6 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
63.2 |
55.0 to 70.7 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
49.8 |
41.3 to 58.2 |
188 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
44.4 |
36.3 to 52.8 |
203 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
64.6 |
56.4 to 72.0 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
72.2 |
63.9 to 79.2 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
65.4 |
55.1 to 74.5 |
249 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
78.5 |
71.0 to 84.4 |
221 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
63.8 |
54.6 to 72.2 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
70.1 |
61.6 to 77.4 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
43.6 |
35.3 to 52.2 |
188 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
53.1 |
43.8 to 62.1 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
66.4 |
57.5 to 74.2 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
70.0 |
61.6 to 77.3 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
59.3 |
50.0 to 68.0 |
180 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
73.3 |
64.7 to 80.4 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
60.3 |
51.8 to 68.1 |
197 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
60.3 |
51.9 to 68.1 |
202 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
66.0 |
59.8 to 71.7 |
359 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
64.5 |
55.0 to 73.0 |
148 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
66.9 |
58.6 to 74.2 |
211 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
66.8 |
58.2 to 74.4 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
70.4 |
62.4 to 77.3 |
204 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
58.8 |
50.8 to 66.5 |
202 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
60.9 |
52.0 to 69.1 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
72.3 |
63.8 to 79.3 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
65.6 |
58.5 to 72.0 |
458 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
85.2 |
78.2 to 90.2 |
188 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
63.0 |
55.1 to 70.2 |
270 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
62.6 |
60.9 to 64.2 |
11104 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
75.1 |
70.9 to 78.8 |
1118 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
64.1 |
59.1 to 68.8 |
556 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
66.5 |
61.9 to 70.8 |
1471 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
57.6 |
53.8 to 61.3 |
1489 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
63.3 |
59.9 to 66.5 |
1274 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
57.0 |
53.4 to 60.5 |
1968 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
57.0 |
52.1 to 61.7 |
716 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
62.9 |
58.3 to 67.3 |
1126 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
66.6 |
59.6 to 72.9 |
684 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
88.7 |
80.5 to 93.7 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
59.3 |
49.9 to 68.1 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
58.8 |
49.8 to 67.2 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
49.6 |
40.2 to 59.2 |
170 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
55.2 |
50.5 to 59.9 |
1193 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
57.1 |
48.2 to 65.5 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
72.4 |
59.9 to 82.1 |
105 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
45.2 |
35.1 to 55.7 |
140 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
80.9 |
72.8 to 87.0 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
62.6 |
53.5 to 70.9 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
53.2 |
46.9 to 59.4 |
452 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
69.2 |
64.0 to 73.9 |
702 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
54.7 |
46.2 to 62.9 |
193 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
73.9 |
65.6 to 80.7 |
192 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
69.0 |
58.3 to 78.0 |
232 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
71.2 |
62.4 to 78.6 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
54.7 |
46.0 to 63.0 |
190 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
65.1 |
56.4 to 73.0 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
44.1 |
35.8 to 52.8 |
191 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
60.4 |
50.9 to 69.1 |
172 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
67.1 |
59.2 to 74.1 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
69.1 |
60.1 to 76.8 |
153 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
56.0 |
46.4 to 65.1 |
153 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
78.4 |
69.2 to 85.5 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
81.9 |
73.0 to 88.3 |
147 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
70.8 |
61.0 to 79.0 |
154 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
70.7 |
60.7 to 79.0 |
149 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
88.9 |
79.5 to 94.3 |
149 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
62.3 |
52.8 to 71.0 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
65.6 |
56.5 to 73.7 |
178 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
66.1 |
56.2 to 74.8 |
150 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
76.1 |
67.2 to 83.1 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
59.8 |
50.1 to 68.8 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
65.8 |
59.6 to 71.5 |
362 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
82.9 |
68.8 to 91.4 |
94 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
62.3 |
55.2 to 68.8 |
268 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
63.3 |
54.7 to 71.1 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
68.4 |
58.7 to 76.7 |
148 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
64.0 |
54.9 to 72.2 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
55.2 |
45.6 to 64.4 |
140 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
64.0 |
54.4 to 72.7 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
61.4 |
51.6 to 70.4 |
157 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
73.1 |
63.7 to 80.8 |
208 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
87.6 |
79.3 to 92.9 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
68.6 |
59.5 to 76.6 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
68.8 |
58.5 to 77.6 |
154 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
44.7 |
35.5 to 54.2 |
149 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
56.4 |
47.1 to 65.3 |
175 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
66.2 |
56.7 to 74.5 |
144 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
70.9 |
61.1 to 79.0 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
66.0 |
57.3 to 73.7 |
172 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
75.1 |
65.2 to 82.9 |
152 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
61.3 |
51.6 to 70.2 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
72.8 |
64.4 to 79.8 |
156 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
67.2 |
59.9 to 73.7 |
299 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
74.1 |
64.5 to 81.8 |
139 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
62.8 |
52.7 to 71.9 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
65.2 |
55.7 to 73.7 |
180 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
70.7 |
60.9 to 78.9 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
66.9 |
57.9 to 74.9 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
52.3 |
44.0 to 60.4 |
203 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
70.7 |
60.4 to 79.2 |
146 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
68.3 |
58.7 to 76.6 |
335 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
93.1 |
86.8 to 96.5 |
122 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
65.1 |
54.4 to 74.5 |
213 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
66.3 |
64.6 to 68.0 |
9772 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
79.6 |
75.2 to 83.4 |
1007 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
65.2 |
59.5 to 70.6 |
473 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
67.6 |
61.9 to 72.8 |
1182 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
61.9 |
58.1 to 65.6 |
1302 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
66.7 |
63.3 to 70.0 |
1188 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
56.9 |
53.1 to 60.6 |
1782 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
62.7 |
57.7 to 67.5 |
643 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
69.7 |
64.8 to 74.2 |
901 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
76.3 |
69.2 to 82.2 |
661 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
91.5 |
84.1 to 95.6 |
181 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
60.7 |
51.3 to 69.4 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
70.8 |
62.4 to 78.0 |
171 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
63.7 |
54.2 to 72.2 |
147 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
55.5 |
50.5 to 60.3 |
1110 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
59.7 |
49.7 to 69.0 |
147 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
63.6 |
51.5 to 74.3 |
101 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
63.5 |
53.1 to 72.7 |
170 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
61.7 |
52.8 to 69.9 |
194 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
53.3 |
47.0 to 59.6 |
498 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
67.6 |
61.3 to 73.3 |
633 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
57.2 |
47.8 to 66.2 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
73.9 |
66.0 to 80.5 |
178 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
64.0 |
50.7 to 75.4 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
68.2 |
57.3 to 77.4 |
133 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
53.7 |
45.2 to 61.9 |
181 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
67.1 |
58.8 to 74.4 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
40.7 |
31.1 to 51.0 |
124 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
61.6 |
51.5 to 70.9 |
153 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
68.1 |
60.3 to 75.0 |
218 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
73.0 |
63.2 to 81.0 |
146 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
64.9 |
56.0 to 72.9 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
77.8 |
65.6 to 86.5 |
148 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
75.6 |
64.9 to 83.8 |
153 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
72.0 |
62.5 to 79.9 |
166 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
75.2 |
66.8 to 82.1 |
163 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
89.6 |
81.1 to 94.6 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
64.4 |
52.3 to 74.9 |
171 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
63.4 |
53.5 to 72.3 |
154 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
65.8 |
55.8 to 74.6 |
139 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
82.4 |
74.2 to 88.4 |
157 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
60.5 |
50.3 to 69.8 |
177 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
71.3 |
64.7 to 77.1 |
328 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
81.5 |
68.5 to 89.9 |
86 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
69.2 |
61.6 to 75.9 |
242 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
65.2 |
56.1 to 73.3 |
163 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
76.0 |
67.4 to 82.8 |
148 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
70.0 |
61.4 to 77.3 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
69.3 |
60.1 to 77.2 |
148 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
71.4 |
61.3 to 79.8 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
65.2 |
55.7 to 73.7 |
162 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
79.4 |
70.9 to 86.0 |
263 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
86.0 |
77.0 to 91.9 |
154 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
75.2 |
66.5 to 82.2 |
146 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
71.9 |
60.6 to 81.1 |
147 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
43.1 |
33.2 to 53.5 |
144 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
64.1 |
53.8 to 73.3 |
148 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
57.6 |
48.0 to 66.7 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
73.9 |
63.5 to 82.2 |
153 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
69.4 |
59.4 to 77.9 |
156 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
70.4 |
60.2 to 79.0 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
62.8 |
52.7 to 71.8 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
81.7 |
74.7 to 87.2 |
205 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
68.2 |
60.1 to 75.4 |
259 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
74.2 |
63.0 to 82.9 |
134 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
64.5 |
53.1 to 74.5 |
125 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
68.9 |
59.0 to 77.4 |
162 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
89.5 |
82.6 to 93.8 |
167 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
66.0 |
56.7 to 74.1 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
60.7 |
52.2 to 68.6 |
201 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
75.3 |
65.3 to 83.2 |
136 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
75.2 |
68.0 to 81.3 |
383 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
88.7 |
78.6 to 94.4 |
134 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
73.4 |
65.3 to 80.2 |
249 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
79.8 |
65.1 to 89.3 |
109 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
69.8 |
67.9 to 71.7 |
9872 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
79.3 |
74.6 to 83.2 |
1084 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
66.4 |
60.1 to 72.2 |
424 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
76.6 |
72.2 to 80.4 |
1344 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
63.3 |
58.8 to 67.5 |
1235 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
69.6 |
66.1 to 72.9 |
1125 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
66.6 |
63.0 to 70.1 |
1712 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
69.4 |
64.2 to 74.1 |
648 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
70.0 |
64.4 to 75.1 |
1005 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
76.7 |
67.5 to 83.9 |
607 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
90.5 |
84.5 to 94.4 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
68.0 |
58.7 to 76.0 |
168 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
75.3 |
67.0 to 82.1 |
189 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
54.3 |
44.0 to 64.2 |
135 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
65.9 |
61.0 to 70.4 |
953 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
68.8 |
59.4 to 76.9 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
75.8 |
62.5 to 85.5 |
87 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
67.6 |
57.9 to 76.1 |
143 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
82.3 |
73.9 to 88.5 |
138 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
63.7 |
57.3 to 69.6 |
430 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
45.9 |
34.0 to 58.4 |
107 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
69.5 |
63.3 to 75.1 |
688 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
63.0 |
52.5 to 72.3 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
78.3 |
71.1 to 84.1 |
244 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
78.9 |
68.4 to 86.6 |
188 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
69.1 |
58.4 to 78.0 |
157 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
62.0 |
53.5 to 69.9 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
66.4 |
57.7 to 74.2 |
176 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
55.2 |
46.3 to 63.8 |
178 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
64.3 |
55.1 to 72.5 |
163 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
70.7 |
60.6 to 79.1 |
157 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
71.4 |
63.1 to 78.6 |
180 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
69.1 |
59.8 to 77.1 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
73.3 |
64.2 to 80.8 |
219 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
81.9 |
74.0 to 87.7 |
187 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
82.0 |
74.3 to 87.8 |
172 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
79.4 |
70.6 to 86.0 |
198 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
89.4 |
81.0 to 94.4 |
215 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
68.1 |
58.4 to 76.4 |
193 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
68.1 |
58.2 to 76.7 |
166 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
61.0 |
51.3 to 69.8 |
157 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
86.4 |
78.6 to 91.7 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
69.4 |
60.2 to 77.3 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
75.0 |
68.4 to 80.5 |
367 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
86.7 |
76.9 to 92.8 |
129 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
72.5 |
64.8 to 79.1 |
238 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
66.7 |
57.5 to 74.8 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
68.5 |
59.4 to 76.4 |
151 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
60.4 |
51.9 to 68.4 |
201 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
68.5 |
58.3 to 77.2 |
127 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
73.5 |
64.7 to 80.8 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
75.9 |
68.6 to 82.0 |
207 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
78.8 |
72.3 to 84.0 |
429 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
89.7 |
84.0 to 93.5 |
193 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
75.9 |
68.1 to 82.2 |
219 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
80.1 |
72.2 to 86.3 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
59.2 |
49.1 to 68.6 |
142 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
68.8 |
60.0 to 76.4 |
222 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
68.6 |
58.8 to 77.0 |
152 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
82.9 |
76.0 to 88.1 |
221 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
65.7 |
56.0 to 74.3 |
183 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
81.8 |
74.3 to 87.5 |
198 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
71.2 |
62.4 to 78.6 |
208 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
74.7 |
66.5 to 81.5 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
77.2 |
71.2 to 82.2 |
387 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
79.8 |
70.4 to 86.7 |
201 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
75.5 |
67.5 to 82.1 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
78.4 |
68.6 to 85.8 |
169 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
76.9 |
68.4 to 83.7 |
203 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
77.7 |
69.1 to 84.4 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
67.6 |
58.8 to 75.4 |
173 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
77.1 |
69.3 to 83.4 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
79.8 |
71.9 to 85.9 |
371 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
82.9 |
72.6 to 89.9 |
138 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
79.4 |
70.4 to 86.1 |
233 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
76.0 |
61.6 to 86.2 |
102 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
73.1 |
71.5 to 74.8 |
10587 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
85.8 |
82.6 to 88.5 |
1132 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
75.2 |
70.3 to 79.5 |
595 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
76.0 |
71.8 to 79.7 |
1699 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
69.9 |
66.0 to 73.5 |
1295 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
75.1 |
71.9 to 78.1 |
1268 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
70.0 |
65.1 to 74.5 |
1282 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
69.0 |
64.4 to 73.2 |
795 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
74.9 |
70.2 to 79.1 |
1050 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
72.9 |
65.9 to 79.0 |
741 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
91.2 |
84.0 to 95.3 |
159 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
70.9 |
61.8 to 78.6 |
167 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
87.0 |
81.1 to 91.3 |
171 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
73.9 |
65.4 to 80.8 |
168 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
69.6 |
62.7 to 75.7 |
578 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
74.2 |
65.1 to 81.6 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
67.0 |
55.0 to 77.1 |
110 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
69.5 |
61.6 to 76.3 |
307 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
73.2 |
67.8 to 78.0 |
730 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
65.6 |
55.4 to 74.6 |
156 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
87.2 |
80.6 to 91.8 |
203 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
71.3 |
62.3 to 78.9 |
324 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
72.4 |
62.9 to 80.2 |
215 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
56.1 |
47.1 to 64.8 |
162 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
74.3 |
65.3 to 81.7 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
63.6 |
54.4 to 71.9 |
181 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
80.2 |
72.1 to 86.4 |
169 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
70.7 |
60.6 to 79.1 |
147 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
79.5 |
71.3 to 85.8 |
169 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
70.4 |
61.6 to 78.0 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
82.8 |
70.7 to 90.6 |
140 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
78.0 |
69.1 to 85.0 |
163 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
79.3 |
71.6 to 85.4 |
181 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
84.7 |
76.6 to 90.4 |
166 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
90.9 |
84.3 to 94.9 |
212 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
70.0 |
59.5 to 78.7 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
74.9 |
63.7 to 83.6 |
142 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
65.4 |
54.4 to 75.0 |
131 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
84.0 |
74.6 to 90.4 |
132 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
76.0 |
67.6 to 82.8 |
181 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
76.6 |
70.0 to 82.2 |
296 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
79.2 |
62.0 to 89.9 |
72 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
76.0 |
68.6 to 82.2 |
224 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
69.0 |
59.4 to 77.2 |
146 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
77.2 |
65.6 to 85.7 |
107 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
70.2 |
59.7 to 78.9 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
73.7 |
63.3 to 81.9 |
129 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
82.6 |
74.7 to 88.4 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
74.9 |
65.7 to 82.3 |
156 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
83.1 |
77.9 to 87.4 |
468 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
88.2 |
80.0 to 93.4 |
151 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
77.2 |
67.6 to 84.6 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
75.1 |
65.7 to 82.6 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
54.3 |
44.6 to 63.7 |
157 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
73.8 |
64.4 to 81.4 |
184 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
79.1 |
70.9 to 85.4 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
79.7 |
70.8 to 86.3 |
168 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
76.4 |
66.6 to 84.0 |
158 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
82.4 |
73.5 to 88.7 |
149 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
64.5 |
54.3 to 73.6 |
170 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
79.9 |
72.3 to 85.9 |
169 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
72.2 |
64.8 to 78.6 |
303 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
74.4 |
63.7 to 82.7 |
147 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
70.7 |
60.3 to 79.4 |
156 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
82.6 |
73.1 to 89.3 |
144 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
87.5 |
77.7 to 93.3 |
104 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
63.0 |
50.2 to 74.3 |
125 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
69.3 |
59.2 to 77.9 |
126 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
87.0 |
80.6 to 91.6 |
165 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
78.0 |
72.0 to 83.0 |
495 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
83.6 |
74.6 to 89.8 |
173 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
77.3 |
70.6 to 82.8 |
322 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
82.9 |
75.3 to 88.5 |
175 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
75.4 |
73.5 to 77.2 |
9579 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
84.1 |
80.0 to 87.5 |
1025 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
69.6 |
63.7 to 74.9 |
473 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
76.2 |
72.3 to 79.7 |
1792 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
74.3 |
70.2 to 77.9 |
1240 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
73.0 |
68.9 to 76.8 |
1069 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
71.1 |
66.0 to 75.8 |
1162 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
74.6 |
69.4 to 79.2 |
619 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
78.6 |
74.0 to 82.6 |
949 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
81.9 |
73.0 to 88.4 |
599 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
89.2 |
80.4 to 94.4 |
116 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
85.6 |
78.4 to 90.7 |
140 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
83.0 |
75.4 to 88.6 |
243 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
69.3 |
59.8 to 77.4 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
69.2 |
62.0 to 75.5 |
528 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
72.1 |
62.0 to 80.3 |
146 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
85.5 |
74.3 to 92.3 |
94 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
67.8 |
59.6 to 75.0 |
288 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
69.4 |
57.4 to 79.3 |
132 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
79.4 |
74.0 to 83.9 |
651 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
79.1 |
70.4 to 85.8 |
160 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
82.2 |
75.9 to 87.1 |
272 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
70.1 |
60.0 to 78.6 |
307 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
77.2 |
67.4 to 84.7 |
158 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
59.8 |
50.0 to 68.9 |
144 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
80.9 |
73.0 to 87.0 |
162 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
61.7 |
50.5 to 71.9 |
124 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
76.4 |
67.0 to 83.7 |
130 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
74.2 |
64.5 to 81.9 |
141 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
78.8 |
70.3 to 85.3 |
144 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
70.8 |
62.2 to 78.2 |
173 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
74.1 |
64.9 to 81.5 |
181 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
78.3 |
70.8 to 84.3 |
182 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
76.8 |
66.2 to 84.9 |
133 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
85.8 |
76.5 to 91.8 |
123 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
85.1 |
74.4 to 91.8 |
124 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
73.9 |
63.4 to 82.2 |
158 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
65.1 |
55.2 to 73.8 |
174 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
75.1 |
64.7 to 83.3 |
120 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
84.2 |
74.8 to 90.5 |
128 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
77.0 |
67.3 to 84.4 |
130 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
79.1 |
72.0 to 84.8 |
336 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
84.7 |
74.4 to 91.3 |
137 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
77.9 |
69.4 to 84.6 |
199 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
73.6 |
63.5 to 81.7 |
142 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
87.2 |
77.9 to 92.9 |
119 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
73.4 |
64.5 to 80.7 |
173 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
62.3 |
52.1 to 71.6 |
137 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
78.2 |
69.4 to 84.9 |
161 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
74.6 |
65.7 to 81.8 |
142 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
82.5 |
72.2 to 89.5 |
185 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
84.5 |
75.4 to 90.7 |
132 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
70.5 |
59.5 to 79.6 |
130 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
88.0 |
81.7 to 92.3 |
179 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
61.4 |
50.1 to 71.6 |
116 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
68.0 |
57.5 to 76.9 |
140 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
83.4 |
75.6 to 89.0 |
155 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
85.7 |
76.2 to 91.8 |
113 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
72.0 |
62.6 to 79.7 |
142 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
85.7 |
76.8 to 91.5 |
116 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
77.5 |
68.0 to 84.8 |
156 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
75.7 |
65.6 to 83.6 |
128 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
82.0 |
75.7 to 86.9 |
273 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
85.9 |
76.5 to 92.0 |
110 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
79.3 |
70.6 to 86.0 |
163 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
75.3 |
65.9 to 82.7 |
186 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
84.5 |
74.9 to 90.9 |
152 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
71.9 |
60.7 to 80.9 |
146 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
67.9 |
57.6 to 76.7 |
140 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
79.4 |
70.5 to 86.1 |
147 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
76.7 |
69.9 to 82.3 |
413 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
91.8 |
83.7 to 96.0 |
151 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
74.7 |
67.1 to 81.0 |
262 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
90.2 |
85.9 to 93.3 |
348 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
74.4 |
72.5 to 76.1 |
8420 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
82.7 |
77.9 to 86.6 |
817 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
80.4 |
75.4 to 84.7 |
429 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
77.2 |
73.3 to 80.7 |
1293 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
70.6 |
66.6 to 74.4 |
1173 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
76.6 |
72.7 to 80.1 |
1070 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
66.1 |
59.8 to 71.8 |
1029 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
76.0 |
70.6 to 80.6 |
545 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
76.4 |
71.7 to 80.5 |
902 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
74.9 |
67.7 to 80.9 |
595 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
95.8 |
88.8 to 98.5 |
146 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
64.5 |
53.9 to 73.9 |
134 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
82.8 |
74.3 to 89.0 |
123 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
73.9 |
63.5 to 82.1 |
138 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
63.0 |
54.3 to 70.9 |
427 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
66.0 |
54.1 to 76.2 |
132 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
79.8 |
66.0 to 88.9 |
67 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
61.6 |
51.7 to 70.6 |
228 |
| HPV |
>=1 Dose, Males |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
80.5 |
75.4 to 84.7 |
567 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
71.0 |
60.3 to 79.7 |
130 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
86.6 |
78.9 to 91.8 |
148 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
74.7 |
67.4 to 80.8 |
314 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
82.7 |
74.1 to 88.9 |
149 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
68.0 |
57.9 to 76.7 |
134 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
82.9 |
73.6 to 89.4 |
137 |
| HPV |
>=1 Dose, Males |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
64.1 |
53.9 to 73.2 |
160 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2006 |
Age |
13-15 Years |
12.6 |
10.8 to 14.7 |
1768 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2006 |
Age |
13-15 Years |
16.7 |
10.5 to 25.5 |
141 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2006 |
Age |
13-15 Years |
15.8 |
11.3 to 21.7 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2006 |
Age |
13-15 Years |
7.4 |
5.0 to 10.9 |
400 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2006 |
Age |
13-15 Years |
13.3 |
9.2 to 18.9 |
272 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2006 |
Age |
13-15 Years |
10.5 |
5.9 to 18.0 |
166 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2006 |
Age |
13-15 Years |
23.2 |
13.5 to 36.8 |
91 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2006 |
Age |
13-15 Years |
14.2 |
9.4 to 20.8 |
212 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2007 |
Age |
13-15 Years |
32.7 |
29.9 to 35.7 |
1787 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-15 Years |
35.8 |
25.9 to 47.0 |
113 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-15 Years |
43.9 |
33.8 to 54.4 |
135 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-15 Years |
42.5 |
33.8 to 51.7 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-15 Years |
29.2 |
22.8 to 36.5 |
291 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-15 Years |
32.6 |
26.9 to 38.9 |
377 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-15 Years |
27.5 |
20.3 to 36.0 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-15 Years |
30.8 |
20.9 to 42.9 |
95 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-15 Years |
26.2 |
16.2 to 39.4 |
72 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-15 Years |
31.3 |
23.5 to 40.2 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2007 |
Age |
13-15 Years |
27.0 |
17.0 to 40.0 |
76 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2008 |
Age |
13-15 Years |
36.9 |
29.9 to 44.5 |
252 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2008 |
Age |
13-15 Years |
31.6 |
24.8 to 39.3 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2008 |
Age |
13-15 Years |
54.2 |
45.0 to 63.1 |
159 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2008 |
Age |
13-15 Years |
20.3 |
14.9 to 27.1 |
240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2008 |
Age |
13-15 Years |
50.4 |
40.8 to 60.0 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2008 |
Age |
13-15 Years |
37.1 |
28.9 to 46.2 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2008 |
Age |
13-15 Years |
46.4 |
37.7 to 55.4 |
173 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2008 |
Age |
13-15 Years |
59.5 |
51.2 to 67.2 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-15 Years |
59.5 |
51.0 to 67.4 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2008 |
Age |
13-15 Years |
37.9 |
29.0 to 47.7 |
177 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2008 |
Age |
13-15 Years |
44.2 |
36.2 to 52.5 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2008 |
Age |
13-15 Years |
41.2 |
33.8 to 49.0 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2008 |
Age |
13-15 Years |
33.3 |
25.2 to 42.5 |
152 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2008 |
Age |
13-15 Years |
41.6 |
34.7 to 48.9 |
474 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-15 Years |
45.9 |
37.9 to 54.0 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-15 Years |
40.4 |
31.9 to 49.5 |
253 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2008 |
Age |
13-15 Years |
34.7 |
28.2 to 42.0 |
213 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2008 |
Age |
13-15 Years |
32.1 |
24.8 to 40.5 |
168 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2008 |
Age |
13-15 Years |
23.2 |
17.0 to 30.9 |
162 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2008 |
Age |
13-15 Years |
35.5 |
27.7 to 44.2 |
162 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2008 |
Age |
13-15 Years |
52.7 |
44.6 to 60.7 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2008 |
Age |
13-15 Years |
39.7 |
32.0 to 47.9 |
189 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2008 |
Age |
13-15 Years |
56.1 |
48.1 to 63.8 |
253 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-15 Years |
61.2 |
53.1 to 68.6 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2008 |
Age |
13-15 Years |
39.1 |
31.1 to 47.8 |
169 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2008 |
Age |
13-15 Years |
42.0 |
34.4 to 49.9 |
203 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2008 |
Age |
13-15 Years |
15.5 |
10.7 to 22.1 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2008 |
Age |
13-15 Years |
34.8 |
27.6 to 42.7 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2008 |
Age |
13-15 Years |
21.2 |
14.4 to 30.1 |
168 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2008 |
Age |
13-15 Years |
44.5 |
37.5 to 51.8 |
227 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2008 |
Age |
13-15 Years |
27.5 |
19.9 to 36.7 |
148 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-15 Years |
49.7 |
40.0 to 59.4 |
172 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2008 |
Age |
13-15 Years |
64.3 |
56.4 to 71.6 |
229 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2008 |
Age |
13-15 Years |
44.7 |
36.5 to 53.2 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2008 |
Age |
13-15 Years |
55.3 |
49.1 to 61.4 |
367 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-15 Years |
54.3 |
45.0 to 63.4 |
180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-15 Years |
56.1 |
47.7 to 64.1 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2008 |
Age |
13-15 Years |
36.0 |
28.7 to 44.0 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2008 |
Age |
13-15 Years |
50.8 |
43.3 to 58.2 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2008 |
Age |
13-15 Years |
42.7 |
34.8 to 51.1 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-15 Years |
29.6 |
22.8 to 37.4 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2008 |
Age |
13-15 Years |
30.7 |
23.2 to 39.5 |
144 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-15 Years |
59.1 |
52.0 to 65.8 |
406 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-15 Years |
67.3 |
59.2 to 74.6 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-15 Years |
57.8 |
49.7 to 65.5 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2008 |
Age |
13-15 Years |
43.9 |
42.0 to 45.7 |
10762 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-15 Years |
52.6 |
48.0 to 57.1 |
1094 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-15 Years |
58.1 |
53.2 to 62.9 |
596 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-15 Years |
55.0 |
50.8 to 59.1 |
1401 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-15 Years |
36.8 |
33.3 to 40.5 |
1695 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-15 Years |
41.7 |
38.4 to 45.1 |
1396 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-15 Years |
38.7 |
32.7 to 45.0 |
1345 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-15 Years |
33.2 |
29.2 to 37.6 |
783 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-15 Years |
33.2 |
28.7 to 38.1 |
1098 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-15 Years |
49.4 |
41.9 to 57.0 |
692 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-15 Years |
62.0 |
52.6 to 70.7 |
172 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2008 |
Age |
13-15 Years |
27.0 |
20.7 to 34.5 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2008 |
Age |
13-15 Years |
9.6 |
6.0 to 15.0 |
199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2008 |
Age |
13-15 Years |
41.9 |
34.0 to 50.2 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2008 |
Age |
13-15 Years |
38.9 |
30.4 to 48.1 |
513 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-15 Years |
42.9 |
34.3 to 51.9 |
173 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-15 Years |
50.5 |
38.8 to 62.2 |
136 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-15 Years |
37.6 |
27.9 to 48.3 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-15 Years |
35.1 |
30.2 to 40.2 |
662 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2008 |
Age |
13-15 Years |
32.9 |
25.1 to 41.9 |
144 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2008 |
Age |
13-15 Years |
19.8 |
14.0 to 27.3 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2008 |
Age |
13-15 Years |
52.0 |
43.1 to 60.7 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2008 |
Age |
13-15 Years |
38.4 |
30.6 to 46.8 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2008 |
Age |
13-15 Years |
30.1 |
23.0 to 38.4 |
182 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-15 Years |
52.9 |
44.0 to 61.7 |
147 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2008 |
Age |
13-15 Years |
34.8 |
27.4 to 43.0 |
169 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2009 |
Age |
13-15 Years |
42.1 |
34.2 to 50.5 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2009 |
Age |
13-15 Years |
34.6 |
27.4 to 42.5 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2009 |
Age |
13-15 Years |
70.7 |
62.2 to 77.9 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2009 |
Age |
13-15 Years |
21.2 |
15.6 to 28.2 |
228 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2009 |
Age |
13-15 Years |
61.9 |
54.0 to 69.2 |
238 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2009 |
Age |
13-15 Years |
50.8 |
42.8 to 58.7 |
250 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2009 |
Age |
13-15 Years |
67.6 |
59.2 to 75.0 |
214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2009 |
Age |
13-15 Years |
65.0 |
56.6 to 72.5 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-15 Years |
80.8 |
74.1 to 86.1 |
260 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2009 |
Age |
13-15 Years |
54.2 |
46.6 to 61.6 |
267 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2009 |
Age |
13-15 Years |
54.9 |
47.3 to 62.3 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2009 |
Age |
13-15 Years |
51.6 |
43.0 to 60.1 |
156 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2009 |
Age |
13-15 Years |
40.9 |
31.8 to 50.7 |
142 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2009 |
Age |
13-15 Years |
55.8 |
49.6 to 61.8 |
462 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-15 Years |
60.0 |
51.9 to 67.6 |
239 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-15 Years |
54.7 |
47.2 to 62.0 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2009 |
Age |
13-15 Years |
39.0 |
32.5 to 46.1 |
504 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2009 |
Age |
13-15 Years |
48.2 |
40.2 to 56.3 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2009 |
Age |
13-15 Years |
38.0 |
29.9 to 46.8 |
159 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2009 |
Age |
13-15 Years |
36.0 |
29.7 to 42.7 |
250 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2009 |
Age |
13-15 Years |
69.1 |
60.0 to 76.9 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2009 |
Age |
13-15 Years |
48.7 |
40.1 to 57.3 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2009 |
Age |
13-15 Years |
61.0 |
50.0 to 71.0 |
144 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-15 Years |
72.0 |
64.6 to 78.4 |
241 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2009 |
Age |
13-15 Years |
55.6 |
48.6 to 62.3 |
292 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2009 |
Age |
13-15 Years |
48.4 |
40.7 to 56.2 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2009 |
Age |
13-15 Years |
20.3 |
15.4 to 26.3 |
281 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2009 |
Age |
13-15 Years |
45.4 |
37.7 to 53.3 |
214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2009 |
Age |
13-15 Years |
28.0 |
21.2 to 35.8 |
176 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2009 |
Age |
13-15 Years |
64.4 |
55.9 to 72.2 |
162 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2009 |
Age |
13-15 Years |
39.8 |
32.3 to 47.7 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-15 Years |
66.3 |
58.1 to 73.7 |
182 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2009 |
Age |
13-15 Years |
75.2 |
67.7 to 81.5 |
238 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2009 |
Age |
13-15 Years |
52.3 |
45.1 to 59.4 |
252 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2009 |
Age |
13-15 Years |
63.4 |
56.7 to 69.7 |
335 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-15 Years |
61.0 |
51.4 to 69.7 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-15 Years |
65.5 |
56.0 to 74.0 |
147 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2009 |
Age |
13-15 Years |
42.9 |
34.9 to 51.3 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2009 |
Age |
13-15 Years |
73.9 |
65.5 to 80.9 |
154 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2009 |
Age |
13-15 Years |
55.9 |
47.7 to 63.7 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-15 Years |
35.7 |
28.7 to 43.3 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2009 |
Age |
13-15 Years |
45.0 |
38.2 to 52.1 |
246 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-15 Years |
68.2 |
60.0 to 75.3 |
373 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-15 Years |
76.1 |
69.2 to 81.8 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-15 Years |
66.8 |
57.3 to 75.1 |
157 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2009 |
Age |
13-15 Years |
54.8 |
53.2 to 56.4 |
12280 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-15 Years |
67.2 |
63.2 to 71.0 |
1314 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-15 Years |
67.0 |
61.8 to 71.8 |
573 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-15 Years |
59.9 |
55.4 to 64.2 |
1381 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-15 Years |
47.1 |
44.0 to 50.2 |
1846 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-15 Years |
52.8 |
49.7 to 55.9 |
1863 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-15 Years |
50.6 |
45.9 to 55.2 |
1794 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-15 Years |
46.9 |
42.5 to 51.3 |
727 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-15 Years |
46.1 |
41.8 to 50.5 |
1184 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-15 Years |
61.6 |
55.3 to 67.6 |
822 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-15 Years |
73.5 |
65.9 to 79.8 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2009 |
Age |
13-15 Years |
36.1 |
28.6 to 44.4 |
180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2009 |
Age |
13-15 Years |
24.2 |
17.6 to 32.3 |
159 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2009 |
Age |
13-15 Years |
54.5 |
46.4 to 62.4 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2009 |
Age |
13-15 Years |
52.0 |
45.3 to 58.6 |
915 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-15 Years |
55.3 |
46.0 to 64.2 |
202 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-15 Years |
71.0 |
60.6 to 79.6 |
141 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-15 Years |
49.3 |
40.2 to 58.4 |
176 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-15 Years |
73.9 |
66.3 to 80.3 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-15 Years |
49.4 |
40.8 to 58.1 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-15 Years |
22.1 |
15.9 to 29.8 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-15 Years |
50.9 |
46.1 to 55.6 |
776 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2009 |
Age |
13-15 Years |
44.6 |
36.9 to 52.5 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2009 |
Age |
13-15 Years |
43.9 |
36.9 to 51.1 |
258 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2009 |
Age |
13-15 Years |
49.8 |
42.4 to 57.3 |
235 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2009 |
Age |
13-15 Years |
58.0 |
50.3 to 65.4 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2009 |
Age |
13-15 Years |
36.3 |
28.5 to 45.0 |
154 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-15 Years |
54.1 |
46.0 to 62.0 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2009 |
Age |
13-15 Years |
53.4 |
46.1 to 60.6 |
227 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2010 |
Age |
13-15 Years |
45.0 |
37.2 to 53.1 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2010 |
Age |
13-15 Years |
41.4 |
33.5 to 49.9 |
176 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2010 |
Age |
13-15 Years |
87.3 |
81.1 to 91.6 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2010 |
Age |
13-15 Years |
32.0 |
24.7 to 40.3 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2010 |
Age |
13-15 Years |
69.4 |
61.7 to 76.1 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2010 |
Age |
13-15 Years |
58.5 |
50.3 to 66.3 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2010 |
Age |
13-15 Years |
68.9 |
61.2 to 75.7 |
242 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2010 |
Age |
13-15 Years |
74.6 |
66.6 to 81.2 |
199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-15 Years |
90.8 |
84.8 to 94.6 |
231 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2010 |
Age |
13-15 Years |
60.0 |
51.4 to 67.9 |
199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2010 |
Age |
13-15 Years |
70.6 |
63.5 to 76.8 |
236 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2010 |
Age |
13-15 Years |
64.2 |
56.6 to 71.1 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2010 |
Age |
13-15 Years |
42.9 |
35.5 to 50.6 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2010 |
Age |
13-15 Years |
52.6 |
46.2 to 58.8 |
454 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-15 Years |
66.9 |
59.0 to 73.9 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-15 Years |
49.1 |
41.6 to 56.7 |
228 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2010 |
Age |
13-15 Years |
72.7 |
64.3 to 79.8 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2010 |
Age |
13-15 Years |
52.9 |
44.6 to 61.1 |
169 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2010 |
Age |
13-15 Years |
54.0 |
46.7 to 61.1 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2010 |
Age |
13-15 Years |
48.4 |
40.8 to 56.0 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2010 |
Age |
13-15 Years |
80.2 |
73.3 to 85.6 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2010 |
Age |
13-15 Years |
60.1 |
52.1 to 67.6 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2010 |
Age |
13-15 Years |
70.9 |
62.1 to 78.4 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-15 Years |
83.8 |
75.8 to 89.5 |
193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2010 |
Age |
13-15 Years |
73.8 |
65.8 to 80.5 |
193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2010 |
Age |
13-15 Years |
54.9 |
46.5 to 63.0 |
180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2010 |
Age |
13-15 Years |
27.6 |
21.3 to 34.9 |
227 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2010 |
Age |
13-15 Years |
49.6 |
42.1 to 57.2 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2010 |
Age |
13-15 Years |
39.4 |
32.1 to 47.1 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2010 |
Age |
13-15 Years |
76.4 |
68.7 to 82.6 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2010 |
Age |
13-15 Years |
58.8 |
50.8 to 66.3 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-15 Years |
69.8 |
61.9 to 76.8 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2010 |
Age |
13-15 Years |
84.0 |
76.5 to 89.5 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2010 |
Age |
13-15 Years |
53.7 |
45.6 to 61.7 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2010 |
Age |
13-15 Years |
69.4 |
63.1 to 75.0 |
424 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-15 Years |
73.6 |
65.9 to 80.1 |
233 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-15 Years |
66.7 |
57.6 to 74.6 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2010 |
Age |
13-15 Years |
57.0 |
49.5 to 64.1 |
235 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2010 |
Age |
13-15 Years |
85.2 |
77.9 to 90.4 |
154 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2010 |
Age |
13-15 Years |
59.9 |
51.8 to 67.5 |
180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-15 Years |
46.1 |
37.8 to 54.5 |
168 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2010 |
Age |
13-15 Years |
54.8 |
46.3 to 63.0 |
180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-15 Years |
82.5 |
77.5 to 86.6 |
471 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-15 Years |
83.9 |
77.6 to 88.7 |
231 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-15 Years |
82.3 |
76.6 to 86.9 |
240 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2010 |
Age |
13-15 Years |
64.8 |
63.2 to 66.2 |
11774 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-15 Years |
75.4 |
71.5 to 79.0 |
1213 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-15 Years |
74.1 |
69.3 to 78.5 |
668 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-15 Years |
69.9 |
66.3 to 73.3 |
1486 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-15 Years |
55.9 |
52.7 to 59.1 |
1680 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-15 Years |
62.5 |
59.2 to 65.7 |
1361 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-15 Years |
67.3 |
63.2 to 71.1 |
1869 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-15 Years |
54.7 |
50.5 to 58.8 |
775 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-15 Years |
55.1 |
50.6 to 59.5 |
1126 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-15 Years |
70.9 |
64.8 to 76.4 |
821 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-15 Years |
82.5 |
75.3 to 87.9 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2010 |
Age |
13-15 Years |
50.4 |
42.1 to 58.6 |
197 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2010 |
Age |
13-15 Years |
32.8 |
25.5 to 41.0 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2010 |
Age |
13-15 Years |
53.3 |
45.2 to 61.2 |
193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2010 |
Age |
13-15 Years |
72.3 |
66.7 to 77.3 |
1098 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-15 Years |
75.3 |
68.3 to 81.1 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-15 Years |
78.9 |
71.8 to 84.6 |
256 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-15 Years |
76.1 |
67.1 to 83.3 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-15 Years |
87.0 |
81.2 to 91.2 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-15 Years |
70.2 |
62.6 to 76.9 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-15 Years |
31.7 |
23.4 to 41.4 |
143 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-15 Years |
57.8 |
53.2 to 62.3 |
775 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2010 |
Age |
13-15 Years |
54.9 |
46.6 to 62.9 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2010 |
Age |
13-15 Years |
55.7 |
47.3 to 63.9 |
193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2010 |
Age |
13-15 Years |
51.3 |
42.7 to 59.8 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2010 |
Age |
13-15 Years |
65.4 |
57.8 to 72.2 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2010 |
Age |
13-15 Years |
46.5 |
39.0 to 54.2 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-15 Years |
66.5 |
57.7 to 74.4 |
166 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2010 |
Age |
13-15 Years |
55.3 |
46.8 to 63.4 |
174 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2011 |
Age |
13-15 Years |
65.6 |
57.6 to 72.9 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2011 |
Age |
13-15 Years |
45.0 |
36.1 to 54.2 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2011 |
Age |
13-15 Years |
83.6 |
74.7 to 89.8 |
269 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2011 |
Age |
13-15 Years |
30.0 |
21.8 to 39.6 |
214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2011 |
Age |
13-15 Years |
76.1 |
70.0 to 81.4 |
356 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2011 |
Age |
13-15 Years |
64.1 |
54.2 to 72.9 |
254 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2011 |
Age |
13-15 Years |
79.3 |
71.8 to 85.2 |
277 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2011 |
Age |
13-15 Years |
77.0 |
70.0 to 82.8 |
267 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-15 Years |
90.3 |
84.6 to 94.0 |
239 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2011 |
Age |
13-15 Years |
64.3 |
56.4 to 71.5 |
287 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2011 |
Age |
13-15 Years |
64.4 |
56.0 to 72.0 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2011 |
Age |
13-15 Years |
67.6 |
59.7 to 74.6 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2011 |
Age |
13-15 Years |
49.8 |
41.1 to 58.5 |
250 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2011 |
Age |
13-15 Years |
65.2 |
58.7 to 71.1 |
524 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-15 Years |
70.5 |
62.4 to 77.4 |
250 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-15 Years |
63.9 |
56.2 to 71.0 |
274 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2011 |
Age |
13-15 Years |
94.5 |
89.3 to 97.2 |
254 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2011 |
Age |
13-15 Years |
64.1 |
55.5 to 71.9 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2011 |
Age |
13-15 Years |
48.1 |
39.1 to 57.1 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2011 |
Age |
13-15 Years |
60.4 |
51.9 to 68.3 |
245 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2011 |
Age |
13-15 Years |
92.3 |
86.9 to 95.6 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2011 |
Age |
13-15 Years |
65.0 |
57.1 to 72.2 |
250 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2011 |
Age |
13-15 Years |
73.1 |
65.5 to 79.5 |
307 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-15 Years |
84.6 |
76.4 to 90.4 |
214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2011 |
Age |
13-15 Years |
81.2 |
73.8 to 86.8 |
248 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2011 |
Age |
13-15 Years |
65.4 |
56.4 to 73.4 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2011 |
Age |
13-15 Years |
34.6 |
26.5 to 43.8 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2011 |
Age |
13-15 Years |
58.1 |
49.8 to 65.9 |
249 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2011 |
Age |
13-15 Years |
42.6 |
32.1 to 53.8 |
220 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2011 |
Age |
13-15 Years |
78.5 |
70.9 to 84.5 |
243 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2011 |
Age |
13-15 Years |
59.3 |
50.3 to 67.8 |
268 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-15 Years |
79.1 |
70.5 to 85.7 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2011 |
Age |
13-15 Years |
87.1 |
81.0 to 91.4 |
252 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2011 |
Age |
13-15 Years |
68.4 |
60.7 to 75.3 |
259 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2011 |
Age |
13-15 Years |
77.0 |
72.2 to 81.1 |
515 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-15 Years |
79.4 |
72.9 to 84.7 |
267 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-15 Years |
75.4 |
68.6 to 81.1 |
248 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2011 |
Age |
13-15 Years |
69.4 |
61.4 to 76.4 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2011 |
Age |
13-15 Years |
87.2 |
75.8 to 93.7 |
171 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2011 |
Age |
13-15 Years |
65.0 |
56.9 to 72.3 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-15 Years |
58.4 |
50.4 to 66.0 |
254 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2011 |
Age |
13-15 Years |
57.6 |
49.2 to 65.5 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-15 Years |
83.9 |
77.3 to 88.9 |
526 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-15 Years |
89.6 |
83.9 to 93.5 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-15 Years |
83.2 |
75.7 to 88.7 |
294 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2011 |
Age |
13-15 Years |
71.5 |
70.1 to 72.8 |
14355 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-15 Years |
80.7 |
76.7 to 84.1 |
1461 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-15 Years |
80.2 |
76.5 to 83.4 |
767 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-15 Years |
73.4 |
69.6 to 76.9 |
1850 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-15 Years |
62.8 |
59.5 to 65.9 |
1934 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-15 Years |
72.8 |
69.7 to 75.7 |
1703 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-15 Years |
75.6 |
71.7 to 79.1 |
2399 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-15 Years |
60.2 |
55.6 to 64.7 |
933 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-15 Years |
62.0 |
56.7 to 67.0 |
1332 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-15 Years |
76.0 |
71.1 to 80.3 |
1103 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-15 Years |
90.9 |
83.2 to 95.3 |
279 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2011 |
Age |
13-15 Years |
60.8 |
52.2 to 68.7 |
229 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2011 |
Age |
13-15 Years |
39.6 |
27.3 to 53.3 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2011 |
Age |
13-15 Years |
62.1 |
53.5 to 70.1 |
261 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2011 |
Age |
13-15 Years |
81.3 |
75.4 to 86.1 |
1376 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-15 Years |
86.7 |
80.8 to 91.0 |
282 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-15 Years |
81.8 |
74.2 to 87.6 |
299 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-15 Years |
87.6 |
81.9 to 91.7 |
276 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-15 Years |
85.6 |
77.8 to 91.0 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-15 Years |
79.9 |
71.8 to 86.0 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-15 Years |
30.8 |
24.8 to 37.5 |
290 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-15 Years |
62.5 |
57.4 to 67.4 |
873 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2011 |
Age |
13-15 Years |
63.2 |
54.1 to 71.5 |
251 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2011 |
Age |
13-15 Years |
63.7 |
55.5 to 71.1 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2011 |
Age |
13-15 Years |
61.5 |
53.4 to 69.0 |
265 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2011 |
Age |
13-15 Years |
70.7 |
61.8 to 78.2 |
208 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2011 |
Age |
13-15 Years |
55.0 |
47.2 to 62.5 |
246 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-15 Years |
72.4 |
63.9 to 79.5 |
229 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2011 |
Age |
13-15 Years |
69.1 |
58.7 to 77.8 |
227 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2012 |
Age |
13-15 Years |
60.1 |
50.7 to 68.8 |
184 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2012 |
Age |
13-15 Years |
48.7 |
40.8 to 56.6 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2012 |
Age |
13-15 Years |
86.3 |
78.9 to 91.4 |
231 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2012 |
Age |
13-15 Years |
37.9 |
29.9 to 46.6 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2012 |
Age |
13-15 Years |
74.9 |
67.6 to 81.1 |
271 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2012 |
Age |
13-15 Years |
74.9 |
66.0 to 82.1 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2012 |
Age |
13-15 Years |
88.5 |
82.7 to 92.6 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2012 |
Age |
13-15 Years |
79.1 |
70.6 to 85.7 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-15 Years |
92.2 |
87.3 to 95.3 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2012 |
Age |
13-15 Years |
67.1 |
58.1 to 75.0 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2012 |
Age |
13-15 Years |
72.4 |
62.5 to 80.6 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2012 |
Age |
13-15 Years |
68.3 |
59.4 to 76.0 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2012 |
Age |
13-15 Years |
68.8 |
60.5 to 76.0 |
212 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2012 |
Age |
13-15 Years |
67.2 |
59.2 to 74.3 |
393 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-15 Years |
77.4 |
69.0 to 84.0 |
183 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-15 Years |
64.7 |
55.0 to 73.3 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2012 |
Age |
13-15 Years |
93.2 |
87.2 to 96.4 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2012 |
Age |
13-15 Years |
57.6 |
48.4 to 66.3 |
183 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2012 |
Age |
13-15 Years |
52.6 |
43.0 to 62.1 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2012 |
Age |
13-15 Years |
68.2 |
59.4 to 75.8 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2012 |
Age |
13-15 Years |
93.3 |
88.2 to 96.3 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2012 |
Age |
13-15 Years |
74.1 |
66.3 to 80.6 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2012 |
Age |
13-15 Years |
72.5 |
62.9 to 80.3 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-15 Years |
86.9 |
80.8 to 91.2 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2012 |
Age |
13-15 Years |
89.4 |
83.3 to 93.4 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2012 |
Age |
13-15 Years |
60.6 |
51.1 to 69.3 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2012 |
Age |
13-15 Years |
42.3 |
33.0 to 52.1 |
184 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2012 |
Age |
13-15 Years |
57.5 |
48.0 to 66.5 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2012 |
Age |
13-15 Years |
61.6 |
53.2 to 69.4 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2012 |
Age |
13-15 Years |
74.7 |
66.2 to 81.6 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2012 |
Age |
13-15 Years |
66.5 |
58.2 to 73.9 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-15 Years |
81.6 |
72.2 to 88.4 |
145 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2012 |
Age |
13-15 Years |
93.1 |
86.6 to 96.6 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2012 |
Age |
13-15 Years |
50.0 |
41.2 to 58.7 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2012 |
Age |
13-15 Years |
77.3 |
71.3 to 82.4 |
387 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-15 Years |
76.3 |
68.2 to 82.8 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-15 Years |
78.0 |
69.1 to 84.8 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2012 |
Age |
13-15 Years |
62.9 |
54.2 to 70.9 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2012 |
Age |
13-15 Years |
87.9 |
80.7 to 92.6 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2012 |
Age |
13-15 Years |
61.9 |
53.0 to 70.0 |
202 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-15 Years |
68.7 |
59.7 to 76.5 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2012 |
Age |
13-15 Years |
58.0 |
49.5 to 66.1 |
229 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-15 Years |
88.9 |
83.2 to 92.8 |
461 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-15 Years |
92.7 |
85.5 to 96.5 |
219 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-15 Years |
88.5 |
82.1 to 92.8 |
242 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2012 |
Age |
13-15 Years |
73.8 |
72.3 to 75.2 |
11790 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-15 Years |
85.8 |
82.7 to 88.4 |
1126 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-15 Years |
82.6 |
78.2 to 86.3 |
602 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-15 Years |
77.6 |
73.5 to 81.2 |
1473 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-15 Years |
65.4 |
61.8 to 68.9 |
1593 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-15 Years |
73.8 |
70.4 to 77.0 |
1419 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-15 Years |
80.5 |
77.3 to 83.3 |
1849 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-15 Years |
58.6 |
53.4 to 63.7 |
755 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-15 Years |
65.7 |
60.7 to 70.4 |
1200 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-15 Years |
75.8 |
70.1 to 80.8 |
910 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-15 Years |
98.0 |
94.3 to 99.3 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2012 |
Age |
13-15 Years |
54.6 |
45.2 to 63.6 |
197 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2012 |
Age |
13-15 Years |
37.3 |
29.7 to 45.5 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2012 |
Age |
13-15 Years |
74.9 |
66.3 to 82.0 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2012 |
Age |
13-15 Years |
87.4 |
82.8 to 90.9 |
999 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-15 Years |
84.4 |
74.4 to 91.0 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-15 Years |
88.6 |
81.6 to 93.1 |
239 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-15 Years |
87.5 |
82.2 to 91.4 |
539 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-15 Years |
37.2 |
31.3 to 43.6 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-15 Years |
65.8 |
60.3 to 70.8 |
863 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2012 |
Age |
13-15 Years |
57.1 |
47.8 to 66.0 |
211 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2012 |
Age |
13-15 Years |
70.1 |
61.2 to 77.8 |
178 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2012 |
Age |
13-15 Years |
66.5 |
56.8 to 75.1 |
212 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2012 |
Age |
13-15 Years |
71.0 |
61.8 to 78.8 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2012 |
Age |
13-15 Years |
62.9 |
52.7 to 72.0 |
166 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-15 Years |
74.0 |
64.6 to 81.6 |
178 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2012 |
Age |
13-15 Years |
58.6 |
49.7 to 66.9 |
197 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2013 |
Age |
13-15 Years |
70.7 |
62.6 to 77.7 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2013 |
Age |
13-15 Years |
50.6 |
42.4 to 58.7 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2013 |
Age |
13-15 Years |
90.9 |
84.8 to 94.7 |
224 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2013 |
Age |
13-15 Years |
40.2 |
31.9 to 49.0 |
185 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2013 |
Age |
13-15 Years |
82.8 |
75.4 to 88.3 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2013 |
Age |
13-15 Years |
73.4 |
65.8 to 79.9 |
211 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2013 |
Age |
13-15 Years |
91.9 |
85.5 to 95.6 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2013 |
Age |
13-15 Years |
79.4 |
71.6 to 85.5 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-15 Years |
92.0 |
79.1 to 97.2 |
129 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2013 |
Age |
13-15 Years |
69.4 |
60.3 to 77.3 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2013 |
Age |
13-15 Years |
78.3 |
68.5 to 85.8 |
160 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2013 |
Age |
13-15 Years |
70.1 |
62.1 to 77.1 |
225 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2013 |
Age |
13-15 Years |
72.6 |
64.2 to 79.6 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2013 |
Age |
13-15 Years |
79.1 |
70.2 to 85.9 |
180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2013 |
Age |
13-15 Years |
80.3 |
74.3 to 85.1 |
335 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-15 Years |
79.6 |
69.4 to 87.0 |
126 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-15 Years |
80.4 |
73.3 to 86.0 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2013 |
Age |
13-15 Years |
93.1 |
88.0 to 96.1 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2013 |
Age |
13-15 Years |
62.2 |
54.7 to 69.2 |
257 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2013 |
Age |
13-15 Years |
51.6 |
43.2 to 60.0 |
180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2013 |
Age |
13-15 Years |
72.0 |
63.3 to 79.2 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2013 |
Age |
13-15 Years |
87.2 |
80.0 to 92.0 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2013 |
Age |
13-15 Years |
67.0 |
59.1 to 74.1 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2013 |
Age |
13-15 Years |
76.8 |
67.2 to 84.2 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-15 Years |
87.7 |
81.4 to 92.0 |
242 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2013 |
Age |
13-15 Years |
94.6 |
90.2 to 97.1 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2013 |
Age |
13-15 Years |
67.2 |
58.9 to 74.5 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2013 |
Age |
13-15 Years |
49.7 |
40.9 to 58.6 |
174 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2013 |
Age |
13-15 Years |
60.1 |
50.7 to 68.7 |
174 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2013 |
Age |
13-15 Years |
51.9 |
43.3 to 60.5 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2013 |
Age |
13-15 Years |
79.0 |
71.8 to 84.8 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2013 |
Age |
13-15 Years |
68.4 |
60.5 to 75.3 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-15 Years |
84.0 |
76.6 to 89.3 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2013 |
Age |
13-15 Years |
91.3 |
84.1 to 95.4 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2013 |
Age |
13-15 Years |
71.1 |
63.5 to 77.7 |
219 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2013 |
Age |
13-15 Years |
81.9 |
76.6 to 86.2 |
399 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-15 Years |
79.7 |
71.2 to 86.1 |
173 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-15 Years |
83.2 |
76.1 to 88.6 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2013 |
Age |
13-15 Years |
73.8 |
66.4 to 80.1 |
202 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2013 |
Age |
13-15 Years |
94.7 |
91.2 to 96.9 |
213 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2013 |
Age |
13-15 Years |
67.0 |
59.0 to 74.1 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-15 Years |
68.8 |
62.0 to 74.9 |
279 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2013 |
Age |
13-15 Years |
66.0 |
58.8 to 72.6 |
236 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-15 Years |
88.9 |
82.9 to 93.0 |
459 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-15 Years |
90.9 |
84.2 to 95.0 |
183 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-15 Years |
88.7 |
81.9 to 93.2 |
276 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2013 |
Age |
13-15 Years |
78.1 |
76.7 to 79.4 |
11221 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-15 Years |
86.6 |
83.4 to 89.3 |
1201 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-15 Years |
85.0 |
81.0 to 88.3 |
600 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-15 Years |
77.4 |
72.8 to 81.4 |
1381 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-15 Years |
70.9 |
67.4 to 74.2 |
1462 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-15 Years |
80.0 |
77.2 to 82.5 |
1382 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-15 Years |
84.1 |
81.1 to 86.7 |
1554 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-15 Years |
61.2 |
56.3 to 65.9 |
790 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-15 Years |
67.2 |
62.8 to 71.3 |
1166 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-15 Years |
82.8 |
77.2 to 87.3 |
845 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-15 Years |
92.2 |
86.0 to 95.8 |
176 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2013 |
Age |
13-15 Years |
71.9 |
63.2 to 79.2 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2013 |
Age |
13-15 Years |
49.6 |
40.9 to 58.2 |
171 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2013 |
Age |
13-15 Years |
67.2 |
58.9 to 74.6 |
182 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2013 |
Age |
13-15 Years |
91.0 |
86.6 to 94.0 |
696 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-15 Years |
92.5 |
86.8 to 95.9 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-15 Years |
90.7 |
82.0 to 95.4 |
161 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-15 Years |
90.9 |
85.7 to 94.3 |
341 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-15 Years |
35.6 |
28.4 to 43.5 |
202 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-15 Years |
74.4 |
69.8 to 78.5 |
840 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2013 |
Age |
13-15 Years |
63.0 |
54.2 to 71.0 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2013 |
Age |
13-15 Years |
77.0 |
68.9 to 83.6 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2013 |
Age |
13-15 Years |
58.0 |
46.6 to 68.7 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2013 |
Age |
13-15 Years |
80.5 |
72.5 to 86.6 |
219 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2013 |
Age |
13-15 Years |
79.5 |
72.0 to 85.4 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-15 Years |
81.2 |
74.4 to 86.6 |
212 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2013 |
Age |
13-15 Years |
57.1 |
48.8 to 65.0 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2014 |
Age |
13-15 Years |
69.8 |
61.4 to 77.0 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2014 |
Age |
13-15 Years |
56.8 |
48.8 to 64.5 |
227 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2014 |
Age |
13-15 Years |
86.3 |
79.2 to 91.2 |
267 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2014 |
Age |
13-15 Years |
65.4 |
57.2 to 72.8 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2014 |
Age |
13-15 Years |
78.1 |
69.7 to 84.6 |
219 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2014 |
Age |
13-15 Years |
76.7 |
69.7 to 82.4 |
233 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2014 |
Age |
13-15 Years |
97.3 |
94.2 to 98.8 |
238 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2014 |
Age |
13-15 Years |
86.5 |
79.0 to 91.6 |
231 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-15 Years |
92.3 |
86.9 to 95.6 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2014 |
Age |
13-15 Years |
72.9 |
64.1 to 80.3 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2014 |
Age |
13-15 Years |
80.4 |
72.5 to 86.5 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2014 |
Age |
13-15 Years |
77.3 |
70.2 to 83.1 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2014 |
Age |
13-15 Years |
82.8 |
74.8 to 88.6 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2014 |
Age |
13-15 Years |
76.9 |
71.1 to 81.8 |
464 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-15 Years |
83.9 |
75.3 to 89.9 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-15 Years |
75.4 |
68.5 to 81.1 |
289 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2014 |
Age |
13-15 Years |
90.5 |
84.2 to 94.4 |
233 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2014 |
Age |
13-15 Years |
70.4 |
61.1 to 78.3 |
178 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2014 |
Age |
13-15 Years |
65.2 |
56.4 to 73.0 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2014 |
Age |
13-15 Years |
86.0 |
80.0 to 90.4 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2014 |
Age |
13-15 Years |
91.8 |
86.4 to 95.2 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2014 |
Age |
13-15 Years |
71.5 |
63.4 to 78.5 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2014 |
Age |
13-15 Years |
87.6 |
80.4 to 92.4 |
245 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-15 Years |
93.8 |
89.6 to 96.4 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2014 |
Age |
13-15 Years |
88.6 |
80.9 to 93.4 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2014 |
Age |
13-15 Years |
74.4 |
66.2 to 81.2 |
169 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2014 |
Age |
13-15 Years |
46.8 |
38.7 to 55.0 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2014 |
Age |
13-15 Years |
63.2 |
54.9 to 70.9 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2014 |
Age |
13-15 Years |
57.6 |
49.2 to 65.7 |
225 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2014 |
Age |
13-15 Years |
73.5 |
65.5 to 80.3 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2014 |
Age |
13-15 Years |
65.5 |
57.8 to 72.5 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-15 Years |
89.1 |
83.9 to 92.8 |
245 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2014 |
Age |
13-15 Years |
95.4 |
90.1 to 97.9 |
211 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2014 |
Age |
13-15 Years |
75.4 |
67.6 to 81.9 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2014 |
Age |
13-15 Years |
78.9 |
72.8 to 84.0 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-15 Years |
86.1 |
78.2 to 91.4 |
164 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-15 Years |
75.0 |
66.4 to 82.0 |
176 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2014 |
Age |
13-15 Years |
74.3 |
66.6 to 80.8 |
241 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2014 |
Age |
13-15 Years |
88.8 |
82.6 to 93.1 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2014 |
Age |
13-15 Years |
72.4 |
64.6 to 79.0 |
265 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-15 Years |
74.2 |
66.6 to 80.5 |
220 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2014 |
Age |
13-15 Years |
69.0 |
61.1 to 76.0 |
259 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-15 Years |
96.6 |
93.8 to 98.2 |
455 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-15 Years |
91.6 |
84.2 to 95.7 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-15 Years |
97.3 |
93.9 to 98.8 |
265 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-15 Years |
84.1 |
73.5 to 91.0 |
132 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2014 |
Age |
13-15 Years |
79.4 |
78.0 to 80.7 |
12764 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-15 Years |
91.8 |
89.7 to 93.5 |
1357 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-15 Years |
84.5 |
80.1 to 88.0 |
551 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-15 Years |
84.7 |
81.1 to 87.6 |
1552 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-15 Years |
73.5 |
70.3 to 76.5 |
1807 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-15 Years |
79.3 |
76.4 to 81.9 |
1542 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-15 Years |
86.4 |
83.5 to 88.8 |
1862 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-15 Years |
66.4 |
61.7 to 70.8 |
815 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-15 Years |
69.7 |
65.7 to 73.5 |
1399 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-15 Years |
78.4 |
72.0 to 83.7 |
949 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-15 Years |
94.5 |
88.0 to 97.6 |
235 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2014 |
Age |
13-15 Years |
67.3 |
58.9 to 74.6 |
236 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2014 |
Age |
13-15 Years |
58.3 |
49.6 to 66.4 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2014 |
Age |
13-15 Years |
73.1 |
64.8 to 80.1 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2014 |
Age |
13-15 Years |
90.2 |
86.0 to 93.2 |
999 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-15 Years |
84.6 |
76.8 to 90.1 |
225 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-15 Years |
87.3 |
79.8 to 92.3 |
233 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-15 Years |
95.5 |
92.1 to 97.5 |
240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-15 Years |
90.5 |
85.5 to 93.9 |
301 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-15 Years |
76.8 |
72.4 to 80.6 |
930 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2014 |
Age |
13-15 Years |
65.6 |
57.5 to 72.9 |
241 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2014 |
Age |
13-15 Years |
80.5 |
73.3 to 86.1 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2014 |
Age |
13-15 Years |
66.7 |
57.1 to 75.0 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2014 |
Age |
13-15 Years |
81.4 |
74.0 to 87.0 |
214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2014 |
Age |
13-15 Years |
79.6 |
71.8 to 85.6 |
224 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-15 Years |
74.6 |
65.9 to 81.6 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2014 |
Age |
13-15 Years |
47.8 |
40.8 to 54.8 |
282 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2015 |
Age |
13-15 Years |
67.1 |
58.9 to 74.4 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2015 |
Age |
13-15 Years |
55.4 |
47.6 to 63.0 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2015 |
Age |
13-15 Years |
87.7 |
82.4 to 91.6 |
272 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2015 |
Age |
13-15 Years |
83.0 |
76.6 to 88.0 |
217 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2015 |
Age |
13-15 Years |
78.0 |
69.6 to 84.5 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2015 |
Age |
13-15 Years |
81.2 |
74.3 to 86.6 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2015 |
Age |
13-15 Years |
94.5 |
89.5 to 97.2 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2015 |
Age |
13-15 Years |
84.3 |
77.4 to 89.4 |
228 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-15 Years |
91.0 |
85.7 to 94.4 |
255 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2015 |
Age |
13-15 Years |
64.9 |
55.9 to 72.9 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2015 |
Age |
13-15 Years |
89.9 |
83.2 to 94.1 |
240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2015 |
Age |
13-15 Years |
74.2 |
67.2 to 80.2 |
242 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2015 |
Age |
13-15 Years |
77.9 |
70.8 to 83.7 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2015 |
Age |
13-15 Years |
84.9 |
77.7 to 90.1 |
217 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2015 |
Age |
13-15 Years |
77.3 |
72.1 to 81.8 |
501 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-15 Years |
81.0 |
73.6 to 86.7 |
185 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-15 Years |
76.4 |
70.2 to 81.7 |
316 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2015 |
Age |
13-15 Years |
89.5 |
83.2 to 93.7 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2015 |
Age |
13-15 Years |
76.0 |
69.0 to 81.9 |
252 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2015 |
Age |
13-15 Years |
64.9 |
57.0 to 72.0 |
227 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2015 |
Age |
13-15 Years |
83.9 |
76.8 to 89.0 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2015 |
Age |
13-15 Years |
88.7 |
82.1 to 93.0 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2015 |
Age |
13-15 Years |
76.1 |
68.6 to 82.3 |
224 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2015 |
Age |
13-15 Years |
88.7 |
82.3 to 93.0 |
257 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-15 Years |
92.1 |
85.3 to 95.9 |
203 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2015 |
Age |
13-15 Years |
94.3 |
89.3 to 97.0 |
245 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2015 |
Age |
13-15 Years |
83.7 |
76.7 to 88.9 |
236 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2015 |
Age |
13-15 Years |
57.5 |
49.9 to 64.7 |
234 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2015 |
Age |
13-15 Years |
68.2 |
59.6 to 75.7 |
199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2015 |
Age |
13-15 Years |
67.4 |
60.1 to 74.0 |
243 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2015 |
Age |
13-15 Years |
76.8 |
70.0 to 82.5 |
247 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2015 |
Age |
13-15 Years |
80.2 |
73.2 to 85.7 |
243 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-15 Years |
85.8 |
78.6 to 90.8 |
171 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2015 |
Age |
13-15 Years |
96.2 |
92.7 to 98.1 |
211 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2015 |
Age |
13-15 Years |
70.5 |
63.2 to 76.9 |
247 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2015 |
Age |
13-15 Years |
85.4 |
80.8 to 89.0 |
390 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-15 Years |
83.0 |
75.5 to 88.6 |
181 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-15 Years |
86.8 |
80.7 to 91.2 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2015 |
Age |
13-15 Years |
76.8 |
69.5 to 82.9 |
231 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2015 |
Age |
13-15 Years |
92.1 |
84.6 to 96.2 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2015 |
Age |
13-15 Years |
75.3 |
66.4 to 82.5 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-15 Years |
68.1 |
59.3 to 75.8 |
177 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2015 |
Age |
13-15 Years |
76.4 |
68.9 to 82.5 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-15 Years |
94.5 |
91.5 to 96.4 |
492 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-15 Years |
89.3 |
82.9 to 93.5 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-15 Years |
95.1 |
91.8 to 97.1 |
292 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-15 Years |
88.6 |
81.8 to 93.0 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2015 |
Age |
13-15 Years |
80.8 |
79.4 to 82.1 |
13488 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-15 Years |
90.8 |
87.8 to 93.1 |
1303 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-15 Years |
89.0 |
85.8 to 91.6 |
601 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-15 Years |
84.2 |
80.5 to 87.3 |
1683 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-15 Years |
74.3 |
71.1 to 77.3 |
1746 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-15 Years |
82.7 |
80.0 to 85.1 |
1605 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-15 Years |
86.5 |
84.2 to 88.4 |
2530 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-15 Years |
70.4 |
66.0 to 74.4 |
925 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-15 Years |
73.2 |
69.2 to 76.8 |
1273 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-15 Years |
79.3 |
72.7 to 84.7 |
937 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-15 Years |
97.6 |
94.9 to 98.9 |
254 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2015 |
Age |
13-15 Years |
72.8 |
65.4 to 79.2 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2015 |
Age |
13-15 Years |
54.7 |
46.8 to 62.3 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2015 |
Age |
13-15 Years |
77.3 |
69.6 to 83.4 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2015 |
Age |
13-15 Years |
90.0 |
87.1 to 92.2 |
1652 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-15 Years |
88.0 |
82.1 to 92.2 |
245 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-15 Years |
85.4 |
77.8 to 90.8 |
168 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-15 Years |
89.1 |
83.7 to 92.8 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-15 Years |
90.6 |
87.0 to 93.2 |
599 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-15 Years |
54.9 |
48.3 to 61.5 |
305 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-15 Years |
75.4 |
71.1 to 79.3 |
885 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2015 |
Age |
13-15 Years |
66.7 |
58.3 to 74.1 |
212 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2015 |
Age |
13-15 Years |
83.6 |
77.1 to 88.5 |
246 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2015 |
Age |
13-15 Years |
65.2 |
54.7 to 74.3 |
241 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2015 |
Age |
13-15 Years |
74.5 |
67.3 to 80.6 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2015 |
Age |
13-15 Years |
85.8 |
79.5 to 90.5 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-15 Years |
80.0 |
73.2 to 85.3 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2015 |
Age |
13-15 Years |
57.3 |
48.9 to 65.4 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2016 |
Age |
13-15 Years |
74.3 |
66.4 to 80.8 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2016 |
Age |
13-15 Years |
63.5 |
55.5 to 70.8 |
231 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2016 |
Age |
13-15 Years |
86.5 |
79.1 to 91.6 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2016 |
Age |
13-15 Years |
89.0 |
83.5 to 92.8 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2016 |
Age |
13-15 Years |
78.1 |
69.7 to 84.8 |
203 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2016 |
Age |
13-15 Years |
72.8 |
64.2 to 80.0 |
199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2016 |
Age |
13-15 Years |
94.0 |
88.0 to 97.1 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2016 |
Age |
13-15 Years |
88.5 |
82.1 to 92.8 |
220 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-15 Years |
85.1 |
77.4 to 90.5 |
242 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2016 |
Age |
13-15 Years |
72.4 |
63.7 to 79.8 |
224 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2016 |
Age |
13-15 Years |
93.1 |
88.0 to 96.1 |
263 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2016 |
Age |
13-15 Years |
76.2 |
70.3 to 81.2 |
323 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2016 |
Age |
13-15 Years |
74.8 |
66.8 to 81.4 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2016 |
Age |
13-15 Years |
87.1 |
80.4 to 91.7 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2016 |
Age |
13-15 Years |
81.3 |
75.7 to 85.8 |
362 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-15 Years |
86.7 |
77.2 to 92.6 |
104 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-15 Years |
79.9 |
73.2 to 85.3 |
258 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2016 |
Age |
13-15 Years |
87.2 |
80.4 to 91.8 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2016 |
Age |
13-15 Years |
74.8 |
67.7 to 80.7 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2016 |
Age |
13-15 Years |
68.2 |
60.4 to 75.2 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2016 |
Age |
13-15 Years |
88.2 |
82.2 to 92.4 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2016 |
Age |
13-15 Years |
92.4 |
87.3 to 95.5 |
212 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2016 |
Age |
13-15 Years |
82.4 |
75.0 to 88.0 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2016 |
Age |
13-15 Years |
89.9 |
83.5 to 94.0 |
305 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-15 Years |
90.3 |
85.1 to 93.9 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2016 |
Age |
13-15 Years |
94.2 |
89.3 to 96.9 |
162 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2016 |
Age |
13-15 Years |
89.6 |
83.3 to 93.7 |
227 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2016 |
Age |
13-15 Years |
59.3 |
51.1 to 67.1 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2016 |
Age |
13-15 Years |
65.6 |
57.2 to 73.1 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2016 |
Age |
13-15 Years |
66.0 |
57.8 to 73.5 |
235 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2016 |
Age |
13-15 Years |
81.1 |
73.5 to 86.8 |
199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2016 |
Age |
13-15 Years |
80.9 |
73.7 to 86.4 |
217 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-15 Years |
85.0 |
78.2 to 90.0 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2016 |
Age |
13-15 Years |
91.6 |
86.1 to 95.1 |
254 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2016 |
Age |
13-15 Years |
77.6 |
70.8 to 83.2 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2016 |
Age |
13-15 Years |
88.3 |
83.8 to 91.7 |
399 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-15 Years |
91.4 |
84.3 to 95.5 |
173 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-15 Years |
86.6 |
80.3 to 91.1 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2016 |
Age |
13-15 Years |
74.2 |
66.3 to 80.9 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2016 |
Age |
13-15 Years |
91.1 |
85.4 to 94.8 |
180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2016 |
Age |
13-15 Years |
76.8 |
68.1 to 83.7 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-15 Years |
69.7 |
60.2 to 77.7 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2016 |
Age |
13-15 Years |
71.1 |
63.3 to 77.8 |
203 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-15 Years |
93.0 |
89.0 to 95.6 |
515 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-15 Years |
88.3 |
82.0 to 92.6 |
203 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-15 Years |
93.6 |
89.0 to 96.3 |
312 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-15 Years |
90.6 |
84.9 to 94.3 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2016 |
Age |
13-15 Years |
81.8 |
80.4 to 83.1 |
12578 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-15 Years |
90.1 |
87.4 to 92.3 |
1227 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-15 Years |
89.4 |
85.9 to 92.1 |
653 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-15 Years |
85.3 |
81.7 to 88.3 |
1768 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-15 Years |
78.1 |
75.0 to 80.8 |
1670 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-15 Years |
84.9 |
82.2 to 87.3 |
1374 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-15 Years |
85.3 |
82.8 to 87.6 |
2031 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-15 Years |
70.1 |
65.7 to 74.2 |
876 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-15 Years |
74.0 |
69.6 to 77.9 |
1263 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-15 Years |
79.4 |
72.7 to 84.7 |
816 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-15 Years |
95.1 |
89.9 to 97.7 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2016 |
Age |
13-15 Years |
68.2 |
58.8 to 76.3 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2016 |
Age |
13-15 Years |
63.0 |
54.2 to 71.0 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2016 |
Age |
13-15 Years |
78.7 |
70.3 to 85.1 |
166 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2016 |
Age |
13-15 Years |
86.5 |
83.0 to 89.3 |
1193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-15 Years |
86.9 |
80.2 to 91.6 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-15 Years |
86.7 |
75.8 to 93.1 |
136 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-15 Years |
87.6 |
80.5 to 92.4 |
176 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-15 Years |
89.5 |
82.1 to 94.1 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-15 Years |
86.1 |
81.5 to 89.7 |
460 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-15 Years |
55.3 |
48.0 to 62.4 |
271 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-15 Years |
73.5 |
68.6 to 77.9 |
900 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2016 |
Age |
13-15 Years |
79.7 |
72.4 to 85.5 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2016 |
Age |
13-15 Years |
84.7 |
78.1 to 89.5 |
212 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2016 |
Age |
13-15 Years |
70.0 |
60.2 to 78.3 |
289 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2016 |
Age |
13-15 Years |
72.1 |
64.0 to 79.0 |
236 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2016 |
Age |
13-15 Years |
88.4 |
82.1 to 92.7 |
197 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-15 Years |
87.3 |
81.7 to 91.3 |
199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2016 |
Age |
13-15 Years |
54.7 |
47.1 to 62.0 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2017 |
Age |
13-15 Years |
78.0 |
71.1 to 83.6 |
238 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2017 |
Age |
13-15 Years |
66.5 |
58.4 to 73.8 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2017 |
Age |
13-15 Years |
82.2 |
74.2 to 88.2 |
193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2017 |
Age |
13-15 Years |
91.0 |
84.8 to 94.8 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2017 |
Age |
13-15 Years |
84.1 |
76.7 to 89.5 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2017 |
Age |
13-15 Years |
81.4 |
74.7 to 86.6 |
235 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2017 |
Age |
13-15 Years |
94.8 |
89.6 to 97.5 |
193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2017 |
Age |
13-15 Years |
88.5 |
81.5 to 93.1 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-15 Years |
88.9 |
80.9 to 93.8 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2017 |
Age |
13-15 Years |
78.6 |
70.7 to 84.8 |
248 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2017 |
Age |
13-15 Years |
95.7 |
90.8 to 98.1 |
224 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2017 |
Age |
13-15 Years |
65.1 |
57.1 to 72.4 |
231 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2017 |
Age |
13-15 Years |
83.6 |
76.2 to 89.1 |
189 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2017 |
Age |
13-15 Years |
93.7 |
89.3 to 96.3 |
214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2017 |
Age |
13-15 Years |
88.9 |
84.3 to 92.3 |
403 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-15 Years |
90.3 |
79.4 to 95.7 |
120 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-15 Years |
88.7 |
83.3 to 92.5 |
283 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2017 |
Age |
13-15 Years |
92.6 |
87.2 to 95.8 |
208 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2017 |
Age |
13-15 Years |
84.9 |
78.5 to 89.6 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2017 |
Age |
13-15 Years |
71.7 |
64.0 to 78.4 |
229 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2017 |
Age |
13-15 Years |
82.9 |
76.2 to 88.0 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2017 |
Age |
13-15 Years |
88.1 |
82.0 to 92.4 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2017 |
Age |
13-15 Years |
86.6 |
80.4 to 91.0 |
217 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2017 |
Age |
13-15 Years |
93.6 |
86.9 to 97.0 |
311 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-15 Years |
94.9 |
90.4 to 97.4 |
262 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2017 |
Age |
13-15 Years |
91.1 |
84.4 to 95.1 |
183 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2017 |
Age |
13-15 Years |
89.4 |
82.9 to 93.7 |
225 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2017 |
Age |
13-15 Years |
64.2 |
56.4 to 71.3 |
208 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2017 |
Age |
13-15 Years |
73.1 |
64.9 to 80.0 |
208 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2017 |
Age |
13-15 Years |
69.1 |
60.6 to 76.4 |
202 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2017 |
Age |
13-15 Years |
82.9 |
75.0 to 88.7 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2017 |
Age |
13-15 Years |
78.3 |
70.6 to 84.5 |
235 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-15 Years |
84.5 |
77.4 to 89.7 |
211 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2017 |
Age |
13-15 Years |
94.3 |
88.4 to 97.3 |
217 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2017 |
Age |
13-15 Years |
75.6 |
67.9 to 81.9 |
220 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2017 |
Age |
13-15 Years |
87.6 |
82.9 to 91.1 |
414 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-15 Years |
84.7 |
77.0 to 90.2 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-15 Years |
89.4 |
83.1 to 93.6 |
224 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2017 |
Age |
13-15 Years |
84.5 |
77.3 to 89.7 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2017 |
Age |
13-15 Years |
91.6 |
86.5 to 94.9 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2017 |
Age |
13-15 Years |
86.7 |
81.2 to 90.8 |
247 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-15 Years |
67.3 |
59.3 to 74.5 |
212 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2017 |
Age |
13-15 Years |
79.6 |
72.8 to 85.1 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-15 Years |
93.8 |
90.0 to 96.3 |
520 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-15 Years |
91.2 |
85.6 to 94.7 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-15 Years |
94.2 |
89.7 to 96.8 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2017 |
Age |
13-15 Years |
84.9 |
83.6 to 86.0 |
12924 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-15 Years |
92.7 |
90.5 to 94.5 |
1302 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-15 Years |
89.7 |
86.1 to 92.4 |
631 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-15 Years |
89.3 |
86.0 to 91.9 |
1721 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-15 Years |
81.6 |
78.8 to 84.1 |
1787 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-15 Years |
88.5 |
86.3 to 90.4 |
1462 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-15 Years |
82.5 |
79.7 to 85.0 |
2247 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-15 Years |
76.8 |
72.7 to 80.4 |
833 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-15 Years |
81.9 |
78.4 to 84.8 |
1310 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-15 Years |
83.5 |
77.7 to 88.0 |
811 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-15 Years |
94.5 |
89.4 to 97.2 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2017 |
Age |
13-15 Years |
78.2 |
70.0 to 84.7 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2017 |
Age |
13-15 Years |
76.9 |
68.6 to 83.5 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2017 |
Age |
13-15 Years |
71.3 |
62.3 to 79.0 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2017 |
Age |
13-15 Years |
83.3 |
79.5 to 86.5 |
1406 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-15 Years |
83.5 |
75.8 to 89.1 |
211 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-15 Years |
92.4 |
85.3 to 96.2 |
104 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-15 Years |
83.5 |
75.0 to 89.5 |
169 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-15 Years |
90.5 |
84.3 to 94.4 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-15 Years |
87.7 |
81.4 to 92.0 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-15 Years |
82.0 |
76.7 to 86.3 |
527 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-15 Years |
83.8 |
79.8 to 87.1 |
820 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2017 |
Age |
13-15 Years |
88.3 |
82.9 to 92.1 |
229 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2017 |
Age |
13-15 Years |
84.1 |
77.3 to 89.1 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2017 |
Age |
13-15 Years |
79.8 |
69.9 to 87.0 |
259 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2017 |
Age |
13-15 Years |
85.0 |
78.0 to 90.1 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2017 |
Age |
13-15 Years |
87.0 |
80.4 to 91.7 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-15 Years |
80.7 |
73.2 to 86.5 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2017 |
Age |
13-15 Years |
59.1 |
51.2 to 66.6 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018 |
Age |
13-15 Years |
80.4 |
73.1 to 86.1 |
197 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018 |
Age |
13-15 Years |
68.4 |
61.2 to 74.8 |
243 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018 |
Age |
13-15 Years |
88.8 |
82.5 to 93.1 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018 |
Age |
13-15 Years |
91.5 |
84.9 to 95.4 |
181 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018 |
Age |
13-15 Years |
84.2 |
75.9 to 90.0 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018 |
Age |
13-15 Years |
85.1 |
76.5 to 91.0 |
167 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018 |
Age |
13-15 Years |
92.3 |
85.3 to 96.1 |
184 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018 |
Age |
13-15 Years |
86.7 |
79.7 to 91.6 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-15 Years |
92.1 |
84.2 to 96.3 |
181 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018 |
Age |
13-15 Years |
77.9 |
70.1 to 84.1 |
208 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018 |
Age |
13-15 Years |
93.8 |
89.2 to 96.5 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2018 |
Age |
13-15 Years |
63.3 |
54.5 to 71.2 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018 |
Age |
13-15 Years |
83.5 |
76.1 to 88.9 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018 |
Age |
13-15 Years |
90.9 |
84.7 to 94.7 |
169 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018 |
Age |
13-15 Years |
90.3 |
86.4 to 93.2 |
452 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-15 Years |
91.4 |
82.4 to 96.1 |
118 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-15 Years |
90.1 |
85.6 to 93.3 |
334 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018 |
Age |
13-15 Years |
87.4 |
81.3 to 91.7 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018 |
Age |
13-15 Years |
89.4 |
81.7 to 94.1 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018 |
Age |
13-15 Years |
73.5 |
65.3 to 80.4 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018 |
Age |
13-15 Years |
83.7 |
75.2 to 89.7 |
150 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018 |
Age |
13-15 Years |
81.7 |
72.8 to 88.1 |
153 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018 |
Age |
13-15 Years |
82.0 |
73.9 to 88.0 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018 |
Age |
13-15 Years |
91.6 |
84.6 to 95.5 |
252 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-15 Years |
92.0 |
84.4 to 96.1 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018 |
Age |
13-15 Years |
95.9 |
90.4 to 98.3 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018 |
Age |
13-15 Years |
92.4 |
85.7 to 96.1 |
168 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018 |
Age |
13-15 Years |
65.9 |
56.8 to 73.9 |
165 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018 |
Age |
13-15 Years |
79.8 |
71.2 to 86.4 |
184 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018 |
Age |
13-15 Years |
71.2 |
62.4 to 78.6 |
176 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018 |
Age |
13-15 Years |
86.2 |
78.4 to 91.5 |
181 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018 |
Age |
13-15 Years |
78.4 |
71.0 to 84.3 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-15 Years |
83.7 |
76.3 to 89.1 |
182 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018 |
Age |
13-15 Years |
90.4 |
83.7 to 94.5 |
203 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018 |
Age |
13-15 Years |
75.9 |
67.3 to 82.9 |
177 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018 |
Age |
13-15 Years |
95.7 |
92.8 to 97.5 |
314 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-15 Years |
93.6 |
88.6 to 96.5 |
162 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-15 Years |
97.1 |
92.5 to 98.9 |
152 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018 |
Age |
13-15 Years |
87.4 |
80.2 to 92.3 |
224 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018 |
Age |
13-15 Years |
92.8 |
86.2 to 96.4 |
173 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018 |
Age |
13-15 Years |
86.4 |
80.5 to 90.7 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-15 Years |
72.8 |
64.6 to 79.6 |
199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018 |
Age |
13-15 Years |
82.7 |
74.6 to 88.7 |
171 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-15 Years |
94.6 |
90.6 to 96.9 |
392 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-15 Years |
94.1 |
88.0 to 97.2 |
152 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-15 Years |
94.6 |
90.1 to 97.2 |
240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018 |
Age |
13-15 Years |
86.2 |
84.9 to 87.4 |
11468 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-15 Years |
90.7 |
87.3 to 93.3 |
1140 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-15 Years |
93.9 |
91.1 to 95.9 |
517 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-15 Years |
89.2 |
85.7 to 91.9 |
1439 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-15 Years |
82.6 |
79.8 to 85.0 |
1562 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-15 Years |
90.1 |
88.1 to 91.8 |
1417 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-15 Years |
84.0 |
81.4 to 86.3 |
2025 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-15 Years |
81.5 |
77.2 to 85.1 |
726 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-15 Years |
85.4 |
81.3 to 88.7 |
1058 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-15 Years |
84.5 |
78.2 to 89.2 |
809 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-15 Years |
98.0 |
95.1 to 99.2 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018 |
Age |
13-15 Years |
74.6 |
66.5 to 81.3 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018 |
Age |
13-15 Years |
87.6 |
81.8 to 91.8 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018 |
Age |
13-15 Years |
81.9 |
74.1 to 87.8 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018 |
Age |
13-15 Years |
85.5 |
82.0 to 88.4 |
1315 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-15 Years |
89.2 |
83.1 to 93.3 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-15 Years |
85.3 |
75.6 to 91.6 |
114 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-15 Years |
83.3 |
73.4 to 89.9 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-15 Years |
89.0 |
82.9 to 93.1 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-15 Years |
84.9 |
80.3 to 88.5 |
587 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-15 Years |
81.3 |
76.2 to 85.5 |
775 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018 |
Age |
13-15 Years |
89.8 |
83.2 to 94.0 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018 |
Age |
13-15 Years |
88.5 |
82.8 to 92.4 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018 |
Age |
13-15 Years |
79.7 |
68.9 to 87.4 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018 |
Age |
13-15 Years |
79.6 |
70.8 to 86.2 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018 |
Age |
13-15 Years |
88.2 |
81.4 to 92.7 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-15 Years |
88.6 |
82.9 to 92.6 |
214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018 |
Age |
13-15 Years |
68.2 |
58.9 to 76.2 |
143 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2019 |
Age |
13-15 Years |
85.9 |
79.3 to 90.6 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2019 |
Age |
13-15 Years |
71.0 |
63.8 to 77.3 |
262 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2019 |
Age |
13-15 Years |
82.0 |
73.5 to 88.3 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2019 |
Age |
13-15 Years |
94.5 |
90.0 to 97.0 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2019 |
Age |
13-15 Years |
93.8 |
88.7 to 96.7 |
170 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2019 |
Age |
13-15 Years |
87.2 |
79.8 to 92.2 |
170 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2019 |
Age |
13-15 Years |
94.8 |
87.5 to 97.9 |
165 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2019 |
Age |
13-15 Years |
85.3 |
77.4 to 90.7 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-15 Years |
84.1 |
73.9 to 90.9 |
171 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2019 |
Age |
13-15 Years |
84.4 |
75.7 to 90.5 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2019 |
Age |
13-15 Years |
94.8 |
90.2 to 97.3 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2019 |
Age |
13-15 Years |
71.5 |
62.8 to 78.8 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2019 |
Age |
13-15 Years |
80.5 |
71.8 to 87.0 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2019 |
Age |
13-15 Years |
88.7 |
82.6 to 92.8 |
217 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2019 |
Age |
13-15 Years |
93.0 |
89.2 to 95.5 |
382 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-15 Years |
94.0 |
85.9 to 97.6 |
100 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-15 Years |
92.8 |
88.4 to 95.6 |
282 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2019 |
Age |
13-15 Years |
90.5 |
83.5 to 94.8 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2019 |
Age |
13-15 Years |
92.9 |
87.6 to 96.0 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2019 |
Age |
13-15 Years |
80.0 |
72.9 to 85.5 |
238 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2019 |
Age |
13-15 Years |
89.8 |
83.1 to 94.0 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2019 |
Age |
13-15 Years |
90.4 |
84.0 to 94.5 |
220 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2019 |
Age |
13-15 Years |
87.4 |
80.7 to 92.0 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2019 |
Age |
13-15 Years |
93.7 |
88.6 to 96.6 |
335 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-15 Years |
94.9 |
89.0 to 97.7 |
177 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2019 |
Age |
13-15 Years |
95.7 |
90.0 to 98.2 |
178 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2019 |
Age |
13-15 Years |
85.9 |
76.5 to 92.0 |
165 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2019 |
Age |
13-15 Years |
55.3 |
45.3 to 64.8 |
160 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2019 |
Age |
13-15 Years |
82.6 |
74.9 to 88.2 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2019 |
Age |
13-15 Years |
71.8 |
63.2 to 79.1 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2019 |
Age |
13-15 Years |
87.7 |
78.6 to 93.3 |
181 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2019 |
Age |
13-15 Years |
87.1 |
79.5 to 92.1 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-15 Years |
85.7 |
77.9 to 91.1 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2019 |
Age |
13-15 Years |
91.7 |
85.1 to 95.6 |
219 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2019 |
Age |
13-15 Years |
84.0 |
77.5 to 88.9 |
257 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2019 |
Age |
13-15 Years |
95.9 |
92.8 to 97.7 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-15 Years |
96.4 |
92.8 to 98.2 |
163 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-15 Years |
95.6 |
90.2 to 98.1 |
154 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2019 |
Age |
13-15 Years |
93.9 |
87.2 to 97.2 |
185 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2019 |
Age |
13-15 Years |
95.6 |
91.9 to 97.7 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2019 |
Age |
13-15 Years |
91.7 |
85.9 to 95.2 |
166 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-15 Years |
77.5 |
69.9 to 83.7 |
214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2019 |
Age |
13-15 Years |
82.0 |
73.5 to 88.3 |
177 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-15 Years |
94.0 |
89.9 to 96.5 |
436 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-15 Years |
91.1 |
83.8 to 95.3 |
143 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-15 Years |
94.4 |
89.6 to 97.1 |
293 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-15 Years |
90.4 |
75.9 to 96.6 |
124 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2019 |
Age |
13-15 Years |
89.1 |
88.1 to 90.1 |
11687 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-15 Years |
93.6 |
90.8 to 95.6 |
1209 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-15 Years |
94.5 |
91.6 to 96.4 |
536 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-15 Years |
90.5 |
87.4 to 93.0 |
1589 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-15 Years |
86.9 |
84.1 to 89.3 |
1501 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-15 Years |
91.8 |
89.7 to 93.5 |
1271 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-15 Years |
85.5 |
82.8 to 87.9 |
2058 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-15 Years |
85.1 |
81.4 to 88.1 |
799 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-15 Years |
86.3 |
82.5 to 89.4 |
1129 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-15 Years |
91.3 |
87.5 to 94.1 |
741 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-15 Years |
98.0 |
95.4 to 99.2 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2019 |
Age |
13-15 Years |
82.0 |
74.2 to 87.9 |
195 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2019 |
Age |
13-15 Years |
89.7 |
83.3 to 93.8 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2019 |
Age |
13-15 Years |
85.8 |
78.0 to 91.2 |
163 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2019 |
Age |
13-15 Years |
85.1 |
81.3 to 88.2 |
1157 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-15 Years |
86.8 |
79.4 to 91.8 |
181 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-15 Years |
93.5 |
83.3 to 97.6 |
120 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-15 Years |
88.7 |
81.9 to 93.2 |
178 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-15 Years |
93.3 |
87.6 to 96.5 |
178 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-15 Years |
83.2 |
78.1 to 87.3 |
500 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-15 Years |
74.4 |
63.5 to 82.9 |
124 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-15 Years |
83.5 |
78.9 to 87.3 |
854 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2019 |
Age |
13-15 Years |
87.2 |
79.4 to 92.3 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2019 |
Age |
13-15 Years |
92.5 |
87.9 to 95.4 |
291 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2019 |
Age |
13-15 Years |
85.0 |
75.8 to 91.1 |
247 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2019 |
Age |
13-15 Years |
84.1 |
76.1 to 89.8 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2019 |
Age |
13-15 Years |
89.8 |
82.7 to 94.2 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-15 Years |
90.3 |
83.8 to 94.3 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2019 |
Age |
13-15 Years |
78.5 |
70.5 to 84.7 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2020 |
Age |
13-15 Years |
83.0 |
75.8 to 88.4 |
184 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2020 |
Age |
13-15 Years |
76.9 |
68.1 to 83.9 |
181 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2020 |
Age |
13-15 Years |
87.2 |
80.9 to 91.7 |
203 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2020 |
Age |
13-15 Years |
94.0 |
87.5 to 97.2 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2020 |
Age |
13-15 Years |
84.7 |
76.7 to 90.3 |
272 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2020 |
Age |
13-15 Years |
86.1 |
78.4 to 91.3 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2020 |
Age |
13-15 Years |
94.7 |
90.0 to 97.3 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2020 |
Age |
13-15 Years |
87.9 |
80.9 to 92.6 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-15 Years |
92.2 |
86.1 to 95.8 |
245 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2020 |
Age |
13-15 Years |
76.4 |
67.1 to 83.7 |
225 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2020 |
Age |
13-15 Years |
96.8 |
92.9 to 98.6 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2020 |
Age |
13-15 Years |
73.2 |
64.6 to 80.3 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2020 |
Age |
13-15 Years |
84.6 |
77.2 to 89.9 |
171 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2020 |
Age |
13-15 Years |
88.6 |
82.3 to 92.9 |
253 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2020 |
Age |
13-15 Years |
92.0 |
87.8 to 94.8 |
420 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-15 Years |
89.7 |
81.5 to 94.5 |
171 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-15 Years |
92.5 |
87.5 to 95.6 |
249 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2020 |
Age |
13-15 Years |
93.5 |
87.8 to 96.7 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2020 |
Age |
13-15 Years |
92.3 |
86.6 to 95.6 |
166 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2020 |
Age |
13-15 Years |
80.0 |
72.5 to 85.9 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2020 |
Age |
13-15 Years |
91.9 |
85.5 to 95.6 |
164 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2020 |
Age |
13-15 Years |
90.2 |
83.2 to 94.5 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2020 |
Age |
13-15 Years |
94.6 |
90.5 to 97.0 |
225 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2020 |
Age |
13-15 Years |
93.7 |
90.5 to 95.9 |
533 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-15 Years |
96.8 |
93.1 to 98.5 |
246 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2020 |
Age |
13-15 Years |
96.8 |
93.3 to 98.5 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2020 |
Age |
13-15 Years |
95.7 |
90.6 to 98.1 |
213 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2020 |
Age |
13-15 Years |
60.9 |
51.9 to 69.2 |
177 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2020 |
Age |
13-15 Years |
80.9 |
73.1 to 86.8 |
258 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2020 |
Age |
13-15 Years |
70.6 |
61.3 to 78.4 |
182 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2020 |
Age |
13-15 Years |
88.2 |
81.8 to 92.6 |
238 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2020 |
Age |
13-15 Years |
86.3 |
78.3 to 91.6 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-15 Years |
90.3 |
85.0 to 93.9 |
219 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2020 |
Age |
13-15 Years |
94.6 |
90.5 to 97.1 |
248 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2020 |
Age |
13-15 Years |
83.2 |
76.0 to 88.5 |
197 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2020 |
Age |
13-15 Years |
92.3 |
88.1 to 95.1 |
444 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-15 Years |
91.5 |
85.2 to 95.3 |
233 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-15 Years |
92.8 |
86.6 to 96.3 |
211 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2020 |
Age |
13-15 Years |
96.3 |
92.8 to 98.2 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2020 |
Age |
13-15 Years |
90.9 |
84.9 to 94.7 |
256 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2020 |
Age |
13-15 Years |
94.1 |
89.0 to 96.9 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-15 Years |
77.1 |
69.6 to 83.2 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2020 |
Age |
13-15 Years |
85.3 |
78.5 to 90.2 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-15 Years |
93.5 |
88.5 to 96.4 |
468 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-15 Years |
92.6 |
85.2 to 96.4 |
164 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-15 Years |
93.6 |
87.8 to 96.8 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-15 Years |
79.1 |
65.2 to 88.4 |
94 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2020 |
Age |
13-15 Years |
88.5 |
87.3 to 89.7 |
12447 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-15 Years |
95.3 |
93.4 to 96.6 |
1297 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-15 Years |
93.1 |
90.1 to 95.2 |
692 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-15 Years |
89.4 |
86.5 to 91.8 |
2067 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-15 Years |
84.9 |
81.7 to 87.6 |
1570 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-15 Years |
93.6 |
91.8 to 95.0 |
1415 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-15 Years |
89.0 |
86.1 to 91.3 |
1541 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-15 Years |
84.2 |
80.4 to 87.3 |
894 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-15 Years |
87.6 |
84.1 to 90.4 |
1211 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-15 Years |
85.2 |
79.1 to 89.7 |
862 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-15 Years |
96.0 |
91.3 to 98.2 |
160 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2020 |
Age |
13-15 Years |
80.5 |
72.7 to 86.5 |
211 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2020 |
Age |
13-15 Years |
93.7 |
88.0 to 96.8 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2020 |
Age |
13-15 Years |
82.6 |
75.0 to 88.2 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2020 |
Age |
13-15 Years |
90.2 |
86.2 to 93.2 |
715 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-15 Years |
89.6 |
83.3 to 93.7 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-15 Years |
88.4 |
79.9 to 93.6 |
143 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-15 Years |
90.4 |
85.7 to 93.7 |
386 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-15 Years |
86.5 |
82.5 to 89.6 |
898 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2020 |
Age |
13-15 Years |
93.4 |
88.6 to 96.2 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2020 |
Age |
13-15 Years |
92.4 |
87.1 to 95.6 |
247 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2020 |
Age |
13-15 Years |
80.0 |
72.1 to 86.0 |
418 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2020 |
Age |
13-15 Years |
87.3 |
80.5 to 92.0 |
276 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2020 |
Age |
13-15 Years |
91.0 |
84.7 to 94.8 |
181 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-15 Years |
88.9 |
81.6 to 93.5 |
168 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2020 |
Age |
13-15 Years |
74.3 |
65.2 to 81.7 |
184 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2021 |
Age |
13-15 Years |
89.9 |
82.7 to 94.3 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2021 |
Age |
13-15 Years |
71.2 |
62.4 to 78.6 |
170 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2021 |
Age |
13-15 Years |
88.7 |
82.0 to 93.1 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2021 |
Age |
13-15 Years |
93.8 |
88.6 to 96.7 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2021 |
Age |
13-15 Years |
88.2 |
77.7 to 94.1 |
182 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2021 |
Age |
13-15 Years |
82.0 |
73.4 to 88.3 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2021 |
Age |
13-15 Years |
94.7 |
89.4 to 97.4 |
212 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2021 |
Age |
13-15 Years |
88.1 |
81.3 to 92.7 |
194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-15 Years |
91.1 |
85.0 to 94.9 |
261 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2021 |
Age |
13-15 Years |
73.8 |
63.1 to 82.3 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2021 |
Age |
13-15 Years |
89.9 |
81.0 to 94.9 |
161 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2021 |
Age |
13-15 Years |
67.1 |
56.1 to 76.5 |
130 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2021 |
Age |
13-15 Years |
89.2 |
82.2 to 93.7 |
145 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2021 |
Age |
13-15 Years |
90.4 |
83.9 to 94.5 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2021 |
Age |
13-15 Years |
95.7 |
92.5 to 97.6 |
355 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-15 Years |
93.7 |
83.0 to 97.8 |
94 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-15 Years |
96.3 |
92.7 to 98.1 |
261 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2021 |
Age |
13-15 Years |
88.5 |
80.6 to 93.4 |
163 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2021 |
Age |
13-15 Years |
95.3 |
88.5 to 98.1 |
127 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2021 |
Age |
13-15 Years |
86.0 |
77.9 to 91.5 |
180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2021 |
Age |
13-15 Years |
86.6 |
77.9 to 92.2 |
144 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2021 |
Age |
13-15 Years |
92.2 |
86.0 to 95.8 |
193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2021 |
Age |
13-15 Years |
89.4 |
82.8 to 93.7 |
183 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2021 |
Age |
13-15 Years |
93.0 |
89.7 to 95.3 |
572 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-15 Years |
93.6 |
86.3 to 97.2 |
163 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2021 |
Age |
13-15 Years |
89.0 |
80.6 to 94.0 |
225 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2021 |
Age |
13-15 Years |
88.0 |
80.0 to 93.1 |
182 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2021 |
Age |
13-15 Years |
60.8 |
51.9 to 69.1 |
189 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2021 |
Age |
13-15 Years |
89.8 |
83.4 to 93.9 |
212 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2021 |
Age |
13-15 Years |
76.3 |
67.8 to 83.1 |
176 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2021 |
Age |
13-15 Years |
89.4 |
83.1 to 93.6 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2021 |
Age |
13-15 Years |
87.6 |
80.0 to 92.6 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-15 Years |
86.4 |
79.2 to 91.4 |
178 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2021 |
Age |
13-15 Years |
93.3 |
86.0 to 97.0 |
183 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2021 |
Age |
13-15 Years |
84.8 |
77.4 to 90.1 |
201 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2021 |
Age |
13-15 Years |
93.2 |
89.4 to 95.7 |
344 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-15 Years |
90.2 |
84.0 to 94.1 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-15 Years |
95.2 |
89.4 to 97.9 |
165 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2021 |
Age |
13-15 Years |
95.6 |
91.7 to 97.7 |
167 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2021 |
Age |
13-15 Years |
92.7 |
85.0 to 96.7 |
104 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2021 |
Age |
13-15 Years |
87.9 |
78.5 to 93.6 |
156 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-15 Years |
78.2 |
69.7 to 84.8 |
151 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2021 |
Age |
13-15 Years |
82.9 |
75.3 to 88.5 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-15 Years |
92.7 |
88.9 to 95.3 |
561 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-15 Years |
91.9 |
84.6 to 95.9 |
198 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-15 Years |
92.8 |
88.5 to 95.6 |
363 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-15 Years |
86.0 |
79.0 to 91.0 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2021 |
Age |
13-15 Years |
88.5 |
87.0 to 89.8 |
11161 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-15 Years |
92.5 |
89.4 to 94.7 |
1186 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-15 Years |
93.2 |
90.0 to 95.5 |
527 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-15 Years |
90.3 |
87.6 to 92.5 |
2095 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-15 Years |
84.0 |
80.4 to 87.0 |
1412 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-15 Years |
90.3 |
87.5 to 92.5 |
1256 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-15 Years |
89.0 |
85.6 to 91.7 |
1333 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-15 Years |
90.1 |
86.8 to 92.7 |
715 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-15 Years |
86.3 |
82.2 to 89.6 |
1112 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-15 Years |
88.3 |
80.6 to 93.1 |
727 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-15 Years |
92.8 |
84.8 to 96.8 |
167 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2021 |
Age |
13-15 Years |
85.4 |
77.5 to 90.8 |
174 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2021 |
Age |
13-15 Years |
97.1 |
94.4 to 98.6 |
276 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2021 |
Age |
13-15 Years |
87.4 |
80.6 to 92.1 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2021 |
Age |
13-15 Years |
89.7 |
84.9 to 93.1 |
592 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-15 Years |
91.0 |
84.5 to 95.0 |
174 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-15 Years |
92.4 |
80.7 to 97.3 |
93 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-15 Years |
89.5 |
83.9 to 93.2 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-15 Years |
81.0 |
70.9 to 88.2 |
163 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-15 Years |
85.7 |
82.0 to 88.7 |
798 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2021 |
Age |
13-15 Years |
92.7 |
86.9 to 96.1 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2021 |
Age |
13-15 Years |
87.0 |
81.6 to 91.0 |
283 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2021 |
Age |
13-15 Years |
85.7 |
77.6 to 91.2 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2021 |
Age |
13-15 Years |
87.4 |
81.3 to 91.7 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2021 |
Age |
13-15 Years |
87.9 |
81.0 to 92.5 |
162 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-15 Years |
90.1 |
83.5 to 94.3 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2021 |
Age |
13-15 Years |
75.4 |
66.3 to 82.6 |
169 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2022 |
Age |
13-15 Years |
85.3 |
77.9 to 90.5 |
157 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2022 |
Age |
13-15 Years |
75.4 |
66.0 to 82.9 |
156 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2022 |
Age |
13-15 Years |
86.8 |
79.2 to 91.9 |
159 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2022 |
Age |
13-15 Years |
94.8 |
90.3 to 97.3 |
193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2022 |
Age |
13-15 Years |
80.5 |
71.3 to 87.2 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2022 |
Age |
13-15 Years |
82.9 |
76.0 to 88.0 |
205 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2022 |
Age |
13-15 Years |
92.5 |
85.2 to 96.3 |
167 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2022 |
Age |
13-15 Years |
90.7 |
82.5 to 95.2 |
145 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-15 Years |
92.1 |
85.5 to 95.9 |
152 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2022 |
Age |
13-15 Years |
82.5 |
73.3 to 89.1 |
183 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2022 |
Age |
13-15 Years |
94.4 |
87.8 to 97.5 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2022 |
Age |
13-15 Years |
65.9 |
54.9 to 75.5 |
147 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2022 |
Age |
13-15 Years |
86.5 |
78.3 to 91.9 |
137 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2022 |
Age |
13-15 Years |
88.0 |
79.0 to 93.5 |
158 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2022 |
Age |
13-15 Years |
93.6 |
88.5 to 96.5 |
383 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-15 Years |
91.5 |
85.2 to 95.3 |
161 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-15 Years |
94.1 |
87.4 to 97.4 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2022 |
Age |
13-15 Years |
91.8 |
85.0 to 95.7 |
167 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2022 |
Age |
13-15 Years |
96.7 |
90.4 to 98.9 |
131 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2022 |
Age |
13-15 Years |
88.2 |
81.0 to 92.9 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2022 |
Age |
13-15 Years |
90.5 |
81.7 to 95.3 |
159 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2022 |
Age |
13-15 Years |
88.5 |
81.4 to 93.2 |
210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2022 |
Age |
13-15 Years |
97.0 |
93.4 to 98.6 |
163 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2022 |
Age |
13-15 Years |
90.9 |
82.5 to 95.5 |
213 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-15 Years |
91.5 |
83.9 to 95.7 |
151 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2022 |
Age |
13-15 Years |
92.3 |
85.1 to 96.2 |
165 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2022 |
Age |
13-15 Years |
93.5 |
87.2 to 96.8 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2022 |
Age |
13-15 Years |
53.6 |
42.9 to 63.9 |
147 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2022 |
Age |
13-15 Years |
90.0 |
83.2 to 94.2 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2022 |
Age |
13-15 Years |
82.9 |
75.6 to 88.3 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2022 |
Age |
13-15 Years |
88.8 |
81.2 to 93.5 |
156 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2022 |
Age |
13-15 Years |
82.6 |
73.8 to 88.8 |
155 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-15 Years |
87.2 |
78.5 to 92.7 |
134 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2022 |
Age |
13-15 Years |
90.4 |
83.3 to 94.7 |
158 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2022 |
Age |
13-15 Years |
84.1 |
75.9 to 89.8 |
185 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2022 |
Age |
13-15 Years |
96.0 |
93.3 to 97.7 |
320 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-15 Years |
95.3 |
89.9 to 97.8 |
146 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-15 Years |
96.5 |
93.0 to 98.3 |
174 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2022 |
Age |
13-15 Years |
90.9 |
83.6 to 95.2 |
229 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2022 |
Age |
13-15 Years |
95.3 |
88.9 to 98.1 |
177 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2022 |
Age |
13-15 Years |
90.8 |
81.9 to 95.5 |
163 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-15 Years |
84.5 |
76.6 to 90.1 |
153 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2022 |
Age |
13-15 Years |
76.1 |
67.2 to 83.2 |
170 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-15 Years |
94.6 |
91.0 to 96.8 |
471 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-15 Years |
91.9 |
83.6 to 96.2 |
169 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-15 Years |
94.9 |
90.8 to 97.3 |
302 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-15 Years |
87.9 |
83.1 to 91.5 |
393 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2022 |
Age |
13-15 Years |
87.5 |
86.1 to 88.9 |
9816 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-15 Years |
92.1 |
88.6 to 94.6 |
947 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-15 Years |
94.2 |
91.4 to 96.1 |
478 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-15 Years |
90.0 |
87.4 to 92.2 |
1494 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-15 Years |
85.4 |
82.1 to 88.1 |
1406 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-15 Years |
92.2 |
89.6 to 94.1 |
1226 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-15 Years |
85.2 |
80.2 to 89.0 |
1229 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-15 Years |
90.9 |
87.6 to 93.4 |
654 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-15 Years |
87.8 |
84.5 to 90.5 |
1085 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-15 Years |
81.7 |
74.8 to 87.1 |
639 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-15 Years |
97.0 |
92.8 to 98.8 |
168 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2022 |
Age |
13-15 Years |
84.5 |
75.4 to 90.6 |
155 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2022 |
Age |
13-15 Years |
95.3 |
89.9 to 97.9 |
158 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2022 |
Age |
13-15 Years |
81.3 |
71.9 to 88.1 |
160 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2022 |
Age |
13-15 Years |
84.0 |
77.0 to 89.2 |
488 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-15 Years |
87.4 |
77.9 to 93.2 |
151 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-15 Years |
85.5 |
74.2 to 92.4 |
98 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-15 Years |
83.7 |
75.7 to 89.5 |
239 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-15 Years |
84.2 |
80.0 to 87.6 |
658 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2022 |
Age |
13-15 Years |
94.2 |
87.4 to 97.4 |
166 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2022 |
Age |
13-15 Years |
89.3 |
81.5 to 94.1 |
164 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2022 |
Age |
13-15 Years |
82.5 |
76.5 to 87.3 |
365 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2022 |
Age |
13-15 Years |
88.5 |
82.0 to 92.8 |
174 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2022 |
Age |
13-15 Years |
91.3 |
85.0 to 95.2 |
148 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-15 Years |
90.7 |
84.7 to 94.5 |
160 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2022 |
Age |
13-15 Years |
71.4 |
61.6 to 79.5 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2006 |
Age |
13-17 Years |
11.7 |
10.3 to 13.2 |
2882 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2006 |
Age |
13-17 Years |
15.2 |
9.2 to 23.9 |
170 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2006 |
Age |
13-17 Years |
14.2 |
9.7 to 20.4 |
227 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2006 |
Age |
13-17 Years |
15.4 |
11.7 to 20.0 |
347 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2006 |
Age |
13-17 Years |
6.2 |
4.4 to 8.6 |
608 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2006 |
Age |
13-17 Years |
13.7 |
10.4 to 18.0 |
458 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2006 |
Age |
13-17 Years |
8.7 |
5.5 to 13.6 |
268 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2006 |
Age |
13-17 Years |
19.3 |
12.6 to 28.5 |
165 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2006 |
Age |
13-17 Years |
14.3 |
10.4 to 19.3 |
362 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
32.4 |
30.2 to 34.7 |
2947 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
33.7 |
26.1 to 42.2 |
190 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-17 Years |
47.8 |
39.9 to 55.8 |
219 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
40.6 |
34.2 to 47.4 |
370 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
27.0 |
22.2 to 32.4 |
501 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
32.0 |
27.4 to 36.8 |
584 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-17 Years |
27.9 |
22.1 to 34.7 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-17 Years |
26.9 |
19.7 to 35.4 |
165 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-17 Years |
24.8 |
16.3 to 35.8 |
112 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
35.3 |
28.6 to 42.8 |
366 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2007 |
Age |
13-17 Years |
19.0 |
12.3 to 28.2 |
118 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
29.9 |
24.8 to 35.5 |
406 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
30.5 |
25.1 to 36.5 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
51.5 |
44.2 to 58.7 |
250 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
14.5 |
10.8 to 19.1 |
382 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
48.0 |
40.6 to 55.5 |
316 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
32.4 |
26.3 to 39.1 |
347 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
45.2 |
38.2 to 52.4 |
292 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
58.6 |
52.1 to 64.7 |
334 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
58.1 |
51.7 to 64.2 |
329 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
33.6 |
26.7 to 41.2 |
284 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
41.6 |
35.2 to 48.3 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
44.1 |
38.1 to 50.3 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
29.9 |
24.1 to 36.5 |
268 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
41.9 |
36.5 to 47.6 |
783 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
41.1 |
35.1 to 47.5 |
343 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
42.1 |
35.5 to 49.1 |
440 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
31.8 |
26.5 to 37.8 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
31.9 |
26.4 to 38.0 |
308 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
25.6 |
20.0 to 32.3 |
271 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
30.9 |
25.3 to 37.0 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
53.6 |
47.5 to 59.6 |
379 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
35.6 |
29.9 to 41.7 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
54.6 |
48.2 to 60.7 |
394 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
55.9 |
49.4 to 62.2 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
39.9 |
33.9 to 46.2 |
320 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
38.9 |
33.0 to 45.1 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2008 |
Age |
13-17 Years |
14.8 |
10.9 to 19.8 |
404 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
35.3 |
29.6 to 41.5 |
351 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
17.8 |
13.1 to 23.6 |
299 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
37.2 |
31.8 to 42.9 |
365 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
29.6 |
23.3 to 36.9 |
235 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
54.6 |
47.3 to 61.7 |
300 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
60.6 |
54.2 to 66.6 |
390 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
39.6 |
33.3 to 46.3 |
310 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
56.0 |
51.1 to 60.8 |
600 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
53.5 |
46.4 to 60.5 |
293 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
57.7 |
51.1 to 64.0 |
307 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
30.7 |
25.2 to 36.9 |
326 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
47.4 |
41.7 to 53.1 |
362 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
37.7 |
31.7 to 44.1 |
311 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
25.1 |
20.0 to 30.9 |
292 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
29.6 |
23.7 to 36.3 |
235 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
59.7 |
54.2 to 65.1 |
682 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
66.3 |
60.1 to 72.1 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
58.7 |
52.4 to 64.8 |
337 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
41.8 |
40.3 to 43.2 |
17835 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
50.1 |
46.6 to 53.7 |
1838 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
57.4 |
53.6 to 61.2 |
990 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
52.7 |
49.4 to 56.0 |
2306 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
32.7 |
30.0 to 35.5 |
2788 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
40.1 |
37.6 to 42.8 |
2361 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
36.6 |
32.2 to 41.3 |
2203 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
32.8 |
29.6 to 36.2 |
1295 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
30.3 |
26.9 to 33.9 |
1854 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
47.4 |
41.5 to 53.4 |
1118 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
62.6 |
55.3 to 69.5 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
25.1 |
20.1 to 30.8 |
367 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
14.0 |
10.3 to 18.9 |
344 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
36.5 |
30.7 to 42.8 |
360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
37.4 |
30.9 to 44.3 |
840 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
43.2 |
36.2 to 50.5 |
269 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
51.9 |
42.9 to 60.7 |
233 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
35.6 |
28.2 to 43.7 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
35.1 |
31.2 to 39.2 |
1082 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2008 |
Age |
13-17 Years |
31.3 |
24.9 to 38.6 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
20.0 |
15.2 to 25.8 |
283 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
43.8 |
37.1 to 50.8 |
272 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
40.0 |
33.5 to 46.8 |
275 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
30.2 |
24.6 to 36.4 |
295 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
52.2 |
45.5 to 58.9 |
264 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
32.8 |
27.2 to 39.0 |
280 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
43.5 |
37.5 to 49.8 |
339 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
40.2 |
33.8 to 46.9 |
274 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
69.7 |
63.4 to 75.3 |
349 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
21.9 |
17.3 to 27.2 |
363 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
58.4 |
52.0 to 64.6 |
379 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
53.7 |
47.5 to 59.9 |
411 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
68.1 |
61.8 to 73.9 |
351 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
58.4 |
51.8 to 64.7 |
371 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
78.3 |
72.6 to 83.1 |
412 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
52.7 |
46.6 to 58.7 |
412 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
53.3 |
47.2 to 59.4 |
383 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
51.0 |
44.2 to 57.7 |
256 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
34.2 |
27.3 to 41.8 |
227 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
53.5 |
48.5 to 58.4 |
754 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
58.4 |
52.2 to 64.3 |
389 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
52.2 |
46.2 to 58.2 |
365 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
41.7 |
36.5 to 47.2 |
873 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
46.4 |
40.4 to 52.6 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
38.3 |
31.7 to 45.4 |
252 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
36.3 |
31.2 to 41.7 |
393 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
65.8 |
58.5 to 72.4 |
281 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
47.3 |
40.7 to 54.1 |
299 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
59.3 |
51.1 to 67.0 |
245 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
74.0 |
68.6 to 78.8 |
397 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
52.6 |
47.0 to 58.1 |
446 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
43.9 |
38.1 to 49.9 |
336 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
19.3 |
15.5 to 23.7 |
438 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
45.5 |
39.6 to 51.4 |
374 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
26.9 |
21.7 to 32.9 |
306 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
53.2 |
46.8 to 59.6 |
286 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
39.5 |
33.4 to 45.9 |
336 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
67.8 |
61.6 to 73.5 |
307 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
71.4 |
65.7 to 76.5 |
427 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
51.2 |
45.6 to 56.8 |
406 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
62.9 |
57.7 to 67.8 |
539 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
61.0 |
53.0 to 68.4 |
269 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
64.2 |
57.4 to 70.4 |
270 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
46.8 |
40.4 to 53.3 |
323 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
66.0 |
59.5 to 72.0 |
272 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
53.7 |
47.5 to 59.9 |
351 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
29.5 |
24.4 to 35.2 |
336 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
41.6 |
36.1 to 47.2 |
386 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
71.9 |
65.8 to 77.3 |
579 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
75.3 |
69.7 to 80.2 |
324 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
71.4 |
64.3 to 77.5 |
255 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
53.6 |
52.4 to 54.9 |
20066 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
68.3 |
65.3 to 71.2 |
2189 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
65.5 |
61.6 to 69.3 |
966 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
60.9 |
57.4 to 64.3 |
2214 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
46.7 |
44.2 to 49.2 |
2984 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
51.2 |
48.8 to 53.6 |
3105 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
48.6 |
45.0 to 52.3 |
2856 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
45.2 |
41.9 to 48.6 |
1250 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
46.2 |
42.8 to 49.7 |
1974 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
58.8 |
53.6 to 63.7 |
1320 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
75.7 |
70.2 to 80.5 |
409 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
34.5 |
28.6 to 40.9 |
299 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
24.9 |
19.6 to 31.1 |
271 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
52.1 |
46.1 to 58.1 |
397 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
51.0 |
45.7 to 56.2 |
1470 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
54.8 |
47.5 to 61.9 |
305 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
64.8 |
56.0 to 72.8 |
239 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
52.5 |
45.2 to 59.6 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
67.4 |
61.5 to 72.9 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
48.1 |
41.1 to 55.2 |
305 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-17 Years |
21.1 |
16.2 to 26.9 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
47.9 |
44.1 to 51.7 |
1208 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
42.1 |
36.0 to 48.3 |
339 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
43.9 |
38.5 to 49.5 |
426 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
48.1 |
41.9 to 54.4 |
358 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
55.8 |
49.4 to 62.0 |
321 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
39.0 |
32.5 to 45.9 |
249 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
55.7 |
49.5 to 61.8 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
47.8 |
42.0 to 53.6 |
375 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
47.7 |
41.3 to 54.2 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
40.9 |
34.7 to 47.4 |
294 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
78.9 |
73.1 to 83.7 |
331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
30.9 |
25.0 to 37.4 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
66.7 |
60.5 to 72.3 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
59.6 |
53.0 to 65.8 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
72.0 |
66.4 to 77.0 |
408 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
71.2 |
65.0 to 76.7 |
348 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
89.5 |
85.1 to 92.8 |
355 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
55.1 |
48.5 to 61.6 |
344 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
63.5 |
57.5 to 69.0 |
373 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
64.5 |
58.4 to 70.1 |
320 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
40.8 |
35.0 to 47.0 |
318 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
56.6 |
51.6 to 61.4 |
739 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
63.8 |
57.4 to 69.8 |
366 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
54.7 |
48.8 to 60.5 |
373 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
70.6 |
64.4 to 76.1 |
316 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
53.7 |
47.1 to 60.3 |
264 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
50.2 |
44.5 to 55.9 |
373 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
44.8 |
38.7 to 51.1 |
309 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
78.6 |
73.2 to 83.1 |
347 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
56.4 |
49.9 to 62.6 |
312 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
68.9 |
62.5 to 74.7 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
82.9 |
77.0 to 87.5 |
306 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
70.9 |
64.5 to 76.5 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
57.0 |
50.6 to 63.2 |
310 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
26.0 |
21.0 to 31.7 |
354 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
49.2 |
43.3 to 55.1 |
347 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
40.2 |
34.4 to 46.2 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
65.7 |
59.3 to 71.6 |
307 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
54.2 |
48.0 to 60.3 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
73.8 |
68.1 to 78.8 |
350 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
81.7 |
75.9 to 86.4 |
399 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
52.9 |
46.6 to 59.0 |
332 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
71.2 |
66.5 to 75.4 |
701 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
75.5 |
69.7 to 80.5 |
388 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
68.4 |
61.5 to 74.5 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
52.4 |
46.3 to 58.3 |
366 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
76.8 |
71.2 to 81.5 |
299 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
61.6 |
55.3 to 67.4 |
302 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
42.6 |
36.4 to 49.1 |
300 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
52.4 |
45.9 to 58.7 |
302 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
79.8 |
75.0 to 83.9 |
742 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
84.5 |
79.6 to 88.4 |
371 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
79.1 |
73.6 to 83.7 |
371 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
62.7 |
61.5 to 63.9 |
19257 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
75.6 |
72.7 to 78.4 |
2026 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
74.5 |
70.9 to 77.9 |
1100 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
68.8 |
65.8 to 71.7 |
2436 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
51.9 |
49.4 to 54.5 |
2679 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
63.7 |
61.2 to 66.1 |
2248 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
61.6 |
58.3 to 64.9 |
3001 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
52.6 |
49.3 to 55.9 |
1291 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
53.2 |
49.7 to 56.7 |
1890 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
67.5 |
62.6 to 72.1 |
1311 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
83.5 |
78.2 to 87.6 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
44.7 |
38.3 to 51.2 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
30.9 |
25.3 to 37.1 |
321 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
50.6 |
44.4 to 56.8 |
320 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
65.4 |
60.5 to 70.0 |
1709 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
72.0 |
66.3 to 77.1 |
382 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
75.9 |
69.9 to 81.0 |
413 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
72.9 |
65.5 to 79.3 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
80.8 |
75.8 to 85.0 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
61.9 |
55.3 to 68.1 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
31.9 |
25.1 to 39.7 |
231 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
58.0 |
54.5 to 61.5 |
1275 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
48.8 |
42.6 to 55.1 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
54.1 |
47.6 to 60.5 |
320 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
54.5 |
47.6 to 61.2 |
332 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
67.6 |
61.9 to 72.8 |
361 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
45.7 |
39.7 to 51.8 |
321 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
69.4 |
62.7 to 75.3 |
277 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
51.5 |
45.0 to 57.9 |
295 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
64.3 |
58.3 to 69.9 |
403 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
46.1 |
39.1 to 53.3 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
82.9 |
76.6 to 87.8 |
416 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
27.6 |
21.2 to 35.1 |
350 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
75.4 |
70.7 to 79.5 |
583 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
64.4 |
57.1 to 71.0 |
431 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
81.1 |
75.6 to 85.7 |
453 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
78.2 |
73.0 to 82.7 |
442 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
90.3 |
86.0 to 93.4 |
415 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
61.2 |
55.0 to 67.1 |
483 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
67.7 |
61.6 to 73.2 |
425 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
70.2 |
64.0 to 75.8 |
339 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
50.5 |
43.3 to 57.6 |
385 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
66.5 |
61.3 to 71.4 |
848 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
72.2 |
66.1 to 77.5 |
407 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
65.2 |
58.8 to 71.0 |
441 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
92.1 |
87.6 to 95.0 |
430 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
60.5 |
53.6 to 67.0 |
359 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
47.7 |
41.1 to 54.3 |
399 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
55.0 |
48.4 to 61.4 |
382 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
90.0 |
85.8 to 93.0 |
473 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
64.9 |
58.8 to 70.5 |
411 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
78.5 |
73.4 to 82.9 |
516 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
84.4 |
78.3 to 89.0 |
365 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
77.9 |
71.5 to 83.3 |
398 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
63.1 |
55.9 to 69.7 |
327 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
34.2 |
27.8 to 41.2 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
54.6 |
48.0 to 61.0 |
402 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
39.8 |
31.8 to 48.5 |
385 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
76.0 |
69.9 to 81.2 |
368 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
60.3 |
52.9 to 67.3 |
412 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
80.6 |
74.9 to 85.3 |
385 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
85.9 |
81.2 to 89.6 |
432 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
64.8 |
58.5 to 70.5 |
431 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
74.9 |
70.9 to 78.5 |
840 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
79.1 |
74.0 to 83.3 |
435 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
72.3 |
66.6 to 77.4 |
405 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
65.9 |
59.4 to 71.9 |
347 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
84.2 |
76.0 to 90.0 |
314 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
66.0 |
59.7 to 71.8 |
381 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
55.3 |
48.6 to 61.8 |
360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
55.8 |
49.0 to 62.3 |
362 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
83.8 |
79.2 to 87.6 |
880 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
88.7 |
84.2 to 92.0 |
387 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
83.2 |
78.0 to 87.4 |
493 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
70.5 |
69.4 to 71.5 |
23564 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
81.0 |
78.1 to 83.7 |
2467 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
78.5 |
75.4 to 81.3 |
1272 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
75.0 |
72.2 to 77.6 |
3073 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
61.2 |
58.7 to 63.7 |
3171 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
72.4 |
69.9 to 74.8 |
2800 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
73.5 |
70.7 to 76.2 |
3838 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
57.2 |
53.6 to 60.8 |
1528 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
59.6 |
55.6 to 63.4 |
2242 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
75.4 |
71.7 to 78.8 |
1750 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
88.9 |
84.0 to 92.4 |
449 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
55.4 |
48.4 to 62.2 |
362 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
37.4 |
28.5 to 47.3 |
355 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
63.3 |
56.7 to 69.5 |
424 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
79.1 |
74.9 to 82.7 |
2224 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
82.2 |
77.3 to 86.2 |
448 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
83.3 |
77.6 to 87.8 |
490 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
75.7 |
68.9 to 81.4 |
441 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
84.2 |
78.4 to 88.6 |
355 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
78.5 |
72.9 to 83.2 |
490 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
31.5 |
26.9 to 36.6 |
485 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
61.6 |
57.6 to 65.4 |
1423 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
58.5 |
51.3 to 65.2 |
393 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
65.7 |
59.7 to 71.2 |
404 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
61.8 |
55.6 to 67.7 |
417 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
69.4 |
62.7 to 75.4 |
346 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
54.9 |
48.8 to 60.8 |
403 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
74.5 |
68.4 to 79.8 |
416 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
60.8 |
52.4 to 68.5 |
364 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
60.5 |
53.1 to 67.3 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
52.7 |
46.5 to 58.9 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
85.5 |
79.7 to 89.8 |
360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
37.5 |
30.9 to 44.7 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
76.0 |
70.0 to 81.0 |
430 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
73.2 |
66.1 to 79.2 |
311 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
88.8 |
84.5 to 92.1 |
323 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
78.0 |
71.2 to 83.5 |
341 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
92.1 |
88.0 to 94.8 |
342 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
68.6 |
61.5 to 75.0 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
73.1 |
65.8 to 79.3 |
328 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
70.4 |
63.7 to 76.3 |
342 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
63.2 |
56.8 to 69.3 |
357 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
67.7 |
61.5 to 73.4 |
632 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
77.0 |
70.3 to 82.6 |
287 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
65.4 |
57.9 to 72.3 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
92.0 |
87.2 to 95.1 |
341 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
64.4 |
57.4 to 70.8 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
55.9 |
48.6 to 63.1 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
62.9 |
55.9 to 69.4 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
90.8 |
86.5 to 93.8 |
370 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
73.7 |
67.1 to 79.3 |
319 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
74.9 |
67.5 to 81.2 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
89.2 |
84.8 to 92.4 |
347 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
87.5 |
82.6 to 91.1 |
368 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
66.6 |
59.4 to 73.0 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
40.7 |
33.8 to 47.9 |
321 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
58.3 |
50.5 to 65.6 |
292 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
58.6 |
51.9 to 65.0 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
75.5 |
68.9 to 81.1 |
328 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
66.3 |
59.8 to 72.4 |
329 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
83.1 |
76.7 to 88.0 |
278 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
91.6 |
86.8 to 94.7 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
54.2 |
47.2 to 61.1 |
331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
78.5 |
74.1 to 82.3 |
627 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
75.3 |
69.0 to 80.6 |
312 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
80.5 |
74.3 to 85.4 |
315 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
68.2 |
61.6 to 74.2 |
347 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
88.1 |
82.3 to 92.2 |
324 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
66.4 |
59.2 to 72.8 |
327 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
63.8 |
56.9 to 70.2 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
58.3 |
51.9 to 64.4 |
381 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
89.4 |
85.3 to 92.5 |
741 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
92.9 |
88.2 to 95.8 |
348 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
88.9 |
84.3 to 92.3 |
393 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
74.0 |
72.9 to 75.1 |
19199 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
86.8 |
84.6 to 88.8 |
1916 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
82.8 |
79.5 to 85.6 |
957 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
77.2 |
74.0 to 80.1 |
2365 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
66.2 |
63.3 to 68.9 |
2612 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
75.0 |
72.3 to 77.4 |
2297 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
78.4 |
75.9 to 80.7 |
2939 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
61.4 |
57.3 to 65.4 |
1285 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
64.7 |
60.8 to 68.4 |
1936 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
76.6 |
71.9 to 80.7 |
1461 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
94.3 |
90.6 to 96.7 |
327 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
58.5 |
51.0 to 65.6 |
310 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
40.0 |
33.4 to 47.0 |
298 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
69.4 |
62.3 to 75.7 |
331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
84.6 |
81.0 to 87.6 |
1594 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
83.6 |
76.7 to 88.7 |
346 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
87.6 |
82.3 to 91.5 |
393 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
84.4 |
80.2 to 87.8 |
855 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
38.1 |
33.4 to 43.0 |
547 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
65.3 |
61.3 to 69.2 |
1431 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
56.5 |
49.4 to 63.3 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
72.6 |
66.2 to 78.3 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
62.1 |
54.5 to 69.2 |
334 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
71.2 |
64.2 to 77.3 |
353 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
64.1 |
56.4 to 71.1 |
282 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
74.4 |
67.7 to 80.1 |
307 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
59.0 |
52.3 to 65.5 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
69.5 |
63.2 to 75.2 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
55.2 |
48.7 to 61.6 |
320 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
86.7 |
81.4 to 90.7 |
359 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
40.4 |
34.1 to 47.0 |
312 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
80.9 |
74.6 to 85.9 |
309 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
73.6 |
67.6 to 78.8 |
331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
90.6 |
85.5 to 94.0 |
328 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
81.8 |
76.2 to 86.3 |
348 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
91.3 |
81.2 to 96.3 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
72.3 |
65.5 to 78.2 |
323 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
76.9 |
69.3 to 83.2 |
253 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
72.4 |
66.4 to 77.7 |
363 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
75.0 |
68.5 to 80.5 |
315 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
71.6 |
64.0 to 78.0 |
272 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
79.0 |
74.2 to 83.2 |
558 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
83.3 |
76.1 to 88.7 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
78.0 |
72.2 to 82.9 |
349 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
93.5 |
90.1 to 95.7 |
381 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
63.6 |
57.6 to 69.3 |
383 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
55.9 |
49.0 to 62.5 |
287 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
71.2 |
64.5 to 77.0 |
291 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
87.7 |
82.6 to 91.5 |
298 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
71.2 |
65.3 to 76.5 |
343 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
78.0 |
70.6 to 83.9 |
320 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
89.6 |
85.4 to 92.8 |
393 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
90.7 |
85.9 to 93.9 |
307 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
66.3 |
59.9 to 72.2 |
369 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
50.1 |
43.2 to 56.9 |
284 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
60.7 |
53.4 to 67.5 |
280 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
51.6 |
45.0 to 58.2 |
320 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
77.5 |
71.9 to 82.3 |
301 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
64.0 |
57.7 to 69.9 |
335 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
85.6 |
80.6 to 89.4 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
91.8 |
86.7 to 95.1 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
70.9 |
65.0 to 76.1 |
357 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
83.3 |
79.7 to 86.4 |
710 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
83.0 |
77.2 to 87.6 |
300 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
83.6 |
78.7 to 87.5 |
410 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
72.4 |
66.4 to 77.7 |
306 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
93.7 |
89.6 to 96.3 |
344 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
69.2 |
62.8 to 74.9 |
319 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
66.2 |
60.7 to 71.3 |
426 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
65.3 |
59.3 to 70.8 |
364 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
90.4 |
86.1 to 93.5 |
751 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
92.1 |
87.4 to 95.1 |
307 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
90.2 |
85.4 to 93.6 |
444 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
77.8 |
76.7 to 78.9 |
18264 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
87.7 |
85.4 to 89.6 |
2050 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
86.1 |
83.3 to 88.5 |
1032 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
79.7 |
76.3 to 82.7 |
2241 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
70.9 |
68.2 to 73.5 |
2374 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
79.9 |
77.7 to 82.0 |
2264 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
81.5 |
78.8 to 83.9 |
2505 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
62.5 |
58.8 to 66.2 |
1251 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
67.0 |
63.6 to 70.2 |
1913 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
80.6 |
75.7 to 84.7 |
1318 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
92.0 |
87.6 to 94.9 |
315 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
68.7 |
61.7 to 74.9 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
51.7 |
44.9 to 58.3 |
292 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
67.8 |
61.4 to 73.6 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
87.6 |
83.7 to 90.7 |
1112 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
87.2 |
82.4 to 90.8 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
91.4 |
85.5 to 95.0 |
278 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
87.4 |
82.8 to 90.9 |
517 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
38.4 |
32.6 to 44.5 |
332 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
72.7 |
69.0 to 76.1 |
1316 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
61.0 |
54.1 to 67.4 |
301 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
79.2 |
73.4 to 84.0 |
326 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
64.2 |
55.4 to 72.2 |
302 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
79.0 |
72.8 to 84.1 |
360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
77.3 |
71.3 to 82.3 |
328 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
81.4 |
76.0 to 85.8 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
63.1 |
56.7 to 69.1 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
71.6 |
65.6 to 76.9 |
378 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
56.9 |
50.7 to 62.9 |
377 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
85.9 |
80.6 to 90.0 |
421 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
64.8 |
58.5 to 70.6 |
368 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
79.3 |
73.0 to 84.5 |
356 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
76.8 |
71.6 to 81.4 |
394 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
94.9 |
91.0 to 97.2 |
386 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
86.7 |
81.3 to 90.7 |
374 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
93.5 |
90.1 to 95.9 |
285 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
72.2 |
65.0 to 78.3 |
363 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
74.9 |
68.4 to 80.5 |
373 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
77.7 |
72.1 to 82.5 |
363 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
78.1 |
71.7 to 83.4 |
341 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
77.1 |
72.6 to 81.0 |
709 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
83.4 |
76.6 to 88.5 |
274 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
75.6 |
70.3 to 80.3 |
435 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
90.0 |
85.3 to 93.3 |
370 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
64.4 |
57.3 to 71.0 |
328 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
65.1 |
58.4 to 71.3 |
352 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
78.2 |
71.9 to 83.3 |
335 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
91.8 |
87.7 to 94.6 |
335 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
73.6 |
67.6 to 78.9 |
341 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
86.5 |
80.7 to 90.7 |
409 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
92.1 |
88.1 to 94.9 |
358 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
90.7 |
86.0 to 94.0 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
75.5 |
69.0 to 81.0 |
286 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
46.0 |
39.6 to 52.6 |
356 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
63.3 |
56.6 to 69.6 |
361 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
60.2 |
53.6 to 66.5 |
367 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
74.1 |
67.9 to 79.5 |
321 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
66.5 |
60.4 to 72.1 |
351 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
90.6 |
86.9 to 93.4 |
402 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
94.9 |
90.5 to 97.3 |
328 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
75.1 |
69.2 to 80.3 |
378 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
79.6 |
75.1 to 83.5 |
594 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
86.8 |
81.1 to 91.0 |
288 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
75.1 |
68.6 to 80.6 |
306 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
74.1 |
68.2 to 79.3 |
372 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
91.8 |
87.8 to 94.6 |
327 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
73.7 |
67.9 to 78.7 |
430 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
70.8 |
64.8 to 76.2 |
356 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
68.4 |
62.1 to 74.1 |
399 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
95.2 |
92.9 to 96.8 |
785 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
92.6 |
87.9 to 95.5 |
343 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
95.6 |
92.9 to 97.3 |
442 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
83.5 |
75.6 to 89.2 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
79.3 |
78.2 to 80.3 |
20827 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
90.8 |
88.8 to 92.5 |
2268 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
84.6 |
81.3 to 87.4 |
922 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
85.9 |
83.4 to 88.1 |
2553 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
71.8 |
69.2 to 74.3 |
2896 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
80.1 |
78.0 to 82.1 |
2465 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
85.0 |
82.7 to 87.1 |
3089 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
65.4 |
61.7 to 68.9 |
1362 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
70.9 |
67.8 to 73.7 |
2290 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
79.5 |
74.5 to 83.6 |
1491 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
94.1 |
89.9 to 96.6 |
414 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
67.3 |
60.7 to 73.3 |
380 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
57.0 |
50.3 to 63.5 |
358 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
74.0 |
67.7 to 79.4 |
339 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
88.6 |
85.2 to 91.3 |
1652 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
84.3 |
78.7 to 88.7 |
385 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
87.4 |
81.6 to 91.6 |
379 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
91.7 |
86.5 to 95.0 |
397 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
88.9 |
84.8 to 91.9 |
491 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
76.2 |
72.9 to 79.3 |
1491 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
66.9 |
60.8 to 72.5 |
398 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
81.3 |
75.7 to 85.9 |
367 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
72.5 |
65.4 to 78.6 |
350 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
82.1 |
76.7 to 86.5 |
374 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
78.9 |
72.7 to 84.0 |
350 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
73.8 |
67.2 to 79.5 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
55.6 |
49.9 to 61.2 |
446 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
72.1 |
66.0 to 77.4 |
361 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
55.7 |
49.5 to 61.8 |
350 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
87.6 |
83.3 to 90.9 |
444 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
81.5 |
76.4 to 85.7 |
362 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
77.2 |
70.8 to 82.5 |
350 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
85.6 |
80.7 to 89.3 |
354 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
93.5 |
89.5 to 96.0 |
358 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
87.5 |
82.8 to 91.1 |
360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
90.9 |
86.9 to 93.8 |
418 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
70.4 |
63.6 to 76.4 |
321 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
87.0 |
81.6 to 90.9 |
374 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
76.2 |
71.1 to 80.7 |
419 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
78.7 |
73.3 to 83.2 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
81.4 |
75.6 to 86.0 |
356 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
79.0 |
75.0 to 82.5 |
779 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
82.8 |
77.1 to 87.3 |
283 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
78.1 |
73.4 to 82.2 |
496 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
92.3 |
88.2 to 95.1 |
328 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
75.0 |
69.3 to 79.9 |
383 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
63.7 |
57.6 to 69.4 |
375 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
79.0 |
73.3 to 83.7 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
90.9 |
86.6 to 93.9 |
382 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
77.7 |
71.9 to 82.5 |
374 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
87.3 |
82.1 to 91.1 |
403 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
89.5 |
84.1 to 93.1 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
95.0 |
91.9 to 97.0 |
373 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
83.6 |
78.2 to 87.9 |
366 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
55.3 |
49.3 to 61.2 |
364 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
69.7 |
62.8 to 75.8 |
300 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
65.8 |
60.2 to 71.0 |
406 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
78.1 |
73.0 to 82.5 |
393 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
78.0 |
72.3 to 82.8 |
372 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
87.7 |
82.5 to 91.5 |
295 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
95.7 |
92.6 to 97.5 |
364 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
72.5 |
67.0 to 77.5 |
396 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
86.2 |
82.9 to 89.0 |
665 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
84.8 |
79.6 to 88.9 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
87.1 |
82.5 to 90.6 |
352 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
78.5 |
72.9 to 83.2 |
358 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
91.6 |
86.7 to 94.8 |
323 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
76.1 |
69.6 to 81.6 |
332 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
68.1 |
61.4 to 74.2 |
291 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
75.2 |
69.3 to 80.3 |
353 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
94.7 |
92.3 to 96.5 |
832 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
91.2 |
87.0 to 94.1 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
95.2 |
92.3 to 97.1 |
492 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
87.9 |
82.9 to 91.6 |
339 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
81.3 |
80.2 to 82.3 |
21875 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
89.7 |
87.2 to 91.7 |
2188 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
89.3 |
86.9 to 91.3 |
1029 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
84.6 |
81.8 to 87.1 |
2742 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
75.1 |
72.6 to 77.4 |
2793 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
83.9 |
81.9 to 85.7 |
2543 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
86.4 |
84.6 to 88.0 |
4048 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
70.7 |
67.3 to 74.0 |
1451 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
76.6 |
73.8 to 79.2 |
2120 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
78.7 |
73.8 to 83.0 |
1506 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
97.7 |
95.6 to 98.8 |
419 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
69.0 |
62.8 to 74.6 |
360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
55.5 |
49.2 to 61.6 |
349 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
76.7 |
70.6 to 81.8 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
89.6 |
87.1 to 91.5 |
2617 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
88.5 |
83.5 to 92.1 |
368 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
87.2 |
81.6 to 91.2 |
259 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
85.5 |
81.2 to 88.9 |
558 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
90.1 |
87.0 to 92.4 |
946 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
56.0 |
50.6 to 61.3 |
458 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
75.1 |
71.8 to 78.1 |
1455 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
71.5 |
65.4 to 76.9 |
357 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
84.4 |
79.6 to 88.2 |
404 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
66.8 |
58.7 to 74.0 |
385 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
75.4 |
69.9 to 80.1 |
396 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
86.0 |
81.1 to 89.7 |
344 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
81.6 |
76.5 to 85.8 |
365 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
58.7 |
52.1 to 64.9 |
331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
72.4 |
66.4 to 77.7 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
67.0 |
61.1 to 72.4 |
392 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
85.2 |
79.7 to 89.3 |
329 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
89.1 |
84.9 to 92.2 |
352 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
79.7 |
73.5 to 84.8 |
327 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
77.5 |
71.3 to 82.7 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
93.9 |
89.9 to 96.4 |
357 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
87.3 |
82.4 to 91.0 |
375 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
86.9 |
81.3 to 91.0 |
377 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
76.3 |
70.2 to 81.5 |
376 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
91.4 |
87.1 to 94.4 |
367 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
77.1 |
72.6 to 81.1 |
535 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
75.8 |
69.7 to 81.1 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
86.5 |
81.4 to 90.4 |
358 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
83.9 |
79.9 to 87.3 |
605 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
91.1 |
84.6 to 95.0 |
157 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
82.3 |
77.6 to 86.3 |
448 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
88.0 |
82.7 to 91.8 |
350 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
74.9 |
69.4 to 79.7 |
382 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
69.7 |
63.5 to 75.3 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
85.9 |
81.2 to 89.6 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
90.9 |
86.9 to 93.8 |
336 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
83.5 |
78.1 to 87.8 |
347 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
84.8 |
79.0 to 89.3 |
451 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
90.4 |
86.2 to 93.5 |
374 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
95.0 |
91.8 to 97.0 |
283 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
85.2 |
80.1 to 89.1 |
375 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
57.4 |
51.0 to 63.5 |
377 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
66.2 |
59.6 to 72.2 |
360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
67.6 |
61.3 to 73.3 |
375 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
80.2 |
74.6 to 84.8 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
78.7 |
72.8 to 83.7 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
88.0 |
83.1 to 91.6 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
91.7 |
87.9 to 94.4 |
422 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
77.8 |
72.5 to 82.4 |
374 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
89.2 |
86.0 to 91.8 |
655 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
89.6 |
84.4 to 93.2 |
291 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
89.0 |
84.5 to 92.3 |
364 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
75.7 |
69.7 to 80.9 |
366 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
92.0 |
87.5 to 94.9 |
293 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
79.6 |
73.4 to 84.7 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
73.6 |
66.6 to 79.6 |
281 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
70.5 |
64.2 to 76.2 |
318 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
92.7 |
89.6 to 94.9 |
875 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
91.2 |
87.1 to 94.1 |
349 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
92.9 |
89.3 to 95.3 |
526 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
89.2 |
85.0 to 92.3 |
405 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
82.2 |
81.2 to 83.2 |
20475 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
90.8 |
88.7 to 92.6 |
2097 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
90.0 |
87.6 to 92.0 |
1077 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
84.7 |
81.9 to 87.1 |
2842 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
77.7 |
75.4 to 79.9 |
2757 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
85.9 |
84.0 to 87.7 |
2284 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
84.9 |
82.8 to 86.8 |
3270 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
70.8 |
67.4 to 74.0 |
1394 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
75.4 |
72.1 to 78.4 |
2022 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
80.3 |
75.5 to 84.4 |
1303 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
96.4 |
93.2 to 98.1 |
326 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
68.9 |
61.9 to 75.2 |
314 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
65.7 |
59.1 to 71.7 |
342 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
76.3 |
70.0 to 81.7 |
291 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
85.5 |
82.6 to 88.0 |
1927 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
87.2 |
81.8 to 91.2 |
334 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
82.9 |
73.8 to 89.3 |
225 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
87.7 |
82.0 to 91.8 |
294 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
91.6 |
86.5 to 94.8 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
85.0 |
81.2 to 88.2 |
729 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
61.3 |
55.5 to 66.7 |
428 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
75.0 |
71.3 to 78.4 |
1429 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
76.6 |
70.5 to 81.7 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
86.4 |
82.0 to 89.9 |
380 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
71.5 |
63.9 to 78.1 |
451 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
75.1 |
68.9 to 80.5 |
361 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
89.0 |
84.5 to 92.3 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
85.6 |
80.7 to 89.4 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
54.2 |
48.1 to 60.1 |
373 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
78.3 |
73.0 to 82.9 |
367 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
68.4 |
62.5 to 73.8 |
349 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
83.8 |
78.3 to 88.1 |
335 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
91.7 |
87.4 to 94.7 |
357 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
82.2 |
75.9 to 87.1 |
306 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
82.4 |
77.2 to 86.6 |
354 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
94.9 |
91.4 to 97.0 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
90.5 |
85.7 to 93.7 |
350 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
91.3 |
85.7 to 94.9 |
318 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
80.2 |
74.3 to 85.0 |
415 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
95.3 |
91.9 to 97.3 |
343 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
68.3 |
62.2 to 73.9 |
382 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
85.9 |
80.6 to 90.0 |
314 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
90.5 |
85.6 to 93.9 |
353 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
89.2 |
85.9 to 91.8 |
683 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
90.9 |
83.4 to 95.2 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
88.9 |
85.0 to 91.8 |
479 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
93.1 |
89.0 to 95.8 |
334 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
83.6 |
78.4 to 87.7 |
343 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
72.1 |
65.8 to 77.6 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
83.3 |
78.3 to 87.4 |
372 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
89.0 |
84.3 to 92.5 |
341 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
83.9 |
78.8 to 88.0 |
347 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
91.8 |
86.5 to 95.1 |
470 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
94.0 |
90.7 to 96.2 |
412 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
93.5 |
89.4 to 96.1 |
328 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
87.5 |
82.4 to 91.3 |
356 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
63.0 |
56.9 to 68.7 |
347 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
74.3 |
68.3 to 79.5 |
335 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
71.2 |
64.9 to 76.8 |
326 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
84.8 |
79.4 to 89.0 |
324 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
77.3 |
71.0 to 82.5 |
344 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
87.9 |
82.9 to 91.6 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
93.3 |
89.4 to 95.9 |
366 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
78.0 |
72.4 to 82.8 |
362 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
89.3 |
85.9 to 91.9 |
651 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
88.8 |
83.6 to 92.6 |
281 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
89.5 |
84.9 to 92.9 |
370 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
84.8 |
79.4 to 89.0 |
336 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
91.9 |
88.3 to 94.4 |
379 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
87.3 |
83.4 to 90.4 |
408 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
71.1 |
64.9 to 76.6 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
77.0 |
71.5 to 81.8 |
359 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
93.4 |
90.3 to 95.6 |
851 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
91.1 |
86.8 to 94.1 |
362 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
93.7 |
90.1 to 96.0 |
489 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
85.1 |
84.2 to 86.1 |
20949 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
92.5 |
90.8 to 93.9 |
2107 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
90.6 |
88.1 to 92.6 |
1017 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
88.8 |
86.3 to 91.0 |
2745 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
82.2 |
80.0 to 84.1 |
2846 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
89.4 |
87.8 to 90.7 |
2433 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
84.4 |
82.4 to 86.2 |
3654 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
77.3 |
74.2 to 80.2 |
1340 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
81.4 |
78.7 to 83.8 |
2108 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
82.2 |
77.4 to 86.2 |
1299 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
94.1 |
90.2 to 96.5 |
319 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
78.6 |
72.4 to 83.7 |
328 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
74.5 |
68.4 to 79.9 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
75.0 |
68.5 to 80.6 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
85.1 |
82.4 to 87.5 |
2256 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
86.0 |
80.3 to 90.3 |
336 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
91.4 |
85.1 to 95.2 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
85.1 |
78.8 to 89.7 |
263 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
89.5 |
84.4 to 93.0 |
320 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
89.1 |
84.4 to 92.4 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
84.1 |
80.4 to 87.2 |
846 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
81.4 |
78.2 to 84.2 |
1400 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
85.1 |
80.3 to 88.9 |
356 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
84.2 |
78.9 to 88.3 |
366 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
80.0 |
72.6 to 85.7 |
413 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
82.6 |
77.2 to 87.0 |
339 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
87.9 |
83.1 to 91.5 |
343 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
83.8 |
78.4 to 88.2 |
324 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
60.7 |
54.5 to 66.6 |
360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
80.0 |
74.2 to 84.8 |
327 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
69.2 |
63.5 to 74.3 |
392 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
89.1 |
84.1 to 92.7 |
288 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
91.7 |
86.9 to 94.8 |
308 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
85.6 |
79.7 to 90.0 |
356 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
84.9 |
78.7 to 89.6 |
278 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
92.1 |
86.6 to 95.5 |
293 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
85.9 |
79.8 to 90.4 |
306 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
93.8 |
88.8 to 96.7 |
283 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
76.3 |
70.0 to 81.5 |
337 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
94.8 |
91.4 to 97.0 |
345 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
68.9 |
62.1 to 75.0 |
309 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
83.6 |
78.0 to 87.9 |
327 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
89.4 |
84.3 to 93.0 |
291 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
91.5 |
88.8 to 93.6 |
721 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
93.7 |
88.2 to 96.7 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
91.0 |
87.8 to 93.4 |
529 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
89.3 |
84.8 to 92.6 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
89.2 |
83.9 to 92.9 |
280 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
75.3 |
69.1 to 80.6 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
84.4 |
78.3 to 89.0 |
270 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
84.9 |
78.8 to 89.5 |
284 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
83.1 |
77.2 to 87.7 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
91.8 |
87.0 to 94.9 |
393 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
94.7 |
90.2 to 97.2 |
328 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
95.9 |
92.4 to 97.8 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
88.9 |
83.5 to 92.8 |
285 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
64.0 |
57.2 to 70.3 |
285 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
78.3 |
72.0 to 83.5 |
319 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
75.6 |
69.2 to 81.0 |
290 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
84.0 |
78.0 to 88.6 |
295 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
80.6 |
75.1 to 85.1 |
334 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
86.2 |
81.0 to 90.2 |
303 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
91.9 |
87.6 to 94.9 |
351 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
79.7 |
73.5 to 84.7 |
295 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
94.9 |
92.0 to 96.8 |
535 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
93.9 |
89.4 to 96.6 |
261 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
95.5 |
91.2 to 97.8 |
274 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
86.1 |
80.8 to 90.1 |
341 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
92.5 |
87.5 to 95.7 |
287 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
85.2 |
80.4 to 89.0 |
329 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
72.9 |
67.0 to 78.1 |
360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
83.0 |
77.3 to 87.5 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
94.3 |
91.0 to 96.4 |
649 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
93.0 |
87.4 to 96.3 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
94.5 |
90.7 to 96.7 |
412 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
86.6 |
85.6 to 87.5 |
18700 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
92.4 |
90.1 to 94.2 |
1902 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
93.9 |
91.7 to 95.6 |
886 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
89.1 |
86.3 to 91.3 |
2295 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
82.5 |
80.3 to 84.5 |
2507 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
89.8 |
88.2 to 91.1 |
2276 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
85.3 |
83.3 to 87.0 |
3326 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
80.9 |
77.7 to 83.7 |
1191 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
83.8 |
80.7 to 86.6 |
1746 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
85.8 |
81.3 to 89.3 |
1305 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
98.7 |
96.9 to 99.4 |
337 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
79.7 |
74.0 to 84.4 |
318 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
85.3 |
80.5 to 89.0 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
85.2 |
79.7 to 89.4 |
284 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
86.7 |
84.1 to 88.9 |
2079 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
89.1 |
84.4 to 92.6 |
298 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
86.7 |
80.1 to 91.4 |
186 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
88.2 |
81.6 to 92.6 |
314 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
87.6 |
82.6 to 91.3 |
364 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
86.3 |
82.9 to 89.0 |
917 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
83.6 |
80.0 to 86.6 |
1266 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
85.2 |
79.4 to 89.5 |
310 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
90.0 |
85.9 to 93.1 |
324 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
79.7 |
71.4 to 86.0 |
327 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
83.7 |
77.5 to 88.5 |
286 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
88.7 |
84.0 to 92.2 |
337 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
85.8 |
80.9 to 89.5 |
332 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
65.1 |
57.8 to 71.7 |
241 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
86.8 |
81.5 to 90.8 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
74.9 |
69.5 to 79.5 |
426 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
87.2 |
81.5 to 91.4 |
308 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
95.6 |
92.5 to 97.4 |
329 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
89.4 |
83.0 to 93.6 |
274 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
89.4 |
84.0 to 93.1 |
262 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
93.7 |
88.5 to 96.6 |
294 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
89.0 |
83.8 to 92.6 |
308 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
88.7 |
81.4 to 93.4 |
282 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
82.9 |
75.7 to 88.3 |
329 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
95.5 |
92.2 to 97.5 |
315 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
73.2 |
66.5 to 79.0 |
278 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
82.5 |
76.3 to 87.3 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
91.3 |
86.9 to 94.3 |
332 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
91.0 |
87.7 to 93.5 |
602 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
92.9 |
86.0 to 96.5 |
160 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
90.6 |
86.7 to 93.5 |
442 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
92.8 |
87.9 to 95.8 |
289 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
93.6 |
89.8 to 96.1 |
302 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
80.7 |
75.1 to 85.3 |
381 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
90.6 |
85.8 to 93.8 |
292 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
92.0 |
87.4 to 95.0 |
336 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
89.1 |
84.4 to 92.5 |
316 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
94.9 |
91.4 to 97.0 |
524 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
96.2 |
92.7 to 98.1 |
300 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
95.4 |
91.9 to 97.4 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
86.9 |
79.9 to 91.7 |
276 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
60.3 |
52.6 to 67.5 |
270 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
84.8 |
78.9 to 89.2 |
288 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
73.1 |
66.6 to 78.8 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
86.3 |
79.9 to 90.9 |
285 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
87.0 |
81.2 to 91.2 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
86.0 |
80.4 to 90.2 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
90.6 |
85.4 to 94.1 |
331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
83.5 |
78.2 to 87.6 |
405 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
95.0 |
92.3 to 96.8 |
498 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
95.3 |
92.2 to 97.1 |
257 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
94.8 |
90.4 to 97.2 |
241 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
93.2 |
88.3 to 96.1 |
305 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
95.8 |
93.1 to 97.5 |
319 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
91.9 |
87.8 to 94.7 |
302 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
77.3 |
71.5 to 82.2 |
369 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
85.0 |
79.0 to 89.5 |
270 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
94.0 |
90.5 to 96.2 |
734 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
93.4 |
88.7 to 96.3 |
242 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
94.0 |
90.0 to 96.5 |
492 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
93.5 |
83.7 to 97.6 |
216 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
88.9 |
88.0 to 89.8 |
18788 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
94.1 |
92.2 to 95.5 |
2034 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
93.5 |
91.1 to 95.3 |
829 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
91.7 |
89.4 to 93.6 |
2520 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
86.4 |
84.0 to 88.4 |
2387 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
91.8 |
90.2 to 93.1 |
2097 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
86.3 |
84.3 to 88.1 |
3289 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
86.1 |
83.2 to 88.5 |
1256 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
86.7 |
83.9 to 89.1 |
1845 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
88.8 |
84.0 to 92.3 |
1199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
98.2 |
96.5 to 99.1 |
319 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
86.4 |
81.2 to 90.4 |
319 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
86.2 |
80.9 to 90.3 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
79.3 |
72.8 to 84.6 |
261 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
85.9 |
83.2 to 88.3 |
1850 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
87.4 |
81.5 to 91.5 |
293 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
92.0 |
84.7 to 96.0 |
174 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
86.6 |
80.6 to 91.0 |
271 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
93.5 |
89.5 to 96.1 |
280 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
84.8 |
81.1 to 87.9 |
832 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
75.0 |
67.1 to 81.5 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
84.5 |
81.0 to 87.5 |
1332 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
86.6 |
80.8 to 90.9 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
93.6 |
90.3 to 95.8 |
472 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
86.7 |
80.1 to 91.4 |
363 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
83.3 |
77.1 to 88.1 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
91.0 |
86.0 to 94.4 |
309 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
90.6 |
86.2 to 93.8 |
331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
73.9 |
67.9 to 79.2 |
329 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
82.7 |
76.8 to 87.2 |
298 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
77.7 |
71.0 to 83.2 |
302 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
87.3 |
82.2 to 91.1 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
93.8 |
89.3 to 96.5 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
85.0 |
78.9 to 89.5 |
403 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
87.3 |
82.1 to 91.2 |
354 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
94.9 |
91.5 to 97.0 |
331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
89.8 |
85.2 to 93.1 |
360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
91.8 |
86.8 to 95.0 |
404 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
80.0 |
73.3 to 85.4 |
355 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
96.2 |
92.6 to 98.1 |
300 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
70.4 |
63.6 to 76.3 |
300 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
86.0 |
80.6 to 90.1 |
290 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
88.7 |
83.8 to 92.2 |
376 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
92.5 |
89.5 to 94.6 |
699 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
89.7 |
83.4 to 93.8 |
271 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
93.0 |
89.6 to 95.4 |
428 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
94.9 |
91.4 to 97.0 |
302 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
90.7 |
86.1 to 93.9 |
280 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
83.3 |
77.8 to 87.7 |
364 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
94.2 |
89.9 to 96.7 |
255 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
90.1 |
84.9 to 93.7 |
356 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
93.7 |
90.2 to 96.0 |
372 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
94.0 |
91.4 to 95.8 |
815 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
96.4 |
93.3 to 98.1 |
394 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
95.7 |
92.3 to 97.6 |
398 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
94.3 |
90.5 to 96.7 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
63.5 |
56.4 to 70.0 |
282 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
85.3 |
79.9 to 89.5 |
397 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
75.8 |
69.3 to 81.4 |
307 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
87.3 |
82.5 to 91.0 |
405 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
87.2 |
81.4 to 91.4 |
369 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
91.1 |
87.5 to 93.7 |
381 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
96.2 |
93.5 to 97.8 |
379 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
85.2 |
80.1 to 89.2 |
352 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
93.7 |
90.8 to 95.7 |
729 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
93.2 |
88.6 to 96.1 |
381 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
94.0 |
89.8 to 96.5 |
348 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
94.4 |
90.1 to 96.8 |
327 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
93.8 |
89.7 to 96.3 |
401 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
93.4 |
89.7 to 95.9 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
80.0 |
74.2 to 84.7 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
87.5 |
82.4 to 91.2 |
308 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
95.5 |
92.4 to 97.3 |
765 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
93.5 |
88.4 to 96.4 |
263 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
95.7 |
92.2 to 97.7 |
502 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
77.2 |
66.5 to 85.2 |
169 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
89.3 |
88.4 to 90.2 |
20163 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
95.1 |
93.6 to 96.2 |
2147 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
94.5 |
92.5 to 96.1 |
1108 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
91.4 |
89.5 to 93.0 |
3331 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
85.7 |
83.5 to 87.7 |
2466 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
93.6 |
92.2 to 94.7 |
2344 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
90.0 |
87.9 to 91.7 |
2509 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
86.4 |
83.7 to 88.7 |
1446 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
87.6 |
85.0 to 89.8 |
2007 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
85.5 |
80.8 to 89.2 |
1402 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
96.2 |
92.2 to 98.2 |
271 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
78.7 |
72.5 to 83.8 |
311 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
94.2 |
90.6 to 96.5 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
83.2 |
77.7 to 87.5 |
338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
91.2 |
88.3 to 93.4 |
1141 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
90.6 |
86.3 to 93.7 |
314 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
89.2 |
82.6 to 93.5 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
91.4 |
88.0 to 93.8 |
606 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
87.4 |
84.4 to 89.9 |
1403 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
90.3 |
85.5 to 93.6 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
91.0 |
86.8 to 94.0 |
398 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
84.0 |
78.7 to 88.1 |
677 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
88.1 |
82.7 to 91.9 |
417 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
91.4 |
86.9 to 94.4 |
310 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
90.2 |
85.4 to 93.6 |
277 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
73.3 |
66.9 to 78.9 |
324 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
88.3 |
82.9 to 92.1 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
75.2 |
68.5 to 81.0 |
268 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
88.8 |
83.6 to 92.5 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
96.1 |
93.0 to 97.9 |
314 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
87.0 |
79.5 to 92.1 |
286 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
84.8 |
78.5 to 89.5 |
298 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
94.9 |
91.4 to 97.1 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
90.8 |
86.3 to 93.9 |
310 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
90.2 |
85.5 to 93.6 |
409 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
76.9 |
69.3 to 83.1 |
312 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
92.5 |
86.8 to 95.9 |
260 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
71.0 |
62.9 to 77.9 |
225 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
88.0 |
82.1 to 92.1 |
258 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
89.1 |
83.7 to 92.9 |
334 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
94.7 |
92.0 to 96.5 |
578 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
90.0 |
80.3 to 95.2 |
144 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
95.7 |
92.9 to 97.4 |
434 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
91.3 |
85.9 to 94.8 |
268 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
95.0 |
88.7 to 97.9 |
199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
86.0 |
79.8 to 90.5 |
300 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
87.7 |
81.5 to 92.1 |
240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
93.7 |
89.6 to 96.3 |
303 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
88.2 |
83.0 to 92.0 |
293 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
93.7 |
91.1 to 95.5 |
857 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
91.8 |
85.7 to 95.5 |
266 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
89.7 |
83.6 to 93.7 |
358 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
91.3 |
86.1 to 94.6 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
60.2 |
53.1 to 66.9 |
303 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
90.4 |
85.7 to 93.7 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
77.1 |
70.7 to 82.5 |
290 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
89.7 |
84.9 to 93.1 |
315 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
89.5 |
84.1 to 93.2 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
88.1 |
82.8 to 91.9 |
282 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
91.8 |
86.4 to 95.2 |
292 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
84.6 |
79.4 to 88.7 |
337 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
93.8 |
90.8 to 95.9 |
581 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
91.2 |
86.2 to 94.5 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
95.6 |
91.0 to 97.9 |
284 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
93.3 |
87.6 to 96.5 |
266 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
95.5 |
90.9 to 97.8 |
191 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
90.3 |
83.5 to 94.5 |
254 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
82.7 |
76.9 to 87.3 |
240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
82.4 |
76.4 to 87.1 |
294 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
92.8 |
90.0 to 94.9 |
929 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
92.6 |
88.0 to 95.6 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
92.8 |
89.6 to 95.1 |
599 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
88.0 |
83.2 to 91.5 |
350 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
89.0 |
87.9 to 90.0 |
18002 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
91.9 |
89.2 to 94.0 |
1923 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
93.2 |
90.6 to 95.1 |
873 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
91.4 |
89.4 to 93.0 |
3338 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
84.9 |
82.3 to 87.2 |
2263 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
91.6 |
89.7 to 93.3 |
2060 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
89.9 |
87.3 to 92.0 |
2184 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
90.4 |
87.8 to 92.5 |
1154 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
88.2 |
85.2 to 90.6 |
1789 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
87.5 |
81.8 to 91.5 |
1173 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
92.8 |
86.3 to 96.3 |
254 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
86.3 |
80.6 to 90.5 |
263 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
96.6 |
94.3 to 98.0 |
445 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
88.1 |
82.9 to 91.9 |
315 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
90.0 |
86.3 to 92.7 |
990 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
90.5 |
85.8 to 93.8 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
93.1 |
86.4 to 96.6 |
167 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
89.7 |
85.4 to 92.8 |
527 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
82.9 |
75.4 to 88.5 |
245 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
84.6 |
81.3 to 87.3 |
1245 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
94.0 |
90.0 to 96.5 |
304 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
88.8 |
85.1 to 91.6 |
488 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
88.0 |
82.3 to 92.1 |
566 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
85.4 |
79.8 to 89.6 |
349 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
90.7 |
85.6 to 94.1 |
267 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
91.7 |
87.3 to 94.6 |
306 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
75.9 |
68.7 to 81.8 |
261 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
84.4 |
78.9 to 88.6 |
269 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
81.3 |
74.5 to 86.6 |
240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
86.7 |
80.8 to 91.0 |
273 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
95.4 |
92.2 to 97.3 |
332 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
81.5 |
75.0 to 86.6 |
321 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
83.6 |
78.7 to 87.6 |
342 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
92.4 |
86.7 to 95.8 |
258 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
89.3 |
82.7 to 93.5 |
250 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
92.9 |
88.4 to 95.7 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
86.9 |
80.8 to 91.3 |
307 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
93.0 |
88.1 to 95.9 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
65.2 |
56.6 to 72.9 |
240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
88.9 |
83.4 to 92.7 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
90.5 |
84.4 to 94.4 |
251 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
93.9 |
90.7 to 96.0 |
630 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
89.1 |
82.6 to 93.4 |
256 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
94.9 |
91.0 to 97.2 |
374 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
92.8 |
88.1 to 95.7 |
258 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
97.9 |
94.0 to 99.3 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
85.9 |
80.0 to 90.3 |
310 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
90.4 |
84.5 to 94.2 |
276 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
90.4 |
85.2 to 93.9 |
330 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
96.3 |
93.0 to 98.0 |
268 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
92.4 |
86.4 to 95.9 |
346 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
93.9 |
88.7 to 96.8 |
268 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
91.2 |
85.2 to 94.9 |
257 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
94.6 |
90.8 to 96.9 |
331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
55.5 |
47.1 to 63.5 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
90.1 |
84.6 to 93.7 |
284 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
81.6 |
75.6 to 86.4 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
88.3 |
82.5 to 92.4 |
247 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
85.9 |
80.0 to 90.3 |
259 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
90.5 |
84.7 to 94.2 |
225 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
91.0 |
86.1 to 94.4 |
289 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
84.4 |
78.1 to 89.2 |
276 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
96.5 |
94.2 to 97.9 |
536 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
95.7 |
90.6 to 98.1 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
97.1 |
94.4 to 98.5 |
314 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
92.8 |
87.9 to 95.8 |
361 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
96.0 |
91.9 to 98.0 |
280 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
92.1 |
86.1 to 95.6 |
269 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
82.2 |
75.8 to 87.3 |
249 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
80.3 |
73.8 to 85.4 |
263 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
94.5 |
91.7 to 96.4 |
752 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
93.1 |
87.6 to 96.3 |
267 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
94.7 |
91.5 to 96.7 |
485 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
89.8 |
86.5 to 92.4 |
671 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
88.6 |
87.6 to 89.6 |
16043 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
93.5 |
90.9 to 95.3 |
1595 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
94.7 |
92.5 to 96.2 |
825 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
91.2 |
89.3 to 92.8 |
2424 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
86.9 |
84.7 to 88.8 |
2291 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
92.5 |
90.7 to 94.0 |
2019 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
87.0 |
83.6 to 89.8 |
1981 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
90.7 |
88.0 to 92.8 |
1048 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
86.9 |
84.3 to 89.2 |
1736 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
82.7 |
77.7 to 86.8 |
1090 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
96.2 |
92.4 to 98.1 |
285 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
85.3 |
79.0 to 89.9 |
269 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
93.0 |
88.0 to 96.0 |
252 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
82.9 |
76.2 to 88.0 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
86.5 |
81.6 to 90.2 |
794 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
91.2 |
85.4 to 94.9 |
253 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
87.4 |
79.3 to 92.6 |
157 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
86.0 |
80.4 to 90.2 |
384 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
87.0 |
83.9 to 89.6 |
1034 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
91.5 |
85.8 to 95.0 |
271 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
91.2 |
86.4 to 94.5 |
291 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
85.0 |
80.7 to 88.6 |
595 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
90.1 |
85.1 to 93.6 |
280 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
94.2 |
90.0 to 96.7 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
90.3 |
85.0 to 93.8 |
274 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
73.2 |
66.0 to 79.4 |
294 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Other |
76.7 |
66.4 to 84.6 |
138 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Other |
80.8 |
74.6 to 85.9 |
316 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Other |
83.5 |
73.3 to 90.3 |
119 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Other |
94.8 |
89.5 to 97.5 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Other |
84.0 |
64.3 to 93.8 |
132 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Other |
88.4 |
81.7 to 92.8 |
133 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Other |
91.0 |
83.2 to 95.4 |
211 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Other |
89.8 |
77.7 to 95.7 |
72 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Other |
95.5 |
80.1 to 99.1 |
44 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Other |
74.7 |
62.2 to 84.1 |
147 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Other |
95.3 |
89.5 to 98.0 |
158 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Other |
79.5 |
70.6 to 86.3 |
157 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Other |
82.5 |
68.7 to 91.1 |
94 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Other |
88.1 |
78.5 to 93.7 |
101 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
88.1 |
77.4 to 94.1 |
73 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Other |
85.9 |
69.1 to 94.4 |
41 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Other |
95.2 |
90.1 to 97.8 |
103 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Other |
84.5 |
79.1 to 88.7 |
316 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Other |
87.3 |
75.6 to 93.9 |
78 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Other |
91.6 |
81.8 to 96.4 |
67 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Other |
82.8 |
70.7 to 90.6 |
83 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Other |
94.1 |
86.6 to 97.5 |
180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Other |
96.0 |
82.6 to 99.2 |
67 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Other |
93.4 |
85.1 to 97.2 |
72 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Other |
78.8 |
54.9 to 91.9 |
49 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Other |
61.1 |
48.6 to 72.3 |
105 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Other |
84.1 |
72.0 to 91.6 |
85 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Other |
80.6 |
72.0 to 87.0 |
150 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Other |
98.5 |
95.9 to 99.5 |
89 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Other |
86.1 |
76.7 to 92.1 |
124 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Other |
88.3 |
75.3 to 94.9 |
72 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Other |
91.3 |
78.3 to 96.8 |
47 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Other |
87.3 |
79.0 to 92.7 |
103 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Other |
95.7 |
93.0 to 97.4 |
365 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Other |
92.9 |
87.2 to 96.2 |
176 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
97.5 |
94.2 to 98.9 |
189 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Other |
89.5 |
81.8 to 94.2 |
153 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Other |
95.9 |
91.8 to 98.0 |
148 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Other |
78.6 |
59.6 to 90.1 |
65 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Other |
78.1 |
70.8 to 84.1 |
217 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Other |
80.7 |
70.4 to 88.0 |
122 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Other |
90.4 |
83.3 to 94.6 |
305 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Other |
96.5 |
92.6 to 98.3 |
143 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
89.2 |
80.7 to 94.2 |
162 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Other |
86.6 |
84.9 to 88.2 |
7253 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Other |
91.5 |
76.3 to 97.3 |
54 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Other |
83.5 |
73.1 to 90.4 |
98 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Other |
91.8 |
82.1 to 96.4 |
135 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Other |
76.3 |
65.6 to 84.4 |
123 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Other |
89.3 |
85.4 to 92.2 |
705 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Other |
87.2 |
79.7 to 92.2 |
211 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Other |
85.6 |
69.5 to 94.0 |
72 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
89.9 |
85.2 to 93.2 |
422 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Other |
91.4 |
80.9 to 96.4 |
103 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Other |
95.2 |
87.9 to 98.2 |
78 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Other |
79.7 |
70.7 to 86.5 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Other |
83.0 |
73.0 to 89.9 |
143 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Other |
96.1 |
89.3 to 98.6 |
99 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Other |
68.6 |
51.8 to 81.7 |
55 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Other |
76.4 |
64.6 to 85.2 |
113 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
84.1 |
80.9 to 86.9 |
806 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
73.5 |
69.5 to 77.1 |
794 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
87.4 |
84.1 to 90.1 |
826 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.1 |
93.1 to 96.5 |
752 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
85.7 |
82.1 to 88.7 |
951 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
86.8 |
83.9 to 89.3 |
950 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.3 |
93.4 to 96.7 |
1000 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.0 |
88.3 to 93.2 |
915 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.0 |
87.9 to 93.3 |
1006 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
82.4 |
78.5 to 85.7 |
892 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.1 |
92.8 to 96.6 |
886 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.9 |
87.3 to 92.0 |
797 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.8 |
86.9 to 92.1 |
911 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
94.4 |
92.9 to 95.6 |
1944 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.9 |
93.2 to 97.6 |
470 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
94.1 |
92.5 to 95.5 |
1474 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
93.0 |
90.6 to 94.8 |
847 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
94.7 |
92.6 to 96.3 |
769 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
82.2 |
78.8 to 85.1 |
970 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.3 |
88.4 to 93.6 |
743 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.6 |
87.5 to 93.0 |
756 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.1 |
88.6 to 93.1 |
943 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
93.9 |
92.0 to 95.4 |
2139 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
94.2 |
91.9 to 95.9 |
1143 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
94.4 |
92.0 to 96.0 |
1070 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.1 |
89.7 to 94.0 |
1092 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
57.1 |
52.1 to 61.9 |
617 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
88.3 |
85.7 to 90.6 |
1032 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
79.7 |
76.2 to 82.8 |
823 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
86.7 |
83.7 to 89.2 |
1027 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
86.4 |
83.3 to 89.1 |
889 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.7 |
88.6 to 92.5 |
1058 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
93.0 |
90.9 to 94.7 |
1192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
83.4 |
79.7 to 86.6 |
721 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.4 |
94.0 to 96.5 |
1581 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.8 |
93.6 to 97.2 |
640 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.3 |
93.3 to 96.7 |
941 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.3 |
89.4 to 94.5 |
906 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.6 |
93.7 to 97.0 |
1015 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.5 |
90.0 to 94.4 |
951 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
72.4 |
67.9 to 76.4 |
632 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
84.6 |
81.4 to 87.3 |
858 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.1 |
93.6 to 96.3 |
2218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
93.7 |
90.2 to 95.9 |
532 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.2 |
93.6 to 96.4 |
1686 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.5 |
88.9 to 90.0 |
54111 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
97.7 |
95.8 to 98.8 |
867 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
83.5 |
80.2 to 86.4 |
805 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.2 |
89.2 to 93.0 |
1100 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
83.5 |
80.1 to 86.4 |
814 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
88.6 |
86.7 to 90.2 |
3327 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.1 |
86.0 to 91.6 |
678 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.5 |
87.4 to 94.4 |
397 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
88.4 |
86.3 to 90.2 |
2252 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.2 |
86.6 to 91.3 |
1130 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.2 |
89.0 to 93.1 |
1194 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
87.0 |
84.0 to 89.4 |
1860 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
88.3 |
85.3 to 90.8 |
930 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.1 |
88.4 to 93.2 |
735 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.2 |
88.9 to 93.0 |
986 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
69.6 |
65.8 to 73.2 |
941 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Any Medicaid |
87.2 |
83.6 to 90.1 |
521 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Any Medicaid |
76.1 |
71.2 to 80.3 |
474 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.0 |
86.5 to 92.7 |
476 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
94.2 |
91.5 to 96.1 |
567 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Any Medicaid |
87.0 |
82.7 to 90.3 |
528 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Any Medicaid |
84.8 |
80.0 to 88.6 |
414 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.8 |
86.7 to 95.1 |
273 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Any Medicaid |
86.6 |
82.3 to 89.9 |
497 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.4 |
89.2 to 94.7 |
549 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Any Medicaid |
81.2 |
76.4 to 85.2 |
503 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
94.0 |
90.5 to 96.3 |
430 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Any Medicaid |
82.9 |
78.2 to 86.8 |
443 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.2 |
88.9 to 94.6 |
521 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.8 |
88.4 to 92.7 |
1112 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Insurance Coverage |
Any Medicaid |
87.7 |
83.1 to 91.2 |
496 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.8 |
88.9 to 94.0 |
616 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.1 |
87.5 to 93.7 |
467 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.0 |
86.8 to 94.0 |
373 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
85.5 |
79.7 to 89.9 |
290 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.3 |
84.4 to 91.4 |
473 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
89.8 |
86.6 to 92.2 |
748 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.8 |
87.5 to 93.3 |
496 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.2 |
88.5 to 94.8 |
569 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Any Medicaid |
96.1 |
92.5 to 98.0 |
332 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.7 |
88.6 to 95.3 |
449 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.0 |
87.5 to 94.9 |
348 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Any Medicaid |
63.8 |
58.9 to 68.4 |
589 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Any Medicaid |
82.5 |
77.6 to 86.6 |
445 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
73.8 |
68.8 to 78.2 |
481 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Any Medicaid |
84.8 |
79.6 to 88.9 |
364 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Any Medicaid |
85.5 |
81.1 to 89.1 |
497 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Any Medicaid |
83.9 |
78.6 to 88.0 |
361 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.8 |
86.2 to 94.0 |
362 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Any Medicaid |
83.9 |
80.5 to 86.8 |
794 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Any Medicaid |
93.9 |
91.7 to 95.6 |
897 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.3 |
89.0 to 94.7 |
580 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
95.6 |
92.0 to 97.7 |
317 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.2 |
88.7 to 94.7 |
471 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
93.4 |
88.9 to 96.1 |
267 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Any Medicaid |
89.3 |
85.5 to 92.2 |
451 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Any Medicaid |
84.9 |
81.3 to 87.9 |
659 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Any Medicaid |
84.0 |
79.4 to 87.7 |
430 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Any Medicaid |
94.0 |
91.7 to 95.7 |
1213 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.1 |
88.9 to 94.5 |
606 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
94.4 |
91.6 to 96.3 |
607 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.3 |
87.5 to 89.0 |
27403 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Any Medicaid |
95.2 |
92.2 to 97.1 |
508 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Any Medicaid |
84.2 |
80.1 to 87.7 |
523 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
93.0 |
89.5 to 95.3 |
381 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Any Medicaid |
87.7 |
83.3 to 91.0 |
439 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.2 |
85.2 to 90.7 |
2274 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.9 |
87.3 to 93.5 |
487 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Any Medicaid |
89.9 |
85.2 to 93.3 |
343 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
87.8 |
84.2 to 90.6 |
1444 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.4 |
84.7 to 94.1 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.2 |
87.3 to 92.5 |
690 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
81.8 |
75.3 to 86.9 |
319 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Any Medicaid |
85.1 |
80.9 to 88.5 |
544 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.9 |
87.7 to 93.4 |
603 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.5 |
87.0 to 93.2 |
454 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.5 |
73.7 to 84.3 |
316 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Uninsured |
67.4 |
48.2 to 82.1 |
44 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Uninsured |
83.3 |
71.6 to 90.8 |
84 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Uninsured |
90.9 |
78.2 to 96.5 |
63 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Uninsured |
74.5 |
55.9 to 87.0 |
37 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Uninsured |
82.3 |
59.4 to 93.7 |
32 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Uninsured |
84.6 |
71.6 to 92.3 |
50 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Uninsured |
72.9 |
58.9 to 83.4 |
98 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Uninsured |
88.3 |
77.2 to 94.4 |
79 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Uninsured |
76.9 |
61.5 to 87.4 |
58 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Uninsured |
85.5 |
73.8 to 92.5 |
73 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
85.9 |
71.1 to 93.8 |
44 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Uninsured |
95.6 |
86.9 to 98.6 |
58 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Uninsured |
63.2 |
48.7 to 75.6 |
76 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Uninsured |
76.3 |
54.2 to 89.8 |
39 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Uninsured |
93.8 |
83.4 to 97.9 |
38 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Uninsured |
71.2 |
53.5 to 84.2 |
44 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Uninsured |
89.4 |
66.6 to 97.3 |
47 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Uninsured |
85.8 |
65.4 to 95.1 |
32 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Uninsured |
55.4 |
40.0 to 69.9 |
61 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Uninsured |
78.0 |
62.9 to 88.2 |
66 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Uninsured |
93.5 |
83.4 to 97.6 |
67 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Uninsured |
86.1 |
75.6 to 92.5 |
98 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Uninsured |
74.5 |
49.0 to 89.9 |
33 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Uninsured |
92.7 |
82.8 to 97.1 |
41 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Uninsured |
68.1 |
47.7 to 83.4 |
47 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Uninsured |
82.9 |
53.5 to 95.4 |
36 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Uninsured |
90.5 |
77.7 to 96.4 |
70 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Uninsured |
82.4 |
64.1 to 92.4 |
48 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Uninsured |
74.9 |
58.3 to 86.5 |
48 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Uninsured |
88.8 |
71.9 to 96.1 |
93 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Uninsured |
92.7 |
77.9 to 97.9 |
58 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
87.7 |
65.7 to 96.4 |
35 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Uninsured |
79.9 |
76.7 to 82.8 |
2929 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Uninsured |
91.7 |
75.1 to 97.6 |
37 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Uninsured |
68.6 |
53.8 to 80.4 |
54 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Uninsured |
75.3 |
57.8 to 87.2 |
51 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Uninsured |
71.5 |
57.4 to 82.3 |
66 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Uninsured |
83.2 |
76.4 to 88.3 |
548 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Uninsured |
92.5 |
84.5 to 96.6 |
78 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Uninsured |
85.4 |
76.4 to 91.4 |
93 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
82.4 |
74.7 to 88.2 |
377 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Uninsured |
90.5 |
77.2 to 96.4 |
63 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Uninsured |
82.8 |
65.2 to 92.5 |
53 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Uninsured |
85.7 |
67.9 to 94.5 |
30 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Uninsured |
64.1 |
49.3 to 76.5 |
79 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Poverty |
Below Poverty Level |
86.0 |
80.4 to 90.2 |
258 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Poverty |
Below Poverty Level |
76.1 |
66.7 to 83.6 |
139 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Poverty |
Below Poverty Level |
93.5 |
89.1 to 96.2 |
230 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Poverty |
Below Poverty Level |
92.9 |
88.3 to 95.8 |
312 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Poverty |
Below Poverty Level |
88.2 |
82.3 to 92.4 |
251 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Poverty |
Below Poverty Level |
85.5 |
77.6 to 90.9 |
157 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Poverty |
Below Poverty Level |
87.9 |
79.0 to 93.3 |
146 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Poverty |
Below Poverty Level |
87.6 |
81.7 to 91.8 |
239 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Poverty |
Below Poverty Level |
95.9 |
91.5 to 98.0 |
268 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Poverty |
Below Poverty Level |
79.8 |
72.4 to 85.5 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Poverty |
Below Poverty Level |
96.4 |
92.2 to 98.4 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Poverty |
Below Poverty Level |
78.9 |
69.3 to 86.1 |
138 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Poverty |
Below Poverty Level |
85.8 |
77.7 to 91.4 |
173 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Poverty |
Below Poverty Level |
90.5 |
87.3 to 93.0 |
607 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Poverty |
Below Poverty Level |
84.1 |
77.4 to 89.0 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
93.1 |
89.2 to 95.7 |
294 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Poverty |
Below Poverty Level |
88.2 |
82.6 to 92.2 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Poverty |
Below Poverty Level |
92.5 |
85.7 to 96.2 |
147 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Poverty |
Below Poverty Level |
86.8 |
81.0 to 91.0 |
229 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Poverty |
Below Poverty Level |
86.5 |
80.0 to 91.1 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Poverty |
Below Poverty Level |
89.1 |
83.7 to 92.9 |
315 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Poverty |
Below Poverty Level |
87.6 |
80.8 to 92.2 |
158 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Poverty |
Below Poverty Level |
96.2 |
93.1 to 97.9 |
243 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Poverty |
Below Poverty Level |
96.7 |
91.6 to 98.7 |
158 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Poverty |
Below Poverty Level |
90.6 |
83.6 to 94.8 |
204 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Poverty |
Below Poverty Level |
88.8 |
77.8 to 94.7 |
96 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Poverty |
Below Poverty Level |
64.1 |
57.4 to 70.4 |
297 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Poverty |
Below Poverty Level |
85.9 |
79.1 to 90.7 |
206 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Poverty |
Below Poverty Level |
72.2 |
63.3 to 79.6 |
165 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Poverty |
Below Poverty Level |
84.0 |
76.5 to 89.4 |
202 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Poverty |
Below Poverty Level |
83.8 |
77.1 to 88.8 |
261 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Poverty |
Below Poverty Level |
82.5 |
72.5 to 89.5 |
105 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Poverty |
Below Poverty Level |
90.3 |
82.8 to 94.7 |
167 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Poverty |
Below Poverty Level |
82.8 |
77.6 to 87.0 |
411 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Poverty |
Below Poverty Level |
94.3 |
92.0 to 96.0 |
533 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Poverty |
Below Poverty Level |
92.9 |
89.5 to 95.2 |
377 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
96.2 |
92.6 to 98.1 |
156 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Poverty |
Below Poverty Level |
91.7 |
85.9 to 95.3 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Poverty |
Below Poverty Level |
94.4 |
85.8 to 97.9 |
109 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Poverty |
Below Poverty Level |
87.9 |
81.3 to 92.4 |
209 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Poverty |
Below Poverty Level |
84.3 |
78.6 to 88.7 |
276 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Poverty |
Below Poverty Level |
81.5 |
73.5 to 87.5 |
173 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Poverty |
Below Poverty Level |
92.7 |
88.7 to 95.4 |
580 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Poverty |
Below Poverty Level |
93.8 |
90.1 to 96.1 |
361 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
92.4 |
87.0 to 95.7 |
219 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Poverty |
Below Poverty Level |
88.2 |
87.1 to 89.3 |
12976 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Poverty |
Below Poverty Level |
92.1 |
86.6 to 95.5 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Poverty |
Below Poverty Level |
81.8 |
74.5 to 87.3 |
221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Poverty |
Below Poverty Level |
95.8 |
91.7 to 97.9 |
157 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Poverty |
Below Poverty Level |
82.8 |
76.3 to 87.8 |
253 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Poverty |
Below Poverty Level |
89.1 |
85.5 to 92.0 |
1639 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Poverty |
Below Poverty Level |
91.8 |
87.3 to 94.8 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Poverty |
Below Poverty Level |
87.3 |
81.9 to 91.3 |
285 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
89.1 |
84.6 to 92.4 |
1032 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Poverty |
Below Poverty Level |
87.7 |
79.1 to 93.1 |
118 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Poverty |
Below Poverty Level |
91.8 |
85.1 to 95.7 |
149 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Poverty |
Below Poverty Level |
83.5 |
74.2 to 89.9 |
136 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Poverty |
Below Poverty Level |
82.4 |
74.8 to 88.0 |
193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Poverty |
Below Poverty Level |
91.9 |
87.6 to 94.8 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Poverty |
Below Poverty Level |
91.3 |
85.3 to 95.0 |
168 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Poverty |
Below Poverty Level |
71.8 |
62.2 to 79.8 |
147 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
83.8 |
81.1 to 86.2 |
1182 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
75.6 |
72.7 to 78.2 |
1449 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
86.2 |
83.5 to 88.5 |
1217 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.9 |
93.3 to 96.1 |
1242 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
84.6 |
81.4 to 87.3 |
1338 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
85.7 |
83.2 to 87.9 |
1331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.7 |
92.9 to 96.1 |
1306 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.6 |
87.2 to 91.7 |
1248 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.8 |
88.3 to 92.8 |
1290 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
81.9 |
78.8 to 84.7 |
1339 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
93.8 |
91.8 to 95.4 |
1292 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
86.9 |
84.5 to 89.0 |
1240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.4 |
88.2 to 92.2 |
1378 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
93.0 |
91.6 to 94.3 |
2501 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.6 |
91.6 to 96.5 |
667 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
92.8 |
91.2 to 94.1 |
1834 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
93.3 |
91.3 to 94.8 |
1138 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
93.7 |
91.8 to 95.2 |
1087 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
81.6 |
78.8 to 84.1 |
1380 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.2 |
87.7 to 92.2 |
1077 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.4 |
89.2 to 93.2 |
1221 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.1 |
88.0 to 91.9 |
1360 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
93.2 |
91.4 to 94.6 |
2603 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.6 |
92.7 to 96.1 |
1335 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.6 |
92.8 to 96.0 |
1363 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.5 |
89.2 to 93.3 |
1373 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
60.2 |
56.3 to 63.9 |
1025 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
86.2 |
83.7 to 88.4 |
1385 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
77.8 |
74.9 to 80.4 |
1284 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
87.7 |
85.3 to 89.8 |
1308 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
86.9 |
84.3 to 89.0 |
1294 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.0 |
86.9 to 90.9 |
1375 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
92.9 |
90.9 to 94.4 |
1395 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
84.1 |
81.3 to 86.4 |
1199 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
95.4 |
94.1 to 96.3 |
2180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.8 |
92.7 to 96.3 |
939 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
95.7 |
94.1 to 96.9 |
1241 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.9 |
89.7 to 93.7 |
1329 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.6 |
92.9 to 95.9 |
1322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.9 |
88.6 to 92.7 |
1244 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
77.7 |
74.8 to 80.4 |
1240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
83.8 |
81.1 to 86.1 |
1223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.2 |
92.8 to 95.4 |
3096 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
92.9 |
90.2 to 94.9 |
916 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.4 |
92.8 to 95.6 |
2180 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
88.6 |
88.1 to 89.0 |
75678 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
97.1 |
95.4 to 98.2 |
1187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
83.6 |
81.0 to 85.9 |
1214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.4 |
88.4 to 92.1 |
1467 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
83.4 |
80.6 to 85.9 |
1143 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
87.4 |
85.6 to 88.9 |
4915 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.3 |
86.8 to 91.4 |
1090 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.5 |
88.0 to 94.1 |
562 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
87.0 |
85.0 to 88.7 |
3263 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.0 |
87.8 to 91.9 |
1362 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.2 |
89.5 to 92.6 |
1780 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
85.7 |
83.0 to 88.0 |
2323 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
86.9 |
84.4 to 89.1 |
1392 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.4 |
89.2 to 93.1 |
1129 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.3 |
87.2 to 91.2 |
1306 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
73.0 |
69.8 to 75.9 |
1271 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
86.8 |
81.6 to 90.7 |
273 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
74.4 |
53.0 to 88.2 |
37 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
86.1 |
73.8 to 93.1 |
48 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
95.2 |
89.4 to 97.9 |
143 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
95.3 |
88.2 to 98.2 |
72 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.6 |
80.0 to 94.8 |
120 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.3 |
83.8 to 93.1 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.5 |
88.3 to 94.0 |
534 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
82.3 |
73.9 to 88.4 |
178 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
94.8 |
91.4 to 96.8 |
376 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.6 |
85.6 to 92.5 |
389 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
88.3 |
82.2 to 92.5 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
90.4 |
84.8 to 94.2 |
171 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.3 |
82.8 to 95.8 |
107 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
86.5 |
69.5 to 94.7 |
37 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.0 |
76.1 to 97.0 |
48 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
92.8 |
82.0 to 97.3 |
78 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.0 |
84.5 to 92.3 |
318 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
93.3 |
89.9 to 95.6 |
638 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
96.2 |
88.1 to 98.8 |
96 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.5 |
83.6 to 95.8 |
139 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
92.5 |
83.9 to 96.7 |
73 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
65.1 |
59.3 to 70.5 |
376 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.6 |
79.7 to 92.7 |
106 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
73.9 |
58.3 to 85.2 |
54 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
84.2 |
74.8 to 90.5 |
116 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.3 |
84.1 to 95.4 |
122 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
94.3 |
90.9 to 96.5 |
322 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
93.2 |
88.8 to 96.0 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
96.1 |
88.3 to 98.8 |
90 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
92.6 |
87.5 to 95.8 |
196 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
98.1 |
87.6 to 99.7 |
40 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
94.5 |
88.7 to 97.4 |
127 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
80.5 |
68.1 to 88.9 |
67 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
92.1 |
88.8 to 94.5 |
667 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
92.2 |
88.7 to 94.6 |
490 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
92.1 |
86.3 to 95.5 |
177 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.1 |
87.9 to 90.1 |
7808 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
99.1 |
96.3 to 99.8 |
82 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
83.8 |
78.0 to 88.2 |
249 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
84.8 |
77.1 to 90.2 |
150 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.8 |
82.9 to 91.5 |
532 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
93.7 |
82.6 to 97.9 |
67 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.9 |
82.0 to 94.5 |
131 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.3 |
81.5 to 91.5 |
334 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
82.8 |
75.2 to 88.4 |
240 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
82.4 |
62.5 to 92.9 |
48 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
95.7 |
86.3 to 98.7 |
35 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
90.9 |
80.6 to 96.0 |
87 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Hispanic |
83.6 |
72.8 to 90.7 |
101 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Hispanic |
75.2 |
65.5 to 82.9 |
134 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Hispanic |
89.3 |
85.5 to 92.2 |
511 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Hispanic |
92.1 |
84.8 to 96.0 |
163 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.7 |
80.3 to 88.2 |
604 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.8 |
84.4 to 92.0 |
365 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.7 |
86.9 to 94.9 |
286 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Hispanic |
86.5 |
79.9 to 91.2 |
238 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Hispanic |
95.5 |
91.2 to 97.8 |
325 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.5 |
79.5 to 88.5 |
465 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Hispanic |
94.6 |
87.6 to 97.7 |
218 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.3 |
82.6 to 92.3 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.7 |
86.2 to 95.2 |
207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Hispanic |
92.2 |
89.5 to 94.2 |
865 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Hispanic |
90.1 |
85.7 to 93.2 |
460 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.1 |
89.6 to 95.5 |
405 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Hispanic |
92.9 |
87.7 to 96.0 |
175 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Hispanic |
94.5 |
86.7 to 97.8 |
119 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Hispanic |
87.1 |
81.4 to 91.2 |
258 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.8 |
79.5 to 94.1 |
104 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Hispanic |
87.4 |
78.6 to 92.9 |
133 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
Hispanic |
78.6 |
62.6 to 88.9 |
64 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Hispanic |
89.5 |
83.0 to 93.7 |
440 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Hispanic |
96.6 |
93.0 to 98.3 |
214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Hispanic |
89.6 |
78.7 to 95.3 |
119 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Hispanic |
86.7 |
76.2 to 93.0 |
113 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Hispanic |
73.5 |
59.1 to 84.1 |
76 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Hispanic |
82.6 |
69.3 to 90.9 |
107 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
Hispanic |
80.7 |
69.3 to 88.5 |
100 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Hispanic |
90.0 |
84.3 to 93.8 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Hispanic |
86.9 |
82.8 to 90.1 |
532 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.9 |
73.6 to 91.9 |
87 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Hispanic |
92.2 |
87.6 to 95.2 |
336 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
Hispanic |
83.6 |
80.3 to 86.4 |
921 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Hispanic |
95.2 |
93.5 to 96.5 |
789 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.6 |
91.0 to 95.5 |
552 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
97.7 |
95.5 to 98.9 |
237 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.3 |
80.9 to 93.0 |
223 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.7 |
80.1 to 96.8 |
67 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Hispanic |
90.2 |
80.8 to 95.3 |
117 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Hispanic |
86.8 |
80.2 to 91.4 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
Hispanic |
86.3 |
80.9 to 90.4 |
239 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Hispanic |
94.1 |
89.4 to 96.8 |
534 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.8 |
89.1 to 96.5 |
290 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
94.2 |
87.8 to 97.3 |
244 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.2 |
87.0 to 89.4 |
16518 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Hispanic |
95.6 |
92.5 to 97.4 |
335 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.4 |
81.2 to 93.1 |
150 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.3 |
78.2 to 94.1 |
78 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.4 |
84.6 to 95.3 |
148 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.7 |
86.6 to 90.5 |
3535 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Hispanic |
89.4 |
86.8 to 91.5 |
907 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Hispanic |
87.9 |
83.9 to 91.1 |
479 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.7 |
86.1 to 90.8 |
2149 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
Hispanic |
92.8 |
86.9 to 96.2 |
193 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.3 |
83.3 to 97.5 |
63 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Hispanic |
86.0 |
78.2 to 91.3 |
289 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Hispanic |
89.6 |
84.3 to 93.3 |
294 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.6 |
76.5 to 97.4 |
60 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.5 |
85.3 to 95.3 |
165 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
Hispanic |
72.3 |
63.1 to 79.9 |
177 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
88.7 |
79.9 to 93.9 |
108 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
80.6 |
75.8 to 84.7 |
477 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
90.0 |
84.1 to 93.8 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
95.4 |
89.8 to 97.9 |
132 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
87.2 |
81.5 to 91.3 |
333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
83.1 |
74.0 to 89.4 |
145 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.5 |
87.8 to 97.6 |
155 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.8 |
78.9 to 92.0 |
167 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.4 |
76.2 to 92.7 |
133 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
80.4 |
70.0 to 87.7 |
149 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.7 |
84.2 to 95.8 |
159 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.7 |
83.7 to 89.3 |
902 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.4 |
80.1 to 94.7 |
113 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
97.1 |
94.9 to 98.4 |
340 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
98.3 |
93.4 to 99.6 |
84 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
97.0 |
94.6 to 98.4 |
256 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.0 |
84.7 to 96.0 |
118 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
97.8 |
93.4 to 99.3 |
88 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
81.1 |
71.9 to 87.8 |
166 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.4 |
81.7 to 94.1 |
118 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.3 |
84.0 to 95.4 |
152 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
87.4 |
80.0 to 92.3 |
117 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.2 |
90.4 to 96.6 |
376 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
96.6 |
91.2 to 98.7 |
183 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.5 |
80.9 to 94.4 |
155 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
93.2 |
85.6 to 96.9 |
167 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
72.9 |
61.4 to 82.0 |
98 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.0 |
80.6 to 94.0 |
143 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
82.1 |
74.8 to 87.7 |
185 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.7 |
79.9 to 95.0 |
107 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
87.8 |
81.7 to 92.1 |
217 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.4 |
84.6 to 95.4 |
133 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.4 |
89.4 to 97.1 |
284 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
87.2 |
79.8 to 92.1 |
148 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.4 |
90.3 to 96.8 |
435 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.2 |
86.9 to 97.5 |
256 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.6 |
88.7 to 97.5 |
179 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.7 |
86.6 to 96.1 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.9 |
89.7 to 97.5 |
187 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.5 |
86.0 to 94.9 |
138 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
81.5 |
76.5 to 85.7 |
426 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
77.0 |
67.6 to 84.3 |
182 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
88.1 |
81.3 to 92.7 |
420 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
96.4 |
91.9 to 98.4 |
165 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
87.1 |
79.4 to 92.2 |
255 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.0 |
87.8 to 90.2 |
10891 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
99.2 |
96.6 to 99.8 |
131 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
85.1 |
75.4 to 91.4 |
94 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
95.4 |
92.1 to 97.4 |
262 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
88.6 |
81.0 to 93.4 |
123 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.1 |
87.4 to 93.8 |
546 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.3 |
83.0 to 96.7 |
96 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
90.7 |
80.3 to 95.9 |
82 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.0 |
86.9 to 94.0 |
368 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.9 |
84.3 to 97.0 |
91 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.5 |
82.0 to 94.1 |
134 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
81.0 |
73.8 to 86.5 |
445 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
83.9 |
77.2 to 88.9 |
291 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.4 |
84.1 to 96.5 |
102 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
93.7 |
87.2 to 97.0 |
139 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
80.4 |
69.8 to 88.0 |
103 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
82.8 |
79.9 to 85.4 |
1012 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
73.0 |
69.4 to 76.3 |
980 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.9 |
82.4 to 88.7 |
759 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.7 |
93.1 to 95.9 |
1167 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
84.8 |
80.0 to 88.5 |
631 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.5 |
82.5 to 88.0 |
999 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
95.0 |
92.9 to 96.6 |
955 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.0 |
87.1 to 92.3 |
897 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.3 |
85.6 to 92.1 |
623 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
77.0 |
72.6 to 80.8 |
848 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.6 |
92.2 to 96.2 |
800 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
80.6 |
74.6 to 85.5 |
279 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.3 |
86.8 to 91.4 |
1245 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
93.0 |
91.1 to 94.5 |
1636 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
97.1 |
93.9 to 98.7 |
261 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
92.7 |
90.8 to 94.3 |
1375 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
92.3 |
90.0 to 94.1 |
1013 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
93.2 |
91.1 to 94.8 |
1024 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
80.5 |
77.4 to 83.3 |
1180 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.2 |
86.5 to 91.3 |
1033 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
91.3 |
88.8 to 93.3 |
1006 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.7 |
88.7 to 92.4 |
1356 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.4 |
92.1 to 96.1 |
1481 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
93.5 |
90.9 to 95.4 |
1063 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
95.1 |
93.3 to 96.4 |
1210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
91.4 |
88.9 to 93.3 |
1165 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
53.8 |
49.6 to 58.0 |
822 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.4 |
82.8 to 87.8 |
1272 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
75.3 |
72.1 to 78.2 |
1181 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
87.2 |
84.5 to 89.5 |
1149 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.1 |
81.5 to 88.2 |
743 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
88.3 |
86.0 to 90.3 |
1287 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
91.9 |
89.3 to 94.0 |
900 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
81.7 |
77.5 to 85.4 |
567 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.8 |
93.1 to 96.2 |
1333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.7 |
91.3 to 96.9 |
378 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.9 |
92.7 to 96.4 |
955 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
92.7 |
90.2 to 94.6 |
994 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.8 |
92.9 to 96.1 |
1184 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.7 |
87.0 to 91.9 |
1110 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
74.7 |
71.0 to 78.1 |
841 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
83.8 |
80.9 to 86.4 |
988 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
95.5 |
94.1 to 96.6 |
2208 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
93.2 |
89.4 to 95.7 |
394 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
95.6 |
94.2 to 96.7 |
1814 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
88.3 |
87.8 to 88.8 |
56479 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
96.0 |
93.5 to 97.5 |
918 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
82.0 |
78.9 to 84.7 |
987 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.2 |
88.0 to 92.0 |
1302 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
81.8 |
78.7 to 84.6 |
1021 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
86.3 |
83.4 to 88.8 |
2241 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.2 |
83.9 to 92.9 |
384 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
95.6 |
91.9 to 97.6 |
213 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.9 |
82.8 to 88.5 |
1644 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
88.6 |
86.1 to 90.8 |
1210 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.8 |
89.0 to 92.4 |
1750 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
86.1 |
82.8 to 88.8 |
1554 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.8 |
82.8 to 88.3 |
1003 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
91.0 |
88.9 to 92.7 |
1270 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
88.7 |
86.3 to 90.7 |
1129 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
71.4 |
68.1 to 74.5 |
1153 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
86.9 |
83.5 to 89.7 |
628 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
77.2 |
73.6 to 80.4 |
896 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
87.8 |
84.8 to 90.3 |
835 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
95.5 |
93.1 to 97.1 |
557 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
85.6 |
81.7 to 88.7 |
806 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
87.4 |
84.2 to 90.0 |
778 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.3 |
85.4 to 93.7 |
350 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
92.4 |
89.0 to 94.8 |
506 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.5 |
89.4 to 93.3 |
1615 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
81.7 |
77.8 to 85.1 |
914 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
96.5 |
93.4 to 98.2 |
475 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
84.6 |
80.3 to 88.2 |
471 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.4 |
86.6 to 93.1 |
581 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
92.2 |
90.0 to 93.9 |
1398 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.0 |
88.3 to 93.2 |
1023 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
93.7 |
89.9 to 96.1 |
375 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.9 |
87.6 to 93.4 |
604 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
94.2 |
90.7 to 96.4 |
393 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
86.2 |
82.4 to 89.3 |
625 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.7 |
88.3 to 94.2 |
502 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.6 |
88.6 to 93.9 |
646 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.7 |
83.7 to 92.2 |
250 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
94.3 |
91.5 to 96.2 |
884 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
94.5 |
90.5 to 96.9 |
268 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
92.3 |
87.9 to 95.2 |
450 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.6 |
88.4 to 93.9 |
659 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
69.5 |
61.6 to 76.4 |
214 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.6 |
84.8 to 91.5 |
619 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
84.1 |
80.1 to 87.4 |
511 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.5 |
85.3 to 91.1 |
753 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
86.7 |
83.8 to 89.0 |
1123 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
89.1 |
82.5 to 93.5 |
200 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
92.3 |
86.0 to 95.9 |
176 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
82.0 |
78.5 to 85.0 |
861 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
94.7 |
93.2 to 95.8 |
1728 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
93.9 |
92.2 to 95.2 |
1418 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
96.9 |
93.7 to 98.5 |
310 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.4 |
88.1 to 93.9 |
690 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
96.4 |
94.1 to 97.9 |
468 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
89.6 |
85.9 to 92.4 |
513 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
81.0 |
76.1 to 85.1 |
408 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
86.4 |
83.1 to 89.1 |
794 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
95.6 |
93.7 to 96.9 |
1606 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
93.1 |
91.2 to 94.7 |
1339 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
97.6 |
93.4 to 99.1 |
267 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.7 |
88.0 to 89.4 |
36713 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
96.8 |
94.1 to 98.2 |
416 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
85.9 |
81.7 to 89.3 |
512 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.3 |
87.8 to 93.9 |
512 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
85.6 |
81.8 to 88.8 |
612 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.6 |
86.3 to 90.5 |
4042 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
89.7 |
87.5 to 91.6 |
1302 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
89.7 |
86.9 to 91.9 |
905 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.1 |
85.0 to 90.7 |
1835 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
92.6 |
89.0 to 95.0 |
467 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
93.5 |
89.1 to 96.2 |
222 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
85.0 |
80.0 to 88.9 |
860 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.8 |
85.8 to 91.2 |
859 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.7 |
86.9 to 93.5 |
450 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
92.5 |
89.6 to 94.7 |
581 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
78.5 |
73.7 to 82.7 |
425 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
83.1 |
79.1 to 86.5 |
555 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
65.0 |
57.6 to 71.7 |
272 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
87.8 |
84.0 to 90.8 |
582 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.9 |
89.4 to 95.3 |
502 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
85.9 |
81.9 to 89.1 |
801 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
84.8 |
80.7 to 88.2 |
592 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
94.6 |
92.5 to 96.1 |
1107 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
87.2 |
84.2 to 89.6 |
1028 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
79.5 |
75.0 to 83.3 |
694 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.8 |
91.4 to 95.6 |
886 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
87.5 |
83.9 to 90.3 |
649 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
91.2 |
87.8 to 93.8 |
548 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.5 |
91.9 to 94.8 |
1608 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.5 |
91.9 to 94.8 |
1608 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
94.0 |
91.3 to 95.9 |
556 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
94.4 |
91.0 to 96.6 |
431 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
80.9 |
76.3 to 84.7 |
529 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.6 |
86.2 to 93.8 |
387 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
88.4 |
84.9 to 91.3 |
737 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.8 |
88.0 to 93.1 |
696 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.7 |
90.6 to 94.4 |
2006 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
94.7 |
92.6 to 96.2 |
1275 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
94.5 |
92.1 to 96.1 |
896 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.8 |
85.7 to 92.9 |
543 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
59.9 |
54.4 to 65.2 |
496 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
87.5 |
84.3 to 90.2 |
696 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
76.5 |
63.0 to 86.1 |
75 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
88.5 |
82.8 to 92.5 |
316 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
85.7 |
80.4 to 89.8 |
300 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.8 |
90.2 to 94.7 |
716 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.3 |
90.3 to 93.9 |
1466 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
86.1 |
80.7 to 90.1 |
323 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
96.0 |
94.2 to 97.2 |
1005 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
96.0 |
94.2 to 97.2 |
1005 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.9 |
90.0 to 95.0 |
672 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.4 |
86.2 to 95.9 |
215 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.0 |
90.4 to 95.0 |
747 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
78.5 |
74.3 to 82.2 |
582 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
82.0 |
77.5 to 85.8 |
450 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.9 |
92.3 to 95.2 |
2130 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.9 |
92.3 to 95.2 |
2130 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.2 |
88.5 to 89.8 |
38031 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
96.3 |
94.3 to 97.6 |
1050 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
82.6 |
79.2 to 85.5 |
805 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.6 |
88.4 to 95.4 |
276 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
83.0 |
78.8 to 86.6 |
573 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
87.6 |
85.4 to 89.5 |
2486 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.4 |
82.9 to 94.8 |
152 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
87.5 |
85.3 to 89.4 |
2334 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.2 |
86.3 to 91.5 |
898 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.6 |
86.8 to 93.4 |
567 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
84.9 |
81.7 to 87.6 |
1551 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
86.4 |
82.4 to 89.7 |
625 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
91.9 |
88.7 to 94.2 |
489 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.4 |
86.1 to 92.0 |
608 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
80.8 |
63.4 to 91.1 |
34 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
81.4 |
75.3 to 86.2 |
311 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
79.0 |
74.1 to 83.1 |
460 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
88.4 |
77.9 to 94.3 |
88 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
95.0 |
92.6 to 96.7 |
546 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
83.4 |
55.9 to 95.2 |
33 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
82.3 |
74.1 to 88.4 |
164 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
98.9 |
92.3 to 99.8 |
59 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
75.0 |
53.1 to 88.8 |
32 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.7 |
85.5 to 95.4 |
192 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
83.6 |
78.1 to 88.0 |
296 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
87.3 |
82.6 to 90.8 |
455 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.0 |
83.1 to 93.0 |
224 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.0 |
83.1 to 93.0 |
224 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.6 |
87.3 to 94.6 |
253 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.0 |
87.6 to 93.6 |
444 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
77.7 |
72.5 to 82.3 |
498 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
85.1 |
80.4 to 88.8 |
444 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.8 |
86.0 to 95.3 |
226 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.8 |
86.4 to 92.4 |
620 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
100.0 |
NA |
45 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
92.6 |
87.6 to 95.7 |
277 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
93.4 |
89.1 to 96.1 |
316 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
57.8 |
53.0 to 62.4 |
662 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
75.8 |
68.8 to 81.7 |
313 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
71.5 |
67.7 to 75.1 |
895 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
84.1 |
79.3 to 87.9 |
478 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
82.0 |
72.9 to 88.5 |
185 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
81.5 |
77.3 to 85.2 |
608 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
84.8 |
80.4 to 88.4 |
481 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
87.1 |
77.7 to 92.9 |
146 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
87.1 |
77.7 to 92.9 |
146 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.2 |
85.7 to 94.7 |
238 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
94.4 |
92.0 to 96.1 |
795 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
85.7 |
78.6 to 90.7 |
232 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
77.8 |
73.3 to 81.8 |
566 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
74.6 |
65.8 to 81.7 |
188 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.5 |
81.5 to 96.3 |
93 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.5 |
81.5 to 96.3 |
93 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
84.5 |
83.5 to 85.4 |
16952 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
76.9 |
68.1 to 83.9 |
163 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
90.5 |
87.9 to 92.6 |
879 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
80.0 |
73.7 to 85.0 |
257 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
88.1 |
82.2 to 92.2 |
326 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
88.1 |
82.2 to 92.2 |
326 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
80.6 |
70.4 to 87.9 |
149 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
90.6 |
88.5 to 92.4 |
1184 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
82.0 |
70.8 to 89.6 |
117 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
70.6 |
60.2 to 79.2 |
152 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.0 |
87.5 to 93.6 |
528 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
84.6 |
79.5 to 88.7 |
331 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
68.0 |
64.2 to 71.7 |
990 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Overall |
Overall |
84.4 |
82.1 to 86.5 |
1494 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Overall |
Overall |
75.7 |
73.0 to 78.2 |
1628 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Overall |
Overall |
87.8 |
85.6 to 89.8 |
1505 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Overall |
Overall |
94.5 |
93.0 to 95.7 |
1605 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Overall |
Overall |
85.7 |
83.0 to 88.0 |
1640 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Overall |
Overall |
86.0 |
83.7 to 88.0 |
1534 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Overall |
Overall |
93.6 |
91.7 to 95.1 |
1516 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Overall |
Overall |
89.0 |
86.7 to 90.8 |
1534 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Overall |
Overall |
91.5 |
89.4 to 93.3 |
1615 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Overall |
Overall |
80.7 |
77.8 to 83.2 |
1640 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Overall |
Overall |
94.4 |
92.7 to 95.7 |
1553 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Overall |
Overall |
85.8 |
83.4 to 87.9 |
1416 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Overall |
Overall |
89.8 |
87.7 to 91.6 |
1584 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Overall |
Overall |
92.7 |
91.5 to 93.8 |
3230 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Overall |
Overall |
91.0 |
88.3 to 93.2 |
1023 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Overall |
Overall |
93.1 |
91.7 to 94.2 |
2207 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Overall |
Overall |
92.2 |
90.4 to 93.7 |
1413 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Overall |
Overall |
93.3 |
91.5 to 94.8 |
1268 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Overall |
Overall |
82.3 |
79.8 to 84.5 |
1652 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Overall |
Overall |
89.5 |
87.2 to 91.3 |
1333 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Overall |
Overall |
90.2 |
88.2 to 92.0 |
1609 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Overall |
Overall |
90.1 |
88.2 to 91.7 |
1566 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Overall |
Overall |
93.3 |
91.7 to 94.7 |
2935 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Overall |
Overall |
94.6 |
92.8 to 96.0 |
1556 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Overall |
Overall |
93.6 |
91.7 to 95.0 |
1623 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Overall |
Overall |
91.3 |
89.2 to 93.0 |
1518 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Overall |
Overall |
60.6 |
57.4 to 63.8 |
1372 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Overall |
Overall |
85.8 |
83.5 to 87.9 |
1628 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Overall |
Overall |
76.7 |
74.0 to 79.3 |
1481 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Overall |
Overall |
87.1 |
84.8 to 89.1 |
1547 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Overall |
Overall |
86.1 |
83.7 to 88.1 |
1608 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Overall |
Overall |
88.4 |
86.3 to 90.2 |
1524 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Overall |
Overall |
92.3 |
90.5 to 93.8 |
1642 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Overall |
Overall |
83.5 |
81.1 to 85.6 |
1665 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Overall |
Overall |
94.8 |
93.7 to 95.7 |
2879 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Overall |
Overall |
93.9 |
92.2 to 95.2 |
1418 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Overall |
Overall |
95.4 |
93.9 to 96.6 |
1461 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Overall |
Overall |
92.0 |
90.0 to 93.6 |
1600 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Overall |
Overall |
94.8 |
93.2 to 96.0 |
1478 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Overall |
Overall |
90.6 |
88.5 to 92.3 |
1492 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Overall |
Overall |
79.1 |
76.6 to 81.4 |
1556 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Overall |
Overall |
83.6 |
81.1 to 85.8 |
1432 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Overall |
Overall |
94.2 |
93.0 to 95.2 |
3829 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Overall |
Overall |
93.1 |
91.2 to 94.7 |
1339 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Overall |
Overall |
94.4 |
93.0 to 95.5 |
2490 |
| Meningococcal Conjugate |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Overall |
Overall |
88.5 |
88.1 to 88.9 |
91696 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Overall |
Overall |
96.4 |
94.9 to 97.5 |
1466 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Overall |
Overall |
83.3 |
80.9 to 85.5 |
1480 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Overall |
Overall |
91.2 |
89.4 to 92.6 |
1667 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Overall |
Overall |
83.7 |
81.3 to 86.0 |
1442 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Overall |
Overall |
88.0 |
86.6 to 89.4 |
6854 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Overall |
Overall |
89.8 |
87.7 to 91.6 |
1454 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Overall |
Overall |
89.7 |
86.9 to 91.9 |
905 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Overall |
Overall |
87.8 |
86.1 to 89.3 |
4495 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Overall |
Overall |
89.6 |
87.5 to 91.4 |
1514 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Overall |
Overall |
90.9 |
89.3 to 92.4 |
1973 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Overall |
Overall |
84.7 |
82.2 to 87.0 |
2528 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Overall |
Overall |
86.2 |
83.8 to 88.2 |
1636 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Overall |
Overall |
91.2 |
89.3 to 92.8 |
1467 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Overall |
Overall |
89.7 |
87.8 to 91.4 |
1520 |
| Meningococcal Conjugate |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Overall |
Overall |
72.4 |
69.4 to 75.1 |
1449 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2006 |
Age |
13-17 Years |
60.1 |
57.8 to 62.4 |
2882 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2006 |
Age |
13-17 Years |
76.3 |
67.9 to 83.0 |
170 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2006 |
Age |
13-17 Years |
59.8 |
51.5 to 67.6 |
227 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2006 |
Age |
13-17 Years |
65.0 |
58.3 to 71.2 |
347 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2006 |
Age |
13-17 Years |
58.2 |
53.3 to 63.0 |
608 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2006 |
Age |
13-17 Years |
59.4 |
53.5 to 65.0 |
458 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2006 |
Age |
13-17 Years |
59.0 |
51.9 to 65.8 |
268 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2006 |
Age |
13-17 Years |
64.7 |
56.4 to 72.2 |
165 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2006 |
Age |
13-17 Years |
53.0 |
40.0 to 65.6 |
118 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2006 |
Age |
13-17 Years |
59.0 |
52.4 to 65.4 |
362 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2006 |
Age |
13-17 Years |
52.9 |
43.4 to 62.1 |
159 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
72.3 |
70.3 to 74.3 |
2947 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
83.7 |
75.8 to 89.4 |
190 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-17 Years |
81.2 |
73.8 to 86.9 |
219 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
75.2 |
69.8 to 79.9 |
370 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
70.2 |
65.4 to 74.6 |
501 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
68.5 |
63.5 to 73.0 |
584 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-17 Years |
74.8 |
68.7 to 80.1 |
322 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-17 Years |
70.7 |
61.7 to 78.3 |
165 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-17 Years |
62.6 |
49.6 to 74.1 |
112 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
71.8 |
65.1 to 77.7 |
366 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2007 |
Age |
13-17 Years |
63.1 |
53.3 to 71.9 |
118 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
70.1 |
64.6 to 75.0 |
406 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
68.3 |
62.2 to 73.7 |
304 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
74.0 |
66.4 to 80.4 |
250 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
46.1 |
40.4 to 52.0 |
382 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
71.3 |
64.1 to 77.5 |
316 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
77.4 |
70.9 to 82.9 |
347 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
79.8 |
73.2 to 85.0 |
292 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
78.6 |
72.9 to 83.3 |
334 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
84.7 |
79.9 to 88.6 |
329 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
79.4 |
70.3 to 86.2 |
284 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
70.9 |
64.5 to 76.5 |
345 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
71.6 |
65.7 to 76.9 |
317 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
51.3 |
44.5 to 58.0 |
268 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
72.9 |
67.7 to 77.6 |
783 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
71.8 |
65.6 to 77.3 |
343 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
73.2 |
66.7 to 78.8 |
440 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
53.6 |
47.4 to 59.7 |
345 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
65.9 |
59.4 to 71.8 |
308 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
69.9 |
63.4 to 75.6 |
271 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
82.0 |
76.2 to 86.6 |
296 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
74.9 |
69.3 to 79.8 |
379 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
75.0 |
69.1 to 80.1 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
79.0 |
73.0 to 83.9 |
394 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
94.4 |
90.5 to 96.8 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
69.9 |
63.9 to 75.3 |
320 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
88.7 |
84.2 to 92.0 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2008 |
Age |
13-17 Years |
28.7 |
23.7 to 34.3 |
404 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
67.9 |
61.9 to 73.4 |
351 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
69.1 |
62.6 to 74.8 |
299 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
71.5 |
65.6 to 76.7 |
365 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
69.0 |
61.6 to 75.5 |
235 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
84.2 |
77.1 to 89.4 |
300 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
78.1 |
72.4 to 83.0 |
390 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
75.1 |
68.8 to 80.5 |
310 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
85.5 |
81.9 to 88.5 |
600 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
85.4 |
80.0 to 89.5 |
293 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
85.6 |
80.6 to 89.5 |
307 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
63.6 |
56.9 to 69.8 |
326 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
75.0 |
69.4 to 79.9 |
362 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
57.8 |
51.2 to 64.1 |
311 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
59.5 |
53.1 to 65.5 |
292 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
64.1 |
56.6 to 71.0 |
235 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
82.0 |
77.1 to 86.0 |
682 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
79.7 |
73.9 to 84.5 |
345 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
82.3 |
76.7 to 86.8 |
337 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
72.2 |
70.8 to 73.4 |
17835 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
87.1 |
84.7 to 89.2 |
1838 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
83.2 |
80.2 to 85.8 |
990 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
76.1 |
73.2 to 78.8 |
2306 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
67.2 |
64.3 to 69.9 |
2788 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
68.4 |
65.9 to 70.9 |
2361 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
74.3 |
70.3 to 77.9 |
2203 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
68.4 |
65.0 to 71.5 |
1295 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
70.0 |
66.3 to 73.4 |
1854 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
71.5 |
65.8 to 76.6 |
1118 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
91.5 |
86.5 to 94.8 |
297 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
53.7 |
47.8 to 59.5 |
367 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
45.3 |
39.3 to 51.4 |
344 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
50.3 |
44.0 to 56.6 |
360 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
79.3 |
73.4 to 84.3 |
840 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
77.7 |
71.0 to 83.2 |
269 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
73.0 |
63.8 to 80.6 |
233 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
80.1 |
73.0 to 85.6 |
338 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
62.7 |
58.5 to 66.8 |
1082 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2008 |
Age |
13-17 Years |
62.7 |
54.9 to 69.9 |
222 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
79.8 |
73.7 to 84.8 |
283 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
70.3 |
63.6 to 76.3 |
272 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
64.2 |
57.4 to 70.5 |
275 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
44.7 |
38.3 to 51.2 |
295 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
75.4 |
69.1 to 80.8 |
264 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
79.1 |
73.1 to 84.1 |
280 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
71.6 |
65.5 to 77.0 |
339 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
70.1 |
63.6 to 75.8 |
274 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
83.6 |
78.3 to 87.8 |
349 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
52.7 |
46.7 to 58.6 |
363 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
76.7 |
71.0 to 81.5 |
379 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
83.6 |
78.8 to 87.5 |
411 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
88.9 |
84.2 to 92.4 |
351 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
74.4 |
67.9 to 80.0 |
371 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
89.3 |
85.4 to 92.2 |
412 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
86.8 |
80.9 to 91.1 |
412 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
73.0 |
67.1 to 78.2 |
383 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
79.1 |
73.0 to 84.1 |
256 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
61.4 |
53.5 to 68.7 |
227 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
72.1 |
67.3 to 76.4 |
754 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
71.4 |
65.2 to 76.8 |
389 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
72.2 |
66.4 to 77.4 |
365 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
57.9 |
52.3 to 63.3 |
873 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
70.5 |
64.2 to 76.1 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
74.5 |
67.8 to 80.2 |
252 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
80.7 |
75.5 to 85.1 |
393 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
70.1 |
63.0 to 76.4 |
281 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
75.7 |
69.4 to 81.0 |
299 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
80.2 |
72.5 to 86.2 |
245 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
93.7 |
89.9 to 96.2 |
397 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
69.3 |
64.0 to 74.2 |
446 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
90.3 |
85.7 to 93.5 |
336 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
29.1 |
24.5 to 34.1 |
438 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
74.7 |
69.3 to 79.4 |
374 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
81.1 |
75.8 to 85.4 |
306 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
78.8 |
73.1 to 83.5 |
286 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
75.3 |
69.0 to 80.7 |
336 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
88.0 |
82.7 to 91.8 |
307 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
81.2 |
76.2 to 85.4 |
427 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
84.4 |
79.8 to 88.1 |
406 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
87.7 |
84.0 to 90.6 |
539 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
89.1 |
84.2 to 92.6 |
269 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
86.7 |
81.3 to 90.8 |
270 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
73.8 |
67.7 to 79.1 |
323 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
85.7 |
80.4 to 89.8 |
272 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
67.7 |
61.6 to 73.2 |
351 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
55.5 |
49.3 to 61.5 |
336 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
68.8 |
63.2 to 73.9 |
386 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
84.7 |
79.6 to 88.7 |
579 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
82.0 |
77.0 to 86.0 |
324 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
85.1 |
79.1 to 89.6 |
255 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
76.2 |
75.1 to 77.2 |
20066 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
89.9 |
87.9 to 91.6 |
2189 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
85.7 |
82.8 to 88.1 |
966 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
80.4 |
77.5 to 83.1 |
2214 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
72.6 |
70.4 to 74.7 |
2984 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
72.0 |
69.8 to 74.2 |
3105 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
72.0 |
68.7 to 75.1 |
2856 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
74.3 |
71.2 to 77.1 |
1250 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
78.6 |
75.8 to 81.1 |
1974 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
77.6 |
73.1 to 81.5 |
1320 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
91.4 |
87.9 to 94.0 |
409 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
52.7 |
45.8 to 59.5 |
299 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
58.0 |
51.2 to 64.4 |
271 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
63.3 |
57.3 to 68.9 |
397 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
75.8 |
71.0 to 80.1 |
1470 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
79.3 |
72.7 to 84.7 |
305 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
76.0 |
67.8 to 82.7 |
239 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
76.2 |
68.9 to 82.2 |
296 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
84.9 |
80.2 to 88.6 |
325 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
75.0 |
68.4 to 80.6 |
305 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-17 Years |
73.5 |
67.0 to 79.1 |
333 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
71.8 |
68.1 to 75.1 |
1208 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
73.2 |
67.1 to 78.6 |
339 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
87.0 |
82.7 to 90.3 |
426 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
79.9 |
74.3 to 84.6 |
358 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
76.3 |
70.1 to 81.5 |
321 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
52.2 |
45.1 to 59.2 |
249 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
85.3 |
80.1 to 89.3 |
345 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
82.8 |
78.0 to 86.7 |
375 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
79.4 |
73.8 to 84.1 |
296 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
76.2 |
70.4 to 81.1 |
294 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
88.1 |
83.4 to 91.6 |
331 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
55.0 |
48.5 to 61.4 |
313 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
81.2 |
75.7 to 85.6 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
89.6 |
85.3 to 92.8 |
317 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
91.1 |
86.7 to 94.2 |
408 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
81.6 |
76.1 to 86.0 |
348 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
89.7 |
85.5 to 92.8 |
355 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
89.8 |
84.8 to 93.3 |
344 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
78.8 |
73.7 to 83.2 |
373 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
78.6 |
72.7 to 83.4 |
320 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
58.0 |
51.8 to 64.0 |
318 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
78.4 |
74.0 to 82.3 |
739 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
76.6 |
70.5 to 81.8 |
366 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
78.9 |
73.5 to 83.4 |
373 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
79.8 |
74.3 to 84.4 |
316 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
70.8 |
64.3 to 76.5 |
264 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
81.9 |
77.2 to 85.9 |
373 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
86.1 |
81.2 to 89.9 |
309 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
84.9 |
80.2 to 88.7 |
347 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
78.4 |
72.3 to 83.4 |
312 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
79.0 |
73.0 to 84.0 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
95.8 |
92.0 to 97.9 |
306 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
81.6 |
76.1 to 86.2 |
304 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
93.2 |
89.2 to 95.7 |
310 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
34.6 |
29.1 to 40.6 |
354 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
76.3 |
70.5 to 81.2 |
347 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
84.5 |
79.9 to 88.2 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
82.7 |
77.1 to 87.1 |
307 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
80.6 |
75.4 to 85.0 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
95.9 |
93.0 to 97.6 |
350 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
85.3 |
80.1 to 89.4 |
399 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
88.8 |
84.1 to 92.3 |
332 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
90.9 |
87.7 to 93.3 |
701 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
92.9 |
89.6 to 95.1 |
388 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
89.6 |
84.6 to 93.1 |
313 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
77.8 |
72.3 to 82.4 |
366 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
88.4 |
83.7 to 91.8 |
299 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
69.3 |
63.2 to 74.8 |
302 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
66.4 |
60.1 to 72.2 |
300 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
75.9 |
69.8 to 81.0 |
302 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
84.7 |
79.9 to 88.5 |
742 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
86.1 |
81.4 to 89.7 |
371 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
84.5 |
79.0 to 88.8 |
371 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
81.2 |
80.2 to 82.2 |
19257 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
92.8 |
91.0 to 94.3 |
2026 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
89.1 |
86.5 to 91.3 |
1100 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
81.4 |
78.7 to 83.9 |
2436 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
77.3 |
75.3 to 79.2 |
2679 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
80.1 |
78.0 to 82.1 |
2248 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
80.0 |
77.4 to 82.5 |
3001 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
77.1 |
74.1 to 79.9 |
1291 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
83.3 |
80.7 to 85.6 |
1890 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
82.0 |
77.7 to 85.6 |
1311 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
96.6 |
93.9 to 98.2 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
60.1 |
53.5 to 66.4 |
317 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
60.8 |
54.4 to 66.8 |
321 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
66.6 |
60.3 to 72.4 |
320 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
83.2 |
79.3 to 86.4 |
1709 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
86.1 |
81.4 to 89.8 |
382 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
82.1 |
76.7 to 86.5 |
413 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
80.6 |
73.5 to 86.2 |
304 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
87.9 |
83.4 to 91.3 |
313 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
83.1 |
77.7 to 87.4 |
297 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
78.7 |
71.5 to 84.4 |
231 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
77.1 |
74.0 to 79.9 |
1275 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
77.3 |
71.2 to 82.5 |
325 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
89.6 |
84.3 to 93.3 |
320 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
82.9 |
76.9 to 87.6 |
332 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
82.8 |
77.9 to 86.8 |
361 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
56.3 |
50.2 to 62.2 |
321 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
91.6 |
87.4 to 94.5 |
277 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
88.6 |
83.9 to 92.0 |
295 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
82.8 |
77.9 to 86.8 |
403 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
70.5 |
63.1 to 76.9 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
89.9 |
83.9 to 93.8 |
416 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
54.9 |
46.9 to 62.7 |
350 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
87.0 |
83.1 to 90.1 |
583 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
87.4 |
80.7 to 92.0 |
431 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
90.6 |
85.9 to 93.8 |
453 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
87.7 |
83.4 to 91.0 |
442 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
92.5 |
88.1 to 95.3 |
415 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
91.7 |
87.0 to 94.8 |
483 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
76.6 |
70.5 to 81.7 |
425 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
79.4 |
73.4 to 84.4 |
339 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
63.3 |
56.1 to 70.0 |
385 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
79.9 |
75.5 to 83.7 |
848 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
79.4 |
74.0 to 83.8 |
407 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
80.0 |
74.6 to 84.5 |
441 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
94.0 |
90.6 to 96.2 |
430 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
78.3 |
72.3 to 83.3 |
359 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
84.4 |
78.6 to 88.9 |
399 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
87.7 |
83.0 to 91.3 |
382 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
92.1 |
88.2 to 94.8 |
473 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
78.6 |
72.7 to 83.4 |
411 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
85.8 |
81.3 to 89.4 |
516 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
96.7 |
93.0 to 98.5 |
365 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
81.7 |
75.3 to 86.7 |
398 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
90.1 |
82.8 to 94.4 |
327 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
43.4 |
36.6 to 50.5 |
345 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
82.5 |
76.9 to 87.0 |
402 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
90.2 |
83.5 to 94.4 |
385 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
87.3 |
82.1 to 91.1 |
368 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
85.8 |
80.1 to 90.1 |
412 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
97.2 |
94.8 to 98.5 |
385 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
91.9 |
88.2 to 94.6 |
432 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
87.9 |
82.4 to 91.9 |
431 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
93.4 |
91.1 to 95.2 |
840 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
93.1 |
89.6 to 95.4 |
435 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
93.7 |
90.4 to 95.9 |
405 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
83.6 |
77.9 to 88.0 |
347 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
92.0 |
85.6 to 95.7 |
314 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
79.0 |
73.4 to 83.6 |
381 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
69.9 |
63.4 to 75.7 |
360 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
86.7 |
81.7 to 90.5 |
362 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
89.3 |
85.2 to 92.3 |
880 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
89.7 |
85.4 to 92.8 |
387 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
89.2 |
84.5 to 92.6 |
493 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
85.3 |
84.5 to 86.1 |
23564 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
93.4 |
91.6 to 94.8 |
2467 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
92.9 |
91.1 to 94.5 |
1272 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
85.8 |
83.3 to 87.9 |
3073 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
80.8 |
78.8 to 82.7 |
3171 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
84.5 |
82.4 to 86.4 |
2800 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
84.6 |
82.5 to 86.5 |
3838 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
82.6 |
79.7 to 85.2 |
1528 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
85.1 |
81.6 to 88.0 |
2242 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
87.1 |
84.0 to 89.7 |
1750 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
95.7 |
93.2 to 97.3 |
449 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
67.0 |
60.0 to 73.4 |
362 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
57.8 |
47.3 to 67.7 |
355 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
75.8 |
69.7 to 81.0 |
424 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
88.4 |
85.6 to 90.8 |
2224 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
93.1 |
90.0 to 95.3 |
448 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
86.2 |
80.5 to 90.4 |
490 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
86.0 |
79.8 to 90.6 |
441 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
87.5 |
82.2 to 91.5 |
355 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
88.6 |
84.7 to 91.5 |
490 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
75.6 |
70.6 to 80.1 |
485 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
81.2 |
77.8 to 84.2 |
1423 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
84.5 |
77.7 to 89.5 |
393 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
93.0 |
89.4 to 95.4 |
404 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
83.4 |
77.2 to 88.2 |
417 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
84.1 |
78.2 to 88.7 |
346 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
68.6 |
62.8 to 73.9 |
403 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
95.0 |
91.0 to 97.3 |
416 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
90.8 |
85.3 to 94.4 |
364 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
87.2 |
80.9 to 91.6 |
317 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
78.5 |
73.2 to 83.0 |
340 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
91.2 |
86.9 to 94.2 |
360 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
69.8 |
63.1 to 75.8 |
322 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
92.7 |
88.5 to 95.5 |
430 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
93.3 |
88.8 to 96.1 |
311 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
92.5 |
87.5 to 95.6 |
323 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
85.0 |
79.1 to 89.4 |
341 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
90.4 |
85.0 to 94.0 |
342 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
93.4 |
88.5 to 96.3 |
325 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
87.9 |
82.5 to 91.8 |
328 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
79.8 |
73.8 to 84.7 |
342 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
70.7 |
64.6 to 76.2 |
357 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
80.2 |
74.3 to 85.0 |
632 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
83.8 |
77.5 to 88.6 |
287 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
79.3 |
72.1 to 85.0 |
345 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
96.9 |
93.6 to 98.6 |
341 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
80.2 |
73.7 to 85.3 |
325 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
93.7 |
89.8 to 96.1 |
340 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
86.0 |
80.6 to 90.0 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
93.5 |
89.6 to 96.0 |
370 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
84.7 |
78.6 to 89.3 |
319 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
82.2 |
75.2 to 87.5 |
325 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
98.5 |
96.7 to 99.3 |
347 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
87.9 |
82.7 to 91.6 |
368 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
90.2 |
83.5 to 94.3 |
322 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
56.8 |
49.5 to 63.8 |
321 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
89.9 |
84.6 to 93.6 |
292 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
92.2 |
88.0 to 95.1 |
325 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
85.2 |
79.1 to 89.8 |
328 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
88.5 |
82.7 to 92.6 |
329 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
97.0 |
94.2 to 98.5 |
278 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
94.3 |
90.2 to 96.8 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
91.4 |
86.3 to 94.7 |
331 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
93.3 |
90.2 to 95.4 |
627 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
91.7 |
87.3 to 94.7 |
312 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
94.2 |
89.4 to 96.9 |
315 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
91.4 |
86.4 to 94.7 |
347 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
92.2 |
86.3 to 95.7 |
324 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
78.9 |
71.8 to 84.5 |
327 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
78.8 |
72.8 to 83.8 |
322 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
88.8 |
84.4 to 92.1 |
381 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
91.4 |
87.8 to 94.1 |
741 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
92.0 |
87.1 to 95.1 |
348 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
91.4 |
87.2 to 94.3 |
393 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
88.5 |
87.6 to 89.3 |
19199 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
95.3 |
93.8 to 96.5 |
1916 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
93.6 |
91.3 to 95.4 |
957 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
88.2 |
85.8 to 90.2 |
2365 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
85.9 |
83.9 to 87.6 |
2612 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
85.9 |
83.5 to 88.0 |
2297 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
86.7 |
84.5 to 88.7 |
2939 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
88.0 |
85.2 to 90.3 |
1285 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
88.6 |
85.9 to 90.8 |
1936 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
92.0 |
88.8 to 94.3 |
1461 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
96.9 |
93.9 to 98.4 |
327 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
67.9 |
60.5 to 74.5 |
310 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
68.3 |
61.7 to 74.3 |
298 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
79.7 |
73.1 to 85.1 |
331 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
88.1 |
85.0 to 90.7 |
1594 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
87.7 |
80.9 to 92.3 |
346 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
89.9 |
85.0 to 93.3 |
393 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
88.0 |
84.3 to 90.9 |
855 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
78.2 |
73.7 to 82.0 |
547 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
86.1 |
83.0 to 88.7 |
1431 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
84.9 |
78.2 to 89.8 |
345 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
94.5 |
89.8 to 97.1 |
322 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
91.1 |
86.0 to 94.4 |
334 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
89.5 |
83.7 to 93.4 |
353 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
73.6 |
66.3 to 79.8 |
282 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
92.6 |
87.8 to 95.5 |
307 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
88.4 |
83.0 to 92.2 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
90.6 |
85.7 to 93.9 |
317 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
77.8 |
71.9 to 82.8 |
320 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
88.5 |
83.1 to 92.4 |
359 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
78.9 |
73.1 to 83.7 |
312 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
91.4 |
85.9 to 94.9 |
309 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
90.5 |
85.9 to 93.8 |
331 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
93.2 |
88.4 to 96.1 |
328 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
87.7 |
82.9 to 91.3 |
348 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
87.2 |
77.9 to 93.0 |
192 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
88.0 |
81.9 to 92.2 |
323 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
85.1 |
77.7 to 90.3 |
253 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
83.4 |
78.3 to 87.4 |
363 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
82.1 |
76.2 to 86.8 |
315 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
82.5 |
75.8 to 87.7 |
272 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
90.2 |
85.9 to 93.3 |
558 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
91.2 |
84.7 to 95.0 |
209 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
90.0 |
84.8 to 93.6 |
349 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
92.8 |
89.1 to 95.3 |
381 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
80.2 |
74.7 to 84.7 |
383 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
86.8 |
81.5 to 90.8 |
287 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
88.2 |
82.7 to 92.1 |
291 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
88.2 |
82.9 to 92.0 |
298 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
85.6 |
80.7 to 89.5 |
343 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
86.7 |
79.7 to 91.6 |
320 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
97.3 |
94.2 to 98.8 |
393 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
88.7 |
83.8 to 92.2 |
307 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
93.9 |
89.4 to 96.5 |
369 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
61.0 |
54.2 to 67.5 |
284 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
82.8 |
76.8 to 87.5 |
280 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
87.0 |
81.3 to 91.2 |
320 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
88.7 |
83.6 to 92.4 |
301 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
90.1 |
85.9 to 93.2 |
335 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
97.6 |
95.1 to 98.8 |
345 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
90.5 |
85.1 to 94.1 |
322 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
89.5 |
84.7 to 93.0 |
357 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
93.2 |
90.5 to 95.2 |
710 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
92.0 |
87.2 to 95.1 |
300 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
94.0 |
90.4 to 96.3 |
410 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
91.7 |
87.3 to 94.6 |
306 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
96.2 |
93.3 to 97.9 |
344 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
86.9 |
81.6 to 90.9 |
319 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
81.3 |
76.3 to 85.4 |
426 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
88.5 |
83.7 to 92.1 |
364 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
93.5 |
90.0 to 95.8 |
751 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
91.5 |
87.0 to 94.6 |
307 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
93.7 |
89.7 to 96.2 |
444 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
89.1 |
88.1 to 89.9 |
18264 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
95.0 |
93.4 to 96.3 |
2050 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
92.3 |
89.9 to 94.2 |
1032 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
88.9 |
86.2 to 91.1 |
2241 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
85.6 |
83.4 to 87.6 |
2374 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
90.5 |
88.7 to 92.1 |
2264 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
88.4 |
85.9 to 90.4 |
2505 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
83.9 |
80.9 to 86.5 |
1251 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
88.7 |
86.2 to 90.8 |
1913 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
90.7 |
86.6 to 93.6 |
1318 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
95.9 |
92.0 to 97.9 |
315 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
74.6 |
67.6 to 80.5 |
296 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
72.7 |
66.0 to 78.5 |
292 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
85.1 |
79.9 to 89.2 |
304 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
90.3 |
86.7 to 92.9 |
1112 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
90.2 |
85.6 to 93.5 |
317 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
91.0 |
84.5 to 94.9 |
278 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
90.2 |
86.0 to 93.2 |
517 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
82.0 |
76.8 to 86.2 |
332 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
88.2 |
85.3 to 90.5 |
1316 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
88.2 |
82.6 to 92.1 |
301 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
93.8 |
89.8 to 96.3 |
326 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
85.7 |
78.5 to 90.8 |
302 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
90.6 |
85.5 to 94.0 |
360 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
79.3 |
73.4 to 84.2 |
328 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
96.1 |
92.8 to 97.9 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
94.3 |
91.1 to 96.4 |
325 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
90.9 |
86.3 to 94.0 |
378 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
77.3 |
71.8 to 81.9 |
377 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
85.2 |
79.8 to 89.4 |
421 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
85.4 |
80.1 to 89.5 |
368 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
90.3 |
85.3 to 93.7 |
356 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
92.4 |
88.5 to 95.1 |
394 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
96.2 |
92.3 to 98.1 |
386 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
91.5 |
87.3 to 94.4 |
374 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
86.4 |
80.2 to 90.9 |
285 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
93.3 |
88.9 to 96.0 |
363 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
87.5 |
82.2 to 91.4 |
373 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
85.4 |
80.3 to 89.3 |
363 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
80.7 |
74.6 to 85.6 |
341 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
94.4 |
92.0 to 96.1 |
709 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
87.9 |
81.5 to 92.3 |
274 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
95.9 |
93.2 to 97.6 |
435 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
90.1 |
85.4 to 93.4 |
370 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
80.1 |
73.3 to 85.6 |
328 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
84.3 |
78.6 to 88.7 |
352 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
89.5 |
84.6 to 93.0 |
335 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
94.7 |
91.6 to 96.7 |
335 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
85.8 |
80.5 to 89.8 |
341 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
89.5 |
84.0 to 93.2 |
409 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
96.0 |
92.4 to 98.0 |
358 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
82.1 |
76.5 to 86.6 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
89.9 |
84.4 to 93.6 |
286 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
71.1 |
64.5 to 77.0 |
356 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
87.8 |
82.8 to 91.5 |
361 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
86.5 |
81.2 to 90.5 |
367 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
85.6 |
79.8 to 89.9 |
321 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
89.2 |
85.2 to 92.2 |
351 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
95.5 |
92.4 to 97.3 |
402 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
95.3 |
91.5 to 97.5 |
328 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
88.7 |
83.2 to 92.5 |
378 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
92.9 |
89.8 to 95.2 |
594 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
91.5 |
86.1 to 94.9 |
288 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
93.8 |
89.5 to 96.5 |
306 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
92.6 |
87.9 to 95.5 |
372 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
94.2 |
90.0 to 96.7 |
327 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
85.0 |
79.8 to 89.0 |
430 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
84.7 |
79.7 to 88.6 |
356 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
89.7 |
85.0 to 93.1 |
399 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
94.4 |
91.4 to 96.4 |
785 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
93.0 |
87.9 to 96.0 |
343 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
94.6 |
91.1 to 96.8 |
442 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
85.5 |
77.9 to 90.8 |
230 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
89.8 |
89.0 to 90.6 |
20827 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
95.0 |
93.3 to 96.3 |
2268 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
93.7 |
91.4 to 95.4 |
922 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
92.4 |
90.5 to 93.9 |
2553 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
88.7 |
86.9 to 90.2 |
2896 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
88.9 |
87.1 to 90.5 |
2465 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
89.3 |
87.0 to 91.3 |
3089 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
85.1 |
82.2 to 87.5 |
1362 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
89.5 |
87.4 to 91.3 |
2290 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
89.4 |
85.6 to 92.3 |
1491 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
94.7 |
90.9 to 97.0 |
414 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
74.8 |
68.3 to 80.4 |
380 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
76.1 |
69.8 to 81.4 |
358 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
88.3 |
83.4 to 91.9 |
339 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
89.5 |
86.1 to 92.2 |
1652 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
89.3 |
85.1 to 92.4 |
385 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
89.8 |
84.4 to 93.4 |
379 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
90.4 |
85.0 to 94.0 |
397 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
89.5 |
85.4 to 92.5 |
491 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
87.6 |
84.9 to 89.9 |
1491 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
88.4 |
83.9 to 91.8 |
398 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
94.9 |
90.6 to 97.2 |
367 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
94.4 |
90.0 to 96.9 |
350 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
89.4 |
84.7 to 92.8 |
374 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
79.6 |
73.3 to 84.7 |
350 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
94.1 |
89.4 to 96.8 |
340 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
90.1 |
86.2 to 93.0 |
446 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
94.6 |
90.9 to 96.8 |
361 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
74.5 |
68.6 to 79.6 |
350 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
88.4 |
84.3 to 91.6 |
444 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
91.9 |
87.9 to 94.6 |
362 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
88.3 |
82.9 to 92.2 |
350 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
95.3 |
92.6 to 97.1 |
354 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
95.3 |
91.9 to 97.3 |
358 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
90.4 |
86.2 to 93.4 |
360 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
87.4 |
82.7 to 91.0 |
418 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
90.1 |
84.6 to 93.7 |
321 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
91.6 |
86.9 to 94.8 |
374 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
82.8 |
78.0 to 86.7 |
419 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
82.1 |
76.9 to 86.2 |
340 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
84.3 |
78.7 to 88.7 |
356 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
91.4 |
88.3 to 93.7 |
779 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
90.4 |
85.6 to 93.8 |
283 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
91.6 |
87.8 to 94.3 |
496 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
91.8 |
87.4 to 94.7 |
328 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
89.6 |
84.8 to 93.0 |
383 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
89.6 |
85.2 to 92.8 |
375 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
86.1 |
81.0 to 89.9 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
93.5 |
89.8 to 95.9 |
382 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
91.0 |
87.0 to 93.8 |
374 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
88.8 |
83.8 to 92.4 |
403 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
93.5 |
89.3 to 96.1 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
76.1 |
70.3 to 81.1 |
373 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
92.6 |
88.4 to 95.4 |
366 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
76.8 |
71.2 to 81.5 |
364 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
86.6 |
81.0 to 90.7 |
300 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
91.2 |
87.4 to 94.0 |
406 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
90.5 |
86.1 to 93.6 |
393 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
89.3 |
84.4 to 92.8 |
372 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
94.3 |
89.8 to 96.9 |
295 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
95.1 |
91.9 to 97.1 |
364 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
91.4 |
87.4 to 94.3 |
396 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
91.7 |
88.6 to 93.9 |
665 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
92.0 |
87.9 to 94.8 |
313 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
91.5 |
87.0 to 94.5 |
352 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
94.3 |
90.9 to 96.5 |
358 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
90.4 |
85.1 to 94.0 |
323 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
90.0 |
84.4 to 93.8 |
332 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
86.3 |
80.9 to 90.3 |
291 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
91.4 |
87.2 to 94.3 |
353 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
94.0 |
91.3 to 95.9 |
832 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
90.9 |
86.8 to 93.9 |
340 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
94.4 |
91.3 to 96.4 |
492 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
87.2 |
82.0 to 91.0 |
339 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
89.6 |
88.7 to 90.4 |
21875 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
94.3 |
92.3 to 95.7 |
2188 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
92.8 |
90.6 to 94.5 |
1029 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
90.1 |
87.7 to 92.0 |
2742 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
89.4 |
87.6 to 91.0 |
2793 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
88.4 |
86.5 to 90.0 |
2543 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
89.7 |
88.0 to 91.2 |
4048 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
88.4 |
85.8 to 90.6 |
1451 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
89.5 |
87.4 to 91.3 |
2120 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
88.3 |
84.1 to 91.4 |
1506 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
98.0 |
96.1 to 98.9 |
419 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
82.4 |
76.6 to 86.9 |
360 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
75.6 |
69.7 to 80.7 |
349 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
85.9 |
80.4 to 90.0 |
325 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
89.2 |
86.9 to 91.2 |
2617 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
87.5 |
82.4 to 91.3 |
368 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
86.4 |
80.6 to 90.6 |
259 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
86.7 |
82.7 to 89.9 |
558 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
89.9 |
86.9 to 92.3 |
946 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
83.1 |
78.8 to 86.6 |
458 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
88.4 |
85.8 to 90.6 |
1455 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
83.6 |
77.9 to 88.0 |
357 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
97.1 |
94.4 to 98.5 |
404 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
85.7 |
78.5 to 90.8 |
385 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
89.3 |
84.7 to 92.7 |
396 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
87.8 |
83.4 to 91.2 |
344 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
91.5 |
87.2 to 94.4 |
365 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
90.8 |
86.7 to 93.7 |
331 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
92.8 |
88.9 to 95.3 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
80.7 |
75.5 to 85.1 |
392 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
88.5 |
83.6 to 92.1 |
329 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
91.6 |
87.8 to 94.3 |
352 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
85.1 |
79.2 to 89.5 |
327 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
88.9 |
83.6 to 92.6 |
322 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
95.3 |
91.3 to 97.5 |
357 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
89.9 |
85.5 to 93.0 |
375 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
90.2 |
85.8 to 93.3 |
377 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
93.7 |
89.4 to 96.4 |
376 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
95.9 |
92.7 to 97.7 |
367 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
79.0 |
74.4 to 82.9 |
535 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
83.6 |
78.0 to 88.0 |
317 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
89.8 |
85.6 to 92.9 |
358 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
94.7 |
92.2 to 96.5 |
605 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
94.6 |
89.4 to 97.3 |
157 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
94.8 |
91.7 to 96.7 |
448 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
90.6 |
85.8 to 93.9 |
350 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
91.0 |
87.2 to 93.7 |
382 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
88.8 |
84.0 to 92.3 |
322 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
91.3 |
87.3 to 94.1 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
95.4 |
92.3 to 97.3 |
336 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
90.0 |
86.1 to 92.9 |
347 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
87.2 |
81.9 to 91.2 |
451 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
98.2 |
96.6 to 99.0 |
374 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
95.5 |
92.4 to 97.3 |
283 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
91.8 |
87.5 to 94.8 |
375 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
83.0 |
77.5 to 87.3 |
377 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
85.7 |
80.6 to 89.6 |
360 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
86.9 |
81.7 to 90.8 |
375 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
90.8 |
86.1 to 94.0 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
88.6 |
83.4 to 92.3 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
96.4 |
92.5 to 98.3 |
313 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
94.0 |
90.4 to 96.4 |
422 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
88.1 |
83.5 to 91.6 |
374 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
94.1 |
91.6 to 95.9 |
655 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
92.5 |
88.4 to 95.2 |
291 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
95.2 |
91.6 to 97.3 |
364 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
90.0 |
85.4 to 93.3 |
366 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
92.9 |
88.6 to 95.7 |
293 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
92.8 |
87.9 to 95.8 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
90.9 |
85.6 to 94.4 |
281 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
86.2 |
80.3 to 90.6 |
318 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
95.0 |
92.4 to 96.7 |
875 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
92.5 |
88.6 to 95.1 |
349 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
95.3 |
92.4 to 97.2 |
526 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
92.8 |
89.3 to 95.2 |
405 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
90.6 |
89.7 to 91.4 |
20475 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
96.4 |
95.2 to 97.3 |
2097 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
94.1 |
92.1 to 95.6 |
1077 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
91.3 |
89.1 to 93.0 |
2842 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
91.5 |
90.0 to 92.8 |
2757 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
93.8 |
92.4 to 95.0 |
2284 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
89.2 |
87.3 to 90.9 |
3270 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
88.2 |
85.7 to 90.3 |
1394 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
86.8 |
84.0 to 89.1 |
2022 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
85.7 |
81.2 to 89.3 |
1303 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
97.3 |
95.0 to 98.5 |
326 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
81.8 |
75.6 to 86.7 |
314 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
80.3 |
74.1 to 85.3 |
342 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
90.6 |
85.6 to 94.0 |
291 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
87.9 |
85.2 to 90.1 |
1927 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
90.9 |
86.1 to 94.2 |
334 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
87.0 |
78.7 to 92.4 |
225 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
84.8 |
78.6 to 89.4 |
294 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
88.1 |
81.7 to 92.4 |
345 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
88.0 |
84.6 to 90.8 |
729 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
81.6 |
76.7 to 85.6 |
428 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
88.1 |
85.1 to 90.6 |
1429 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
83.9 |
78.5 to 88.2 |
317 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
95.9 |
93.0 to 97.6 |
380 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
88.8 |
82.6 to 92.9 |
451 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
89.5 |
84.4 to 93.0 |
361 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
92.4 |
88.4 to 95.1 |
313 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
96.5 |
94.1 to 98.0 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
88.2 |
83.3 to 91.7 |
373 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
89.7 |
85.5 to 92.8 |
367 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
80.5 |
74.9 to 85.1 |
349 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
84.1 |
78.6 to 88.5 |
335 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
93.0 |
89.3 to 95.5 |
357 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
85.5 |
79.4 to 90.0 |
306 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
90.2 |
85.5 to 93.4 |
354 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
95.2 |
92.3 to 97.1 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
90.8 |
85.9 to 94.2 |
350 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
90.2 |
84.8 to 93.8 |
318 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
92.2 |
88.2 to 94.9 |
415 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
96.1 |
92.8 to 97.9 |
343 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
79.0 |
73.4 to 83.7 |
382 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
85.9 |
80.5 to 90.0 |
314 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
90.1 |
85.4 to 93.4 |
353 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
94.6 |
92.0 to 96.4 |
683 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
93.7 |
88.4 to 96.7 |
204 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
94.9 |
91.7 to 96.8 |
479 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
95.7 |
92.9 to 97.4 |
334 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
94.2 |
90.8 to 96.5 |
343 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
91.4 |
87.2 to 94.4 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
88.5 |
84.0 to 91.9 |
372 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
93.2 |
89.4 to 95.7 |
341 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
86.0 |
80.6 to 90.0 |
347 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
89.2 |
83.4 to 93.2 |
470 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
98.3 |
96.3 to 99.2 |
412 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
94.6 |
90.6 to 97.0 |
328 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
91.1 |
86.4 to 94.3 |
356 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
94.9 |
91.9 to 96.8 |
347 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
80.1 |
74.1 to 85.0 |
335 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
91.0 |
86.4 to 94.1 |
326 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
95.3 |
91.2 to 97.6 |
324 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
84.8 |
79.1 to 89.1 |
344 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
95.6 |
92.1 to 97.6 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
93.1 |
88.8 to 95.8 |
366 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
86.9 |
81.7 to 90.8 |
362 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
94.9 |
92.7 to 96.5 |
651 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
95.9 |
93.1 to 97.6 |
281 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
94.3 |
90.9 to 96.5 |
370 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
93.7 |
90.1 to 96.0 |
336 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
92.4 |
89.0 to 94.8 |
379 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
93.1 |
89.9 to 95.4 |
408 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
87.5 |
82.5 to 91.1 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
88.4 |
83.8 to 91.8 |
359 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
91.1 |
87.1 to 93.9 |
851 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
93.9 |
90.3 to 96.2 |
362 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
90.7 |
86.2 to 93.9 |
489 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
90.7 |
89.8 to 91.5 |
20949 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
95.8 |
94.7 to 96.7 |
2107 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
94.3 |
92.4 to 95.8 |
1017 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
91.2 |
88.9 to 93.1 |
2745 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
92.5 |
91.1 to 93.8 |
2846 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
93.8 |
92.5 to 94.9 |
2433 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
87.6 |
85.7 to 89.3 |
3654 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
87.8 |
85.0 to 90.1 |
1340 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
90.0 |
87.8 to 91.9 |
2108 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
85.3 |
80.6 to 89.0 |
1299 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
95.0 |
91.3 to 97.1 |
319 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
90.3 |
85.5 to 93.6 |
328 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
80.3 |
74.4 to 85.1 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
91.0 |
86.5 to 94.2 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
86.3 |
83.7 to 88.5 |
2256 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
86.9 |
81.2 to 91.0 |
336 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
89.9 |
82.5 to 94.4 |
187 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
83.3 |
76.9 to 88.3 |
263 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
91.5 |
86.8 to 94.6 |
320 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
88.7 |
84.0 to 92.1 |
304 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
85.9 |
82.4 to 88.8 |
846 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
89.8 |
87.4 to 91.8 |
1400 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
91.6 |
87.7 to 94.3 |
356 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
93.1 |
89.5 to 95.5 |
366 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
93.3 |
88.2 to 96.3 |
413 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
91.6 |
87.4 to 94.4 |
339 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
89.4 |
84.9 to 92.6 |
343 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
92.0 |
87.9 to 94.9 |
324 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
88.7 |
83.8 to 92.3 |
360 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
92.3 |
87.4 to 95.4 |
327 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
80.6 |
75.4 to 85.0 |
392 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
89.8 |
85.1 to 93.1 |
288 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
92.0 |
87.6 to 95.0 |
308 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
91.9 |
86.7 to 95.2 |
356 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
93.2 |
88.1 to 96.1 |
278 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
95.7 |
91.9 to 97.8 |
293 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
90.7 |
85.5 to 94.1 |
306 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
89.1 |
83.0 to 93.2 |
283 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
92.7 |
88.5 to 95.4 |
337 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
94.5 |
91.1 to 96.7 |
345 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
73.2 |
66.2 to 79.1 |
309 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
86.5 |
81.4 to 90.4 |
327 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
89.3 |
84.1 to 93.0 |
291 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
93.8 |
91.3 to 95.6 |
721 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
95.8 |
89.4 to 98.4 |
192 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
93.4 |
90.5 to 95.4 |
529 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
92.3 |
87.9 to 95.2 |
296 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
95.7 |
92.2 to 97.7 |
280 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
90.2 |
85.1 to 93.7 |
297 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
86.6 |
80.8 to 90.8 |
270 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
91.1 |
85.6 to 94.6 |
284 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
88.1 |
82.7 to 92.0 |
317 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
91.3 |
87.2 to 94.2 |
393 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
93.7 |
89.3 to 96.4 |
328 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
94.7 |
90.8 to 97.0 |
313 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
94.3 |
90.3 to 96.7 |
285 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
91.8 |
86.8 to 95.0 |
285 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
82.0 |
76.0 to 86.8 |
319 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
89.8 |
85.0 to 93.2 |
290 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
91.1 |
85.7 to 94.6 |
295 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
87.2 |
82.3 to 90.8 |
334 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
98.5 |
97.0 to 99.2 |
303 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
93.1 |
88.7 to 95.9 |
351 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
90.9 |
86.4 to 94.1 |
295 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
93.1 |
90.3 to 95.1 |
535 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
89.6 |
84.9 to 93.0 |
261 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
95.3 |
91.3 to 97.5 |
274 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
90.4 |
85.6 to 93.7 |
341 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
91.1 |
85.9 to 94.6 |
287 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
91.5 |
87.6 to 94.3 |
329 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
87.6 |
82.4 to 91.4 |
360 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
89.3 |
83.8 to 93.1 |
297 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
92.5 |
87.7 to 95.5 |
649 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
94.2 |
89.3 to 96.9 |
237 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
92.3 |
86.8 to 95.6 |
412 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
91.2 |
90.4 to 91.9 |
18700 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
94.6 |
92.5 to 96.1 |
1902 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
93.1 |
90.8 to 94.8 |
886 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
91.8 |
89.2 to 93.7 |
2295 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
91.9 |
90.4 to 93.3 |
2507 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
93.1 |
91.7 to 94.3 |
2276 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
87.6 |
85.6 to 89.3 |
3326 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
88.1 |
85.2 to 90.5 |
1191 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
91.5 |
89.0 to 93.4 |
1746 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
91.2 |
87.3 to 93.9 |
1305 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
98.5 |
96.7 to 99.3 |
337 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
90.9 |
86.4 to 94.0 |
318 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
88.4 |
83.8 to 91.8 |
340 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
92.1 |
87.9 to 95.0 |
284 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
86.4 |
83.8 to 88.6 |
2079 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
89.9 |
85.2 to 93.2 |
298 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
85.8 |
78.4 to 90.9 |
186 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
88.8 |
82.2 to 93.2 |
314 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
87.6 |
82.5 to 91.3 |
364 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
85.9 |
82.5 to 88.7 |
917 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
87.4 |
83.9 to 90.3 |
1266 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
90.4 |
85.5 to 93.8 |
310 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
96.0 |
93.2 to 97.7 |
324 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
91.5 |
85.0 to 95.3 |
327 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
86.6 |
80.2 to 91.1 |
286 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
90.8 |
86.1 to 94.0 |
337 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
91.7 |
87.3 to 94.6 |
332 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
90.6 |
85.5 to 94.0 |
241 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
94.0 |
90.0 to 96.5 |
296 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
82.9 |
77.9 to 86.9 |
426 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
92.7 |
89.1 to 95.1 |
308 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
96.0 |
93.2 to 97.6 |
329 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
87.8 |
80.3 to 92.7 |
274 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
92.1 |
86.5 to 95.5 |
262 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
96.5 |
93.1 to 98.3 |
294 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
90.6 |
85.6 to 94.0 |
308 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
88.1 |
81.0 to 92.7 |
282 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
97.2 |
94.8 to 98.6 |
329 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
96.3 |
92.8 to 98.1 |
315 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
79.1 |
72.7 to 84.4 |
278 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
84.4 |
78.4 to 89.0 |
304 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
89.3 |
84.0 to 93.0 |
332 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
91.9 |
88.4 to 94.4 |
602 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
92.1 |
83.3 to 96.4 |
160 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
91.8 |
87.9 to 94.6 |
442 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
94.0 |
89.2 to 96.8 |
289 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
94.8 |
91.5 to 96.9 |
302 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
93.0 |
89.6 to 95.4 |
381 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
91.2 |
86.5 to 94.3 |
292 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
94.6 |
90.3 to 97.0 |
336 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
93.8 |
89.7 to 96.3 |
316 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
93.6 |
89.9 to 96.0 |
524 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
97.4 |
93.6 to 99.0 |
300 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
94.0 |
90.4 to 96.3 |
297 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
91.7 |
85.4 to 95.4 |
276 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
90.4 |
84.4 to 94.2 |
270 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
85.2 |
79.3 to 89.6 |
288 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
92.2 |
87.7 to 95.1 |
297 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
92.7 |
87.1 to 96.0 |
285 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
89.7 |
84.3 to 93.4 |
313 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
95.1 |
90.8 to 97.4 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
92.1 |
87.3 to 95.2 |
331 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
89.9 |
85.6 to 93.1 |
405 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
94.9 |
92.2 to 96.7 |
498 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
92.3 |
87.4 to 95.4 |
257 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
96.5 |
92.9 to 98.4 |
241 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
92.0 |
86.8 to 95.3 |
305 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
97.3 |
95.2 to 98.5 |
319 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
94.7 |
91.4 to 96.8 |
302 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
89.8 |
85.7 to 92.8 |
369 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
91.1 |
85.8 to 94.6 |
270 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
94.9 |
91.8 to 96.9 |
734 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
95.2 |
90.5 to 97.6 |
242 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
94.9 |
91.3 to 97.1 |
492 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
90.5 |
80.5 to 95.6 |
216 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
91.9 |
90.9 to 92.7 |
18788 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
96.5 |
94.9 to 97.6 |
2034 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
94.0 |
91.7 to 95.6 |
829 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
93.3 |
91.2 to 94.9 |
2520 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
94.3 |
93.0 to 95.4 |
2387 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
93.2 |
91.7 to 94.4 |
2097 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
88.4 |
86.4 to 90.1 |
3289 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
90.1 |
87.4 to 92.2 |
1256 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
91.2 |
88.4 to 93.4 |
1845 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
88.5 |
82.9 to 92.5 |
1199 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
96.7 |
94.1 to 98.2 |
319 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
93.2 |
89.3 to 95.8 |
319 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
91.4 |
86.8 to 94.5 |
313 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
91.0 |
85.5 to 94.6 |
261 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
86.5 |
83.7 to 88.9 |
1850 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
87.2 |
81.2 to 91.5 |
293 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
93.5 |
87.4 to 96.8 |
174 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
86.6 |
80.8 to 90.8 |
271 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
93.0 |
88.8 to 95.8 |
280 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
85.5 |
81.8 to 88.6 |
832 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
81.8 |
74.3 to 87.6 |
218 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
90.2 |
87.5 to 92.4 |
1332 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
88.4 |
82.5 to 92.6 |
325 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
95.3 |
91.8 to 97.3 |
472 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
91.4 |
85.1 to 95.2 |
363 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
90.8 |
86.2 to 93.9 |
304 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
92.4 |
87.7 to 95.4 |
309 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
92.1 |
87.6 to 95.1 |
331 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
92.7 |
88.1 to 95.6 |
329 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
92.2 |
87.6 to 95.2 |
298 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
85.8 |
80.2 to 90.0 |
302 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
88.6 |
83.8 to 92.2 |
340 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
95.3 |
91.6 to 97.4 |
322 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
90.2 |
84.8 to 93.9 |
403 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
92.2 |
87.9 to 95.0 |
354 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
95.0 |
90.6 to 97.3 |
331 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
88.0 |
82.8 to 91.8 |
360 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
87.3 |
81.5 to 91.4 |
404 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
91.2 |
85.5 to 94.7 |
355 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
94.9 |
90.8 to 97.2 |
300 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
76.0 |
69.6 to 81.3 |
300 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
84.4 |
78.4 to 89.0 |
290 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
87.7 |
82.5 to 91.5 |
376 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
93.2 |
90.2 to 95.4 |
699 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
94.0 |
89.0 to 96.9 |
271 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
93.1 |
89.4 to 95.5 |
428 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
96.4 |
93.9 to 97.9 |
302 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
92.8 |
88.8 to 95.4 |
280 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
89.5 |
84.7 to 92.9 |
364 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
94.4 |
90.5 to 96.7 |
255 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
93.7 |
89.7 to 96.2 |
356 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
94.4 |
90.7 to 96.6 |
372 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
92.0 |
89.1 to 94.2 |
815 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
94.3 |
90.3 to 96.7 |
394 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
94.9 |
91.3 to 97.0 |
398 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
94.5 |
90.8 to 96.7 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
93.3 |
89.3 to 95.9 |
282 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
86.0 |
80.7 to 90.1 |
397 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
87.4 |
81.1 to 91.7 |
307 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
93.3 |
89.7 to 95.7 |
405 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
87.3 |
81.4 to 91.5 |
369 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
95.5 |
92.5 to 97.4 |
381 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
97.1 |
94.5 to 98.5 |
379 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
90.0 |
85.6 to 93.2 |
352 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
94.6 |
92.0 to 96.4 |
729 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
93.0 |
88.8 to 95.7 |
381 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
95.6 |
91.9 to 97.7 |
348 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
93.4 |
88.1 to 96.4 |
327 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
92.3 |
87.6 to 95.3 |
401 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
93.9 |
90.6 to 96.1 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
87.5 |
82.6 to 91.2 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
88.4 |
83.4 to 92.1 |
308 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
96.5 |
94.4 to 97.9 |
765 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
91.7 |
86.5 to 95.0 |
263 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
97.2 |
94.6 to 98.5 |
502 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
74.5 |
63.2 to 83.3 |
169 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
92.0 |
91.2 to 92.8 |
20163 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
94.8 |
92.9 to 96.3 |
2147 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
95.4 |
93.6 to 96.7 |
1108 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
93.9 |
92.4 to 95.1 |
3331 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
92.4 |
90.6 to 94.0 |
2466 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
94.2 |
92.9 to 95.2 |
2344 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
89.1 |
86.6 to 91.2 |
2509 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
89.3 |
86.8 to 91.4 |
1446 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
91.5 |
89.2 to 93.3 |
2007 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
89.7 |
85.6 to 92.7 |
1402 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
96.4 |
92.4 to 98.3 |
271 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
90.9 |
85.3 to 94.4 |
311 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
92.2 |
87.6 to 95.2 |
317 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
90.1 |
85.4 to 93.4 |
338 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
88.0 |
84.4 to 90.9 |
1141 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
89.7 |
84.8 to 93.2 |
314 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
89.3 |
82.8 to 93.5 |
221 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
87.8 |
83.6 to 91.0 |
606 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
90.6 |
87.9 to 92.7 |
1403 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
91.3 |
86.7 to 94.4 |
304 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
96.9 |
94.7 to 98.2 |
398 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
92.8 |
88.6 to 95.6 |
677 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
93.1 |
88.2 to 96.0 |
417 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
92.2 |
87.7 to 95.2 |
310 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
92.6 |
88.0 to 95.6 |
277 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
91.5 |
87.0 to 94.6 |
324 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
94.6 |
89.8 to 97.2 |
304 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
82.2 |
75.7 to 87.2 |
268 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
91.5 |
87.4 to 94.3 |
296 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
95.2 |
91.2 to 97.5 |
314 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
90.9 |
84.7 to 94.7 |
286 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
91.9 |
86.6 to 95.2 |
298 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
95.5 |
91.0 to 97.8 |
340 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
91.1 |
86.6 to 94.2 |
310 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
90.0 |
85.4 to 93.3 |
409 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
93.0 |
87.4 to 96.2 |
312 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
95.1 |
89.7 to 97.8 |
260 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
74.4 |
66.4 to 81.0 |
225 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
91.7 |
87.0 to 94.8 |
258 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
91.4 |
86.4 to 94.7 |
334 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
94.5 |
91.7 to 96.4 |
578 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
92.7 |
83.5 to 96.9 |
144 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
94.9 |
91.9 to 96.9 |
434 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
92.2 |
86.9 to 95.5 |
268 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
93.6 |
87.3 to 96.9 |
199 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
91.1 |
85.9 to 94.6 |
300 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
86.3 |
79.6 to 91.1 |
240 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
96.3 |
92.7 to 98.2 |
303 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
91.3 |
86.4 to 94.5 |
293 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
91.9 |
89.2 to 94.0 |
857 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
96.4 |
91.5 to 98.5 |
266 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
91.5 |
86.2 to 94.9 |
358 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
93.1 |
88.3 to 96.0 |
296 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
90.5 |
85.0 to 94.1 |
303 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
91.0 |
86.0 to 94.3 |
340 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
90.1 |
85.3 to 93.5 |
290 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
94.0 |
90.1 to 96.4 |
315 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
91.4 |
86.1 to 94.8 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
97.0 |
92.8 to 98.8 |
282 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
93.1 |
87.7 to 96.2 |
292 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
90.8 |
85.8 to 94.2 |
337 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
89.5 |
85.8 to 92.4 |
581 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
86.2 |
80.1 to 90.6 |
297 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
91.8 |
86.6 to 95.1 |
284 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
95.5 |
89.9 to 98.1 |
266 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
96.6 |
92.6 to 98.5 |
191 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
92.8 |
86.3 to 96.4 |
254 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
87.3 |
81.8 to 91.3 |
240 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
88.8 |
83.2 to 92.6 |
294 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
92.4 |
89.5 to 94.5 |
929 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
90.6 |
85.6 to 93.9 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
92.6 |
89.4 to 94.9 |
599 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
89.6 |
85.5 to 92.7 |
350 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
92.2 |
91.2 to 93.0 |
18002 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
95.7 |
93.6 to 97.2 |
1923 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
90.7 |
87.8 to 93.0 |
873 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
92.0 |
90.2 to 93.5 |
3338 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
93.5 |
91.6 to 95.0 |
2263 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
93.3 |
91.5 to 94.7 |
2060 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
90.7 |
88.2 to 92.7 |
2184 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
92.0 |
89.5 to 94.0 |
1154 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
93.1 |
90.6 to 95.0 |
1789 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
91.0 |
86.4 to 94.1 |
1173 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
96.6 |
90.8 to 98.8 |
254 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
94.1 |
89.8 to 96.6 |
263 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
97.0 |
94.4 to 98.4 |
445 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
94.0 |
89.8 to 96.5 |
315 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
89.9 |
86.3 to 92.6 |
990 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
87.3 |
82.0 to 91.2 |
296 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
90.4 |
82.9 to 94.8 |
167 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
90.1 |
85.9 to 93.1 |
527 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
82.7 |
74.9 to 88.4 |
245 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
89.4 |
86.2 to 91.9 |
1245 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
94.1 |
89.6 to 96.7 |
304 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
95.5 |
92.8 to 97.2 |
488 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
91.7 |
86.5 to 95.1 |
566 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
89.8 |
84.1 to 93.6 |
349 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
92.4 |
88.3 to 95.1 |
267 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
95.9 |
92.8 to 97.8 |
306 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
92.3 |
86.5 to 95.7 |
261 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
94.2 |
90.2 to 96.6 |
269 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
85.0 |
78.3 to 90.0 |
240 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
86.6 |
80.3 to 91.1 |
273 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
94.4 |
91.0 to 96.5 |
332 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
88.1 |
82.5 to 92.1 |
321 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
92.8 |
89.0 to 95.3 |
342 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
93.5 |
88.4 to 96.4 |
258 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
89.1 |
82.7 to 93.3 |
250 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
91.3 |
85.9 to 94.8 |
237 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
97.2 |
94.7 to 98.5 |
307 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
92.2 |
87.0 to 95.4 |
333 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
76.7 |
68.7 to 83.1 |
240 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
92.3 |
87.7 to 95.3 |
237 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
90.7 |
84.9 to 94.4 |
251 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
94.6 |
91.3 to 96.6 |
630 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
92.1 |
86.8 to 95.3 |
256 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
95.1 |
91.0 to 97.4 |
374 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
95.3 |
91.5 to 97.4 |
258 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
97.3 |
91.0 to 99.2 |
207 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
89.5 |
84.0 to 93.3 |
310 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
88.7 |
82.6 to 92.9 |
276 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
94.3 |
90.0 to 96.8 |
330 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
97.1 |
94.4 to 98.5 |
268 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
89.0 |
82.0 to 93.5 |
346 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
94.5 |
89.8 to 97.1 |
268 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
94.4 |
89.9 to 97.0 |
257 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
94.2 |
90.3 to 96.5 |
331 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
87.4 |
80.7 to 92.0 |
232 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
91.9 |
87.4 to 94.8 |
284 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
90.5 |
85.5 to 93.9 |
297 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
91.5 |
86.4 to 94.8 |
247 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
90.3 |
85.3 to 93.8 |
259 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
93.4 |
88.8 to 96.2 |
225 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
89.6 |
84.3 to 93.3 |
289 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
87.2 |
81.0 to 91.5 |
276 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
92.0 |
88.8 to 94.4 |
536 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
93.1 |
87.8 to 96.2 |
222 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
91.3 |
86.8 to 94.4 |
314 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
93.8 |
89.5 to 96.4 |
361 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
94.3 |
89.6 to 97.0 |
280 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
92.1 |
86.3 to 95.5 |
269 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
91.6 |
87.3 to 94.5 |
249 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
91.9 |
87.5 to 94.9 |
263 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
94.1 |
90.9 to 96.2 |
752 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
94.3 |
89.4 to 97.0 |
267 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
94.0 |
90.4 to 96.4 |
485 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
89.9 |
86.7 to 92.5 |
671 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
91.7 |
90.8 to 92.5 |
16043 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
94.5 |
92.3 to 96.1 |
1595 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
91.2 |
88.5 to 93.3 |
825 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
92.2 |
90.2 to 93.8 |
2424 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
93.7 |
92.3 to 94.9 |
2291 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
93.8 |
92.2 to 95.2 |
2019 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
88.2 |
84.7 to 90.9 |
1981 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
92.5 |
90.2 to 94.3 |
1048 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
93.0 |
90.8 to 94.8 |
1736 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
88.1 |
83.9 to 91.4 |
1090 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
96.4 |
92.7 to 98.2 |
285 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
93.8 |
88.6 to 96.7 |
269 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
93.5 |
88.6 to 96.4 |
252 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
92.2 |
87.0 to 95.4 |
244 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
86.3 |
81.4 to 90.1 |
794 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
88.2 |
81.7 to 92.6 |
253 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
89.1 |
81.1 to 94.0 |
157 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
86.0 |
80.3 to 90.2 |
384 |
| Td or Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
93.6 |
91.6 to 95.2 |
1034 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
94.0 |
88.3 to 97.1 |
271 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
95.1 |
91.0 to 97.4 |
291 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
91.9 |
88.4 to 94.5 |
595 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
96.3 |
93.0 to 98.0 |
280 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
93.1 |
89.0 to 95.7 |
244 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
92.8 |
87.7 to 95.9 |
274 |
| Td or Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
90.4 |
85.1 to 94.0 |
294 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2006 |
Age |
13-15 Years |
13.4 |
11.5 to 15.5 |
1768 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2006 |
Age |
13-15 Years |
16.9 |
10.4 to 26.2 |
141 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2006 |
Age |
13-15 Years |
12.3 |
8.2 to 18.1 |
209 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2006 |
Age |
13-15 Years |
9.5 |
6.4 to 13.8 |
400 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2006 |
Age |
13-15 Years |
16.4 |
11.9 to 22.3 |
272 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2006 |
Age |
13-15 Years |
13.0 |
7.5 to 21.6 |
166 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2006 |
Age |
13-15 Years |
22.2 |
14.0 to 33.5 |
91 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2006 |
Age |
13-15 Years |
12.8 |
8.3 to 19.4 |
212 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2007 |
Age |
13-15 Years |
35.9 |
33.0 to 39.0 |
1787 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-15 Years |
38.3 |
27.6 to 50.2 |
113 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-15 Years |
40.8 |
31.2 to 51.2 |
135 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-15 Years |
42.9 |
34.0 to 52.4 |
221 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-15 Years |
26.5 |
20.4 to 33.7 |
291 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-15 Years |
29.0 |
23.9 to 34.8 |
377 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-15 Years |
39.8 |
30.9 to 49.5 |
191 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-15 Years |
46.9 |
35.2 to 59.1 |
95 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-15 Years |
47.9 |
33.9 to 62.2 |
72 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-15 Years |
41.2 |
32.1 to 50.8 |
216 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2007 |
Age |
13-15 Years |
26.5 |
17.1 to 38.6 |
76 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2008 |
Age |
13-15 Years |
46.3 |
39.0 to 53.8 |
252 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2008 |
Age |
13-15 Years |
44.7 |
37.1 to 52.6 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2008 |
Age |
13-15 Years |
58.9 |
49.6 to 67.6 |
159 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2008 |
Age |
13-15 Years |
31.3 |
24.7 to 38.9 |
240 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2008 |
Age |
13-15 Years |
48.7 |
39.2 to 58.3 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2008 |
Age |
13-15 Years |
69.0 |
60.4 to 76.3 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2008 |
Age |
13-15 Years |
51.0 |
42.1 to 59.8 |
173 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2008 |
Age |
13-15 Years |
52.7 |
44.5 to 60.8 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-15 Years |
34.6 |
27.2 to 42.9 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2008 |
Age |
13-15 Years |
37.6 |
28.9 to 47.1 |
177 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2008 |
Age |
13-15 Years |
43.9 |
36.0 to 52.1 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2008 |
Age |
13-15 Years |
32.5 |
25.7 to 40.2 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2008 |
Age |
13-15 Years |
34.9 |
26.7 to 44.1 |
152 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2008 |
Age |
13-15 Years |
48.1 |
40.9 to 55.4 |
474 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-15 Years |
48.6 |
40.6 to 56.7 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-15 Years |
47.9 |
39.0 to 57.0 |
253 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2008 |
Age |
13-15 Years |
33.1 |
26.6 to 40.3 |
213 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2008 |
Age |
13-15 Years |
50.6 |
41.9 to 59.2 |
168 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2008 |
Age |
13-15 Years |
46.3 |
37.8 to 55.0 |
162 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2008 |
Age |
13-15 Years |
35.0 |
27.1 to 43.9 |
162 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2008 |
Age |
13-15 Years |
41.4 |
33.7 to 49.5 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2008 |
Age |
13-15 Years |
51.0 |
42.7 to 59.2 |
189 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2008 |
Age |
13-15 Years |
45.8 |
38.0 to 53.7 |
253 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-15 Years |
49.8 |
41.7 to 57.9 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2008 |
Age |
13-15 Years |
36.7 |
28.9 to 45.3 |
169 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2008 |
Age |
13-15 Years |
53.3 |
45.4 to 61.0 |
203 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2008 |
Age |
13-15 Years |
22.8 |
17.0 to 29.8 |
244 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2008 |
Age |
13-15 Years |
43.8 |
36.1 to 51.7 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2008 |
Age |
13-15 Years |
58.1 |
49.2 to 66.4 |
168 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2008 |
Age |
13-15 Years |
55.2 |
47.8 to 62.3 |
227 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2008 |
Age |
13-15 Years |
44.9 |
36.0 to 54.1 |
148 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-15 Years |
62.1 |
51.9 to 71.4 |
172 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2008 |
Age |
13-15 Years |
47.7 |
39.8 to 55.7 |
229 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2008 |
Age |
13-15 Years |
56.3 |
47.8 to 64.5 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2008 |
Age |
13-15 Years |
61.3 |
55.1 to 67.1 |
367 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-15 Years |
56.1 |
46.7 to 65.1 |
180 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-15 Years |
65.0 |
56.7 to 72.5 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2008 |
Age |
13-15 Years |
34.0 |
27.0 to 41.7 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2008 |
Age |
13-15 Years |
61.8 |
54.0 to 69.0 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2008 |
Age |
13-15 Years |
38.3 |
30.7 to 46.5 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-15 Years |
33.8 |
26.7 to 41.7 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2008 |
Age |
13-15 Years |
40.0 |
31.6 to 49.1 |
144 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-15 Years |
55.2 |
48.3 to 62.0 |
406 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-15 Years |
53.1 |
45.0 to 60.9 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-15 Years |
55.6 |
47.6 to 63.3 |
201 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2008 |
Age |
13-15 Years |
46.7 |
44.8 to 48.6 |
10762 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-15 Years |
51.2 |
46.6 to 55.8 |
1094 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-15 Years |
57.0 |
52.1 to 61.9 |
596 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-15 Years |
53.2 |
49.1 to 57.3 |
1401 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-15 Years |
37.9 |
34.3 to 41.5 |
1695 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-15 Years |
43.9 |
40.5 to 47.3 |
1396 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-15 Years |
45.4 |
39.0 to 52.0 |
1345 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-15 Years |
47.2 |
42.8 to 51.7 |
783 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-15 Years |
59.4 |
54.6 to 64.0 |
1098 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-15 Years |
49.6 |
42.1 to 57.2 |
692 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-15 Years |
45.4 |
36.2 to 54.8 |
172 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2008 |
Age |
13-15 Years |
33.0 |
26.4 to 40.3 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2008 |
Age |
13-15 Years |
23.4 |
17.4 to 30.8 |
199 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2008 |
Age |
13-15 Years |
41.2 |
33.4 to 49.5 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2008 |
Age |
13-15 Years |
48.3 |
38.9 to 57.7 |
513 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-15 Years |
49.7 |
40.6 to 58.8 |
173 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-15 Years |
43.7 |
32.3 to 55.7 |
136 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-15 Years |
48.5 |
37.8 to 59.5 |
204 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-15 Years |
39.4 |
34.5 to 44.5 |
662 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2008 |
Age |
13-15 Years |
56.7 |
47.3 to 65.6 |
144 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2008 |
Age |
13-15 Years |
54.5 |
46.0 to 62.7 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2008 |
Age |
13-15 Years |
62.5 |
53.9 to 70.3 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2008 |
Age |
13-15 Years |
39.4 |
31.7 to 47.7 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2008 |
Age |
13-15 Years |
26.6 |
19.9 to 34.6 |
182 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-15 Years |
61.8 |
52.7 to 70.2 |
147 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2008 |
Age |
13-15 Years |
39.7 |
31.9 to 48.1 |
169 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2009 |
Age |
13-15 Years |
59.0 |
50.5 to 67.0 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2009 |
Age |
13-15 Years |
55.5 |
47.2 to 63.5 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2009 |
Age |
13-15 Years |
73.7 |
65.7 to 80.4 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2009 |
Age |
13-15 Years |
38.4 |
31.0 to 46.4 |
228 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2009 |
Age |
13-15 Years |
64.8 |
57.1 to 71.8 |
238 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2009 |
Age |
13-15 Years |
72.8 |
65.2 to 79.3 |
250 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2009 |
Age |
13-15 Years |
77.2 |
69.9 to 83.2 |
214 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2009 |
Age |
13-15 Years |
65.0 |
56.5 to 72.6 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-15 Years |
50.9 |
43.3 to 58.3 |
260 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2009 |
Age |
13-15 Years |
62.8 |
55.0 to 70.0 |
267 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2009 |
Age |
13-15 Years |
56.5 |
48.8 to 63.9 |
244 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2009 |
Age |
13-15 Years |
52.6 |
44.0 to 61.1 |
156 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2009 |
Age |
13-15 Years |
40.9 |
31.8 to 50.7 |
142 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2009 |
Age |
13-15 Years |
57.4 |
51.1 to 63.4 |
462 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-15 Years |
57.1 |
48.9 to 64.8 |
239 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-15 Years |
57.5 |
49.9 to 64.7 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2009 |
Age |
13-15 Years |
44.1 |
37.1 to 51.3 |
504 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2009 |
Age |
13-15 Years |
67.0 |
58.6 to 74.5 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2009 |
Age |
13-15 Years |
60.5 |
51.5 to 68.9 |
159 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2009 |
Age |
13-15 Years |
44.2 |
37.3 to 51.3 |
250 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2009 |
Age |
13-15 Years |
54.0 |
44.9 to 62.8 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2009 |
Age |
13-15 Years |
57.8 |
49.0 to 66.1 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2009 |
Age |
13-15 Years |
61.9 |
50.9 to 71.8 |
144 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-15 Years |
75.2 |
68.3 to 81.1 |
241 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2009 |
Age |
13-15 Years |
52.8 |
45.9 to 59.7 |
292 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2009 |
Age |
13-15 Years |
68.2 |
60.2 to 75.2 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2009 |
Age |
13-15 Years |
24.6 |
19.2 to 31.0 |
281 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2009 |
Age |
13-15 Years |
59.3 |
51.5 to 66.6 |
214 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2009 |
Age |
13-15 Years |
78.1 |
70.9 to 83.9 |
176 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2009 |
Age |
13-15 Years |
64.2 |
55.6 to 71.9 |
162 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2009 |
Age |
13-15 Years |
73.6 |
65.6 to 80.2 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-15 Years |
77.7 |
70.4 to 83.6 |
182 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2009 |
Age |
13-15 Years |
68.5 |
61.0 to 75.1 |
238 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2009 |
Age |
13-15 Years |
69.2 |
61.9 to 75.6 |
252 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2009 |
Age |
13-15 Years |
73.9 |
67.6 to 79.3 |
335 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-15 Years |
75.7 |
67.3 to 82.5 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-15 Years |
72.4 |
63.0 to 80.2 |
147 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2009 |
Age |
13-15 Years |
58.6 |
50.3 to 66.5 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2009 |
Age |
13-15 Years |
80.4 |
72.6 to 86.5 |
154 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2009 |
Age |
13-15 Years |
55.7 |
47.6 to 63.4 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-15 Years |
43.5 |
36.1 to 51.2 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2009 |
Age |
13-15 Years |
59.7 |
52.5 to 66.5 |
246 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-15 Years |
69.2 |
61.1 to 76.3 |
373 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-15 Years |
66.0 |
58.5 to 72.7 |
216 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-15 Years |
69.8 |
60.2 to 77.9 |
157 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2009 |
Age |
13-15 Years |
62.2 |
60.6 to 63.7 |
12280 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-15 Years |
73.7 |
70.0 to 77.1 |
1314 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-15 Years |
72.3 |
67.4 to 76.7 |
573 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-15 Years |
66.1 |
61.6 to 70.3 |
1381 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-15 Years |
55.0 |
51.8 to 58.1 |
1846 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-15 Years |
57.3 |
54.2 to 60.4 |
1863 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-15 Years |
58.2 |
53.6 to 62.6 |
1794 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-15 Years |
61.9 |
57.5 to 66.1 |
727 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-15 Years |
72.3 |
68.3 to 76.0 |
1184 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-15 Years |
66.2 |
60.0 to 71.9 |
822 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-15 Years |
62.8 |
54.7 to 70.3 |
244 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2009 |
Age |
13-15 Years |
41.7 |
33.6 to 50.2 |
180 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2009 |
Age |
13-15 Years |
49.4 |
40.6 to 58.1 |
159 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2009 |
Age |
13-15 Years |
56.1 |
48.0 to 63.9 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2009 |
Age |
13-15 Years |
62.1 |
55.6 to 68.2 |
915 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-15 Years |
59.8 |
50.6 to 68.3 |
202 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-15 Years |
53.6 |
43.2 to 63.8 |
141 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-15 Years |
55.4 |
46.0 to 64.5 |
176 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-15 Years |
75.2 |
68.1 to 81.2 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-15 Years |
63.2 |
54.6 to 71.1 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-15 Years |
43.0 |
34.8 to 51.6 |
206 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-15 Years |
61.7 |
57.1 to 66.1 |
776 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2009 |
Age |
13-15 Years |
74.3 |
66.6 to 80.7 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2009 |
Age |
13-15 Years |
78.5 |
72.5 to 83.6 |
258 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2009 |
Age |
13-15 Years |
69.9 |
62.5 to 76.4 |
235 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2009 |
Age |
13-15 Years |
68.2 |
60.7 to 74.9 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2009 |
Age |
13-15 Years |
43.5 |
34.8 to 52.6 |
154 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-15 Years |
75.3 |
67.0 to 82.0 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2009 |
Age |
13-15 Years |
71.5 |
64.7 to 77.5 |
227 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2010 |
Age |
13-15 Years |
67.0 |
58.7 to 74.3 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2010 |
Age |
13-15 Years |
63.1 |
54.9 to 70.6 |
176 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2010 |
Age |
13-15 Years |
81.8 |
73.9 to 87.7 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2010 |
Age |
13-15 Years |
47.0 |
38.8 to 55.4 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2010 |
Age |
13-15 Years |
76.7 |
69.3 to 82.7 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2010 |
Age |
13-15 Years |
84.1 |
77.7 to 89.0 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2010 |
Age |
13-15 Years |
80.7 |
73.8 to 86.1 |
242 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2010 |
Age |
13-15 Years |
77.3 |
70.0 to 83.3 |
199 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-15 Years |
73.0 |
65.7 to 79.2 |
231 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2010 |
Age |
13-15 Years |
77.4 |
69.4 to 83.7 |
199 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2010 |
Age |
13-15 Years |
68.6 |
61.0 to 75.4 |
236 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2010 |
Age |
13-15 Years |
60.5 |
52.7 to 67.7 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2010 |
Age |
13-15 Years |
53.5 |
45.8 to 61.1 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2010 |
Age |
13-15 Years |
64.9 |
58.6 to 70.8 |
454 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-15 Years |
69.2 |
61.4 to 76.0 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-15 Years |
63.9 |
56.3 to 70.9 |
228 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2010 |
Age |
13-15 Years |
74.6 |
66.2 to 81.5 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2010 |
Age |
13-15 Years |
63.0 |
54.5 to 70.7 |
169 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2010 |
Age |
13-15 Years |
77.2 |
70.9 to 82.5 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2010 |
Age |
13-15 Years |
67.3 |
59.6 to 74.2 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2010 |
Age |
13-15 Years |
70.6 |
63.1 to 77.1 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2010 |
Age |
13-15 Years |
65.7 |
57.5 to 72.9 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2010 |
Age |
13-15 Years |
67.1 |
58.2 to 75.0 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-15 Years |
85.3 |
78.0 to 90.4 |
193 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2010 |
Age |
13-15 Years |
70.0 |
61.4 to 77.4 |
193 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2010 |
Age |
13-15 Years |
84.3 |
76.5 to 89.8 |
180 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2010 |
Age |
13-15 Years |
30.5 |
23.9 to 38.0 |
227 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2010 |
Age |
13-15 Years |
60.6 |
52.8 to 67.9 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2010 |
Age |
13-15 Years |
83.7 |
77.3 to 88.5 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2010 |
Age |
13-15 Years |
81.9 |
73.8 to 87.8 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2010 |
Age |
13-15 Years |
82.4 |
75.4 to 87.7 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-15 Years |
90.8 |
85.2 to 94.4 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2010 |
Age |
13-15 Years |
75.2 |
67.3 to 81.8 |
244 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2010 |
Age |
13-15 Years |
75.3 |
67.4 to 81.7 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2010 |
Age |
13-15 Years |
89.6 |
85.2 to 92.9 |
424 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-15 Years |
88.9 |
83.0 to 92.9 |
233 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-15 Years |
90.1 |
83.3 to 94.4 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2010 |
Age |
13-15 Years |
78.5 |
71.6 to 84.0 |
235 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2010 |
Age |
13-15 Years |
86.1 |
78.8 to 91.1 |
154 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2010 |
Age |
13-15 Years |
63.0 |
54.9 to 70.4 |
180 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-15 Years |
61.3 |
52.8 to 69.3 |
168 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2010 |
Age |
13-15 Years |
78.0 |
70.5 to 84.1 |
180 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-15 Years |
79.2 |
73.4 to 84.0 |
471 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-15 Years |
74.2 |
67.2 to 80.2 |
231 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-15 Years |
80.0 |
73.3 to 85.3 |
240 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2010 |
Age |
13-15 Years |
74.2 |
72.8 to 75.6 |
11774 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-15 Years |
83.4 |
79.8 to 86.4 |
1213 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-15 Years |
84.9 |
81.1 to 88.1 |
668 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-15 Years |
76.5 |
72.9 to 79.7 |
1486 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-15 Years |
68.7 |
65.7 to 71.5 |
1680 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-15 Years |
70.7 |
67.5 to 73.7 |
1361 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-15 Years |
71.9 |
68.1 to 75.5 |
1869 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-15 Years |
67.5 |
63.3 to 71.5 |
775 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-15 Years |
79.9 |
76.3 to 83.1 |
1126 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-15 Years |
77.2 |
71.4 to 82.2 |
821 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-15 Years |
92.5 |
88.0 to 95.4 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2010 |
Age |
13-15 Years |
56.3 |
48.0 to 64.4 |
197 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2010 |
Age |
13-15 Years |
53.7 |
45.4 to 61.9 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2010 |
Age |
13-15 Years |
62.8 |
54.6 to 70.4 |
193 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2010 |
Age |
13-15 Years |
75.8 |
70.4 to 80.5 |
1098 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-15 Years |
75.8 |
68.8 to 81.6 |
244 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-15 Years |
73.4 |
65.5 to 80.0 |
256 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-15 Years |
75.5 |
66.8 to 82.5 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-15 Years |
83.7 |
77.1 to 88.7 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-15 Years |
75.7 |
68.3 to 81.8 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-15 Years |
72.1 |
63.1 to 79.7 |
143 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-15 Years |
73.6 |
69.2 to 77.5 |
775 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2010 |
Age |
13-15 Years |
77.7 |
69.9 to 84.0 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2010 |
Age |
13-15 Years |
85.2 |
77.6 to 90.6 |
193 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2010 |
Age |
13-15 Years |
83.5 |
76.4 to 88.8 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2010 |
Age |
13-15 Years |
77.9 |
70.6 to 83.9 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2010 |
Age |
13-15 Years |
55.3 |
47.6 to 62.8 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-15 Years |
85.4 |
78.6 to 90.3 |
166 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2010 |
Age |
13-15 Years |
83.0 |
75.9 to 88.3 |
174 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2011 |
Age |
13-15 Years |
73.4 |
65.9 to 79.7 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2011 |
Age |
13-15 Years |
63.0 |
53.6 to 71.5 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2011 |
Age |
13-15 Years |
83.4 |
74.6 to 89.6 |
269 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2011 |
Age |
13-15 Years |
56.4 |
46.1 to 66.1 |
214 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2011 |
Age |
13-15 Years |
81.2 |
75.3 to 86.0 |
356 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2011 |
Age |
13-15 Years |
87.8 |
77.8 to 93.7 |
254 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2011 |
Age |
13-15 Years |
82.4 |
74.5 to 88.2 |
277 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2011 |
Age |
13-15 Years |
82.2 |
75.8 to 87.2 |
267 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-15 Years |
84.1 |
77.2 to 89.2 |
239 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2011 |
Age |
13-15 Years |
86.2 |
79.4 to 91.0 |
287 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2011 |
Age |
13-15 Years |
74.0 |
65.7 to 80.9 |
244 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2011 |
Age |
13-15 Years |
67.9 |
59.7 to 75.1 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2011 |
Age |
13-15 Years |
58.4 |
49.5 to 66.8 |
250 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2011 |
Age |
13-15 Years |
69.1 |
62.9 to 74.8 |
524 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-15 Years |
68.1 |
60.3 to 75.0 |
250 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-15 Years |
69.4 |
61.8 to 76.1 |
274 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2011 |
Age |
13-15 Years |
93.8 |
88.7 to 96.7 |
254 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2011 |
Age |
13-15 Years |
77.6 |
70.3 to 83.6 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2011 |
Age |
13-15 Years |
80.5 |
72.0 to 86.9 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2011 |
Age |
13-15 Years |
77.5 |
68.8 to 84.3 |
245 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2011 |
Age |
13-15 Years |
89.8 |
83.7 to 93.9 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2011 |
Age |
13-15 Years |
70.7 |
62.8 to 77.5 |
250 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2011 |
Age |
13-15 Years |
71.1 |
63.5 to 77.6 |
307 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-15 Years |
94.6 |
88.8 to 97.5 |
214 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2011 |
Age |
13-15 Years |
76.5 |
68.6 to 82.9 |
248 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2011 |
Age |
13-15 Years |
90.5 |
83.2 to 94.9 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2011 |
Age |
13-15 Years |
37.7 |
29.5 to 46.7 |
216 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2011 |
Age |
13-15 Years |
79.6 |
71.7 to 85.7 |
249 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2011 |
Age |
13-15 Years |
85.0 |
74.6 to 91.7 |
220 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2011 |
Age |
13-15 Years |
84.3 |
77.3 to 89.4 |
243 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2011 |
Age |
13-15 Years |
82.8 |
74.3 to 88.9 |
268 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-15 Years |
95.9 |
91.9 to 98.0 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2011 |
Age |
13-15 Years |
84.3 |
77.9 to 89.1 |
252 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2011 |
Age |
13-15 Years |
84.3 |
77.1 to 89.5 |
259 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2011 |
Age |
13-15 Years |
90.8 |
87.5 to 93.3 |
515 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-15 Years |
89.1 |
84.5 to 92.4 |
267 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-15 Years |
91.9 |
86.9 to 95.1 |
248 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2011 |
Age |
13-15 Years |
87.1 |
80.9 to 91.5 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2011 |
Age |
13-15 Years |
88.1 |
77.1 to 94.2 |
171 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2011 |
Age |
13-15 Years |
73.9 |
66.6 to 80.1 |
244 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-15 Years |
65.7 |
57.6 to 72.9 |
254 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2011 |
Age |
13-15 Years |
86.8 |
79.9 to 91.6 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-15 Years |
82.7 |
76.4 to 87.5 |
526 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-15 Years |
81.7 |
74.2 to 87.4 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-15 Years |
82.8 |
75.7 to 88.2 |
294 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2011 |
Age |
13-15 Years |
80.5 |
79.2 to 81.6 |
14355 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-15 Years |
89.2 |
86.1 to 91.6 |
1461 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-15 Years |
88.7 |
85.8 to 91.1 |
767 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-15 Years |
77.9 |
74.1 to 81.2 |
1850 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-15 Years |
76.5 |
73.7 to 79.1 |
1934 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-15 Years |
79.4 |
76.5 to 82.0 |
1703 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-15 Years |
79.7 |
76.4 to 82.7 |
2399 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-15 Years |
80.0 |
75.9 to 83.5 |
933 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-15 Years |
85.1 |
80.3 to 88.9 |
1332 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-15 Years |
81.3 |
76.6 to 85.2 |
1103 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-15 Years |
91.7 |
87.4 to 94.6 |
279 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2011 |
Age |
13-15 Years |
64.5 |
55.9 to 72.3 |
229 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2011 |
Age |
13-15 Years |
61.2 |
48.0 to 72.9 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2011 |
Age |
13-15 Years |
70.5 |
61.7 to 78.0 |
261 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2011 |
Age |
13-15 Years |
82.6 |
77.9 to 86.5 |
1376 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-15 Years |
91.2 |
86.9 to 94.2 |
282 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-15 Years |
72.2 |
63.6 to 79.5 |
299 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-15 Years |
82.6 |
75.6 to 88.0 |
276 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-15 Years |
85.7 |
78.7 to 90.7 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-15 Years |
82.7 |
76.2 to 87.7 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-15 Years |
66.6 |
59.9 to 72.7 |
290 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-15 Years |
76.7 |
71.7 to 81.0 |
873 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2011 |
Age |
13-15 Years |
84.9 |
75.7 to 91.1 |
251 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2011 |
Age |
13-15 Years |
91.6 |
86.5 to 94.9 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2011 |
Age |
13-15 Years |
78.1 |
69.3 to 85.0 |
265 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2011 |
Age |
13-15 Years |
78.0 |
69.1 to 84.9 |
208 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2011 |
Age |
13-15 Years |
62.8 |
55.2 to 69.9 |
246 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-15 Years |
93.0 |
86.8 to 96.4 |
229 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2011 |
Age |
13-15 Years |
90.3 |
83.0 to 94.7 |
227 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2012 |
Age |
13-15 Years |
85.3 |
76.5 to 91.1 |
184 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2012 |
Age |
13-15 Years |
71.0 |
63.4 to 77.6 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2012 |
Age |
13-15 Years |
89.0 |
82.6 to 93.3 |
231 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2012 |
Age |
13-15 Years |
73.9 |
65.4 to 81.0 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2012 |
Age |
13-15 Years |
87.1 |
80.5 to 91.6 |
271 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2012 |
Age |
13-15 Years |
91.7 |
84.6 to 95.6 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2012 |
Age |
13-15 Years |
91.8 |
86.2 to 95.3 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2012 |
Age |
13-15 Years |
83.1 |
75.0 to 88.9 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-15 Years |
86.0 |
77.8 to 91.6 |
216 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2012 |
Age |
13-15 Years |
88.4 |
81.0 to 93.1 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2012 |
Age |
13-15 Years |
78.0 |
68.1 to 85.5 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2012 |
Age |
13-15 Years |
71.4 |
62.6 to 78.9 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2012 |
Age |
13-15 Years |
69.1 |
60.9 to 76.2 |
212 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2012 |
Age |
13-15 Years |
76.8 |
69.1 to 83.0 |
393 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-15 Years |
77.8 |
69.2 to 84.5 |
183 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-15 Years |
76.5 |
67.0 to 83.9 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2012 |
Age |
13-15 Years |
96.9 |
93.2 to 98.6 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2012 |
Age |
13-15 Years |
71.8 |
62.6 to 79.5 |
183 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2012 |
Age |
13-15 Years |
94.1 |
88.2 to 97.1 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2012 |
Age |
13-15 Years |
84.5 |
77.6 to 89.6 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2012 |
Age |
13-15 Years |
90.5 |
84.2 to 94.4 |
230 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2012 |
Age |
13-15 Years |
81.4 |
73.6 to 87.2 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2012 |
Age |
13-15 Years |
78.5 |
70.1 to 85.0 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-15 Years |
95.6 |
90.7 to 98.0 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2012 |
Age |
13-15 Years |
85.0 |
77.4 to 90.3 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2012 |
Age |
13-15 Years |
85.2 |
75.5 to 91.5 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2012 |
Age |
13-15 Years |
58.6 |
48.8 to 67.9 |
184 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2012 |
Age |
13-15 Years |
86.8 |
79.2 to 91.8 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2012 |
Age |
13-15 Years |
91.5 |
85.6 to 95.2 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2012 |
Age |
13-15 Years |
84.4 |
77.0 to 89.8 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2012 |
Age |
13-15 Years |
88.8 |
82.4 to 93.2 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-15 Years |
94.7 |
89.7 to 97.4 |
145 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2012 |
Age |
13-15 Years |
92.2 |
85.3 to 96.0 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2012 |
Age |
13-15 Years |
83.4 |
75.1 to 89.3 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2012 |
Age |
13-15 Years |
89.0 |
84.2 to 92.5 |
387 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-15 Years |
83.6 |
76.4 to 88.9 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-15 Years |
92.7 |
85.0 to 96.6 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2012 |
Age |
13-15 Years |
93.9 |
88.8 to 96.8 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2012 |
Age |
13-15 Years |
89.0 |
81.1 to 93.9 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2012 |
Age |
13-15 Years |
76.8 |
68.2 to 83.6 |
202 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-15 Years |
82.2 |
75.0 to 87.7 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2012 |
Age |
13-15 Years |
87.8 |
80.6 to 92.6 |
229 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-15 Years |
88.8 |
83.3 to 92.6 |
461 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-15 Years |
87.8 |
79.8 to 92.9 |
219 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-15 Years |
88.9 |
82.7 to 93.1 |
242 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2012 |
Age |
13-15 Years |
85.3 |
84.1 to 86.5 |
11790 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-15 Years |
93.1 |
90.8 to 94.9 |
1126 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-15 Years |
90.1 |
86.4 to 92.9 |
602 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-15 Years |
85.5 |
82.4 to 88.2 |
1473 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-15 Years |
83.4 |
80.5 to 85.9 |
1593 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-15 Years |
83.0 |
79.8 to 85.8 |
1419 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-15 Years |
84.2 |
81.1 to 86.9 |
1849 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-15 Years |
85.0 |
81.0 to 88.2 |
755 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-15 Years |
84.5 |
80.2 to 88.0 |
1200 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-15 Years |
87.1 |
82.0 to 90.8 |
910 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-15 Years |
94.5 |
89.3 to 97.3 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2012 |
Age |
13-15 Years |
65.2 |
55.7 to 73.7 |
197 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2012 |
Age |
13-15 Years |
60.0 |
51.5 to 67.9 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2012 |
Age |
13-15 Years |
86.6 |
79.0 to 91.7 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2012 |
Age |
13-15 Years |
84.7 |
80.2 to 88.3 |
999 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-15 Years |
80.6 |
70.0 to 88.1 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-15 Years |
82.9 |
75.2 to 88.5 |
239 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-15 Years |
85.1 |
79.9 to 89.2 |
539 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-15 Years |
75.1 |
69.4 to 80.0 |
333 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-15 Years |
82.2 |
77.5 to 86.1 |
863 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2012 |
Age |
13-15 Years |
76.9 |
66.7 to 84.8 |
211 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2012 |
Age |
13-15 Years |
94.4 |
86.4 to 97.8 |
178 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2012 |
Age |
13-15 Years |
90.3 |
84.1 to 94.3 |
212 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2012 |
Age |
13-15 Years |
83.8 |
75.1 to 89.9 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2012 |
Age |
13-15 Years |
65.3 |
55.3 to 74.2 |
166 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-15 Years |
88.2 |
80.1 to 93.3 |
178 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2012 |
Age |
13-15 Years |
84.7 |
76.8 to 90.3 |
197 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2013 |
Age |
13-15 Years |
89.2 |
83.0 to 93.3 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2013 |
Age |
13-15 Years |
67.7 |
59.3 to 75.1 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2013 |
Age |
13-15 Years |
86.7 |
79.9 to 91.4 |
224 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2013 |
Age |
13-15 Years |
84.7 |
78.0 to 89.6 |
185 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2013 |
Age |
13-15 Years |
93.7 |
87.6 to 96.9 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2013 |
Age |
13-15 Years |
87.7 |
81.1 to 92.3 |
211 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2013 |
Age |
13-15 Years |
89.6 |
82.1 to 94.2 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2013 |
Age |
13-15 Years |
82.1 |
74.7 to 87.7 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-15 Years |
84.3 |
72.4 to 91.7 |
129 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2013 |
Age |
13-15 Years |
87.3 |
78.2 to 92.9 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2013 |
Age |
13-15 Years |
81.4 |
71.0 to 88.7 |
160 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2013 |
Age |
13-15 Years |
73.5 |
65.8 to 80.0 |
225 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2013 |
Age |
13-15 Years |
80.2 |
73.1 to 85.9 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2013 |
Age |
13-15 Years |
79.5 |
71.0 to 86.0 |
180 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2013 |
Age |
13-15 Years |
87.0 |
80.9 to 91.4 |
335 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-15 Years |
87.8 |
78.4 to 93.4 |
126 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-15 Years |
86.8 |
79.2 to 91.9 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2013 |
Age |
13-15 Years |
90.6 |
85.1 to 94.2 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2013 |
Age |
13-15 Years |
76.5 |
69.2 to 82.4 |
257 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2013 |
Age |
13-15 Years |
82.7 |
75.5 to 88.1 |
180 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2013 |
Age |
13-15 Years |
87.5 |
80.1 to 92.4 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2013 |
Age |
13-15 Years |
87.2 |
79.6 to 92.2 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2013 |
Age |
13-15 Years |
79.9 |
72.8 to 85.6 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2013 |
Age |
13-15 Years |
82.8 |
73.7 to 89.3 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-15 Years |
97.2 |
93.6 to 98.8 |
242 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2013 |
Age |
13-15 Years |
86.4 |
79.8 to 91.1 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2013 |
Age |
13-15 Years |
89.9 |
83.2 to 94.1 |
230 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2013 |
Age |
13-15 Years |
65.4 |
56.4 to 73.4 |
174 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2013 |
Age |
13-15 Years |
78.7 |
70.4 to 85.2 |
174 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2013 |
Age |
13-15 Years |
86.4 |
78.5 to 91.7 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2013 |
Age |
13-15 Years |
86.8 |
79.4 to 91.7 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2013 |
Age |
13-15 Years |
89.5 |
83.2 to 93.6 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-15 Years |
95.1 |
88.9 to 97.9 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2013 |
Age |
13-15 Years |
87.8 |
79.9 to 92.9 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2013 |
Age |
13-15 Years |
88.4 |
82.2 to 92.7 |
219 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2013 |
Age |
13-15 Years |
89.2 |
84.5 to 92.6 |
399 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-15 Years |
87.2 |
79.6 to 92.3 |
173 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-15 Years |
90.5 |
83.9 to 94.6 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2013 |
Age |
13-15 Years |
93.2 |
88.0 to 96.2 |
202 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2013 |
Age |
13-15 Years |
94.4 |
89.6 to 97.0 |
213 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2013 |
Age |
13-15 Years |
87.5 |
80.9 to 92.0 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-15 Years |
83.1 |
76.9 to 87.8 |
279 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2013 |
Age |
13-15 Years |
88.8 |
83.1 to 92.7 |
236 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-15 Years |
87.1 |
81.1 to 91.4 |
459 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-15 Years |
88.7 |
82.0 to 93.2 |
183 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-15 Years |
86.9 |
80.1 to 91.7 |
276 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2013 |
Age |
13-15 Years |
87.5 |
86.4 to 88.6 |
11221 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-15 Years |
93.2 |
90.8 to 95.0 |
1201 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-15 Years |
88.8 |
84.9 to 91.7 |
600 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-15 Years |
85.1 |
81.3 to 88.3 |
1381 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-15 Years |
85.0 |
81.9 to 87.6 |
1462 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-15 Years |
87.8 |
85.3 to 89.9 |
1382 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-15 Years |
88.0 |
84.8 to 90.6 |
1554 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-15 Years |
80.1 |
75.8 to 83.7 |
790 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-15 Years |
86.3 |
82.7 to 89.3 |
1166 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-15 Years |
92.1 |
87.8 to 95.0 |
845 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-15 Years |
95.2 |
90.0 to 97.8 |
176 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2013 |
Age |
13-15 Years |
74.2 |
65.0 to 81.6 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2013 |
Age |
13-15 Years |
69.4 |
60.6 to 77.0 |
171 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2013 |
Age |
13-15 Years |
83.6 |
76.3 to 89.0 |
182 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2013 |
Age |
13-15 Years |
89.1 |
84.4 to 92.5 |
696 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-15 Years |
88.5 |
81.7 to 93.0 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-15 Years |
85.3 |
75.5 to 91.6 |
161 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-15 Years |
89.4 |
84.0 to 93.2 |
341 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-15 Years |
75.0 |
67.6 to 81.1 |
202 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-15 Years |
85.9 |
81.9 to 89.2 |
840 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2013 |
Age |
13-15 Years |
85.7 |
78.1 to 91.0 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2013 |
Age |
13-15 Years |
90.1 |
83.4 to 94.2 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2013 |
Age |
13-15 Years |
85.4 |
75.5 to 91.8 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2013 |
Age |
13-15 Years |
88.1 |
80.6 to 93.0 |
219 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2013 |
Age |
13-15 Years |
79.2 |
71.5 to 85.3 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-15 Years |
87.4 |
80.1 to 92.3 |
212 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2013 |
Age |
13-15 Years |
92.7 |
87.8 to 95.7 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2014 |
Age |
13-15 Years |
87.0 |
80.0 to 91.8 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2014 |
Age |
13-15 Years |
71.9 |
64.6 to 78.2 |
227 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2014 |
Age |
13-15 Years |
84.1 |
77.1 to 89.3 |
267 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2014 |
Age |
13-15 Years |
87.9 |
80.7 to 92.6 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2014 |
Age |
13-15 Years |
88.1 |
81.2 to 92.7 |
219 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2014 |
Age |
13-15 Years |
89.3 |
83.8 to 93.1 |
233 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2014 |
Age |
13-15 Years |
96.2 |
91.5 to 98.4 |
238 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2014 |
Age |
13-15 Years |
91.4 |
85.2 to 95.2 |
231 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-15 Years |
80.9 |
72.0 to 87.4 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2014 |
Age |
13-15 Years |
89.4 |
81.7 to 94.1 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2014 |
Age |
13-15 Years |
89.4 |
83.1 to 93.6 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2014 |
Age |
13-15 Years |
82.1 |
75.4 to 87.3 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2014 |
Age |
13-15 Years |
75.7 |
67.5 to 82.4 |
230 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2014 |
Age |
13-15 Years |
92.7 |
89.7 to 94.9 |
464 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-15 Years |
84.0 |
75.4 to 90.0 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-15 Years |
94.6 |
91.3 to 96.7 |
289 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2014 |
Age |
13-15 Years |
90.1 |
83.6 to 94.2 |
233 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2014 |
Age |
13-15 Years |
83.9 |
75.2 to 89.9 |
178 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2014 |
Age |
13-15 Years |
80.8 |
72.8 to 86.9 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2014 |
Age |
13-15 Years |
87.9 |
81.8 to 92.2 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2014 |
Age |
13-15 Years |
95.3 |
91.5 to 97.5 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2014 |
Age |
13-15 Years |
84.6 |
77.3 to 89.9 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2014 |
Age |
13-15 Years |
84.6 |
76.3 to 90.4 |
245 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-15 Years |
93.7 |
87.8 to 96.8 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2014 |
Age |
13-15 Years |
74.8 |
66.5 to 81.7 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2014 |
Age |
13-15 Years |
87.4 |
80.0 to 92.3 |
169 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2014 |
Age |
13-15 Years |
81.3 |
73.6 to 87.2 |
230 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2014 |
Age |
13-15 Years |
85.3 |
78.1 to 90.5 |
230 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2014 |
Age |
13-15 Years |
82.4 |
74.8 to 88.1 |
225 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2014 |
Age |
13-15 Years |
84.5 |
76.9 to 89.9 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2014 |
Age |
13-15 Years |
85.6 |
79.7 to 89.9 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-15 Years |
94.9 |
90.7 to 97.2 |
245 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2014 |
Age |
13-15 Years |
89.7 |
82.3 to 94.3 |
211 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2014 |
Age |
13-15 Years |
85.7 |
77.9 to 91.0 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2014 |
Age |
13-15 Years |
91.7 |
86.8 to 94.8 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-15 Years |
88.6 |
80.1 to 93.7 |
164 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-15 Years |
93.4 |
86.6 to 96.9 |
176 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2014 |
Age |
13-15 Years |
90.7 |
83.4 to 95.0 |
241 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2014 |
Age |
13-15 Years |
91.2 |
84.7 to 95.1 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2014 |
Age |
13-15 Years |
84.7 |
77.6 to 89.9 |
265 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-15 Years |
86.1 |
79.8 to 90.6 |
220 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2014 |
Age |
13-15 Years |
85.7 |
78.8 to 90.5 |
259 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-15 Years |
94.8 |
91.3 to 96.9 |
455 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-15 Years |
87.9 |
79.4 to 93.1 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-15 Years |
95.7 |
91.6 to 97.8 |
265 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-15 Years |
86.0 |
75.4 to 92.4 |
132 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2014 |
Age |
13-15 Years |
88.3 |
87.2 to 89.3 |
12764 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-15 Years |
93.8 |
91.1 to 95.6 |
1357 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-15 Years |
91.0 |
87.2 to 93.8 |
551 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-15 Years |
91.0 |
88.4 to 93.0 |
1552 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-15 Years |
87.8 |
85.2 to 90.0 |
1807 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-15 Years |
86.9 |
84.5 to 89.1 |
1542 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-15 Years |
89.4 |
86.4 to 91.7 |
1862 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-15 Years |
84.0 |
80.0 to 87.2 |
815 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-15 Years |
87.6 |
84.7 to 90.1 |
1399 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-15 Years |
87.3 |
82.1 to 91.1 |
949 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-15 Years |
94.9 |
89.2 to 97.7 |
235 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2014 |
Age |
13-15 Years |
77.5 |
69.4 to 83.9 |
236 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2014 |
Age |
13-15 Years |
73.7 |
65.2 to 80.7 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2014 |
Age |
13-15 Years |
87.5 |
80.7 to 92.1 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2014 |
Age |
13-15 Years |
89.4 |
85.1 to 92.5 |
999 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-15 Years |
86.1 |
79.2 to 90.9 |
225 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-15 Years |
87.3 |
79.9 to 92.2 |
233 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-15 Years |
92.5 |
87.1 to 95.8 |
240 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-15 Years |
89.6 |
84.4 to 93.2 |
301 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-15 Years |
84.5 |
80.9 to 87.5 |
930 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2014 |
Age |
13-15 Years |
89.1 |
83.3 to 93.0 |
241 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2014 |
Age |
13-15 Years |
95.4 |
90.8 to 97.7 |
216 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2014 |
Age |
13-15 Years |
93.3 |
87.6 to 96.4 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2014 |
Age |
13-15 Years |
87.9 |
81.8 to 92.2 |
214 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2014 |
Age |
13-15 Years |
79.9 |
72.1 to 85.9 |
224 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-15 Years |
93.7 |
87.2 to 97.0 |
216 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2014 |
Age |
13-15 Years |
88.9 |
83.7 to 92.6 |
282 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2015 |
Age |
13-15 Years |
91.6 |
85.3 to 95.4 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2015 |
Age |
13-15 Years |
66.0 |
58.1 to 73.1 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2015 |
Age |
13-15 Years |
86.3 |
80.4 to 90.6 |
272 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2015 |
Age |
13-15 Years |
91.0 |
85.2 to 94.6 |
217 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2015 |
Age |
13-15 Years |
86.6 |
79.2 to 91.6 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2015 |
Age |
13-15 Years |
93.0 |
88.6 to 95.8 |
216 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2015 |
Age |
13-15 Years |
94.6 |
89.8 to 97.2 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2015 |
Age |
13-15 Years |
88.2 |
82.2 to 92.3 |
228 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-15 Years |
84.9 |
78.6 to 89.6 |
255 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2015 |
Age |
13-15 Years |
87.8 |
80.2 to 92.8 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2015 |
Age |
13-15 Years |
87.2 |
80.1 to 92.0 |
240 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2015 |
Age |
13-15 Years |
78.6 |
71.9 to 84.0 |
242 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2015 |
Age |
13-15 Years |
76.1 |
68.8 to 82.1 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2015 |
Age |
13-15 Years |
85.8 |
78.9 to 90.7 |
217 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2015 |
Age |
13-15 Years |
88.5 |
84.0 to 91.8 |
501 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-15 Years |
85.9 |
78.6 to 91.0 |
185 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-15 Years |
89.1 |
83.6 to 92.8 |
316 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2015 |
Age |
13-15 Years |
89.1 |
82.5 to 93.4 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2015 |
Age |
13-15 Years |
87.3 |
80.7 to 91.9 |
252 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2015 |
Age |
13-15 Years |
86.5 |
79.6 to 91.3 |
227 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2015 |
Age |
13-15 Years |
83.2 |
76.2 to 88.5 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2015 |
Age |
13-15 Years |
91.0 |
85.1 to 94.7 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2015 |
Age |
13-15 Years |
85.1 |
78.3 to 90.0 |
224 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2015 |
Age |
13-15 Years |
88.5 |
81.7 to 93.0 |
257 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-15 Years |
95.9 |
91.4 to 98.1 |
203 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2015 |
Age |
13-15 Years |
69.7 |
61.9 to 76.6 |
245 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2015 |
Age |
13-15 Years |
90.7 |
85.0 to 94.3 |
236 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2015 |
Age |
13-15 Years |
85.9 |
79.7 to 90.5 |
234 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2015 |
Age |
13-15 Years |
80.6 |
72.6 to 86.7 |
199 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2015 |
Age |
13-15 Years |
91.3 |
85.8 to 94.7 |
243 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2015 |
Age |
13-15 Years |
85.8 |
79.3 to 90.5 |
247 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2015 |
Age |
13-15 Years |
89.7 |
82.9 to 94.0 |
243 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-15 Years |
92.3 |
85.2 to 96.2 |
171 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2015 |
Age |
13-15 Years |
84.6 |
77.4 to 89.8 |
211 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2015 |
Age |
13-15 Years |
89.6 |
84.4 to 93.2 |
247 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2015 |
Age |
13-15 Years |
89.7 |
85.2 to 93.0 |
390 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-15 Years |
90.9 |
85.0 to 94.6 |
181 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-15 Years |
89.0 |
82.2 to 93.4 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2015 |
Age |
13-15 Years |
94.1 |
89.3 to 96.8 |
231 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2015 |
Age |
13-15 Years |
88.0 |
79.7 to 93.2 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2015 |
Age |
13-15 Years |
87.2 |
78.9 to 92.6 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-15 Years |
85.8 |
78.7 to 90.8 |
177 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2015 |
Age |
13-15 Years |
89.9 |
84.2 to 93.7 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-15 Years |
92.3 |
88.6 to 94.9 |
492 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-15 Years |
86.4 |
79.2 to 91.3 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-15 Years |
93.0 |
88.8 to 95.7 |
292 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-15 Years |
83.4 |
75.8 to 89.0 |
207 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2015 |
Age |
13-15 Years |
87.1 |
85.9 to 88.2 |
13488 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-15 Years |
94.3 |
92.2 to 95.9 |
1303 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-15 Years |
88.0 |
84.3 to 90.9 |
601 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-15 Years |
88.4 |
85.1 to 91.0 |
1683 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-15 Years |
87.7 |
85.2 to 89.9 |
1746 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-15 Years |
84.9 |
82.2 to 87.2 |
1605 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-15 Years |
86.9 |
84.5 to 89.1 |
2530 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-15 Years |
84.1 |
80.2 to 87.3 |
925 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-15 Years |
86.8 |
83.6 to 89.4 |
1273 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-15 Years |
86.4 |
80.8 to 90.6 |
937 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-15 Years |
96.4 |
93.2 to 98.1 |
254 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2015 |
Age |
13-15 Years |
84.3 |
77.7 to 89.2 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2015 |
Age |
13-15 Years |
73.1 |
65.4 to 79.7 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2015 |
Age |
13-15 Years |
81.9 |
74.9 to 87.3 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2015 |
Age |
13-15 Years |
85.9 |
82.4 to 88.7 |
1652 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-15 Years |
85.6 |
79.3 to 90.2 |
245 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-15 Years |
82.9 |
74.8 to 88.7 |
168 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-15 Years |
86.7 |
81.4 to 90.7 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-15 Years |
86.2 |
81.9 to 89.6 |
599 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-15 Years |
80.3 |
75.0 to 84.8 |
305 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-15 Years |
87.2 |
83.8 to 90.0 |
885 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2015 |
Age |
13-15 Years |
79.3 |
71.2 to 85.6 |
212 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2015 |
Age |
13-15 Years |
95.1 |
90.6 to 97.5 |
246 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2015 |
Age |
13-15 Years |
83.2 |
73.2 to 89.9 |
241 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2015 |
Age |
13-15 Years |
88.5 |
82.3 to 92.7 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2015 |
Age |
13-15 Years |
85.9 |
80.1 to 90.2 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-15 Years |
88.5 |
82.6 to 92.7 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2015 |
Age |
13-15 Years |
88.7 |
82.4 to 93.0 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2016 |
Age |
13-15 Years |
94.5 |
90.5 to 96.9 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2016 |
Age |
13-15 Years |
73.3 |
65.6 to 79.8 |
231 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2016 |
Age |
13-15 Years |
84.8 |
77.5 to 90.0 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2016 |
Age |
13-15 Years |
91.1 |
86.3 to 94.4 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2016 |
Age |
13-15 Years |
82.8 |
74.6 to 88.8 |
203 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2016 |
Age |
13-15 Years |
86.8 |
78.9 to 92.0 |
199 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2016 |
Age |
13-15 Years |
94.9 |
88.6 to 97.8 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2016 |
Age |
13-15 Years |
87.6 |
81.5 to 91.9 |
220 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-15 Years |
83.9 |
77.2 to 89.0 |
242 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2016 |
Age |
13-15 Years |
87.7 |
79.0 to 93.1 |
224 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2016 |
Age |
13-15 Years |
92.2 |
86.0 to 95.7 |
263 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2016 |
Age |
13-15 Years |
77.7 |
71.8 to 82.7 |
323 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2016 |
Age |
13-15 Years |
80.8 |
73.5 to 86.5 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2016 |
Age |
13-15 Years |
88.9 |
82.9 to 92.9 |
230 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2016 |
Age |
13-15 Years |
90.8 |
86.4 to 93.8 |
362 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-15 Years |
85.2 |
74.2 to 92.1 |
104 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-15 Years |
92.1 |
87.1 to 95.3 |
258 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2016 |
Age |
13-15 Years |
89.3 |
83.0 to 93.5 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2016 |
Age |
13-15 Years |
90.1 |
84.8 to 93.6 |
230 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2016 |
Age |
13-15 Years |
84.5 |
77.4 to 89.7 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2016 |
Age |
13-15 Years |
91.2 |
86.2 to 94.5 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2016 |
Age |
13-15 Years |
97.2 |
94.3 to 98.6 |
212 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2016 |
Age |
13-15 Years |
86.1 |
80.3 to 90.4 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2016 |
Age |
13-15 Years |
87.7 |
81.4 to 92.1 |
305 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-15 Years |
96.5 |
93.6 to 98.1 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2016 |
Age |
13-15 Years |
93.7 |
87.2 to 97.0 |
162 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2016 |
Age |
13-15 Years |
91.0 |
85.1 to 94.8 |
227 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2016 |
Age |
13-15 Years |
92.4 |
86.7 to 95.8 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2016 |
Age |
13-15 Years |
81.3 |
74.3 to 86.8 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2016 |
Age |
13-15 Years |
82.4 |
74.6 to 88.2 |
235 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2016 |
Age |
13-15 Years |
89.1 |
82.8 to 93.3 |
199 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2016 |
Age |
13-15 Years |
87.3 |
80.8 to 91.8 |
217 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-15 Years |
93.4 |
87.1 to 96.8 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2016 |
Age |
13-15 Years |
89.1 |
82.6 to 93.4 |
254 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2016 |
Age |
13-15 Years |
84.3 |
77.6 to 89.2 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2016 |
Age |
13-15 Years |
91.9 |
88.0 to 94.6 |
399 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-15 Years |
93.2 |
88.8 to 95.9 |
173 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-15 Years |
91.2 |
85.3 to 94.9 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2016 |
Age |
13-15 Years |
87.0 |
80.2 to 91.7 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2016 |
Age |
13-15 Years |
91.5 |
85.9 to 95.1 |
180 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2016 |
Age |
13-15 Years |
87.8 |
80.2 to 92.7 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-15 Years |
91.1 |
85.4 to 94.7 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2016 |
Age |
13-15 Years |
87.5 |
80.7 to 92.2 |
203 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-15 Years |
90.7 |
86.2 to 93.8 |
515 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-15 Years |
87.7 |
81.2 to 92.2 |
203 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-15 Years |
91.1 |
85.9 to 94.5 |
312 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-15 Years |
92.3 |
87.2 to 95.5 |
230 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2016 |
Age |
13-15 Years |
88.0 |
86.7 to 89.2 |
12578 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-15 Years |
94.7 |
92.9 to 96.1 |
1227 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-15 Years |
91.0 |
87.8 to 93.4 |
653 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-15 Years |
88.7 |
85.7 to 91.1 |
1768 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-15 Years |
89.3 |
86.6 to 91.5 |
1670 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-15 Years |
90.3 |
88.0 to 92.3 |
1374 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-15 Years |
87.1 |
84.4 to 89.3 |
2031 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-15 Years |
84.9 |
81.3 to 87.9 |
876 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-15 Years |
86.4 |
82.6 to 89.4 |
1263 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-15 Years |
83.3 |
76.9 to 88.2 |
816 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-15 Years |
95.3 |
91.4 to 97.5 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2016 |
Age |
13-15 Years |
81.3 |
72.4 to 87.8 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2016 |
Age |
13-15 Years |
77.4 |
69.0 to 84.1 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2016 |
Age |
13-15 Years |
90.2 |
83.1 to 94.5 |
166 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2016 |
Age |
13-15 Years |
84.8 |
81.1 to 87.9 |
1193 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-15 Years |
84.9 |
78.1 to 89.8 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-15 Years |
89.9 |
80.1 to 95.2 |
136 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-15 Years |
85.0 |
77.4 to 90.4 |
176 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-15 Years |
81.9 |
72.8 to 88.5 |
216 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-15 Years |
84.4 |
79.5 to 88.4 |
460 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-15 Years |
74.1 |
67.0 to 80.2 |
271 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-15 Years |
85.6 |
81.5 to 88.9 |
900 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2016 |
Age |
13-15 Years |
87.6 |
81.0 to 92.1 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2016 |
Age |
13-15 Years |
93.7 |
88.2 to 96.7 |
212 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2016 |
Age |
13-15 Years |
86.7 |
78.5 to 92.1 |
289 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2016 |
Age |
13-15 Years |
84.8 |
77.8 to 90.0 |
236 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2016 |
Age |
13-15 Years |
89.2 |
83.2 to 93.2 |
197 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-15 Years |
89.9 |
83.4 to 94.1 |
199 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2016 |
Age |
13-15 Years |
87.2 |
80.9 to 91.6 |
244 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2017 |
Age |
13-15 Years |
89.6 |
84.2 to 93.3 |
238 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2017 |
Age |
13-15 Years |
71.5 |
63.3 to 78.4 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2017 |
Age |
13-15 Years |
81.3 |
72.7 to 87.7 |
193 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2017 |
Age |
13-15 Years |
93.5 |
88.9 to 96.3 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2017 |
Age |
13-15 Years |
85.9 |
78.5 to 91.1 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2017 |
Age |
13-15 Years |
86.3 |
79.1 to 91.2 |
235 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2017 |
Age |
13-15 Years |
94.0 |
89.5 to 96.6 |
193 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2017 |
Age |
13-15 Years |
89.5 |
82.5 to 94.0 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-15 Years |
83.1 |
74.8 to 89.1 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2017 |
Age |
13-15 Years |
90.4 |
84.8 to 94.0 |
248 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2017 |
Age |
13-15 Years |
94.4 |
88.6 to 97.3 |
224 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2017 |
Age |
13-15 Years |
73.0 |
65.1 to 79.7 |
231 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2017 |
Age |
13-15 Years |
84.2 |
76.7 to 89.6 |
189 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2017 |
Age |
13-15 Years |
90.0 |
83.9 to 94.0 |
214 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2017 |
Age |
13-15 Years |
91.1 |
86.6 to 94.3 |
403 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-15 Years |
93.9 |
87.4 to 97.1 |
120 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-15 Years |
90.6 |
85.1 to 94.2 |
283 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2017 |
Age |
13-15 Years |
94.0 |
89.9 to 96.6 |
208 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2017 |
Age |
13-15 Years |
92.8 |
87.9 to 95.8 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2017 |
Age |
13-15 Years |
89.5 |
83.3 to 93.6 |
229 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2017 |
Age |
13-15 Years |
87.7 |
81.9 to 91.8 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2017 |
Age |
13-15 Years |
91.5 |
86.4 to 94.7 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2017 |
Age |
13-15 Years |
86.2 |
79.3 to 91.0 |
217 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2017 |
Age |
13-15 Years |
91.1 |
83.8 to 95.3 |
311 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-15 Years |
96.4 |
92.3 to 98.4 |
262 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2017 |
Age |
13-15 Years |
90.7 |
83.6 to 94.9 |
183 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2017 |
Age |
13-15 Years |
88.5 |
81.7 to 93.0 |
225 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2017 |
Age |
13-15 Years |
93.2 |
88.3 to 96.2 |
208 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2017 |
Age |
13-15 Years |
76.1 |
67.8 to 82.8 |
208 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2017 |
Age |
13-15 Years |
88.1 |
81.7 to 92.5 |
202 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2017 |
Age |
13-15 Years |
89.2 |
81.5 to 94.0 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2017 |
Age |
13-15 Years |
83.9 |
76.7 to 89.2 |
235 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-15 Years |
92.5 |
87.3 to 95.7 |
211 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2017 |
Age |
13-15 Years |
87.0 |
79.5 to 92.0 |
217 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2017 |
Age |
13-15 Years |
84.4 |
77.2 to 89.7 |
220 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2017 |
Age |
13-15 Years |
93.1 |
89.7 to 95.4 |
414 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-15 Years |
91.9 |
87.0 to 95.1 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-15 Years |
93.8 |
88.6 to 96.7 |
224 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2017 |
Age |
13-15 Years |
93.9 |
89.4 to 96.5 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2017 |
Age |
13-15 Years |
89.3 |
83.6 to 93.2 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2017 |
Age |
13-15 Years |
90.8 |
85.6 to 94.2 |
247 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-15 Years |
82.3 |
75.2 to 87.7 |
212 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2017 |
Age |
13-15 Years |
87.8 |
82.0 to 91.9 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-15 Years |
90.9 |
85.7 to 94.3 |
520 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-15 Years |
90.5 |
84.9 to 94.2 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-15 Years |
90.9 |
84.9 to 94.7 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2017 |
Age |
13-15 Years |
88.6 |
87.4 to 89.6 |
12924 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-15 Years |
94.3 |
92.4 to 95.8 |
1302 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-15 Years |
91.2 |
88.0 to 93.6 |
631 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-15 Years |
90.3 |
87.1 to 92.7 |
1721 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-15 Years |
91.2 |
89.2 to 92.8 |
1787 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-15 Years |
90.7 |
88.6 to 92.4 |
1462 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-15 Years |
83.9 |
81.1 to 86.3 |
2247 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-15 Years |
84.8 |
80.9 to 88.0 |
833 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-15 Years |
87.5 |
84.1 to 90.3 |
1310 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-15 Years |
85.2 |
79.5 to 89.5 |
811 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-15 Years |
94.8 |
90.2 to 97.3 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2017 |
Age |
13-15 Years |
90.5 |
84.3 to 94.4 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2017 |
Age |
13-15 Years |
80.1 |
72.3 to 86.1 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2017 |
Age |
13-15 Years |
86.0 |
78.8 to 91.1 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2017 |
Age |
13-15 Years |
82.0 |
78.1 to 85.3 |
1406 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-15 Years |
82.5 |
74.7 to 88.3 |
211 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-15 Years |
92.9 |
85.1 to 96.8 |
104 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-15 Years |
82.8 |
74.4 to 88.8 |
169 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-15 Years |
90.0 |
83.5 to 94.2 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-15 Years |
86.8 |
80.2 to 91.4 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-15 Years |
80.3 |
75.0 to 84.7 |
527 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-15 Years |
86.9 |
83.2 to 89.9 |
820 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2017 |
Age |
13-15 Years |
90.9 |
85.7 to 94.3 |
229 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2017 |
Age |
13-15 Years |
92.8 |
88.2 to 95.7 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2017 |
Age |
13-15 Years |
90.1 |
81.2 to 95.1 |
259 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2017 |
Age |
13-15 Years |
87.2 |
80.4 to 91.8 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2017 |
Age |
13-15 Years |
85.4 |
78.8 to 90.2 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-15 Years |
87.4 |
80.8 to 92.0 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2017 |
Age |
13-15 Years |
84.8 |
77.8 to 89.8 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018 |
Age |
13-15 Years |
87.1 |
79.3 to 92.3 |
197 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018 |
Age |
13-15 Years |
75.9 |
68.7 to 81.8 |
243 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018 |
Age |
13-15 Years |
82.6 |
75.1 to 88.2 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018 |
Age |
13-15 Years |
88.1 |
81.0 to 92.8 |
181 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018 |
Age |
13-15 Years |
88.5 |
80.4 to 93.5 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018 |
Age |
13-15 Years |
91.1 |
83.5 to 95.4 |
167 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018 |
Age |
13-15 Years |
94.8 |
89.2 to 97.6 |
184 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018 |
Age |
13-15 Years |
90.5 |
84.4 to 94.3 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-15 Years |
89.1 |
80.3 to 94.2 |
181 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018 |
Age |
13-15 Years |
89.2 |
83.0 to 93.3 |
208 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018 |
Age |
13-15 Years |
92.7 |
87.6 to 95.7 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2018 |
Age |
13-15 Years |
68.8 |
60.0 to 76.5 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018 |
Age |
13-15 Years |
84.3 |
77.3 to 89.4 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018 |
Age |
13-15 Years |
86.3 |
78.9 to 91.4 |
169 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018 |
Age |
13-15 Years |
92.7 |
89.1 to 95.1 |
452 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-15 Years |
93.0 |
82.6 to 97.4 |
118 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-15 Years |
92.6 |
88.5 to 95.3 |
334 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018 |
Age |
13-15 Years |
89.1 |
83.1 to 93.1 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018 |
Age |
13-15 Years |
94.6 |
89.5 to 97.3 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018 |
Age |
13-15 Years |
88.3 |
81.1 to 93.0 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018 |
Age |
13-15 Years |
86.0 |
77.6 to 91.6 |
150 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018 |
Age |
13-15 Years |
87.5 |
78.8 to 92.9 |
153 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018 |
Age |
13-15 Years |
85.8 |
78.0 to 91.1 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018 |
Age |
13-15 Years |
93.2 |
88.2 to 96.2 |
252 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-15 Years |
91.1 |
84.3 to 95.1 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018 |
Age |
13-15 Years |
95.8 |
90.2 to 98.3 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018 |
Age |
13-15 Years |
90.3 |
82.6 to 94.8 |
168 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018 |
Age |
13-15 Years |
88.3 |
80.6 to 93.2 |
165 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018 |
Age |
13-15 Years |
78.1 |
69.1 to 85.0 |
184 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018 |
Age |
13-15 Years |
85.5 |
77.7 to 90.9 |
176 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018 |
Age |
13-15 Years |
91.6 |
85.4 to 95.3 |
181 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018 |
Age |
13-15 Years |
85.0 |
78.1 to 90.0 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-15 Years |
97.4 |
92.9 to 99.1 |
182 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018 |
Age |
13-15 Years |
87.8 |
81.2 to 92.4 |
203 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018 |
Age |
13-15 Years |
86.5 |
79.4 to 91.4 |
177 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018 |
Age |
13-15 Years |
89.2 |
84.7 to 92.6 |
314 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-15 Years |
86.7 |
79.8 to 91.5 |
162 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-15 Years |
90.9 |
84.1 to 95.0 |
152 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018 |
Age |
13-15 Years |
88.9 |
82.3 to 93.3 |
224 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018 |
Age |
13-15 Years |
89.6 |
82.7 to 93.9 |
173 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018 |
Age |
13-15 Years |
90.8 |
85.1 to 94.4 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-15 Years |
83.0 |
75.0 to 88.9 |
199 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018 |
Age |
13-15 Years |
84.6 |
76.4 to 90.3 |
171 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-15 Years |
87.0 |
79.6 to 92.0 |
392 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-15 Years |
89.7 |
82.0 to 94.3 |
152 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-15 Years |
86.6 |
78.2 to 92.1 |
240 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018 |
Age |
13-15 Years |
88.2 |
87.0 to 89.3 |
11468 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-15 Years |
92.6 |
89.5 to 94.9 |
1140 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-15 Years |
88.8 |
85.2 to 91.6 |
517 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-15 Years |
89.5 |
85.7 to 92.4 |
1439 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-15 Years |
89.4 |
87.1 to 91.3 |
1562 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-15 Years |
91.3 |
89.3 to 92.9 |
1417 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-15 Years |
83.3 |
80.4 to 85.8 |
2025 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-15 Years |
85.9 |
81.6 to 89.3 |
726 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-15 Years |
89.8 |
86.2 to 92.5 |
1058 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-15 Years |
87.4 |
81.4 to 91.6 |
809 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-15 Years |
95.5 |
90.5 to 98.0 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018 |
Age |
13-15 Years |
86.6 |
79.7 to 91.4 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018 |
Age |
13-15 Years |
87.5 |
81.0 to 92.1 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018 |
Age |
13-15 Years |
90.8 |
84.6 to 94.7 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018 |
Age |
13-15 Years |
82.1 |
78.3 to 85.4 |
1315 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-15 Years |
86.6 |
79.2 to 91.6 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-15 Years |
83.0 |
72.1 to 90.3 |
114 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-15 Years |
80.4 |
70.3 to 87.7 |
190 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-15 Years |
86.7 |
80.2 to 91.3 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-15 Years |
81.2 |
76.2 to 85.4 |
587 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-15 Years |
82.2 |
76.9 to 86.5 |
775 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018 |
Age |
13-15 Years |
89.7 |
82.9 to 93.9 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018 |
Age |
13-15 Years |
93.7 |
88.7 to 96.6 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018 |
Age |
13-15 Years |
91.1 |
81.6 to 95.9 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018 |
Age |
13-15 Years |
80.6 |
71.5 to 87.4 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018 |
Age |
13-15 Years |
86.2 |
78.8 to 91.3 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-15 Years |
85.5 |
78.6 to 90.4 |
214 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018 |
Age |
13-15 Years |
87.5 |
80.3 to 92.3 |
143 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2019 |
Age |
13-15 Years |
91.6 |
85.8 to 95.1 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2019 |
Age |
13-15 Years |
76.3 |
69.2 to 82.2 |
262 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2019 |
Age |
13-15 Years |
88.6 |
82.9 to 92.6 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2019 |
Age |
13-15 Years |
90.8 |
84.4 to 94.7 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2019 |
Age |
13-15 Years |
91.5 |
83.4 to 95.8 |
170 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2019 |
Age |
13-15 Years |
92.0 |
84.7 to 96.0 |
170 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2019 |
Age |
13-15 Years |
96.6 |
91.5 to 98.7 |
165 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2019 |
Age |
13-15 Years |
88.5 |
81.5 to 93.1 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-15 Years |
83.2 |
73.3 to 90.0 |
171 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2019 |
Age |
13-15 Years |
96.5 |
92.7 to 98.3 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2019 |
Age |
13-15 Years |
91.5 |
84.9 to 95.4 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2019 |
Age |
13-15 Years |
78.5 |
70.4 to 84.9 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2019 |
Age |
13-15 Years |
80.3 |
71.4 to 87.0 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2019 |
Age |
13-15 Years |
87.2 |
80.6 to 91.9 |
217 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2019 |
Age |
13-15 Years |
91.9 |
87.3 to 95.0 |
382 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-15 Years |
94.9 |
87.6 to 98.0 |
100 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-15 Years |
91.4 |
85.9 to 94.8 |
282 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2019 |
Age |
13-15 Years |
90.9 |
83.9 to 95.1 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2019 |
Age |
13-15 Years |
93.5 |
89.1 to 96.3 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2019 |
Age |
13-15 Years |
92.9 |
88.3 to 95.7 |
238 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2019 |
Age |
13-15 Years |
91.1 |
85.2 to 94.8 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2019 |
Age |
13-15 Years |
93.9 |
88.0 to 97.0 |
220 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2019 |
Age |
13-15 Years |
91.3 |
85.8 to 94.8 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2019 |
Age |
13-15 Years |
90.4 |
84.2 to 94.3 |
335 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-15 Years |
93.7 |
86.3 to 97.2 |
177 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2019 |
Age |
13-15 Years |
88.6 |
80.9 to 93.5 |
178 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2019 |
Age |
13-15 Years |
90.5 |
80.5 to 95.6 |
165 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2019 |
Age |
13-15 Years |
89.3 |
80.8 to 94.3 |
160 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2019 |
Age |
13-15 Years |
81.8 |
73.9 to 87.7 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2019 |
Age |
13-15 Years |
90.4 |
83.9 to 94.5 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2019 |
Age |
13-15 Years |
90.4 |
81.8 to 95.2 |
181 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2019 |
Age |
13-15 Years |
88.1 |
80.6 to 92.9 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-15 Years |
92.3 |
85.1 to 96.2 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2019 |
Age |
13-15 Years |
87.7 |
80.1 to 92.7 |
219 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2019 |
Age |
13-15 Years |
86.3 |
80.3 to 90.7 |
257 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2019 |
Age |
13-15 Years |
93.2 |
89.6 to 95.7 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-15 Years |
90.3 |
83.2 to 94.6 |
163 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-15 Years |
95.4 |
91.1 to 97.7 |
154 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2019 |
Age |
13-15 Years |
92.2 |
84.6 to 96.2 |
185 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2019 |
Age |
13-15 Years |
96.7 |
93.3 to 98.4 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2019 |
Age |
13-15 Years |
94.8 |
89.7 to 97.5 |
166 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-15 Years |
87.1 |
81.2 to 91.4 |
214 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2019 |
Age |
13-15 Years |
89.3 |
81.2 to 94.2 |
177 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-15 Years |
92.8 |
88.3 to 95.7 |
436 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-15 Years |
94.6 |
89.9 to 97.1 |
143 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-15 Years |
92.6 |
87.3 to 95.8 |
293 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-15 Years |
87.3 |
72.3 to 94.8 |
124 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2019 |
Age |
13-15 Years |
90.8 |
89.7 to 91.8 |
11687 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-15 Years |
94.3 |
91.0 to 96.4 |
1209 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-15 Years |
91.3 |
87.9 to 93.8 |
536 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-15 Years |
91.6 |
88.8 to 93.7 |
1589 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-15 Years |
93.0 |
91.0 to 94.5 |
1501 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-15 Years |
91.5 |
89.2 to 93.3 |
1271 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-15 Years |
87.0 |
84.4 to 89.2 |
2058 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-15 Years |
88.0 |
84.3 to 90.8 |
799 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-15 Years |
90.3 |
86.5 to 93.2 |
1129 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-15 Years |
90.6 |
84.9 to 94.3 |
741 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-15 Years |
96.9 |
93.4 to 98.6 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2019 |
Age |
13-15 Years |
91.9 |
86.4 to 95.3 |
195 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2019 |
Age |
13-15 Years |
88.9 |
82.1 to 93.3 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2019 |
Age |
13-15 Years |
91.5 |
83.9 to 95.6 |
163 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2019 |
Age |
13-15 Years |
85.7 |
82.0 to 88.7 |
1157 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-15 Years |
84.9 |
76.7 to 90.5 |
181 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-15 Years |
93.4 |
85.8 to 97.1 |
120 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-15 Years |
87.0 |
80.2 to 91.7 |
178 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-15 Years |
87.6 |
80.3 to 92.4 |
178 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-15 Years |
84.7 |
79.8 to 88.6 |
500 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-15 Years |
75.4 |
64.4 to 83.8 |
124 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-15 Years |
89.2 |
85.8 to 92.0 |
854 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2019 |
Age |
13-15 Years |
86.7 |
78.1 to 92.3 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2019 |
Age |
13-15 Years |
92.4 |
86.7 to 95.8 |
291 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2019 |
Age |
13-15 Years |
92.2 |
84.7 to 96.2 |
247 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2019 |
Age |
13-15 Years |
91.1 |
85.5 to 94.6 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2019 |
Age |
13-15 Years |
87.6 |
80.6 to 92.3 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-15 Years |
90.4 |
83.8 to 94.5 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2019 |
Age |
13-15 Years |
93.6 |
88.1 to 96.6 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2020 |
Age |
13-15 Years |
92.9 |
87.4 to 96.1 |
184 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2020 |
Age |
13-15 Years |
84.3 |
77.0 to 89.6 |
181 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2020 |
Age |
13-15 Years |
87.7 |
81.9 to 91.9 |
203 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2020 |
Age |
13-15 Years |
94.8 |
88.9 to 97.6 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2020 |
Age |
13-15 Years |
88.9 |
82.0 to 93.4 |
272 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2020 |
Age |
13-15 Years |
88.6 |
80.7 to 93.6 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2020 |
Age |
13-15 Years |
93.2 |
86.6 to 96.7 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2020 |
Age |
13-15 Years |
81.1 |
72.6 to 87.5 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-15 Years |
87.6 |
80.4 to 92.5 |
245 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2020 |
Age |
13-15 Years |
85.7 |
77.0 to 91.6 |
225 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2020 |
Age |
13-15 Years |
91.4 |
84.4 to 95.4 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2020 |
Age |
13-15 Years |
76.5 |
68.1 to 83.1 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2020 |
Age |
13-15 Years |
82.0 |
73.8 to 88.0 |
171 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2020 |
Age |
13-15 Years |
86.6 |
79.8 to 91.4 |
253 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2020 |
Age |
13-15 Years |
90.8 |
86.2 to 94.0 |
420 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-15 Years |
87.9 |
78.9 to 93.5 |
171 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-15 Years |
91.4 |
85.9 to 94.9 |
249 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2020 |
Age |
13-15 Years |
93.0 |
87.4 to 96.2 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2020 |
Age |
13-15 Years |
90.0 |
84.2 to 93.9 |
166 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2020 |
Age |
13-15 Years |
87.5 |
80.8 to 92.2 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2020 |
Age |
13-15 Years |
93.2 |
87.7 to 96.3 |
164 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2020 |
Age |
13-15 Years |
92.5 |
86.8 to 95.8 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2020 |
Age |
13-15 Years |
94.0 |
88.7 to 96.9 |
225 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2020 |
Age |
13-15 Years |
89.4 |
85.1 to 92.6 |
533 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-15 Years |
93.1 |
87.0 to 96.4 |
246 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2020 |
Age |
13-15 Years |
93.2 |
87.3 to 96.4 |
230 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2020 |
Age |
13-15 Years |
93.7 |
88.5 to 96.6 |
213 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2020 |
Age |
13-15 Years |
90.4 |
84.3 to 94.3 |
177 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2020 |
Age |
13-15 Years |
80.2 |
72.3 to 86.3 |
258 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2020 |
Age |
13-15 Years |
83.9 |
74.7 to 90.2 |
182 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2020 |
Age |
13-15 Years |
94.5 |
89.7 to 97.1 |
238 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2020 |
Age |
13-15 Years |
84.1 |
75.9 to 89.9 |
216 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-15 Years |
94.1 |
89.2 to 96.8 |
219 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2020 |
Age |
13-15 Years |
92.3 |
85.4 to 96.1 |
248 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2020 |
Age |
13-15 Years |
89.2 |
83.2 to 93.3 |
197 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2020 |
Age |
13-15 Years |
92.3 |
88.4 to 95.0 |
444 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-15 Years |
90.6 |
85.0 to 94.3 |
233 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-15 Years |
93.4 |
87.4 to 96.7 |
211 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2020 |
Age |
13-15 Years |
95.4 |
90.6 to 97.8 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2020 |
Age |
13-15 Years |
87.5 |
80.0 to 92.5 |
256 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2020 |
Age |
13-15 Years |
93.8 |
88.9 to 96.6 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-15 Years |
82.7 |
75.7 to 88.0 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2020 |
Age |
13-15 Years |
86.2 |
78.8 to 91.3 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-15 Years |
93.5 |
89.1 to 96.2 |
468 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-15 Years |
87.8 |
79.9 to 92.9 |
164 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-15 Years |
94.3 |
89.1 to 97.1 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-15 Years |
73.5 |
58.7 to 84.4 |
94 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2020 |
Age |
13-15 Years |
89.7 |
88.5 to 90.7 |
12447 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-15 Years |
93.4 |
90.5 to 95.5 |
1297 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-15 Years |
92.3 |
89.1 to 94.6 |
692 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-15 Years |
90.9 |
88.3 to 92.9 |
2067 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-15 Years |
89.8 |
86.9 to 92.1 |
1570 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-15 Years |
92.5 |
90.6 to 94.1 |
1415 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-15 Years |
86.3 |
82.6 to 89.3 |
1541 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-15 Years |
85.9 |
82.1 to 89.1 |
894 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-15 Years |
89.7 |
86.2 to 92.4 |
1211 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-15 Years |
88.3 |
83.1 to 92.1 |
862 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-15 Years |
94.1 |
87.9 to 97.2 |
160 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2020 |
Age |
13-15 Years |
90.6 |
83.0 to 95.0 |
211 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2020 |
Age |
13-15 Years |
92.5 |
86.8 to 95.9 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2020 |
Age |
13-15 Years |
85.4 |
78.4 to 90.5 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2020 |
Age |
13-15 Years |
84.8 |
79.5 to 89.0 |
715 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-15 Years |
85.3 |
77.8 to 90.5 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-15 Years |
88.9 |
80.8 to 93.9 |
143 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-15 Years |
84.5 |
78.4 to 89.1 |
386 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-15 Years |
88.1 |
84.2 to 91.1 |
898 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2020 |
Age |
13-15 Years |
92.6 |
87.6 to 95.6 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2020 |
Age |
13-15 Years |
96.0 |
92.4 to 97.9 |
247 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2020 |
Age |
13-15 Years |
89.1 |
82.3 to 93.5 |
418 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2020 |
Age |
13-15 Years |
89.7 |
83.1 to 93.9 |
276 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2020 |
Age |
13-15 Years |
91.5 |
85.2 to 95.3 |
181 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-15 Years |
90.9 |
83.9 to 95.0 |
168 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2020 |
Age |
13-15 Years |
87.0 |
78.5 to 92.5 |
184 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2021 |
Age |
13-15 Years |
91.7 |
84.4 to 95.8 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2021 |
Age |
13-15 Years |
76.5 |
68.0 to 83.3 |
170 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2021 |
Age |
13-15 Years |
88.8 |
82.7 to 92.9 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2021 |
Age |
13-15 Years |
92.9 |
86.6 to 96.4 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2021 |
Age |
13-15 Years |
92.2 |
85.1 to 96.1 |
182 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2021 |
Age |
13-15 Years |
87.4 |
79.5 to 92.5 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2021 |
Age |
13-15 Years |
92.6 |
85.8 to 96.3 |
212 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2021 |
Age |
13-15 Years |
86.6 |
79.6 to 91.4 |
194 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-15 Years |
88.6 |
82.3 to 92.8 |
261 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2021 |
Age |
13-15 Years |
91.5 |
84.0 to 95.6 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2021 |
Age |
13-15 Years |
91.2 |
82.5 to 95.8 |
161 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2021 |
Age |
13-15 Years |
68.9 |
57.8 to 78.2 |
130 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2021 |
Age |
13-15 Years |
89.6 |
83.3 to 93.8 |
145 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2021 |
Age |
13-15 Years |
92.6 |
86.7 to 96.0 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2021 |
Age |
13-15 Years |
90.1 |
85.4 to 93.4 |
355 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-15 Years |
88.8 |
75.6 to 95.3 |
94 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-15 Years |
90.5 |
85.2 to 94.0 |
261 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2021 |
Age |
13-15 Years |
85.8 |
77.9 to 91.3 |
163 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2021 |
Age |
13-15 Years |
93.7 |
86.7 to 97.1 |
127 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2021 |
Age |
13-15 Years |
88.8 |
81.7 to 93.4 |
180 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2021 |
Age |
13-15 Years |
84.3 |
74.7 to 90.7 |
144 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2021 |
Age |
13-15 Years |
94.2 |
88.8 to 97.1 |
193 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2021 |
Age |
13-15 Years |
88.6 |
81.2 to 93.3 |
183 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2021 |
Age |
13-15 Years |
89.7 |
85.9 to 92.6 |
572 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-15 Years |
93.9 |
83.4 to 98.0 |
163 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2021 |
Age |
13-15 Years |
84.7 |
76.2 to 90.6 |
225 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2021 |
Age |
13-15 Years |
89.2 |
81.7 to 93.8 |
182 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2021 |
Age |
13-15 Years |
90.8 |
84.2 to 94.8 |
189 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2021 |
Age |
13-15 Years |
87.1 |
80.0 to 92.0 |
212 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2021 |
Age |
13-15 Years |
88.5 |
81.2 to 93.2 |
176 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2021 |
Age |
13-15 Years |
91.2 |
85.3 to 94.9 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2021 |
Age |
13-15 Years |
91.2 |
84.1 to 95.3 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-15 Years |
95.6 |
89.4 to 98.2 |
178 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2021 |
Age |
13-15 Years |
89.2 |
81.3 to 94.0 |
183 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2021 |
Age |
13-15 Years |
89.2 |
82.1 to 93.7 |
201 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2021 |
Age |
13-15 Years |
85.0 |
79.7 to 89.1 |
344 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-15 Years |
81.6 |
73.6 to 87.6 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-15 Years |
87.2 |
79.6 to 92.3 |
165 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2021 |
Age |
13-15 Years |
96.2 |
92.2 to 98.1 |
167 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2021 |
Age |
13-15 Years |
92.4 |
84.1 to 96.6 |
104 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2021 |
Age |
13-15 Years |
86.9 |
77.0 to 93.0 |
156 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-15 Years |
82.6 |
73.8 to 88.8 |
151 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2021 |
Age |
13-15 Years |
85.4 |
77.5 to 90.8 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-15 Years |
90.8 |
87.0 to 93.6 |
561 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-15 Years |
87.2 |
79.3 to 92.4 |
198 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-15 Years |
91.3 |
87.0 to 94.3 |
363 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-15 Years |
83.5 |
76.2 to 88.9 |
205 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2021 |
Age |
13-15 Years |
89.8 |
88.6 to 90.8 |
11161 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-15 Years |
93.1 |
89.2 to 95.7 |
1186 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-15 Years |
86.4 |
82.2 to 89.7 |
527 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-15 Years |
89.8 |
87.2 to 92.0 |
2095 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-15 Years |
91.8 |
89.3 to 93.7 |
1412 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-15 Years |
87.9 |
85.0 to 90.4 |
1256 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-15 Years |
88.2 |
84.4 to 91.1 |
1333 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-15 Years |
89.5 |
85.9 to 92.2 |
715 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-15 Years |
90.1 |
86.3 to 93.0 |
1112 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-15 Years |
91.6 |
86.5 to 94.9 |
727 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-15 Years |
91.9 |
82.3 to 96.5 |
167 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2021 |
Age |
13-15 Years |
91.2 |
84.4 to 95.2 |
174 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2021 |
Age |
13-15 Years |
96.1 |
91.5 to 98.3 |
276 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2021 |
Age |
13-15 Years |
92.2 |
86.2 to 95.8 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2021 |
Age |
13-15 Years |
87.5 |
82.2 to 91.4 |
592 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-15 Years |
84.1 |
76.5 to 89.5 |
174 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-15 Years |
85.7 |
70.7 to 93.7 |
93 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-15 Years |
87.9 |
81.8 to 92.1 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-15 Years |
82.3 |
72.7 to 89.0 |
163 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-15 Years |
89.2 |
85.8 to 91.8 |
798 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2021 |
Age |
13-15 Years |
92.6 |
86.0 to 96.2 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2021 |
Age |
13-15 Years |
94.7 |
90.6 to 97.1 |
283 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2021 |
Age |
13-15 Years |
89.6 |
81.8 to 94.3 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2021 |
Age |
13-15 Years |
91.7 |
86.5 to 95.0 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2021 |
Age |
13-15 Years |
86.2 |
79.0 to 91.2 |
162 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-15 Years |
92.3 |
86.1 to 95.9 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2021 |
Age |
13-15 Years |
90.5 |
83.7 to 94.7 |
169 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2022 |
Age |
13-15 Years |
95.4 |
89.4 to 98.1 |
157 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2022 |
Age |
13-15 Years |
79.5 |
70.1 to 86.5 |
156 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2022 |
Age |
13-15 Years |
83.9 |
75.2 to 90.0 |
159 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2022 |
Age |
13-15 Years |
93.2 |
88.3 to 96.1 |
193 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2022 |
Age |
13-15 Years |
80.7 |
71.1 to 87.6 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2022 |
Age |
13-15 Years |
91.9 |
86.3 to 95.3 |
205 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2022 |
Age |
13-15 Years |
93.1 |
87.5 to 96.3 |
167 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2022 |
Age |
13-15 Years |
88.9 |
80.3 to 94.0 |
145 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-15 Years |
89.9 |
82.8 to 94.3 |
152 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2022 |
Age |
13-15 Years |
95.2 |
91.4 to 97.4 |
183 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2022 |
Age |
13-15 Years |
91.5 |
84.2 to 95.6 |
216 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2022 |
Age |
13-15 Years |
77.8 |
67.7 to 85.4 |
147 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2022 |
Age |
13-15 Years |
88.5 |
81.3 to 93.2 |
137 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2022 |
Age |
13-15 Years |
88.8 |
80.4 to 93.9 |
158 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2022 |
Age |
13-15 Years |
91.6 |
86.3 to 95.0 |
383 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-15 Years |
91.0 |
84.6 to 94.9 |
161 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-15 Years |
91.8 |
84.9 to 95.7 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2022 |
Age |
13-15 Years |
92.6 |
86.0 to 96.2 |
167 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2022 |
Age |
13-15 Years |
95.5 |
85.9 to 98.7 |
131 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2022 |
Age |
13-15 Years |
90.4 |
83.5 to 94.6 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2022 |
Age |
13-15 Years |
88.7 |
79.2 to 94.1 |
159 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2022 |
Age |
13-15 Years |
92.0 |
85.3 to 95.8 |
210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2022 |
Age |
13-15 Years |
96.9 |
93.6 to 98.5 |
163 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2022 |
Age |
13-15 Years |
87.4 |
77.3 to 93.3 |
213 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-15 Years |
93.4 |
87.1 to 96.7 |
151 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2022 |
Age |
13-15 Years |
91.4 |
84.4 to 95.4 |
165 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2022 |
Age |
13-15 Years |
93.2 |
86.9 to 96.6 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2022 |
Age |
13-15 Years |
85.3 |
76.0 to 91.4 |
147 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2022 |
Age |
13-15 Years |
88.3 |
81.4 to 92.9 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2022 |
Age |
13-15 Years |
88.8 |
82.1 to 93.3 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2022 |
Age |
13-15 Years |
88.1 |
80.3 to 93.0 |
156 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2022 |
Age |
13-15 Years |
89.1 |
81.7 to 93.7 |
155 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-15 Years |
90.6 |
83.6 to 94.8 |
134 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2022 |
Age |
13-15 Years |
85.3 |
76.7 to 91.1 |
158 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2022 |
Age |
13-15 Years |
84.8 |
76.6 to 90.5 |
185 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2022 |
Age |
13-15 Years |
86.7 |
81.3 to 90.7 |
320 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-15 Years |
90.2 |
82.2 to 94.8 |
146 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-15 Years |
84.2 |
76.2 to 89.8 |
174 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2022 |
Age |
13-15 Years |
93.2 |
87.6 to 96.4 |
229 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2022 |
Age |
13-15 Years |
94.0 |
87.8 to 97.2 |
177 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2022 |
Age |
13-15 Years |
91.5 |
83.3 to 95.9 |
163 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-15 Years |
89.8 |
83.4 to 93.9 |
153 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2022 |
Age |
13-15 Years |
88.8 |
82.5 to 93.1 |
170 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-15 Years |
93.1 |
88.4 to 95.9 |
471 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-15 Years |
92.1 |
84.9 to 96.1 |
169 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-15 Years |
93.2 |
87.8 to 96.3 |
302 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-15 Years |
84.6 |
79.4 to 88.7 |
393 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2022 |
Age |
13-15 Years |
89.1 |
87.6 to 90.4 |
9816 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-15 Years |
93.5 |
90.6 to 95.5 |
947 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-15 Years |
86.2 |
81.8 to 89.7 |
478 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-15 Years |
90.2 |
87.3 to 92.5 |
1494 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-15 Years |
92.7 |
90.7 to 94.3 |
1406 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-15 Years |
91.9 |
89.4 to 93.8 |
1226 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-15 Years |
86.1 |
81.3 to 89.9 |
1229 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-15 Years |
90.3 |
86.9 to 93.0 |
654 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-15 Years |
92.9 |
90.1 to 94.9 |
1085 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-15 Years |
81.9 |
74.6 to 87.4 |
639 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-15 Years |
96.0 |
91.1 to 98.2 |
168 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2022 |
Age |
13-15 Years |
93.4 |
85.0 to 97.2 |
155 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2022 |
Age |
13-15 Years |
95.7 |
90.4 to 98.1 |
158 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2022 |
Age |
13-15 Years |
90.1 |
82.0 to 94.8 |
160 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2022 |
Age |
13-15 Years |
84.4 |
77.5 to 89.4 |
488 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-15 Years |
85.2 |
75.6 to 91.4 |
151 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-15 Years |
87.2 |
75.9 to 93.7 |
98 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-15 Years |
84.1 |
76.3 to 89.7 |
239 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-15 Years |
91.0 |
88.0 to 93.3 |
658 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2022 |
Age |
13-15 Years |
94.7 |
88.3 to 97.7 |
166 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2022 |
Age |
13-15 Years |
93.0 |
86.0 to 96.7 |
164 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2022 |
Age |
13-15 Years |
88.3 |
82.8 to 92.2 |
365 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2022 |
Age |
13-15 Years |
94.3 |
89.5 to 97.0 |
174 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2022 |
Age |
13-15 Years |
89.5 |
83.2 to 93.6 |
148 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-15 Years |
91.9 |
85.9 to 95.5 |
160 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2022 |
Age |
13-15 Years |
88.8 |
81.5 to 93.5 |
188 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2006 |
Age |
13-17 Years |
10.8 |
9.4 to 12.3 |
2882 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2006 |
Age |
13-17 Years |
6.6 |
3.7 to 11.4 |
170 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2006 |
Age |
13-17 Years |
13.5 |
8.7 to 20.5 |
227 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2006 |
Age |
13-17 Years |
11.7 |
8.5 to 16.0 |
347 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2006 |
Age |
13-17 Years |
7.9 |
5.6 to 11.0 |
608 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2006 |
Age |
13-17 Years |
12.0 |
8.9 to 16.0 |
458 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2006 |
Age |
13-17 Years |
9.0 |
5.4 to 14.6 |
268 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2006 |
Age |
13-17 Years |
13.7 |
8.8 to 20.7 |
165 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2006 |
Age |
13-17 Years |
11.5 |
8.1 to 16.1 |
362 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2006 |
Age |
13-17 Years |
6.6 |
3.7 to 11.5 |
159 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
30.4 |
28.2 to 32.7 |
2947 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
31.8 |
24.1 to 40.6 |
190 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-17 Years |
35.4 |
28.3 to 43.3 |
219 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
36.3 |
29.7 to 43.4 |
370 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
21.2 |
16.9 to 26.2 |
501 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
27.1 |
22.9 to 31.7 |
584 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-17 Years |
29.5 |
23.2 to 36.7 |
322 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-17 Years |
34.5 |
26.3 to 43.6 |
165 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-17 Years |
45.8 |
33.9 to 58.1 |
112 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
35.4 |
28.6 to 42.8 |
366 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2007 |
Age |
13-17 Years |
26.7 |
17.7 to 38.0 |
118 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
44.0 |
38.4 to 49.8 |
406 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
42.1 |
36.2 to 48.3 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
53.8 |
46.4 to 60.9 |
250 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
23.8 |
19.2 to 29.1 |
382 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
43.7 |
36.4 to 51.3 |
316 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
63.0 |
56.0 to 69.5 |
347 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
45.4 |
38.5 to 52.5 |
292 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
43.1 |
36.9 to 49.6 |
334 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
32.7 |
27.1 to 38.9 |
329 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
29.0 |
22.6 to 36.2 |
284 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
37.8 |
31.6 to 44.4 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
32.0 |
26.5 to 38.0 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
31.7 |
25.7 to 38.3 |
268 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
45.4 |
39.9 to 51.0 |
783 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
44.2 |
38.0 to 50.5 |
343 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
45.7 |
39.0 to 52.6 |
440 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
31.2 |
26.1 to 36.7 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
43.5 |
37.4 to 49.9 |
308 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
46.8 |
40.1 to 53.7 |
271 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
28.1 |
22.6 to 34.3 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
35.3 |
29.8 to 41.3 |
379 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
43.0 |
36.9 to 49.3 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
37.9 |
32.2 to 44.0 |
394 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
43.3 |
37.1 to 49.8 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
33.6 |
27.9 to 39.8 |
320 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
40.7 |
34.8 to 46.8 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2008 |
Age |
13-17 Years |
19.6 |
15.3 to 24.7 |
404 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
44.1 |
38.1 to 50.3 |
351 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
44.2 |
37.8 to 50.7 |
299 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
42.2 |
36.5 to 48.0 |
365 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
45.9 |
38.6 to 53.2 |
235 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
53.1 |
45.8 to 60.2 |
300 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
43.0 |
37.0 to 49.3 |
390 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
50.4 |
43.7 to 57.0 |
310 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
53.8 |
48.9 to 58.6 |
600 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
49.4 |
42.3 to 56.5 |
293 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
56.8 |
50.1 to 63.2 |
307 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
28.0 |
22.8 to 33.8 |
326 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
47.8 |
42.2 to 53.5 |
362 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
30.6 |
25.2 to 36.7 |
311 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
28.6 |
23.3 to 34.5 |
292 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
38.9 |
32.2 to 45.9 |
235 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
51.2 |
45.8 to 56.7 |
682 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
48.6 |
42.4 to 54.8 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
51.7 |
45.4 to 57.9 |
337 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
40.8 |
39.3 to 42.2 |
17835 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
44.9 |
41.4 to 48.4 |
1838 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
50.4 |
46.6 to 54.3 |
990 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
45.9 |
42.6 to 49.2 |
2306 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
31.4 |
28.8 to 34.1 |
2788 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
38.4 |
36.0 to 41.0 |
2361 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
38.3 |
33.6 to 43.2 |
2203 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
44.3 |
40.9 to 47.7 |
1295 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
50.7 |
46.9 to 54.6 |
1854 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
44.9 |
38.9 to 51.0 |
1118 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
41.6 |
34.7 to 48.9 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
27.3 |
22.4 to 32.9 |
367 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
19.3 |
15.1 to 24.4 |
344 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
34.3 |
28.5 to 40.5 |
360 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
40.8 |
34.0 to 48.1 |
840 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
42.0 |
35.0 to 49.3 |
269 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
42.6 |
34.0 to 51.8 |
233 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
40.6 |
32.7 to 49.0 |
338 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
36.0 |
32.1 to 40.0 |
1082 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2008 |
Age |
13-17 Years |
46.8 |
39.4 to 54.3 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
49.2 |
42.5 to 55.9 |
283 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
49.1 |
42.1 to 56.1 |
272 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
34.7 |
28.7 to 41.2 |
275 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
24.1 |
19.1 to 29.9 |
295 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
53.8 |
47.1 to 60.4 |
264 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
28.3 |
23.0 to 34.3 |
280 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
57.6 |
51.4 to 63.6 |
339 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
55.8 |
49.0 to 62.4 |
274 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
66.6 |
60.0 to 72.7 |
349 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
34.6 |
28.9 to 40.7 |
363 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
53.1 |
46.7 to 59.5 |
379 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
76.6 |
70.9 to 81.5 |
411 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
68.3 |
62.2 to 73.8 |
351 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
53.4 |
46.9 to 59.7 |
371 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
46.2 |
40.2 to 52.2 |
412 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
47.2 |
41.2 to 53.3 |
412 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
50.8 |
44.7 to 56.9 |
383 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
46.1 |
39.3 to 52.9 |
256 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
38.6 |
31.4 to 46.3 |
227 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
59.5 |
54.5 to 64.3 |
754 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
58.7 |
52.5 to 64.7 |
389 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
59.6 |
53.6 to 65.5 |
365 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
44.4 |
39.0 to 49.9 |
873 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
61.2 |
54.9 to 67.1 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
63.6 |
56.6 to 70.0 |
252 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
37.5 |
32.1 to 43.1 |
393 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
47.3 |
40.2 to 54.6 |
281 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
54.0 |
47.2 to 60.6 |
299 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
51.8 |
43.9 to 59.7 |
245 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
62.7 |
56.8 to 68.2 |
397 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
46.2 |
40.8 to 51.8 |
446 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
52.0 |
46.0 to 58.0 |
336 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
22.6 |
18.4 to 27.3 |
438 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
60.1 |
54.3 to 65.7 |
374 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
63.8 |
57.6 to 69.6 |
306 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
51.6 |
45.1 to 57.9 |
286 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
64.0 |
57.4 to 70.1 |
336 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
72.2 |
66.2 to 77.5 |
307 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
61.1 |
55.4 to 66.5 |
427 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
63.5 |
57.8 to 68.8 |
406 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
69.2 |
64.3 to 73.7 |
539 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
72.2 |
65.1 to 78.4 |
269 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
67.2 |
60.4 to 73.2 |
270 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
54.7 |
48.3 to 61.1 |
323 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
71.6 |
65.4 to 77.1 |
272 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
50.2 |
44.0 to 56.4 |
351 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
35.1 |
29.6 to 41.1 |
336 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
55.5 |
49.9 to 61.1 |
386 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
67.9 |
61.7 to 73.5 |
579 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
65.2 |
59.2 to 70.8 |
324 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
68.3 |
61.1 to 74.7 |
255 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
55.6 |
54.3 to 56.8 |
20066 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
64.4 |
61.3 to 67.4 |
2189 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
66.7 |
62.9 to 70.2 |
966 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
59.2 |
55.6 to 62.6 |
2214 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
47.1 |
44.6 to 49.6 |
2984 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
53.5 |
51.1 to 55.9 |
3105 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
52.7 |
49.0 to 56.3 |
2856 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
59.9 |
56.6 to 63.2 |
1250 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
67.4 |
64.3 to 70.4 |
1974 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
55.3 |
50.1 to 60.4 |
1320 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
60.1 |
54.0 to 65.9 |
409 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
37.5 |
31.4 to 44.0 |
299 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
39.6 |
33.2 to 46.4 |
271 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
48.0 |
42.0 to 54.0 |
397 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
57.2 |
52.0 to 62.3 |
1470 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
56.4 |
49.1 to 63.4 |
305 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
52.6 |
44.0 to 61.0 |
239 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
54.4 |
47.1 to 61.5 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
64.5 |
58.7 to 70.0 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
57.8 |
50.7 to 64.5 |
305 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-17 Years |
34.9 |
28.9 to 41.3 |
333 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
55.7 |
51.9 to 59.5 |
1208 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
64.1 |
57.9 to 70.0 |
339 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
70.7 |
65.4 to 75.6 |
426 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
56.1 |
49.7 to 62.3 |
358 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
60.1 |
53.8 to 66.2 |
321 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
40.5 |
33.8 to 47.5 |
249 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
72.3 |
66.3 to 77.5 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
48.2 |
42.4 to 54.0 |
375 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
68.4 |
62.0 to 74.2 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
63.9 |
57.6 to 69.8 |
294 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
76.5 |
70.3 to 81.7 |
331 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
43.0 |
36.6 to 49.6 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
71.2 |
65.1 to 76.5 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
85.7 |
80.9 to 89.5 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
76.2 |
70.8 to 80.8 |
408 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
65.5 |
59.3 to 71.2 |
348 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
71.6 |
65.7 to 76.8 |
355 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
61.9 |
55.3 to 68.1 |
344 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
62.2 |
56.2 to 67.9 |
373 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
58.1 |
51.9 to 64.1 |
320 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
49.2 |
43.0 to 55.3 |
318 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
66.2 |
61.4 to 70.8 |
739 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
69.5 |
63.2 to 75.1 |
366 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
65.4 |
59.5 to 70.8 |
373 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
72.3 |
66.2 to 77.7 |
316 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
64.2 |
57.6 to 70.4 |
264 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
76.8 |
71.8 to 81.2 |
373 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
53.1 |
46.7 to 59.3 |
309 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
69.3 |
63.4 to 74.6 |
347 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
63.2 |
56.6 to 69.3 |
312 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
61.2 |
54.7 to 67.3 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
82.4 |
76.5 to 87.0 |
306 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
66.2 |
59.7 to 72.3 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
70.3 |
64.0 to 75.8 |
310 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
29.0 |
23.8 to 34.9 |
354 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
66.0 |
60.0 to 71.5 |
347 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
76.1 |
70.6 to 80.8 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
70.3 |
64.1 to 75.8 |
307 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
68.3 |
62.2 to 73.9 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
87.9 |
83.5 to 91.3 |
350 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
68.9 |
62.6 to 74.6 |
399 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
71.8 |
65.7 to 77.2 |
332 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
82.9 |
79.2 to 86.1 |
701 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
82.0 |
76.9 to 86.2 |
388 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
83.6 |
78.1 to 87.8 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
67.7 |
61.7 to 73.1 |
366 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
83.1 |
77.9 to 87.3 |
299 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
60.3 |
54.0 to 66.2 |
302 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
54.8 |
48.3 to 61.2 |
300 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
66.6 |
60.2 to 72.4 |
302 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
74.0 |
68.8 to 78.6 |
742 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
70.4 |
64.7 to 75.6 |
371 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
74.5 |
68.5 to 79.6 |
371 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
68.7 |
67.5 to 69.8 |
19257 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
79.4 |
76.4 to 82.0 |
2026 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
78.5 |
75.2 to 81.3 |
1100 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
69.2 |
66.1 to 72.1 |
2436 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
59.6 |
57.1 to 62.1 |
2679 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
67.7 |
65.2 to 70.1 |
2248 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
67.9 |
64.7 to 70.9 |
3001 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
68.5 |
65.2 to 71.6 |
1291 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
76.3 |
73.4 to 78.9 |
1890 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
71.4 |
66.6 to 75.8 |
1311 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
79.5 |
74.0 to 84.0 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
48.1 |
41.6 to 54.6 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
52.5 |
46.1 to 58.7 |
321 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
58.7 |
52.4 to 64.8 |
320 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
71.9 |
67.4 to 76.0 |
1709 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
72.1 |
66.5 to 77.0 |
382 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
71.3 |
65.2 to 76.7 |
413 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
72.5 |
65.2 to 78.7 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
79.5 |
74.2 to 83.9 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
71.5 |
65.3 to 77.0 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
62.8 |
55.2 to 69.7 |
231 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
66.2 |
62.7 to 69.5 |
1275 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
68.8 |
62.5 to 74.5 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
82.7 |
76.9 to 87.2 |
320 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
72.0 |
65.3 to 77.9 |
332 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
70.6 |
64.9 to 75.6 |
361 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
49.9 |
43.8 to 55.9 |
321 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
81.3 |
75.2 to 86.1 |
277 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
65.0 |
58.5 to 71.0 |
295 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
74.4 |
68.8 to 79.2 |
403 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
65.6 |
58.3 to 72.3 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
85.3 |
79.2 to 89.9 |
416 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
48.4 |
40.6 to 56.4 |
350 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
82.5 |
78.3 to 86.0 |
583 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
84.7 |
78.0 to 89.6 |
431 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
83.0 |
77.6 to 87.3 |
453 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
80.7 |
75.8 to 84.7 |
442 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
82.0 |
76.5 to 86.5 |
415 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
77.5 |
71.8 to 82.3 |
483 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
68.0 |
61.8 to 73.6 |
425 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
67.7 |
61.2 to 73.5 |
339 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
58.3 |
51.0 to 65.2 |
385 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
71.8 |
66.9 to 76.2 |
848 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
69.8 |
63.9 to 75.1 |
407 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
72.3 |
66.4 to 77.5 |
441 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
92.7 |
89.1 to 95.1 |
430 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
74.7 |
68.4 to 80.2 |
359 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
79.1 |
73.0 to 84.1 |
399 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
70.0 |
63.6 to 75.6 |
382 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
85.9 |
81.1 to 89.6 |
473 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
69.2 |
63.3 to 74.6 |
411 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
72.9 |
67.3 to 77.9 |
516 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
91.6 |
87.4 to 94.5 |
365 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
71.0 |
64.1 to 77.0 |
398 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
82.5 |
75.7 to 87.8 |
327 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
36.9 |
30.4 to 43.8 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
79.6 |
73.8 to 84.4 |
402 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
85.0 |
78.0 to 90.0 |
385 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
81.8 |
76.0 to 86.4 |
368 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
80.2 |
73.9 to 85.4 |
412 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
95.0 |
91.9 to 96.9 |
385 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
78.9 |
73.5 to 83.5 |
432 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
81.3 |
75.7 to 85.9 |
431 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
88.5 |
85.7 to 90.8 |
840 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
87.0 |
82.8 to 90.2 |
435 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
89.5 |
85.6 to 92.5 |
405 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
77.8 |
71.7 to 82.8 |
347 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
87.5 |
80.1 to 92.4 |
314 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
72.7 |
66.9 to 77.8 |
381 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
66.0 |
59.4 to 72.0 |
360 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
83.1 |
77.5 to 87.5 |
362 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
81.0 |
76.3 to 85.0 |
880 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
81.0 |
75.1 to 85.8 |
387 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
81.0 |
75.7 to 85.4 |
493 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
78.2 |
77.2 to 79.1 |
23564 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
87.4 |
85.1 to 89.4 |
2467 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
85.4 |
82.8 to 87.6 |
1272 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
77.3 |
74.5 to 79.9 |
3073 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
70.6 |
68.2 to 72.9 |
3171 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
77.5 |
75.2 to 79.7 |
2800 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
77.6 |
75.0 to 80.0 |
3838 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
78.7 |
75.6 to 81.5 |
1528 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
81.8 |
78.3 to 84.8 |
2242 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
82.4 |
79.0 to 85.3 |
1750 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
87.5 |
83.6 to 90.5 |
449 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
59.4 |
52.3 to 66.2 |
362 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
54.4 |
44.1 to 64.3 |
355 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
67.6 |
61.0 to 73.6 |
424 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
80.7 |
77.1 to 83.9 |
2224 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
85.2 |
80.8 to 88.8 |
448 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
76.1 |
69.5 to 81.6 |
490 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
76.9 |
70.2 to 82.5 |
441 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
83.6 |
78.1 to 87.9 |
355 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
81.1 |
76.3 to 85.2 |
490 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
63.5 |
58.3 to 68.4 |
485 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
74.4 |
70.6 to 78.0 |
1423 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
81.4 |
74.7 to 86.7 |
393 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
90.1 |
86.3 to 92.9 |
404 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
77.9 |
71.7 to 83.0 |
417 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
75.0 |
68.2 to 80.7 |
346 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
60.1 |
54.0 to 65.9 |
403 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
89.7 |
84.8 to 93.1 |
416 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
86.2 |
80.6 to 90.4 |
364 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
81.7 |
75.0 to 87.0 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
77.1 |
71.7 to 81.7 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
87.5 |
82.3 to 91.4 |
360 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
64.4 |
57.3 to 70.9 |
322 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
89.4 |
85.0 to 92.7 |
430 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
93.2 |
88.7 to 96.0 |
311 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
89.3 |
83.4 to 93.2 |
323 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
77.8 |
71.3 to 83.2 |
341 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
84.5 |
78.6 to 89.0 |
342 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
86.8 |
80.8 to 91.1 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
80.5 |
73.9 to 85.8 |
328 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
74.1 |
67.8 to 79.5 |
342 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
64.5 |
58.2 to 70.4 |
357 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
77.3 |
71.5 to 82.2 |
632 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
78.5 |
71.8 to 84.0 |
287 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
77.0 |
69.8 to 82.9 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
94.4 |
90.6 to 96.8 |
341 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
77.8 |
71.3 to 83.2 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
92.2 |
88.2 to 94.9 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
80.0 |
73.8 to 85.0 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
89.8 |
85.5 to 92.9 |
370 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
79.5 |
73.0 to 84.9 |
319 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
78.1 |
70.8 to 84.0 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
95.7 |
92.6 to 97.6 |
347 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
84.2 |
78.8 to 88.4 |
368 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
85.6 |
78.4 to 90.7 |
322 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
53.5 |
46.2 to 60.7 |
321 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
88.0 |
82.3 to 92.1 |
292 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
90.2 |
85.7 to 93.3 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
81.4 |
74.9 to 86.5 |
328 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
86.3 |
80.4 to 90.6 |
329 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
96.3 |
93.3 to 98.0 |
278 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
90.9 |
86.0 to 94.2 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
82.6 |
76.2 to 87.5 |
331 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
90.3 |
87.0 to 92.8 |
627 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
86.4 |
81.2 to 90.3 |
312 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
92.7 |
87.9 to 95.7 |
315 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
87.9 |
82.6 to 91.8 |
347 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
89.5 |
83.3 to 93.6 |
324 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
73.8 |
66.5 to 80.0 |
327 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
77.1 |
71.0 to 82.2 |
322 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
86.0 |
80.8 to 89.9 |
381 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
88.4 |
84.5 to 91.5 |
741 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
87.2 |
81.6 to 91.2 |
348 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
88.6 |
84.2 to 91.9 |
393 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
84.6 |
83.7 to 85.5 |
19199 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
92.5 |
90.5 to 94.1 |
1916 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
90.5 |
87.9 to 92.6 |
957 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
84.9 |
82.3 to 87.1 |
2365 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
80.7 |
78.3 to 82.8 |
2612 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
82.3 |
79.7 to 84.5 |
2297 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
81.5 |
79.1 to 83.8 |
2939 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
85.8 |
82.9 to 88.3 |
1285 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
86.9 |
84.0 to 89.3 |
1936 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
88.6 |
85.2 to 91.4 |
1461 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
94.0 |
90.4 to 96.3 |
327 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
64.9 |
57.4 to 71.7 |
310 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
65.9 |
59.2 to 72.1 |
298 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
77.4 |
70.6 to 82.9 |
331 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
82.5 |
79.0 to 85.6 |
1594 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
78.6 |
70.6 to 84.9 |
346 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
82.5 |
76.1 to 87.4 |
393 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
82.9 |
78.8 to 86.3 |
855 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
72.0 |
67.3 to 76.3 |
547 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
82.5 |
79.3 to 85.4 |
1431 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
81.5 |
74.4 to 87.0 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
93.1 |
88.5 to 96.0 |
322 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
88.7 |
83.6 to 92.4 |
334 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
86.0 |
80.1 to 90.3 |
353 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
68.2 |
60.7 to 74.8 |
282 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
89.8 |
84.5 to 93.4 |
307 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
85.4 |
79.8 to 89.6 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
87.3 |
82.1 to 91.1 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
74.3 |
68.0 to 79.7 |
320 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
84.4 |
78.8 to 88.8 |
359 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
77.7 |
71.9 to 82.5 |
312 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
91.1 |
85.5 to 94.6 |
309 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
87.1 |
82.0 to 90.9 |
331 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
90.8 |
85.5 to 94.2 |
328 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
84.4 |
79.3 to 88.4 |
348 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
83.1 |
73.2 to 89.8 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
84.8 |
78.5 to 89.5 |
323 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
82.0 |
74.4 to 87.7 |
253 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
73.8 |
68.1 to 78.9 |
363 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
80.2 |
74.3 to 85.0 |
315 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
74.6 |
67.4 to 80.6 |
272 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
86.2 |
81.5 to 89.9 |
558 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
89.7 |
83.3 to 93.9 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
85.4 |
79.7 to 89.7 |
349 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
90.6 |
86.8 to 93.4 |
381 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
79.6 |
74.1 to 84.2 |
383 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
84.6 |
79.0 to 88.9 |
287 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
84.4 |
78.6 to 88.9 |
291 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
87.9 |
82.6 to 91.8 |
298 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
83.0 |
77.8 to 87.2 |
343 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
83.2 |
76.0 to 88.6 |
320 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
94.9 |
91.6 to 96.9 |
393 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
81.0 |
75.3 to 85.7 |
307 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
91.4 |
86.8 to 94.5 |
369 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
60.2 |
53.3 to 66.6 |
284 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
81.5 |
75.5 to 86.4 |
280 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
84.3 |
78.6 to 88.7 |
320 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
86.1 |
80.7 to 90.2 |
301 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
88.3 |
83.5 to 91.8 |
335 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
94.7 |
91.0 to 97.0 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
85.5 |
79.5 to 90.0 |
322 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
85.6 |
80.5 to 89.6 |
357 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
89.5 |
86.2 to 92.0 |
710 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
88.9 |
83.6 to 92.7 |
300 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
89.8 |
85.4 to 93.0 |
410 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
89.4 |
84.7 to 92.8 |
306 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
95.0 |
91.2 to 97.2 |
344 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
84.4 |
78.9 to 88.7 |
319 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
78.1 |
72.8 to 82.5 |
426 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
87.0 |
82.0 to 90.7 |
364 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
89.9 |
85.8 to 92.9 |
751 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
89.6 |
84.7 to 93.1 |
307 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
89.9 |
85.3 to 93.2 |
444 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
86.0 |
85.1 to 87.0 |
18264 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
92.7 |
90.8 to 94.2 |
2050 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
88.2 |
85.3 to 90.5 |
1032 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
85.8 |
82.9 to 88.2 |
2241 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
82.5 |
80.1 to 84.6 |
2374 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
86.3 |
84.2 to 88.1 |
2264 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
84.9 |
82.2 to 87.3 |
2505 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
82.4 |
79.3 to 85.1 |
1251 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
86.1 |
83.3 to 88.4 |
1913 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
89.7 |
85.6 to 92.8 |
1318 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
95.5 |
91.6 to 97.7 |
315 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
71.9 |
64.8 to 78.0 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
70.0 |
63.3 to 76.0 |
292 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
80.0 |
74.1 to 84.9 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
86.1 |
82.1 to 89.3 |
1112 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
86.6 |
81.4 to 90.5 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
86.5 |
79.8 to 91.2 |
278 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
86.0 |
81.3 to 89.7 |
517 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
76.4 |
70.9 to 81.2 |
332 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
84.1 |
80.9 to 86.9 |
1316 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
86.2 |
80.6 to 90.4 |
301 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
91.8 |
87.4 to 94.8 |
326 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
83.6 |
76.0 to 89.1 |
302 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
86.2 |
80.4 to 90.4 |
360 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
76.7 |
70.7 to 81.8 |
328 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
89.6 |
84.6 to 93.1 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
92.3 |
88.8 to 94.8 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
88.6 |
84.0 to 92.1 |
378 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
73.8 |
68.1 to 78.9 |
377 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
84.2 |
78.8 to 88.4 |
421 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
84.6 |
79.3 to 88.7 |
368 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
87.7 |
82.3 to 91.7 |
356 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
90.2 |
86.0 to 93.3 |
394 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
94.8 |
90.5 to 97.2 |
386 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
90.5 |
86.1 to 93.7 |
374 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
81.4 |
74.8 to 86.6 |
285 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
90.7 |
85.6 to 94.1 |
363 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
86.1 |
80.6 to 90.2 |
373 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
82.3 |
76.9 to 86.6 |
363 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
70.8 |
64.1 to 76.7 |
341 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
91.9 |
89.1 to 94.0 |
709 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
84.6 |
77.9 to 89.6 |
274 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
93.6 |
90.4 to 95.7 |
435 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
88.6 |
83.8 to 92.1 |
370 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
76.7 |
69.7 to 82.5 |
328 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
79.8 |
73.5 to 84.8 |
352 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
85.5 |
79.9 to 89.7 |
335 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
93.8 |
90.3 to 96.0 |
335 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
85.4 |
80.1 to 89.4 |
341 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
85.0 |
78.9 to 89.6 |
409 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
93.2 |
88.9 to 95.9 |
358 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
79.3 |
73.3 to 84.2 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
87.2 |
81.3 to 91.4 |
286 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
70.8 |
64.2 to 76.7 |
356 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
86.1 |
80.8 to 90.0 |
361 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
84.7 |
79.4 to 88.9 |
367 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
82.2 |
76.2 to 87.0 |
321 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
87.6 |
83.3 to 90.9 |
351 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
94.4 |
91.1 to 96.6 |
402 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
90.1 |
84.7 to 93.7 |
328 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
83.3 |
77.4 to 88.0 |
378 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
91.5 |
88.1 to 93.9 |
594 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
88.7 |
82.9 to 92.7 |
288 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
93.2 |
88.8 to 96.0 |
306 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
92.3 |
87.6 to 95.3 |
372 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
92.1 |
87.1 to 95.3 |
327 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
83.0 |
77.7 to 87.3 |
430 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
82.6 |
77.4 to 86.8 |
356 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
88.0 |
83.1 to 91.7 |
399 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
93.0 |
89.8 to 95.2 |
785 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
90.3 |
85.1 to 93.8 |
343 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
93.4 |
89.7 to 95.8 |
442 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
81.7 |
73.4 to 87.8 |
230 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
87.6 |
86.7 to 88.5 |
20827 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
93.0 |
90.9 to 94.6 |
2268 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
91.0 |
88.3 to 93.1 |
922 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
89.8 |
87.7 to 91.6 |
2553 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
86.8 |
84.9 to 88.5 |
2896 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
86.7 |
84.8 to 88.4 |
2465 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
87.8 |
85.5 to 89.9 |
3089 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
82.1 |
79.1 to 84.8 |
1362 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
87.1 |
84.7 to 89.1 |
2290 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
87.1 |
83.0 to 90.3 |
1491 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
92.4 |
88.2 to 95.2 |
414 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
72.6 |
66.0 to 78.3 |
380 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
75.0 |
68.7 to 80.4 |
358 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
86.0 |
80.9 to 89.9 |
339 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
88.2 |
84.8 to 91.0 |
1652 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
85.7 |
80.8 to 89.5 |
385 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
87.8 |
82.4 to 91.7 |
379 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
86.3 |
80.4 to 90.6 |
397 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
88.5 |
84.4 to 91.7 |
491 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
85.1 |
82.3 to 87.5 |
1491 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
84.8 |
79.7 to 88.8 |
398 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
93.4 |
89.1 to 96.0 |
367 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
91.2 |
86.4 to 94.4 |
350 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
88.5 |
83.8 to 92.0 |
374 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
77.9 |
71.5 to 83.2 |
350 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
93.3 |
88.5 to 96.1 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
89.1 |
85.1 to 92.1 |
446 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
93.3 |
89.2 to 95.9 |
361 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
69.7 |
63.6 to 75.2 |
350 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
86.6 |
82.3 to 90.0 |
444 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
91.2 |
87.2 to 94.0 |
362 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
82.5 |
76.2 to 87.4 |
350 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
93.3 |
89.7 to 95.7 |
354 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
93.7 |
90.0 to 96.1 |
358 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
88.7 |
84.3 to 92.0 |
360 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
81.3 |
75.8 to 85.8 |
418 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
87.3 |
81.6 to 91.4 |
321 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
90.2 |
85.5 to 93.5 |
374 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
79.6 |
74.7 to 83.8 |
419 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
79.6 |
74.3 to 84.1 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
82.5 |
76.7 to 87.1 |
356 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
89.1 |
85.8 to 91.7 |
779 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
87.2 |
81.7 to 91.1 |
283 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
89.5 |
85.5 to 92.5 |
496 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
89.7 |
85.0 to 93.1 |
328 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
85.5 |
80.2 to 89.5 |
383 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
87.3 |
82.4 to 91.0 |
375 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
84.0 |
78.8 to 88.1 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
91.0 |
86.9 to 93.9 |
382 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
87.7 |
83.1 to 91.1 |
374 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
86.5 |
81.3 to 90.4 |
403 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
91.2 |
86.1 to 94.5 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
74.0 |
68.1 to 79.2 |
373 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
90.4 |
85.7 to 93.6 |
366 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
74.7 |
69.0 to 79.7 |
364 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
85.7 |
80.1 to 89.9 |
300 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
89.5 |
85.2 to 92.6 |
406 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
87.7 |
82.9 to 91.2 |
393 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
88.3 |
83.2 to 92.0 |
372 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
92.4 |
87.5 to 95.5 |
295 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
87.2 |
82.2 to 90.9 |
364 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
85.9 |
81.1 to 89.6 |
396 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
89.0 |
85.7 to 91.6 |
665 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
90.6 |
86.4 to 93.6 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
88.0 |
83.1 to 91.7 |
352 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
93.4 |
89.7 to 95.8 |
358 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
88.9 |
83.5 to 92.7 |
323 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
86.7 |
80.8 to 91.0 |
332 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
84.4 |
79.0 to 88.6 |
291 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
89.4 |
85.0 to 92.7 |
353 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
91.7 |
88.6 to 94.0 |
832 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
86.1 |
80.7 to 90.1 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
92.5 |
88.9 to 95.0 |
492 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
82.5 |
76.7 to 87.1 |
339 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
86.4 |
85.4 to 87.3 |
21875 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
92.3 |
89.9 to 94.1 |
2188 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
88.4 |
85.8 to 90.6 |
1029 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
87.4 |
84.9 to 89.6 |
2742 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
86.9 |
84.9 to 88.6 |
2793 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
85.8 |
83.8 to 87.6 |
2543 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
86.1 |
84.1 to 87.9 |
4048 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
86.3 |
83.5 to 88.6 |
1451 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
87.5 |
85.2 to 89.5 |
2120 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
83.3 |
78.4 to 87.2 |
1506 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
97.1 |
95.0 to 98.3 |
419 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
77.8 |
71.8 to 82.8 |
360 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
72.4 |
66.2 to 77.7 |
349 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
79.7 |
73.8 to 84.5 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
85.1 |
82.3 to 87.5 |
2617 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
85.7 |
80.6 to 89.7 |
368 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
83.3 |
77.4 to 88.0 |
259 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
83.4 |
79.1 to 87.0 |
558 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
85.4 |
81.9 to 88.4 |
946 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
82.0 |
77.7 to 85.6 |
458 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
85.3 |
82.3 to 87.8 |
1455 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
82.0 |
76.2 to 86.6 |
357 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
95.8 |
92.6 to 97.7 |
404 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
82.2 |
74.8 to 87.8 |
385 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
85.3 |
80.2 to 89.3 |
396 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
85.8 |
81.2 to 89.5 |
344 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
88.0 |
83.2 to 91.5 |
365 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
87.9 |
83.2 to 91.4 |
331 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
91.7 |
87.8 to 94.4 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
79.4 |
74.1 to 83.9 |
392 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
84.3 |
78.7 to 88.6 |
329 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
91.0 |
87.1 to 93.8 |
352 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
82.1 |
75.9 to 86.9 |
327 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
87.5 |
82.1 to 91.4 |
322 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
93.9 |
89.6 to 96.5 |
357 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
87.5 |
83.0 to 91.0 |
375 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
86.5 |
81.5 to 90.3 |
377 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
89.7 |
84.5 to 93.3 |
376 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
92.8 |
88.3 to 95.6 |
367 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
77.5 |
72.9 to 81.6 |
535 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
82.2 |
76.5 to 86.7 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
87.5 |
83.0 to 90.9 |
358 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
91.0 |
87.9 to 93.3 |
605 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
84.2 |
75.2 to 90.3 |
157 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
92.5 |
89.2 to 94.8 |
448 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
89.5 |
84.6 to 92.9 |
350 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
89.2 |
85.0 to 92.2 |
382 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
87.3 |
82.1 to 91.2 |
322 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
89.0 |
84.6 to 92.2 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
93.7 |
89.8 to 96.2 |
336 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
87.5 |
83.1 to 90.9 |
347 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
85.0 |
79.7 to 89.2 |
451 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
96.7 |
94.4 to 98.0 |
374 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
93.6 |
89.4 to 96.2 |
283 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
89.7 |
85.0 to 93.1 |
375 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
82.0 |
76.5 to 86.5 |
377 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
83.9 |
78.7 to 88.0 |
360 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
85.7 |
80.4 to 89.7 |
375 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
86.8 |
81.5 to 90.8 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
87.1 |
81.8 to 91.0 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
95.3 |
91.5 to 97.5 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
89.9 |
85.5 to 93.1 |
422 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
84.3 |
79.2 to 88.4 |
374 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
91.1 |
88.2 to 93.4 |
655 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
88.9 |
84.1 to 92.3 |
291 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
92.6 |
88.6 to 95.3 |
364 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
89.1 |
84.5 to 92.5 |
366 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
92.0 |
87.5 to 94.9 |
293 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
90.8 |
85.6 to 94.3 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
89.6 |
84.2 to 93.3 |
281 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
83.2 |
77.0 to 88.0 |
318 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
92.0 |
88.9 to 94.2 |
875 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
89.8 |
85.4 to 93.0 |
349 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
92.3 |
88.7 to 94.7 |
526 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
91.2 |
87.5 to 93.9 |
405 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
88.0 |
87.1 to 88.9 |
20475 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
94.8 |
93.4 to 96.0 |
2097 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
90.8 |
88.4 to 92.7 |
1077 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
88.9 |
86.6 to 90.8 |
2842 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
88.9 |
87.1 to 90.5 |
2757 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
91.2 |
89.5 to 92.6 |
2284 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
86.7 |
84.6 to 88.5 |
3270 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
86.2 |
83.6 to 88.4 |
1394 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
85.9 |
83.1 to 88.3 |
2022 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
82.7 |
77.9 to 86.6 |
1303 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
95.4 |
92.5 to 97.2 |
326 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
77.5 |
70.7 to 83.1 |
314 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
79.4 |
73.1 to 84.5 |
342 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
89.3 |
84.1 to 92.9 |
291 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
85.0 |
82.1 to 87.5 |
1927 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
85.4 |
80.1 to 89.5 |
334 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
86.2 |
77.9 to 91.7 |
225 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
83.0 |
76.7 to 87.9 |
294 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
83.4 |
76.6 to 88.6 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
85.2 |
81.4 to 88.3 |
729 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
78.9 |
73.7 to 83.2 |
428 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
85.5 |
82.3 to 88.1 |
1429 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
83.9 |
78.5 to 88.2 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
93.8 |
90.4 to 96.1 |
380 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
87.1 |
81.0 to 91.5 |
451 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
86.8 |
81.5 to 90.7 |
361 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
89.7 |
85.3 to 92.9 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
91.6 |
87.2 to 94.5 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
86.7 |
81.7 to 90.5 |
373 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
88.7 |
84.3 to 92.0 |
367 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
78.9 |
73.2 to 83.6 |
349 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
82.4 |
76.7 to 87.0 |
335 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
92.4 |
88.6 to 94.9 |
357 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
83.5 |
77.2 to 88.3 |
306 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
88.6 |
83.6 to 92.2 |
354 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
94.9 |
91.9 to 96.8 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
89.6 |
84.5 to 93.2 |
350 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
86.1 |
80.2 to 90.4 |
318 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
91.1 |
87.1 to 94.0 |
415 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
93.3 |
89.3 to 95.9 |
343 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
77.3 |
71.6 to 82.1 |
382 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
84.8 |
79.3 to 89.1 |
314 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
87.3 |
82.1 to 91.1 |
353 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
92.4 |
89.4 to 94.6 |
683 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
90.5 |
84.9 to 94.2 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
92.8 |
89.2 to 95.3 |
479 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
95.1 |
92.3 to 96.9 |
334 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
93.4 |
89.8 to 95.8 |
343 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
89.7 |
84.9 to 93.1 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
86.4 |
81.7 to 90.0 |
372 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
90.1 |
85.5 to 93.4 |
341 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
85.1 |
79.8 to 89.3 |
347 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
88.3 |
82.2 to 92.5 |
470 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
96.2 |
93.4 to 97.8 |
412 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
93.4 |
89.2 to 96.0 |
328 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
87.5 |
82.2 to 91.4 |
356 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
92.4 |
88.6 to 95.0 |
347 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
80.1 |
74.1 to 85.0 |
335 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
90.4 |
85.8 to 93.7 |
326 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
92.3 |
87.5 to 95.4 |
324 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
82.5 |
76.6 to 87.1 |
344 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
95.1 |
91.6 to 97.2 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
90.0 |
85.3 to 93.3 |
366 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
85.5 |
80.3 to 89.5 |
362 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
92.9 |
90.3 to 94.8 |
651 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
92.9 |
89.0 to 95.5 |
281 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
92.8 |
89.1 to 95.4 |
370 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
91.9 |
87.8 to 94.7 |
336 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
90.6 |
86.8 to 93.5 |
379 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
90.6 |
86.9 to 93.3 |
408 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
86.7 |
81.7 to 90.5 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
86.3 |
81.6 to 90.0 |
359 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
90.6 |
86.7 to 93.5 |
851 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
91.6 |
87.4 to 94.5 |
362 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
90.5 |
85.9 to 93.7 |
489 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
88.7 |
87.8 to 89.6 |
20949 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
94.6 |
93.1 to 95.7 |
2107 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
91.9 |
89.7 to 93.7 |
1017 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
89.5 |
87.0 to 91.6 |
2745 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
90.9 |
89.3 to 92.2 |
2846 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
91.8 |
90.4 to 93.0 |
2433 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
85.0 |
83.0 to 86.8 |
3654 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
86.8 |
84.0 to 89.2 |
1340 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
89.1 |
86.6 to 91.1 |
2108 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
83.3 |
78.5 to 87.2 |
1299 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
94.6 |
91.0 to 96.8 |
319 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
89.4 |
84.5 to 92.8 |
328 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
79.5 |
73.6 to 84.4 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
89.4 |
84.8 to 92.8 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
83.2 |
80.4 to 85.7 |
2256 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
83.7 |
77.8 to 88.3 |
336 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
87.9 |
80.2 to 92.9 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
77.0 |
69.8 to 83.0 |
263 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
89.6 |
84.8 to 93.0 |
320 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
85.9 |
80.9 to 89.8 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
83.1 |
79.3 to 86.3 |
846 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
87.2 |
84.5 to 89.5 |
1400 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
91.6 |
87.7 to 94.3 |
356 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
92.8 |
89.2 to 95.2 |
366 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
89.3 |
83.2 to 93.4 |
413 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
88.6 |
83.8 to 92.1 |
339 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
87.5 |
82.8 to 91.0 |
343 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
90.3 |
85.8 to 93.5 |
324 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
86.4 |
81.2 to 90.3 |
360 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
89.4 |
84.0 to 93.2 |
327 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
79.6 |
74.3 to 84.0 |
392 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
82.9 |
77.0 to 87.6 |
288 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
90.2 |
85.4 to 93.5 |
308 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
89.7 |
84.2 to 93.4 |
356 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
90.3 |
85.2 to 93.8 |
278 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
95.4 |
91.6 to 97.5 |
293 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
89.1 |
83.9 to 92.8 |
306 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
86.1 |
79.5 to 90.8 |
283 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
90.1 |
85.5 to 93.3 |
337 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
94.2 |
90.7 to 96.4 |
345 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
70.2 |
63.2 to 76.3 |
309 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
85.8 |
80.7 to 89.7 |
327 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
86.7 |
81.2 to 90.8 |
291 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
91.7 |
88.9 to 93.9 |
721 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
93.0 |
85.5 to 96.8 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
91.5 |
88.3 to 93.8 |
529 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
88.5 |
83.4 to 92.3 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
94.0 |
90.3 to 96.3 |
280 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
89.4 |
84.2 to 93.0 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
84.9 |
79.0 to 89.3 |
270 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
90.8 |
85.3 to 94.4 |
284 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
85.8 |
80.1 to 90.0 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
88.4 |
83.6 to 92.0 |
393 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
91.2 |
86.1 to 94.6 |
328 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
93.8 |
89.8 to 96.3 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
90.7 |
85.3 to 94.2 |
285 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
90.0 |
84.8 to 93.6 |
285 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
80.6 |
74.4 to 85.6 |
319 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
86.7 |
81.2 to 90.8 |
290 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
89.0 |
83.3 to 92.9 |
295 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
85.2 |
80.0 to 89.2 |
334 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
97.5 |
94.9 to 98.8 |
303 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
88.4 |
83.5 to 92.0 |
351 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
88.1 |
83.2 to 91.7 |
295 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
91.7 |
88.7 to 94.0 |
535 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
88.5 |
83.6 to 92.1 |
261 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
93.8 |
89.6 to 96.4 |
274 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
89.1 |
84.3 to 92.6 |
341 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
90.2 |
85.0 to 93.8 |
287 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
89.1 |
84.6 to 92.4 |
329 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
87.1 |
81.9 to 90.9 |
360 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
86.1 |
80.4 to 90.3 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
90.0 |
84.9 to 93.5 |
649 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
90.1 |
84.3 to 93.9 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
90.0 |
84.1 to 93.8 |
412 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
88.9 |
88.0 to 89.7 |
18700 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
92.9 |
90.5 to 94.7 |
1902 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
90.6 |
88.2 to 92.6 |
886 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
89.6 |
86.9 to 91.8 |
2295 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
90.2 |
88.5 to 91.7 |
2507 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
90.5 |
88.9 to 91.9 |
2276 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
85.2 |
83.1 to 87.0 |
3326 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
86.6 |
83.7 to 89.2 |
1191 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
89.6 |
87.0 to 91.7 |
1746 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
88.4 |
84.2 to 91.5 |
1305 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
96.3 |
93.2 to 98.0 |
337 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
88.9 |
84.1 to 92.3 |
318 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
86.6 |
81.6 to 90.4 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
90.7 |
86.2 to 93.8 |
284 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
83.4 |
80.6 to 85.9 |
2079 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
86.2 |
80.7 to 90.4 |
298 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
82.8 |
75.1 to 88.5 |
186 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
83.8 |
76.9 to 89.0 |
314 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
84.7 |
79.2 to 88.9 |
364 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
83.1 |
79.4 to 86.2 |
917 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
83.7 |
79.9 to 86.9 |
1266 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
89.9 |
85.0 to 93.4 |
310 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
95.1 |
91.8 to 97.1 |
324 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
90.3 |
83.8 to 94.4 |
327 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
82.0 |
75.2 to 87.3 |
286 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
87.9 |
83.0 to 91.6 |
337 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
87.2 |
82.1 to 91.0 |
332 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
89.1 |
83.8 to 92.7 |
241 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
91.8 |
87.1 to 94.9 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
81.7 |
76.6 to 85.9 |
426 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
89.9 |
85.7 to 93.0 |
308 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
93.4 |
89.3 to 96.0 |
329 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
86.3 |
78.9 to 91.5 |
274 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
91.3 |
85.8 to 94.8 |
262 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
96.5 |
93.1 to 98.3 |
294 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
89.7 |
84.5 to 93.2 |
308 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
86.0 |
78.9 to 90.9 |
282 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
95.6 |
91.4 to 97.8 |
329 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
92.5 |
87.7 to 95.5 |
315 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
78.7 |
72.3 to 84.0 |
278 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
83.4 |
77.2 to 88.1 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
88.0 |
82.5 to 91.9 |
332 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
90.4 |
86.8 to 93.2 |
602 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
90.4 |
82.0 to 95.2 |
160 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
90.4 |
86.2 to 93.5 |
442 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
93.1 |
88.2 to 96.0 |
289 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
94.1 |
90.6 to 96.3 |
302 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
91.9 |
88.3 to 94.5 |
381 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
89.2 |
84.3 to 92.8 |
292 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
94.1 |
89.9 to 96.7 |
336 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
91.9 |
87.8 to 94.7 |
316 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
91.6 |
87.1 to 94.6 |
524 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
95.7 |
91.1 to 98.0 |
300 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
89.2 |
84.2 to 92.8 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
90.0 |
83.2 to 94.2 |
276 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
90.4 |
84.4 to 94.2 |
270 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
82.4 |
76.2 to 87.2 |
288 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
90.1 |
85.1 to 93.5 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
91.2 |
85.6 to 94.7 |
285 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
89.0 |
83.6 to 92.8 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
94.2 |
89.9 to 96.8 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
89.0 |
83.6 to 92.8 |
331 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
87.8 |
83.3 to 91.2 |
405 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
93.4 |
90.5 to 95.4 |
498 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
88.9 |
83.4 to 92.8 |
257 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
96.2 |
92.5 to 98.1 |
241 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
92.0 |
86.7 to 95.3 |
305 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
96.7 |
94.5 to 98.1 |
319 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
94.2 |
90.7 to 96.4 |
302 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
88.0 |
83.7 to 91.3 |
369 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
90.2 |
84.8 to 93.8 |
270 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
93.8 |
90.3 to 96.0 |
734 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
92.9 |
87.1 to 96.2 |
242 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
93.9 |
89.9 to 96.3 |
492 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
86.9 |
76.5 to 93.1 |
216 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
90.2 |
89.2 to 91.1 |
18788 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
95.4 |
93.5 to 96.8 |
2034 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
91.9 |
89.4 to 93.9 |
829 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
91.5 |
89.2 to 93.4 |
2520 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
92.5 |
90.9 to 93.9 |
2387 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
91.4 |
89.7 to 92.8 |
2097 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
86.7 |
84.7 to 88.5 |
3289 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
88.3 |
85.4 to 90.6 |
1256 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
90.0 |
87.1 to 92.3 |
1845 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
86.9 |
81.3 to 91.1 |
1199 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
96.4 |
93.7 to 97.9 |
319 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
91.9 |
87.9 to 94.7 |
319 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
90.0 |
85.2 to 93.4 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
89.1 |
83.5 to 93.0 |
261 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
84.8 |
81.9 to 87.3 |
1850 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
83.8 |
77.3 to 88.7 |
293 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
91.8 |
85.7 to 95.4 |
174 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
84.6 |
78.8 to 89.1 |
271 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
89.1 |
84.0 to 92.7 |
280 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
84.1 |
80.3 to 87.3 |
832 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
79.2 |
71.2 to 85.4 |
218 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
89.2 |
86.4 to 91.4 |
1332 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
86.8 |
80.7 to 91.3 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
94.3 |
90.8 to 96.6 |
472 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
89.1 |
82.4 to 93.5 |
363 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
89.8 |
85.1 to 93.1 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
89.4 |
84.4 to 92.9 |
309 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
90.7 |
86.1 to 93.9 |
331 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
90.7 |
85.9 to 94.0 |
329 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
92.1 |
87.5 to 95.1 |
298 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
85.8 |
80.2 to 90.0 |
302 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
86.6 |
81.5 to 90.4 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
94.2 |
90.5 to 96.5 |
322 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
89.6 |
84.2 to 93.3 |
403 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
90.0 |
85.1 to 93.4 |
354 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
94.0 |
89.6 to 96.5 |
331 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
85.4 |
79.7 to 89.7 |
360 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
85.8 |
79.9 to 90.2 |
404 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
86.1 |
79.6 to 90.8 |
355 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
90.8 |
85.4 to 94.3 |
300 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
74.5 |
68.0 to 80.0 |
300 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
83.7 |
77.7 to 88.3 |
290 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
87.0 |
81.7 to 90.9 |
376 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
91.4 |
88.2 to 93.8 |
699 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
88.2 |
81.4 to 92.8 |
271 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
92.1 |
88.3 to 94.7 |
428 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
94.4 |
90.9 to 96.6 |
302 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
91.4 |
87.3 to 94.3 |
280 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
89.4 |
84.6 to 92.8 |
364 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
93.7 |
89.7 to 96.2 |
255 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
92.1 |
87.9 to 94.9 |
356 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
93.3 |
89.4 to 95.9 |
372 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
90.2 |
86.9 to 92.7 |
815 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
93.0 |
88.9 to 95.6 |
394 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
91.9 |
87.5 to 94.8 |
398 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
92.8 |
88.3 to 95.6 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
93.0 |
88.9 to 95.6 |
282 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
84.2 |
78.6 to 88.6 |
397 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
87.0 |
80.7 to 91.4 |
307 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
91.3 |
87.3 to 94.1 |
405 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
86.9 |
81.0 to 91.1 |
369 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
94.5 |
91.4 to 96.5 |
381 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
94.5 |
90.2 to 97.0 |
379 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
89.3 |
84.9 to 92.6 |
352 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
93.0 |
90.2 to 95.1 |
729 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
91.6 |
87.2 to 94.6 |
381 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
93.9 |
89.7 to 96.5 |
348 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
92.5 |
87.3 to 95.7 |
327 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
91.0 |
85.9 to 94.4 |
401 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
93.4 |
90.0 to 95.7 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
83.8 |
78.3 to 88.2 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
87.4 |
82.0 to 91.4 |
308 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
95.2 |
92.5 to 96.9 |
765 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
90.1 |
84.7 to 93.8 |
263 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
95.8 |
92.7 to 97.7 |
502 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
70.0 |
58.5 to 79.4 |
169 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
90.1 |
89.2 to 90.9 |
20163 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
93.6 |
91.6 to 95.1 |
2147 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
93.5 |
91.3 to 95.2 |
1108 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
92.3 |
90.7 to 93.7 |
3331 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
89.8 |
87.6 to 91.6 |
2466 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
92.5 |
91.1 to 93.7 |
2344 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
85.7 |
82.8 to 88.3 |
2509 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
87.9 |
85.3 to 90.2 |
1446 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
90.2 |
87.8 to 92.3 |
2007 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
88.9 |
84.8 to 92.0 |
1402 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
94.4 |
90.0 to 96.9 |
271 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
89.2 |
83.6 to 93.0 |
311 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
91.5 |
86.8 to 94.6 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
88.8 |
84.0 to 92.3 |
338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
84.0 |
79.9 to 87.5 |
1141 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
87.2 |
82.1 to 90.9 |
314 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
87.6 |
80.9 to 92.1 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
83.5 |
78.7 to 87.4 |
606 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
89.2 |
86.3 to 91.5 |
1403 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
91.3 |
86.7 to 94.4 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
95.1 |
92.4 to 96.9 |
398 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
90.9 |
86.5 to 94.0 |
677 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
91.1 |
86.2 to 94.4 |
417 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
92.2 |
87.7 to 95.2 |
310 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
91.6 |
86.8 to 94.7 |
277 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
87.7 |
82.2 to 91.7 |
324 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
91.2 |
85.8 to 94.6 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
81.7 |
75.3 to 86.8 |
268 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
89.4 |
84.9 to 92.7 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
94.9 |
90.8 to 97.2 |
314 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
89.1 |
82.6 to 93.3 |
286 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
90.2 |
84.7 to 93.8 |
298 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
93.9 |
89.3 to 96.6 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
89.6 |
85.0 to 93.0 |
310 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
87.3 |
82.2 to 91.1 |
409 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
89.7 |
83.1 to 93.9 |
312 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
92.7 |
87.1 to 95.9 |
260 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
72.7 |
64.7 to 79.4 |
225 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
88.6 |
83.2 to 92.5 |
258 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
89.4 |
84.1 to 93.1 |
334 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
89.5 |
85.7 to 92.4 |
578 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
88.9 |
79.7 to 94.3 |
144 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
89.6 |
85.3 to 92.8 |
434 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
87.9 |
82.1 to 91.9 |
268 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
92.3 |
86.1 to 95.9 |
199 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
87.8 |
81.7 to 92.1 |
300 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
83.5 |
76.5 to 88.7 |
240 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
93.1 |
88.4 to 96.0 |
303 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
89.7 |
84.4 to 93.4 |
293 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
89.5 |
86.4 to 91.9 |
857 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
94.3 |
88.2 to 97.4 |
266 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
85.4 |
79.0 to 90.1 |
358 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
90.5 |
85.0 to 94.1 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
89.1 |
83.5 to 92.9 |
303 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
89.6 |
84.6 to 93.1 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
88.8 |
83.6 to 92.5 |
290 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
92.3 |
88.0 to 95.1 |
315 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
91.2 |
85.8 to 94.6 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
94.9 |
90.5 to 97.3 |
282 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
88.9 |
82.7 to 93.1 |
292 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
87.8 |
82.5 to 91.7 |
337 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
87.3 |
83.4 to 90.4 |
581 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
82.6 |
76.3 to 87.4 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
90.5 |
85.1 to 94.0 |
284 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
94.5 |
88.9 to 97.4 |
266 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
94.9 |
90.0 to 97.5 |
191 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
90.8 |
84.4 to 94.8 |
254 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
85.4 |
79.4 to 89.9 |
240 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
85.6 |
79.6 to 90.1 |
294 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
91.1 |
88.2 to 93.4 |
929 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
88.9 |
83.8 to 92.6 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
91.4 |
88.1 to 93.9 |
599 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
85.4 |
80.5 to 89.3 |
350 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
89.6 |
88.6 to 90.5 |
18002 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
93.8 |
91.2 to 95.7 |
1923 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
87.9 |
84.7 to 90.5 |
873 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
89.7 |
87.7 to 91.4 |
3338 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
91.0 |
88.8 to 92.8 |
2263 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
89.4 |
87.3 to 91.1 |
2060 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
88.1 |
85.3 to 90.4 |
2184 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
90.2 |
87.6 to 92.4 |
1154 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
91.6 |
89.0 to 93.6 |
1789 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
89.2 |
84.4 to 92.7 |
1173 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
93.8 |
87.2 to 97.1 |
254 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
91.1 |
86.1 to 94.4 |
263 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
95.6 |
92.3 to 97.5 |
445 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
92.0 |
87.3 to 95.0 |
315 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
87.1 |
83.1 to 90.3 |
990 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
84.3 |
78.6 to 88.7 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
86.0 |
76.9 to 91.9 |
167 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
87.4 |
82.8 to 90.9 |
527 |
| Tdap |
>=1 Dose |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
81.5 |
73.7 to 87.4 |
245 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
86.9 |
83.6 to 89.6 |
1245 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
92.9 |
88.3 to 95.8 |
304 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
94.2 |
91.4 to 96.2 |
488 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
88.3 |
82.5 to 92.4 |
566 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
87.4 |
81.6 to 91.5 |
349 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
88.4 |
83.6 to 92.0 |
267 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
93.5 |
89.5 to 96.1 |
306 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
89.8 |
83.9 to 93.7 |
261 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
93.4 |
89.0 to 96.1 |
269 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
83.0 |
76.0 to 88.2 |
240 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
85.2 |
78.9 to 89.8 |
273 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
93.6 |
90.2 to 95.9 |
332 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
82.7 |
76.0 to 87.9 |
321 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
92.4 |
88.6 to 95.0 |
342 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
92.7 |
87.7 to 95.8 |
258 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
88.2 |
81.8 to 92.6 |
250 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
89.7 |
84.1 to 93.5 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
96.0 |
93.2 to 97.6 |
307 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
91.1 |
86.0 to 94.5 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
72.6 |
64.3 to 79.5 |
240 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
90.6 |
85.8 to 94.0 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
89.9 |
84.1 to 93.8 |
251 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
93.6 |
90.3 to 95.9 |
630 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
90.5 |
85.2 to 94.1 |
256 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
94.3 |
90.1 to 96.8 |
374 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
94.2 |
90.1 to 96.6 |
258 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
97.3 |
91.0 to 99.2 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
89.2 |
83.7 to 93.0 |
310 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
86.4 |
79.9 to 91.0 |
276 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
94.1 |
89.8 to 96.7 |
330 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
94.4 |
90.1 to 96.9 |
268 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
89.0 |
81.9 to 93.5 |
346 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
94.1 |
89.5 to 96.8 |
268 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
92.7 |
88.0 to 95.7 |
257 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
93.8 |
90.0 to 96.2 |
331 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
87.0 |
80.3 to 91.6 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
90.0 |
85.2 to 93.3 |
284 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
89.6 |
84.5 to 93.2 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
90.1 |
84.9 to 93.6 |
247 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
89.2 |
83.9 to 92.9 |
259 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
92.8 |
87.9 to 95.8 |
225 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
86.0 |
80.0 to 90.4 |
289 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
84.1 |
77.6 to 89.0 |
276 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
90.4 |
86.9 to 93.0 |
536 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
91.7 |
86.1 to 95.2 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
89.5 |
84.6 to 93.0 |
314 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
91.2 |
86.3 to 94.5 |
361 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
93.8 |
89.1 to 96.6 |
280 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
91.7 |
86.0 to 95.2 |
269 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
89.6 |
84.6 to 93.1 |
249 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
90.7 |
86.1 to 93.9 |
263 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
93.9 |
90.7 to 96.1 |
752 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
93.2 |
88.1 to 96.2 |
267 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
94.0 |
90.4 to 96.4 |
485 |
| Tdap |
>=1 Dose |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
85.5 |
81.6 to 88.6 |
671 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
89.9 |
88.9 to 90.9 |
16043 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
93.7 |
91.4 to 95.4 |
1595 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
88.9 |
85.9 to 91.3 |
825 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
91.4 |
89.4 to 93.1 |
2424 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
92.3 |
90.8 to 93.6 |
2291 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
92.8 |
91.0 to 94.2 |
2019 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
86.9 |
83.3 to 89.8 |
1981 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
91.4 |
89.0 to 93.4 |
1048 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
92.6 |
90.3 to 94.3 |
1736 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
83.7 |
78.5 to 87.8 |
1090 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
95.1 |
91.3 to 97.3 |
285 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
93.6 |
88.4 to 96.5 |
269 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
93.5 |
88.6 to 96.4 |
252 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
90.6 |
84.6 to 94.4 |
244 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
85.0 |
79.9 to 89.0 |
794 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
88.1 |
81.6 to 92.5 |
253 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
89.1 |
81.1 to 94.0 |
157 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
84.5 |
78.6 to 89.0 |
384 |
| Tdap |
>=1 Dose |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
92.4 |
90.1 to 94.1 |
1034 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
93.5 |
87.9 to 96.6 |
271 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
92.1 |
87.0 to 95.3 |
291 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
89.7 |
85.9 to 92.6 |
595 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
94.9 |
91.3 to 97.1 |
280 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
92.7 |
88.5 to 95.4 |
244 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
90.2 |
85.0 to 93.7 |
274 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
89.1 |
83.7 to 92.8 |
294 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Other |
85.2 |
75.7 to 91.4 |
138 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Other |
82.0 |
75.8 to 86.9 |
316 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Other |
82.1 |
72.0 to 89.1 |
119 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Other |
93.8 |
88.4 to 96.7 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Other |
86.5 |
66.8 to 95.3 |
132 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Other |
93.7 |
87.8 to 96.9 |
133 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Other |
92.9 |
85.7 to 96.6 |
211 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Other |
88.0 |
75.4 to 94.6 |
72 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Other |
95.6 |
84.5 to 98.9 |
44 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Other |
92.3 |
85.8 to 96.0 |
147 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Other |
95.5 |
91.3 to 97.7 |
158 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Other |
86.4 |
78.7 to 91.6 |
157 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Other |
79.4 |
65.2 to 88.9 |
94 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Other |
81.3 |
67.6 to 90.1 |
101 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
81.7 |
65.9 to 91.1 |
73 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Other |
94.1 |
81.5 to 98.3 |
41 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Other |
91.2 |
84.2 to 95.3 |
103 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Other |
88.5 |
83.0 to 92.4 |
316 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Other |
91.1 |
80.6 to 96.1 |
78 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Other |
91.7 |
82.3 to 96.3 |
67 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Other |
89.5 |
78.8 to 95.2 |
83 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Other |
95.9 |
92.3 to 97.8 |
180 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Other |
95.9 |
88.0 to 98.7 |
67 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Other |
93.3 |
85.0 to 97.2 |
72 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Other |
85.1 |
64.6 to 94.7 |
49 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Other |
87.2 |
75.4 to 93.8 |
105 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Other |
84.4 |
72.4 to 91.8 |
85 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Other |
88.7 |
80.4 to 93.7 |
150 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Other |
96.3 |
87.7 to 99.0 |
89 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Other |
88.1 |
78.5 to 93.8 |
124 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Other |
93.1 |
79.3 to 98.0 |
72 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Other |
82.5 |
59.4 to 93.8 |
47 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Other |
92.3 |
85.8 to 96.0 |
103 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Other |
91.0 |
87.0 to 93.8 |
365 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Other |
85.4 |
77.4 to 90.9 |
176 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
94.4 |
89.8 to 97.0 |
189 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Other |
93.2 |
87.6 to 96.4 |
153 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Other |
94.6 |
88.7 to 97.5 |
148 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Other |
81.3 |
66.5 to 90.5 |
65 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Other |
86.4 |
79.0 to 91.5 |
217 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Other |
91.8 |
86.2 to 95.3 |
122 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Other |
86.1 |
76.9 to 92.0 |
305 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Other |
95.2 |
87.5 to 98.2 |
143 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
84.3 |
73.5 to 91.3 |
162 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Other |
89.0 |
87.4 to 90.4 |
7253 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Other |
89.5 |
70.2 to 96.9 |
54 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Other |
86.0 |
75.3 to 92.6 |
98 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Other |
90.9 |
81.5 to 95.8 |
135 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Other |
88.1 |
79.2 to 93.4 |
123 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Other |
87.4 |
83.1 to 90.7 |
705 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Other |
84.2 |
76.1 to 89.9 |
211 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Other |
90.8 |
77.1 to 96.6 |
72 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
87.6 |
82.4 to 91.4 |
422 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Other |
92.7 |
82.0 to 97.3 |
103 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Other |
93.6 |
80.5 to 98.1 |
78 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Other |
84.9 |
76.3 to 90.7 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Other |
90.4 |
82.2 to 95.0 |
143 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Other |
94.9 |
87.6 to 98.0 |
99 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Other |
77.8 |
60.4 to 88.9 |
55 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Other |
89.1 |
76.6 to 95.4 |
113 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
93.5 |
91.0 to 95.3 |
806 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
83.6 |
79.9 to 86.8 |
794 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
87.4 |
84.2 to 90.1 |
826 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
94.5 |
92.4 to 96.1 |
752 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
88.3 |
85.1 to 90.9 |
951 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.1 |
89.8 to 94.0 |
950 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.4 |
93.5 to 96.7 |
1000 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.3 |
88.6 to 93.3 |
915 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
87.7 |
84.6 to 90.3 |
1006 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
93.0 |
90.3 to 95.0 |
892 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.5 |
89.8 to 94.5 |
886 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.0 |
87.5 to 92.1 |
797 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
87.1 |
84.0 to 89.7 |
911 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.5 |
90.8 to 94.0 |
1944 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
93.4 |
89.6 to 95.9 |
470 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.4 |
90.4 to 94.0 |
1474 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.3 |
89.8 to 94.3 |
847 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
96.0 |
94.2 to 97.3 |
769 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.6 |
87.9 to 92.7 |
970 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.1 |
85.8 to 91.6 |
743 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
93.2 |
90.6 to 95.2 |
756 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.1 |
89.6 to 94.0 |
943 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.0 |
87.7 to 92.0 |
2139 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
93.8 |
91.6 to 95.5 |
1143 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.6 |
89.1 to 93.5 |
1070 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.5 |
90.1 to 94.3 |
1092 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
88.9 |
85.5 to 91.6 |
617 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
86.7 |
83.9 to 89.1 |
1032 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.0 |
88.3 to 93.1 |
823 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.9 |
88.5 to 92.9 |
1027 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.7 |
86.7 to 92.2 |
889 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.9 |
94.2 to 97.0 |
1058 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.9 |
89.6 to 93.8 |
1192 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
88.1 |
84.9 to 90.8 |
721 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.6 |
90.8 to 94.0 |
1581 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.3 |
86.9 to 92.9 |
640 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
93.6 |
91.5 to 95.2 |
941 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.3 |
89.4 to 94.4 |
906 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
94.6 |
92.5 to 96.1 |
1015 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.2 |
89.6 to 94.2 |
951 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
85.1 |
81.4 to 88.2 |
632 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.3 |
86.4 to 91.6 |
858 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
94.3 |
92.6 to 95.6 |
2218 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.9 |
86.0 to 92.8 |
532 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
94.6 |
92.8 to 96.0 |
1686 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.8 |
90.3 to 91.3 |
54111 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
96.5 |
94.8 to 97.7 |
867 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.9 |
89.3 to 93.8 |
805 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.6 |
90.4 to 94.3 |
1100 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.3 |
87.5 to 92.6 |
814 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
85.5 |
83.3 to 87.4 |
3327 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
84.7 |
80.9 to 87.8 |
678 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.2 |
84.2 to 92.8 |
397 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
85.3 |
82.9 to 87.5 |
2252 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.4 |
87.9 to 92.5 |
1130 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
95.0 |
93.2 to 96.3 |
1194 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
91.1 |
88.6 to 93.1 |
1860 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.6 |
87.6 to 92.9 |
930 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
90.7 |
88.2 to 92.8 |
735 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.7 |
90.6 to 94.4 |
986 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
89.3 |
86.5 to 91.5 |
941 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.0 |
88.8 to 94.4 |
521 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Any Medicaid |
81.6 |
77.1 to 85.3 |
474 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.7 |
85.3 to 91.5 |
476 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.5 |
89.6 to 94.6 |
567 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Any Medicaid |
86.8 |
82.2 to 90.3 |
528 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Any Medicaid |
89.1 |
84.7 to 92.3 |
414 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Any Medicaid |
93.3 |
88.9 to 96.1 |
273 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Any Medicaid |
85.5 |
81.2 to 89.0 |
497 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
86.5 |
82.4 to 89.7 |
549 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.3 |
87.5 to 94.0 |
503 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.3 |
88.3 to 95.1 |
430 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Any Medicaid |
81.9 |
77.0 to 85.9 |
443 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.6 |
88.1 to 94.1 |
521 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.3 |
87.8 to 92.3 |
1112 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.4 |
83.8 to 91.9 |
496 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.0 |
87.9 to 93.3 |
616 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.4 |
86.8 to 93.1 |
467 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.3 |
86.9 to 94.3 |
373 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
89.1 |
83.9 to 92.8 |
290 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Any Medicaid |
86.1 |
81.9 to 89.4 |
473 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.6 |
89.8 to 94.7 |
748 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.3 |
86.7 to 93.0 |
496 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Any Medicaid |
87.8 |
83.4 to 91.2 |
569 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.8 |
88.1 to 95.8 |
332 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.4 |
84.0 to 91.8 |
449 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.8 |
85.8 to 94.2 |
348 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.1 |
87.5 to 93.8 |
589 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Any Medicaid |
83.9 |
79.2 to 87.7 |
445 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
85.4 |
81.1 to 88.9 |
481 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Any Medicaid |
89.0 |
84.1 to 92.5 |
364 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Any Medicaid |
86.9 |
82.8 to 90.2 |
497 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.9 |
89.1 to 95.4 |
361 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Any Medicaid |
84.0 |
78.6 to 88.3 |
362 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Any Medicaid |
86.9 |
83.6 to 89.6 |
794 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Any Medicaid |
89.2 |
86.4 to 91.4 |
897 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.4 |
85.1 to 91.1 |
580 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.0 |
85.2 to 93.4 |
317 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.3 |
87.5 to 94.1 |
471 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.5 |
85.2 to 94.1 |
267 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.9 |
89.7 to 95.2 |
451 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.3 |
85.1 to 90.9 |
659 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Any Medicaid |
85.5 |
80.9 to 89.2 |
430 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.2 |
89.4 to 94.2 |
1213 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.4 |
87.1 to 92.9 |
606 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
92.5 |
89.2 to 94.9 |
607 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Any Medicaid |
89.0 |
88.1 to 89.7 |
27403 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Any Medicaid |
94.1 |
90.8 to 96.2 |
508 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.9 |
87.4 to 93.5 |
523 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.9 |
86.9 to 93.8 |
381 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.8 |
87.9 to 94.5 |
439 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
84.7 |
81.4 to 87.5 |
2274 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.0 |
84.1 to 91.1 |
487 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Any Medicaid |
86.5 |
81.4 to 90.4 |
343 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
84.2 |
80.3 to 87.4 |
1444 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.6 |
86.1 to 95.1 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Any Medicaid |
93.0 |
90.3 to 95.0 |
690 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.8 |
82.8 to 92.8 |
319 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Any Medicaid |
87.7 |
83.8 to 90.8 |
544 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
89.0 |
85.7 to 91.7 |
603 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Any Medicaid |
88.3 |
84.2 to 91.4 |
454 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.4 |
86.0 to 93.6 |
316 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Uninsured |
75.9 |
58.3 to 87.6 |
44 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Uninsured |
76.0 |
63.7 to 85.1 |
84 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Uninsured |
87.2 |
74.5 to 94.1 |
63 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Uninsured |
75.0 |
55.9 to 87.6 |
37 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Uninsured |
91.5 |
77.9 to 97.0 |
32 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Uninsured |
79.4 |
64.9 to 88.9 |
50 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Uninsured |
83.6 |
71.1 to 91.4 |
98 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Uninsured |
83.1 |
71.1 to 90.8 |
79 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Uninsured |
85.7 |
71.3 to 93.5 |
58 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Uninsured |
88.9 |
76.0 to 95.3 |
73 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
90.3 |
72.6 to 97.0 |
44 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Uninsured |
92.1 |
80.9 to 97.0 |
58 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Uninsured |
84.1 |
69.7 to 92.4 |
76 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Uninsured |
73.3 |
51.7 to 87.6 |
39 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Uninsured |
95.9 |
88.0 to 98.7 |
38 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Uninsured |
80.5 |
64.6 to 90.4 |
44 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Uninsured |
86.4 |
69.1 to 94.7 |
47 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Uninsured |
89.7 |
70.7 to 96.9 |
32 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Uninsured |
88.1 |
76.9 to 94.3 |
61 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Uninsured |
79.3 |
64.1 to 89.2 |
66 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Uninsured |
92.8 |
80.5 to 97.6 |
67 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Uninsured |
85.4 |
74.9 to 92.0 |
98 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Uninsured |
89.4 |
64.3 to 97.5 |
33 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Uninsured |
91.8 |
80.2 to 96.8 |
41 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Uninsured |
76.1 |
54.8 to 89.3 |
47 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Uninsured |
88.3 |
68.1 to 96.4 |
36 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Uninsured |
89.6 |
77.0 to 95.7 |
70 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Uninsured |
82.9 |
64.7 to 92.8 |
48 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Uninsured |
85.7 |
70.4 to 93.8 |
48 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Uninsured |
89.8 |
72.4 to 96.8 |
93 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Uninsured |
97.3 |
90.9 to 99.3 |
58 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
87.7 |
65.7 to 96.4 |
35 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Uninsured |
83.9 |
81.0 to 86.4 |
2929 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Uninsured |
90.2 |
68.2 to 97.5 |
37 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Uninsured |
88.3 |
75.1 to 94.9 |
54 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Uninsured |
81.0 |
64.9 to 90.7 |
51 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Uninsured |
81.7 |
69.4 to 89.8 |
66 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Uninsured |
80.0 |
72.9 to 85.6 |
548 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Uninsured |
83.7 |
71.4 to 91.3 |
78 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Uninsured |
82.4 |
71.6 to 89.8 |
93 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
79.6 |
71.4 to 85.9 |
377 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Uninsured |
93.6 |
83.1 to 97.7 |
63 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Uninsured |
89.8 |
69.8 to 97.1 |
53 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Uninsured |
88.6 |
74.0 to 95.5 |
30 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Uninsured |
84.2 |
72.2 to 91.6 |
79 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Poverty |
Below Poverty Level |
91.1 |
86.0 to 94.5 |
258 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Poverty |
Below Poverty Level |
75.3 |
65.7 to 82.9 |
139 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Poverty |
Below Poverty Level |
92.1 |
87.8 to 95.0 |
230 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Poverty |
Below Poverty Level |
90.5 |
85.4 to 93.9 |
312 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Poverty |
Below Poverty Level |
89.5 |
83.4 to 93.6 |
251 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Poverty |
Below Poverty Level |
90.0 |
83.6 to 94.1 |
157 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Poverty |
Below Poverty Level |
92.4 |
84.8 to 96.4 |
146 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Poverty |
Below Poverty Level |
83.4 |
76.5 to 88.6 |
239 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Poverty |
Below Poverty Level |
89.4 |
83.4 to 93.4 |
268 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Poverty |
Below Poverty Level |
92.2 |
86.0 to 95.7 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Poverty |
Below Poverty Level |
93.0 |
87.8 to 96.0 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Poverty |
Below Poverty Level |
80.3 |
70.7 to 87.3 |
138 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Poverty |
Below Poverty Level |
84.8 |
76.3 to 90.6 |
173 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Poverty |
Below Poverty Level |
91.3 |
88.1 to 93.7 |
607 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Poverty |
Below Poverty Level |
88.4 |
82.9 to 92.3 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
92.5 |
88.3 to 95.3 |
294 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Poverty |
Below Poverty Level |
88.0 |
82.6 to 91.8 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Poverty |
Below Poverty Level |
92.5 |
85.9 to 96.2 |
147 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Poverty |
Below Poverty Level |
90.2 |
85.0 to 93.8 |
229 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Poverty |
Below Poverty Level |
88.8 |
83.0 to 92.8 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Poverty |
Below Poverty Level |
90.0 |
84.8 to 93.5 |
315 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Poverty |
Below Poverty Level |
89.1 |
82.3 to 93.5 |
158 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Poverty |
Below Poverty Level |
90.4 |
84.4 to 94.2 |
243 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Poverty |
Below Poverty Level |
90.8 |
83.6 to 95.0 |
158 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Poverty |
Below Poverty Level |
86.7 |
78.9 to 91.9 |
204 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Poverty |
Below Poverty Level |
82.8 |
70.5 to 90.6 |
96 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Poverty |
Below Poverty Level |
92.6 |
87.9 to 95.6 |
297 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Poverty |
Below Poverty Level |
87.1 |
80.6 to 91.6 |
206 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Poverty |
Below Poverty Level |
85.2 |
77.3 to 90.7 |
165 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Poverty |
Below Poverty Level |
88.9 |
82.2 to 93.2 |
202 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Poverty |
Below Poverty Level |
85.0 |
78.5 to 89.7 |
261 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Poverty |
Below Poverty Level |
95.1 |
86.4 to 98.3 |
105 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Poverty |
Below Poverty Level |
84.3 |
76.2 to 90.0 |
167 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Poverty |
Below Poverty Level |
85.1 |
79.8 to 89.2 |
411 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Poverty |
Below Poverty Level |
88.8 |
85.3 to 91.6 |
533 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Poverty |
Below Poverty Level |
86.5 |
82.0 to 90.0 |
377 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
91.9 |
85.4 to 95.7 |
156 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Poverty |
Below Poverty Level |
88.5 |
81.9 to 92.9 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Poverty |
Below Poverty Level |
92.3 |
82.5 to 96.8 |
109 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Poverty |
Below Poverty Level |
88.9 |
82.3 to 93.3 |
209 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Poverty |
Below Poverty Level |
86.2 |
80.8 to 90.3 |
276 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Poverty |
Below Poverty Level |
83.7 |
76.1 to 89.2 |
173 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Poverty |
Below Poverty Level |
88.9 |
83.9 to 92.4 |
580 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Poverty |
Below Poverty Level |
91.7 |
87.7 to 94.5 |
361 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
88.0 |
81.5 to 92.4 |
219 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Poverty |
Below Poverty Level |
88.8 |
87.7 to 89.9 |
12976 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Poverty |
Below Poverty Level |
92.0 |
85.7 to 95.7 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Poverty |
Below Poverty Level |
92.0 |
85.7 to 95.6 |
221 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Poverty |
Below Poverty Level |
93.7 |
88.5 to 96.7 |
157 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Poverty |
Below Poverty Level |
91.4 |
86.2 to 94.7 |
253 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Poverty |
Below Poverty Level |
84.7 |
80.4 to 88.2 |
1639 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Poverty |
Below Poverty Level |
88.7 |
83.7 to 92.3 |
322 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Poverty |
Below Poverty Level |
83.6 |
77.7 to 88.2 |
285 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
84.4 |
79.1 to 88.6 |
1032 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Poverty |
Below Poverty Level |
86.9 |
77.3 to 92.9 |
118 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Poverty |
Below Poverty Level |
95.3 |
90.8 to 97.6 |
149 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Poverty |
Below Poverty Level |
89.2 |
80.4 to 94.4 |
136 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Poverty |
Below Poverty Level |
83.5 |
76.0 to 89.0 |
193 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Poverty |
Below Poverty Level |
89.7 |
84.9 to 93.1 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Poverty |
Below Poverty Level |
92.0 |
85.3 to 95.8 |
168 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Poverty |
Below Poverty Level |
89.2 |
81.1 to 94.1 |
147 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.8 |
89.6 to 93.6 |
1182 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
83.1 |
80.5 to 85.4 |
1449 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
84.8 |
82.1 to 87.2 |
1217 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.1 |
92.5 to 95.4 |
1242 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
86.9 |
83.9 to 89.5 |
1338 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.1 |
88.8 to 92.9 |
1331 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.9 |
93.2 to 96.2 |
1306 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.7 |
87.3 to 91.7 |
1248 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
86.4 |
83.5 to 88.8 |
1290 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.4 |
89.1 to 93.3 |
1339 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
92.3 |
90.1 to 94.1 |
1292 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
87.3 |
85.0 to 89.3 |
1240 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
88.5 |
86.1 to 90.5 |
1378 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.3 |
89.6 to 92.7 |
2501 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.5 |
87.6 to 94.2 |
667 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.2 |
89.4 to 92.8 |
1834 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
92.7 |
90.6 to 94.3 |
1138 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.1 |
92.2 to 95.6 |
1087 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.3 |
86.9 to 91.3 |
1380 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
87.5 |
84.8 to 89.8 |
1077 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.1 |
92.2 to 95.5 |
1221 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.1 |
89.0 to 92.8 |
1360 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.2 |
88.2 to 91.9 |
2603 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.1 |
92.0 to 95.6 |
1335 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.2 |
89.2 to 92.9 |
1363 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
92.4 |
90.3 to 94.1 |
1373 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
88.3 |
85.4 to 90.7 |
1025 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
85.1 |
82.5 to 87.4 |
1385 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.5 |
87.2 to 91.4 |
1284 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.9 |
88.7 to 92.7 |
1308 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.2 |
86.8 to 91.2 |
1294 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.5 |
92.8 to 95.8 |
1375 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.8 |
88.6 to 92.6 |
1395 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.0 |
86.8 to 91.0 |
1199 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.9 |
90.4 to 93.2 |
2180 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.7 |
86.9 to 92.0 |
939 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
93.1 |
91.2 to 94.6 |
1241 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
92.6 |
90.4 to 94.3 |
1329 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
93.4 |
91.6 to 94.9 |
1322 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
92.0 |
89.9 to 93.7 |
1244 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
86.8 |
84.3 to 88.9 |
1240 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
88.8 |
86.5 to 90.8 |
1223 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
93.8 |
92.3 to 95.0 |
3096 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.4 |
88.7 to 93.5 |
916 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.0 |
92.4 to 95.3 |
2180 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.0 |
89.5 to 90.4 |
75678 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
95.8 |
94.1 to 97.0 |
1187 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.3 |
88.1 to 92.1 |
1214 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.3 |
89.2 to 92.9 |
1467 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.7 |
87.3 to 91.7 |
1143 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
85.0 |
83.2 to 86.7 |
4915 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
84.8 |
81.8 to 87.4 |
1090 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.2 |
86.4 to 93.0 |
562 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
84.8 |
82.7 to 86.6 |
3263 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
91.8 |
89.7 to 93.6 |
1362 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
94.4 |
92.8 to 95.6 |
1780 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.4 |
86.9 to 91.4 |
2323 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.2 |
87.9 to 92.1 |
1392 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.3 |
88.2 to 92.1 |
1129 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
90.2 |
88.1 to 92.0 |
1306 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
89.5 |
87.2 to 91.4 |
1271 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
94.8 |
90.9 to 97.1 |
273 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
90.1 |
70.5 to 97.2 |
37 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
84.9 |
72.5 to 92.3 |
48 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
95.2 |
89.6 to 97.8 |
143 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
88.0 |
71.4 to 95.6 |
72 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
93.4 |
85.5 to 97.1 |
120 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.7 |
82.1 to 91.7 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.4 |
83.6 to 90.3 |
534 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
93.3 |
87.1 to 96.7 |
178 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.5 |
87.1 to 94.4 |
376 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.4 |
82.9 to 90.8 |
389 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
85.4 |
78.3 to 90.5 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
88.7 |
82.4 to 92.9 |
171 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
88.2 |
79.5 to 93.5 |
107 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
94.1 |
81.7 to 98.3 |
37 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
90.9 |
72.9 to 97.4 |
48 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.9 |
75.5 to 94.5 |
78 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.7 |
87.8 to 94.5 |
318 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.2 |
85.3 to 92.1 |
638 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
94.3 |
86.4 to 97.8 |
96 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.8 |
79.4 to 93.1 |
139 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
85.2 |
71.4 to 93.0 |
73 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
90.1 |
85.7 to 93.3 |
376 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
82.2 |
73.0 to 88.7 |
106 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.5 |
80.7 to 96.5 |
54 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
84.6 |
74.7 to 91.0 |
116 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
80.6 |
70.8 to 87.7 |
122 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.7 |
85.4 to 92.8 |
322 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
88.7 |
83.5 to 92.5 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.1 |
82.4 to 95.7 |
90 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.1 |
85.3 to 94.7 |
196 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
86.3 |
67.6 to 95.0 |
40 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
96.9 |
92.9 to 98.7 |
127 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.4 |
81.3 to 96.3 |
67 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.5 |
82.0 to 91.5 |
667 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
90.4 |
86.8 to 93.1 |
490 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
85.2 |
75.4 to 91.5 |
177 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.5 |
88.3 to 90.6 |
7808 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
96.0 |
90.8 to 98.3 |
82 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
90.6 |
85.6 to 94.0 |
249 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
90.9 |
84.6 to 94.9 |
150 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
83.9 |
78.0 to 88.4 |
532 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
86.1 |
72.9 to 93.4 |
67 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.5 |
82.5 to 93.9 |
131 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
83.1 |
76.3 to 88.3 |
334 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.0 |
82.5 to 93.3 |
240 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
86.3 |
69.3 to 94.6 |
48 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
90.4 |
72.9 to 97.0 |
35 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.1 |
77.0 to 93.2 |
87 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Hispanic |
83.0 |
72.1 to 90.3 |
101 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Hispanic |
82.9 |
74.2 to 89.2 |
134 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.1 |
84.4 to 91.0 |
511 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Hispanic |
90.3 |
83.2 to 94.6 |
163 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Hispanic |
87.1 |
83.0 to 90.4 |
604 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.1 |
89.7 to 95.5 |
365 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Hispanic |
92.3 |
87.4 to 95.4 |
286 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.6 |
82.7 to 92.6 |
238 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.2 |
82.4 to 92.3 |
325 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Hispanic |
90.8 |
86.5 to 93.8 |
465 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.7 |
81.2 to 93.5 |
218 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
Hispanic |
87.1 |
81.4 to 91.3 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.8 |
88.5 to 96.8 |
207 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Hispanic |
90.4 |
87.3 to 92.8 |
865 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.2 |
87.5 to 93.9 |
460 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
90.0 |
85.6 to 93.2 |
405 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Hispanic |
89.2 |
82.8 to 93.4 |
175 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Hispanic |
96.4 |
91.4 to 98.5 |
119 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.7 |
82.7 to 92.8 |
258 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Hispanic |
86.5 |
75.8 to 92.9 |
104 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Hispanic |
89.9 |
78.7 to 95.6 |
133 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
Hispanic |
86.0 |
68.7 to 94.5 |
64 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.2 |
76.8 to 89.5 |
440 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.8 |
85.2 to 95.7 |
214 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Hispanic |
81.4 |
70.1 to 89.2 |
119 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Hispanic |
87.8 |
77.8 to 93.7 |
113 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Hispanic |
95.9 |
90.1 to 98.4 |
76 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Hispanic |
85.1 |
73.6 to 92.1 |
107 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
Hispanic |
86.8 |
74.0 to 93.9 |
100 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.5 |
82.2 to 92.7 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.4 |
84.5 to 91.4 |
532 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.9 |
87.6 to 97.2 |
87 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Hispanic |
89.7 |
84.8 to 93.2 |
336 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
Hispanic |
87.1 |
84.0 to 89.6 |
921 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Hispanic |
89.7 |
86.8 to 92.0 |
789 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.3 |
84.6 to 91.2 |
552 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.9 |
86.5 to 95.3 |
237 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.9 |
82.1 to 93.4 |
223 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Hispanic |
89.8 |
77.9 to 95.7 |
67 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Hispanic |
92.1 |
84.2 to 96.2 |
117 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Hispanic |
85.7 |
78.5 to 90.8 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
Hispanic |
87.6 |
82.0 to 91.6 |
239 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Hispanic |
92.8 |
88.5 to 95.6 |
534 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.4 |
86.2 to 94.8 |
290 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.3 |
87.5 to 96.5 |
244 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.0 |
86.8 to 89.1 |
16518 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.7 |
89.1 to 96.5 |
335 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Hispanic |
95.0 |
88.2 to 97.9 |
150 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.5 |
77.9 to 94.4 |
78 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.3 |
87.9 to 96.4 |
148 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.5 |
82.0 to 86.7 |
3535 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Hispanic |
85.4 |
82.3 to 88.0 |
907 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.9 |
80.3 to 88.6 |
479 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.4 |
81.3 to 87.0 |
2149 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
Hispanic |
92.7 |
86.7 to 96.2 |
193 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
Hispanic |
98.3 |
88.8 to 99.8 |
63 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Hispanic |
85.6 |
77.5 to 91.1 |
289 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Hispanic |
90.5 |
85.4 to 93.9 |
294 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Hispanic |
86.4 |
70.8 to 94.4 |
60 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Hispanic |
91.6 |
85.5 to 95.2 |
165 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.6 |
81.2 to 93.4 |
177 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
95.2 |
87.5 to 98.2 |
108 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
82.9 |
78.1 to 86.9 |
477 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
85.9 |
78.5 to 91.0 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.6 |
81.7 to 94.3 |
132 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.0 |
80.1 to 90.3 |
333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
85.5 |
76.4 to 91.5 |
145 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.7 |
87.7 to 97.8 |
155 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
85.3 |
77.2 to 90.8 |
167 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
81.7 |
70.7 to 89.2 |
133 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.4 |
84.4 to 96.5 |
149 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.9 |
84.9 to 95.8 |
159 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.6 |
83.6 to 89.1 |
902 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
85.2 |
75.1 to 91.6 |
113 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.9 |
87.9 to 95.9 |
340 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.7 |
86.2 to 98.1 |
84 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.7 |
87.2 to 95.9 |
256 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.9 |
84.3 to 96.9 |
118 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
95.4 |
89.4 to 98.1 |
88 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
84.0 |
74.7 to 90.3 |
166 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.9 |
77.1 to 92.9 |
118 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
93.5 |
87.8 to 96.6 |
152 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.3 |
79.7 to 94.6 |
117 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.2 |
90.8 to 96.4 |
376 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
95.9 |
90.3 to 98.3 |
183 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
90.8 |
84.5 to 94.7 |
155 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.2 |
88.0 to 97.3 |
167 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.1 |
81.8 to 95.9 |
98 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
87.5 |
78.6 to 93.0 |
143 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.2 |
82.9 to 93.4 |
185 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
94.7 |
88.7 to 97.6 |
107 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.3 |
83.6 to 93.2 |
217 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
95.1 |
88.2 to 98.0 |
133 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.4 |
86.5 to 95.9 |
284 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
90.3 |
83.0 to 94.7 |
148 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.6 |
85.0 to 92.9 |
435 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
90.6 |
85.3 to 94.2 |
256 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
88.7 |
80.9 to 93.6 |
179 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
90.5 |
82.8 to 94.9 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.4 |
86.1 to 96.0 |
187 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.2 |
85.3 to 94.9 |
138 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
88.7 |
84.8 to 91.7 |
426 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
83.2 |
75.2 to 89.0 |
182 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.4 |
82.6 to 93.8 |
420 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
93.4 |
87.8 to 96.5 |
165 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
88.9 |
81.1 to 93.8 |
255 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.3 |
88.1 to 90.5 |
10891 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
98.8 |
95.7 to 99.7 |
131 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
90.6 |
82.8 to 95.1 |
94 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.7 |
88.3 to 95.6 |
262 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
93.2 |
86.0 to 96.9 |
123 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.8 |
81.3 to 90.9 |
546 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
88.2 |
79.5 to 93.5 |
96 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.9 |
78.9 to 95.5 |
82 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.6 |
80.4 to 91.0 |
368 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
92.8 |
85.1 to 96.7 |
91 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.0 |
81.0 to 93.9 |
134 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
87.6 |
80.9 to 92.2 |
445 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.0 |
79.3 to 90.8 |
291 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.6 |
80.7 to 94.7 |
102 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
93.0 |
86.5 to 96.5 |
139 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.5 |
83.1 to 95.9 |
103 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.6 |
87.9 to 92.7 |
1012 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
81.5 |
78.2 to 84.4 |
980 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.9 |
82.5 to 88.6 |
759 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
93.8 |
92.1 to 95.2 |
1167 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.1 |
84.7 to 92.3 |
631 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.8 |
88.1 to 92.9 |
999 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
95.6 |
93.9 to 96.9 |
955 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.4 |
86.3 to 91.8 |
897 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
86.4 |
82.7 to 89.4 |
623 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
91.1 |
87.9 to 93.4 |
848 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.1 |
91.9 to 95.7 |
800 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.0 |
79.5 to 89.3 |
279 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
87.1 |
84.4 to 89.4 |
1245 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
92.7 |
90.9 to 94.2 |
1636 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
96.2 |
92.5 to 98.1 |
261 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
92.5 |
90.6 to 94.1 |
1375 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
92.4 |
90.1 to 94.1 |
1013 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
93.4 |
91.3 to 95.0 |
1024 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.5 |
88.2 to 92.4 |
1180 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
87.7 |
84.9 to 89.9 |
1033 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.0 |
91.9 to 95.6 |
1006 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
91.6 |
89.7 to 93.2 |
1356 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.7 |
87.9 to 92.9 |
1481 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
93.7 |
91.3 to 95.4 |
1063 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
92.3 |
90.2 to 93.9 |
1210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
92.3 |
90.0 to 94.1 |
1165 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
88.9 |
86.0 to 91.2 |
822 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.8 |
83.2 to 88.0 |
1272 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
88.7 |
86.2 to 90.8 |
1181 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.8 |
88.4 to 92.8 |
1149 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
88.9 |
85.6 to 91.5 |
743 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
95.0 |
93.3 to 96.2 |
1287 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.4 |
87.6 to 92.6 |
900 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
86.7 |
82.9 to 89.7 |
567 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
92.8 |
91.0 to 94.3 |
1333 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
88.0 |
82.8 to 91.8 |
378 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.0 |
92.0 to 95.6 |
955 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
93.5 |
91.2 to 95.2 |
994 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.2 |
92.4 to 95.7 |
1184 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.9 |
88.3 to 92.9 |
1110 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.3 |
82.2 to 88.0 |
841 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.5 |
86.9 to 91.6 |
988 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.3 |
92.7 to 95.6 |
2208 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
91.1 |
86.7 to 94.1 |
394 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.4 |
92.7 to 95.8 |
1814 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.8 |
90.3 to 91.2 |
56479 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
95.1 |
92.9 to 96.7 |
918 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.5 |
88.1 to 92.5 |
987 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
91.3 |
89.1 to 93.1 |
1302 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.3 |
86.6 to 91.5 |
1021 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.4 |
82.7 to 87.8 |
2241 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
87.4 |
81.9 to 91.3 |
384 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
93.4 |
88.9 to 96.2 |
213 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.1 |
82.1 to 87.6 |
1644 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.6 |
88.2 to 92.6 |
1210 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
94.7 |
93.2 to 95.8 |
1750 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
91.5 |
88.8 to 93.6 |
1554 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.7 |
86.8 to 91.9 |
1003 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.3 |
88.3 to 92.0 |
1270 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
90.5 |
88.2 to 92.4 |
1129 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.2 |
86.7 to 91.3 |
1153 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
93.8 |
91.2 to 95.7 |
628 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
83.8 |
80.5 to 86.6 |
896 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
85.8 |
82.7 to 88.4 |
835 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
94.0 |
91.1 to 96.0 |
557 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
87.8 |
84.1 to 90.7 |
806 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.7 |
88.9 to 93.8 |
778 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.4 |
86.8 to 94.5 |
350 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.1 |
87.5 to 93.7 |
506 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
87.1 |
84.6 to 89.2 |
1615 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.8 |
87.6 to 93.2 |
914 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
94.0 |
90.2 to 96.3 |
475 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
86.4 |
82.3 to 89.7 |
471 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
89.1 |
85.3 to 92.0 |
581 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.3 |
89.1 to 93.2 |
1398 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.2 |
87.3 to 92.5 |
1023 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
92.8 |
88.8 to 95.5 |
375 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.8 |
85.2 to 91.6 |
604 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
94.0 |
90.2 to 96.4 |
393 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.3 |
86.9 to 92.9 |
625 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
87.3 |
83.2 to 90.6 |
502 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
93.0 |
90.0 to 95.1 |
646 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.5 |
85.5 to 93.9 |
250 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
89.4 |
85.5 to 92.4 |
884 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
94.0 |
88.8 to 96.8 |
268 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.7 |
86.4 to 93.7 |
450 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.0 |
87.7 to 93.6 |
659 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.5 |
81.5 to 93.1 |
214 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.3 |
84.4 to 91.3 |
619 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.3 |
88.0 to 93.8 |
511 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.3 |
88.5 to 93.4 |
753 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.4 |
85.7 to 90.6 |
1123 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
96.6 |
92.9 to 98.4 |
200 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
86.3 |
79.1 to 91.3 |
176 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
85.9 |
82.7 to 88.6 |
861 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
89.9 |
88.0 to 91.5 |
1728 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.7 |
86.5 to 90.6 |
1418 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
93.3 |
89.0 to 96.0 |
310 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.6 |
88.3 to 94.0 |
690 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
94.0 |
90.7 to 96.2 |
468 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.2 |
87.8 to 93.7 |
513 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
87.1 |
82.9 to 90.4 |
408 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.2 |
85.2 to 90.7 |
794 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
93.0 |
90.3 to 95.0 |
1606 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.1 |
88.9 to 92.8 |
1339 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
94.6 |
89.2 to 97.4 |
267 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
89.6 |
88.9 to 90.2 |
36713 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
95.3 |
92.4 to 97.1 |
416 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.9 |
88.5 to 94.4 |
512 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.8 |
84.9 to 91.8 |
512 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
92.1 |
89.1 to 94.3 |
612 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
84.9 |
82.3 to 87.1 |
4042 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
86.3 |
83.8 to 88.5 |
1302 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
87.5 |
84.4 to 90.0 |
905 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
84.1 |
80.5 to 87.1 |
1835 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
93.2 |
89.7 to 95.6 |
467 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
93.0 |
87.6 to 96.1 |
222 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.0 |
87.0 to 93.8 |
860 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.4 |
87.4 to 92.8 |
859 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.2 |
87.8 to 93.7 |
450 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
91.9 |
89.0 to 94.1 |
581 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
90.2 |
86.7 to 92.9 |
425 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.2 |
85.3 to 92.2 |
555 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
75.0 |
67.6 to 81.1 |
272 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
88.1 |
84.6 to 90.8 |
582 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.3 |
89.0 to 94.6 |
502 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
86.8 |
82.8 to 90.0 |
801 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.3 |
86.7 to 93.0 |
592 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
95.7 |
94.0 to 96.9 |
1107 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
87.0 |
84.1 to 89.5 |
1028 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.6 |
89.8 to 94.7 |
694 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
91.4 |
88.7 to 93.5 |
886 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
87.1 |
83.6 to 90.0 |
649 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
88.2 |
84.3 to 91.3 |
548 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.9 |
88.9 to 92.5 |
1608 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.9 |
88.9 to 92.5 |
1608 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
94.0 |
91.4 to 95.9 |
556 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
94.2 |
91.0 to 96.3 |
431 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.0 |
86.1 to 92.8 |
529 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.8 |
86.7 to 93.8 |
387 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.1 |
90.3 to 95.1 |
737 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.6 |
89.7 to 94.7 |
696 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.9 |
87.6 to 91.8 |
2006 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.5 |
91.4 to 95.2 |
1275 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
91.1 |
88.4 to 93.3 |
896 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.7 |
89.0 to 95.2 |
543 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
91.5 |
87.8 to 94.2 |
496 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
86.0 |
82.5 to 88.9 |
696 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
87.7 |
77.0 to 93.8 |
75 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.3 |
86.9 to 95.5 |
316 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
88.3 |
83.2 to 92.0 |
300 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
94.4 |
92.0 to 96.2 |
716 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.8 |
87.5 to 91.8 |
1466 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.4 |
85.5 to 93.7 |
323 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.7 |
90.4 to 94.4 |
1005 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.7 |
90.4 to 94.4 |
1005 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.2 |
89.0 to 94.5 |
672 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
91.6 |
85.3 to 95.3 |
215 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.5 |
90.9 to 95.3 |
747 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
85.5 |
81.7 to 88.6 |
582 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.0 |
85.2 to 92.0 |
450 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.3 |
91.5 to 94.7 |
2130 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
93.3 |
91.5 to 94.7 |
2130 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.1 |
89.4 to 90.7 |
38031 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
95.1 |
93.0 to 96.6 |
1050 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.6 |
86.7 to 91.9 |
805 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
92.6 |
87.7 to 95.6 |
276 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.7 |
86.3 to 92.4 |
573 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
85.2 |
82.9 to 87.3 |
2486 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
82.5 |
72.9 to 89.1 |
152 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
85.3 |
82.9 to 87.4 |
2334 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
90.4 |
87.6 to 92.7 |
898 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
95.8 |
93.5 to 97.3 |
567 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.2 |
86.3 to 91.6 |
1551 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.9 |
86.4 to 92.6 |
625 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.7 |
86.2 to 92.4 |
489 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.2 |
85.8 to 91.8 |
608 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
94.7 |
83.0 to 98.5 |
34 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.3 |
86.6 to 94.5 |
311 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
83.9 |
79.2 to 87.6 |
460 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.2 |
80.4 to 94.3 |
88 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
93.5 |
90.7 to 95.4 |
546 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
97.3 |
85.9 to 99.5 |
33 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
88.0 |
80.5 to 92.8 |
164 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
94.3 |
80.1 to 98.6 |
59 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.6 |
69.3 to 97.0 |
32 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.9 |
86.0 to 95.4 |
192 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
84.7 |
79.4 to 88.9 |
296 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
87.1 |
82.5 to 90.6 |
455 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
95.1 |
90.9 to 97.4 |
224 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
95.1 |
90.9 to 97.4 |
224 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
93.7 |
90.0 to 96.1 |
253 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
93.2 |
90.3 to 95.2 |
444 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
87.6 |
83.2 to 91.0 |
498 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
84.1 |
79.2 to 88.0 |
444 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.7 |
85.4 to 95.4 |
226 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.1 |
85.7 to 91.8 |
620 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.0 |
65.3 to 97.2 |
45 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
88.4 |
82.9 to 92.3 |
277 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
90.7 |
86.0 to 93.9 |
316 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.1 |
85.7 to 91.8 |
662 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
77.8 |
71.3 to 83.2 |
313 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
86.5 |
83.2 to 89.2 |
895 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.0 |
84.8 to 92.1 |
478 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
88.0 |
79.2 to 93.4 |
185 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
94.5 |
91.7 to 96.3 |
608 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
88.3 |
84.2 to 91.4 |
481 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
92.4 |
85.9 to 96.1 |
146 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
92.4 |
85.9 to 96.1 |
146 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
92.0 |
86.2 to 95.5 |
238 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
93.5 |
91.0 to 95.4 |
795 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
88.5 |
81.7 to 93.0 |
232 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
88.3 |
84.7 to 91.2 |
566 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
83.9 |
75.3 to 90.0 |
188 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
85.5 |
74.1 to 92.4 |
93 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
85.5 |
74.1 to 92.4 |
93 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.0 |
88.1 to 89.8 |
16952 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
94.4 |
88.4 to 97.4 |
163 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
93.0 |
90.6 to 94.8 |
879 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
86.3 |
79.6 to 91.0 |
257 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
82.3 |
74.2 to 88.3 |
326 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
82.3 |
74.2 to 88.3 |
326 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
85.8 |
76.0 to 92.0 |
149 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
93.6 |
91.5 to 95.2 |
1184 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
87.8 |
76.8 to 94.0 |
117 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
78.7 |
68.5 to 86.3 |
152 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
89.6 |
86.1 to 92.4 |
528 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
91.0 |
86.2 to 94.3 |
331 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
88.4 |
85.4 to 90.9 |
990 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alabama |
2018-2022 |
Overall |
Overall |
91.6 |
89.6 to 93.2 |
1494 |
| Tdap |
>=1 Dose |
States/Local Areas |
Alaska |
2018-2022 |
Overall |
Overall |
82.4 |
79.9 to 84.6 |
1628 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arizona |
2018-2022 |
Overall |
Overall |
86.8 |
84.6 to 88.7 |
1505 |
| Tdap |
>=1 Dose |
States/Local Areas |
Arkansas |
2018-2022 |
Overall |
Overall |
93.3 |
91.7 to 94.6 |
1605 |
| Tdap |
>=1 Dose |
States/Local Areas |
California |
2018-2022 |
Overall |
Overall |
87.5 |
84.9 to 89.7 |
1640 |
| Tdap |
>=1 Dose |
States/Local Areas |
Colorado |
2018-2022 |
Overall |
Overall |
90.8 |
88.8 to 92.5 |
1534 |
| Tdap |
>=1 Dose |
States/Local Areas |
Connecticut |
2018-2022 |
Overall |
Overall |
94.5 |
92.8 to 95.8 |
1516 |
| Tdap |
>=1 Dose |
States/Local Areas |
Delaware |
2018-2022 |
Overall |
Overall |
88.4 |
86.2 to 90.3 |
1534 |
| Tdap |
>=1 Dose |
States/Local Areas |
District of Columbia |
2018-2022 |
Overall |
Overall |
87.1 |
84.6 to 89.2 |
1615 |
| Tdap |
>=1 Dose |
States/Local Areas |
Florida |
2018-2022 |
Overall |
Overall |
91.5 |
89.5 to 93.2 |
1640 |
| Tdap |
>=1 Dose |
States/Local Areas |
Georgia |
2018-2022 |
Overall |
Overall |
92.2 |
90.3 to 93.8 |
1553 |
| Tdap |
>=1 Dose |
States/Local Areas |
Hawaii |
2018-2022 |
Overall |
Overall |
86.4 |
84.2 to 88.5 |
1416 |
| Tdap |
>=1 Dose |
States/Local Areas |
Idaho |
2018-2022 |
Overall |
Overall |
88.2 |
86.0 to 90.2 |
1584 |
| Tdap |
>=1 Dose |
States/Local Areas |
Illinois |
2018-2022 |
Overall |
Overall |
91.3 |
90.0 to 92.6 |
3230 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Overall |
Overall |
90.2 |
87.3 to 92.5 |
1023 |
| Tdap |
>=1 Dose |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Overall |
Overall |
91.6 |
90.0 to 92.9 |
2207 |
| Tdap |
>=1 Dose |
States/Local Areas |
Indiana |
2018-2022 |
Overall |
Overall |
91.6 |
89.7 to 93.2 |
1413 |
| Tdap |
>=1 Dose |
States/Local Areas |
Iowa |
2018-2022 |
Overall |
Overall |
93.9 |
92.1 to 95.2 |
1268 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kansas |
2018-2022 |
Overall |
Overall |
89.5 |
87.5 to 91.3 |
1652 |
| Tdap |
>=1 Dose |
States/Local Areas |
Kentucky |
2018-2022 |
Overall |
Overall |
87.5 |
85.1 to 89.6 |
1333 |
| Tdap |
>=1 Dose |
States/Local Areas |
Louisiana |
2018-2022 |
Overall |
Overall |
92.9 |
91.1 to 94.3 |
1609 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maine |
2018-2022 |
Overall |
Overall |
91.0 |
89.1 to 92.6 |
1566 |
| Tdap |
>=1 Dose |
States/Local Areas |
Maryland |
2018-2022 |
Overall |
Overall |
89.7 |
87.8 to 91.4 |
2935 |
| Tdap |
>=1 Dose |
States/Local Areas |
Massachusetts |
2018-2022 |
Overall |
Overall |
93.7 |
91.8 to 95.1 |
1556 |
| Tdap |
>=1 Dose |
States/Local Areas |
Michigan |
2018-2022 |
Overall |
Overall |
90.6 |
88.6 to 92.3 |
1623 |
| Tdap |
>=1 Dose |
States/Local Areas |
Minnesota |
2018-2022 |
Overall |
Overall |
91.6 |
89.5 to 93.3 |
1518 |
| Tdap |
>=1 Dose |
States/Local Areas |
Mississippi |
2018-2022 |
Overall |
Overall |
89.9 |
87.6 to 91.7 |
1372 |
| Tdap |
>=1 Dose |
States/Local Areas |
Missouri |
2018-2022 |
Overall |
Overall |
85.4 |
83.1 to 87.5 |
1628 |
| Tdap |
>=1 Dose |
States/Local Areas |
Montana |
2018-2022 |
Overall |
Overall |
88.5 |
86.2 to 90.3 |
1481 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nebraska |
2018-2022 |
Overall |
Overall |
90.8 |
88.8 to 92.4 |
1547 |
| Tdap |
>=1 Dose |
States/Local Areas |
Nevada |
2018-2022 |
Overall |
Overall |
88.3 |
86.1 to 90.2 |
1608 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Hampshire |
2018-2022 |
Overall |
Overall |
94.8 |
93.2 to 96.0 |
1524 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Jersey |
2018-2022 |
Overall |
Overall |
89.3 |
87.1 to 91.2 |
1642 |
| Tdap |
>=1 Dose |
States/Local Areas |
New Mexico |
2018-2022 |
Overall |
Overall |
87.4 |
85.2 to 89.3 |
1665 |
| Tdap |
>=1 Dose |
States/Local Areas |
New York |
2018-2022 |
Overall |
Overall |
91.2 |
89.8 to 92.4 |
2879 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-City of New York |
2018-2022 |
Overall |
Overall |
88.7 |
86.5 to 90.6 |
1418 |
| Tdap |
>=1 Dose |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Overall |
Overall |
92.8 |
91.0 to 94.2 |
1461 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Carolina |
2018-2022 |
Overall |
Overall |
91.9 |
89.9 to 93.5 |
1600 |
| Tdap |
>=1 Dose |
States/Local Areas |
North Dakota |
2018-2022 |
Overall |
Overall |
93.4 |
91.6 to 94.8 |
1478 |
| Tdap |
>=1 Dose |
States/Local Areas |
Ohio |
2018-2022 |
Overall |
Overall |
91.8 |
89.9 to 93.4 |
1492 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oklahoma |
2018-2022 |
Overall |
Overall |
86.8 |
84.6 to 88.7 |
1556 |
| Tdap |
>=1 Dose |
States/Local Areas |
Oregon |
2018-2022 |
Overall |
Overall |
88.0 |
85.8 to 89.9 |
1432 |
| Tdap |
>=1 Dose |
States/Local Areas |
Pennsylvania |
2018-2022 |
Overall |
Overall |
92.8 |
91.4 to 94.0 |
3829 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Overall |
Overall |
91.1 |
88.9 to 92.8 |
1339 |
| Tdap |
>=1 Dose |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Overall |
Overall |
93.0 |
91.4 to 94.4 |
2490 |
| Tdap |
>=1 Dose |
HHS Regions/National |
United States |
2018-2022 |
Overall |
Overall |
89.7 |
89.3 to 90.1 |
91696 |
| Tdap |
>=1 Dose |
States/Local Areas |
Rhode Island |
2018-2022 |
Overall |
Overall |
95.2 |
93.6 to 96.4 |
1466 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Carolina |
2018-2022 |
Overall |
Overall |
91.0 |
89.0 to 92.6 |
1480 |
| Tdap |
>=1 Dose |
States/Local Areas |
South Dakota |
2018-2022 |
Overall |
Overall |
91.5 |
89.7 to 93.0 |
1667 |
| Tdap |
>=1 Dose |
States/Local Areas |
Tennessee |
2018-2022 |
Overall |
Overall |
90.2 |
88.2 to 92.0 |
1442 |
| Tdap |
>=1 Dose |
States/Local Areas |
Texas |
2018-2022 |
Overall |
Overall |
84.9 |
83.2 to 86.4 |
6854 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Overall |
Overall |
85.9 |
83.5 to 88.1 |
1454 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Overall |
Overall |
87.5 |
84.4 to 90.0 |
905 |
| Tdap |
>=1 Dose |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Overall |
Overall |
84.6 |
82.7 to 86.3 |
4495 |
| Tdap |
>=1 Dose |
States/Local Areas |
Utah |
2018-2022 |
Overall |
Overall |
91.0 |
88.9 to 92.7 |
1514 |
| Tdap |
>=1 Dose |
States/Local Areas |
Vermont |
2018-2022 |
Overall |
Overall |
94.2 |
92.7 to 95.3 |
1973 |
| Tdap |
>=1 Dose |
States/Local Areas |
Virginia |
2018-2022 |
Overall |
Overall |
89.7 |
87.5 to 91.5 |
2528 |
| Tdap |
>=1 Dose |
States/Local Areas |
Washington |
2018-2022 |
Overall |
Overall |
89.1 |
86.9 to 91.0 |
1636 |
| Tdap |
>=1 Dose |
States/Local Areas |
West Virginia |
2018-2022 |
Overall |
Overall |
90.1 |
88.2 to 91.8 |
1467 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wisconsin |
2018-2022 |
Overall |
Overall |
90.6 |
88.7 to 92.2 |
1520 |
| Tdap |
>=1 Dose |
States/Local Areas |
Wyoming |
2018-2022 |
Overall |
Overall |
89.3 |
87.1 to 91.1 |
1449 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2006 |
Age |
13-17 Years |
65.5 |
61.4 to 69.4 |
901 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2006 |
Age |
13-17 Years |
84.4 |
70.7 to 92.4 |
46 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2006 |
Age |
13-17 Years |
66.6 |
51.3 to 79.1 |
85 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2006 |
Age |
13-17 Years |
73.3 |
63.8 to 81.0 |
135 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2006 |
Age |
13-17 Years |
59.1 |
49.9 to 67.7 |
192 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2006 |
Age |
13-17 Years |
65.6 |
52.5 to 76.6 |
118 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2006 |
Age |
13-17 Years |
73.1 |
61.8 to 82.0 |
83 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2006 |
Age |
13-17 Years |
50.3 |
32.3 to 68.2 |
40 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2006 |
Age |
13-17 Years |
65.0 |
54.8 to 74.1 |
135 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2006 |
Age |
13-17 Years |
54.3 |
37.9 to 69.9 |
40 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
75.7 |
72.2 to 79.0 |
1047 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
92.0 |
81.4 to 96.8 |
72 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-17 Years |
81.3 |
66.2 to 90.6 |
77 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
83.5 |
75.9 to 89.0 |
145 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
72.8 |
64.9 to 79.5 |
188 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
77.2 |
69.4 to 83.5 |
194 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-17 Years |
77.7 |
66.7 to 85.9 |
102 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-17 Years |
52.0 |
32.1 to 71.3 |
36 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-17 Years |
54.5 |
33.1 to 74.3 |
36 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
72.3 |
61.3 to 81.1 |
160 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2007 |
Age |
13-17 Years |
78.8 |
60.4 to 90.1 |
37 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
71.2 |
61.7 to 79.2 |
181 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
66.7 |
55.4 to 76.4 |
95 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
85.4 |
74.1 to 92.3 |
95 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
84.9 |
77.5 to 90.1 |
143 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
92.9 |
87.4 to 96.1 |
143 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
85.3 |
77.2 to 90.9 |
140 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
97.6 |
91.6 to 99.4 |
129 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
86.1 |
78.7 to 91.2 |
144 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
96.4 |
92.1 to 98.4 |
177 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
80.0 |
66.1 to 89.1 |
117 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
91.4 |
83.2 to 95.8 |
133 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
89.7 |
82.4 to 94.3 |
163 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
61.1 |
47.3 to 73.3 |
71 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
74.2 |
65.0 to 81.6 |
308 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
79.3 |
70.8 to 85.8 |
145 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
72.6 |
61.0 to 81.8 |
163 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
70.4 |
59.8 to 79.1 |
115 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
68.4 |
56.4 to 78.4 |
90 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
62.5 |
49.4 to 73.9 |
87 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
74.7 |
63.9 to 83.1 |
95 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
68.9 |
57.3 to 78.6 |
127 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
89.7 |
81.5 to 94.5 |
105 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
86.7 |
78.4 to 92.1 |
191 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
95.0 |
85.1 to 98.4 |
132 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
86.8 |
77.6 to 92.5 |
112 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
84.8 |
76.2 to 90.6 |
138 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2008 |
Age |
13-17 Years |
40.0 |
31.0 to 49.8 |
138 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
62.7 |
51.5 to 72.7 |
111 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
70.1 |
58.4 to 79.7 |
93 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
86.1 |
78.3 to 91.4 |
126 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
64.8 |
53.0 to 75.0 |
104 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
93.2 |
85.7 to 96.9 |
130 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
86.2 |
78.9 to 91.2 |
182 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
69.0 |
58.7 to 77.8 |
132 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
88.7 |
83.0 to 92.6 |
279 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
85.7 |
75.1 to 92.3 |
144 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
90.9 |
84.1 to 95.0 |
135 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
57.7 |
47.1 to 67.7 |
135 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
76.1 |
66.1 to 83.8 |
118 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
77.4 |
65.9 to 85.9 |
106 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
83.1 |
73.6 to 89.6 |
113 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
89.0 |
79.6 to 94.3 |
90 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
94.2 |
89.7 to 96.8 |
370 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
91.8 |
85.8 to 95.4 |
191 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
94.5 |
89.2 to 97.3 |
179 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
81.9 |
80.2 to 83.6 |
6982 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
95.3 |
91.7 to 97.4 |
737 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
87.9 |
83.6 to 91.2 |
461 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
85.1 |
81.0 to 88.4 |
1124 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
73.0 |
68.3 to 77.2 |
1078 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
79.3 |
75.3 to 82.8 |
867 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
78.2 |
70.4 to 84.4 |
830 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
67.1 |
60.9 to 72.8 |
414 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
76.3 |
70.9 to 81.0 |
621 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
90.6 |
86.2 to 93.7 |
505 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
97.8 |
89.1 to 99.6 |
149 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
61.0 |
51.3 to 69.9 |
146 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
52.7 |
41.0 to 64.1 |
96 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
72.0 |
62.4 to 79.8 |
133 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
79.4 |
66.6 to 88.2 |
315 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
83.6 |
71.0 to 91.4 |
90 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
86.0 |
75.6 to 92.5 |
98 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
78.2 |
62.5 to 88.5 |
127 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
79.9 |
73.5 to 85.0 |
345 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2008 |
Age |
13-17 Years |
67.5 |
53.7 to 78.7 |
71 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
93.0 |
83.8 to 97.2 |
92 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
69.4 |
57.6 to 79.1 |
123 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
78.9 |
67.7 to 87.0 |
89 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
66.5 |
55.0 to 76.3 |
119 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
84.4 |
73.1 to 91.5 |
88 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
69.5 |
58.8 to 78.5 |
103 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
90.2 |
84.1 to 94.1 |
160 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
81.0 |
70.1 to 88.5 |
114 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
78.0 |
68.8 to 85.0 |
166 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
82.8 |
75.4 to 88.3 |
165 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
88.0 |
81.6 to 92.4 |
214 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
86.6 |
79.2 to 91.6 |
202 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
94.0 |
85.8 to 97.6 |
183 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
84.0 |
75.1 to 90.1 |
179 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
96.6 |
91.6 to 98.7 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
88.2 |
81.5 to 92.7 |
209 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
91.8 |
83.3 to 96.2 |
187 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
95.5 |
89.2 to 98.2 |
143 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
74.6 |
62.0 to 84.1 |
81 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
82.1 |
75.6 to 87.1 |
351 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
80.3 |
71.7 to 86.7 |
211 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
82.7 |
74.1 to 88.9 |
140 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
75.0 |
64.7 to 83.1 |
352 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
81.4 |
72.5 to 87.8 |
122 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
78.4 |
67.1 to 86.6 |
91 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
84.8 |
77.5 to 90.1 |
179 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
80.9 |
69.8 to 88.6 |
124 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
91.8 |
84.3 to 95.9 |
122 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
96.5 |
90.2 to 98.8 |
136 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
97.9 |
94.1 to 99.3 |
196 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
93.5 |
88.2 to 96.5 |
217 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
91.5 |
84.9 to 95.4 |
145 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
47.2 |
38.7 to 55.9 |
176 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
78.6 |
70.6 to 84.9 |
140 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
69.4 |
58.9 to 78.1 |
111 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
91.4 |
84.8 to 95.3 |
124 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
83.8 |
75.2 to 89.8 |
164 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
97.1 |
92.9 to 98.8 |
138 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
88.2 |
81.8 to 92.6 |
232 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
77.0 |
69.1 to 83.5 |
201 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
89.1 |
82.9 to 93.3 |
253 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
87.4 |
76.3 to 93.7 |
131 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
90.5 |
82.1 to 95.2 |
122 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
81.3 |
72.6 to 87.8 |
128 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
88.9 |
80.8 to 93.8 |
107 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
82.9 |
73.0 to 89.6 |
145 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
87.6 |
80.5 to 92.3 |
169 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
89.5 |
84.2 to 93.2 |
210 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
97.2 |
94.5 to 98.6 |
358 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
93.0 |
87.4 to 96.2 |
217 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
97.9 |
94.4 to 99.2 |
141 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
87.0 |
85.7 to 88.2 |
9391 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
95.9 |
93.6 to 97.4 |
1067 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
88.8 |
84.4 to 92.1 |
485 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
92.6 |
90.0 to 94.6 |
1213 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
83.8 |
81.0 to 86.3 |
1367 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
86.7 |
83.7 to 89.2 |
1368 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
87.1 |
83.3 to 90.1 |
1395 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
81.1 |
76.7 to 84.9 |
477 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
81.5 |
77.2 to 85.2 |
797 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
86.9 |
81.7 to 90.8 |
687 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
96.5 |
92.4 to 98.4 |
249 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
76.4 |
64.6 to 85.1 |
142 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
69.1 |
56.6 to 79.4 |
88 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
78.9 |
70.7 to 85.2 |
186 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
89.3 |
83.6 to 93.2 |
736 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
87.3 |
79.2 to 92.5 |
151 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
89.3 |
81.3 to 94.1 |
133 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
88.7 |
81.3 to 93.4 |
154 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
86.8 |
79.5 to 91.7 |
159 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
89.7 |
80.9 to 94.7 |
139 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-17 Years |
82.3 |
74.6 to 88.0 |
261 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
82.9 |
77.8 to 86.9 |
535 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
77.7 |
67.8 to 85.2 |
133 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
90.0 |
83.3 to 94.3 |
179 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
83.0 |
73.9 to 89.3 |
166 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
80.0 |
70.2 to 87.2 |
130 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
78.7 |
68.3 to 86.4 |
104 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
95.7 |
91.2 to 98.0 |
158 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
79.6 |
71.6 to 85.8 |
156 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
88.7 |
81.4 to 93.4 |
164 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
76.6 |
67.6 to 83.7 |
140 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
91.0 |
84.1 to 95.1 |
183 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
89.3 |
83.4 to 93.3 |
178 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
90.8 |
84.1 to 94.8 |
197 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
94.8 |
90.4 to 97.2 |
190 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
98.1 |
95.1 to 99.3 |
268 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
88.2 |
80.4 to 93.1 |
200 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
97.5 |
94.8 to 98.8 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
89.4 |
80.2 to 94.6 |
194 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
93.9 |
88.3 to 96.9 |
208 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
95.6 |
91.3 to 97.9 |
216 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
76.6 |
67.0 to 84.0 |
120 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
87.2 |
81.7 to 91.1 |
387 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
86.4 |
79.7 to 91.2 |
200 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
87.4 |
80.5 to 92.1 |
187 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
85.8 |
77.8 to 91.3 |
129 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
84.2 |
74.7 to 90.6 |
105 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
88.4 |
82.2 to 92.6 |
174 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
86.1 |
78.8 to 91.2 |
161 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
84.4 |
76.4 to 90.1 |
184 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
91.7 |
84.3 to 95.8 |
164 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
97.6 |
94.9 to 98.9 |
226 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
98.6 |
96.2 to 99.5 |
192 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
97.4 |
93.4 to 99.0 |
172 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
92.7 |
87.6 to 95.8 |
166 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
69.4 |
60.7 to 77.0 |
162 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
76.9 |
69.3 to 83.1 |
193 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
82.9 |
74.8 to 88.8 |
146 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
92.5 |
86.1 to 96.1 |
145 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
86.0 |
79.0 to 90.9 |
176 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
97.5 |
93.1 to 99.1 |
193 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
91.0 |
83.9 to 95.1 |
238 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
83.6 |
75.4 to 89.4 |
174 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
94.8 |
90.9 to 97.1 |
457 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
95.0 |
90.7 to 97.4 |
262 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
94.6 |
87.9 to 97.7 |
195 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
80.0 |
73.2 to 85.5 |
201 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
90.7 |
83.8 to 94.9 |
127 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
92.4 |
86.8 to 95.7 |
163 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
95.4 |
90.6 to 97.8 |
157 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
87.8 |
80.5 to 92.7 |
177 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
96.0 |
92.0 to 98.0 |
508 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
96.4 |
93.3 to 98.1 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
95.9 |
91.1 to 98.1 |
238 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
90.5 |
89.4 to 91.5 |
10542 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
97.8 |
96.6 to 98.6 |
1192 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
93.7 |
90.5 to 95.9 |
695 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
93.0 |
90.7 to 94.8 |
1538 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
86.7 |
83.9 to 89.1 |
1447 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
91.7 |
89.6 to 93.4 |
1167 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
90.9 |
88.1 to 93.1 |
1674 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
82.5 |
78.3 to 86.1 |
617 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
90.2 |
87.2 to 92.6 |
851 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
90.7 |
85.5 to 94.2 |
772 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
99.7 |
98.1 to 100.0 |
226 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
81.9 |
73.2 to 88.3 |
172 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
74.0 |
63.7 to 82.2 |
116 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
86.1 |
79.3 to 91.0 |
185 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
92.2 |
88.0 to 95.0 |
981 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
93.3 |
88.9 to 96.0 |
212 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
91.2 |
84.7 to 95.1 |
254 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
93.7 |
88.9 to 96.5 |
192 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
94.4 |
89.4 to 97.1 |
168 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
91.8 |
85.6 to 95.5 |
155 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
92.9 |
87.0 to 96.2 |
205 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
84.4 |
79.9 to 88.1 |
589 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
87.2 |
78.5 to 92.7 |
148 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
93.8 |
88.4 to 96.8 |
149 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
87.7 |
81.0 to 92.2 |
206 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
84.8 |
76.4 to 90.5 |
152 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
74.2 |
65.3 to 81.4 |
141 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
93.8 |
86.6 to 97.2 |
150 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
85.4 |
77.7 to 90.8 |
124 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
94.8 |
91.5 to 96.9 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
88.3 |
80.2 to 93.3 |
174 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
93.3 |
86.4 to 96.9 |
262 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
93.5 |
88.6 to 96.4 |
203 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
86.1 |
80.5 to 90.3 |
410 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
94.5 |
89.2 to 97.3 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
99.5 |
98.0 to 99.9 |
318 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
92.9 |
87.6 to 96.0 |
306 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
96.2 |
91.2 to 98.4 |
321 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
95.5 |
90.7 to 97.9 |
313 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
98.1 |
96.0 to 99.1 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
96.2 |
92.1 to 98.3 |
255 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
87.8 |
79.7 to 92.9 |
181 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
91.7 |
88.2 to 94.3 |
546 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
86.6 |
80.4 to 91.1 |
272 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
93.0 |
88.6 to 95.7 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
94.8 |
86.1 to 98.2 |
221 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
86.3 |
77.9 to 91.9 |
172 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
89.0 |
77.9 to 94.9 |
212 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
92.3 |
85.9 to 95.9 |
225 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
98.8 |
96.7 to 99.5 |
284 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
95.4 |
91.2 to 97.6 |
253 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
97.8 |
95.3 to 99.0 |
343 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
98.2 |
94.6 to 99.4 |
260 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
95.3 |
88.7 to 98.1 |
275 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
94.2 |
84.2 to 98.0 |
197 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
81.5 |
73.1 to 87.7 |
194 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
81.9 |
73.3 to 88.2 |
226 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
79.9 |
68.0 to 88.2 |
193 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
94.7 |
89.1 to 97.5 |
221 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
90.5 |
84.4 to 94.4 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
98.6 |
96.6 to 99.5 |
260 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
96.6 |
92.9 to 98.4 |
285 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
93.8 |
88.1 to 96.9 |
266 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
95.4 |
92.1 to 97.3 |
566 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
97.1 |
93.9 to 98.7 |
302 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
94.2 |
88.8 to 97.1 |
264 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
86.5 |
79.4 to 91.5 |
212 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
83.9 |
72.0 to 91.3 |
166 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
89.9 |
83.1 to 94.2 |
231 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
95.2 |
91.4 to 97.4 |
235 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
96.5 |
93.0 to 98.3 |
243 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
97.9 |
96.0 to 98.9 |
664 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
96.5 |
92.9 to 98.2 |
307 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
98.1 |
95.8 to 99.2 |
357 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
92.3 |
91.3 to 93.2 |
14882 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
98.0 |
96.6 to 98.8 |
1653 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
95.8 |
93.4 to 97.3 |
851 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
94.0 |
92.0 to 95.4 |
2161 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
93.2 |
91.3 to 94.6 |
1961 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
92.9 |
90.7 to 94.7 |
1731 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
93.4 |
89.4 to 95.9 |
2476 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
86.1 |
81.5 to 89.7 |
831 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
89.6 |
86.1 to 92.3 |
1234 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
87.5 |
82.9 to 91.0 |
1197 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
96.1 |
87.5 to 98.8 |
333 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
93.8 |
87.0 to 97.2 |
230 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
82.6 |
63.8 to 92.8 |
168 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
92.7 |
85.3 to 96.5 |
260 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
92.2 |
86.3 to 95.7 |
1488 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
97.7 |
95.1 to 98.9 |
293 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
93.8 |
88.5 to 96.7 |
354 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
94.0 |
86.8 to 97.4 |
296 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
93.7 |
88.5 to 96.6 |
223 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
91.3 |
83.0 to 95.7 |
322 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
95.2 |
92.6 to 96.9 |
418 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
91.0 |
87.1 to 93.8 |
787 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
85.7 |
77.0 to 91.5 |
229 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
92.0 |
84.7 to 96.0 |
229 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
87.2 |
80.5 to 91.8 |
290 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
88.7 |
81.2 to 93.4 |
189 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
77.3 |
69.9 to 83.4 |
237 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
94.0 |
84.2 to 97.9 |
261 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
93.4 |
86.9 to 96.7 |
204 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
97.4 |
92.4 to 99.2 |
221 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
92.1 |
86.3 to 95.6 |
194 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
92.4 |
87.3 to 95.6 |
239 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
91.8 |
85.4 to 95.5 |
228 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
94.5 |
89.6 to 97.2 |
324 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
95.0 |
87.8 to 98.1 |
236 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
99.9 |
99.3 to 100.0 |
241 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
95.2 |
88.9 to 98.0 |
240 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
97.6 |
92.2 to 99.3 |
282 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
98.6 |
96.1 to 99.5 |
242 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
95.8 |
90.2 to 98.2 |
229 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
98.0 |
95.4 to 99.1 |
260 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
89.9 |
83.7 to 93.8 |
195 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
88.4 |
82.1 to 92.7 |
439 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
88.7 |
81.4 to 93.4 |
216 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
88.3 |
80.2 to 93.4 |
223 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
95.1 |
88.7 to 98.0 |
206 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
89.0 |
82.1 to 93.5 |
187 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
96.3 |
91.6 to 98.5 |
211 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
92.5 |
86.6 to 96.0 |
223 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
97.1 |
92.4 to 98.9 |
242 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
95.3 |
90.5 to 97.8 |
217 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
94.4 |
89.5 to 97.1 |
259 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
100.0 |
NA |
272 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
97.2 |
92.9 to 98.9 |
260 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
97.8 |
94.7 to 99.1 |
205 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
91.6 |
84.4 to 95.7 |
192 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
87.5 |
76.5 to 93.8 |
188 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
93.4 |
87.4 to 96.6 |
175 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
94.3 |
88.2 to 97.3 |
224 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
97.3 |
94.5 to 98.7 |
225 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
97.9 |
94.8 to 99.1 |
190 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
92.6 |
86.9 to 96.0 |
252 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
94.2 |
88.7 to 97.1 |
238 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
97.5 |
95.3 to 98.7 |
465 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
94.8 |
89.6 to 97.4 |
235 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
99.2 |
96.9 to 99.8 |
230 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
92.7 |
86.1 to 96.3 |
229 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
93.2 |
84.8 to 97.1 |
206 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
90.3 |
81.9 to 95.0 |
206 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
95.8 |
92.2 to 97.8 |
222 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
96.0 |
92.2 to 98.0 |
284 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
97.7 |
94.8 to 99.0 |
599 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
96.7 |
91.8 to 98.7 |
296 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
97.8 |
94.3 to 99.2 |
303 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
94.7 |
93.9 to 95.4 |
13197 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
99.2 |
98.7 to 99.5 |
1366 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
95.9 |
93.7 to 97.4 |
717 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
95.7 |
94.1 to 97.0 |
1804 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
95.4 |
93.9 to 96.5 |
1779 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
93.5 |
91.1 to 95.3 |
1527 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
94.4 |
92.3 to 96.0 |
2075 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
90.6 |
85.6 to 94.0 |
810 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
93.7 |
90.3 to 95.9 |
1189 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
94.5 |
90.7 to 96.8 |
1048 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
98.7 |
94.3 to 99.7 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
92.8 |
87.0 to 96.1 |
218 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
88.4 |
81.4 to 93.0 |
161 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
92.9 |
85.9 to 96.6 |
225 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
94.1 |
90.9 to 96.2 |
1145 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
95.3 |
89.4 to 98.0 |
250 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
97.4 |
94.1 to 98.9 |
297 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
93.7 |
89.9 to 96.1 |
598 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
92.7 |
89.4 to 95.0 |
475 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
91.9 |
87.5 to 94.9 |
882 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
92.0 |
85.7 to 95.7 |
222 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
95.8 |
91.8 to 97.9 |
189 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
94.9 |
90.6 to 97.3 |
258 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
89.7 |
80.5 to 94.8 |
209 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
88.4 |
81.0 to 93.1 |
166 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
98.4 |
95.8 to 99.4 |
211 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
97.1 |
93.5 to 98.8 |
189 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
96.1 |
90.9 to 98.3 |
241 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
95.0 |
90.8 to 97.3 |
220 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
90.1 |
84.4 to 93.9 |
254 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
94.8 |
90.4 to 97.2 |
220 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
93.0 |
86.5 to 96.5 |
242 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
95.1 |
90.9 to 97.4 |
265 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
99.1 |
97.2 to 99.7 |
255 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
97.5 |
94.5 to 98.9 |
264 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
88.6 |
76.3 to 94.9 |
157 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
94.8 |
88.9 to 97.7 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
98.5 |
89.8 to 99.8 |
195 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
74.2 |
65.6 to 81.3 |
186 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
97.5 |
92.1 to 99.2 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
89.5 |
81.6 to 94.2 |
162 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
95.0 |
91.8 to 97.0 |
407 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
91.3 |
83.3 to 95.6 |
165 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
96.1 |
92.2 to 98.1 |
242 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
98.3 |
95.3 to 99.4 |
237 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
93.0 |
87.6 to 96.1 |
258 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
96.1 |
92.0 to 98.1 |
187 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
96.9 |
93.1 to 98.7 |
210 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
96.0 |
92.1 to 98.0 |
230 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
93.6 |
87.9 to 96.8 |
237 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
98.3 |
95.6 to 99.4 |
265 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
98.1 |
94.6 to 99.4 |
316 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
97.6 |
94.3 to 99.0 |
231 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
94.6 |
88.6 to 97.5 |
256 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
94.8 |
87.9 to 97.8 |
200 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
90.4 |
84.0 to 94.4 |
198 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
82.7 |
73.8 to 89.1 |
191 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
96.1 |
91.9 to 98.2 |
215 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
97.7 |
95.4 to 98.9 |
251 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
97.3 |
92.9 to 99.0 |
247 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
95.8 |
90.5 to 98.2 |
264 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
96.8 |
94.0 to 98.4 |
272 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
96.6 |
93.8 to 98.1 |
553 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
98.0 |
95.0 to 99.2 |
238 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
95.7 |
91.2 to 97.9 |
315 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
93.0 |
87.8 to 96.1 |
241 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
96.3 |
91.6 to 98.4 |
224 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
92.4 |
86.8 to 95.7 |
227 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
95.7 |
92.1 to 97.7 |
322 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
96.5 |
92.9 to 98.3 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
97.2 |
92.8 to 98.9 |
613 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
97.9 |
93.7 to 99.4 |
259 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
97.1 |
91.9 to 99.0 |
354 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
94.9 |
94.0 to 95.7 |
13428 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
97.9 |
96.5 to 98.8 |
1536 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
96.3 |
94.0 to 97.7 |
817 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
96.6 |
94.4 to 98.0 |
1764 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
95.2 |
93.4 to 96.6 |
1790 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
95.5 |
94.0 to 96.7 |
1604 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
94.1 |
91.2 to 96.1 |
1878 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
92.9 |
89.9 to 95.0 |
858 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
93.0 |
90.5 to 94.9 |
1284 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
93.0 |
88.1 to 96.0 |
1017 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
98.5 |
95.1 to 99.6 |
264 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
95.8 |
92.1 to 97.8 |
226 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
91.2 |
84.8 to 95.1 |
189 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
92.5 |
86.0 to 96.2 |
220 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
93.4 |
88.9 to 96.1 |
834 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
95.8 |
91.3 to 98.1 |
230 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
97.7 |
93.4 to 99.2 |
213 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
92.8 |
87.6 to 96.0 |
391 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
96.4 |
93.2 to 98.1 |
299 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
93.6 |
90.6 to 95.7 |
880 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
91.1 |
84.4 to 95.0 |
192 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
96.7 |
93.1 to 98.4 |
217 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
96.1 |
88.6 to 98.7 |
252 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
92.6 |
86.7 to 96.0 |
228 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
88.8 |
83.0 to 92.9 |
213 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
96.9 |
92.9 to 98.7 |
246 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
96.5 |
92.3 to 98.5 |
223 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
97.1 |
93.2 to 98.8 |
298 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
91.8 |
86.8 to 95.0 |
269 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
92.3 |
87.1 to 95.5 |
329 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
92.0 |
86.7 to 95.3 |
291 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
96.7 |
94.0 to 98.2 |
302 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
94.8 |
90.6 to 97.2 |
322 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
98.0 |
94.2 to 99.3 |
329 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
97.2 |
93.0 to 98.9 |
319 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
92.2 |
86.5 to 95.6 |
260 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
97.1 |
92.4 to 98.9 |
292 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
97.6 |
94.0 to 99.1 |
308 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
93.9 |
89.8 to 96.5 |
303 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
88.6 |
81.9 to 93.0 |
241 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
94.8 |
91.7 to 96.7 |
576 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
93.0 |
86.7 to 96.5 |
232 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
95.2 |
91.5 to 97.3 |
344 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
97.9 |
94.4 to 99.2 |
269 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
93.2 |
88.7 to 95.9 |
237 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
88.2 |
82.0 to 92.5 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
94.6 |
89.3 to 97.3 |
265 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
96.4 |
92.2 to 98.4 |
262 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
97.7 |
94.4 to 99.1 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
93.9 |
88.8 to 96.7 |
361 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
96.2 |
92.2 to 98.2 |
295 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
96.8 |
93.4 to 98.5 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
95.0 |
89.7 to 97.7 |
223 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
96.2 |
92.4 to 98.1 |
265 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
86.4 |
79.6 to 91.2 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
84.2 |
77.4 to 89.2 |
252 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
96.8 |
93.2 to 98.5 |
247 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
91.8 |
87.3 to 94.7 |
276 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
97.8 |
95.4 to 98.9 |
332 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
98.7 |
96.9 to 99.5 |
276 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
91.3 |
85.3 to 95.0 |
291 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
96.6 |
93.8 to 98.2 |
489 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
96.2 |
92.7 to 98.1 |
232 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
96.8 |
92.2 to 98.7 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
94.7 |
90.6 to 97.1 |
306 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
95.8 |
90.5 to 98.2 |
228 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
91.2 |
85.7 to 94.7 |
329 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
95.5 |
91.6 to 97.6 |
272 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
95.0 |
90.5 to 97.4 |
328 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
99.3 |
98.4 to 99.7 |
652 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
97.6 |
92.0 to 99.3 |
281 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
99.5 |
98.6 to 99.8 |
371 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
95.1 |
87.9 to 98.1 |
205 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
95.2 |
94.6 to 95.7 |
16461 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
97.2 |
95.4 to 98.3 |
1862 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
97.3 |
95.5 to 98.4 |
765 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
95.7 |
93.8 to 97.0 |
2147 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
96.4 |
95.1 to 97.4 |
2312 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
94.8 |
93.3 to 96.1 |
1936 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
93.7 |
91.2 to 95.5 |
2416 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
89.7 |
86.4 to 92.2 |
1015 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
92.7 |
90.3 to 94.5 |
1667 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
95.8 |
93.8 to 97.2 |
1210 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
99.3 |
97.1 to 99.8 |
358 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
94.5 |
90.4 to 96.9 |
309 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
94.4 |
88.7 to 97.3 |
253 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
97.4 |
95.3 to 98.6 |
269 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
93.4 |
89.7 to 95.8 |
1300 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
95.8 |
92.1 to 97.8 |
303 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
91.6 |
86.0 to 95.1 |
318 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
93.5 |
87.6 to 96.7 |
303 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
93.4 |
88.8 to 96.2 |
376 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
92.1 |
89.4 to 94.2 |
1131 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
90.0 |
84.2 to 93.8 |
286 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
96.8 |
92.8 to 98.7 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
93.0 |
87.0 to 96.4 |
299 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
91.3 |
86.5 to 94.5 |
293 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
88.7 |
83.2 to 92.6 |
256 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
95.4 |
90.0 to 97.9 |
269 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
96.7 |
94.1 to 98.2 |
326 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
97.2 |
93.0 to 98.9 |
295 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
93.5 |
89.9 to 95.9 |
279 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
91.9 |
87.6 to 94.8 |
357 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
95.7 |
91.3 to 97.9 |
294 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
90.2 |
84.0 to 94.2 |
304 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
96.9 |
94.2 to 98.3 |
293 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
97.5 |
94.4 to 98.9 |
312 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
97.1 |
92.8 to 98.8 |
301 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
93.4 |
89.0 to 96.2 |
388 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
95.7 |
89.8 to 98.3 |
266 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
98.2 |
94.8 to 99.4 |
324 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
79.9 |
73.0 to 85.4 |
234 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
94.1 |
90.2 to 96.5 |
292 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
87.1 |
80.5 to 91.7 |
254 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
95.3 |
92.7 to 96.9 |
645 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
93.8 |
89.5 to 96.4 |
246 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
95.6 |
92.4 to 97.5 |
399 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
96.6 |
93.2 to 98.4 |
254 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
94.4 |
90.3 to 96.8 |
317 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
93.5 |
88.7 to 96.3 |
285 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
97.8 |
95.7 to 98.9 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
96.6 |
93.6 to 98.3 |
326 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
97.8 |
94.5 to 99.2 |
301 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
96.9 |
92.0 to 98.8 |
337 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
99.2 |
97.5 to 99.8 |
295 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
95.7 |
92.2 to 97.7 |
321 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
95.3 |
91.1 to 97.6 |
305 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
95.4 |
91.8 to 97.5 |
278 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
93.4 |
89.0 to 96.1 |
247 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
94.8 |
90.8 to 97.1 |
283 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
97.0 |
93.7 to 98.6 |
321 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
94.5 |
90.4 to 97.0 |
312 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
99.1 |
96.4 to 99.8 |
246 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
97.3 |
94.7 to 98.7 |
309 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
92.9 |
88.4 to 95.8 |
327 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
97.4 |
95.7 to 98.4 |
565 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
94.9 |
90.9 to 97.2 |
269 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
99.1 |
97.8 to 99.6 |
296 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
95.4 |
91.4 to 97.6 |
297 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
96.8 |
92.8 to 98.6 |
240 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
94.2 |
89.4 to 96.9 |
266 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
98.2 |
96.2 to 99.2 |
249 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
97.2 |
94.3 to 98.6 |
287 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
97.5 |
94.2 to 98.9 |
729 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
95.5 |
92.2 to 97.5 |
298 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
97.7 |
93.7 to 99.2 |
431 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
97.2 |
93.9 to 98.8 |
308 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
94.9 |
94.1 to 95.6 |
17892 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
98.7 |
97.7 to 99.2 |
1827 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
97.4 |
96.1 to 98.2 |
874 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
95.4 |
93.2 to 96.9 |
2339 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
96.4 |
94.8 to 97.5 |
2287 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
95.5 |
94.2 to 96.6 |
2096 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
94.7 |
93.3 to 95.9 |
3296 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
94.1 |
92.0 to 95.7 |
1170 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
93.7 |
91.8 to 95.2 |
1619 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
90.8 |
86.0 to 94.1 |
1265 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
99.6 |
98.5 to 99.9 |
361 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
95.1 |
91.1 to 97.3 |
289 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
92.3 |
86.7 to 95.7 |
255 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
96.0 |
92.2 to 98.0 |
268 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
94.0 |
91.9 to 95.5 |
2100 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
92.5 |
87.8 to 95.5 |
309 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
96.4 |
92.8 to 98.2 |
226 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
88.8 |
84.3 to 92.1 |
442 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
94.3 |
91.6 to 96.2 |
742 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
93.6 |
90.8 to 95.6 |
431 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
93.0 |
90.5 to 94.9 |
1119 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
88.5 |
83.4 to 92.2 |
288 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
99.0 |
97.5 to 99.6 |
312 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
91.7 |
84.6 to 95.7 |
321 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
92.0 |
87.3 to 95.1 |
299 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
90.4 |
85.3 to 93.8 |
263 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
97.6 |
95.1 to 98.9 |
305 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
94.9 |
91.0 to 97.2 |
260 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
98.2 |
96.2 to 99.2 |
295 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
95.9 |
91.7 to 98.0 |
325 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
91.1 |
85.5 to 94.7 |
277 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
94.0 |
90.0 to 96.4 |
303 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
92.1 |
86.5 to 95.6 |
284 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
97.1 |
94.3 to 98.6 |
283 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
98.5 |
94.6 to 99.6 |
322 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
97.8 |
94.9 to 99.0 |
335 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
98.7 |
97.2 to 99.4 |
339 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
98.4 |
96.1 to 99.4 |
326 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
99.3 |
98.3 to 99.7 |
319 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
77.7 |
71.5 to 83.0 |
338 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
95.8 |
92.5 to 97.6 |
271 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
88.8 |
83.6 to 92.6 |
290 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
96.6 |
94.2 to 98.0 |
497 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
96.0 |
90.1 to 98.5 |
131 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
96.7 |
93.8 to 98.3 |
366 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
97.1 |
94.0 to 98.6 |
282 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
95.6 |
92.4 to 97.5 |
302 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
95.1 |
90.9 to 97.4 |
262 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
96.1 |
91.9 to 98.1 |
273 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
97.3 |
93.9 to 98.8 |
279 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
97.3 |
94.9 to 98.6 |
296 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
95.0 |
91.0 to 97.3 |
407 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
98.6 |
96.8 to 99.4 |
334 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
98.3 |
96.1 to 99.3 |
241 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
97.3 |
94.5 to 98.7 |
299 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
95.6 |
91.1 to 97.9 |
314 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
93.7 |
89.5 to 96.4 |
299 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
91.9 |
86.5 to 95.2 |
285 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
96.8 |
93.1 to 98.6 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
94.5 |
89.7 to 97.1 |
279 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
98.8 |
96.2 to 99.6 |
269 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
97.1 |
94.6 to 98.4 |
377 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
95.5 |
92.5 to 97.3 |
313 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
97.2 |
95.5 to 98.3 |
573 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
96.8 |
94.0 to 98.3 |
246 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
97.5 |
94.8 to 98.9 |
327 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
93.1 |
87.8 to 96.2 |
305 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
94.9 |
90.6 to 97.3 |
237 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
91.9 |
86.1 to 95.4 |
281 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
93.5 |
88.2 to 96.5 |
249 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
93.6 |
88.3 to 96.7 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
96.8 |
94.5 to 98.1 |
782 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
96.3 |
92.9 to 98.1 |
313 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
96.8 |
94.3 to 98.3 |
469 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
95.9 |
92.4 to 97.8 |
374 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
95.0 |
94.2 to 95.6 |
17328 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
98.4 |
97.4 to 99.0 |
1815 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
97.2 |
95.8 to 98.1 |
950 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
94.4 |
92.4 to 95.9 |
2518 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
96.8 |
95.7 to 97.6 |
2341 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
96.1 |
94.8 to 97.2 |
1887 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
93.8 |
92.1 to 95.2 |
2765 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
94.9 |
92.8 to 96.3 |
1137 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
92.1 |
89.6 to 94.0 |
1620 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
92.2 |
87.9 to 95.1 |
1111 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
97.8 |
94.0 to 99.2 |
289 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
92.1 |
87.1 to 95.3 |
259 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
95.4 |
90.6 to 97.8 |
258 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
96.4 |
91.4 to 98.5 |
250 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
93.2 |
90.8 to 95.1 |
1621 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
96.6 |
93.3 to 98.3 |
271 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
92.4 |
84.1 to 96.6 |
197 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
91.1 |
85.3 to 94.8 |
260 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
92.1 |
86.1 to 95.6 |
287 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
93.4 |
90.1 to 95.6 |
606 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
89.8 |
85.8 to 92.7 |
404 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
92.1 |
88.9 to 94.5 |
1184 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
83.0 |
76.3 to 88.1 |
265 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
97.8 |
95.5 to 99.0 |
305 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
90.4 |
84.0 to 94.4 |
402 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
91.7 |
85.5 to 95.4 |
295 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
92.6 |
88.4 to 95.3 |
253 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
97.4 |
94.5 to 98.8 |
287 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
95.3 |
91.5 to 97.5 |
292 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
96.3 |
93.3 to 98.0 |
321 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
95.3 |
91.8 to 97.3 |
297 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
95.3 |
91.7 to 97.3 |
288 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
96.9 |
93.4 to 98.6 |
299 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
92.1 |
86.2 to 95.6 |
269 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
95.6 |
92.3 to 97.5 |
309 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
97.9 |
93.3 to 99.4 |
279 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
96.1 |
92.1 to 98.1 |
307 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
94.8 |
89.8 to 97.5 |
288 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
97.8 |
95.3 to 99.0 |
358 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
97.3 |
93.4 to 98.9 |
312 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
77.7 |
70.7 to 83.5 |
256 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
95.3 |
91.8 to 97.3 |
282 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
94.7 |
90.5 to 97.1 |
282 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
97.1 |
95.4 to 98.2 |
605 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
90.8 |
82.9 to 95.3 |
178 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
98.4 |
96.9 to 99.2 |
427 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
99.3 |
98.0 to 99.7 |
302 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
97.2 |
94.6 to 98.5 |
294 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
94.3 |
90.3 to 96.7 |
288 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
96.2 |
92.5 to 98.1 |
321 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
97.7 |
94.0 to 99.1 |
305 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
97.3 |
94.7 to 98.6 |
298 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
94.5 |
88.5 to 97.5 |
415 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
96.6 |
92.2 to 98.6 |
365 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
97.8 |
94.6 to 99.1 |
285 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
97.5 |
93.4 to 99.0 |
307 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
97.9 |
95.5 to 99.0 |
288 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
93.9 |
89.9 to 96.4 |
287 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
96.6 |
91.8 to 98.6 |
256 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
98.2 |
96.2 to 99.2 |
271 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
93.9 |
89.4 to 96.6 |
303 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
97.7 |
94.6 to 99.0 |
277 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
94.4 |
89.9 to 97.0 |
324 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
91.9 |
87.4 to 94.9 |
324 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
97.8 |
96.0 to 98.8 |
563 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
96.0 |
92.2 to 98.0 |
247 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
99.0 |
96.8 to 99.7 |
316 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
95.3 |
91.7 to 97.4 |
303 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
96.0 |
92.5 to 97.9 |
321 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
95.5 |
92.6 to 97.3 |
339 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
92.1 |
87.5 to 95.1 |
291 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
97.8 |
95.7 to 98.8 |
301 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
98.6 |
96.8 to 99.4 |
760 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
98.9 |
96.8 to 99.6 |
321 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
98.6 |
96.4 to 99.5 |
439 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
95.5 |
94.8 to 96.1 |
18152 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
97.2 |
95.2 to 98.4 |
1816 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
96.7 |
94.9 to 97.8 |
887 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
96.8 |
95.3 to 97.9 |
2437 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
96.7 |
95.7 to 97.5 |
2496 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
97.2 |
96.3 to 97.9 |
2117 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
92.7 |
91.1 to 94.1 |
3164 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
95.3 |
93.5 to 96.7 |
1140 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
95.3 |
93.5 to 96.6 |
1784 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
92.7 |
88.3 to 95.6 |
1142 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
98.3 |
95.4 to 99.4 |
289 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
93.7 |
89.4 to 96.4 |
296 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
95.3 |
91.8 to 97.4 |
284 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
97.4 |
94.8 to 98.7 |
297 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
91.7 |
89.4 to 93.5 |
1945 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
93.1 |
88.2 to 96.0 |
288 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
89.6 |
82.3 to 94.1 |
162 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
89.2 |
83.0 to 93.4 |
235 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
92.9 |
88.4 to 95.8 |
278 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
94.1 |
90.1 to 96.5 |
256 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
91.9 |
88.7 to 94.2 |
726 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
95.9 |
94.1 to 97.1 |
1169 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
94.4 |
90.6 to 96.7 |
308 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
96.5 |
92.7 to 98.3 |
308 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
97.2 |
93.0 to 98.9 |
371 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
95.2 |
92.0 to 97.2 |
289 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
89.9 |
84.6 to 93.5 |
296 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
97.2 |
94.2 to 98.7 |
279 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
95.0 |
90.9 to 97.4 |
306 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
94.6 |
89.8 to 97.2 |
295 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
93.0 |
89.1 to 95.6 |
344 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
88.8 |
82.8 to 92.9 |
254 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
93.4 |
88.4 to 96.3 |
273 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
94.2 |
90.4 to 96.6 |
318 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
97.0 |
94.3 to 98.5 |
256 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
97.5 |
93.6 to 99.0 |
265 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
96.5 |
92.0 to 98.5 |
283 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
97.7 |
94.4 to 99.1 |
303 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
97.7 |
93.7 to 99.2 |
315 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
79.2 |
71.6 to 85.2 |
214 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
96.2 |
93.2 to 97.9 |
290 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
94.0 |
89.6 to 96.6 |
243 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
96.7 |
94.6 to 98.0 |
636 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
98.2 |
94.9 to 99.4 |
170 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
96.4 |
93.9 to 97.9 |
466 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
98.1 |
95.1 to 99.3 |
251 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
97.6 |
94.1 to 99.1 |
235 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
91.6 |
86.3 to 95.0 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
96.2 |
92.4 to 98.1 |
230 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
96.0 |
90.9 to 98.3 |
245 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
97.3 |
93.5 to 98.9 |
291 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
97.1 |
94.0 to 98.6 |
356 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
99.1 |
96.9 to 99.8 |
293 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
94.9 |
90.2 to 97.4 |
286 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
96.0 |
92.3 to 98.0 |
249 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
94.5 |
89.4 to 97.2 |
242 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
93.7 |
89.1 to 96.5 |
284 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
95.8 |
91.6 to 97.9 |
245 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
95.3 |
90.8 to 97.7 |
250 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
91.4 |
86.3 to 94.7 |
292 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
98.3 |
94.5 to 99.5 |
276 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
93.9 |
88.5 to 96.9 |
306 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
93.6 |
89.0 to 96.3 |
256 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
97.3 |
94.2 to 98.7 |
465 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
98.5 |
96.3 to 99.4 |
222 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
96.5 |
91.3 to 98.6 |
243 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
93.6 |
88.7 to 96.4 |
291 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
98.1 |
95.4 to 99.2 |
256 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
95.1 |
91.1 to 97.4 |
282 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
92.4 |
88.2 to 95.1 |
325 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
95.7 |
91.4 to 97.9 |
266 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
97.7 |
95.5 to 98.8 |
604 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
94.4 |
88.3 to 97.4 |
222 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
98.1 |
95.6 to 99.2 |
382 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
94.9 |
94.3 to 95.4 |
16483 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
98.4 |
97.2 to 99.0 |
1708 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
96.2 |
93.7 to 97.7 |
771 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
95.7 |
94.1 to 96.9 |
2080 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
96.4 |
95.2 to 97.3 |
2209 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
95.7 |
94.4 to 96.7 |
2001 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
90.9 |
89.0 to 92.4 |
2896 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
94.3 |
92.1 to 96.0 |
1026 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
96.5 |
94.9 to 97.6 |
1536 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
93.4 |
90.4 to 95.4 |
1154 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
98.5 |
95.6 to 99.5 |
307 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
94.8 |
90.7 to 97.2 |
289 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
96.7 |
93.2 to 98.5 |
298 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
98.2 |
95.1 to 99.4 |
244 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
89.5 |
86.9 to 91.6 |
1797 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
90.5 |
85.0 to 94.2 |
253 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
88.9 |
81.9 to 93.4 |
171 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
87.1 |
79.9 to 92.0 |
265 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
91.8 |
87.4 to 94.8 |
321 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
89.3 |
85.9 to 92.0 |
787 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
94.7 |
92.4 to 96.4 |
1102 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
95.8 |
91.7 to 97.9 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
98.2 |
96.3 to 99.1 |
276 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
93.4 |
88.0 to 96.5 |
288 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
94.6 |
90.3 to 97.0 |
249 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
91.6 |
87.4 to 94.5 |
290 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
93.2 |
88.7 to 95.9 |
297 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
95.4 |
91.0 to 97.7 |
207 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
97.4 |
94.0 to 98.9 |
276 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
96.3 |
93.5 to 98.0 |
380 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
91.4 |
86.4 to 94.7 |
282 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
97.3 |
94.6 to 98.7 |
292 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
94.0 |
86.6 to 97.4 |
254 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
95.4 |
89.5 to 98.0 |
238 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
98.2 |
94.9 to 99.4 |
278 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
96.4 |
92.0 to 98.4 |
283 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
90.9 |
83.9 to 95.0 |
265 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
95.7 |
90.8 to 98.0 |
304 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
97.5 |
94.8 to 98.9 |
281 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
82.0 |
75.3 to 87.3 |
210 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
94.1 |
89.4 to 96.8 |
281 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
91.9 |
86.5 to 95.2 |
296 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
96.9 |
94.1 to 98.4 |
544 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
94.9 |
89.3 to 97.7 |
153 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
97.3 |
93.7 to 98.9 |
391 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
96.3 |
92.9 to 98.2 |
264 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
98.8 |
96.7 to 99.6 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
93.2 |
89.1 to 95.8 |
332 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
96.7 |
92.7 to 98.5 |
265 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
96.0 |
92.6 to 97.9 |
308 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
95.2 |
90.8 to 97.6 |
289 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
95.8 |
91.9 to 97.9 |
479 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
97.0 |
92.1 to 98.9 |
275 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
97.3 |
93.6 to 98.9 |
269 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
98.9 |
96.1 to 99.7 |
256 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
94.0 |
88.6 to 97.0 |
242 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
92.6 |
86.4 to 96.1 |
254 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
94.4 |
89.2 to 97.1 |
251 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
95.0 |
90.1 to 97.5 |
260 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
92.0 |
86.9 to 95.3 |
278 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
96.5 |
92.2 to 98.4 |
318 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
95.1 |
90.5 to 97.5 |
309 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
92.8 |
88.3 to 95.7 |
364 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
97.3 |
94.6 to 98.6 |
439 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
94.5 |
88.1 to 97.6 |
228 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
99.1 |
97.5 to 99.7 |
211 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
96.0 |
91.7 to 98.1 |
282 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
96.1 |
91.6 to 98.2 |
292 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
95.6 |
91.6 to 97.7 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
94.0 |
90.4 to 96.3 |
318 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
96.4 |
92.2 to 98.4 |
244 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
97.6 |
95.4 to 98.8 |
684 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
97.4 |
94.2 to 98.9 |
218 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
97.7 |
95.0 to 98.9 |
466 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
94.6 |
85.7 to 98.1 |
206 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
95.2 |
94.3 to 95.9 |
17010 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
97.2 |
95.2 to 98.3 |
1862 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
96.5 |
94.3 to 97.8 |
748 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
96.7 |
95.2 to 97.7 |
2323 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
96.2 |
94.7 to 97.2 |
2186 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
97.0 |
95.8 to 97.8 |
1900 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
91.7 |
89.8 to 93.2 |
2948 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
94.4 |
91.8 to 96.2 |
1116 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
95.0 |
92.6 to 96.7 |
1642 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
93.5 |
88.3 to 96.5 |
1095 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
97.6 |
94.2 to 99.0 |
284 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
97.5 |
95.1 to 98.7 |
300 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
94.5 |
90.1 to 97.0 |
280 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
94.1 |
89.3 to 96.8 |
236 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
90.1 |
87.6 to 92.2 |
1666 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
90.0 |
84.2 to 93.8 |
263 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
88.9 |
79.9 to 94.2 |
155 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
85.6 |
79.0 to 90.4 |
240 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
93.7 |
88.6 to 96.6 |
247 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
90.7 |
87.2 to 93.2 |
761 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
90.2 |
84.0 to 94.2 |
211 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
95.0 |
92.4 to 96.7 |
1190 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
94.1 |
90.0 to 96.6 |
298 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
97.0 |
93.7 to 98.6 |
418 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
96.4 |
91.6 to 98.5 |
330 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
94.9 |
90.0 to 97.5 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
95.6 |
92.0 to 97.6 |
282 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
98.2 |
95.3 to 99.3 |
293 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
98.4 |
96.3 to 99.3 |
283 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
97.4 |
95.0 to 98.7 |
277 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
96.0 |
92.0 to 98.0 |
278 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
91.2 |
86.2 to 94.6 |
312 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
97.1 |
93.1 to 98.8 |
298 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
92.7 |
87.7 to 95.8 |
370 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
95.4 |
91.7 to 97.5 |
327 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
98.5 |
95.2 to 99.5 |
309 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
96.5 |
93.2 to 98.2 |
333 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
93.5 |
89.3 to 96.1 |
372 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
95.9 |
92.1 to 97.9 |
335 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
99.5 |
98.5 to 99.8 |
288 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
81.4 |
74.6 to 86.7 |
233 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
96.8 |
93.4 to 98.5 |
267 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
91.9 |
87.1 to 95.0 |
325 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
95.8 |
93.1 to 97.5 |
642 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
91.5 |
83.6 to 95.7 |
248 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
96.7 |
93.5 to 98.4 |
394 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
98.7 |
96.8 to 99.5 |
275 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
96.9 |
93.8 to 98.5 |
251 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
96.2 |
92.8 to 98.0 |
319 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
98.9 |
95.9 to 99.7 |
236 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
96.7 |
93.4 to 98.3 |
329 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
97.1 |
93.8 to 98.7 |
338 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
95.8 |
93.2 to 97.5 |
754 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
97.7 |
95.1 to 99.0 |
372 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
96.2 |
92.6 to 98.0 |
374 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
98.4 |
96.5 to 99.3 |
300 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
97.0 |
93.2 to 98.7 |
251 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
95.0 |
91.1 to 97.3 |
353 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
95.6 |
91.7 to 97.8 |
278 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
93.3 |
89.5 to 95.8 |
368 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
88.5 |
82.2 to 92.7 |
340 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
99.8 |
98.7 to 100.0 |
349 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
95.7 |
91.6 to 97.9 |
361 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
96.1 |
93.0 to 97.9 |
323 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
97.9 |
96.5 to 98.8 |
673 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
95.7 |
92.4 to 97.6 |
350 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
99.3 |
98.0 to 99.8 |
323 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
98.2 |
93.5 to 99.5 |
303 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
98.8 |
96.6 to 99.6 |
368 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
95.8 |
91.8 to 97.9 |
317 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
95.9 |
92.4 to 97.8 |
301 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
97.3 |
94.2 to 98.8 |
280 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
97.0 |
94.1 to 98.5 |
709 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
96.9 |
93.6 to 98.5 |
243 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
97.0 |
93.7 to 98.6 |
466 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
70.7 |
58.3 to 80.7 |
162 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
95.6 |
94.9 to 96.2 |
18513 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
98.0 |
96.8 to 98.8 |
1984 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
97.2 |
95.6 to 98.2 |
1034 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
96.0 |
94.6 to 97.1 |
3077 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
97.5 |
96.3 to 98.3 |
2285 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
96.5 |
95.3 to 97.4 |
2164 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
93.7 |
91.5 to 95.3 |
2291 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
95.4 |
93.7 to 96.7 |
1291 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
95.0 |
93.0 to 96.5 |
1834 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
92.4 |
88.7 to 94.9 |
1289 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
97.3 |
94.1 to 98.8 |
252 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
95.9 |
91.6 to 98.0 |
289 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
97.8 |
95.3 to 98.9 |
290 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
97.5 |
94.3 to 98.9 |
306 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
92.4 |
89.3 to 94.7 |
1040 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
89.0 |
84.3 to 92.5 |
288 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
91.7 |
86.2 to 95.2 |
207 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
92.8 |
89.1 to 95.2 |
545 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
95.9 |
94.0 to 97.2 |
1264 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
92.8 |
88.1 to 95.8 |
275 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
97.9 |
95.8 to 99.0 |
364 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
94.9 |
91.4 to 97.0 |
633 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
96.2 |
92.5 to 98.1 |
381 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
95.2 |
91.5 to 97.3 |
276 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
95.6 |
91.0 to 97.9 |
256 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
96.2 |
92.8 to 98.1 |
296 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
97.6 |
94.4 to 99.0 |
282 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
93.8 |
89.1 to 96.6 |
244 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
94.5 |
90.8 to 96.8 |
276 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
95.2 |
91.0 to 97.4 |
293 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
93.2 |
86.0 to 96.8 |
267 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
96.8 |
94.0 to 98.3 |
277 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
98.8 |
96.2 to 99.6 |
322 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
97.1 |
93.5 to 98.7 |
287 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
93.4 |
89.3 to 96.0 |
387 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
97.1 |
92.2 to 99.0 |
296 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
97.2 |
91.1 to 99.2 |
244 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
77.2 |
68.0 to 84.3 |
181 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
94.4 |
88.9 to 97.3 |
237 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
92.6 |
88.0 to 95.5 |
305 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
97.0 |
95.0 to 98.3 |
548 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
96.6 |
88.2 to 99.1 |
135 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
97.1 |
94.9 to 98.4 |
413 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
96.0 |
90.8 to 98.3 |
249 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
98.7 |
96.4 to 99.5 |
187 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
92.6 |
86.8 to 95.9 |
278 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
95.9 |
91.0 to 98.2 |
209 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
95.5 |
91.3 to 97.7 |
287 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
96.7 |
93.1 to 98.5 |
270 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
95.6 |
93.6 to 97.0 |
804 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
97.8 |
93.1 to 99.3 |
248 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
93.1 |
88.1 to 96.0 |
338 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
98.6 |
96.0 to 99.5 |
276 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
94.6 |
89.7 to 97.3 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
95.4 |
90.6 to 97.8 |
316 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
96.4 |
93.0 to 98.1 |
262 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
94.4 |
90.6 to 96.7 |
292 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
93.8 |
88.9 to 96.6 |
303 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
99.2 |
97.3 to 99.8 |
263 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
94.7 |
89.1 to 97.4 |
276 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
91.0 |
86.2 to 94.3 |
315 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
96.9 |
94.0 to 98.4 |
535 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
94.5 |
89.3 to 97.2 |
277 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
98.6 |
92.4 to 99.7 |
258 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
97.3 |
90.9 to 99.2 |
247 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
97.9 |
94.7 to 99.1 |
174 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
96.7 |
90.4 to 98.9 |
237 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
94.4 |
90.4 to 96.8 |
220 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
94.8 |
89.7 to 97.4 |
271 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
94.2 |
91.1 to 96.3 |
886 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
96.1 |
92.4 to 98.0 |
315 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
94.0 |
90.4 to 96.3 |
571 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
86.0 |
80.3 to 90.2 |
339 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
94.9 |
94.0 to 95.7 |
16725 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
97.9 |
96.1 to 98.8 |
1785 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
96.1 |
93.7 to 97.7 |
811 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
95.1 |
93.5 to 96.3 |
3141 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
97.0 |
95.4 to 98.0 |
2088 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
96.4 |
94.9 to 97.4 |
1930 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
90.1 |
87.0 to 92.6 |
2039 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
95.4 |
93.2 to 96.9 |
1073 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
96.5 |
94.9 to 97.6 |
1632 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
93.4 |
88.2 to 96.4 |
1083 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
95.3 |
89.1 to 98.0 |
240 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
98.2 |
95.5 to 99.3 |
249 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
98.9 |
97.5 to 99.5 |
413 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
96.2 |
92.6 to 98.1 |
287 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
88.2 |
83.7 to 91.6 |
924 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
88.9 |
82.9 to 93.0 |
276 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
84.6 |
74.6 to 91.2 |
157 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
88.5 |
83.2 to 92.2 |
491 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
91.2 |
84.4 to 95.2 |
240 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
94.5 |
91.9 to 96.3 |
1143 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
95.8 |
91.5 to 97.9 |
274 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
97.4 |
95.4 to 98.6 |
442 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
96.6 |
92.4 to 98.5 |
535 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
95.0 |
90.1 to 97.5 |
323 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
90.8 |
84.7 to 94.6 |
242 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
98.1 |
94.9 to 99.3 |
282 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
93.9 |
88.4 to 96.9 |
232 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
96.4 |
92.4 to 98.4 |
252 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
94.5 |
89.2 to 97.3 |
220 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
94.0 |
90.1 to 96.4 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
94.3 |
90.2 to 96.8 |
313 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
89.9 |
84.7 to 93.4 |
303 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
94.4 |
91.0 to 96.6 |
321 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
97.7 |
94.2 to 99.1 |
246 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
94.6 |
88.8 to 97.5 |
234 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
84.5 |
76.1 to 90.3 |
222 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
99.3 |
97.8 to 99.8 |
292 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
95.1 |
90.7 to 97.5 |
317 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
78.7 |
69.5 to 85.7 |
204 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
94.5 |
89.5 to 97.2 |
221 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
94.6 |
90.0 to 97.2 |
225 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
96.5 |
93.7 to 98.1 |
591 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
93.9 |
88.5 to 96.8 |
241 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
97.1 |
93.5 to 98.7 |
350 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
96.1 |
92.3 to 98.1 |
239 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
97.3 |
92.5 to 99.1 |
190 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
94.2 |
89.9 to 96.8 |
291 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
95.4 |
90.8 to 97.7 |
252 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
97.3 |
94.4 to 98.7 |
302 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
98.1 |
94.6 to 99.3 |
251 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
96.4 |
90.4 to 98.7 |
318 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
98.0 |
95.3 to 99.2 |
244 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
95.6 |
89.7 to 98.2 |
239 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
98.1 |
96.3 to 99.0 |
314 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
92.9 |
87.7 to 96.0 |
218 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
93.8 |
89.3 to 96.4 |
266 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
96.2 |
93.1 to 98.0 |
267 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
93.2 |
88.0 to 96.2 |
232 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
90.3 |
85.0 to 93.9 |
241 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
98.4 |
95.9 to 99.4 |
208 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
95.8 |
92.1 to 97.8 |
272 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
91.1 |
85.0 to 94.9 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
98.0 |
96.4 to 98.9 |
507 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
97.8 |
94.8 to 99.1 |
216 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
98.1 |
95.9 to 99.1 |
291 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
97.1 |
94.0 to 98.7 |
335 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
98.3 |
95.4 to 99.4 |
264 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
93.7 |
87.8 to 96.8 |
254 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
93.4 |
87.7 to 96.6 |
229 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
94.8 |
90.7 to 97.1 |
241 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
97.3 |
95.3 to 98.4 |
709 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
98.5 |
95.6 to 99.5 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
97.1 |
94.8 to 98.4 |
452 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
88.9 |
85.4 to 91.6 |
661 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
94.1 |
93.2 to 94.8 |
14960 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
97.9 |
96.7 to 98.7 |
1490 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
97.2 |
95.7 to 98.2 |
779 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
95.2 |
93.7 to 96.3 |
2266 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
96.8 |
95.7 to 97.6 |
2156 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
95.8 |
94.2 to 97.0 |
1894 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
88.0 |
84.0 to 91.1 |
1834 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
94.5 |
92.4 to 96.1 |
979 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
94.2 |
91.8 to 95.9 |
1600 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
90.6 |
86.6 to 93.5 |
1022 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
98.5 |
95.8 to 99.5 |
273 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
97.2 |
93.9 to 98.8 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
95.2 |
91.1 to 97.5 |
235 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
94.4 |
89.1 to 97.2 |
233 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
85.1 |
79.4 to 89.5 |
733 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
92.1 |
86.8 to 95.4 |
232 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
93.6 |
84.9 to 97.4 |
145 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
84.0 |
77.4 to 88.9 |
356 |
| Varicella |
>=1 Dose with no disease history |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
94.5 |
91.5 to 96.4 |
940 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
92.2 |
85.5 to 95.9 |
254 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
96.5 |
92.5 to 98.4 |
268 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
91.8 |
88.4 to 94.3 |
557 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
94.3 |
88.3 to 97.3 |
254 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
96.1 |
92.7 to 98.0 |
226 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
96.3 |
91.9 to 98.4 |
257 |
| Varicella |
>=1 Dose with no disease history |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
96.4 |
91.8 to 98.4 |
259 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
51.7 |
45.3 to 58.0 |
333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
61.1 |
55.0 to 66.9 |
392 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
63.1 |
56.6 to 69.2 |
329 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
54.4 |
48.1 to 60.5 |
352 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
72.6 |
66.1 to 78.2 |
327 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
63.5 |
56.5 to 69.9 |
322 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
62.2 |
55.8 to 68.2 |
357 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
70.7 |
64.9 to 75.8 |
375 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
79.2 |
73.5 to 84.0 |
377 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
55.9 |
49.2 to 62.5 |
376 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
67.3 |
60.9 to 73.2 |
367 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
67.4 |
62.4 to 72.1 |
535 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
64.8 |
58.3 to 70.8 |
317 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
57.2 |
50.9 to 63.3 |
358 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
63.5 |
58.6 to 68.1 |
605 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
73.1 |
63.2 to 81.2 |
157 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
61.4 |
55.8 to 66.6 |
448 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
45.2 |
38.9 to 51.7 |
350 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
60.7 |
54.8 to 66.3 |
382 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
51.8 |
45.2 to 58.3 |
322 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
48.0 |
41.7 to 54.4 |
333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
60.5 |
54.4 to 66.3 |
336 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
70.0 |
63.9 to 75.4 |
347 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
64.5 |
58.1 to 70.5 |
451 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
71.4 |
65.7 to 76.5 |
374 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
61.3 |
54.2 to 67.9 |
283 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
59.1 |
53.0 to 65.0 |
375 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
45.6 |
39.4 to 52.0 |
377 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
51.6 |
45.0 to 58.1 |
360 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
55.3 |
48.9 to 61.5 |
375 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
63.7 |
57.2 to 69.8 |
330 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
64.9 |
58.5 to 70.8 |
330 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
69.9 |
63.7 to 75.5 |
313 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
58.5 |
52.4 to 64.3 |
422 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
60.5 |
54.4 to 66.3 |
374 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
71.5 |
67.3 to 75.4 |
655 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
76.8 |
70.8 to 81.9 |
291 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
68.1 |
62.3 to 73.5 |
364 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
57.5 |
51.0 to 63.8 |
366 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
67.6 |
60.9 to 73.5 |
293 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
56.2 |
49.5 to 62.8 |
338 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
56.9 |
49.5 to 63.9 |
281 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
61.7 |
55.2 to 67.9 |
318 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
64.4 |
59.3 to 69.2 |
875 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
80.7 |
75.4 to 85.0 |
349 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
62.3 |
56.6 to 67.6 |
526 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
75.8 |
70.2 to 80.6 |
405 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
60.4 |
59.2 to 61.6 |
20475 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
69.9 |
66.7 to 72.9 |
2097 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
67.2 |
63.8 to 70.5 |
1077 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
61.2 |
57.9 to 64.4 |
2842 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
55.8 |
53.1 to 58.5 |
2757 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
58.4 |
55.8 to 61.0 |
2284 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
52.0 |
49.3 to 54.8 |
3270 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
55.3 |
51.8 to 58.8 |
1394 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
57.4 |
53.6 to 61.0 |
2022 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
70.6 |
65.6 to 75.2 |
1303 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
88.9 |
84.7 to 92.1 |
326 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
44.2 |
37.4 to 51.3 |
314 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
55.9 |
49.2 to 62.3 |
342 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
55.3 |
48.5 to 61.9 |
291 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
49.3 |
45.6 to 53.0 |
1927 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
53.4 |
46.7 to 59.9 |
334 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
62.6 |
53.6 to 70.9 |
225 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
45.7 |
38.5 to 53.1 |
294 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
79.8 |
73.6 to 84.9 |
345 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
46.8 |
42.0 to 51.6 |
729 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
41.9 |
36.2 to 47.7 |
428 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
62.6 |
58.8 to 66.3 |
1429 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
49.7 |
43.1 to 56.2 |
317 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
70.3 |
64.6 to 75.5 |
380 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
53.6 |
46.0 to 61.0 |
451 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
64.8 |
58.5 to 70.6 |
361 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
54.2 |
47.5 to 60.8 |
313 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
61.9 |
55.5 to 67.9 |
333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
43.4 |
37.5 to 49.5 |
373 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
58.0 |
52.0 to 63.9 |
367 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
64.5 |
58.4 to 70.1 |
349 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
65.0 |
58.4 to 71.2 |
335 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
61.1 |
54.7 to 67.0 |
357 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
71.9 |
65.4 to 77.5 |
306 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
72.1 |
66.2 to 77.3 |
354 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
71.3 |
64.9 to 76.9 |
330 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
75.3 |
69.3 to 80.5 |
350 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
91.9 |
87.6 to 94.8 |
318 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
59.8 |
53.1 to 66.1 |
415 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
64.3 |
57.5 to 70.6 |
343 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
67.5 |
61.4 to 73.0 |
382 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
69.4 |
63.0 to 75.1 |
314 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
62.4 |
55.7 to 68.6 |
353 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
66.1 |
61.5 to 70.4 |
683 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
81.9 |
73.9 to 87.8 |
204 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
62.7 |
57.4 to 67.7 |
479 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
59.3 |
52.8 to 65.5 |
334 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
71.4 |
65.6 to 76.5 |
343 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
52.4 |
46.0 to 58.8 |
338 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
49.6 |
43.5 to 55.6 |
372 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
69.1 |
63.3 to 74.4 |
341 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
75.8 |
70.2 to 80.6 |
347 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
69.2 |
62.1 to 75.6 |
470 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
81.9 |
76.9 to 85.9 |
412 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
67.3 |
61.1 to 73.0 |
328 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
68.1 |
61.9 to 73.7 |
356 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
49.6 |
43.4 to 55.9 |
347 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
57.8 |
51.3 to 64.0 |
335 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
65.5 |
58.9 to 71.5 |
326 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
71.0 |
64.8 to 76.5 |
324 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
64.9 |
58.3 to 70.9 |
344 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
74.2 |
68.5 to 79.2 |
333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
65.8 |
59.8 to 71.3 |
366 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
66.9 |
60.9 to 72.4 |
362 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
68.5 |
64.0 to 72.7 |
651 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
73.3 |
66.9 to 78.9 |
281 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
65.5 |
59.3 to 71.2 |
370 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
66.8 |
60.4 to 72.6 |
336 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
72.5 |
67.0 to 77.4 |
379 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
64.1 |
58.4 to 69.3 |
408 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
58.5 |
52.1 to 64.6 |
338 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
71.2 |
65.4 to 76.4 |
359 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
67.3 |
62.2 to 72.1 |
851 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
84.9 |
80.0 to 88.7 |
362 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
65.0 |
59.2 to 70.4 |
489 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
65.5 |
64.3 to 66.7 |
20949 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
78.2 |
75.4 to 80.8 |
2107 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
67.6 |
64.1 to 71.0 |
1017 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
70.3 |
67.0 to 73.3 |
2745 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
60.0 |
57.3 to 62.6 |
2846 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
65.5 |
63.2 to 67.8 |
2433 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
59.7 |
57.1 to 62.2 |
3654 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
61.5 |
58.0 to 64.8 |
1340 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
65.7 |
62.4 to 68.8 |
2108 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
70.4 |
65.4 to 75.0 |
1299 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
88.6 |
83.3 to 92.4 |
319 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
59.6 |
52.7 to 66.0 |
328 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
63.2 |
56.7 to 69.2 |
333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
56.1 |
49.3 to 62.6 |
338 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
57.8 |
54.3 to 61.2 |
2256 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
62.9 |
56.6 to 68.8 |
336 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
73.0 |
63.9 to 80.4 |
187 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
54.5 |
46.9 to 62.0 |
263 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
82.8 |
77.2 to 87.2 |
320 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
69.7 |
63.3 to 75.4 |
304 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
54.5 |
49.9 to 59.1 |
846 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
69.9 |
66.3 to 73.3 |
1400 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
58.8 |
52.6 to 64.8 |
356 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
78.7 |
73.2 to 83.3 |
366 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
75.6 |
68.4 to 81.6 |
413 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
71.9 |
65.8 to 77.3 |
339 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
60.9 |
54.6 to 66.9 |
343 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
69.2 |
63.0 to 74.8 |
324 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
46.9 |
40.8 to 53.1 |
360 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
64.7 |
58.1 to 70.7 |
327 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
66.4 |
60.7 to 71.7 |
392 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
67.2 |
60.4 to 73.4 |
288 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
60.8 |
54.1 to 67.1 |
308 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
73.5 |
66.7 to 79.4 |
356 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
77.2 |
70.4 to 82.8 |
278 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
70.5 |
63.7 to 76.5 |
293 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
73.9 |
67.1 to 79.7 |
306 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
86.0 |
79.5 to 90.6 |
283 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
64.1 |
57.3 to 70.4 |
337 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
68.1 |
61.8 to 73.8 |
345 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
65.8 |
59.0 to 72.0 |
309 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
76.7 |
70.8 to 81.8 |
327 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
63.6 |
56.7 to 70.0 |
291 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
69.4 |
65.2 to 73.4 |
721 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
84.1 |
75.3 to 90.2 |
192 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
66.3 |
61.4 to 70.9 |
529 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
65.0 |
58.6 to 70.9 |
296 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
73.4 |
67.0 to 78.9 |
280 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
62.3 |
55.5 to 68.6 |
297 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
56.9 |
50.0 to 63.5 |
270 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
67.2 |
60.3 to 73.4 |
284 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
65.0 |
58.1 to 71.3 |
317 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
74.7 |
68.3 to 80.2 |
393 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
85.2 |
79.1 to 89.8 |
328 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
72.5 |
66.0 to 78.1 |
313 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
76.7 |
70.0 to 82.3 |
285 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
51.7 |
44.9 to 58.5 |
285 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
61.6 |
55.0 to 67.8 |
319 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
66.4 |
59.6 to 72.5 |
290 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
75.6 |
68.9 to 81.3 |
295 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
66.0 |
59.8 to 71.7 |
334 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
77.4 |
70.8 to 82.8 |
303 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
65.4 |
58.6 to 71.6 |
351 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
71.8 |
65.3 to 77.4 |
295 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
67.3 |
61.8 to 72.3 |
535 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
72.1 |
64.5 to 78.5 |
261 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
64.1 |
56.5 to 71.1 |
274 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
68.6 |
62.2 to 74.5 |
341 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
76.7 |
70.0 to 82.2 |
287 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
68.3 |
62.0 to 73.9 |
329 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
59.1 |
52.9 to 65.0 |
360 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
75.3 |
68.9 to 80.8 |
297 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
72.0 |
65.7 to 77.6 |
649 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
89.8 |
84.3 to 93.5 |
237 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
69.7 |
62.6 to 76.0 |
412 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
68.1 |
66.8 to 69.3 |
18700 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
79.0 |
75.8 to 81.9 |
1902 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
66.6 |
62.4 to 70.6 |
886 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
70.9 |
67.0 to 74.4 |
2295 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
64.3 |
61.6 to 66.9 |
2507 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
70.0 |
67.6 to 72.3 |
2276 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
61.2 |
58.5 to 63.8 |
3326 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
66.4 |
62.8 to 69.7 |
1191 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
71.4 |
67.8 to 74.7 |
1746 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
72.2 |
66.9 to 77.0 |
1305 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
89.3 |
84.5 to 92.7 |
337 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
63.7 |
57.0 to 69.8 |
318 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
68.7 |
62.7 to 74.2 |
340 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
62.3 |
55.4 to 68.8 |
284 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
59.9 |
56.4 to 63.4 |
2079 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
65.4 |
58.4 to 71.7 |
298 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
70.1 |
61.6 to 77.4 |
186 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
66.3 |
58.6 to 73.3 |
314 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
62.8 |
56.4 to 68.7 |
364 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
58.0 |
53.4 to 62.4 |
917 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
71.1 |
66.9 to 74.9 |
1266 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
66.7 |
60.2 to 72.6 |
310 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
78.3 |
73.0 to 82.8 |
324 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
67.2 |
58.0 to 75.3 |
327 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
71.3 |
64.2 to 77.6 |
286 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
61.3 |
55.2 to 67.0 |
337 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
69.8 |
64.0 to 75.1 |
332 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
53.5 |
46.0 to 60.9 |
241 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
65.6 |
58.6 to 71.9 |
296 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
68.6 |
63.0 to 73.6 |
426 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
71.8 |
65.3 to 77.6 |
308 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
67.9 |
61.5 to 73.6 |
329 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
78.7 |
70.6 to 85.1 |
274 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
80.2 |
73.1 to 85.8 |
262 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
70.6 |
63.5 to 76.8 |
294 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
75.4 |
69.3 to 80.7 |
308 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
86.8 |
79.8 to 91.6 |
282 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
67.9 |
59.6 to 75.2 |
329 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
65.9 |
59.0 to 72.3 |
315 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
63.3 |
56.2 to 69.9 |
278 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
79.4 |
73.1 to 84.5 |
304 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
64.0 |
56.8 to 70.7 |
332 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
71.7 |
66.8 to 76.1 |
602 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
81.1 |
71.5 to 88.0 |
160 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
69.7 |
64.2 to 74.8 |
442 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
66.3 |
59.4 to 72.5 |
289 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
75.1 |
69.1 to 80.3 |
302 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
65.9 |
59.5 to 71.9 |
381 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
74.4 |
68.2 to 79.8 |
292 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
73.9 |
66.9 to 80.0 |
336 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
65.1 |
58.2 to 71.4 |
316 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
78.9 |
72.9 to 83.8 |
524 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
87.9 |
82.3 to 91.8 |
300 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
73.7 |
67.3 to 79.2 |
297 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
73.8 |
66.0 to 80.4 |
276 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
49.5 |
42.0 to 57.1 |
270 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
69.0 |
61.9 to 75.4 |
288 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
63.7 |
56.8 to 70.0 |
297 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
73.9 |
66.7 to 80.1 |
285 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
68.9 |
61.8 to 75.1 |
313 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
75.1 |
68.5 to 80.7 |
333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
67.1 |
60.3 to 73.3 |
331 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
73.3 |
67.4 to 78.4 |
405 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
70.8 |
65.1 to 76.0 |
498 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
73.3 |
65.7 to 79.6 |
257 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
69.3 |
61.0 to 76.4 |
241 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
71.3 |
64.4 to 77.3 |
305 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
88.8 |
84.5 to 92.0 |
319 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
69.7 |
63.3 to 75.5 |
302 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
65.6 |
59.6 to 71.2 |
369 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
74.6 |
67.5 to 80.5 |
270 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
77.0 |
72.0 to 81.4 |
734 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
90.0 |
84.2 to 93.8 |
242 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
75.3 |
69.7 to 80.2 |
492 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
75.7 |
64.9 to 84.0 |
216 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
71.5 |
70.1 to 72.8 |
18788 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
80.4 |
77.3 to 83.2 |
2034 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
69.6 |
65.2 to 73.6 |
829 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
76.3 |
73.1 to 79.2 |
2520 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
67.1 |
64.1 to 70.1 |
2387 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
71.2 |
68.7 to 73.6 |
2097 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
66.6 |
63.9 to 69.1 |
3289 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
70.4 |
66.8 to 73.8 |
1256 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
74.4 |
70.6 to 77.8 |
1845 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
77.2 |
71.0 to 82.4 |
1199 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
91.9 |
87.4 to 95.0 |
319 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
71.8 |
65.4 to 77.4 |
319 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
73.6 |
67.3 to 79.0 |
313 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
61.9 |
54.6 to 68.8 |
261 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
65.1 |
61.5 to 68.4 |
1850 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
67.2 |
60.4 to 73.4 |
293 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
79.9 |
71.0 to 86.6 |
174 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
68.1 |
60.9 to 74.4 |
271 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
83.9 |
78.4 to 88.1 |
280 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
62.2 |
57.6 to 66.6 |
832 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
48.8 |
40.2 to 57.6 |
218 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
71.4 |
67.1 to 75.3 |
1332 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
68.8 |
61.6 to 75.2 |
325 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
82.0 |
77.3 to 85.8 |
472 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
75.2 |
67.4 to 81.6 |
363 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
72.0 |
64.9 to 78.2 |
304 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
64.7 |
58.2 to 70.7 |
309 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
72.2 |
66.0 to 77.6 |
331 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
59.1 |
52.6 to 65.3 |
329 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
67.3 |
60.7 to 73.3 |
298 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
71.9 |
65.0 to 77.8 |
302 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
70.7 |
64.4 to 76.3 |
340 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
70.9 |
64.3 to 76.8 |
322 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
78.2 |
71.8 to 83.4 |
403 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
81.6 |
76.1 to 86.0 |
354 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
82.2 |
76.6 to 86.6 |
331 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
78.0 |
72.0 to 83.0 |
360 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
87.4 |
81.7 to 91.6 |
404 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
68.3 |
61.3 to 74.6 |
355 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
73.1 |
66.2 to 79.0 |
300 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
68.3 |
61.5 to 74.4 |
300 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
84.9 |
79.4 to 89.1 |
290 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
72.5 |
66.4 to 77.8 |
376 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
75.9 |
71.0 to 80.2 |
699 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
86.3 |
79.9 to 91.0 |
271 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
73.7 |
67.9 to 78.8 |
428 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
73.6 |
67.3 to 79.0 |
302 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
74.2 |
67.8 to 79.7 |
280 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
63.3 |
57.0 to 69.3 |
364 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
75.6 |
69.0 to 81.3 |
255 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
75.3 |
69.1 to 80.5 |
356 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
74.4 |
68.8 to 79.3 |
372 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
83.1 |
79.2 to 86.5 |
815 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
87.4 |
83.1 to 90.8 |
394 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
76.9 |
71.4 to 81.7 |
398 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
81.0 |
75.0 to 85.8 |
330 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
55.2 |
48.2 to 61.9 |
282 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
69.9 |
63.5 to 75.6 |
397 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
73.7 |
67.1 to 79.4 |
307 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
82.6 |
77.5 to 86.8 |
405 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
70.1 |
63.3 to 76.1 |
369 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
82.5 |
77.5 to 86.6 |
381 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
73.1 |
67.1 to 78.4 |
379 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
77.4 |
71.9 to 82.0 |
352 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
79.1 |
74.9 to 82.8 |
729 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
81.0 |
74.9 to 86.0 |
381 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
77.9 |
72.0 to 82.8 |
348 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
80.3 |
74.1 to 85.3 |
327 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
79.8 |
74.2 to 84.5 |
401 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
75.5 |
69.5 to 80.7 |
338 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
65.5 |
59.3 to 71.2 |
338 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
78.5 |
72.7 to 83.4 |
308 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
78.4 |
73.0 to 83.0 |
765 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
84.8 |
78.3 to 89.5 |
263 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
77.6 |
71.4 to 82.7 |
502 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
69.9 |
58.5 to 79.4 |
169 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
75.1 |
73.9 to 76.2 |
20163 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
84.9 |
82.4 to 87.0 |
2147 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
77.1 |
73.7 to 80.2 |
1108 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
77.1 |
74.3 to 79.8 |
3331 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
71.3 |
68.6 to 73.9 |
2466 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
76.5 |
74.2 to 78.6 |
2344 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
72.5 |
69.2 to 75.6 |
2509 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
71.3 |
67.9 to 74.4 |
1446 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
76.2 |
72.9 to 79.1 |
2007 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
76.8 |
71.9 to 81.0 |
1402 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
93.0 |
88.4 to 95.9 |
271 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
70.1 |
63.7 to 75.9 |
311 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
84.5 |
79.7 to 88.4 |
317 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
71.7 |
65.7 to 77.0 |
338 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
72.8 |
68.2 to 77.0 |
1141 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
75.7 |
69.6 to 80.9 |
314 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
77.1 |
69.2 to 83.5 |
221 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
72.3 |
67.0 to 77.0 |
606 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
75.2 |
71.4 to 78.6 |
1403 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
68.6 |
61.6 to 74.8 |
304 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
87.0 |
82.3 to 90.6 |
398 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
73.7 |
67.7 to 79.0 |
677 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
74.6 |
68.1 to 80.1 |
417 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
59.7 |
53.2 to 65.9 |
310 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
77.8 |
71.6 to 83.0 |
277 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
64.6 |
57.8 to 70.8 |
324 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
78.5 |
72.4 to 83.6 |
304 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
70.3 |
62.9 to 76.7 |
268 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
81.3 |
75.6 to 85.9 |
296 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
73.2 |
67.2 to 78.5 |
314 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
81.7 |
73.7 to 87.7 |
286 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
80.0 |
73.6 to 85.2 |
298 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
77.9 |
71.7 to 83.0 |
340 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
83.5 |
77.7 to 88.0 |
310 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
89.6 |
85.1 to 92.9 |
409 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
67.7 |
59.5 to 74.9 |
312 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
78.6 |
71.6 to 84.3 |
260 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
70.0 |
62.2 to 76.8 |
225 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
83.8 |
77.8 to 88.4 |
258 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
78.8 |
72.9 to 83.7 |
334 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
76.6 |
71.8 to 80.7 |
578 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
82.9 |
71.6 to 90.4 |
144 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
75.2 |
69.7 to 79.9 |
434 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
72.1 |
65.2 to 78.1 |
268 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
79.2 |
70.8 to 85.7 |
199 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
76.5 |
69.6 to 82.3 |
300 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
70.3 |
62.4 to 77.1 |
240 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
81.1 |
75.1 to 86.0 |
303 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
77.5 |
71.1 to 82.8 |
293 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
85.5 |
82.1 to 88.4 |
857 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
89.3 |
83.0 to 93.4 |
266 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
79.0 |
72.6 to 84.2 |
358 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
79.9 |
73.2 to 85.2 |
296 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
56.2 |
49.2 to 63.1 |
303 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
76.2 |
70.0 to 81.5 |
340 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
75.3 |
68.9 to 80.7 |
290 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
82.7 |
76.8 to 87.3 |
315 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
76.1 |
69.3 to 81.7 |
333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
84.6 |
78.9 to 89.0 |
282 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
65.4 |
57.7 to 72.4 |
292 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
80.9 |
75.4 to 85.5 |
337 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
75.9 |
70.8 to 80.4 |
581 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
80.0 |
73.3 to 85.3 |
297 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
73.2 |
65.8 to 79.5 |
284 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
85.0 |
78.2 to 90.0 |
266 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
83.8 |
76.4 to 89.2 |
191 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
72.4 |
63.6 to 79.8 |
254 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
72.4 |
65.4 to 78.5 |
240 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
82.3 |
76.3 to 87.0 |
294 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
77.7 |
73.4 to 81.5 |
929 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
87.1 |
81.8 to 91.1 |
330 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
76.4 |
71.6 to 80.7 |
599 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
86.1 |
81.4 to 89.8 |
350 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
76.9 |
75.6 to 78.2 |
18002 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
84.7 |
81.7 to 87.4 |
1923 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
72.4 |
68.2 to 76.2 |
873 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
79.1 |
76.5 to 81.5 |
3338 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
74.7 |
71.7 to 77.5 |
2263 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
76.5 |
73.7 to 79.1 |
2060 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
72.9 |
69.1 to 76.4 |
2184 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
77.9 |
74.4 to 81.0 |
1154 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
80.0 |
76.7 to 82.9 |
1789 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
81.3 |
75.3 to 86.2 |
1173 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
90.1 |
83.2 to 94.3 |
254 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
81.8 |
75.9 to 86.5 |
263 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
87.4 |
82.8 to 90.9 |
445 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
75.3 |
68.9 to 80.8 |
315 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
71.3 |
66.0 to 76.1 |
990 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
77.3 |
70.9 to 82.7 |
296 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
79.9 |
70.8 to 86.7 |
167 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
70.1 |
64.0 to 75.6 |
527 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
71.8 |
63.2 to 79.1 |
245 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
79.4 |
75.8 to 82.6 |
1245 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
80.9 |
75.2 to 85.6 |
304 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
83.4 |
79.0 to 87.1 |
488 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
77.3 |
70.6 to 82.9 |
566 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
79.0 |
72.8 to 84.1 |
349 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
70.5 |
63.7 to 76.5 |
267 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
82.4 |
76.8 to 86.8 |
306 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
64.8 |
56.9 to 71.9 |
261 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
76.8 |
70.5 to 82.0 |
269 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
76.1 |
68.9 to 82.1 |
240 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
76.5 |
69.9 to 81.9 |
273 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
74.7 |
68.8 to 79.8 |
332 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
72.2 |
65.2 to 78.2 |
321 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
79.7 |
74.3 to 84.2 |
342 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
80.0 |
73.1 to 85.4 |
258 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
84.2 |
77.8 to 89.0 |
250 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
86.5 |
80.0 to 91.2 |
237 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
75.6 |
68.5 to 81.5 |
307 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
70.8 |
64.0 to 76.8 |
333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
69.8 |
61.5 to 77.0 |
240 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
86.4 |
80.4 to 90.7 |
237 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
80.8 |
74.4 to 85.9 |
251 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
80.3 |
75.4 to 84.4 |
630 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
83.0 |
75.4 to 88.6 |
256 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
79.7 |
73.9 to 84.5 |
374 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
75.5 |
68.4 to 81.4 |
258 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
87.9 |
81.5 to 92.2 |
207 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
73.4 |
67.0 to 79.1 |
310 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
66.4 |
59.3 to 72.8 |
276 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
79.8 |
73.8 to 84.8 |
330 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
77.9 |
71.4 to 83.2 |
268 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
84.0 |
77.0 to 89.2 |
346 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
85.6 |
79.3 to 90.3 |
268 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
76.3 |
69.1 to 82.3 |
257 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
86.9 |
82.3 to 90.5 |
331 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
61.0 |
52.8 to 68.6 |
232 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
74.0 |
67.2 to 79.8 |
284 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
81.8 |
76.0 to 86.4 |
297 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
81.1 |
74.3 to 86.4 |
247 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
75.0 |
68.3 to 80.7 |
259 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
85.7 |
79.6 to 90.3 |
225 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
75.5 |
68.6 to 81.2 |
289 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
79.4 |
72.8 to 84.8 |
276 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
81.8 |
77.5 to 85.4 |
536 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
84.3 |
77.8 to 89.2 |
222 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
80.1 |
74.2 to 84.9 |
314 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
73.1 |
66.4 to 78.9 |
361 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
82.9 |
76.3 to 88.0 |
280 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
76.8 |
69.1 to 83.1 |
269 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
69.1 |
61.7 to 75.7 |
249 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
80.7 |
74.4 to 85.8 |
263 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
76.4 |
71.5 to 80.6 |
752 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
91.1 |
85.0 to 94.8 |
267 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
74.5 |
69.0 to 79.2 |
485 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
88.4 |
84.9 to 91.1 |
671 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
76.0 |
74.7 to 77.3 |
16043 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
84.2 |
81.0 to 87.1 |
1595 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
79.6 |
76.0 to 82.8 |
825 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
78.3 |
75.5 to 80.8 |
2424 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
72.5 |
69.8 to 75.1 |
2291 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
78.9 |
76.3 to 81.3 |
2019 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
71.8 |
67.4 to 75.9 |
1981 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
78.0 |
74.5 to 81.1 |
1048 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
77.2 |
73.9 to 80.2 |
1736 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
73.3 |
67.9 to 78.1 |
1090 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
94.6 |
90.7 to 96.9 |
285 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
69.9 |
62.3 to 76.6 |
269 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
79.0 |
72.1 to 84.6 |
252 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
74.1 |
66.7 to 80.3 |
244 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
70.3 |
64.0 to 75.8 |
794 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
75.9 |
68.1 to 82.3 |
253 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
81.0 |
72.1 to 87.6 |
157 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
69.0 |
61.9 to 75.4 |
384 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
83.0 |
79.6 to 85.9 |
1034 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
73.0 |
65.6 to 79.3 |
271 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
88.0 |
82.6 to 91.8 |
291 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
77.5 |
72.6 to 81.7 |
595 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
85.4 |
79.9 to 89.7 |
280 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
69.9 |
62.8 to 76.2 |
244 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
80.5 |
73.8 to 85.8 |
274 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
65.5 |
58.0 to 72.3 |
294 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Other |
60.1 |
49.5 to 69.9 |
138 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Other |
73.2 |
66.6 to 78.9 |
316 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Other |
68.9 |
57.1 to 78.7 |
119 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Other |
70.5 |
63.0 to 77.0 |
223 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Other |
77.7 |
59.8 to 89.1 |
132 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Other |
75.7 |
64.1 to 84.4 |
133 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Other |
75.0 |
66.3 to 82.1 |
211 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Other |
84.8 |
72.7 to 92.1 |
72 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Other |
90.2 |
76.3 to 96.4 |
44 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Other |
61.3 |
48.5 to 72.7 |
147 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Other |
72.9 |
63.2 to 80.7 |
158 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Other |
73.4 |
63.9 to 81.1 |
157 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Other |
57.0 |
43.7 to 69.4 |
94 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Other |
53.9 |
39.6 to 67.6 |
101 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
49.6 |
34.3 to 64.9 |
73 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Other |
64.1 |
45.0 to 79.6 |
41 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Other |
79.9 |
70.5 to 86.8 |
103 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Other |
70.7 |
64.1 to 76.5 |
316 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Other |
64.8 |
51.0 to 76.5 |
78 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Other |
73.1 |
58.3 to 84.1 |
67 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Other |
68.7 |
56.0 to 79.1 |
83 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Other |
69.8 |
58.5 to 79.0 |
180 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Other |
92.1 |
80.6 to 97.0 |
67 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Other |
68.1 |
53.1 to 80.1 |
72 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Other |
59.7 |
39.8 to 76.8 |
49 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Other |
44.9 |
33.6 to 56.8 |
105 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Other |
62.7 |
48.6 to 74.9 |
85 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Other |
64.6 |
55.0 to 73.1 |
150 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Other |
83.4 |
71.6 to 90.9 |
89 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Other |
78.7 |
69.2 to 85.8 |
124 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Other |
73.6 |
59.2 to 84.3 |
72 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Other |
73.3 |
51.1 to 87.9 |
47 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Other |
74.1 |
63.8 to 82.3 |
103 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Other |
72.1 |
65.5 to 77.8 |
365 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Other |
69.5 |
59.9 to 77.7 |
176 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
73.6 |
64.6 to 81.0 |
189 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Other |
68.6 |
57.8 to 77.7 |
153 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Other |
76.8 |
67.2 to 84.3 |
148 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Other |
67.0 |
50.3 to 80.2 |
65 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Other |
56.0 |
47.7 to 64.0 |
217 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Other |
76.9 |
66.4 to 84.9 |
122 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Other |
69.7 |
60.2 to 77.8 |
305 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Other |
89.8 |
83.4 to 93.9 |
143 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
65.8 |
54.8 to 75.4 |
162 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Other |
69.5 |
67.4 to 71.5 |
7253 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Other |
90.9 |
76.1 to 96.9 |
54 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Other |
63.5 |
50.5 to 74.7 |
98 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Other |
74.5 |
64.3 to 82.5 |
135 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Other |
58.9 |
47.9 to 69.1 |
123 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Other |
67.4 |
60.4 to 73.7 |
705 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Other |
72.1 |
63.4 to 79.4 |
211 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Other |
73.4 |
58.4 to 84.5 |
72 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
66.2 |
57.8 to 73.7 |
422 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Other |
71.0 |
58.2 to 81.2 |
103 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Other |
83.2 |
70.4 to 91.2 |
78 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Other |
70.9 |
62.2 to 78.3 |
296 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Other |
78.6 |
68.6 to 86.1 |
143 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Other |
72.6 |
61.8 to 81.3 |
99 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Other |
51.3 |
35.8 to 66.5 |
55 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Other |
60.6 |
48.5 to 71.6 |
113 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
64.4 |
60.3 to 68.3 |
806 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
68.8 |
64.5 to 72.7 |
794 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
67.8 |
63.8 to 71.6 |
826 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
66.1 |
61.9 to 70.1 |
752 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
74.4 |
70.1 to 78.3 |
951 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
81.1 |
77.8 to 84.0 |
950 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
75.1 |
71.7 to 78.2 |
1000 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
78.2 |
74.7 to 81.3 |
915 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
84.6 |
80.9 to 87.8 |
1006 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
69.3 |
64.7 to 73.5 |
892 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
70.1 |
66.0 to 73.8 |
886 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
84.9 |
81.9 to 87.6 |
797 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
69.7 |
65.7 to 73.3 |
911 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
74.5 |
71.8 to 77.0 |
1944 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
82.6 |
76.5 to 87.4 |
470 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
73.3 |
70.4 to 76.1 |
1474 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
70.0 |
66.3 to 73.5 |
847 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
79.1 |
75.3 to 82.4 |
769 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
65.3 |
61.4 to 69.0 |
970 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
68.4 |
64.2 to 72.3 |
743 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
66.3 |
61.9 to 70.5 |
756 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
72.6 |
69.0 to 76.0 |
943 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
81.8 |
78.8 to 84.4 |
2139 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
86.4 |
83.5 to 88.9 |
1143 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
75.9 |
72.5 to 79.0 |
1070 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
80.5 |
77.3 to 83.3 |
1092 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
45.6 |
40.7 to 50.5 |
617 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
71.2 |
67.7 to 74.6 |
1032 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
72.9 |
69.1 to 76.4 |
823 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
78.3 |
74.9 to 81.5 |
1027 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
66.0 |
61.9 to 69.9 |
889 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
83.9 |
81.1 to 86.4 |
1058 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
68.1 |
64.6 to 71.5 |
1192 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
73.2 |
69.1 to 77.0 |
721 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
73.3 |
70.3 to 76.2 |
1581 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
76.9 |
72.3 to 80.9 |
640 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
71.7 |
67.7 to 75.4 |
941 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
75.5 |
71.5 to 79.1 |
906 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
83.8 |
80.6 to 86.5 |
1015 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
72.0 |
68.1 to 75.5 |
951 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
58.6 |
53.9 to 63.1 |
632 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
77.4 |
73.8 to 80.7 |
858 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
75.6 |
72.7 to 78.4 |
2218 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
88.6 |
84.4 to 91.7 |
532 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
74.7 |
71.5 to 77.6 |
1686 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
72.5 |
71.7 to 73.2 |
54111 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
92.0 |
89.5 to 94.0 |
867 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
69.0 |
64.9 to 72.7 |
805 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
79.3 |
76.3 to 82.0 |
1100 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
67.6 |
63.5 to 71.3 |
814 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
65.1 |
62.2 to 67.9 |
3327 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
66.2 |
61.5 to 70.6 |
678 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
78.8 |
73.3 to 83.5 |
397 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
64.2 |
61.0 to 67.3 |
2252 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
69.8 |
66.2 to 73.1 |
1130 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
84.2 |
81.5 to 86.6 |
1194 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
75.2 |
71.5 to 78.6 |
1860 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
76.2 |
72.4 to 79.7 |
930 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
58.8 |
54.6 to 62.8 |
735 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
76.9 |
73.7 to 79.9 |
986 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
59.2 |
55.2 to 63.1 |
941 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Any Medicaid |
80.1 |
75.9 to 83.7 |
521 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Any Medicaid |
72.3 |
67.3 to 76.8 |
474 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Any Medicaid |
83.4 |
79.2 to 86.8 |
476 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
73.4 |
68.8 to 77.5 |
567 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Any Medicaid |
80.3 |
75.5 to 84.4 |
528 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.3 |
74.2 to 83.7 |
414 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Any Medicaid |
82.2 |
75.6 to 87.4 |
273 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Any Medicaid |
80.1 |
75.4 to 84.0 |
497 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
90.1 |
86.5 to 92.8 |
549 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Any Medicaid |
73.7 |
68.4 to 78.4 |
503 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
76.7 |
71.4 to 81.2 |
430 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Any Medicaid |
81.8 |
77.2 to 85.7 |
443 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.2 |
74.7 to 83.1 |
521 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Any Medicaid |
77.0 |
73.6 to 80.1 |
1112 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Insurance Coverage |
Any Medicaid |
83.9 |
78.8 to 88.0 |
496 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
74.7 |
70.4 to 78.6 |
616 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
72.0 |
66.9 to 76.6 |
467 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Any Medicaid |
76.5 |
71.0 to 81.2 |
373 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
78.2 |
71.8 to 83.5 |
290 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Any Medicaid |
70.6 |
65.6 to 75.2 |
473 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
82.5 |
78.7 to 85.6 |
748 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Any Medicaid |
71.9 |
66.8 to 76.5 |
496 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Any Medicaid |
82.3 |
77.4 to 86.3 |
569 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Any Medicaid |
87.7 |
82.6 to 91.5 |
332 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Any Medicaid |
76.7 |
71.3 to 81.3 |
449 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
81.6 |
75.7 to 86.3 |
348 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Any Medicaid |
63.6 |
58.8 to 68.2 |
589 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Any Medicaid |
71.0 |
65.4 to 76.0 |
445 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
74.6 |
69.7 to 78.8 |
481 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Any Medicaid |
80.2 |
74.6 to 84.9 |
364 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Any Medicaid |
78.0 |
73.1 to 82.3 |
497 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Any Medicaid |
76.7 |
70.9 to 81.6 |
361 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Any Medicaid |
72.7 |
66.6 to 78.1 |
362 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.9 |
76.3 to 83.1 |
794 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.7 |
76.0 to 82.9 |
897 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Any Medicaid |
81.8 |
77.4 to 85.6 |
580 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
77.3 |
71.1 to 82.5 |
317 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Any Medicaid |
77.6 |
72.6 to 81.8 |
471 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
82.8 |
76.5 to 87.7 |
267 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Any Medicaid |
75.6 |
70.3 to 80.2 |
451 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Any Medicaid |
74.7 |
70.5 to 78.5 |
659 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Any Medicaid |
81.0 |
76.2 to 85.0 |
430 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.7 |
75.8 to 83.1 |
1213 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
87.8 |
84.1 to 90.8 |
606 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
77.9 |
73.3 to 82.0 |
607 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Any Medicaid |
77.3 |
76.3 to 78.3 |
27403 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Any Medicaid |
91.6 |
87.7 to 94.3 |
508 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Any Medicaid |
75.8 |
71.1 to 80.0 |
523 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.8 |
74.4 to 84.3 |
381 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Any Medicaid |
74.9 |
69.4 to 79.7 |
439 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
73.8 |
70.0 to 77.3 |
2274 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.8 |
75.2 to 83.7 |
487 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.2 |
73.0 to 84.2 |
343 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
72.8 |
68.3 to 76.8 |
1444 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.1 |
72.2 to 84.6 |
218 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Any Medicaid |
83.4 |
79.9 to 86.4 |
690 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
75.4 |
68.3 to 81.3 |
319 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Any Medicaid |
78.1 |
73.3 to 82.3 |
544 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
70.7 |
66.2 to 74.8 |
603 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Any Medicaid |
79.7 |
75.1 to 83.7 |
454 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Any Medicaid |
68.1 |
61.4 to 74.1 |
316 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Uninsured |
60.3 |
41.5 to 76.4 |
44 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Uninsured |
65.3 |
52.5 to 76.2 |
84 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Uninsured |
61.4 |
46.7 to 74.3 |
63 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Uninsured |
66.3 |
46.9 to 81.5 |
37 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Uninsured |
58.0 |
36.7 to 76.6 |
32 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Uninsured |
72.9 |
55.8 to 85.1 |
50 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Uninsured |
49.5 |
36.3 to 62.8 |
98 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Uninsured |
43.1 |
30.6 to 56.6 |
79 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Uninsured |
63.3 |
47.6 to 76.7 |
58 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Uninsured |
67.7 |
52.1 to 80.2 |
73 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
59.6 |
40.8 to 76.0 |
44 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Uninsured |
69.1 |
53.6 to 81.3 |
58 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Uninsured |
54.7 |
40.7 to 67.9 |
76 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Uninsured |
58.4 |
39.1 to 75.4 |
39 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Uninsured |
57.4 |
37.1 to 75.5 |
38 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Uninsured |
65.4 |
47.6 to 79.7 |
44 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Uninsured |
88.4 |
73.1 to 95.5 |
47 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Uninsured |
73.0 |
47.9 to 88.9 |
32 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Uninsured |
50.9 |
35.8 to 65.9 |
61 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Uninsured |
53.6 |
38.4 to 68.2 |
66 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Uninsured |
80.5 |
66.4 to 89.6 |
67 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Uninsured |
68.2 |
56.2 to 78.1 |
98 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Uninsured |
68.9 |
45.1 to 85.6 |
33 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Uninsured |
60.2 |
40.4 to 77.1 |
41 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Uninsured |
64.8 |
45.0 to 80.5 |
47 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Uninsured |
47.9 |
28.7 to 67.8 |
36 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Uninsured |
76.4 |
62.7 to 86.2 |
70 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Uninsured |
73.1 |
55.4 to 85.6 |
48 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Uninsured |
76.7 |
61.9 to 87.0 |
48 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Uninsured |
66.3 |
46.5 to 81.7 |
93 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Uninsured |
93.8 |
86.9 to 97.2 |
58 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
58.6 |
35.4 to 78.5 |
35 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Uninsured |
60.8 |
57.3 to 64.2 |
2929 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Uninsured |
92.0 |
75.8 to 97.7 |
37 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Uninsured |
64.2 |
49.4 to 76.8 |
54 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Uninsured |
72.5 |
55.9 to 84.6 |
51 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Uninsured |
64.8 |
50.8 to 76.7 |
66 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Uninsured |
60.6 |
52.9 to 67.7 |
548 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Uninsured |
62.5 |
48.8 to 74.5 |
78 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Uninsured |
71.4 |
59.6 to 80.9 |
93 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
59.4 |
50.7 to 67.6 |
377 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Uninsured |
73.9 |
59.2 to 84.7 |
63 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Uninsured |
64.8 |
44.3 to 81.0 |
53 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Uninsured |
56.2 |
34.6 to 75.6 |
30 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Uninsured |
60.2 |
46.0 to 73.0 |
79 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Poverty |
Below Poverty Level |
79.5 |
73.1 to 84.7 |
258 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Poverty |
Below Poverty Level |
72.1 |
62.4 to 80.1 |
139 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Poverty |
Below Poverty Level |
87.5 |
82.0 to 91.5 |
230 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Poverty |
Below Poverty Level |
72.9 |
66.7 to 78.3 |
312 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Poverty |
Below Poverty Level |
83.2 |
76.6 to 88.2 |
251 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Poverty |
Below Poverty Level |
83.8 |
75.7 to 89.5 |
157 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Poverty |
Below Poverty Level |
79.6 |
70.3 to 86.5 |
146 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Poverty |
Below Poverty Level |
80.8 |
74.0 to 86.2 |
239 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Poverty |
Below Poverty Level |
90.3 |
83.9 to 94.3 |
268 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Poverty |
Below Poverty Level |
72.2 |
64.1 to 79.0 |
237 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Poverty |
Below Poverty Level |
80.3 |
73.4 to 85.7 |
215 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Poverty |
Below Poverty Level |
81.2 |
71.8 to 88.0 |
138 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Poverty |
Below Poverty Level |
76.7 |
67.7 to 83.8 |
173 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Poverty |
Below Poverty Level |
76.3 |
71.3 to 80.6 |
607 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Poverty |
Below Poverty Level |
84.0 |
77.7 to 88.8 |
313 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
73.2 |
66.7 to 78.8 |
294 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Poverty |
Below Poverty Level |
72.5 |
65.4 to 78.6 |
232 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Poverty |
Below Poverty Level |
81.6 |
73.0 to 88.0 |
147 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Poverty |
Below Poverty Level |
76.5 |
69.2 to 82.4 |
229 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Poverty |
Below Poverty Level |
74.6 |
67.3 to 80.8 |
209 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Poverty |
Below Poverty Level |
84.9 |
79.3 to 89.2 |
315 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Poverty |
Below Poverty Level |
66.5 |
57.1 to 74.8 |
158 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Poverty |
Below Poverty Level |
84.0 |
76.7 to 89.3 |
243 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Poverty |
Below Poverty Level |
89.8 |
82.4 to 94.3 |
158 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Poverty |
Below Poverty Level |
78.8 |
70.9 to 85.0 |
204 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Poverty |
Below Poverty Level |
79.9 |
67.8 to 88.3 |
96 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Poverty |
Below Poverty Level |
64.3 |
57.7 to 70.3 |
297 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Poverty |
Below Poverty Level |
71.3 |
63.0 to 78.5 |
206 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Poverty |
Below Poverty Level |
73.4 |
64.5 to 80.7 |
165 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Poverty |
Below Poverty Level |
78.1 |
70.0 to 84.5 |
202 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Poverty |
Below Poverty Level |
76.5 |
69.4 to 82.4 |
261 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Poverty |
Below Poverty Level |
78.2 |
67.4 to 86.1 |
105 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Poverty |
Below Poverty Level |
77.7 |
68.8 to 84.7 |
167 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Poverty |
Below Poverty Level |
80.0 |
74.8 to 84.4 |
411 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Poverty |
Below Poverty Level |
81.3 |
76.5 to 85.2 |
533 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Poverty |
Below Poverty Level |
81.3 |
75.4 to 86.1 |
377 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
81.2 |
72.9 to 87.4 |
156 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Poverty |
Below Poverty Level |
80.9 |
73.7 to 86.5 |
223 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Poverty |
Below Poverty Level |
81.1 |
70.0 to 88.8 |
109 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Poverty |
Below Poverty Level |
80.6 |
73.0 to 86.5 |
209 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Poverty |
Below Poverty Level |
70.2 |
63.4 to 76.3 |
276 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Poverty |
Below Poverty Level |
78.7 |
70.7 to 85.0 |
173 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Poverty |
Below Poverty Level |
86.5 |
81.4 to 90.3 |
580 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Poverty |
Below Poverty Level |
89.3 |
84.7 to 92.7 |
361 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
85.6 |
79.0 to 90.4 |
219 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Poverty |
Below Poverty Level |
79.2 |
77.9 to 80.6 |
12976 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Poverty |
Below Poverty Level |
90.5 |
84.0 to 94.5 |
221 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Poverty |
Below Poverty Level |
76.7 |
69.5 to 82.6 |
221 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Poverty |
Below Poverty Level |
83.7 |
75.6 to 89.5 |
157 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Poverty |
Below Poverty Level |
72.2 |
64.6 to 78.7 |
253 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Poverty |
Below Poverty Level |
77.1 |
72.6 to 81.1 |
1639 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Poverty |
Below Poverty Level |
80.3 |
74.6 to 85.0 |
322 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Poverty |
Below Poverty Level |
76.2 |
69.4 to 81.8 |
285 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
76.9 |
71.4 to 81.6 |
1032 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Poverty |
Below Poverty Level |
86.0 |
77.9 to 91.4 |
118 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Poverty |
Below Poverty Level |
77.9 |
68.9 to 84.8 |
149 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Poverty |
Below Poverty Level |
82.1 |
71.8 to 89.2 |
136 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Poverty |
Below Poverty Level |
80.8 |
73.1 to 86.7 |
193 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Poverty |
Below Poverty Level |
75.0 |
69.1 to 80.2 |
296 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Poverty |
Below Poverty Level |
84.8 |
78.2 to 89.7 |
168 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Poverty |
Below Poverty Level |
65.5 |
55.7 to 74.1 |
147 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
67.4 |
64.1 to 70.5 |
1182 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
70.3 |
67.3 to 73.2 |
1449 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
70.0 |
66.7 to 73.0 |
1217 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
68.2 |
65.0 to 71.3 |
1242 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
75.6 |
72.0 to 78.8 |
1338 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
79.1 |
76.2 to 81.7 |
1331 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
75.8 |
72.8 to 78.6 |
1306 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
78.6 |
75.6 to 81.3 |
1248 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
86.1 |
83.2 to 88.6 |
1290 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
69.6 |
65.9 to 73.0 |
1339 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
69.1 |
65.8 to 72.2 |
1292 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
82.5 |
79.9 to 84.9 |
1240 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
71.1 |
68.0 to 74.0 |
1378 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
74.6 |
72.3 to 76.8 |
2501 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
84.2 |
79.5 to 88.0 |
667 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
72.9 |
70.3 to 75.4 |
1834 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
70.3 |
67.1 to 73.4 |
1138 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
77.5 |
74.4 to 80.4 |
1087 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
66.4 |
63.1 to 69.4 |
1380 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
67.1 |
63.6 to 70.4 |
1077 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
72.5 |
69.2 to 75.6 |
1221 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
72.5 |
69.5 to 75.3 |
1360 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
81.0 |
78.4 to 83.3 |
2603 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
86.1 |
83.4 to 88.5 |
1335 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
74.7 |
71.7 to 77.6 |
1363 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
79.0 |
76.0 to 81.6 |
1373 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
52.5 |
48.7 to 56.3 |
1025 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
69.9 |
66.8 to 72.8 |
1385 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
72.8 |
69.8 to 75.6 |
1284 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
79.4 |
76.4 to 82.1 |
1308 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
69.5 |
66.2 to 72.6 |
1294 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
81.3 |
78.6 to 83.7 |
1375 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
68.5 |
65.2 to 71.6 |
1395 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
76.0 |
73.0 to 78.9 |
1199 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
73.7 |
71.1 to 76.1 |
2180 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
77.6 |
73.9 to 80.8 |
939 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
71.7 |
68.3 to 74.9 |
1241 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
74.2 |
71.0 to 77.2 |
1329 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
82.4 |
79.6 to 84.9 |
1322 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
70.2 |
66.7 to 73.4 |
1244 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
64.8 |
61.5 to 68.0 |
1240 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
78.2 |
75.2 to 80.9 |
1223 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
74.0 |
71.4 to 76.4 |
3096 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
88.5 |
85.6 to 90.9 |
916 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
72.5 |
69.7 to 75.2 |
2180 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
72.3 |
71.7 to 73.0 |
75678 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
92.0 |
89.8 to 93.8 |
1187 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
70.0 |
66.7 to 73.1 |
1214 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
78.4 |
75.7 to 80.9 |
1467 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
67.6 |
64.2 to 70.8 |
1143 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
65.4 |
63.0 to 67.8 |
4915 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
69.5 |
65.9 to 72.9 |
1090 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
77.2 |
72.3 to 81.4 |
562 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
64.5 |
61.7 to 67.1 |
3263 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
71.1 |
67.9 to 74.0 |
1362 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
84.9 |
82.8 to 86.7 |
1780 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
73.1 |
69.8 to 76.2 |
2323 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
75.5 |
72.4 to 78.4 |
1392 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
61.4 |
58.0 to 64.7 |
1129 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
75.0 |
72.1 to 77.7 |
1306 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
61.4 |
57.9 to 64.7 |
1271 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
80.1 |
74.1 to 85.0 |
273 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
81.1 |
59.5 to 92.6 |
37 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
80.3 |
66.9 to 89.1 |
48 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
77.8 |
69.3 to 84.5 |
143 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
84.8 |
68.8 to 93.4 |
72 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
80.3 |
70.2 to 87.5 |
120 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
81.3 |
75.0 to 86.3 |
232 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
86.3 |
82.5 to 89.4 |
534 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
73.9 |
64.9 to 81.2 |
178 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
72.7 |
66.9 to 77.9 |
376 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
76.8 |
71.1 to 81.6 |
389 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
78.8 |
71.2 to 84.9 |
218 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
75.4 |
67.1 to 82.1 |
171 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
72.2 |
61.3 to 81.0 |
107 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
75.5 |
58.0 to 87.3 |
37 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
73.9 |
57.2 to 85.8 |
48 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
82.0 |
69.6 to 90.0 |
78 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
84.3 |
79.4 to 88.2 |
318 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
79.9 |
75.0 to 84.1 |
638 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
91.3 |
81.5 to 96.2 |
96 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
81.1 |
72.6 to 87.4 |
139 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
80.7 |
67.2 to 89.5 |
73 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
64.1 |
58.4 to 69.5 |
376 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
84.0 |
75.5 to 90.0 |
106 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
73.2 |
57.7 to 84.6 |
54 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
68.2 |
57.0 to 77.6 |
116 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
69.8 |
59.6 to 78.4 |
122 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
70.4 |
63.7 to 76.4 |
322 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
73.7 |
66.3 to 80.0 |
232 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
65.2 |
52.2 to 76.3 |
90 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
74.6 |
66.7 to 81.1 |
196 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
93.9 |
84.7 to 97.7 |
40 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
87.5 |
78.9 to 92.9 |
127 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
77.1 |
64.9 to 86.0 |
67 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
81.5 |
75.5 to 86.3 |
667 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
89.1 |
85.3 to 92.0 |
490 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
75.6 |
65.4 to 83.5 |
177 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
76.6 |
75.0 to 78.1 |
7808 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
97.4 |
92.3 to 99.2 |
82 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
73.5 |
66.9 to 79.2 |
249 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
81.9 |
73.7 to 88.0 |
150 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
67.9 |
61.0 to 74.1 |
532 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
55.7 |
41.8 to 68.7 |
67 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
79.1 |
69.9 to 86.1 |
131 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
67.1 |
59.2 to 74.2 |
334 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
76.5 |
68.4 to 83.0 |
240 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
85.9 |
69.5 to 94.2 |
48 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
65.8 |
46.5 to 80.9 |
35 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
84.2 |
74.0 to 90.9 |
87 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Hispanic |
77.1 |
66.0 to 85.4 |
101 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Hispanic |
71.0 |
60.9 to 79.4 |
134 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Hispanic |
80.0 |
75.6 to 83.7 |
511 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.7 |
61.8 to 78.2 |
163 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Hispanic |
78.6 |
74.0 to 82.6 |
604 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.0 |
79.1 to 87.9 |
365 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Hispanic |
82.9 |
76.9 to 87.5 |
286 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Hispanic |
82.8 |
76.0 to 88.0 |
238 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Hispanic |
93.6 |
89.1 to 96.3 |
325 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.1 |
63.9 to 75.6 |
465 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Hispanic |
79.6 |
71.9 to 85.7 |
218 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
Hispanic |
82.3 |
75.9 to 87.4 |
223 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
Hispanic |
81.9 |
74.6 to 87.5 |
207 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Hispanic |
79.9 |
75.8 to 83.4 |
865 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Hispanic |
87.1 |
82.1 to 90.9 |
460 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
76.6 |
71.1 to 81.3 |
405 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.8 |
61.9 to 78.4 |
175 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Hispanic |
83.3 |
73.6 to 89.9 |
119 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Hispanic |
79.0 |
72.1 to 84.6 |
258 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Hispanic |
71.5 |
60.4 to 80.6 |
104 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Hispanic |
74.0 |
63.9 to 82.1 |
133 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
Hispanic |
69.7 |
53.9 to 81.9 |
64 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.8 |
77.9 to 89.8 |
440 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Hispanic |
90.3 |
83.6 to 94.5 |
214 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Hispanic |
78.7 |
67.7 to 86.7 |
119 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Hispanic |
80.7 |
69.7 to 88.4 |
113 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.5 |
56.1 to 81.8 |
76 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Hispanic |
67.2 |
54.1 to 78.1 |
107 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
Hispanic |
71.8 |
59.5 to 81.5 |
100 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Hispanic |
87.5 |
81.5 to 91.7 |
237 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Hispanic |
75.7 |
70.9 to 80.0 |
532 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.6 |
73.6 to 91.6 |
87 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Hispanic |
78.3 |
72.4 to 83.3 |
336 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
Hispanic |
79.2 |
75.7 to 82.3 |
921 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Hispanic |
82.3 |
78.5 to 85.5 |
789 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Hispanic |
85.1 |
81.0 to 88.4 |
552 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
78.0 |
70.5 to 84.0 |
237 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Hispanic |
81.3 |
73.7 to 87.1 |
223 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Hispanic |
82.7 |
70.6 to 90.5 |
67 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Hispanic |
72.6 |
59.8 to 82.5 |
117 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Hispanic |
75.8 |
68.1 to 82.1 |
222 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
Hispanic |
84.4 |
78.4 to 88.9 |
239 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Hispanic |
82.8 |
77.2 to 87.2 |
534 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Hispanic |
88.0 |
81.9 to 92.2 |
290 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
81.3 |
74.2 to 86.8 |
244 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Hispanic |
77.9 |
76.5 to 79.2 |
16518 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Hispanic |
96.1 |
92.4 to 98.0 |
335 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Hispanic |
82.0 |
74.4 to 87.7 |
150 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
Hispanic |
73.8 |
60.7 to 83.6 |
78 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Hispanic |
77.8 |
69.0 to 84.6 |
148 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Hispanic |
73.4 |
70.5 to 76.2 |
3535 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Hispanic |
74.6 |
71.0 to 77.8 |
907 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Hispanic |
76.3 |
71.2 to 80.8 |
479 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
73.0 |
69.6 to 76.3 |
2149 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
Hispanic |
81.4 |
73.8 to 87.2 |
193 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
Hispanic |
94.8 |
86.9 to 98.1 |
63 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Hispanic |
83.5 |
75.1 to 89.4 |
289 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Hispanic |
83.4 |
77.2 to 88.2 |
294 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Hispanic |
67.8 |
50.8 to 81.1 |
60 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Hispanic |
85.5 |
77.8 to 90.8 |
165 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
Hispanic |
67.6 |
58.1 to 75.8 |
177 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
75.6 |
65.5 to 83.5 |
108 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
78.6 |
73.8 to 82.8 |
477 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
75.5 |
66.9 to 82.4 |
187 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
70.8 |
61.2 to 78.9 |
132 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
76.5 |
69.0 to 82.6 |
333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
78.6 |
69.7 to 85.5 |
145 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
74.8 |
64.4 to 82.9 |
155 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
74.0 |
65.0 to 81.3 |
167 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
84.7 |
74.4 to 91.3 |
133 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
71.6 |
61.3 to 80.0 |
149 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
66.9 |
56.6 to 75.7 |
159 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
84.9 |
81.8 to 87.5 |
902 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
77.4 |
65.9 to 85.9 |
113 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
79.1 |
72.5 to 84.5 |
340 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
90.1 |
77.9 to 95.9 |
84 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
78.0 |
70.8 to 83.8 |
256 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
72.1 |
62.1 to 80.3 |
118 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
83.8 |
72.5 to 91.0 |
88 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
66.7 |
57.0 to 75.2 |
166 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
69.7 |
59.2 to 78.6 |
118 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
84.2 |
75.7 to 90.1 |
152 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
71.9 |
60.8 to 80.8 |
117 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
78.0 |
70.6 to 83.9 |
376 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
89.1 |
83.3 to 93.1 |
183 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
73.5 |
63.9 to 81.2 |
155 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.7 |
78.0 to 92.3 |
167 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
61.7 |
49.4 to 72.7 |
98 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
68.5 |
57.8 to 77.5 |
143 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
81.2 |
73.7 to 87.0 |
185 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
77.1 |
65.9 to 85.5 |
107 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
75.6 |
67.6 to 82.1 |
217 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
85.5 |
76.5 to 91.4 |
133 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
66.5 |
58.8 to 73.3 |
284 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
81.7 |
73.7 to 87.7 |
148 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
82.7 |
77.2 to 87.0 |
435 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
85.9 |
78.8 to 90.9 |
256 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
79.9 |
71.3 to 86.4 |
179 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
82.0 |
74.3 to 87.7 |
187 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
84.6 |
76.8 to 90.1 |
187 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
79.2 |
70.3 to 86.0 |
138 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
66.1 |
60.4 to 71.4 |
426 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
77.2 |
68.3 to 84.1 |
182 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
76.2 |
68.4 to 82.5 |
420 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
90.0 |
83.5 to 94.1 |
165 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
74.4 |
65.7 to 81.5 |
255 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
75.5 |
73.8 to 77.2 |
10891 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
91.0 |
83.9 to 95.1 |
131 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
74.9 |
62.9 to 84.0 |
94 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
86.1 |
80.3 to 90.4 |
262 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
68.9 |
58.1 to 77.9 |
123 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
66.5 |
59.8 to 72.7 |
546 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
81.6 |
71.5 to 88.6 |
96 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
79.2 |
63.8 to 89.2 |
82 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
65.0 |
57.5 to 71.8 |
368 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
83.9 |
73.7 to 90.6 |
91 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
82.1 |
73.4 to 88.4 |
134 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
69.0 |
60.5 to 76.4 |
445 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
76.5 |
69.1 to 82.6 |
291 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
75.5 |
65.4 to 83.4 |
102 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
85.6 |
78.3 to 90.7 |
139 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
63.7 |
51.6 to 74.2 |
103 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
64.6 |
61.0 to 68.1 |
1012 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
65.5 |
61.6 to 69.1 |
980 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
65.6 |
61.3 to 69.6 |
759 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
66.9 |
63.6 to 70.0 |
1167 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
71.6 |
66.0 to 76.7 |
631 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
77.8 |
74.3 to 80.9 |
999 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
72.7 |
69.0 to 76.1 |
955 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
77.6 |
74.0 to 80.9 |
897 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.8 |
81.9 to 89.0 |
623 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
64.8 |
60.1 to 69.3 |
848 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
68.4 |
64.2 to 72.3 |
800 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
73.1 |
66.4 to 78.9 |
279 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
68.8 |
65.4 to 71.9 |
1245 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
70.7 |
67.7 to 73.5 |
1636 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
81.2 |
71.4 to 88.2 |
261 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
70.0 |
66.9 to 73.0 |
1375 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
70.0 |
66.6 to 73.3 |
1013 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
77.1 |
73.8 to 80.1 |
1024 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
65.2 |
61.8 to 68.6 |
1180 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
66.9 |
63.4 to 70.2 |
1033 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
68.0 |
64.1 to 71.7 |
1006 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
72.1 |
69.1 to 74.9 |
1356 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
82.0 |
78.6 to 85.0 |
1481 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
85.2 |
82.0 to 87.9 |
1063 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
74.4 |
71.1 to 77.4 |
1210 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
78.3 |
75.1 to 81.2 |
1165 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
44.1 |
40.0 to 48.4 |
822 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
68.2 |
64.9 to 71.4 |
1272 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
70.5 |
67.2 to 73.5 |
1181 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
77.9 |
74.6 to 80.9 |
1149 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
66.0 |
61.6 to 70.2 |
743 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
80.3 |
77.5 to 82.9 |
1287 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
65.2 |
61.0 to 69.3 |
900 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
68.8 |
64.0 to 73.3 |
567 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
70.7 |
67.4 to 73.8 |
1333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
67.3 |
60.8 to 73.2 |
378 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
71.5 |
67.7 to 75.1 |
955 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
73.1 |
69.4 to 76.5 |
994 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
81.3 |
78.2 to 84.1 |
1184 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
68.6 |
64.9 to 72.1 |
1110 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
61.6 |
57.5 to 65.5 |
841 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
76.4 |
73.0 to 79.5 |
988 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
74.1 |
71.2 to 76.9 |
2208 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
87.3 |
82.8 to 90.7 |
394 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
73.7 |
70.6 to 76.5 |
1814 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
70.1 |
69.4 to 70.8 |
56479 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
89.4 |
86.4 to 91.8 |
918 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
68.2 |
64.6 to 71.6 |
987 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
77.0 |
74.1 to 79.7 |
1302 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
64.7 |
61.0 to 68.3 |
1021 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
59.5 |
55.7 to 63.2 |
2241 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
67.9 |
61.4 to 73.7 |
384 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
80.3 |
72.9 to 86.0 |
213 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
58.4 |
54.3 to 62.4 |
1644 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
68.2 |
64.7 to 71.5 |
1210 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
83.5 |
81.3 to 85.5 |
1750 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
72.4 |
68.3 to 76.1 |
1554 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
73.5 |
69.7 to 77.0 |
1003 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
64.3 |
61.2 to 67.3 |
1270 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
73.0 |
69.8 to 76.0 |
1129 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
60.0 |
56.4 to 63.5 |
1153 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
76.3 |
72.3 to 80.0 |
628 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
73.4 |
69.5 to 76.9 |
896 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
75.3 |
71.5 to 78.7 |
835 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
73.7 |
69.1 to 77.8 |
557 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
76.4 |
72.0 to 80.2 |
806 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
82.9 |
79.4 to 85.8 |
778 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
81.9 |
76.6 to 86.2 |
350 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
82.1 |
77.7 to 85.8 |
506 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
87.3 |
84.8 to 89.4 |
1615 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
68.1 |
63.6 to 72.3 |
914 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
77.7 |
72.5 to 82.2 |
475 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
82.5 |
77.8 to 86.3 |
471 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
73.9 |
69.1 to 78.2 |
581 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
79.1 |
75.8 to 82.1 |
1398 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
83.5 |
79.9 to 86.6 |
1023 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
73.0 |
66.9 to 78.4 |
375 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
75.2 |
70.9 to 79.1 |
604 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
80.8 |
75.8 to 84.9 |
393 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
73.7 |
69.2 to 77.7 |
625 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
75.8 |
71.1 to 79.9 |
502 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
76.2 |
71.9 to 80.0 |
646 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
75.2 |
68.1 to 81.0 |
250 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
82.6 |
78.1 to 86.3 |
884 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
92.0 |
87.7 to 94.9 |
268 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
76.2 |
70.8 to 80.9 |
450 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
82.9 |
79.0 to 86.2 |
659 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
62.9 |
54.7 to 70.4 |
214 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
78.9 |
74.5 to 82.6 |
619 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
81.1 |
77.0 to 84.7 |
511 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
83.7 |
80.1 to 86.7 |
753 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
72.0 |
68.5 to 75.2 |
1123 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
81.7 |
74.4 to 87.2 |
200 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
74.2 |
65.2 to 81.5 |
176 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
78.0 |
74.4 to 81.2 |
861 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
78.7 |
76.0 to 81.2 |
1728 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
78.2 |
75.2 to 80.9 |
1418 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
80.3 |
73.8 to 85.5 |
310 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
76.7 |
72.3 to 80.7 |
690 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
87.3 |
83.0 to 90.6 |
468 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
78.7 |
74.1 to 82.7 |
513 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
68.8 |
63.3 to 73.8 |
408 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
81.8 |
78.3 to 84.8 |
794 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
84.5 |
80.9 to 87.5 |
1606 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
88.6 |
86.2 to 90.6 |
1339 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
81.2 |
74.8 to 86.2 |
267 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
76.5 |
75.5 to 77.4 |
36713 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
96.5 |
94.2 to 97.8 |
416 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
75.6 |
70.8 to 79.9 |
512 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
82.9 |
78.8 to 86.3 |
512 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
73.9 |
69.5 to 77.9 |
612 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
72.3 |
69.2 to 75.2 |
4042 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
73.3 |
70.2 to 76.2 |
1302 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
77.7 |
74.0 to 81.0 |
905 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
71.0 |
66.7 to 74.9 |
1835 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
75.0 |
69.7 to 79.6 |
467 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
83.4 |
76.8 to 88.4 |
222 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
77.9 |
72.4 to 82.6 |
860 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
79.1 |
75.2 to 82.5 |
859 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
69.8 |
64.6 to 74.6 |
450 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
82.2 |
78.2 to 85.6 |
581 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
61.2 |
55.5 to 66.5 |
425 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
67.4 |
62.5 to 71.9 |
555 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
58.2 |
50.8 to 65.3 |
272 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
70.9 |
66.4 to 75.0 |
582 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
70.7 |
65.6 to 75.2 |
502 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
77.1 |
72.5 to 81.1 |
801 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
76.5 |
71.7 to 80.7 |
592 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
74.3 |
70.9 to 77.5 |
1107 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
77.5 |
74.1 to 80.5 |
1028 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
69.0 |
64.1 to 73.6 |
694 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
68.3 |
64.2 to 72.0 |
886 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
83.9 |
80.3 to 87.0 |
649 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
73.9 |
69.1 to 78.2 |
548 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
74.6 |
71.9 to 77.2 |
1608 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
74.6 |
71.9 to 77.2 |
1608 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
68.1 |
63.3 to 72.5 |
556 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
78.8 |
73.5 to 83.3 |
431 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
64.9 |
59.8 to 69.8 |
529 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
72.8 |
67.2 to 77.7 |
387 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
74.4 |
70.1 to 78.4 |
737 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
73.3 |
69.1 to 77.1 |
696 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
80.3 |
77.4 to 83.0 |
2006 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
86.1 |
83.4 to 88.5 |
1275 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
75.6 |
71.9 to 78.9 |
896 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
78.9 |
74.0 to 83.1 |
543 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
54.7 |
49.2 to 60.1 |
496 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
72.5 |
68.3 to 76.4 |
696 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
71.3 |
57.9 to 81.8 |
75 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
80.1 |
73.8 to 85.3 |
316 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
69.2 |
62.5 to 75.2 |
300 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
83.3 |
79.7 to 86.3 |
716 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
68.6 |
65.4 to 71.6 |
1466 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
76.4 |
70.3 to 81.7 |
323 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
71.7 |
68.0 to 75.2 |
1005 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
71.7 |
68.0 to 75.2 |
1005 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
74.5 |
70.0 to 78.5 |
672 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
81.7 |
73.9 to 87.6 |
215 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
71.8 |
67.4 to 75.9 |
747 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
62.9 |
58.1 to 67.4 |
582 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
75.0 |
70.0 to 79.5 |
450 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
74.4 |
71.5 to 77.0 |
2130 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
74.4 |
71.5 to 77.0 |
2130 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
72.5 |
71.7 to 73.3 |
38031 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
89.9 |
87.2 to 92.1 |
1050 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
69.3 |
65.2 to 73.0 |
805 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
79.8 |
73.2 to 85.0 |
276 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
65.4 |
60.4 to 70.1 |
573 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
64.4 |
61.3 to 67.3 |
2486 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
64.3 |
54.2 to 73.2 |
152 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
64.4 |
61.3 to 67.3 |
2334 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
71.9 |
68.1 to 75.5 |
898 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
82.1 |
77.7 to 85.8 |
567 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
73.1 |
69.2 to 76.7 |
1551 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
75.2 |
70.5 to 79.4 |
625 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
63.4 |
58.4 to 68.3 |
489 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
74.5 |
70.1 to 78.4 |
608 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
57.8 |
37.5 to 75.7 |
34 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
64.0 |
57.1 to 70.4 |
311 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
72.5 |
67.3 to 77.2 |
460 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
75.0 |
63.1 to 84.0 |
88 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
63.7 |
58.7 to 68.5 |
546 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
83.6 |
56.2 to 95.3 |
33 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
74.6 |
65.6 to 81.9 |
164 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
70.3 |
54.1 to 82.7 |
59 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
83.2 |
61.9 to 93.8 |
32 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
70.2 |
61.5 to 77.7 |
192 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
77.5 |
71.6 to 82.5 |
296 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
68.0 |
62.3 to 73.2 |
455 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
60.0 |
52.1 to 67.5 |
224 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
60.0 |
52.1 to 67.5 |
224 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
63.8 |
56.4 to 70.6 |
253 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
74.0 |
69.0 to 78.4 |
444 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
64.4 |
58.6 to 69.7 |
498 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
54.6 |
48.9 to 60.2 |
444 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
77.0 |
69.7 to 83.0 |
226 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
68.9 |
64.2 to 73.2 |
620 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
92.7 |
83.5 to 97.0 |
45 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
74.6 |
67.3 to 80.7 |
277 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
72.6 |
65.3 to 78.9 |
316 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
51.7 |
46.9 to 56.4 |
662 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
45.6 |
38.6 to 52.9 |
313 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
66.2 |
62.3 to 69.9 |
895 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
71.3 |
65.6 to 76.3 |
478 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
70.3 |
61.0 to 78.2 |
185 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
77.5 |
72.9 to 81.6 |
608 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
73.7 |
68.7 to 78.1 |
481 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
63.0 |
51.5 to 73.2 |
146 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
63.0 |
51.5 to 73.2 |
146 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
75.6 |
68.0 to 81.8 |
238 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
79.5 |
75.6 to 82.9 |
795 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
60.8 |
52.1 to 68.9 |
232 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
68.6 |
63.6 to 73.2 |
566 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
71.0 |
62.2 to 78.5 |
188 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
61.4 |
49.0 to 72.4 |
93 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
61.4 |
49.0 to 72.4 |
93 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
66.9 |
65.6 to 68.2 |
16952 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
67.7 |
58.1 to 76.0 |
163 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
75.5 |
71.7 to 78.9 |
879 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
64.4 |
56.9 to 71.3 |
257 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
65.8 |
56.5 to 74.0 |
326 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
65.8 |
56.5 to 74.0 |
326 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
56.2 |
44.9 to 66.9 |
149 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
84.6 |
82.1 to 86.9 |
1184 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
68.2 |
55.5 to 78.6 |
117 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
68.4 |
57.9 to 77.4 |
152 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
63.0 |
58.1 to 67.6 |
528 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
69.7 |
63.6 to 75.2 |
331 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
62.1 |
58.2 to 65.9 |
990 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Overall |
Overall |
70.7 |
67.8 to 73.3 |
1494 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Overall |
Overall |
70.6 |
67.8 to 73.3 |
1628 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Overall |
Overall |
73.6 |
70.8 to 76.2 |
1505 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Overall |
Overall |
69.6 |
66.8 to 72.2 |
1605 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
California |
2018-2022 |
Overall |
Overall |
76.8 |
73.7 to 79.6 |
1640 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Overall |
Overall |
79.7 |
77.1 to 82.2 |
1534 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Overall |
Overall |
76.2 |
73.4 to 78.8 |
1516 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Overall |
Overall |
79.0 |
76.4 to 81.5 |
1534 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Overall |
Overall |
87.3 |
84.8 to 89.4 |
1615 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Overall |
Overall |
68.8 |
65.5 to 71.9 |
1640 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Overall |
Overall |
71.3 |
68.4 to 74.1 |
1553 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Overall |
Overall |
82.2 |
79.7 to 84.5 |
1416 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Overall |
Overall |
72.2 |
69.4 to 74.9 |
1584 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Overall |
Overall |
74.8 |
72.7 to 76.7 |
3230 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Overall |
Overall |
83.5 |
79.9 to 86.6 |
1023 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Overall |
Overall |
72.9 |
70.5 to 75.2 |
2207 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Overall |
Overall |
70.5 |
67.6 to 73.3 |
1413 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Overall |
Overall |
78.1 |
75.2 to 80.7 |
1268 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Overall |
Overall |
68.4 |
65.5 to 71.1 |
1652 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Overall |
Overall |
68.7 |
65.7 to 71.6 |
1333 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Overall |
Overall |
75.5 |
72.8 to 78.1 |
1609 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Overall |
Overall |
72.0 |
69.2 to 74.7 |
1566 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Overall |
Overall |
81.3 |
78.9 to 83.4 |
2935 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Overall |
Overall |
87.1 |
84.7 to 89.1 |
1556 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Overall |
Overall |
75.7 |
72.9 to 78.2 |
1623 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Overall |
Overall |
79.7 |
77.0 to 82.2 |
1518 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Overall |
Overall |
54.8 |
51.5 to 58.0 |
1372 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Overall |
Overall |
70.2 |
67.3 to 72.9 |
1628 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Overall |
Overall |
72.3 |
69.5 to 75.0 |
1481 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Overall |
Overall |
79.2 |
76.5 to 81.7 |
1547 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Overall |
Overall |
71.3 |
68.4 to 74.0 |
1608 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Overall |
Overall |
81.1 |
78.5 to 83.4 |
1524 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Overall |
Overall |
69.4 |
66.4 to 72.2 |
1642 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Overall |
Overall |
76.6 |
74.0 to 79.0 |
1665 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Overall |
Overall |
75.0 |
72.8 to 77.1 |
2879 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Overall |
Overall |
78.2 |
75.2 to 80.9 |
1418 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Overall |
Overall |
72.9 |
69.8 to 75.8 |
1461 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Overall |
Overall |
75.7 |
72.9 to 78.3 |
1600 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Overall |
Overall |
82.5 |
79.8 to 84.8 |
1478 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Overall |
Overall |
72.6 |
69.5 to 75.4 |
1492 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Overall |
Overall |
66.4 |
63.5 to 69.2 |
1556 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Overall |
Overall |
78.3 |
75.6 to 80.8 |
1432 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Overall |
Overall |
76.3 |
74.0 to 78.4 |
3829 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Overall |
Overall |
88.6 |
86.2 to 90.6 |
1339 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Overall |
Overall |
74.7 |
72.2 to 77.1 |
2490 |
| HPV |
>=1 Dose, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Overall |
Overall |
73.5 |
73.0 to 74.1 |
91696 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Overall |
Overall |
91.8 |
89.8 to 93.4 |
1466 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Overall |
Overall |
71.5 |
68.6 to 74.3 |
1480 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Overall |
Overall |
78.7 |
76.2 to 81.0 |
1667 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Overall |
Overall |
69.2 |
66.2 to 72.0 |
1442 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Overall |
Overall |
67.9 |
65.8 to 70.0 |
6854 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Overall |
Overall |
72.4 |
69.4 to 75.2 |
1454 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Overall |
Overall |
77.7 |
74.0 to 81.0 |
905 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Overall |
Overall |
66.9 |
64.5 to 69.2 |
4495 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Overall |
Overall |
71.7 |
68.7 to 74.5 |
1514 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Overall |
Overall |
83.8 |
81.7 to 85.6 |
1973 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Overall |
Overall |
74.2 |
71.2 to 77.1 |
2528 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Overall |
Overall |
76.6 |
73.8 to 79.2 |
1636 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Overall |
Overall |
65.2 |
62.3 to 68.0 |
1467 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Overall |
Overall |
76.6 |
74.0 to 79.0 |
1520 |
| HPV |
>=1 Dose, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Overall |
Overall |
61.6 |
58.4 to 64.7 |
1449 |
| Hep A |
>=2 Doses |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
74.1 |
67.7 to 79.5 |
298 |
| Hep A |
>=2 Doses |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
91.0 |
85.8 to 94.4 |
302 |
| Hep A |
>=2 Doses |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
88.1 |
83.5 to 91.6 |
340 |
| Hep A |
>=2 Doses |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
77.9 |
71.7 to 83.1 |
322 |
| Hep A |
>=2 Doses |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
84.2 |
78.4 to 88.7 |
403 |
| Hep A |
>=2 Doses |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
84.6 |
79.4 to 88.8 |
354 |
| Hep A |
>=2 Doses |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
77.8 |
72.0 to 82.6 |
331 |
| Hep A |
>=2 Doses |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
78.7 |
72.7 to 83.7 |
360 |
| Hep A |
>=2 Doses |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
84.6 |
78.6 to 89.1 |
404 |
| Hep A |
>=2 Doses |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
78.2 |
71.8 to 83.5 |
355 |
| Hep A |
>=2 Doses |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
91.1 |
86.3 to 94.4 |
300 |
| Hep A |
>=2 Doses |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
65.2 |
58.4 to 71.5 |
300 |
| Hep A |
>=2 Doses |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
90.0 |
84.9 to 93.5 |
290 |
| Hep A |
>=2 Doses |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
87.2 |
82.3 to 90.9 |
376 |
| Hep A |
>=2 Doses |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
77.2 |
72.7 to 81.1 |
699 |
| Hep A |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
79.7 |
71.9 to 85.8 |
271 |
| Hep A |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
76.6 |
71.3 to 81.1 |
428 |
| Hep A |
>=2 Doses |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
84.5 |
78.6 to 89.0 |
302 |
| Hep A |
>=2 Doses |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
68.7 |
62.2 to 74.5 |
280 |
| Hep A |
>=2 Doses |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
82.9 |
77.8 to 87.1 |
364 |
| Hep A |
>=2 Doses |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
90.7 |
85.7 to 94.1 |
255 |
| Hep A |
>=2 Doses |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
73.2 |
66.9 to 78.7 |
356 |
| Hep A |
>=2 Doses |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
86.0 |
81.6 to 89.5 |
372 |
| Hep A |
>=2 Doses |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
80.8 |
76.6 to 84.4 |
815 |
| Hep A |
>=2 Doses |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
77.4 |
71.9 to 82.1 |
394 |
| Hep A |
>=2 Doses |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
85.0 |
80.2 to 88.8 |
398 |
| Hep A |
>=2 Doses |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
81.6 |
75.7 to 86.4 |
330 |
| Hep A |
>=2 Doses |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
55.0 |
48.0 to 61.8 |
282 |
| Hep A |
>=2 Doses |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
77.6 |
71.6 to 82.6 |
397 |
| Hep A |
>=2 Doses |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
82.7 |
77.4 to 87.0 |
307 |
| Hep A |
>=2 Doses |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
76.9 |
71.5 to 81.5 |
405 |
| Hep A |
>=2 Doses |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
86.5 |
80.5 to 90.8 |
369 |
| Hep A |
>=2 Doses |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
77.8 |
72.6 to 82.2 |
381 |
| Hep A |
>=2 Doses |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
81.9 |
76.3 to 86.5 |
379 |
| Hep A |
>=2 Doses |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
89.3 |
84.8 to 92.6 |
352 |
| Hep A |
>=2 Doses |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
76.8 |
72.4 to 80.7 |
729 |
| Hep A |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
86.1 |
81.0 to 90.1 |
381 |
| Hep A |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
70.8 |
64.3 to 76.5 |
348 |
| Hep A |
>=2 Doses |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
88.1 |
82.3 to 92.1 |
327 |
| Hep A |
>=2 Doses |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
88.7 |
83.7 to 92.3 |
401 |
| Hep A |
>=2 Doses |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
75.5 |
69.5 to 80.5 |
338 |
| Hep A |
>=2 Doses |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
92.9 |
89.4 to 95.4 |
338 |
| Hep A |
>=2 Doses |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
95.6 |
92.3 to 97.6 |
308 |
| Hep A |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
85.9 |
81.0 to 89.8 |
765 |
| Hep A |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
90.8 |
85.5 to 94.4 |
263 |
| Hep A |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
85.3 |
79.7 to 89.5 |
502 |
| Hep A |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
44.9 |
34.0 to 56.4 |
169 |
| Hep A |
>=2 Doses |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
82.1 |
81.1 to 83.1 |
20163 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
78.8 |
75.9 to 81.5 |
2147 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
78.5 |
75.1 to 81.6 |
1108 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
82.8 |
80.2 to 85.1 |
3331 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
79.9 |
77.5 to 82.0 |
2466 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
79.7 |
77.5 to 81.7 |
2344 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
85.7 |
83.0 to 88.0 |
2509 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
76.6 |
73.5 to 79.5 |
1446 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
85.0 |
82.2 to 87.4 |
2007 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
85.1 |
80.6 to 88.7 |
1402 |
| Hep A |
>=2 Doses |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
88.0 |
82.7 to 91.8 |
271 |
| Hep A |
>=2 Doses |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
52.4 |
45.5 to 59.2 |
311 |
| Hep A |
>=2 Doses |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
84.1 |
79.3 to 88.0 |
317 |
| Hep A |
>=2 Doses |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
81.9 |
76.2 to 86.4 |
338 |
| Hep A |
>=2 Doses |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
87.1 |
83.3 to 90.1 |
1141 |
| Hep A |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
87.3 |
82.4 to 90.9 |
314 |
| Hep A |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
85.2 |
78.5 to 90.1 |
221 |
| Hep A |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
87.2 |
82.8 to 90.6 |
606 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
89.8 |
86.7 to 92.2 |
1403 |
| Hep A |
>=2 Doses |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
88.1 |
82.5 to 92.0 |
304 |
| Hep A |
>=2 Doses |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
72.5 |
66.8 to 77.6 |
398 |
| Hep A |
>=2 Doses |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
81.1 |
75.6 to 85.6 |
677 |
| Hep A |
>=2 Doses |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
87.3 |
81.6 to 91.4 |
417 |
| Hep A |
>=2 Doses |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
77.7 |
72.1 to 82.4 |
310 |
| Hep A |
>=2 Doses |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
77.1 |
70.9 to 82.3 |
277 |
| Hep A |
>=2 Doses |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
67.7 |
60.9 to 73.8 |
324 |
| Hep A |
>=2 Doses |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
83.0 |
77.5 to 87.3 |
304 |
| Hep A |
>=2 Doses |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
89.0 |
83.1 to 93.0 |
268 |
| Hep A |
>=2 Doses |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
85.9 |
80.1 to 90.2 |
296 |
| Hep A |
>=2 Doses |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
84.2 |
78.7 to 88.4 |
314 |
| Hep A |
>=2 Doses |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
88.9 |
81.1 to 93.7 |
286 |
| Hep A |
>=2 Doses |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
88.4 |
83.4 to 92.0 |
298 |
| Hep A |
>=2 Doses |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
87.6 |
83.0 to 91.1 |
340 |
| Hep A |
>=2 Doses |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
85.7 |
79.7 to 90.1 |
310 |
| Hep A |
>=2 Doses |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
84.2 |
78.5 to 88.6 |
409 |
| Hep A |
>=2 Doses |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
75.4 |
67.1 to 82.2 |
312 |
| Hep A |
>=2 Doses |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
88.9 |
81.9 to 93.4 |
260 |
| Hep A |
>=2 Doses |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
68.5 |
60.2 to 75.7 |
225 |
| Hep A |
>=2 Doses |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
89.5 |
84.2 to 93.2 |
258 |
| Hep A |
>=2 Doses |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
90.4 |
85.7 to 93.6 |
334 |
| Hep A |
>=2 Doses |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
81.2 |
76.6 to 85.1 |
578 |
| Hep A |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
91.5 |
82.2 to 96.1 |
144 |
| Hep A |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
79.0 |
73.6 to 83.5 |
434 |
| Hep A |
>=2 Doses |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
90.6 |
85.2 to 94.2 |
268 |
| Hep A |
>=2 Doses |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
86.5 |
79.9 to 91.2 |
199 |
| Hep A |
>=2 Doses |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
83.9 |
77.3 to 88.9 |
300 |
| Hep A |
>=2 Doses |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
91.5 |
86.4 to 94.8 |
240 |
| Hep A |
>=2 Doses |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
79.7 |
73.6 to 84.7 |
303 |
| Hep A |
>=2 Doses |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
84.5 |
78.6 to 89.0 |
293 |
| Hep A |
>=2 Doses |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
85.6 |
82.0 to 88.5 |
857 |
| Hep A |
>=2 Doses |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
87.6 |
81.8 to 91.7 |
266 |
| Hep A |
>=2 Doses |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
84.6 |
78.4 to 89.2 |
358 |
| Hep A |
>=2 Doses |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
91.2 |
87.4 to 94.0 |
296 |
| Hep A |
>=2 Doses |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
52.5 |
45.4 to 59.5 |
303 |
| Hep A |
>=2 Doses |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
79.6 |
73.5 to 84.6 |
340 |
| Hep A |
>=2 Doses |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
81.4 |
75.9 to 85.8 |
290 |
| Hep A |
>=2 Doses |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
83.8 |
78.4 to 88.1 |
315 |
| Hep A |
>=2 Doses |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
90.1 |
84.7 to 93.7 |
333 |
| Hep A |
>=2 Doses |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
84.1 |
78.5 to 88.5 |
282 |
| Hep A |
>=2 Doses |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
80.0 |
72.7 to 85.8 |
292 |
| Hep A |
>=2 Doses |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
87.8 |
83.0 to 91.4 |
337 |
| Hep A |
>=2 Doses |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
82.2 |
77.7 to 85.9 |
581 |
| Hep A |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
90.1 |
85.0 to 93.6 |
297 |
| Hep A |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
76.9 |
70.2 to 82.6 |
284 |
| Hep A |
>=2 Doses |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
90.8 |
83.6 to 95.0 |
266 |
| Hep A |
>=2 Doses |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
96.9 |
93.9 to 98.4 |
191 |
| Hep A |
>=2 Doses |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
83.8 |
76.5 to 89.2 |
254 |
| Hep A |
>=2 Doses |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
91.4 |
86.6 to 94.6 |
240 |
| Hep A |
>=2 Doses |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
94.8 |
90.6 to 97.2 |
294 |
| Hep A |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
86.7 |
82.9 to 89.8 |
929 |
| Hep A |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
91.0 |
86.0 to 94.3 |
330 |
| Hep A |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
86.2 |
81.9 to 89.6 |
599 |
| Hep A |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
62.6 |
55.8 to 68.9 |
350 |
| Hep A |
>=2 Doses |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
85.0 |
83.8 to 86.1 |
18002 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
86.6 |
83.8 to 89.0 |
1923 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
81.5 |
77.7 to 84.7 |
873 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
85.8 |
83.5 to 87.9 |
3338 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
81.9 |
78.9 to 84.5 |
2263 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
84.9 |
82.6 to 87.0 |
2060 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
84.6 |
81.4 to 87.4 |
2184 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
82.6 |
79.4 to 85.5 |
1154 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
89.3 |
87.0 to 91.3 |
1789 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
88.5 |
82.8 to 92.5 |
1173 |
| Hep A |
>=2 Doses |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
85.9 |
79.4 to 90.6 |
254 |
| Hep A |
>=2 Doses |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
68.4 |
60.9 to 75.2 |
263 |
| Hep A |
>=2 Doses |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
87.2 |
82.7 to 90.7 |
445 |
| Hep A |
>=2 Doses |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
91.4 |
87.0 to 94.4 |
315 |
| Hep A |
>=2 Doses |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
84.3 |
79.7 to 88.0 |
990 |
| Hep A |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
86.5 |
80.4 to 90.9 |
296 |
| Hep A |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
79.8 |
69.3 to 87.3 |
167 |
| Hep A |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
84.5 |
79.2 to 88.6 |
527 |
| Hep A |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
78.9 |
70.6 to 85.4 |
245 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
89.4 |
86.3 to 91.8 |
1245 |
| Hep A |
>=2 Doses |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
94.3 |
90.5 to 96.7 |
304 |
| Hep A |
>=2 Doses |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
79.7 |
75.3 to 83.5 |
488 |
| Hep A |
>=2 Doses |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
85.6 |
79.5 to 90.1 |
566 |
| Hep A |
>=2 Doses |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
86.2 |
80.6 to 90.4 |
349 |
| Hep A |
>=2 Doses |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
81.3 |
74.8 to 86.5 |
267 |
| Hep A |
>=2 Doses |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
82.2 |
76.3 to 86.9 |
306 |
| Hep A |
>=2 Doses |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
71.1 |
63.3 to 77.8 |
261 |
| Hep A |
>=2 Doses |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
77.4 |
70.9 to 82.7 |
269 |
| Hep A |
>=2 Doses |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
93.2 |
88.5 to 96.0 |
240 |
| Hep A |
>=2 Doses |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
90.8 |
86.2 to 94.0 |
273 |
| Hep A |
>=2 Doses |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
87.0 |
82.1 to 90.6 |
332 |
| Hep A |
>=2 Doses |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
81.2 |
74.5 to 86.5 |
321 |
| Hep A |
>=2 Doses |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
85.5 |
81.1 to 89.1 |
342 |
| Hep A |
>=2 Doses |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
90.9 |
85.3 to 94.5 |
258 |
| Hep A |
>=2 Doses |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
86.7 |
80.3 to 91.2 |
250 |
| Hep A |
>=2 Doses |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
75.3 |
66.6 to 82.3 |
237 |
| Hep A |
>=2 Doses |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
81.3 |
74.0 to 86.9 |
307 |
| Hep A |
>=2 Doses |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
91.9 |
87.0 to 95.1 |
333 |
| Hep A |
>=2 Doses |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
72.2 |
63.7 to 79.4 |
240 |
| Hep A |
>=2 Doses |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
90.0 |
84.2 to 93.8 |
237 |
| Hep A |
>=2 Doses |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
91.1 |
85.7 to 94.7 |
251 |
| Hep A |
>=2 Doses |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
83.5 |
78.9 to 87.2 |
630 |
| Hep A |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
87.1 |
80.4 to 91.8 |
256 |
| Hep A |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
82.7 |
77.2 to 87.0 |
374 |
| Hep A |
>=2 Doses |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
94.4 |
90.2 to 96.9 |
258 |
| Hep A |
>=2 Doses |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
86.6 |
80.2 to 91.1 |
207 |
| Hep A |
>=2 Doses |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
85.3 |
79.3 to 89.8 |
310 |
| Hep A |
>=2 Doses |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
90.0 |
84.1 to 93.9 |
276 |
| Hep A |
>=2 Doses |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
88.9 |
84.1 to 92.4 |
330 |
| Hep A |
>=2 Doses |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
91.1 |
86.6 to 94.2 |
268 |
| Hep A |
>=2 Doses |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
87.4 |
80.6 to 92.0 |
346 |
| Hep A |
>=2 Doses |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
86.5 |
80.3 to 91.0 |
268 |
| Hep A |
>=2 Doses |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
88.1 |
81.5 to 92.5 |
257 |
| Hep A |
>=2 Doses |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
92.8 |
88.8 to 95.4 |
331 |
| Hep A |
>=2 Doses |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
64.8 |
56.8 to 72.1 |
232 |
| Hep A |
>=2 Doses |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
80.9 |
74.5 to 86.0 |
284 |
| Hep A |
>=2 Doses |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
80.7 |
74.9 to 85.5 |
297 |
| Hep A |
>=2 Doses |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
86.6 |
80.9 to 90.9 |
247 |
| Hep A |
>=2 Doses |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
86.0 |
80.0 to 90.4 |
259 |
| Hep A |
>=2 Doses |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
86.7 |
80.9 to 90.9 |
225 |
| Hep A |
>=2 Doses |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
86.4 |
80.4 to 90.8 |
289 |
| Hep A |
>=2 Doses |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
87.3 |
81.0 to 91.8 |
276 |
| Hep A |
>=2 Doses |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
86.7 |
82.8 to 89.8 |
536 |
| Hep A |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
85.8 |
78.7 to 90.9 |
222 |
| Hep A |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
87.3 |
82.4 to 91.0 |
314 |
| Hep A |
>=2 Doses |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
89.2 |
83.8 to 92.9 |
361 |
| Hep A |
>=2 Doses |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
94.5 |
89.2 to 97.3 |
280 |
| Hep A |
>=2 Doses |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
75.7 |
67.6 to 82.3 |
269 |
| Hep A |
>=2 Doses |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
89.1 |
82.8 to 93.2 |
249 |
| Hep A |
>=2 Doses |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
94.3 |
90.5 to 96.7 |
263 |
| Hep A |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
87.8 |
83.8 to 90.9 |
752 |
| Hep A |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
95.8 |
91.0 to 98.1 |
267 |
| Hep A |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
86.7 |
82.2 to 90.2 |
485 |
| Hep A |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
74.3 |
69.6 to 78.5 |
671 |
| Hep A |
>=2 Doses |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
85.0 |
83.8 to 86.1 |
16043 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
88.5 |
85.4 to 91.0 |
1595 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
86.6 |
83.4 to 89.3 |
825 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
86.6 |
84.3 to 88.7 |
2424 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
84.9 |
82.4 to 87.1 |
2291 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
85.3 |
82.8 to 87.5 |
2019 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
82.9 |
78.8 to 86.4 |
1981 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
83.9 |
80.7 to 86.7 |
1048 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
86.1 |
83.3 to 88.4 |
1736 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
83.1 |
78.0 to 87.3 |
1090 |
| Hep A |
>=2 Doses |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
93.5 |
89.0 to 96.3 |
285 |
| Hep A |
>=2 Doses |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
80.9 |
74.1 to 86.3 |
269 |
| Hep A |
>=2 Doses |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
87.3 |
81.9 to 91.2 |
252 |
| Hep A |
>=2 Doses |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
91.2 |
85.6 to 94.8 |
244 |
| Hep A |
>=2 Doses |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
80.6 |
74.7 to 85.4 |
794 |
| Hep A |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
87.5 |
81.1 to 92.0 |
253 |
| Hep A |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
86.6 |
77.6 to 92.3 |
157 |
| Hep A |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
79.7 |
72.8 to 85.1 |
384 |
| Hep A |
>=2 Doses |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
88.8 |
85.2 to 91.6 |
1034 |
| Hep A |
>=2 Doses |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
87.6 |
80.7 to 92.2 |
271 |
| Hep A |
>=2 Doses |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
85.0 |
79.5 to 89.2 |
291 |
| Hep A |
>=2 Doses |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
84.1 |
79.7 to 87.7 |
595 |
| Hep A |
>=2 Doses |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
84.7 |
78.1 to 89.6 |
280 |
| Hep A |
>=2 Doses |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
91.6 |
86.9 to 94.7 |
244 |
| Hep A |
>=2 Doses |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
85.0 |
78.4 to 89.9 |
274 |
| Hep A |
>=2 Doses |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
77.1 |
70.0 to 82.9 |
294 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
16.9 |
14.6 to 19.6 |
1441 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
23.0 |
14.6 to 34.2 |
90 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-17 Years |
26.2 |
17.8 to 36.7 |
105 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
17.6 |
12.3 to 24.5 |
183 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
14.8 |
10.1 to 21.2 |
262 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
12.2 |
8.5 to 17.2 |
281 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-17 Years |
13.7 |
8.5 to 21.3 |
156 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-17 Years |
18.4 |
11.0 to 29.1 |
81 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
23.9 |
15.9 to 34.3 |
170 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
22.3 |
16.1 to 30.0 |
185 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
28.3 |
20.9 to 37.1 |
149 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
29.8 |
21.6 to 39.5 |
120 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
11.5 |
7.2 to 17.9 |
185 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
36.8 |
26.8 to 48.0 |
150 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
24.5 |
17.5 to 33.2 |
181 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
37.2 |
28.4 to 46.8 |
143 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
34.6 |
26.6 to 43.6 |
164 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
21.0 |
14.4 to 29.6 |
161 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
26.8 |
18.8 to 36.7 |
149 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
14.1 |
9.5 to 20.4 |
167 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
27.6 |
21.0 to 35.4 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
22.1 |
15.0 to 31.3 |
131 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
19.6 |
14.4 to 26.1 |
373 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
20.5 |
14.1 to 28.8 |
173 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
19.3 |
13.1 to 27.5 |
200 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
18.5 |
13.1 to 25.4 |
173 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
36.8 |
27.9 to 46.8 |
127 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
21.4 |
14.1 to 31.1 |
137 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
20.7 |
14.2 to 29.2 |
133 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
27.5 |
19.9 to 36.6 |
179 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
28.8 |
21.6 to 37.3 |
169 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
31.8 |
23.7 to 41.2 |
198 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
44.5 |
35.4 to 54.0 |
152 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
22.1 |
15.5 to 30.5 |
143 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
27.9 |
21.3 to 35.5 |
167 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Mississippi |
2008 |
Age |
13-17 Years |
9.1 |
5.1 to 15.5 |
187 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
23.3 |
16.3 to 32.3 |
158 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
13.3 |
8.3 to 20.5 |
142 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
24.4 |
18.4 to 31.5 |
186 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
22.2 |
14.5 to 32.4 |
117 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
45.5 |
35.4 to 56.0 |
151 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
31.6 |
23.9 to 40.6 |
187 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
34.2 |
25.2 to 44.4 |
143 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
42.0 |
35.0 to 49.3 |
270 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
38.7 |
28.9 to 49.6 |
135 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
44.2 |
34.8 to 54.0 |
135 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
28.1 |
20.8 to 36.7 |
157 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
23.9 |
17.6 to 31.6 |
177 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
21.8 |
15.2 to 30.3 |
154 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
29.3 |
21.7 to 38.2 |
141 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
29.9 |
21.2 to 40.2 |
106 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
37.0 |
30.0 to 44.5 |
346 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
36.1 |
28.0 to 45.0 |
178 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
37.1 |
29.2 to 45.8 |
168 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
28.3 |
26.4 to 30.3 |
8607 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
41.8 |
36.8 to 46.9 |
911 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
38.8 |
33.3 to 44.5 |
457 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
32.3 |
28.2 to 36.7 |
1176 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
22.2 |
19.1 to 25.6 |
1333 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
22.9 |
20.0 to 26.2 |
1123 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
22.1 |
17.1 to 28.0 |
1018 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
26.0 |
21.7 to 30.9 |
608 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
20.4 |
16.7 to 24.7 |
911 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
34.9 |
26.8 to 43.9 |
549 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
50.7 |
40.5 to 60.8 |
152 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
17.3 |
11.9 to 24.3 |
183 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
41.6 |
33.8 to 49.8 |
178 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
25.7 |
17.9 to 35.5 |
172 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
20.3 |
13.5 to 29.3 |
370 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
26.5 |
18.0 to 37.1 |
114 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
23.1 |
14.8 to 34.3 |
102 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
19.5 |
11.9 to 30.4 |
154 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
34.6 |
28.8 to 40.8 |
521 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
44.8 |
35.5 to 54.5 |
144 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
27.4 |
20.0 to 36.2 |
151 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
41.0 |
31.8 to 50.9 |
135 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
24.3 |
17.4 to 32.7 |
156 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
34.9 |
25.7 to 45.4 |
113 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
28.4 |
20.8 to 37.5 |
124 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
36.7 |
28.7 to 45.4 |
166 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
27.7 |
20.1 to 36.9 |
136 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
40.8 |
32.1 to 50.1 |
184 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
25.6 |
18.5 to 34.2 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
37.1 |
28.9 to 46.3 |
190 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
42.7 |
34.0 to 51.9 |
198 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
50.3 |
41.7 to 58.9 |
191 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
45.0 |
36.1 to 54.1 |
186 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
37.8 |
30.1 to 46.1 |
198 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
33.2 |
25.8 to 41.5 |
216 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
33.9 |
26.4 to 42.3 |
182 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
50.4 |
40.6 to 60.2 |
115 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
23.7 |
15.6 to 34.5 |
105 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
31.2 |
25.0 to 38.0 |
365 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
27.4 |
21.0 to 34.8 |
199 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
32.2 |
24.7 to 40.7 |
166 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
28.5 |
22.3 to 35.5 |
404 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
37.9 |
30.1 to 46.5 |
174 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
35.3 |
25.5 to 46.4 |
117 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
26.7 |
19.9 to 34.7 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
36.2 |
25.9 to 47.9 |
127 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
37.5 |
29.1 to 46.8 |
140 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
31.8 |
21.8 to 43.8 |
110 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
59.9 |
51.0 to 68.1 |
181 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
29.2 |
22.4 to 37.1 |
220 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
34.7 |
27.2 to 43.0 |
164 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
14.9 |
10.0 to 21.7 |
191 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
24.8 |
18.6 to 32.3 |
173 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
28.6 |
21.0 to 37.6 |
146 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
40.7 |
31.9 to 50.1 |
143 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
25.6 |
18.1 to 34.9 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
53.0 |
44.1 to 61.7 |
150 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
35.2 |
28.0 to 43.1 |
197 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
43.5 |
35.8 to 51.4 |
195 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
43.8 |
36.5 to 51.3 |
262 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
37.1 |
27.3 to 48.1 |
137 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
48.3 |
38.6 to 58.1 |
125 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
39.1 |
30.5 to 48.4 |
157 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
41.0 |
32.1 to 50.6 |
133 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
33.9 |
25.6 to 43.4 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
20.3 |
14.4 to 27.8 |
158 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
42.9 |
35.3 to 50.9 |
200 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
43.3 |
34.3 to 52.6 |
262 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
41.6 |
33.0 to 50.8 |
148 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
43.5 |
33.3 to 54.3 |
114 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
35.8 |
34.1 to 37.6 |
9621 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
54.7 |
50.0 to 59.3 |
1022 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
41.1 |
35.6 to 46.8 |
459 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
36.8 |
31.9 to 42.0 |
1049 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
32.3 |
29.1 to 35.7 |
1416 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
32.2 |
29.0 to 35.6 |
1507 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
31.8 |
27.4 to 36.5 |
1352 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
32.0 |
27.7 to 36.5 |
607 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
37.2 |
32.5 to 42.2 |
962 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
37.3 |
30.6 to 44.6 |
648 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
64.7 |
55.4 to 73.0 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
21.8 |
15.3 to 30.0 |
148 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
55.8 |
46.3 to 64.9 |
142 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
34.5 |
27.0 to 42.9 |
180 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
32.3 |
26.3 to 39.0 |
696 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
29.1 |
21.1 to 38.7 |
145 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
33.8 |
22.5 to 47.3 |
112 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
39.9 |
30.1 to 50.5 |
131 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
46.3 |
37.9 to 54.9 |
153 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
30.8 |
22.9 to 40.0 |
155 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
42.7 |
37.5 to 48.2 |
599 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
25.7 |
18.5 to 34.5 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
49.9 |
41.7 to 58.1 |
184 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
30.4 |
22.9 to 39.1 |
175 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
49.1 |
40.4 to 58.0 |
158 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
31.6 |
23.4 to 41.2 |
118 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
38.6 |
30.6 to 47.2 |
178 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
37.6 |
30.1 to 45.7 |
184 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
31.3 |
23.7 to 40.2 |
143 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
32.0 |
24.0 to 41.2 |
134 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
40.7 |
31.7 to 50.3 |
151 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
24.1 |
17.0 to 33.0 |
135 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
43.4 |
34.8 to 52.4 |
163 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
46.2 |
37.5 to 55.2 |
166 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
52.0 |
43.6 to 60.4 |
182 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
53.4 |
44.1 to 62.5 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
44.4 |
35.9 to 53.2 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
37.0 |
27.6 to 47.4 |
147 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
34.8 |
27.8 to 42.6 |
195 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
50.6 |
41.2 to 60.0 |
133 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
22.1 |
15.7 to 30.3 |
152 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
31.7 |
25.9 to 38.1 |
362 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
41.0 |
32.2 to 50.4 |
175 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
29.3 |
22.6 to 37.1 |
187 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
31.2 |
23.9 to 39.6 |
168 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
43.1 |
34.1 to 52.6 |
128 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
37.3 |
29.3 to 46.1 |
170 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
32.0 |
24.0 to 41.3 |
142 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
46.9 |
37.8 to 56.1 |
142 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
42.0 |
33.1 to 51.5 |
144 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
37.5 |
28.8 to 47.0 |
140 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
57.7 |
47.7 to 67.2 |
140 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
39.1 |
30.1 to 48.9 |
145 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
43.3 |
34.4 to 52.7 |
139 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
24.9 |
18.1 to 33.3 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
34.4 |
27.0 to 42.7 |
170 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
40.1 |
31.7 to 49.1 |
163 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
48.5 |
39.1 to 57.9 |
148 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
38.3 |
30.1 to 47.2 |
165 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
46.9 |
38.8 to 55.1 |
173 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
29.8 |
22.3 to 38.5 |
180 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
40.6 |
32.6 to 49.1 |
174 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
48.1 |
41.4 to 54.9 |
329 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
54.8 |
46.2 to 63.1 |
182 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
43.7 |
34.4 to 53.5 |
147 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
45.0 |
36.2 to 54.2 |
156 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
34.1 |
26.7 to 42.5 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
40.1 |
31.5 to 49.3 |
150 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
38.9 |
30.6 to 47.9 |
163 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
45.4 |
36.0 to 55.2 |
129 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
48.8 |
41.3 to 56.3 |
360 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
54.8 |
46.4 to 63.0 |
185 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
47.9 |
39.4 to 56.5 |
175 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
40.7 |
38.9 to 42.5 |
9220 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
54.0 |
48.9 to 59.0 |
953 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
42.3 |
36.9 to 47.8 |
509 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
46.4 |
41.8 to 51.1 |
1161 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
35.5 |
31.8 to 39.3 |
1272 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
38.0 |
34.5 to 41.7 |
1099 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
36.6 |
32.1 to 41.5 |
1438 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
38.8 |
34.3 to 43.5 |
616 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
42.3 |
37.6 to 47.2 |
970 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
43.0 |
36.0 to 50.2 |
612 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
65.8 |
57.0 to 73.6 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
34.9 |
26.4 to 44.5 |
164 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
61.5 |
52.6 to 69.6 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
29.5 |
22.5 to 37.7 |
149 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
35.6 |
29.2 to 42.5 |
824 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
36.0 |
28.8 to 43.9 |
203 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
40.8 |
32.4 to 49.8 |
197 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
22.5 |
15.2 to 32.0 |
135 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
55.4 |
46.4 to 64.0 |
148 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
35.7 |
27.2 to 45.2 |
141 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
13.1 |
7.5 to 21.9 |
116 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
49.3 |
44.0 to 54.5 |
590 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
32.9 |
25.2 to 41.8 |
170 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
48.2 |
39.1 to 57.5 |
155 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
51.1 |
41.4 to 60.7 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
60.4 |
52.1 to 68.1 |
175 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
35.2 |
27.6 to 43.7 |
164 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
49.1 |
39.4 to 58.9 |
135 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
46.2 |
37.4 to 55.2 |
150 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
38.3 |
29.8 to 47.5 |
180 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
47.6 |
38.0 to 57.4 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
45.2 |
35.3 to 55.5 |
191 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
29.7 |
19.0 to 43.1 |
152 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
54.2 |
46.8 to 61.3 |
270 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
32.9 |
24.8 to 42.3 |
220 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
51.7 |
42.8 to 60.5 |
223 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
52.7 |
43.9 to 61.3 |
203 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
45.2 |
36.4 to 54.3 |
210 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
42.5 |
34.1 to 51.3 |
240 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
38.1 |
29.7 to 47.2 |
215 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
63.2 |
53.6 to 71.8 |
154 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
38.7 |
29.0 to 49.4 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
42.7 |
35.2 to 50.6 |
404 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
36.7 |
28.2 to 46.1 |
181 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
44.1 |
35.1 to 53.6 |
223 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
33.8 |
25.7 to 42.9 |
199 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
51.5 |
41.5 to 61.4 |
169 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
28.8 |
21.7 to 37.2 |
198 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
38.0 |
29.2 to 47.8 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
52.1 |
42.9 to 61.1 |
214 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
50.6 |
42.3 to 58.8 |
211 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
36.3 |
29.1 to 44.2 |
255 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
55.7 |
46.5 to 64.4 |
178 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
48.2 |
38.6 to 57.9 |
185 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
46.0 |
36.3 to 56.1 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
22.9 |
14.8 to 33.5 |
167 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
37.7 |
28.9 to 47.3 |
191 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
49.8 |
38.1 to 61.6 |
204 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
40.6 |
31.7 to 50.2 |
174 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
39.5 |
29.3 to 50.7 |
189 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
52.8 |
44.2 to 61.3 |
191 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
49.5 |
41.3 to 57.7 |
219 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
44.1 |
35.5 to 53.1 |
209 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
41.5 |
35.9 to 47.3 |
399 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
51.4 |
43.6 to 59.2 |
209 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
35.3 |
28.0 to 43.4 |
190 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
40.2 |
30.8 to 50.3 |
161 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
38.8 |
27.8 to 51.1 |
142 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
36.7 |
28.9 to 45.4 |
181 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
37.3 |
28.2 to 47.5 |
175 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
49.8 |
39.7 to 59.9 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
46.2 |
38.5 to 54.0 |
435 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
63.5 |
54.0 to 72.1 |
188 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
43.9 |
35.4 to 52.7 |
247 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
43.9 |
42.3 to 45.6 |
11236 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
55.0 |
50.1 to 59.8 |
1211 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
44.1 |
39.4 to 48.9 |
618 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
41.6 |
37.3 to 46.2 |
1458 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
38.5 |
34.8 to 42.3 |
1505 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
43.4 |
39.7 to 47.2 |
1338 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
40.1 |
35.5 to 45.0 |
1807 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
39.2 |
34.1 to 44.4 |
732 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
39.5 |
34.1 to 45.1 |
1090 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
52.4 |
46.4 to 58.3 |
804 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
71.1 |
62.7 to 78.2 |
203 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
30.7 |
21.9 to 41.1 |
161 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
54.7 |
40.9 to 67.7 |
179 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
39.5 |
30.5 to 49.2 |
205 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
39.3 |
33.0 to 46.1 |
1057 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
46.1 |
37.4 to 55.0 |
213 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
39.8 |
31.4 to 48.8 |
250 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
29.7 |
21.8 to 38.9 |
196 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
59.0 |
49.3 to 68.1 |
169 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
38.9 |
30.5 to 48.1 |
229 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
17.3 |
12.5 to 23.4 |
232 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
51.7 |
45.8 to 57.5 |
673 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
40.9 |
30.6 to 52.1 |
170 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
55.8 |
47.1 to 64.2 |
205 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
36.5 |
27.9 to 46.0 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
56.5 |
47.1 to 65.5 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
45.0 |
36.0 to 54.3 |
179 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
59.3 |
49.9 to 68.0 |
210 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
51.4 |
40.5 to 62.1 |
175 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
36.9 |
27.4 to 47.4 |
146 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
46.3 |
37.0 to 55.9 |
145 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
43.4 |
34.3 to 53.0 |
178 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
32.4 |
23.2 to 43.1 |
156 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
48.4 |
39.7 to 57.2 |
202 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
44.9 |
34.1 to 56.3 |
156 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
53.9 |
43.5 to 64.0 |
141 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
64.5 |
54.1 to 73.6 |
157 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
52.8 |
42.7 to 62.7 |
158 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
33.4 |
24.6 to 43.5 |
150 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
36.8 |
27.6 to 47.1 |
156 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
58.1 |
48.1 to 67.5 |
152 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
41.6 |
32.4 to 51.4 |
173 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
28.5 |
21.4 to 36.7 |
308 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
44.5 |
33.9 to 55.5 |
143 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
24.5 |
16.5 to 34.7 |
165 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
42.7 |
33.4 to 52.5 |
154 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
46.4 |
36.9 to 56.1 |
151 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
32.8 |
23.9 to 43.2 |
157 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
43.5 |
33.4 to 54.1 |
154 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
52.6 |
43.5 to 61.5 |
186 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
53.4 |
43.7 to 62.9 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
39.3 |
29.4 to 50.1 |
148 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
58.9 |
49.8 to 67.4 |
165 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
39.2 |
30.1 to 49.1 |
171 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
46.0 |
35.7 to 56.8 |
164 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
22.3 |
15.5 to 30.9 |
160 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
40.4 |
30.8 to 50.8 |
150 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
46.5 |
36.8 to 56.6 |
150 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
58.3 |
47.4 to 68.5 |
146 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
44.6 |
34.7 to 54.9 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
43.6 |
33.6 to 54.1 |
121 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
44.9 |
35.5 to 54.6 |
145 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
38.7 |
29.8 to 48.5 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
50.5 |
43.3 to 57.6 |
303 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
49.0 |
40.2 to 57.9 |
158 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
51.4 |
41.2 to 61.5 |
145 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
46.5 |
37.0 to 56.3 |
163 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
49.7 |
39.8 to 59.5 |
151 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
39.5 |
29.5 to 50.5 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
49.5 |
40.1 to 59.0 |
167 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
46.7 |
37.4 to 56.2 |
160 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
52.1 |
44.0 to 60.1 |
337 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
68.5 |
58.6 to 77.0 |
166 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
50.0 |
40.9 to 59.0 |
171 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
43.4 |
41.5 to 45.2 |
9058 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
56.3 |
51.2 to 61.2 |
900 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
48.6 |
42.9 to 54.4 |
448 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
45.4 |
40.4 to 50.5 |
1089 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
37.1 |
33.1 to 41.3 |
1230 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
38.4 |
34.3 to 42.5 |
1089 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
42.5 |
38.4 to 46.7 |
1466 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
42.4 |
37.0 to 48.1 |
604 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
43.5 |
37.6 to 49.5 |
908 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
47.7 |
40.8 to 54.8 |
691 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
67.8 |
57.3 to 76.7 |
153 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
31.6 |
22.7 to 42.1 |
153 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
46.5 |
36.7 to 56.6 |
135 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
40.9 |
30.8 to 52.0 |
148 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
41.2 |
35.6 to 47.0 |
798 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
33.4 |
24.5 to 43.8 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
46.0 |
36.7 to 55.6 |
189 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
41.4 |
35.0 to 48.1 |
433 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
16.4 |
11.7 to 22.7 |
262 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
50.1 |
44.1 to 56.1 |
633 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
39.0 |
29.5 to 49.3 |
163 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
58.0 |
48.5 to 66.9 |
158 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
38.0 |
28.4 to 48.7 |
155 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
54.6 |
44.4 to 64.4 |
155 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
41.2 |
31.1 to 52.0 |
134 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
45.0 |
34.6 to 55.8 |
133 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
41.4 |
32.2 to 51.2 |
153 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
46.6 |
37.6 to 55.7 |
152 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
36.1 |
27.7 to 45.5 |
158 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
47.9 |
38.6 to 57.4 |
171 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
35.4 |
27.1 to 44.7 |
157 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
57.3 |
47.2 to 66.9 |
148 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
50.0 |
41.2 to 58.7 |
163 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
49.0 |
39.8 to 58.2 |
157 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
59.4 |
50.5 to 67.8 |
183 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
43.0 |
29.5 to 57.6 |
84 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
40.7 |
31.1 to 50.9 |
157 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
42.3 |
32.4 to 52.9 |
132 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
45.2 |
36.5 to 54.2 |
164 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
46.6 |
36.9 to 56.6 |
141 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
45.8 |
35.6 to 56.4 |
124 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
42.6 |
35.3 to 50.3 |
268 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
49.2 |
36.8 to 61.8 |
94 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
41.1 |
32.6 to 50.1 |
174 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
44.2 |
36.2 to 52.5 |
194 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
52.2 |
43.4 to 60.9 |
183 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
29.9 |
21.6 to 39.9 |
133 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
38.6 |
29.6 to 48.4 |
140 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
54.1 |
44.5 to 63.4 |
138 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
55.4 |
46.4 to 64.0 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
45.5 |
34.5 to 56.9 |
148 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
48.9 |
40.4 to 57.5 |
183 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
49.4 |
39.7 to 59.3 |
131 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
45.8 |
36.7 to 55.2 |
167 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
35.6 |
26.9 to 45.4 |
148 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
38.1 |
28.6 to 48.6 |
135 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
37.9 |
29.4 to 47.2 |
149 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
55.3 |
45.9 to 64.3 |
141 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
38.9 |
30.1 to 48.4 |
150 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
57.2 |
48.4 to 65.6 |
168 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
39.1 |
30.1 to 49.0 |
157 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
56.1 |
46.8 to 64.9 |
166 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
55.6 |
49.1 to 61.9 |
344 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
56.1 |
46.6 to 65.2 |
154 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
55.3 |
46.6 to 63.7 |
190 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
47.4 |
37.8 to 57.1 |
149 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
51.0 |
41.7 to 60.3 |
168 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
47.6 |
38.4 to 57.0 |
156 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
46.5 |
38.0 to 55.1 |
184 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
54.9 |
45.9 to 63.5 |
164 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
53.5 |
45.3 to 61.5 |
379 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
71.2 |
62.6 to 78.5 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
51.1 |
42.1 to 60.2 |
220 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
47.7 |
45.7 to 49.6 |
8710 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
51.8 |
47.0 to 56.5 |
978 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
50.2 |
44.8 to 55.6 |
501 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
48.0 |
42.6 to 53.4 |
1101 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
42.9 |
38.9 to 47.0 |
1165 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
46.1 |
42.4 to 50.0 |
1076 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
46.9 |
41.7 to 52.2 |
1159 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
41.7 |
36.4 to 47.2 |
592 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
43.4 |
38.5 to 48.4 |
919 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
54.8 |
46.7 to 62.5 |
610 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
68.5 |
59.2 to 76.5 |
147 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
53.0 |
42.9 to 62.9 |
145 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
52.0 |
42.3 to 61.5 |
141 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
39.8 |
30.9 to 49.4 |
142 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
46.3 |
39.0 to 53.7 |
514 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
45.7 |
36.8 to 54.9 |
155 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
51.9 |
40.8 to 62.9 |
119 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
45.9 |
37.5 to 54.5 |
240 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
17.7 |
12.0 to 25.4 |
156 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
51.2 |
45.3 to 57.1 |
609 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
30.9 |
22.8 to 40.4 |
151 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
53.5 |
44.3 to 62.5 |
161 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
41.4 |
29.8 to 54.0 |
155 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
52.3 |
42.4 to 62.0 |
163 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
43.6 |
34.8 to 52.9 |
152 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
47.8 |
38.6 to 57.2 |
160 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
49.5 |
40.2 to 58.8 |
147 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
40.7 |
32.1 to 50.0 |
172 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
45.2 |
36.8 to 54.0 |
200 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
46.2 |
37.1 to 55.6 |
194 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
37.8 |
29.6 to 46.8 |
183 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
61.5 |
51.3 to 70.7 |
166 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
55.1 |
46.4 to 63.6 |
189 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
59.9 |
51.0 to 68.2 |
185 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
51.4 |
41.6 to 61.1 |
180 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
67.8 |
56.8 to 77.1 |
142 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
39.6 |
30.1 to 49.9 |
173 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
56.3 |
46.7 to 65.4 |
187 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
49.3 |
40.7 to 58.0 |
186 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
54.2 |
44.0 to 64.1 |
156 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
58.0 |
51.2 to 64.5 |
349 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
68.8 |
58.6 to 77.4 |
141 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
55.5 |
47.5 to 63.3 |
208 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
54.3 |
45.4 to 63.0 |
184 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
52.5 |
42.6 to 62.2 |
157 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
30.4 |
22.4 to 39.8 |
158 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
45.1 |
35.9 to 54.6 |
174 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
43.8 |
34.8 to 53.1 |
168 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
52.9 |
44.2 to 61.5 |
165 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
52.6 |
42.7 to 62.4 |
192 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
62.5 |
53.2 to 71.0 |
163 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
50.9 |
41.7 to 60.0 |
172 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
53.9 |
43.6 to 63.8 |
134 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
30.6 |
22.6 to 39.9 |
160 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
36.3 |
28.0 to 45.4 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
51.0 |
41.9 to 60.1 |
197 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
51.2 |
41.8 to 60.5 |
154 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
43.5 |
35.2 to 52.1 |
184 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
61.2 |
53.1 to 68.7 |
181 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
39.9 |
30.8 to 49.8 |
145 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
48.7 |
39.7 to 57.7 |
202 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
47.2 |
39.8 to 54.7 |
283 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
46.2 |
36.3 to 56.5 |
144 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
47.8 |
37.7 to 58.0 |
139 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
60.0 |
50.7 to 68.6 |
173 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
48.7 |
39.3 to 58.2 |
168 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
47.3 |
38.7 to 56.1 |
202 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
50.8 |
41.6 to 60.0 |
170 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
51.7 |
42.6 to 60.8 |
193 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
57.9 |
49.7 to 65.6 |
380 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
74.1 |
64.4 to 82.0 |
157 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
55.7 |
46.6 to 64.4 |
223 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
60.7 |
47.5 to 72.6 |
107 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
50.3 |
48.4 to 52.2 |
10084 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
61.0 |
56.1 to 65.7 |
1070 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
44.8 |
39.0 to 50.8 |
428 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
54.3 |
49.4 to 59.2 |
1222 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
46.3 |
42.2 to 50.3 |
1386 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
52.7 |
49.1 to 56.4 |
1206 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
44.6 |
39.7 to 49.6 |
1516 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
40.6 |
35.8 to 45.7 |
645 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
48.5 |
43.7 to 53.3 |
1153 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
58.0 |
50.2 to 65.5 |
730 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
67.8 |
59.2 to 75.4 |
194 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
46.5 |
37.2 to 56.0 |
193 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
44.0 |
34.9 to 53.6 |
177 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
39.4 |
30.4 to 49.3 |
154 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
44.2 |
37.5 to 51.3 |
793 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
39.0 |
30.4 to 48.3 |
179 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
55.2 |
45.5 to 64.5 |
197 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
61.7 |
50.6 to 71.7 |
189 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
43.0 |
35.0 to 51.2 |
228 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
52.9 |
47.2 to 58.6 |
728 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
40.0 |
31.9 to 48.8 |
199 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
55.8 |
46.6 to 64.7 |
182 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
51.1 |
40.7 to 61.4 |
166 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
54.1 |
44.8 to 63.1 |
179 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
48.3 |
39.1 to 57.5 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
52.1 |
42.1 to 61.9 |
165 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
42.4 |
34.6 to 50.5 |
223 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
50.4 |
41.1 to 59.6 |
165 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
46.3 |
37.8 to 55.1 |
165 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
56.1 |
47.9 to 63.9 |
215 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
49.4 |
40.7 to 58.2 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
59.7 |
49.6 to 69.1 |
174 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
57.7 |
48.9 to 66.0 |
180 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
64.3 |
55.3 to 72.4 |
155 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
60.9 |
51.7 to 69.3 |
161 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
67.5 |
58.2 to 75.5 |
199 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
44.6 |
35.2 to 54.4 |
161 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
38.7 |
30.3 to 47.9 |
172 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
50.5 |
42.3 to 58.8 |
192 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
64.1 |
55.3 to 72.0 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
43.5 |
34.8 to 52.5 |
177 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
52.0 |
45.9 to 58.1 |
401 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
62.1 |
52.8 to 70.6 |
147 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
49.9 |
42.8 to 57.0 |
254 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
43.1 |
34.6 to 52.1 |
167 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
62.3 |
53.8 to 70.0 |
190 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
43.6 |
35.2 to 52.3 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
42.7 |
34.3 to 51.5 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
53.3 |
44.3 to 62.0 |
163 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
53.9 |
45.1 to 62.4 |
186 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
61.7 |
52.3 to 70.3 |
203 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
63.0 |
53.0 to 71.9 |
158 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
56.9 |
47.8 to 65.5 |
168 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
51.3 |
42.5 to 60.1 |
179 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
37.2 |
29.8 to 45.2 |
205 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
43.4 |
33.4 to 54.0 |
141 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
41.8 |
33.7 to 50.2 |
192 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
55.5 |
46.9 to 63.7 |
184 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
57.6 |
48.5 to 66.3 |
176 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
59.7 |
49.4 to 69.2 |
137 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
56.3 |
47.6 to 64.6 |
178 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
55.6 |
47.6 to 63.2 |
214 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
56.4 |
49.8 to 62.8 |
298 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
60.0 |
50.7 to 68.6 |
142 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
54.1 |
45.1 to 62.8 |
156 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
53.5 |
44.5 to 62.2 |
172 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
60.9 |
51.7 to 69.5 |
159 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
47.8 |
38.1 to 57.6 |
146 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
43.4 |
33.9 to 53.5 |
129 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
55.4 |
46.3 to 64.1 |
168 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
56.4 |
48.6 to 64.0 |
397 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
68.1 |
59.6 to 75.6 |
175 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
54.9 |
46.2 to 63.4 |
222 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
52.7 |
43.1 to 62.2 |
158 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
52.2 |
50.3 to 54.0 |
10508 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
63.1 |
57.9 to 68.0 |
1026 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
56.4 |
51.1 to 61.5 |
476 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
53.9 |
48.9 to 58.8 |
1295 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
45.0 |
41.2 to 48.9 |
1375 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
50.9 |
47.3 to 54.6 |
1232 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
50.2 |
46.4 to 54.1 |
1962 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
49.3 |
44.0 to 54.6 |
691 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
47.9 |
43.1 to 52.9 |
1026 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
59.2 |
51.2 to 66.7 |
727 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
77.9 |
70.4 to 83.8 |
201 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
43.3 |
34.6 to 52.3 |
172 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
42.3 |
33.7 to 51.4 |
162 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
46.7 |
37.9 to 55.7 |
166 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
50.4 |
45.2 to 55.5 |
1294 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
46.5 |
38.1 to 55.1 |
198 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
58.1 |
47.1 to 68.3 |
116 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
64.6 |
57.1 to 71.4 |
276 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
49.1 |
42.8 to 55.5 |
453 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
25.8 |
19.5 to 33.3 |
222 |
| HPV |
>=2 Doses, Females |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
53.4 |
48.2 to 58.6 |
698 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
35.9 |
27.6 to 45.1 |
171 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
59.1 |
50.6 to 67.1 |
189 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
43.9 |
33.0 to 55.4 |
171 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
55.8 |
47.4 to 63.9 |
188 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
49.7 |
41.0 to 58.5 |
164 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
53.2 |
44.3 to 61.9 |
171 |
| HPV |
>=2 Doses, Females |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
37.6 |
28.7 to 47.4 |
162 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
0.4 |
0.3 to 0.7 |
10037 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
10.0 |
6.0 to 16.2 |
230 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
6.7 |
3.9 to 11.2 |
239 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
3.9 |
2.2 to 6.8 |
444 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
7.4 |
4.2 to 12.5 |
259 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
6.2 |
3.5 to 10.9 |
199 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
3.8 |
3.2 to 4.5 |
12328 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
4.9 |
3.5 to 7.0 |
1256 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
3.3 |
1.9 to 5.6 |
654 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
3.9 |
2.6 to 5.9 |
1615 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
2.6 |
1.8 to 3.8 |
1666 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
3.0 |
2.0 to 4.6 |
1462 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
4.8 |
3.6 to 6.4 |
2031 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
2.3 |
1.3 to 4.0 |
796 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
10.3 |
6.8 to 15.4 |
246 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
4.9 |
3.3 to 7.2 |
1167 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
5.4 |
3.0 to 9.4 |
245 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
15.3 |
9.8 to 23.2 |
186 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
3.9 |
2.2 to 7.0 |
750 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
7.5 |
4.6 to 12.1 |
195 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
12.8 |
8.1 to 19.8 |
182 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
19.3 |
13.7 to 26.5 |
228 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
14.6 |
9.6 to 21.7 |
182 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
17.9 |
12.1 to 25.6 |
184 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
12.3 |
7.4 to 19.8 |
184 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
15.4 |
8.9 to 25.5 |
175 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
8.7 |
5.0 to 14.7 |
172 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
27.5 |
19.6 to 37.2 |
190 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
15.0 |
9.4 to 23.0 |
324 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
27.8 |
18.9 to 38.9 |
144 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
10.8 |
6.1 to 18.3 |
187 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
13.5 |
8.2 to 21.3 |
174 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
11.1 |
6.1 to 19.4 |
183 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
12.6 |
7.1 to 21.3 |
184 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
17.4 |
11.5 to 25.5 |
157 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
13.8 |
8.6 to 21.4 |
177 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
10.4 |
6.3 to 16.6 |
182 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
11.2 |
6.2 to 19.4 |
161 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
10.0 |
5.4 to 17.5 |
175 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
11.6 |
7.4 to 17.7 |
182 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
12.2 |
7.6 to 18.9 |
157 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
10.7 |
6.3 to 17.8 |
185 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
12.8 |
7.3 to 21.5 |
172 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
12.3 |
8.4 to 17.7 |
324 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
19.2 |
11.9 to 29.5 |
154 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
11.8 |
7.2 to 18.7 |
184 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
13.1 |
7.6 to 21.5 |
173 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
6.9 |
3.9 to 11.9 |
168 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
14.8 |
9.7 to 21.8 |
155 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
7.2 |
4.0 to 12.8 |
221 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
13.2 |
9.1 to 18.8 |
404 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
27.5 |
19.5 to 37.4 |
182 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
11.4 |
7.1 to 17.8 |
222 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
12.7 |
11.5 to 14.0 |
10141 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
14.4 |
11.6 to 17.6 |
1016 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
11.8 |
8.6 to 15.9 |
509 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
11.5 |
9.1 to 14.6 |
1276 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
11.5 |
8.9 to 14.7 |
1382 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
10.5 |
8.2 to 13.4 |
1208 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
13.4 |
10.8 to 16.7 |
1473 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
11.0 |
8.0 to 14.8 |
681 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
13.0 |
8.1 to 20.4 |
1028 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
18.0 |
13.4 to 23.6 |
770 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
34.8 |
26.6 to 43.9 |
174 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
15.9 |
9.1 to 26.3 |
157 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
10.7 |
5.9 to 18.4 |
163 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
14.2 |
10.6 to 18.8 |
796 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
23.8 |
16.0 to 34.0 |
204 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
13.8 |
9.8 to 19.2 |
422 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
8.9 |
6.1 to 12.7 |
798 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
19.4 |
12.7 to 28.3 |
164 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
9.6 |
5.3 to 16.6 |
198 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
10.3 |
5.8 to 17.7 |
174 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
10.9 |
6.7 to 17.3 |
165 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
17.8 |
11.9 to 25.8 |
162 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
33.5 |
25.7 to 42.4 |
188 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
33.2 |
24.3 to 43.5 |
161 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
21.7 |
15.1 to 30.2 |
168 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
36.4 |
28.1 to 45.7 |
171 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
25.0 |
18.3 to 33.2 |
165 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
40.2 |
26.9 to 55.1 |
108 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
16.0 |
10.4 to 23.7 |
166 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
31.0 |
21.4 to 42.5 |
121 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
8.6 |
5.3 to 13.8 |
199 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
29.0 |
21.6 to 37.7 |
174 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
21.6 |
14.1 to 31.6 |
148 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
21.2 |
15.4 to 28.6 |
290 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
29.1 |
19.8 to 40.5 |
115 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
19.4 |
12.8 to 28.4 |
175 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
13.5 |
8.8 to 20.0 |
187 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
24.0 |
17.5 to 32.0 |
200 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
19.3 |
12.7 to 28.4 |
154 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
10.8 |
6.6 to 17.3 |
151 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
20.5 |
13.9 to 29.2 |
160 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
31.1 |
23.8 to 39.4 |
181 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
23.1 |
15.4 to 33.2 |
172 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
37.8 |
30.1 to 46.1 |
210 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
16.8 |
11.1 to 24.6 |
176 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
13.1 |
8.4 to 19.8 |
202 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
17.2 |
11.2 to 25.4 |
171 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
26.4 |
19.4 to 34.9 |
160 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
20.4 |
14.1 to 28.5 |
185 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
28.5 |
21.4 to 37.0 |
177 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
25.7 |
18.2 to 35.0 |
165 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
27.0 |
20.4 to 34.8 |
191 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
29.3 |
23.9 to 35.5 |
366 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
36.0 |
27.4 to 45.7 |
146 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
25.1 |
18.4 to 33.3 |
220 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
24.4 |
17.3 to 33.3 |
157 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
26.6 |
19.0 to 35.8 |
176 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
19.7 |
13.5 to 27.8 |
163 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
31.1 |
24.7 to 38.4 |
242 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
20.8 |
14.7 to 28.5 |
200 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
26.8 |
20.4 to 34.3 |
372 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
35.7 |
27.3 to 45.0 |
148 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
25.7 |
18.8 to 34.1 |
224 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
23.5 |
21.8 to 25.3 |
9554 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
36.9 |
32.6 to 41.5 |
1072 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
28.1 |
23.6 to 33.2 |
531 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
24.5 |
20.3 to 29.3 |
1140 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
18.6 |
15.7 to 22.0 |
1209 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
18.2 |
15.4 to 21.2 |
1188 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
24.2 |
20.3 to 28.6 |
1346 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
16.6 |
13.5 to 20.4 |
659 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
16.6 |
13.1 to 20.7 |
994 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
32.5 |
25.3 to 40.6 |
708 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
58.0 |
48.8 to 66.6 |
168 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
13.1 |
7.7 to 21.4 |
151 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
17.0 |
11.6 to 24.4 |
151 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
18.0 |
11.9 to 26.3 |
162 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
25.2 |
19.7 to 31.5 |
598 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
19.1 |
13.2 to 26.9 |
162 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
27.8 |
20.2 to 37.0 |
159 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
25.4 |
19.2 to 32.7 |
277 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
19.3 |
15.6 to 23.6 |
707 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
26.3 |
19.1 to 35.0 |
165 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
22.4 |
13.7 to 34.4 |
147 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
18.0 |
12.5 to 25.1 |
197 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
19.2 |
12.9 to 27.5 |
176 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
20.9 |
14.3 to 29.6 |
170 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
12.3 |
8.0 to 18.7 |
178 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
16.1 |
11.1 to 22.7 |
206 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
25.9 |
18.9 to 34.4 |
177 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
28.2 |
21.3 to 36.3 |
227 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
21.8 |
15.0 to 30.6 |
185 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
41.2 |
32.3 to 50.6 |
190 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
30.8 |
23.5 to 39.1 |
205 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
38.4 |
30.1 to 47.4 |
201 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
43.8 |
34.3 to 53.8 |
194 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
54.3 |
43.3 to 64.8 |
143 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
30.0 |
21.5 to 40.3 |
190 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
28.0 |
20.9 to 36.5 |
186 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
47.1 |
38.4 to 55.9 |
177 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
22.8 |
15.9 to 31.7 |
185 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
34.2 |
28.2 to 40.8 |
360 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
44.3 |
34.0 to 55.2 |
133 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
31.9 |
25.1 to 39.7 |
227 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
17.0 |
11.8 to 23.8 |
186 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
26.7 |
19.1 to 36.0 |
171 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
23.5 |
16.6 to 32.1 |
194 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
17.5 |
11.4 to 25.8 |
161 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
32.2 |
24.3 to 41.4 |
167 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
42.5 |
34.0 to 51.5 |
176 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
37.3 |
28.4 to 47.1 |
217 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
46.2 |
37.8 to 54.8 |
195 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
31.9 |
23.5 to 41.5 |
158 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
36.6 |
27.4 to 46.8 |
152 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
16.2 |
10.4 to 24.5 |
196 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
20.1 |
13.5 to 28.8 |
185 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
19.1 |
12.6 to 27.8 |
170 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
31.0 |
23.0 to 40.4 |
167 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
28.3 |
20.9 to 37.2 |
167 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
46.9 |
39.1 to 54.8 |
221 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
26.7 |
18.9 to 36.3 |
183 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
33.2 |
24.9 to 42.6 |
176 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
38.2 |
31.8 to 45.1 |
311 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
46.3 |
36.4 to 56.5 |
144 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
33.1 |
25.1 to 42.3 |
167 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
31.9 |
24.2 to 40.8 |
199 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
32.1 |
24.4 to 41.0 |
159 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
29.3 |
22.2 to 37.5 |
228 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
30.2 |
22.7 to 39.1 |
186 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
23.0 |
16.7 to 30.7 |
206 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
35.9 |
28.8 to 43.6 |
405 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
49.9 |
40.6 to 59.3 |
186 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
34.1 |
26.4 to 42.8 |
219 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
41.6 |
29.9 to 54.4 |
123 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
31.4 |
29.7 to 33.2 |
10743 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
44.4 |
39.8 to 49.1 |
1198 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
34.5 |
29.3 to 40.0 |
494 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
34.5 |
30.0 to 39.3 |
1331 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
25.6 |
22.2 to 29.4 |
1510 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
31.2 |
28.0 to 34.7 |
1259 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
27.1 |
23.1 to 31.5 |
1573 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
23.8 |
19.7 to 28.3 |
717 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
25.7 |
21.8 to 30.1 |
1137 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
38.8 |
31.8 to 46.3 |
761 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
56.8 |
48.6 to 64.7 |
220 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
22.5 |
15.7 to 31.3 |
187 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
28.4 |
20.5 to 37.9 |
181 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
19.4 |
13.2 to 27.7 |
185 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
26.0 |
20.6 to 32.1 |
859 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
26.2 |
18.7 to 35.6 |
206 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
38.6 |
29.6 to 48.5 |
182 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
42.9 |
33.1 to 53.2 |
208 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
24.2 |
18.0 to 31.5 |
263 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
32.9 |
27.9 to 38.3 |
763 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
19.6 |
13.6 to 27.3 |
199 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
40.5 |
31.9 to 49.8 |
185 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
29.7 |
20.8 to 40.4 |
184 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
41.8 |
33.4 to 50.8 |
195 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
28.8 |
21.5 to 37.3 |
188 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
39.3 |
30.3 to 49.0 |
175 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
19.3 |
13.5 to 26.7 |
223 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
30.3 |
22.7 to 39.2 |
196 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
30.3 |
23.1 to 38.6 |
185 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
40.6 |
32.7 to 49.1 |
229 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
28.9 |
22.2 to 36.6 |
200 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
41.8 |
32.6 to 51.7 |
176 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
52.7 |
43.7 to 61.4 |
174 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
58.2 |
50.0 to 66.1 |
203 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
53.2 |
45.3 to 61.1 |
199 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
57.6 |
48.5 to 66.1 |
219 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
33.2 |
24.8 to 42.9 |
160 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
42.5 |
34.4 to 51.0 |
202 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
38.0 |
30.8 to 45.8 |
227 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
50.2 |
41.8 to 58.5 |
178 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
36.4 |
28.3 to 45.3 |
179 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
34.3 |
28.6 to 40.4 |
378 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
53.9 |
44.1 to 63.4 |
136 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
29.9 |
23.5 to 37.3 |
242 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
34.3 |
26.3 to 43.3 |
161 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
37.0 |
29.2 to 45.6 |
193 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
26.3 |
19.6 to 34.3 |
199 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
25.2 |
18.5 to 33.4 |
168 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
39.1 |
31.6 to 47.1 |
219 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
58.7 |
50.2 to 66.6 |
188 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
46.6 |
37.3 to 56.1 |
200 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
50.9 |
41.9 to 59.9 |
180 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
40.2 |
32.4 to 48.6 |
205 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
36.2 |
28.4 to 44.8 |
187 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
29.6 |
21.8 to 38.8 |
159 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
33.7 |
24.9 to 43.7 |
159 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
33.3 |
26.1 to 41.4 |
214 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
46.9 |
39.2 to 54.7 |
209 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
31.9 |
24.3 to 40.5 |
196 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
55.1 |
46.0 to 63.9 |
158 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
41.4 |
33.1 to 50.2 |
186 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
49.9 |
41.5 to 58.3 |
182 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
49.4 |
43.3 to 55.6 |
367 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
60.1 |
51.4 to 68.3 |
171 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
42.6 |
34.6 to 51.0 |
196 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
40.3 |
32.2 to 49.0 |
186 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
53.1 |
44.0 to 61.9 |
164 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
32.0 |
24.5 to 40.6 |
186 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
40.1 |
31.5 to 49.3 |
162 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
48.2 |
39.7 to 56.9 |
185 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
48.2 |
41.2 to 55.3 |
435 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
61.2 |
52.3 to 69.4 |
165 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
46.5 |
38.7 to 54.5 |
270 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
44.3 |
35.5 to 53.5 |
181 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
39.0 |
37.3 to 40.8 |
11367 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
55.2 |
50.3 to 59.9 |
1162 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
46.8 |
41.8 to 51.8 |
553 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
43.0 |
38.4 to 47.6 |
1447 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
33.7 |
30.2 to 37.4 |
1418 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
36.0 |
32.8 to 39.3 |
1311 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
34.7 |
31.5 to 38.1 |
2086 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
34.6 |
30.0 to 39.6 |
760 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
42.6 |
37.7 to 47.6 |
1094 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
41.3 |
33.9 to 49.1 |
779 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
66.6 |
59.2 to 73.3 |
218 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
26.4 |
19.4 to 34.8 |
188 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
28.6 |
21.4 to 37.0 |
187 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
26.0 |
18.7 to 34.8 |
159 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
32.9 |
28.6 to 37.4 |
1323 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
28.9 |
21.3 to 37.8 |
170 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
46.4 |
36.7 to 56.5 |
143 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
47.8 |
40.7 to 55.0 |
282 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
30.9 |
25.8 to 36.5 |
493 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
18.6 |
13.7 to 24.8 |
236 |
| HPV |
>=2 Doses, Males |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
41.9 |
37.1 to 47.0 |
757 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
33.7 |
25.6 to 42.9 |
186 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
56.9 |
48.9 to 64.5 |
215 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
32.0 |
23.0 to 42.5 |
214 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
41.2 |
33.7 to 49.2 |
208 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
36.6 |
28.8 to 45.2 |
180 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
42.1 |
34.3 to 50.4 |
194 |
| HPV |
>=2 Doses, Males |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
30.8 |
22.9 to 39.9 |
169 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2006 |
Age |
13-17 Years |
86.9 |
85.2 to 88.5 |
2882 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2006 |
Age |
13-17 Years |
99.4 |
97.6 to 99.9 |
170 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2006 |
Age |
13-17 Years |
86.3 |
78.9 to 91.4 |
227 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2006 |
Age |
13-17 Years |
86.7 |
82.0 to 90.3 |
347 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2006 |
Age |
13-17 Years |
88.0 |
84.4 to 90.9 |
608 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2006 |
Age |
13-17 Years |
86.1 |
81.1 to 89.9 |
458 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2006 |
Age |
13-17 Years |
88.6 |
83.5 to 92.3 |
268 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2006 |
Age |
13-17 Years |
87.1 |
80.2 to 91.8 |
165 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2006 |
Age |
13-17 Years |
88.5 |
79.4 to 93.9 |
118 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2006 |
Age |
13-17 Years |
83.2 |
77.1 to 88.0 |
362 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2006 |
Age |
13-17 Years |
79.3 |
70.3 to 86.1 |
159 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
88.9 |
87.3 to 90.4 |
2947 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
95.1 |
89.7 to 97.8 |
190 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-17 Years |
90.5 |
84.8 to 94.3 |
219 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
87.5 |
82.9 to 91.0 |
370 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
91.4 |
87.8 to 94.0 |
501 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
90.2 |
86.5 to 92.9 |
584 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-17 Years |
87.8 |
83.0 to 91.4 |
322 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-17 Years |
85.1 |
76.5 to 91.0 |
165 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-17 Years |
86.2 |
72.5 to 93.7 |
112 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
88.0 |
81.7 to 92.3 |
366 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2007 |
Age |
13-17 Years |
79.0 |
69.5 to 86.1 |
118 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
89.8 |
85.7 to 92.8 |
406 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
84.4 |
79.3 to 88.5 |
304 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
82.4 |
75.7 to 87.6 |
250 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
90.2 |
86.3 to 93.1 |
382 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
91.9 |
87.0 to 95.1 |
316 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
91.0 |
86.8 to 94.0 |
347 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
95.7 |
91.5 to 97.9 |
292 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
94.8 |
90.4 to 97.3 |
334 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
94.6 |
89.9 to 97.2 |
329 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
92.3 |
85.8 to 96.0 |
284 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
92.8 |
87.3 to 96.0 |
345 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
91.4 |
86.9 to 94.4 |
317 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
73.2 |
66.4 to 79.0 |
268 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
89.5 |
85.1 to 92.7 |
783 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
83.4 |
78.3 to 87.5 |
343 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
91.0 |
85.2 to 94.7 |
440 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
91.7 |
88.2 to 94.1 |
345 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
86.4 |
81.7 to 90.1 |
308 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
84.1 |
78.3 to 88.6 |
271 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
96.2 |
93.2 to 97.9 |
296 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
89.0 |
84.8 to 92.2 |
379 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
92.6 |
88.9 to 95.2 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
92.3 |
88.2 to 95.1 |
394 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
99.5 |
98.2 to 99.8 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
94.6 |
91.4 to 96.7 |
320 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
90.1 |
85.5 to 93.3 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2008 |
Age |
13-17 Years |
94.5 |
91.6 to 96.5 |
404 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
84.2 |
79.0 to 88.4 |
351 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
84.1 |
78.6 to 88.3 |
299 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
88.5 |
83.7 to 92.0 |
365 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
88.8 |
83.5 to 92.6 |
235 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
94.9 |
90.0 to 97.5 |
300 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
91.8 |
87.6 to 94.6 |
390 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
84.2 |
78.2 to 88.7 |
310 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
92.6 |
89.7 to 94.8 |
600 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
89.7 |
84.0 to 93.5 |
293 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
94.6 |
91.2 to 96.8 |
307 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
82.2 |
76.4 to 86.8 |
326 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
93.7 |
90.4 to 96.0 |
362 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
84.8 |
79.7 to 88.8 |
311 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
90.2 |
85.9 to 93.3 |
292 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
87.7 |
82.3 to 91.6 |
235 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
94.6 |
91.5 to 96.6 |
682 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
89.3 |
84.7 to 92.6 |
345 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
95.4 |
91.7 to 97.5 |
337 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
89.3 |
88.4 to 90.2 |
17835 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
97.0 |
95.9 to 97.9 |
1838 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
92.4 |
90.1 to 94.2 |
990 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
90.3 |
88.1 to 92.1 |
2306 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
90.3 |
88.2 to 92.0 |
2788 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
90.2 |
88.5 to 91.7 |
2361 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
84.1 |
80.1 to 87.4 |
2203 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
85.3 |
82.5 to 87.6 |
1295 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
87.7 |
85.2 to 89.8 |
1854 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
90.5 |
86.7 to 93.2 |
1118 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
96.3 |
92.9 to 98.1 |
297 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
90.9 |
87.0 to 93.7 |
367 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
86.7 |
82.1 to 90.2 |
344 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
85.9 |
80.6 to 89.9 |
360 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
81.6 |
75.6 to 86.5 |
840 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
82.2 |
75.6 to 87.2 |
269 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
87.0 |
80.2 to 91.7 |
233 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
81.1 |
73.9 to 86.6 |
338 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
80.6 |
76.9 to 83.8 |
1082 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2008 |
Age |
13-17 Years |
82.6 |
76.5 to 87.4 |
222 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
95.2 |
91.5 to 97.4 |
283 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
83.0 |
76.7 to 87.9 |
272 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
78.0 |
71.7 to 83.3 |
275 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
80.8 |
75.1 to 85.5 |
295 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
93.0 |
89.0 to 95.7 |
264 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
87.3 |
82.2 to 91.1 |
280 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
91.4 |
87.0 to 94.4 |
339 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
87.4 |
82.2 to 91.2 |
274 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
81.4 |
75.8 to 85.9 |
349 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
85.9 |
81.2 to 89.5 |
363 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
87.2 |
82.6 to 90.8 |
379 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
88.6 |
84.5 to 91.7 |
411 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
94.4 |
89.1 to 97.2 |
351 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
94.4 |
90.2 to 96.8 |
371 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
99.4 |
98.2 to 99.8 |
412 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
90.4 |
84.9 to 94.1 |
412 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
93.0 |
88.5 to 95.8 |
383 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
93.7 |
89.1 to 96.4 |
256 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
83.7 |
76.8 to 88.9 |
227 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
90.9 |
87.7 to 93.4 |
754 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
84.6 |
79.1 to 88.8 |
389 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
92.5 |
88.4 to 95.2 |
365 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
89.5 |
85.7 to 92.3 |
873 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
88.1 |
83.8 to 91.4 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
84.2 |
78.3 to 88.8 |
252 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
93.3 |
90.1 to 95.6 |
393 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
91.6 |
86.4 to 94.9 |
281 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
89.4 |
84.7 to 92.8 |
299 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
92.5 |
86.5 to 95.9 |
245 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
97.3 |
94.4 to 98.7 |
397 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
93.0 |
89.0 to 95.6 |
446 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
90.7 |
86.6 to 93.6 |
336 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
93.1 |
90.0 to 95.3 |
438 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
86.2 |
81.0 to 90.1 |
374 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
81.0 |
75.1 to 85.9 |
306 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
89.4 |
84.7 to 92.7 |
286 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
88.1 |
82.8 to 91.9 |
336 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
95.2 |
92.1 to 97.1 |
307 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
90.8 |
86.7 to 93.7 |
427 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
86.7 |
82.1 to 90.2 |
406 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
92.1 |
89.1 to 94.4 |
539 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
88.9 |
83.3 to 92.8 |
269 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
94.3 |
90.5 to 96.7 |
270 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
84.1 |
77.7 to 88.9 |
323 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
96.0 |
92.6 to 97.9 |
272 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
94.4 |
91.3 to 96.5 |
351 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
86.9 |
82.2 to 90.6 |
336 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
89.0 |
85.0 to 92.0 |
386 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
93.5 |
89.6 to 96.1 |
579 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
88.4 |
83.5 to 91.9 |
324 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
94.3 |
89.5 to 97.0 |
255 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
89.1 |
88.3 to 89.9 |
20066 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
95.6 |
94.0 to 96.8 |
2189 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
91.7 |
89.4 to 93.6 |
966 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
91.8 |
89.5 to 93.6 |
2214 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
89.7 |
87.8 to 91.4 |
2984 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
92.0 |
90.6 to 93.2 |
3105 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
83.8 |
80.8 to 86.4 |
2856 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
86.6 |
83.9 to 88.9 |
1250 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
87.9 |
85.6 to 89.9 |
1974 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
86.7 |
83.0 to 89.6 |
1320 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
96.9 |
93.7 to 98.5 |
409 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
89.7 |
85.3 to 92.9 |
299 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
88.5 |
83.1 to 92.4 |
271 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
85.2 |
79.5 to 89.6 |
397 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
81.5 |
77.1 to 85.2 |
1470 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
80.7 |
73.9 to 86.1 |
305 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
78.6 |
70.8 to 84.8 |
239 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
77.4 |
70.5 to 83.1 |
296 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
85.6 |
80.5 to 89.5 |
325 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
82.3 |
76.2 to 87.1 |
305 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-17 Years |
86.1 |
80.5 to 90.3 |
333 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
85.9 |
83.0 to 88.4 |
1208 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
87.3 |
82.1 to 91.2 |
339 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
96.5 |
94.2 to 97.9 |
426 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
90.2 |
84.9 to 93.8 |
358 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
84.5 |
79.4 to 88.6 |
321 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
79.9 |
73.2 to 85.3 |
249 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
91.8 |
87.9 to 94.5 |
345 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
87.4 |
83.2 to 90.7 |
375 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
93.5 |
89.3 to 96.1 |
296 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
87.8 |
82.6 to 91.7 |
294 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
84.5 |
79.2 to 88.6 |
331 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
89.2 |
84.7 to 92.4 |
313 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
87.9 |
82.2 to 92.0 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
92.6 |
88.6 to 95.2 |
317 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
97.6 |
94.5 to 99.0 |
408 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
94.1 |
90.2 to 96.6 |
348 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
98.4 |
96.6 to 99.3 |
355 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
94.2 |
89.6 to 96.9 |
344 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
94.8 |
91.8 to 96.7 |
373 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
93.7 |
90.2 to 96.1 |
320 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
84.2 |
79.0 to 88.3 |
318 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
93.7 |
91.1 to 95.6 |
739 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
88.8 |
83.9 to 92.3 |
366 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
95.0 |
91.8 to 97.0 |
373 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
92.6 |
88.6 to 95.2 |
316 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
83.0 |
77.2 to 87.5 |
264 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
91.3 |
87.4 to 94.0 |
373 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
93.0 |
88.9 to 95.7 |
309 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
92.6 |
88.3 to 95.5 |
347 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
93.7 |
89.4 to 96.3 |
312 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
95.1 |
91.9 to 97.0 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
93.7 |
87.5 to 96.9 |
306 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
93.6 |
88.7 to 96.5 |
304 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
93.5 |
88.9 to 96.3 |
310 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
87.8 |
82.6 to 91.7 |
354 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
88.1 |
83.6 to 91.4 |
347 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
88.8 |
84.1 to 92.3 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
92.8 |
88.9 to 95.5 |
307 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
88.8 |
83.8 to 92.4 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
97.2 |
94.6 to 98.6 |
350 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
92.6 |
88.2 to 95.4 |
399 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
85.8 |
80.3 to 89.9 |
332 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
94.4 |
91.2 to 96.5 |
701 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
94.5 |
90.6 to 96.8 |
388 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
94.4 |
89.1 to 97.2 |
313 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
85.7 |
80.8 to 89.5 |
366 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
94.2 |
90.6 to 96.5 |
299 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
90.7 |
86.5 to 93.7 |
302 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
87.9 |
83.1 to 91.5 |
300 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
88.6 |
83.4 to 92.3 |
302 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
96.2 |
94.2 to 97.6 |
742 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
90.9 |
86.8 to 93.8 |
371 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
97.0 |
94.6 to 98.4 |
371 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
90.5 |
89.6 to 91.3 |
19257 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
95.4 |
92.8 to 97.1 |
2026 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
93.8 |
91.4 to 95.6 |
1100 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
92.3 |
90.5 to 93.8 |
2436 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
91.8 |
90.3 to 93.2 |
2679 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
92.5 |
91.0 to 93.8 |
2248 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
86.0 |
83.4 to 88.3 |
3001 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
88.3 |
85.9 to 90.3 |
1291 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
89.9 |
87.8 to 91.7 |
1890 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
87.7 |
83.3 to 91.0 |
1311 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
97.0 |
93.4 to 98.7 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
89.4 |
84.9 to 92.7 |
317 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
84.6 |
78.5 to 89.2 |
321 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
91.6 |
87.3 to 94.5 |
320 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
84.3 |
80.4 to 87.5 |
1709 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
85.6 |
80.9 to 89.2 |
382 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
82.3 |
76.7 to 86.8 |
413 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
81.4 |
73.9 to 87.0 |
304 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
87.5 |
82.7 to 91.1 |
313 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
84.6 |
79.2 to 88.7 |
297 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
90.9 |
85.7 to 94.3 |
231 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
86.2 |
83.4 to 88.6 |
1275 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
86.7 |
81.9 to 90.3 |
325 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
96.8 |
94.1 to 98.3 |
320 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
86.0 |
80.1 to 90.3 |
332 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
85.2 |
80.5 to 89.0 |
361 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
79.7 |
74.3 to 84.3 |
321 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
90.3 |
85.5 to 93.6 |
277 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
90.0 |
85.5 to 93.2 |
295 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
89.1 |
83.6 to 92.9 |
403 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
88.6 |
82.6 to 92.7 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
88.2 |
82.5 to 92.2 |
416 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
87.7 |
82.2 to 91.7 |
350 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
90.3 |
86.7 to 93.0 |
583 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
88.1 |
81.9 to 92.4 |
431 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
96.1 |
92.2 to 98.1 |
453 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
94.1 |
88.8 to 97.0 |
442 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
96.9 |
93.0 to 98.7 |
415 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
93.9 |
89.8 to 96.4 |
483 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
97.6 |
95.6 to 98.7 |
425 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
95.2 |
91.8 to 97.2 |
339 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
79.9 |
72.9 to 85.5 |
385 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
93.7 |
91.4 to 95.5 |
848 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
92.0 |
88.3 to 94.7 |
407 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
94.2 |
91.2 to 96.1 |
441 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
95.2 |
91.1 to 97.4 |
430 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
88.3 |
82.3 to 92.5 |
359 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
86.6 |
79.7 to 91.4 |
399 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
95.3 |
92.0 to 97.3 |
382 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
95.8 |
92.2 to 97.8 |
473 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
94.9 |
91.6 to 96.9 |
411 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
93.4 |
89.3 to 96.0 |
516 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
95.4 |
91.4 to 97.6 |
365 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
94.3 |
91.1 to 96.4 |
398 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
90.3 |
84.3 to 94.2 |
327 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
94.8 |
90.8 to 97.2 |
345 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
85.5 |
79.7 to 89.9 |
402 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
89.1 |
82.5 to 93.5 |
385 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
94.0 |
89.6 to 96.6 |
368 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
86.0 |
79.5 to 90.6 |
412 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
97.0 |
94.4 to 98.4 |
385 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
93.4 |
89.4 to 96.0 |
432 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
90.2 |
85.1 to 93.6 |
431 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
93.4 |
91.0 to 95.2 |
840 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
90.8 |
87.0 to 93.6 |
435 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
95.0 |
91.6 to 97.1 |
405 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
89.4 |
84.6 to 92.8 |
347 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
90.7 |
83.6 to 94.9 |
314 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
86.5 |
81.1 to 90.6 |
381 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
91.2 |
86.6 to 94.3 |
360 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
86.2 |
79.6 to 90.9 |
362 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
93.3 |
89.3 to 95.9 |
880 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
91.4 |
86.8 to 94.5 |
387 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
93.5 |
88.9 to 96.3 |
493 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
91.1 |
90.4 to 91.8 |
23564 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
95.7 |
93.8 to 97.0 |
2467 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
93.4 |
91.4 to 95.0 |
1272 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
91.9 |
89.9 to 93.5 |
3073 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
92.7 |
91.2 to 93.9 |
3171 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
91.8 |
90.1 to 93.2 |
2800 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
89.4 |
87.3 to 91.1 |
3838 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
87.5 |
84.4 to 90.0 |
1528 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
88.3 |
85.1 to 91.0 |
2242 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
89.9 |
87.0 to 92.2 |
1750 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
96.6 |
94.1 to 98.1 |
449 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
91.7 |
87.0 to 94.8 |
362 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
90.6 |
80.3 to 95.8 |
355 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
86.6 |
80.8 to 90.8 |
424 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
88.1 |
85.2 to 90.6 |
2224 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
93.4 |
89.9 to 95.8 |
448 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
87.7 |
83.1 to 91.2 |
490 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
84.8 |
78.8 to 89.4 |
441 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
88.4 |
83.8 to 91.9 |
355 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
88.0 |
84.0 to 91.2 |
490 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
94.0 |
91.4 to 95.8 |
485 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
86.3 |
82.9 to 89.0 |
1423 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
87.4 |
80.7 to 92.0 |
393 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
92.5 |
87.5 to 95.6 |
404 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
90.6 |
86.5 to 93.5 |
417 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
87.6 |
82.2 to 91.6 |
346 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
79.8 |
74.4 to 84.3 |
403 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
90.9 |
84.8 to 94.7 |
416 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
88.6 |
81.9 to 93.0 |
364 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
95.5 |
91.2 to 97.8 |
317 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
90.6 |
86.6 to 93.5 |
340 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
85.4 |
79.1 to 90.1 |
360 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
89.5 |
84.1 to 93.2 |
322 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
90.7 |
86.4 to 93.8 |
430 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
94.6 |
90.4 to 97.0 |
311 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
96.6 |
93.1 to 98.3 |
323 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
95.7 |
92.0 to 97.8 |
341 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
93.6 |
88.6 to 96.4 |
342 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
96.7 |
93.2 to 98.4 |
325 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
96.1 |
92.0 to 98.1 |
328 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
90.9 |
86.3 to 94.1 |
342 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
84.5 |
79.1 to 88.7 |
357 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
87.8 |
82.4 to 91.7 |
632 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
88.4 |
82.7 to 92.4 |
287 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
87.6 |
80.9 to 92.2 |
345 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
91.6 |
86.9 to 94.8 |
341 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
91.5 |
86.7 to 94.7 |
325 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
88.6 |
83.2 to 92.4 |
340 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
93.0 |
88.4 to 95.8 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
93.6 |
90.0 to 96.0 |
370 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
94.1 |
90.6 to 96.3 |
319 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
92.6 |
87.2 to 95.8 |
325 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
95.2 |
90.7 to 97.6 |
347 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
95.0 |
91.2 to 97.2 |
368 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
94.3 |
90.7 to 96.5 |
322 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
95.6 |
92.6 to 97.4 |
321 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
87.0 |
80.4 to 91.7 |
292 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
88.9 |
84.2 to 92.3 |
325 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
90.6 |
85.5 to 94.0 |
328 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
94.0 |
90.7 to 96.2 |
329 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
97.5 |
94.7 to 98.8 |
278 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
93.7 |
89.2 to 96.3 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
87.2 |
81.6 to 91.2 |
331 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
93.8 |
90.6 to 96.0 |
627 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
89.4 |
84.1 to 93.0 |
312 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
96.6 |
91.2 to 98.7 |
315 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
93.2 |
89.2 to 95.8 |
347 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
89.8 |
83.7 to 93.8 |
324 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
86.6 |
79.9 to 91.4 |
327 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
93.1 |
89.7 to 95.4 |
322 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
92.6 |
88.5 to 95.3 |
381 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
93.1 |
89.2 to 95.7 |
741 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
90.9 |
85.2 to 94.6 |
348 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
93.4 |
88.9 to 96.1 |
393 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
91.4 |
90.6 to 92.1 |
19199 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
95.9 |
93.9 to 97.2 |
1916 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
93.8 |
91.3 to 95.6 |
957 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
91.5 |
89.2 to 93.4 |
2365 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
94.4 |
93.1 to 95.5 |
2612 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
90.8 |
88.6 to 92.5 |
2297 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
88.4 |
86.3 to 90.2 |
2939 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
88.8 |
85.7 to 91.3 |
1285 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
89.7 |
87.2 to 91.8 |
1936 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
90.2 |
86.8 to 92.8 |
1461 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
97.0 |
93.6 to 98.7 |
327 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
90.1 |
85.0 to 93.6 |
310 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
89.5 |
84.5 to 93.0 |
298 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
90.0 |
83.8 to 94.0 |
331 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
86.9 |
83.8 to 89.4 |
1594 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
88.6 |
82.2 to 92.9 |
346 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
84.0 |
77.7 to 88.7 |
393 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
87.0 |
83.4 to 89.9 |
855 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
91.7 |
88.8 to 93.9 |
547 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
88.3 |
85.0 to 90.9 |
1431 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
82.6 |
76.5 to 87.4 |
345 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
95.9 |
93.0 to 97.6 |
322 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
89.1 |
83.6 to 92.9 |
334 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
86.6 |
80.5 to 91.1 |
353 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
85.0 |
79.1 to 89.5 |
282 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
94.0 |
90.3 to 96.3 |
307 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
91.0 |
86.6 to 94.1 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
93.4 |
89.4 to 96.0 |
317 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
92.0 |
87.4 to 95.0 |
320 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
85.4 |
80.2 to 89.4 |
359 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
89.5 |
85.0 to 92.7 |
312 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
91.5 |
86.2 to 94.9 |
309 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
92.4 |
88.3 to 95.2 |
331 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
97.3 |
93.4 to 98.9 |
328 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
95.3 |
92.2 to 97.2 |
348 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
85.9 |
75.0 to 92.5 |
192 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
93.5 |
88.5 to 96.5 |
323 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
96.4 |
91.6 to 98.5 |
253 |
| MMR |
>=2 Doses |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
84.8 |
79.7 to 88.8 |
363 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
90.4 |
84.9 to 94.1 |
315 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
85.2 |
78.9 to 89.9 |
272 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
93.5 |
90.5 to 95.6 |
558 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
88.8 |
82.3 to 93.2 |
209 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
94.6 |
90.9 to 96.8 |
349 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
93.7 |
89.8 to 96.2 |
381 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
90.2 |
85.5 to 93.5 |
383 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
86.9 |
81.6 to 90.8 |
287 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
92.7 |
88.1 to 95.7 |
291 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
97.4 |
93.6 to 99.0 |
298 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
88.8 |
83.6 to 92.5 |
343 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
93.8 |
88.6 to 96.7 |
320 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
95.8 |
92.3 to 97.7 |
393 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
94.0 |
89.6 to 96.6 |
307 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
94.0 |
89.8 to 96.5 |
369 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
92.3 |
87.4 to 95.4 |
284 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
88.3 |
82.6 to 92.4 |
280 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
90.5 |
85.6 to 93.8 |
320 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
92.3 |
88.4 to 94.9 |
301 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
92.8 |
88.5 to 95.6 |
335 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
97.4 |
94.0 to 98.9 |
345 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
94.9 |
90.5 to 97.3 |
322 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
92.3 |
88.7 to 94.9 |
357 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
93.3 |
90.3 to 95.4 |
710 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
90.9 |
85.8 to 94.3 |
300 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
94.8 |
90.6 to 97.1 |
410 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
87.1 |
81.6 to 91.1 |
306 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
96.1 |
93.7 to 97.7 |
344 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
92.9 |
88.7 to 95.6 |
319 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
89.5 |
85.5 to 92.4 |
426 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
92.3 |
88.5 to 94.9 |
364 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
93.8 |
90.4 to 96.1 |
751 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
90.2 |
84.6 to 93.9 |
307 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
94.3 |
90.3 to 96.7 |
444 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
91.8 |
91.0 to 92.6 |
18264 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
95.7 |
94.0 to 96.9 |
2050 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
93.8 |
91.5 to 95.5 |
1032 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
92.6 |
90.4 to 94.4 |
2241 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
92.2 |
90.4 to 93.6 |
2374 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
93.6 |
92.1 to 94.8 |
2264 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
89.0 |
86.3 to 91.2 |
2505 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
89.0 |
86.2 to 91.2 |
1251 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
91.0 |
88.7 to 92.9 |
1913 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
90.7 |
86.8 to 93.6 |
1318 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
95.6 |
91.6 to 97.7 |
315 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
91.0 |
86.5 to 94.2 |
296 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
94.1 |
89.9 to 96.6 |
292 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
88.4 |
82.9 to 92.2 |
304 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
87.3 |
83.3 to 90.4 |
1112 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
87.0 |
81.9 to 90.8 |
317 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
86.8 |
80.6 to 91.3 |
278 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
87.3 |
82.7 to 90.9 |
517 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
92.0 |
88.4 to 94.6 |
332 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
90.0 |
87.4 to 92.2 |
1316 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
87.5 |
82.1 to 91.4 |
301 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
94.5 |
91.1 to 96.7 |
326 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
92.0 |
85.5 to 95.8 |
302 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
89.9 |
85.0 to 93.2 |
360 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
83.2 |
77.9 to 87.5 |
328 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
93.9 |
89.8 to 96.4 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
90.6 |
85.8 to 93.9 |
325 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
95.0 |
91.4 to 97.2 |
378 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
89.0 |
84.5 to 92.3 |
377 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
83.5 |
77.5 to 88.1 |
421 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
88.6 |
83.9 to 92.1 |
368 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
91.4 |
87.3 to 94.3 |
356 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
92.1 |
88.1 to 94.8 |
394 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
97.7 |
94.6 to 99.0 |
386 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
95.6 |
91.9 to 97.7 |
374 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
92.7 |
87.5 to 95.9 |
285 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
94.1 |
90.0 to 96.6 |
363 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
96.4 |
93.2 to 98.1 |
373 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
88.6 |
83.5 to 92.2 |
363 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
84.5 |
79.0 to 88.8 |
341 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
93.1 |
90.2 to 95.1 |
709 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
90.1 |
84.1 to 94.0 |
274 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
93.7 |
90.3 to 96.0 |
435 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
93.7 |
89.6 to 96.2 |
370 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
94.2 |
90.5 to 96.5 |
328 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
84.6 |
78.9 to 88.9 |
352 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
93.4 |
89.1 to 96.1 |
335 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
91.8 |
87.2 to 94.9 |
335 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
95.0 |
91.3 to 97.2 |
341 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
91.6 |
86.5 to 94.9 |
409 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
95.3 |
91.9 to 97.3 |
358 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
92.2 |
87.0 to 95.4 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
93.9 |
88.9 to 96.8 |
286 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
93.4 |
89.6 to 95.9 |
356 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
83.9 |
77.8 to 88.5 |
361 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
85.0 |
80.0 to 88.9 |
367 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
94.5 |
90.3 to 96.9 |
321 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
87.4 |
83.0 to 90.9 |
351 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
97.2 |
94.8 to 98.5 |
402 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
94.8 |
90.3 to 97.3 |
328 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
84.7 |
79.0 to 89.2 |
378 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
91.6 |
88.2 to 94.1 |
594 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
91.0 |
85.8 to 94.4 |
288 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
92.0 |
87.1 to 95.1 |
306 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
88.3 |
83.3 to 92.0 |
372 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
91.3 |
86.2 to 94.7 |
327 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
88.2 |
83.3 to 91.7 |
430 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
92.1 |
88.4 to 94.7 |
356 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
86.1 |
80.6 to 90.2 |
399 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
92.8 |
88.9 to 95.4 |
785 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
96.6 |
92.9 to 98.4 |
343 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
92.3 |
87.9 to 95.2 |
442 |
| MMR |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
91.2 |
84.6 to 95.1 |
230 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
90.7 |
89.9 to 91.4 |
20827 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
96.2 |
94.7 to 97.4 |
2268 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
92.6 |
90.1 to 94.6 |
922 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
90.8 |
88.4 to 92.7 |
2553 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
92.9 |
91.5 to 94.2 |
2896 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
92.1 |
90.5 to 93.5 |
2465 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
86.1 |
83.3 to 88.6 |
3089 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
87.7 |
84.8 to 90.2 |
1362 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
88.5 |
86.2 to 90.5 |
2290 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
90.0 |
86.9 to 92.5 |
1491 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
97.9 |
95.5 to 99.0 |
414 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
85.8 |
80.4 to 90.0 |
380 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
94.8 |
90.8 to 97.1 |
358 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
93.9 |
90.3 to 96.2 |
339 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
84.3 |
80.2 to 87.7 |
1652 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
88.0 |
83.8 to 91.3 |
385 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
81.1 |
74.5 to 86.2 |
379 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
78.9 |
72.1 to 84.4 |
397 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
84.5 |
79.6 to 88.4 |
491 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
87.1 |
84.4 to 89.5 |
1491 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
82.0 |
76.6 to 86.3 |
398 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
95.2 |
91.3 to 97.4 |
367 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
88.4 |
82.4 to 92.6 |
350 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
88.2 |
83.7 to 91.6 |
374 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
81.2 |
75.4 to 85.8 |
350 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
94.3 |
90.0 to 96.8 |
340 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
90.1 |
86.1 to 93.1 |
446 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
93.7 |
89.3 to 96.4 |
361 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
88.4 |
83.9 to 91.8 |
350 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
85.4 |
80.5 to 89.3 |
444 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
90.2 |
85.6 to 93.4 |
362 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
87.6 |
82.2 to 91.6 |
350 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
92.3 |
88.6 to 94.9 |
354 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
96.6 |
93.4 to 98.3 |
358 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
94.0 |
90.0 to 96.5 |
360 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
90.0 |
85.3 to 93.3 |
418 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
93.4 |
88.5 to 96.3 |
321 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
95.5 |
91.9 to 97.5 |
374 |
| MMR |
>=2 Doses |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
82.5 |
77.7 to 86.5 |
419 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
91.5 |
87.5 to 94.3 |
340 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
80.4 |
74.7 to 85.0 |
356 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
89.9 |
86.8 to 92.3 |
779 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
91.6 |
87.1 to 94.6 |
283 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
89.5 |
85.8 to 92.4 |
496 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
94.1 |
90.6 to 96.3 |
328 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
94.4 |
91.3 to 96.5 |
383 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
87.6 |
82.6 to 91.4 |
375 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
93.2 |
89.5 to 95.6 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
94.7 |
91.6 to 96.7 |
382 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
95.1 |
91.2 to 97.3 |
374 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
93.6 |
88.7 to 96.5 |
403 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
97.1 |
94.2 to 98.6 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
95.1 |
91.5 to 97.2 |
373 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
95.8 |
92.3 to 97.7 |
366 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
92.3 |
88.5 to 94.9 |
364 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
85.9 |
79.9 to 90.3 |
300 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
90.1 |
86.2 to 93.0 |
406 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
92.2 |
88.7 to 94.8 |
393 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
90.0 |
85.3 to 93.4 |
372 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
97.1 |
93.6 to 98.7 |
295 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
90.2 |
85.6 to 93.4 |
364 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
88.8 |
84.3 to 92.1 |
396 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
94.6 |
92.6 to 96.1 |
665 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
90.5 |
86.2 to 93.6 |
313 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
97.2 |
95.3 to 98.3 |
352 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
91.5 |
87.0 to 94.5 |
358 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
89.1 |
83.8 to 92.8 |
323 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
90.0 |
85.4 to 93.2 |
332 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
93.4 |
89.9 to 95.8 |
291 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
91.3 |
86.8 to 94.4 |
353 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
92.5 |
88.9 to 94.9 |
832 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
91.5 |
87.5 to 94.3 |
340 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
92.6 |
88.5 to 95.3 |
492 |
| MMR |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
94.5 |
90.4 to 96.9 |
339 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
90.7 |
89.9 to 91.4 |
21875 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
96.8 |
95.4 to 97.8 |
2188 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
93.1 |
91.2 to 94.7 |
1029 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
90.6 |
88.2 to 92.5 |
2742 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
92.9 |
91.3 to 94.2 |
2793 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
92.6 |
91.2 to 93.8 |
2543 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
87.1 |
85.2 to 88.8 |
4048 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
89.0 |
86.3 to 91.3 |
1451 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
89.6 |
87.4 to 91.4 |
2120 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
87.6 |
83.4 to 90.8 |
1506 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
97.4 |
95.1 to 98.6 |
419 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
89.5 |
84.8 to 92.8 |
360 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
90.4 |
85.7 to 93.7 |
349 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
91.1 |
86.3 to 94.3 |
325 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
84.7 |
82.0 to 87.1 |
2617 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
84.7 |
79.5 to 88.8 |
368 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
83.2 |
76.8 to 88.0 |
259 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
77.9 |
73.0 to 82.1 |
558 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
85.3 |
81.9 to 88.1 |
946 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
88.6 |
85.0 to 91.5 |
458 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
87.9 |
85.3 to 90.2 |
1455 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
84.9 |
80.0 to 88.8 |
357 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
97.0 |
94.8 to 98.3 |
404 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
87.0 |
80.5 to 91.6 |
385 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
88.1 |
83.5 to 91.5 |
396 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
82.1 |
76.9 to 86.4 |
344 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
94.9 |
91.3 to 97.1 |
365 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
92.1 |
88.0 to 94.9 |
331 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
93.7 |
89.7 to 96.2 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
91.6 |
87.5 to 94.4 |
392 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
81.7 |
75.6 to 86.6 |
329 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
89.5 |
85.2 to 92.7 |
352 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
88.7 |
83.7 to 92.3 |
327 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
91.5 |
86.8 to 94.6 |
322 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
98.7 |
96.7 to 99.5 |
357 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
94.8 |
90.9 to 97.1 |
375 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
94.8 |
91.3 to 96.9 |
377 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
95.6 |
92.9 to 97.3 |
376 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
97.1 |
93.7 to 98.6 |
367 |
| MMR |
>=2 Doses |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
75.3 |
70.3 to 79.7 |
535 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
93.0 |
89.1 to 95.6 |
317 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
85.7 |
81.0 to 89.4 |
358 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
93.5 |
90.8 to 95.4 |
605 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
92.6 |
86.6 to 96.0 |
157 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
93.7 |
90.5 to 95.8 |
448 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
93.3 |
89.5 to 95.7 |
350 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
94.0 |
90.9 to 96.0 |
382 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
89.8 |
85.2 to 93.1 |
322 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
93.0 |
88.9 to 95.7 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
96.5 |
93.2 to 98.3 |
336 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
95.6 |
92.6 to 97.5 |
347 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
89.2 |
84.4 to 92.7 |
451 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
97.2 |
94.3 to 98.7 |
374 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
96.4 |
93.6 to 97.9 |
283 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
91.3 |
86.7 to 94.4 |
375 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
94.7 |
91.2 to 96.8 |
377 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
87.2 |
82.4 to 90.9 |
360 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
86.6 |
81.3 to 90.6 |
375 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
89.7 |
84.7 to 93.2 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
89.5 |
84.5 to 93.0 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
98.5 |
95.9 to 99.5 |
313 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
94.1 |
90.7 to 96.2 |
422 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
90.3 |
86.2 to 93.2 |
374 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
92.9 |
90.2 to 94.9 |
655 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
88.0 |
82.3 to 92.0 |
291 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
96.0 |
93.1 to 97.7 |
364 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
87.5 |
82.2 to 91.4 |
366 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
92.7 |
87.7 to 95.7 |
293 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
93.3 |
89.0 to 96.0 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
90.5 |
85.7 to 93.8 |
281 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
88.5 |
83.2 to 92.3 |
318 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
93.4 |
90.7 to 95.3 |
875 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
93.0 |
89.5 to 95.4 |
349 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
93.4 |
90.4 to 95.5 |
526 |
| MMR |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
92.7 |
88.7 to 95.3 |
405 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
90.9 |
90.1 to 91.6 |
20475 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
97.4 |
96.2 to 98.3 |
2097 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
93.3 |
91.2 to 94.9 |
1077 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
90.2 |
88.0 to 92.0 |
2842 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
93.3 |
91.9 to 94.4 |
2757 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
94.0 |
92.7 to 95.1 |
2284 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
86.2 |
84.1 to 88.1 |
3270 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
89.6 |
87.3 to 91.6 |
1394 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
88.0 |
85.4 to 90.2 |
2022 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
87.9 |
84.0 to 90.9 |
1303 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
96.9 |
92.9 to 98.7 |
326 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
89.9 |
85.3 to 93.2 |
314 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
96.7 |
93.4 to 98.4 |
342 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
91.1 |
85.5 to 94.7 |
291 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
83.5 |
80.5 to 86.1 |
1927 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
86.8 |
81.8 to 90.6 |
334 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
77.5 |
68.8 to 84.4 |
225 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
81.0 |
74.1 to 86.3 |
294 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
85.7 |
80.2 to 89.9 |
345 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
83.9 |
80.0 to 87.2 |
729 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
84.8 |
80.1 to 88.5 |
428 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
88.5 |
85.6 to 90.8 |
1429 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
80.0 |
74.3 to 84.8 |
317 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
93.7 |
89.7 to 96.2 |
380 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
86.1 |
79.9 to 90.7 |
451 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
88.9 |
84.0 to 92.5 |
361 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
86.8 |
81.7 to 90.6 |
313 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
96.4 |
93.2 to 98.1 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
92.1 |
88.4 to 94.6 |
373 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
93.4 |
90.0 to 95.8 |
367 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
91.4 |
87.7 to 94.1 |
349 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
89.2 |
84.7 to 92.5 |
335 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
91.5 |
87.5 to 94.2 |
357 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
89.8 |
84.1 to 93.5 |
306 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
90.2 |
85.4 to 93.6 |
354 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
96.9 |
93.5 to 98.5 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
95.1 |
91.6 to 97.2 |
350 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
92.9 |
87.8 to 95.9 |
318 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
93.6 |
89.1 to 96.3 |
415 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
97.7 |
94.7 to 99.1 |
343 |
| MMR |
>=2 Doses |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
80.2 |
74.9 to 84.5 |
382 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
90.2 |
85.5 to 93.5 |
314 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
87.8 |
82.2 to 91.8 |
353 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
93.1 |
90.6 to 95.0 |
683 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
86.2 |
78.4 to 91.5 |
204 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
94.6 |
91.9 to 96.5 |
479 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
95.7 |
92.0 to 97.8 |
334 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
96.0 |
93.4 to 97.6 |
343 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
89.4 |
84.5 to 92.8 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
91.6 |
87.1 to 94.7 |
372 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
96.6 |
93.3 to 98.3 |
341 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
96.3 |
93.6 to 97.8 |
347 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
92.4 |
86.8 to 95.7 |
470 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
97.5 |
94.5 to 98.8 |
412 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
97.4 |
94.1 to 98.9 |
328 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
95.1 |
91.9 to 97.1 |
356 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
96.2 |
93.7 to 97.7 |
347 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
87.6 |
83.1 to 91.1 |
335 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
95.4 |
91.6 to 97.5 |
326 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
93.4 |
88.8 to 96.2 |
324 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
92.4 |
88.3 to 95.2 |
344 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
97.0 |
93.2 to 98.7 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
88.5 |
83.4 to 92.1 |
366 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
88.3 |
83.6 to 91.8 |
362 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
94.1 |
91.7 to 95.9 |
651 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
92.7 |
88.8 to 95.3 |
281 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
95.1 |
91.5 to 97.2 |
370 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
93.0 |
89.2 to 95.5 |
336 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
93.0 |
89.5 to 95.3 |
379 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
94.2 |
91.4 to 96.1 |
408 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
89.9 |
85.5 to 93.1 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
89.8 |
85.3 to 93.1 |
359 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
95.7 |
93.3 to 97.2 |
851 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
94.5 |
90.5 to 96.9 |
362 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
95.8 |
93.1 to 97.5 |
489 |
| MMR |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
92.1 |
91.3 to 92.8 |
20949 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
96.9 |
95.5 to 97.9 |
2107 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
92.3 |
90.0 to 94.1 |
1017 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
94.5 |
92.8 to 95.8 |
2745 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
93.7 |
92.2 to 94.9 |
2846 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
95.0 |
94.0 to 95.9 |
2433 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
87.0 |
85.1 to 88.7 |
3654 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
90.7 |
88.4 to 92.5 |
1340 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
90.4 |
87.9 to 92.4 |
2108 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
89.9 |
85.6 to 93.0 |
1299 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
95.6 |
92.0 to 97.6 |
319 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
89.9 |
84.9 to 93.4 |
328 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
94.6 |
91.0 to 96.9 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
91.3 |
86.8 to 94.4 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
84.7 |
82.1 to 87.0 |
2256 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
83.3 |
77.6 to 87.7 |
336 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
83.8 |
76.3 to 89.3 |
187 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
77.8 |
70.4 to 83.8 |
263 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
84.6 |
78.8 to 89.0 |
320 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
86.5 |
81.5 to 90.3 |
304 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
85.7 |
82.1 to 88.7 |
846 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
90.5 |
88.1 to 92.5 |
1400 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
87.6 |
82.7 to 91.2 |
356 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
93.9 |
89.6 to 96.5 |
366 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
96.2 |
91.9 to 98.3 |
413 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
91.5 |
87.4 to 94.3 |
339 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
85.0 |
80.0 to 89.0 |
343 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
96.2 |
93.2 to 97.9 |
324 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
92.7 |
88.7 to 95.3 |
360 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
92.8 |
87.6 to 95.9 |
327 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
91.2 |
87.1 to 94.0 |
392 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
88.3 |
82.9 to 92.2 |
288 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
92.0 |
87.5 to 95.0 |
308 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
91.1 |
86.7 to 94.2 |
356 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
92.7 |
87.2 to 96.0 |
278 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
95.9 |
92.3 to 97.8 |
293 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
95.7 |
92.2 to 97.6 |
306 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
96.1 |
91.7 to 98.2 |
337 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
97.0 |
93.4 to 98.7 |
345 |
| MMR |
>=2 Doses |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
76.3 |
69.9 to 81.8 |
309 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
93.7 |
90.5 to 95.9 |
327 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
88.5 |
83.6 to 92.1 |
291 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
94.6 |
92.4 to 96.3 |
721 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
94.9 |
89.1 to 97.6 |
192 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
94.6 |
92.0 to 96.4 |
529 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
95.9 |
92.6 to 97.8 |
296 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
96.0 |
92.9 to 97.8 |
280 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
86.5 |
80.5 to 90.9 |
297 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
91.7 |
86.9 to 94.9 |
270 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
94.8 |
90.4 to 97.3 |
284 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
94.6 |
90.5 to 97.0 |
317 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
94.1 |
89.9 to 96.6 |
393 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
97.9 |
93.9 to 99.3 |
328 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
91.0 |
85.6 to 94.5 |
313 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
97.1 |
94.2 to 98.5 |
285 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
94.2 |
89.9 to 96.7 |
285 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
89.4 |
84.8 to 92.7 |
319 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
92.3 |
88.2 to 95.1 |
290 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
93.1 |
88.8 to 95.8 |
295 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
89.0 |
84.3 to 92.5 |
334 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
98.8 |
96.9 to 99.5 |
303 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
90.5 |
85.2 to 94.1 |
351 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
90.4 |
85.6 to 93.6 |
295 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
95.2 |
92.4 to 97.0 |
535 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
94.9 |
91.4 to 97.1 |
261 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
95.4 |
90.9 to 97.7 |
274 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
92.5 |
88.2 to 95.3 |
341 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
96.4 |
92.4 to 98.4 |
287 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
89.5 |
84.7 to 93.0 |
329 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
87.7 |
82.9 to 91.3 |
360 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
93.2 |
88.2 to 96.2 |
297 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
96.2 |
93.6 to 97.8 |
649 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
94.7 |
89.7 to 97.4 |
237 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
96.4 |
93.4 to 98.0 |
412 |
| MMR |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
91.9 |
91.2 to 92.6 |
18700 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
97.1 |
95.5 to 98.1 |
1902 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
93.7 |
91.2 to 95.4 |
886 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
93.8 |
92.0 to 95.2 |
2295 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
94.5 |
93.1 to 95.6 |
2507 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
93.2 |
91.6 to 94.5 |
2276 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
85.6 |
83.5 to 87.5 |
3326 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
90.8 |
88.4 to 92.7 |
1191 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
92.1 |
89.5 to 94.1 |
1746 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
90.7 |
87.3 to 93.2 |
1305 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
97.8 |
95.5 to 99.0 |
337 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
92.5 |
88.1 to 95.4 |
318 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
97.2 |
94.9 to 98.5 |
340 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
93.6 |
89.1 to 96.3 |
284 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
83.1 |
80.2 to 85.6 |
2079 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
85.8 |
80.3 to 90.0 |
298 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
82.2 |
74.7 to 87.9 |
186 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
78.3 |
71.2 to 83.9 |
314 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
85.1 |
80.0 to 89.1 |
364 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
82.9 |
79.2 to 86.1 |
917 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
89.8 |
86.7 to 92.3 |
1266 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
89.5 |
84.7 to 93.0 |
310 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
96.0 |
93.3 to 97.6 |
324 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
92.3 |
87.0 to 95.5 |
327 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
88.3 |
82.6 to 92.3 |
286 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
86.5 |
81.7 to 90.2 |
337 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
93.9 |
89.8 to 96.4 |
332 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
90.0 |
84.9 to 93.5 |
241 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
95.3 |
91.4 to 97.4 |
296 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
94.0 |
91.0 to 96.0 |
426 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
87.6 |
82.3 to 91.5 |
308 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
94.8 |
91.6 to 96.8 |
329 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
87.4 |
79.4 to 92.5 |
274 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
91.0 |
84.3 to 95.1 |
262 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
96.8 |
93.5 to 98.4 |
294 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
96.5 |
92.9 to 98.3 |
308 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
89.1 |
82.1 to 93.6 |
282 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
94.5 |
88.6 to 97.4 |
329 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
96.2 |
93.1 to 98.0 |
315 |
| MMR |
>=2 Doses |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
81.7 |
75.6 to 86.5 |
278 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
92.1 |
87.2 to 95.3 |
304 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
86.9 |
81.1 to 91.2 |
332 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
95.3 |
92.6 to 97.0 |
602 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
92.0 |
85.2 to 95.8 |
160 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
96.0 |
92.8 to 97.8 |
442 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
95.4 |
91.2 to 97.7 |
289 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
96.4 |
92.2 to 98.4 |
302 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
90.0 |
85.6 to 93.2 |
381 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
94.5 |
90.4 to 96.9 |
292 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
94.0 |
88.8 to 96.9 |
336 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
94.2 |
90.0 to 96.6 |
316 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
93.8 |
89.6 to 96.3 |
524 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
96.0 |
91.8 to 98.1 |
300 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
95.2 |
91.4 to 97.4 |
297 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
97.0 |
93.3 to 98.6 |
276 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
92.1 |
86.9 to 95.3 |
270 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
90.4 |
84.8 to 94.1 |
288 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
87.1 |
81.4 to 91.2 |
297 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
91.4 |
85.9 to 94.9 |
285 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
88.1 |
82.5 to 92.1 |
313 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
95.6 |
91.7 to 97.7 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
92.1 |
87.3 to 95.2 |
331 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
87.9 |
82.7 to 91.7 |
405 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
92.4 |
88.6 to 95.1 |
498 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
88.8 |
82.9 to 92.8 |
257 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
94.8 |
88.6 to 97.7 |
241 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
94.3 |
90.6 to 96.6 |
305 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
97.4 |
94.2 to 98.9 |
319 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
92.7 |
88.7 to 95.3 |
302 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
90.4 |
86.3 to 93.4 |
369 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
96.0 |
92.5 to 97.9 |
270 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
95.8 |
93.0 to 97.5 |
734 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
96.6 |
93.3 to 98.4 |
242 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
95.7 |
92.5 to 97.6 |
492 |
| MMR |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
96.0 |
87.5 to 98.8 |
216 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
91.9 |
90.8 to 92.8 |
18788 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
96.1 |
94.3 to 97.4 |
2034 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
92.3 |
89.5 to 94.5 |
829 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
93.4 |
91.3 to 95.0 |
2520 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
94.6 |
92.9 to 95.9 |
2387 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
95.1 |
93.8 to 96.1 |
2097 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
86.6 |
84.4 to 88.6 |
3289 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
91.8 |
89.2 to 93.8 |
1256 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
91.0 |
87.9 to 93.4 |
1845 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
87.6 |
81.6 to 91.8 |
1199 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
96.1 |
92.2 to 98.1 |
319 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
94.7 |
91.2 to 96.8 |
319 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
93.4 |
88.8 to 96.2 |
313 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
93.0 |
88.2 to 95.9 |
261 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
84.2 |
81.1 to 86.8 |
1850 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
89.1 |
83.9 to 92.8 |
293 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
85.6 |
77.1 to 91.3 |
174 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
80.2 |
73.3 to 85.6 |
271 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
91.3 |
86.3 to 94.6 |
280 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
83.8 |
79.7 to 87.2 |
832 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
81.3 |
73.5 to 87.2 |
218 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
93.3 |
90.9 to 95.1 |
1332 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
89.7 |
84.2 to 93.4 |
325 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
98.1 |
96.3 to 99.0 |
472 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
89.8 |
83.6 to 93.8 |
363 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
93.7 |
89.2 to 96.4 |
304 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
91.3 |
86.2 to 94.7 |
309 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
96.9 |
94.1 to 98.4 |
331 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
95.6 |
91.7 to 97.7 |
329 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
95.7 |
92.1 to 97.7 |
298 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
92.3 |
87.8 to 95.2 |
302 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
85.3 |
80.0 to 89.3 |
340 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
95.2 |
91.7 to 97.3 |
322 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
86.6 |
80.9 to 90.7 |
403 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
94.0 |
90.5 to 96.3 |
354 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
97.3 |
93.7 to 98.9 |
331 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
94.6 |
90.6 to 96.9 |
360 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
88.7 |
83.7 to 92.3 |
404 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
95.4 |
92.0 to 97.3 |
355 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
96.8 |
93.7 to 98.4 |
300 |
| MMR |
>=2 Doses |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
80.5 |
74.7 to 85.3 |
300 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
94.5 |
91.0 to 96.6 |
290 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
89.7 |
85.1 to 93.0 |
376 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
93.3 |
90.5 to 95.3 |
699 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
91.6 |
85.4 to 95.3 |
271 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
93.7 |
90.3 to 95.9 |
428 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
98.3 |
96.5 to 99.2 |
302 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
95.2 |
92.2 to 97.1 |
280 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
92.3 |
88.2 to 95.0 |
364 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
95.9 |
92.4 to 97.8 |
255 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
95.7 |
92.2 to 97.7 |
356 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
95.8 |
91.9 to 97.9 |
372 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
93.8 |
90.8 to 95.8 |
815 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
97.6 |
94.9 to 98.8 |
394 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
94.9 |
91.1 to 97.1 |
398 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
97.1 |
94.2 to 98.6 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
95.2 |
91.1 to 97.5 |
282 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
92.6 |
88.5 to 95.3 |
397 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
95.5 |
92.6 to 97.3 |
307 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
91.1 |
86.9 to 94.0 |
405 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
84.2 |
78.1 to 88.8 |
369 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
98.8 |
97.3 to 99.5 |
381 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
92.9 |
88.4 to 95.8 |
379 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
93.4 |
89.7 to 95.9 |
352 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
94.4 |
91.8 to 96.2 |
729 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
92.1 |
88.2 to 94.7 |
381 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
95.8 |
91.8 to 97.9 |
348 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
95.5 |
90.6 to 97.9 |
327 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
97.0 |
94.0 to 98.5 |
401 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
93.3 |
89.2 to 95.9 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
90.8 |
86.9 to 93.6 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
96.3 |
93.4 to 98.0 |
308 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
95.4 |
91.9 to 97.4 |
765 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
95.8 |
91.7 to 97.9 |
263 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
95.4 |
91.3 to 97.6 |
502 |
| MMR |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
67.5 |
55.7 to 77.4 |
169 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
92.4 |
91.6 to 93.2 |
20163 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
97.4 |
96.1 to 98.3 |
2147 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
93.9 |
91.7 to 95.5 |
1108 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
94.2 |
92.5 to 95.5 |
3331 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
95.4 |
94.1 to 96.4 |
2466 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
94.9 |
93.6 to 95.9 |
2344 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
88.3 |
85.7 to 90.5 |
2509 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
92.9 |
90.9 to 94.4 |
1446 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
92.5 |
90.4 to 94.1 |
2007 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
86.4 |
82.1 to 89.8 |
1402 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
97.1 |
93.4 to 98.8 |
271 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
92.3 |
87.4 to 95.4 |
311 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
97.6 |
95.1 to 98.8 |
317 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
94.6 |
90.7 to 96.9 |
338 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
85.9 |
82.2 to 89.0 |
1141 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
85.0 |
79.8 to 89.0 |
314 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
85.6 |
79.0 to 90.4 |
221 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
86.0 |
81.7 to 89.4 |
606 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
93.0 |
90.3 to 95.0 |
1403 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
87.9 |
82.9 to 91.6 |
304 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
97.2 |
93.8 to 98.7 |
398 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
93.3 |
89.5 to 95.8 |
677 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
92.2 |
87.1 to 95.4 |
417 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
92.8 |
89.3 to 95.2 |
310 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
94.9 |
91.1 to 97.1 |
277 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
90.8 |
86.2 to 93.9 |
324 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
95.8 |
91.9 to 97.9 |
304 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
91.8 |
86.8 to 95.1 |
268 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
86.4 |
80.9 to 90.5 |
296 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
94.0 |
90.0 to 96.4 |
314 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
89.3 |
81.9 to 93.9 |
286 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
95.6 |
92.5 to 97.5 |
298 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
96.2 |
92.5 to 98.2 |
340 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
92.5 |
87.2 to 95.7 |
310 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
87.8 |
82.6 to 91.6 |
409 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
95.2 |
90.0 to 97.8 |
312 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
95.5 |
90.0 to 98.0 |
260 |
| MMR |
>=2 Doses |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
78.7 |
71.0 to 84.7 |
225 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
91.6 |
86.2 to 95.0 |
258 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
89.2 |
84.0 to 92.9 |
334 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
96.0 |
93.6 to 97.5 |
578 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
92.2 |
82.2 to 96.8 |
144 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
96.8 |
94.6 to 98.1 |
434 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
92.5 |
86.9 to 95.8 |
268 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
97.7 |
95.2 to 98.9 |
199 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
94.6 |
90.0 to 97.2 |
300 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
94.6 |
90.1 to 97.1 |
240 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
94.1 |
89.5 to 96.7 |
303 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
94.9 |
90.9 to 97.2 |
293 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
94.8 |
92.4 to 96.4 |
857 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
97.0 |
92.5 to 98.8 |
266 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
88.9 |
83.0 to 92.9 |
358 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
95.2 |
89.9 to 97.8 |
296 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
92.3 |
87.1 to 95.5 |
303 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
88.3 |
82.9 to 92.2 |
340 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
94.2 |
90.5 to 96.5 |
290 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
94.0 |
90.1 to 96.5 |
315 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
90.3 |
85.5 to 93.7 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
97.2 |
93.8 to 98.7 |
282 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
90.0 |
84.1 to 93.9 |
292 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
88.1 |
83.2 to 91.8 |
337 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
94.2 |
90.9 to 96.3 |
581 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
91.5 |
86.0 to 95.0 |
297 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
95.9 |
91.0 to 98.2 |
284 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
95.3 |
88.8 to 98.1 |
266 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
98.3 |
95.7 to 99.3 |
191 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
95.0 |
89.8 to 97.6 |
254 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
91.8 |
87.4 to 94.8 |
240 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
92.4 |
87.6 to 95.4 |
294 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
92.7 |
89.6 to 95.0 |
929 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
93.9 |
89.3 to 96.6 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
92.6 |
89.0 to 95.0 |
599 |
| MMR |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
80.9 |
74.9 to 85.8 |
350 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
92.2 |
91.2 to 93.2 |
18002 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
96.5 |
94.6 to 97.7 |
1923 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
92.8 |
90.0 to 94.8 |
873 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
93.4 |
91.7 to 94.8 |
3338 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
95.1 |
93.4 to 96.4 |
2263 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
94.2 |
92.5 to 95.5 |
2060 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
86.6 |
83.4 to 89.3 |
2184 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
92.5 |
90.0 to 94.5 |
1154 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
94.8 |
93.1 to 96.1 |
1789 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
89.0 |
83.6 to 92.7 |
1173 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
94.8 |
90.5 to 97.2 |
254 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
95.3 |
91.9 to 97.3 |
263 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
98.0 |
96.0 to 99.0 |
445 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
95.1 |
91.3 to 97.2 |
315 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
84.1 |
79.6 to 87.8 |
990 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
85.5 |
79.3 to 90.1 |
296 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
77.5 |
66.8 to 85.5 |
167 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
84.5 |
79.2 to 88.7 |
527 |
| MMR |
>=2 Doses |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
85.2 |
77.0 to 90.8 |
245 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
92.3 |
89.8 to 94.2 |
1245 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
93.1 |
89.1 to 95.7 |
304 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
97.1 |
94.5 to 98.4 |
488 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
94.8 |
90.3 to 97.3 |
566 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
93.2 |
88.9 to 96.0 |
349 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
87.6 |
81.6 to 91.8 |
267 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
98.6 |
96.3 to 99.5 |
306 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
91.3 |
86.1 to 94.6 |
261 |
| MMR |
>=2 Doses |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
95.7 |
91.5 to 97.8 |
269 |
| MMR |
>=2 Doses |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
91.4 |
85.2 to 95.1 |
240 |
| MMR |
>=2 Doses |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
91.0 |
86.3 to 94.2 |
273 |
| MMR |
>=2 Doses |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
93.8 |
89.9 to 96.2 |
332 |
| MMR |
>=2 Doses |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
85.4 |
79.3 to 89.9 |
321 |
| MMR |
>=2 Doses |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
91.6 |
87.8 to 94.3 |
342 |
| MMR |
>=2 Doses |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
95.7 |
91.4 to 97.9 |
258 |
| MMR |
>=2 Doses |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
93.9 |
88.4 to 96.8 |
250 |
| MMR |
>=2 Doses |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
74.0 |
65.2 to 81.3 |
237 |
| MMR |
>=2 Doses |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
96.3 |
92.6 to 98.2 |
307 |
| MMR |
>=2 Doses |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
95.2 |
91.2 to 97.4 |
333 |
| MMR |
>=2 Doses |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
79.3 |
71.4 to 85.4 |
240 |
| MMR |
>=2 Doses |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
92.2 |
87.2 to 95.3 |
237 |
| MMR |
>=2 Doses |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
92.7 |
87.4 to 95.9 |
251 |
| MMR |
>=2 Doses |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
93.0 |
89.4 to 95.4 |
630 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
92.1 |
86.5 to 95.5 |
256 |
| MMR |
>=2 Doses |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
93.2 |
88.8 to 96.0 |
374 |
| MMR |
>=2 Doses |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
95.7 |
91.3 to 97.9 |
258 |
| MMR |
>=2 Doses |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
95.0 |
90.3 to 97.5 |
207 |
| MMR |
>=2 Doses |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
91.9 |
87.7 to 94.8 |
310 |
| MMR |
>=2 Doses |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
92.0 |
86.5 to 95.3 |
276 |
| MMR |
>=2 Doses |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
96.3 |
93.5 to 97.9 |
330 |
| MMR |
>=2 Doses |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
94.0 |
89.2 to 96.8 |
268 |
| MMR |
>=2 Doses |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
92.0 |
85.9 to 95.5 |
346 |
| MMR |
>=2 Doses |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
93.4 |
87.8 to 96.5 |
268 |
| MMR |
>=2 Doses |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
93.4 |
88.0 to 96.5 |
257 |
| MMR |
>=2 Doses |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
96.2 |
92.8 to 98.1 |
331 |
| MMR |
>=2 Doses |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
90.6 |
85.1 to 94.2 |
232 |
| MMR |
>=2 Doses |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
89.3 |
83.6 to 93.2 |
284 |
| MMR |
>=2 Doses |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
93.4 |
89.9 to 95.8 |
297 |
| MMR |
>=2 Doses |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
90.6 |
85.4 to 94.0 |
247 |
| MMR |
>=2 Doses |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
86.0 |
79.9 to 90.4 |
259 |
| MMR |
>=2 Doses |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
97.8 |
95.4 to 99.0 |
225 |
| MMR |
>=2 Doses |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
93.5 |
89.5 to 96.1 |
289 |
| MMR |
>=2 Doses |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
90.0 |
84.0 to 93.9 |
276 |
| MMR |
>=2 Doses |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
95.3 |
92.5 to 97.1 |
536 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
94.0 |
88.4 to 97.0 |
222 |
| MMR |
>=2 Doses |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
96.1 |
92.6 to 98.0 |
314 |
| MMR |
>=2 Doses |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
96.1 |
92.6 to 98.0 |
361 |
| MMR |
>=2 Doses |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
97.6 |
93.8 to 99.1 |
280 |
| MMR |
>=2 Doses |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
89.6 |
83.0 to 93.9 |
269 |
| MMR |
>=2 Doses |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
89.1 |
83.1 to 93.1 |
249 |
| MMR |
>=2 Doses |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
94.3 |
90.2 to 96.8 |
263 |
| MMR |
>=2 Doses |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
94.9 |
92.1 to 96.7 |
752 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
97.0 |
93.8 to 98.6 |
267 |
| MMR |
>=2 Doses |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
94.6 |
91.4 to 96.6 |
485 |
| MMR |
>=2 Doses |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
88.4 |
85.0 to 91.1 |
671 |
| MMR |
>=2 Doses |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
91.2 |
90.2 to 92.1 |
16043 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
94.7 |
92.1 to 96.4 |
1595 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
94.7 |
92.5 to 96.2 |
825 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
92.3 |
90.5 to 93.8 |
2424 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
95.0 |
93.7 to 96.1 |
2291 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
93.1 |
91.2 to 94.6 |
2019 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
84.4 |
80.3 to 87.8 |
1981 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
91.3 |
88.7 to 93.4 |
1048 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
91.4 |
88.8 to 93.4 |
1736 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
86.4 |
81.7 to 90.0 |
1090 |
| MMR |
>=2 Doses |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
95.6 |
91.5 to 97.8 |
285 |
| MMR |
>=2 Doses |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
94.9 |
90.0 to 97.5 |
269 |
| MMR |
>=2 Doses |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
95.6 |
92.0 to 97.6 |
252 |
| MMR |
>=2 Doses |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
93.3 |
88.3 to 96.3 |
244 |
| MMR |
>=2 Doses |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
80.9 |
75.1 to 85.6 |
794 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
90.4 |
85.1 to 93.9 |
253 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
86.7 |
77.7 to 92.4 |
157 |
| MMR |
>=2 Doses |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
79.7 |
73.0 to 85.1 |
384 |
| MMR |
>=2 Doses |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
93.8 |
91.0 to 95.7 |
1034 |
| MMR |
>=2 Doses |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
88.2 |
81.7 to 92.6 |
271 |
| MMR |
>=2 Doses |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
95.3 |
91.9 to 97.3 |
291 |
| MMR |
>=2 Doses |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
89.8 |
86.2 to 92.6 |
595 |
| MMR |
>=2 Doses |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
94.1 |
88.7 to 97.0 |
280 |
| MMR |
>=2 Doses |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
92.0 |
87.1 to 95.2 |
244 |
| MMR |
>=2 Doses |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
93.3 |
88.1 to 96.4 |
274 |
| MMR |
>=2 Doses |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
93.6 |
89.2 to 96.3 |
294 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2006 |
Age |
13-17 Years |
71.1 |
68.9 to 73.2 |
2882 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2006 |
Age |
13-17 Years |
80.6 |
73.2 to 86.2 |
170 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2006 |
Age |
13-17 Years |
65.6 |
57.5 to 73.0 |
227 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2006 |
Age |
13-17 Years |
66.9 |
60.6 to 72.6 |
347 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2006 |
Age |
13-17 Years |
70.3 |
65.4 to 74.7 |
608 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2006 |
Age |
13-17 Years |
75.1 |
69.7 to 79.9 |
458 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2006 |
Age |
13-17 Years |
72.3 |
65.4 to 78.3 |
268 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2006 |
Age |
13-17 Years |
77.9 |
69.8 to 84.3 |
165 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2006 |
Age |
13-17 Years |
75.3 |
63.3 to 84.4 |
118 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2006 |
Age |
13-17 Years |
65.6 |
59.2 to 71.4 |
362 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2006 |
Age |
13-17 Years |
74.5 |
66.0 to 81.4 |
159 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
72.3 |
70.1 to 74.4 |
2947 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
70.5 |
62.1 to 77.7 |
190 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-17 Years |
72.7 |
65.1 to 79.2 |
219 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
73.1 |
67.2 to 78.4 |
370 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
68.7 |
63.4 to 73.5 |
501 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
77.4 |
73.2 to 81.1 |
584 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-17 Years |
75.6 |
69.2 to 81.0 |
322 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-17 Years |
78.1 |
68.9 to 85.2 |
165 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-17 Years |
71.4 |
58.3 to 81.7 |
112 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
66.2 |
58.8 to 72.8 |
366 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2007 |
Age |
13-17 Years |
76.7 |
66.5 to 84.5 |
118 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
63.7 |
57.8 to 69.2 |
406 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
77.4 |
71.9 to 82.1 |
304 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
75.8 |
68.6 to 81.8 |
250 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
70.9 |
65.4 to 75.8 |
382 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
73.9 |
66.5 to 80.1 |
316 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
77.4 |
70.8 to 82.8 |
347 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
81.4 |
75.3 to 86.2 |
292 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
71.5 |
65.6 to 76.8 |
334 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
69.2 |
63.0 to 74.7 |
329 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
65.2 |
57.0 to 72.6 |
284 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
79.0 |
73.4 to 83.7 |
345 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
69.0 |
63.0 to 74.4 |
317 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
77.5 |
71.3 to 82.7 |
268 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
74.4 |
69.4 to 78.8 |
783 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
69.0 |
63.0 to 74.4 |
343 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
75.8 |
69.6 to 81.0 |
440 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
74.8 |
69.1 to 79.7 |
345 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
76.9 |
71.0 to 81.9 |
308 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
75.6 |
69.0 to 81.2 |
271 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
74.5 |
68.3 to 79.9 |
296 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
75.8 |
70.0 to 80.8 |
379 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
81.8 |
76.8 to 85.9 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
69.7 |
63.4 to 75.4 |
394 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
72.5 |
66.2 to 77.9 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
77.4 |
71.7 to 82.2 |
320 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
74.9 |
69.2 to 79.8 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2008 |
Age |
13-17 Years |
68.6 |
63.0 to 73.6 |
404 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
77.4 |
72.1 to 82.0 |
351 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
73.7 |
67.7 to 79.0 |
299 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
78.3 |
73.0 to 82.8 |
365 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
65.4 |
57.9 to 72.3 |
235 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
76.1 |
69.2 to 81.8 |
300 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
70.6 |
64.8 to 75.7 |
390 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
68.6 |
62.0 to 74.5 |
310 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
72.6 |
67.9 to 76.7 |
600 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
75.1 |
68.3 to 80.8 |
293 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
70.9 |
64.5 to 76.5 |
307 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
66.7 |
60.0 to 72.7 |
326 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
76.8 |
71.5 to 81.3 |
362 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
79.5 |
73.9 to 84.2 |
311 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
67.6 |
61.3 to 73.3 |
292 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
70.8 |
63.6 to 77.1 |
235 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
72.4 |
67.3 to 77.0 |
682 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
72.6 |
66.7 to 77.8 |
345 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
72.4 |
66.5 to 77.6 |
337 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
73.5 |
72.2 to 74.8 |
17835 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
76.8 |
73.5 to 79.7 |
1838 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
71.9 |
68.3 to 75.3 |
990 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
70.3 |
67.1 to 73.2 |
2306 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
69.4 |
66.5 to 72.1 |
2788 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
76.6 |
74.4 to 78.8 |
2361 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
75.5 |
71.3 to 79.3 |
2203 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
77.0 |
74.0 to 79.8 |
1295 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
76.2 |
72.8 to 79.3 |
1854 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
73.6 |
67.7 to 78.7 |
1118 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
80.7 |
74.0 to 85.9 |
297 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
63.4 |
57.5 to 68.9 |
367 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
72.6 |
66.8 to 77.7 |
344 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
74.8 |
69.2 to 79.7 |
360 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
77.6 |
71.2 to 83.0 |
840 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
73.7 |
66.4 to 79.9 |
269 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
77.4 |
69.1 to 84.0 |
233 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
78.0 |
70.4 to 84.1 |
338 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
74.9 |
71.1 to 78.4 |
1082 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2008 |
Age |
13-17 Years |
77.0 |
70.4 to 82.5 |
222 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
78.5 |
72.2 to 83.7 |
283 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
67.8 |
60.6 to 74.2 |
272 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
76.3 |
70.0 to 81.6 |
275 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
66.9 |
60.2 to 72.9 |
295 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
78.2 |
71.9 to 83.4 |
264 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
70.8 |
64.5 to 76.4 |
280 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
68.5 |
62.2 to 74.2 |
339 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
77.1 |
70.8 to 82.4 |
274 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
81.0 |
75.7 to 85.5 |
349 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
65.3 |
59.6 to 70.7 |
363 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
74.1 |
68.1 to 79.3 |
379 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
79.8 |
74.4 to 84.2 |
411 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
79.8 |
73.7 to 84.8 |
351 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
76.2 |
70.3 to 81.2 |
371 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
82.4 |
76.8 to 86.9 |
412 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
71.2 |
65.3 to 76.5 |
412 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
85.3 |
80.3 to 89.2 |
383 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
75.7 |
69.4 to 81.1 |
256 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
71.5 |
63.5 to 78.3 |
227 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
76.8 |
72.6 to 80.6 |
754 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
68.6 |
62.5 to 74.1 |
389 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
78.9 |
73.8 to 83.3 |
365 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
77.1 |
71.9 to 81.5 |
873 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
76.1 |
70.1 to 81.2 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
81.3 |
75.5 to 86.0 |
252 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
68.2 |
62.8 to 73.2 |
393 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
77.2 |
70.3 to 82.9 |
281 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
80.4 |
74.7 to 85.1 |
299 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
73.0 |
65.7 to 79.3 |
245 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
76.8 |
71.4 to 81.4 |
397 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
74.9 |
69.8 to 79.3 |
446 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
82.4 |
77.4 to 86.5 |
336 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
63.8 |
58.3 to 68.9 |
438 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
78.8 |
73.7 to 83.1 |
374 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
72.2 |
66.2 to 77.6 |
306 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
77.9 |
72.3 to 82.7 |
286 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
69.4 |
62.9 to 75.2 |
336 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
85.1 |
79.8 to 89.2 |
307 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
73.8 |
68.4 to 78.5 |
427 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
71.5 |
66.1 to 76.4 |
406 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
76.6 |
72.0 to 80.7 |
539 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
70.2 |
62.3 to 77.1 |
269 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
81.0 |
75.3 to 85.6 |
270 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
82.8 |
77.9 to 86.9 |
323 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
82.3 |
76.8 to 86.7 |
272 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
74.5 |
68.4 to 79.8 |
351 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
67.6 |
61.8 to 73.0 |
336 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
73.6 |
68.3 to 78.3 |
386 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
80.9 |
75.1 to 85.5 |
579 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
78.1 |
72.5 to 82.7 |
324 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
81.3 |
74.6 to 86.5 |
255 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
75.7 |
74.6 to 76.8 |
20066 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
79.6 |
76.7 to 82.2 |
2189 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
75.7 |
72.2 to 78.9 |
966 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
76.1 |
72.9 to 79.1 |
2214 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
73.4 |
71.1 to 75.5 |
2984 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
77.5 |
75.3 to 79.5 |
3105 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
74.1 |
70.9 to 77.1 |
2856 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
78.6 |
75.8 to 81.2 |
1250 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
77.4 |
74.5 to 80.0 |
1974 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
74.8 |
70.1 to 79.1 |
1320 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
83.4 |
78.7 to 87.2 |
409 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
60.2 |
53.2 to 66.9 |
299 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
71.5 |
64.9 to 77.3 |
271 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
67.5 |
61.3 to 73.1 |
397 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
75.7 |
71.0 to 79.9 |
1470 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
68.5 |
61.2 to 75.0 |
305 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
69.5 |
60.4 to 77.3 |
239 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
72.6 |
65.7 to 78.6 |
296 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
76.5 |
71.0 to 81.3 |
325 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
77.4 |
70.9 to 82.8 |
305 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-17 Years |
47.9 |
41.3 to 54.6 |
333 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
77.3 |
73.9 to 80.3 |
1208 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
76.1 |
70.3 to 81.1 |
339 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
86.2 |
82.0 to 89.6 |
426 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
71.0 |
64.9 to 76.4 |
358 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
80.8 |
75.1 to 85.4 |
321 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
73.5 |
67.0 to 79.2 |
249 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
85.8 |
81.1 to 89.5 |
345 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
76.0 |
71.0 to 80.4 |
375 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
68.5 |
62.2 to 74.2 |
296 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
74.1 |
68.2 to 79.3 |
294 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
80.0 |
74.4 to 84.6 |
331 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
60.2 |
53.6 to 66.4 |
313 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
74.4 |
68.3 to 79.6 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
78.7 |
73.2 to 83.4 |
317 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
86.4 |
81.0 to 90.5 |
408 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
81.9 |
76.5 to 86.2 |
348 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
89.5 |
85.0 to 92.8 |
355 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
69.1 |
62.3 to 75.1 |
344 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
86.5 |
81.8 to 90.2 |
373 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
76.1 |
70.2 to 81.0 |
320 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
78.2 |
72.7 to 82.8 |
318 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
75.8 |
71.3 to 79.8 |
739 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
79.9 |
74.6 to 84.3 |
366 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
74.7 |
69.2 to 79.6 |
373 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
83.3 |
78.2 to 87.4 |
316 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
76.7 |
70.5 to 81.9 |
264 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
82.9 |
78.2 to 86.8 |
373 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
69.1 |
63.1 to 74.6 |
309 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
80.7 |
75.0 to 85.4 |
347 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
79.2 |
73.6 to 83.8 |
312 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
73.3 |
67.1 to 78.8 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
83.7 |
77.9 to 88.2 |
306 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
81.1 |
75.6 to 85.7 |
304 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
82.7 |
77.5 to 87.0 |
310 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
66.8 |
61.1 to 72.0 |
354 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
68.2 |
62.3 to 73.5 |
347 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
73.8 |
68.3 to 78.7 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
81.2 |
75.2 to 86.0 |
307 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
76.4 |
70.9 to 81.1 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
87.5 |
82.8 to 91.0 |
350 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
79.1 |
73.5 to 83.8 |
399 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
78.4 |
72.9 to 83.0 |
332 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
75.3 |
70.9 to 79.3 |
701 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
77.3 |
71.5 to 82.2 |
388 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
74.0 |
67.6 to 79.6 |
313 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
75.6 |
70.3 to 80.3 |
366 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
84.0 |
78.8 to 88.1 |
299 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
72.2 |
66.0 to 77.6 |
302 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
69.7 |
63.3 to 75.4 |
300 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
77.8 |
72.0 to 82.7 |
302 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
87.4 |
83.6 to 90.4 |
742 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
84.5 |
79.5 to 88.5 |
371 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
87.8 |
83.4 to 91.1 |
371 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
76.8 |
75.7 to 77.9 |
19257 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
85.2 |
82.3 to 87.6 |
2026 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
76.5 |
73.1 to 79.7 |
1100 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
77.3 |
74.6 to 79.8 |
2436 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
73.1 |
70.7 to 75.4 |
2679 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
79.0 |
76.8 to 81.1 |
2248 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
77.2 |
74.4 to 79.9 |
3001 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
74.9 |
71.8 to 77.8 |
1291 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
77.5 |
74.6 to 80.3 |
1890 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
75.3 |
70.5 to 79.5 |
1311 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
90.0 |
85.6 to 93.2 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
63.6 |
56.9 to 69.8 |
317 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
70.1 |
64.0 to 75.5 |
321 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
75.3 |
69.5 to 80.3 |
320 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
79.5 |
75.4 to 83.0 |
1709 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
76.1 |
70.6 to 80.9 |
382 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
81.7 |
76.4 to 86.1 |
413 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
75.9 |
69.7 to 81.2 |
304 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
82.0 |
77.0 to 86.1 |
313 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
79.9 |
74.2 to 84.6 |
297 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
66.7 |
59.3 to 73.4 |
231 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
81.2 |
78.3 to 83.8 |
1275 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
77.4 |
71.3 to 82.5 |
325 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
91.9 |
87.6 to 94.8 |
320 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
63.6 |
56.7 to 69.9 |
332 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
84.7 |
80.0 to 88.5 |
361 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
73.9 |
68.3 to 78.8 |
321 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
88.4 |
83.5 to 91.9 |
277 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
78.5 |
72.8 to 83.3 |
295 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
69.8 |
63.8 to 75.2 |
403 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
78.7 |
71.5 to 84.4 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
76.2 |
69.6 to 81.7 |
416 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
70.8 |
63.6 to 77.1 |
350 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
77.4 |
72.7 to 81.5 |
583 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
84.1 |
78.0 to 88.8 |
431 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
91.4 |
87.5 to 94.2 |
453 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
85.7 |
81.3 to 89.2 |
442 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
94.0 |
90.2 to 96.4 |
415 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
78.4 |
72.9 to 83.1 |
483 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
91.5 |
87.5 to 94.3 |
425 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
80.4 |
74.5 to 85.1 |
339 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
76.1 |
69.3 to 81.7 |
385 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
77.1 |
72.6 to 81.1 |
848 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
78.6 |
73.1 to 83.1 |
407 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
76.8 |
71.3 to 81.5 |
441 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
92.7 |
88.3 to 95.5 |
430 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
77.0 |
70.8 to 82.2 |
359 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
79.9 |
73.4 to 85.2 |
399 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
69.6 |
63.4 to 75.1 |
382 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
90.6 |
86.3 to 93.7 |
473 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
81.1 |
76.2 to 85.2 |
411 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
78.9 |
74.0 to 83.1 |
516 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
87.6 |
82.5 to 91.3 |
365 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
87.1 |
81.9 to 91.0 |
398 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
88.9 |
83.0 to 93.0 |
327 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
61.2 |
54.2 to 67.7 |
345 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
69.6 |
63.2 to 75.4 |
402 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
76.9 |
68.9 to 83.3 |
385 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
85.9 |
80.3 to 90.1 |
368 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
71.4 |
64.0 to 77.9 |
412 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
91.9 |
88.2 to 94.5 |
385 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
80.9 |
76.0 to 84.9 |
432 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
82.3 |
76.8 to 86.7 |
431 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
78.7 |
75.1 to 81.9 |
840 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
78.7 |
73.6 to 83.0 |
435 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
78.7 |
73.6 to 83.0 |
405 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
76.7 |
70.4 to 82.0 |
347 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
78.8 |
70.8 to 85.1 |
314 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
76.6 |
70.7 to 81.6 |
381 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
67.5 |
60.9 to 73.5 |
360 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
75.0 |
68.4 to 80.7 |
362 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
89.0 |
85.0 to 92.1 |
880 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
84.6 |
79.1 to 88.9 |
387 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
89.6 |
84.9 to 92.9 |
493 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
79.9 |
78.9 to 80.8 |
23564 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
88.5 |
86.1 to 90.5 |
2467 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
79.4 |
76.6 to 82.0 |
1272 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
80.8 |
78.2 to 83.1 |
3073 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
77.2 |
74.9 to 79.2 |
3171 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
83.7 |
81.6 to 85.6 |
2800 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
81.2 |
78.5 to 83.7 |
3838 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
75.6 |
72.2 to 78.8 |
1528 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
79.8 |
76.5 to 82.7 |
2242 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
77.0 |
73.2 to 80.3 |
1750 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
87.5 |
82.0 to 91.5 |
449 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
68.1 |
60.9 to 74.6 |
362 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
72.0 |
62.8 to 79.6 |
355 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
76.0 |
69.3 to 81.7 |
424 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
82.6 |
78.7 to 86.0 |
2224 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
81.5 |
76.5 to 85.7 |
448 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
85.0 |
79.6 to 89.1 |
490 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
81.3 |
75.4 to 86.0 |
441 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
84.4 |
78.8 to 88.7 |
355 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
82.6 |
77.1 to 86.9 |
490 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
71.0 |
66.2 to 75.5 |
485 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
78.2 |
74.6 to 81.4 |
1423 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
74.8 |
68.3 to 80.4 |
393 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
89.9 |
85.1 to 93.2 |
404 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
71.0 |
64.7 to 76.5 |
417 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
80.4 |
74.5 to 85.3 |
346 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
67.5 |
61.7 to 72.9 |
403 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
91.6 |
86.1 to 95.1 |
416 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
88.3 |
82.0 to 92.6 |
364 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
76.9 |
69.8 to 82.8 |
317 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
85.2 |
80.0 to 89.2 |
340 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
83.1 |
78.0 to 87.2 |
360 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
67.8 |
60.9 to 74.0 |
322 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
81.3 |
75.9 to 85.7 |
430 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
86.5 |
80.6 to 90.8 |
311 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
95.1 |
90.7 to 97.5 |
323 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
89.7 |
84.3 to 93.4 |
341 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
93.6 |
87.9 to 96.7 |
342 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
81.1 |
73.8 to 86.7 |
325 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
92.6 |
88.0 to 95.5 |
328 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
82.9 |
77.4 to 87.3 |
342 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
74.9 |
68.7 to 80.2 |
357 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
76.7 |
71.0 to 81.5 |
632 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
79.6 |
72.6 to 85.2 |
287 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
75.9 |
69.0 to 81.7 |
345 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
90.7 |
85.4 to 94.2 |
341 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
78.8 |
72.9 to 83.7 |
325 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
87.3 |
82.3 to 91.1 |
340 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
71.7 |
65.1 to 77.5 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
89.7 |
85.6 to 92.8 |
370 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
84.1 |
78.3 to 88.6 |
319 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
84.8 |
78.5 to 89.5 |
325 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
91.2 |
86.6 to 94.3 |
347 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
91.2 |
86.9 to 94.2 |
368 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
89.8 |
84.9 to 93.2 |
322 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
67.8 |
60.7 to 74.1 |
321 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
70.3 |
62.5 to 77.0 |
292 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
79.9 |
74.0 to 84.8 |
325 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
88.2 |
83.0 to 92.0 |
328 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
78.5 |
72.1 to 83.8 |
329 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
95.2 |
91.6 to 97.3 |
278 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
80.4 |
74.0 to 85.5 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
72.6 |
65.7 to 78.5 |
331 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
80.8 |
76.5 to 84.5 |
627 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
77.2 |
70.6 to 82.7 |
312 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
83.0 |
77.1 to 87.7 |
315 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
79.1 |
73.1 to 84.0 |
347 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
81.3 |
74.6 to 86.6 |
324 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
76.5 |
69.6 to 82.2 |
327 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
75.0 |
68.9 to 80.3 |
322 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
81.7 |
76.3 to 86.0 |
381 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
92.6 |
88.5 to 95.3 |
741 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
91.7 |
86.8 to 94.9 |
348 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
92.7 |
87.9 to 95.7 |
393 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
82.6 |
81.6 to 83.6 |
19199 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
92.4 |
90.2 to 94.2 |
1916 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
80.7 |
77.2 to 83.7 |
957 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
86.0 |
83.4 to 88.3 |
2365 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
80.3 |
77.7 to 82.6 |
2612 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
84.2 |
81.9 to 86.3 |
2297 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
83.2 |
81.0 to 85.1 |
2939 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
78.2 |
74.3 to 81.6 |
1285 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
81.0 |
77.7 to 83.9 |
1936 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
81.4 |
77.2 to 85.0 |
1461 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
94.8 |
90.9 to 97.1 |
327 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
71.6 |
64.5 to 77.7 |
310 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
72.0 |
65.9 to 77.3 |
298 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
80.4 |
73.3 to 85.9 |
331 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
85.7 |
82.6 to 88.2 |
1594 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
80.0 |
72.6 to 85.7 |
346 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
83.7 |
77.5 to 88.5 |
393 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
86.3 |
82.8 to 89.2 |
855 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
78.7 |
74.5 to 82.4 |
547 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
82.2 |
78.7 to 85.2 |
1431 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
73.2 |
66.5 to 79.1 |
345 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
95.3 |
92.3 to 97.2 |
322 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
77.9 |
71.4 to 83.3 |
334 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
84.0 |
77.7 to 88.8 |
353 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
76.7 |
70.0 to 82.3 |
282 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
92.2 |
87.8 to 95.1 |
307 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
93.6 |
89.5 to 96.2 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
84.6 |
79.4 to 88.8 |
317 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
87.1 |
82.3 to 90.8 |
320 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
76.7 |
70.7 to 81.7 |
359 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
72.3 |
66.2 to 77.6 |
312 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
83.9 |
78.1 to 88.3 |
309 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
82.5 |
77.3 to 86.8 |
331 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
97.0 |
93.5 to 98.6 |
328 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
84.8 |
79.2 to 89.1 |
348 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
86.2 |
75.9 to 92.5 |
192 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
81.2 |
74.8 to 86.2 |
323 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
95.1 |
88.8 to 97.9 |
253 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
72.7 |
66.7 to 77.9 |
363 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
86.2 |
80.7 to 90.4 |
315 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
80.6 |
74.1 to 85.7 |
272 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
86.2 |
82.0 to 89.5 |
558 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
83.9 |
76.1 to 89.6 |
209 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
86.7 |
81.8 to 90.4 |
349 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
94.9 |
91.6 to 97.0 |
381 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
74.8 |
69.0 to 79.8 |
383 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
87.7 |
83.1 to 91.2 |
287 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
76.0 |
69.6 to 81.4 |
291 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
91.6 |
87.5 to 94.4 |
298 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
79.9 |
74.0 to 84.8 |
343 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
82.1 |
75.2 to 87.4 |
320 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
92.9 |
88.6 to 95.7 |
393 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
94.1 |
90.6 to 96.4 |
307 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
90.4 |
85.0 to 93.9 |
369 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
68.5 |
61.8 to 74.5 |
284 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
70.3 |
63.2 to 76.6 |
280 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
75.1 |
68.9 to 80.5 |
320 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
88.9 |
84.2 to 92.4 |
301 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
81.5 |
75.8 to 86.0 |
335 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
93.9 |
90.0 to 96.3 |
345 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
83.4 |
77.3 to 88.2 |
322 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
79.1 |
73.6 to 83.7 |
357 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
83.5 |
79.6 to 86.7 |
710 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
84.5 |
78.7 to 89.0 |
300 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
82.8 |
77.5 to 87.0 |
410 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
79.4 |
73.4 to 84.2 |
306 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
91.2 |
87.2 to 94.1 |
344 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
76.6 |
70.6 to 81.6 |
319 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
75.6 |
70.4 to 80.2 |
426 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
88.6 |
84.5 to 91.7 |
364 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
93.9 |
90.6 to 96.1 |
751 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
93.2 |
88.4 to 96.1 |
307 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
94.0 |
90.2 to 96.4 |
444 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
84.0 |
82.9 to 85.0 |
18264 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
93.1 |
91.1 to 94.7 |
2050 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
83.5 |
80.3 to 86.2 |
1032 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
84.4 |
81.4 to 87.0 |
2241 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
82.0 |
79.7 to 84.1 |
2374 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
88.1 |
86.2 to 89.7 |
2264 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
83.3 |
80.4 to 85.8 |
2505 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
77.6 |
74.0 to 80.7 |
1251 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
79.8 |
76.8 to 82.5 |
1913 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
82.8 |
78.3 to 86.5 |
1318 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
94.5 |
90.7 to 96.8 |
315 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
68.5 |
61.4 to 74.8 |
296 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
66.9 |
60.2 to 73.0 |
292 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
85.3 |
79.7 to 89.5 |
304 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
84.5 |
80.2 to 87.9 |
1112 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
85.3 |
80.2 to 89.3 |
317 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
86.3 |
79.6 to 91.1 |
278 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
84.2 |
79.3 to 88.2 |
517 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
80.0 |
74.7 to 84.4 |
332 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
84.0 |
80.6 to 86.9 |
1316 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
76.1 |
69.7 to 81.6 |
301 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
94.2 |
90.4 to 96.5 |
326 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
73.8 |
65.3 to 80.9 |
302 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
82.1 |
75.8 to 86.9 |
360 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
73.5 |
67.2 to 79.0 |
328 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
95.2 |
91.5 to 97.3 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
93.2 |
89.3 to 95.7 |
325 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
83.3 |
78.0 to 87.6 |
378 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
83.4 |
78.3 to 87.6 |
377 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
78.2 |
72.3 to 83.2 |
421 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
74.3 |
68.2 to 79.7 |
368 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
84.9 |
79.5 to 89.1 |
356 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
87.2 |
82.5 to 90.8 |
394 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
95.8 |
92.5 to 97.7 |
386 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
91.8 |
87.3 to 94.8 |
374 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
91.9 |
86.7 to 95.2 |
285 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
86.3 |
80.6 to 90.4 |
363 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
95.1 |
91.4 to 97.2 |
373 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
80.8 |
75.2 to 85.3 |
363 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
76.7 |
70.5 to 82.0 |
341 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
86.3 |
82.5 to 89.3 |
709 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
87.8 |
81.8 to 92.0 |
274 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
85.9 |
81.4 to 89.5 |
435 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
92.5 |
88.8 to 95.0 |
370 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
79.1 |
73.0 to 84.2 |
328 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
84.1 |
78.6 to 88.3 |
352 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
81.0 |
75.0 to 85.9 |
335 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
92.4 |
87.9 to 95.3 |
335 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
87.3 |
82.4 to 91.0 |
341 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
83.7 |
77.8 to 88.3 |
409 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
94.1 |
89.9 to 96.6 |
358 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
92.2 |
87.6 to 95.2 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
88.7 |
82.9 to 92.7 |
286 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
69.1 |
62.6 to 74.9 |
356 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
72.8 |
66.3 to 78.5 |
361 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
75.0 |
68.9 to 80.3 |
367 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
87.5 |
82.2 to 91.4 |
321 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
77.4 |
72.0 to 82.1 |
351 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
95.6 |
92.4 to 97.5 |
402 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
86.1 |
81.0 to 89.9 |
328 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
81.4 |
75.8 to 86.0 |
378 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
83.5 |
79.5 to 86.8 |
594 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
87.4 |
81.8 to 91.4 |
288 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
81.0 |
75.4 to 85.6 |
306 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
77.8 |
72.3 to 82.5 |
372 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
89.5 |
84.1 to 93.2 |
327 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
80.1 |
74.3 to 84.8 |
430 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
86.5 |
82.0 to 90.1 |
356 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
79.4 |
73.5 to 84.3 |
399 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
95.3 |
92.2 to 97.2 |
785 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
92.7 |
87.3 to 95.9 |
343 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
95.6 |
92.0 to 97.6 |
442 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
79.5 |
70.8 to 86.1 |
230 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
85.0 |
84.0 to 85.9 |
20827 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
94.3 |
92.4 to 95.8 |
2268 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
84.3 |
81.3 to 86.9 |
922 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
87.0 |
84.5 to 89.2 |
2553 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
83.8 |
81.8 to 85.6 |
2896 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
87.8 |
85.9 to 89.5 |
2465 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
85.0 |
82.3 to 87.4 |
3089 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
78.6 |
75.3 to 81.6 |
1362 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
82.3 |
79.7 to 84.7 |
2290 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
83.5 |
79.3 to 86.9 |
1491 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
96.9 |
94.0 to 98.4 |
414 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
66.8 |
60.2 to 72.7 |
380 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
74.1 |
67.9 to 79.4 |
358 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
88.8 |
83.8 to 92.5 |
339 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
85.0 |
81.1 to 88.3 |
1652 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
87.0 |
82.4 to 90.6 |
385 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
85.3 |
79.5 to 89.6 |
379 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
82.5 |
75.8 to 87.6 |
397 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
85.0 |
80.3 to 88.8 |
491 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
81.3 |
78.0 to 84.1 |
1491 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
76.5 |
70.8 to 81.4 |
398 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
94.8 |
90.6 to 97.1 |
367 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
79.5 |
72.4 to 85.1 |
350 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
83.3 |
77.8 to 87.6 |
374 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
71.1 |
64.7 to 76.7 |
350 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
93.0 |
88.3 to 95.9 |
340 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
91.0 |
87.4 to 93.7 |
446 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
89.2 |
84.8 to 92.5 |
361 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
87.8 |
83.1 to 91.3 |
350 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
82.1 |
77.2 to 86.1 |
444 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
87.2 |
82.3 to 90.8 |
362 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
81.7 |
75.6 to 86.5 |
350 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
93.1 |
89.7 to 95.4 |
354 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
94.4 |
90.9 to 96.6 |
358 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
92.6 |
88.7 to 95.3 |
360 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
89.3 |
84.6 to 92.7 |
418 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
87.1 |
81.5 to 91.2 |
321 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
94.3 |
90.5 to 96.7 |
374 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
73.6 |
68.2 to 78.3 |
419 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
85.9 |
81.2 to 89.6 |
340 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
77.7 |
71.9 to 82.7 |
356 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
87.5 |
84.2 to 90.2 |
779 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
90.3 |
85.8 to 93.5 |
283 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
86.9 |
82.9 to 90.1 |
496 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
94.0 |
90.3 to 96.3 |
328 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
83.5 |
78.4 to 87.5 |
383 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
85.8 |
80.6 to 89.8 |
375 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
82.4 |
77.0 to 86.8 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
94.1 |
91.1 to 96.2 |
382 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
87.5 |
82.8 to 91.1 |
374 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
85.6 |
80.1 to 89.7 |
403 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
96.3 |
93.0 to 98.1 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
94.2 |
90.9 to 96.3 |
373 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
91.8 |
87.1 to 94.8 |
366 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
78.4 |
73.2 to 82.8 |
364 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
75.2 |
68.8 to 80.6 |
300 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
80.7 |
75.7 to 84.9 |
406 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
90.7 |
86.5 to 93.8 |
393 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
85.1 |
79.9 to 89.2 |
372 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
96.5 |
92.8 to 98.3 |
295 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
87.4 |
82.5 to 91.1 |
364 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
83.7 |
78.9 to 87.6 |
396 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
86.7 |
83.2 to 89.6 |
665 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
84.4 |
78.9 to 88.6 |
313 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
88.3 |
83.5 to 91.8 |
352 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
85.9 |
81.1 to 89.6 |
358 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
92.6 |
88.0 to 95.5 |
323 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
80.4 |
74.0 to 85.5 |
332 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
80.8 |
74.9 to 85.7 |
291 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
88.6 |
84.3 to 91.9 |
353 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
92.2 |
88.3 to 94.9 |
832 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
91.3 |
87.5 to 94.0 |
340 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
92.3 |
87.8 to 95.3 |
492 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
86.2 |
80.9 to 90.2 |
339 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
86.1 |
85.2 to 87.0 |
21875 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
95.1 |
93.5 to 96.4 |
2188 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
87.0 |
84.2 to 89.3 |
1029 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
84.8 |
81.9 to 87.3 |
2742 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
86.9 |
84.9 to 88.6 |
2793 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
89.2 |
87.3 to 90.8 |
2543 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
86.0 |
84.0 to 87.7 |
4048 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
81.4 |
78.3 to 84.2 |
1451 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
84.6 |
82.2 to 86.7 |
2120 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
82.0 |
77.4 to 85.9 |
1506 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
96.6 |
94.0 to 98.1 |
419 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
74.5 |
68.7 to 79.5 |
360 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
75.1 |
69.3 to 80.2 |
349 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
89.5 |
84.4 to 93.1 |
325 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
85.4 |
82.7 to 87.7 |
2617 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
83.4 |
77.9 to 87.7 |
368 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
82.5 |
76.1 to 87.5 |
259 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
81.9 |
77.3 to 85.8 |
558 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
86.2 |
82.8 to 89.0 |
946 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
83.7 |
79.4 to 87.2 |
458 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
85.0 |
82.1 to 87.5 |
1455 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
73.5 |
67.5 to 78.7 |
357 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
97.1 |
94.8 to 98.4 |
404 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
73.7 |
65.9 to 80.3 |
385 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
84.7 |
79.7 to 88.6 |
396 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
76.8 |
71.0 to 81.7 |
344 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
93.8 |
90.1 to 96.2 |
365 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
88.8 |
83.8 to 92.4 |
331 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
88.0 |
83.5 to 91.4 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
90.3 |
85.9 to 93.5 |
392 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
79.5 |
73.4 to 84.4 |
329 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
90.5 |
86.2 to 93.6 |
352 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
83.4 |
77.6 to 87.9 |
327 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
91.4 |
86.7 to 94.6 |
322 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
96.9 |
93.8 to 98.5 |
357 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
93.3 |
89.7 to 95.7 |
375 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
95.9 |
93.4 to 97.5 |
377 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
93.3 |
89.3 to 95.8 |
376 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
97.3 |
93.5 to 98.9 |
367 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
70.9 |
65.7 to 75.6 |
535 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
89.1 |
84.3 to 92.6 |
317 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
80.0 |
74.5 to 84.6 |
358 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
93.6 |
91.1 to 95.4 |
605 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
91.3 |
84.3 to 95.3 |
157 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
94.1 |
91.2 to 96.0 |
448 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
93.0 |
89.0 to 95.7 |
350 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
85.6 |
81.1 to 89.1 |
382 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
91.3 |
86.8 to 94.4 |
322 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
90.2 |
85.8 to 93.3 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
96.0 |
92.8 to 97.8 |
336 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
91.7 |
88.0 to 94.3 |
347 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
83.0 |
77.1 to 87.6 |
451 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
97.5 |
95.4 to 98.6 |
374 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
96.6 |
93.9 to 98.1 |
283 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
89.5 |
84.4 to 93.1 |
375 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
79.9 |
74.3 to 84.5 |
377 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
76.4 |
70.2 to 81.6 |
360 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
87.6 |
82.3 to 91.5 |
375 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
89.0 |
83.9 to 92.6 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
87.6 |
82.3 to 91.6 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
95.2 |
91.1 to 97.5 |
313 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
89.0 |
84.7 to 92.2 |
422 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
87.2 |
82.8 to 90.7 |
374 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
90.2 |
86.9 to 92.7 |
655 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
87.7 |
82.2 to 91.7 |
291 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
91.7 |
87.4 to 94.6 |
364 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
81.4 |
75.5 to 86.1 |
366 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
93.4 |
88.7 to 96.2 |
293 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
84.5 |
79.0 to 88.8 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
80.3 |
74.0 to 85.4 |
281 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
83.7 |
77.8 to 88.3 |
318 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
92.9 |
89.9 to 95.1 |
875 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
92.4 |
88.6 to 95.0 |
349 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
93.0 |
89.5 to 95.4 |
526 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
90.0 |
85.8 to 93.0 |
405 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
87.8 |
86.9 to 88.6 |
20475 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
96.4 |
95.2 to 97.3 |
2097 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
89.8 |
87.3 to 91.8 |
1077 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
87.0 |
84.5 to 89.1 |
2842 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
89.1 |
87.5 to 90.6 |
2757 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
91.8 |
90.2 to 93.1 |
2284 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
85.5 |
83.3 to 87.4 |
3270 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
83.4 |
80.4 to 86.0 |
1394 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
85.1 |
82.3 to 87.6 |
2022 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
83.2 |
78.8 to 86.9 |
1303 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
94.6 |
90.5 to 97.0 |
326 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
77.0 |
70.6 to 82.3 |
314 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
83.4 |
77.8 to 87.8 |
342 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
89.4 |
83.6 to 93.3 |
291 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
83.9 |
80.9 to 86.5 |
1927 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
86.8 |
81.7 to 90.6 |
334 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
79.9 |
71.0 to 86.6 |
225 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
82.3 |
76.0 to 87.3 |
294 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
85.6 |
79.6 to 90.1 |
345 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
84.1 |
80.2 to 87.3 |
729 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
80.9 |
76.1 to 85.0 |
428 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
85.8 |
82.7 to 88.5 |
1429 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
73.4 |
67.0 to 79.0 |
317 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
96.0 |
93.0 to 97.8 |
380 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
81.1 |
74.3 to 86.4 |
451 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
88.1 |
82.8 to 92.0 |
361 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
81.3 |
75.8 to 85.8 |
313 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
94.6 |
91.2 to 96.8 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
91.3 |
87.3 to 94.1 |
373 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
87.9 |
83.6 to 91.1 |
367 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
90.9 |
87.0 to 93.8 |
349 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
85.1 |
79.9 to 89.2 |
335 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
92.3 |
88.5 to 95.0 |
357 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
85.7 |
79.7 to 90.1 |
306 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
91.1 |
87.1 to 93.9 |
354 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
98.1 |
94.4 to 99.4 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
91.6 |
86.9 to 94.7 |
350 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
92.3 |
86.8 to 95.6 |
318 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
90.8 |
86.1 to 93.9 |
415 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
96.6 |
93.1 to 98.4 |
343 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
72.4 |
66.5 to 77.5 |
382 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
89.7 |
84.9 to 93.1 |
314 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
85.0 |
79.7 to 89.1 |
353 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
94.0 |
91.8 to 95.7 |
683 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
88.0 |
80.8 to 92.8 |
204 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
95.3 |
93.0 to 96.9 |
479 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
96.7 |
93.2 to 98.5 |
334 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
90.5 |
86.2 to 93.5 |
343 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
89.1 |
84.2 to 92.6 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
90.1 |
85.6 to 93.3 |
372 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
95.7 |
92.1 to 97.7 |
341 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
94.5 |
91.1 to 96.7 |
347 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
88.9 |
82.7 to 93.0 |
470 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
94.1 |
90.2 to 96.5 |
412 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
96.4 |
93.0 to 98.1 |
328 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
92.2 |
87.9 to 95.1 |
356 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
91.1 |
87.2 to 93.9 |
347 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
79.9 |
74.4 to 84.4 |
335 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
93.8 |
89.9 to 96.3 |
326 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
94.1 |
89.6 to 96.7 |
324 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
88.7 |
83.9 to 92.2 |
344 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
95.7 |
92.0 to 97.7 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
87.8 |
83.1 to 91.3 |
366 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
84.2 |
79.1 to 88.2 |
362 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
94.5 |
91.9 to 96.3 |
651 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
92.9 |
88.7 to 95.7 |
281 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
95.5 |
91.8 to 97.6 |
370 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
92.0 |
88.1 to 94.7 |
336 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
93.5 |
90.2 to 95.8 |
379 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
91.0 |
87.6 to 93.5 |
408 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
83.4 |
78.3 to 87.5 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
88.3 |
83.9 to 91.6 |
359 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
95.1 |
92.3 to 96.9 |
851 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
95.6 |
92.5 to 97.5 |
362 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
95.0 |
91.8 to 97.0 |
489 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
90.1 |
89.3 to 90.9 |
20949 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
95.5 |
93.7 to 96.8 |
2107 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
92.3 |
90.1 to 94.0 |
1017 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
90.7 |
88.4 to 92.6 |
2745 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
91.2 |
89.6 to 92.5 |
2846 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
94.2 |
93.0 to 95.2 |
2433 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
86.7 |
84.8 to 88.3 |
3654 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
86.2 |
83.5 to 88.5 |
1340 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
89.2 |
86.9 to 91.1 |
2108 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
85.9 |
81.3 to 89.4 |
1299 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
96.6 |
92.9 to 98.4 |
319 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
81.2 |
75.3 to 86.0 |
328 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
86.0 |
81.0 to 89.9 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
92.2 |
87.9 to 95.1 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
85.3 |
82.7 to 87.6 |
2256 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
87.7 |
82.6 to 91.4 |
336 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
85.0 |
77.8 to 90.2 |
187 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
73.8 |
66.1 to 80.2 |
263 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
86.5 |
80.9 to 90.7 |
320 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
86.8 |
81.6 to 90.7 |
304 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
86.4 |
82.9 to 89.3 |
846 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
90.5 |
88.3 to 92.3 |
1400 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
84.8 |
79.8 to 88.7 |
356 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
94.6 |
90.9 to 96.8 |
366 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
87.7 |
81.2 to 92.2 |
413 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
93.2 |
89.7 to 95.5 |
339 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
79.6 |
73.9 to 84.2 |
343 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
96.0 |
93.3 to 97.7 |
324 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
92.2 |
87.9 to 95.1 |
360 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
90.3 |
85.5 to 93.6 |
327 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
90.3 |
86.3 to 93.2 |
392 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
83.8 |
77.8 to 88.4 |
288 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
91.4 |
86.7 to 94.6 |
308 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
88.0 |
82.7 to 91.9 |
356 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
91.7 |
86.1 to 95.1 |
278 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
96.8 |
93.3 to 98.6 |
293 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
94.5 |
89.8 to 97.1 |
306 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
94.8 |
90.7 to 97.1 |
337 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
96.8 |
93.2 to 98.5 |
345 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
71.6 |
64.9 to 77.4 |
309 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
92.1 |
88.3 to 94.8 |
327 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
87.6 |
82.5 to 91.3 |
291 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
94.5 |
92.1 to 96.2 |
721 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
92.9 |
85.6 to 96.6 |
192 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
94.8 |
92.2 to 96.6 |
529 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
97.8 |
95.0 to 99.0 |
296 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
94.9 |
90.9 to 97.1 |
280 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
85.2 |
79.1 to 89.7 |
297 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
91.6 |
87.1 to 94.7 |
270 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
94.1 |
89.0 to 96.9 |
284 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
91.9 |
86.8 to 95.1 |
317 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
93.4 |
89.3 to 95.9 |
393 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
98.8 |
96.9 to 99.5 |
328 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
94.1 |
89.7 to 96.7 |
313 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
94.2 |
89.5 to 96.8 |
285 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
90.4 |
85.7 to 93.7 |
285 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
86.9 |
82.0 to 90.7 |
319 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
92.0 |
87.6 to 94.9 |
290 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
92.9 |
88.3 to 95.8 |
295 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
88.6 |
83.8 to 92.1 |
334 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
96.9 |
92.9 to 98.7 |
303 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
87.1 |
81.4 to 91.2 |
351 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
91.0 |
86.2 to 94.2 |
295 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
93.4 |
90.2 to 95.6 |
535 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
93.8 |
89.4 to 96.4 |
261 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
93.1 |
88.3 to 96.0 |
274 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
91.2 |
86.8 to 94.3 |
341 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
96.7 |
93.6 to 98.3 |
287 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
92.7 |
88.7 to 95.4 |
329 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
81.0 |
75.6 to 85.5 |
360 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
89.9 |
85.2 to 93.2 |
297 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
96.0 |
93.4 to 97.6 |
649 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
93.5 |
87.9 to 96.7 |
237 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
96.3 |
93.3 to 98.0 |
412 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
90.8 |
90.0 to 91.6 |
18700 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
97.2 |
96.1 to 98.0 |
1902 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
91.3 |
88.6 to 93.4 |
886 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
92.0 |
89.7 to 93.8 |
2295 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
93.2 |
91.7 to 94.4 |
2507 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
94.2 |
92.8 to 95.3 |
2276 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
85.9 |
83.8 to 87.7 |
3326 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
89.2 |
86.6 to 91.3 |
1191 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
90.8 |
88.1 to 93.0 |
1746 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
87.6 |
83.5 to 90.8 |
1305 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
96.4 |
93.2 to 98.2 |
337 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
87.0 |
82.3 to 90.6 |
318 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
92.6 |
88.5 to 95.3 |
340 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
94.2 |
90.3 to 96.6 |
284 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
84.4 |
81.6 to 86.8 |
2079 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
84.8 |
79.1 to 89.2 |
298 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
82.4 |
74.8 to 88.1 |
186 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
82.9 |
76.4 to 87.9 |
314 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
86.6 |
81.9 to 90.3 |
364 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
84.4 |
80.7 to 87.4 |
917 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
87.8 |
84.6 to 90.5 |
1266 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
88.0 |
82.9 to 91.8 |
310 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
94.9 |
91.8 to 96.9 |
324 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
87.3 |
79.9 to 92.3 |
327 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
86.5 |
80.6 to 90.9 |
286 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
83.2 |
78.0 to 87.4 |
337 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
92.3 |
88.1 to 95.1 |
332 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
90.1 |
84.8 to 93.7 |
241 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
95.1 |
91.1 to 97.3 |
296 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
92.8 |
89.2 to 95.2 |
426 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
86.6 |
81.4 to 90.6 |
308 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
96.0 |
93.0 to 97.7 |
329 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
86.6 |
78.6 to 92.0 |
274 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
94.2 |
89.2 to 97.0 |
262 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
94.7 |
90.2 to 97.2 |
294 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
94.3 |
89.5 to 97.0 |
308 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
87.3 |
80.0 to 92.2 |
282 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
93.9 |
88.3 to 96.9 |
329 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
95.2 |
90.9 to 97.5 |
315 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
76.2 |
70.1 to 81.4 |
278 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
89.5 |
84.2 to 93.2 |
304 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
86.6 |
81.1 to 90.7 |
332 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
93.2 |
90.0 to 95.4 |
602 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
88.3 |
80.4 to 93.2 |
160 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
94.2 |
90.4 to 96.5 |
442 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
94.8 |
90.6 to 97.2 |
289 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
97.1 |
94.7 to 98.4 |
302 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
89.9 |
85.5 to 93.1 |
381 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
95.2 |
91.3 to 97.3 |
292 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
95.9 |
92.9 to 97.7 |
336 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
92.3 |
87.4 to 95.5 |
316 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
93.2 |
89.3 to 95.8 |
524 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
96.9 |
92.6 to 98.7 |
300 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
95.8 |
92.0 to 97.9 |
297 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
95.6 |
91.4 to 97.8 |
276 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
91.6 |
86.3 to 94.9 |
270 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
89.1 |
83.0 to 93.2 |
288 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
90.3 |
85.2 to 93.8 |
297 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
90.3 |
84.8 to 94.0 |
285 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
89.1 |
83.8 to 92.8 |
313 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
93.8 |
89.2 to 96.6 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
90.1 |
84.8 to 93.7 |
331 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
88.9 |
83.9 to 92.4 |
405 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
94.3 |
91.5 to 96.2 |
498 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
90.1 |
83.9 to 94.1 |
257 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
97.0 |
94.4 to 98.5 |
241 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
92.1 |
87.5 to 95.1 |
305 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
95.9 |
91.8 to 98.0 |
319 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
92.9 |
88.9 to 95.6 |
302 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
89.4 |
85.3 to 92.5 |
369 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
95.1 |
91.3 to 97.3 |
270 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
96.8 |
94.7 to 98.1 |
734 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
96.1 |
92.7 to 97.9 |
242 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
96.9 |
94.5 to 98.3 |
492 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
92.1 |
83.4 to 96.4 |
216 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
91.5 |
90.4 to 92.4 |
18788 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
95.6 |
93.7 to 96.9 |
2034 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
92.9 |
90.5 to 94.8 |
829 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
94.2 |
92.5 to 95.6 |
2520 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
93.6 |
91.9 to 95.0 |
2387 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
94.4 |
93.0 to 95.5 |
2097 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
86.4 |
84.2 to 88.4 |
3289 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
91.2 |
88.5 to 93.4 |
1256 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
91.5 |
88.9 to 93.6 |
1845 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
86.9 |
80.8 to 91.2 |
1199 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
95.9 |
92.6 to 97.8 |
319 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
92.3 |
88.1 to 95.0 |
319 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
91.9 |
87.3 to 94.9 |
313 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
92.4 |
87.9 to 95.4 |
261 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
83.6 |
80.5 to 86.3 |
1850 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
87.2 |
81.5 to 91.3 |
293 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
87.0 |
78.6 to 92.4 |
174 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
80.5 |
73.7 to 85.8 |
271 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
91.2 |
86.0 to 94.6 |
280 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
83.0 |
78.9 to 86.5 |
832 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
80.1 |
72.1 to 86.2 |
218 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
92.1 |
89.5 to 94.1 |
1332 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
86.8 |
80.9 to 91.1 |
325 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
95.9 |
92.5 to 97.8 |
472 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
92.8 |
87.5 to 95.9 |
363 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
92.0 |
87.1 to 95.2 |
304 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
87.9 |
82.8 to 91.6 |
309 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
96.3 |
93.4 to 97.9 |
331 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
95.1 |
91.3 to 97.3 |
329 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
95.2 |
91.7 to 97.3 |
298 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
92.0 |
87.5 to 94.9 |
302 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
85.6 |
80.4 to 89.6 |
340 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
96.2 |
92.4 to 98.1 |
322 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
87.1 |
81.3 to 91.2 |
403 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
93.8 |
90.0 to 96.2 |
354 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
96.9 |
93.8 to 98.5 |
331 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
94.3 |
90.4 to 96.7 |
360 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
87.0 |
81.7 to 91.0 |
404 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
95.2 |
91.6 to 97.4 |
355 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
96.3 |
93.0 to 98.1 |
300 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
74.8 |
68.2 to 80.5 |
300 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
92.0 |
87.3 to 95.0 |
290 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
90.3 |
85.7 to 93.5 |
376 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
94.4 |
91.6 to 96.3 |
699 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
90.6 |
83.5 to 94.9 |
271 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
95.2 |
91.9 to 97.2 |
428 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
97.4 |
95.0 to 98.7 |
302 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
96.6 |
93.8 to 98.1 |
280 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
92.4 |
87.9 to 95.3 |
364 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
96.8 |
93.6 to 98.4 |
255 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
96.1 |
93.1 to 97.8 |
356 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
96.2 |
92.8 to 98.0 |
372 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
94.2 |
91.7 to 95.9 |
815 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
96.2 |
93.4 to 97.9 |
394 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
95.6 |
92.2 to 97.5 |
398 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
97.3 |
94.5 to 98.7 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
95.5 |
91.4 to 97.7 |
282 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
91.9 |
87.9 to 94.7 |
397 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
93.8 |
89.7 to 96.3 |
307 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
88.7 |
84.1 to 92.2 |
405 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
85.1 |
79.0 to 89.6 |
369 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
99.0 |
97.4 to 99.6 |
381 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
90.9 |
86.0 to 94.2 |
379 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
94.1 |
90.4 to 96.4 |
352 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
94.1 |
91.3 to 96.0 |
729 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
90.3 |
85.3 to 93.7 |
381 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
96.5 |
92.5 to 98.4 |
348 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
96.6 |
92.4 to 98.5 |
327 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
97.2 |
94.3 to 98.7 |
401 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
92.4 |
88.1 to 95.2 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
90.9 |
86.5 to 94.0 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
94.4 |
90.7 to 96.7 |
308 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
95.0 |
91.7 to 97.0 |
765 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
94.4 |
89.7 to 97.0 |
263 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
95.0 |
91.3 to 97.2 |
502 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
67.8 |
55.8 to 77.8 |
169 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
92.6 |
91.7 to 93.3 |
20163 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
96.6 |
95.3 to 97.6 |
2147 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
93.0 |
90.7 to 94.8 |
1108 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
93.9 |
92.3 to 95.2 |
3331 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
95.3 |
94.0 to 96.3 |
2466 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
94.9 |
93.6 to 95.9 |
2344 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
90.0 |
87.6 to 92.0 |
2509 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
92.6 |
90.6 to 94.2 |
1446 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
92.7 |
90.6 to 94.4 |
2007 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
86.9 |
82.5 to 90.2 |
1402 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
96.4 |
92.7 to 98.3 |
271 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
90.8 |
85.4 to 94.3 |
311 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
95.8 |
92.2 to 97.8 |
317 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
93.9 |
90.0 to 96.4 |
338 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
88.2 |
84.7 to 91.0 |
1141 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
85.8 |
80.7 to 89.7 |
314 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
85.0 |
78.2 to 90.0 |
221 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
88.6 |
84.5 to 91.7 |
606 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
93.1 |
90.7 to 94.9 |
1403 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
89.4 |
84.6 to 92.9 |
304 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
95.8 |
92.6 to 97.6 |
398 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
93.2 |
89.4 to 95.6 |
677 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
93.3 |
88.9 to 96.0 |
417 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
90.1 |
85.8 to 93.2 |
310 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
94.1 |
89.6 to 96.7 |
277 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
92.9 |
88.6 to 95.6 |
324 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
96.1 |
92.2 to 98.1 |
304 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
90.5 |
85.1 to 94.0 |
268 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
89.1 |
84.1 to 92.7 |
296 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
94.3 |
90.0 to 96.8 |
314 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
89.2 |
82.0 to 93.7 |
286 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
95.0 |
91.5 to 97.0 |
298 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
96.4 |
92.6 to 98.2 |
340 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
93.6 |
89.0 to 96.3 |
310 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
86.9 |
81.5 to 90.8 |
409 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
95.7 |
91.2 to 98.0 |
312 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
94.0 |
87.4 to 97.3 |
260 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
68.9 |
60.7 to 76.1 |
225 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
92.3 |
87.1 to 95.5 |
258 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
90.1 |
85.3 to 93.5 |
334 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
94.4 |
91.5 to 96.4 |
578 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
93.6 |
84.0 to 97.6 |
144 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
94.6 |
91.4 to 96.6 |
434 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
92.7 |
87.4 to 95.9 |
268 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
97.3 |
94.5 to 98.7 |
199 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
92.9 |
87.5 to 96.1 |
300 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
95.3 |
90.8 to 97.7 |
240 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
94.5 |
90.0 to 97.0 |
303 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
95.0 |
91.5 to 97.1 |
293 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
92.9 |
90.0 to 94.9 |
857 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
96.3 |
90.8 to 98.6 |
266 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
90.2 |
84.7 to 93.8 |
358 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
97.0 |
94.0 to 98.5 |
296 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
91.9 |
86.7 to 95.2 |
303 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
89.8 |
84.4 to 93.5 |
340 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
95.5 |
92.5 to 97.4 |
290 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
94.5 |
90.9 to 96.7 |
315 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
90.0 |
85.0 to 93.5 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
98.2 |
95.2 to 99.3 |
282 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
86.8 |
80.4 to 91.3 |
292 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
88.9 |
84.0 to 92.5 |
337 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
94.7 |
91.2 to 96.9 |
581 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
92.1 |
86.1 to 95.6 |
297 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
96.5 |
91.0 to 98.7 |
284 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
93.3 |
86.9 to 96.7 |
266 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
95.2 |
90.4 to 97.7 |
191 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
95.0 |
89.2 to 97.8 |
254 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
90.8 |
86.3 to 93.9 |
240 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
93.2 |
88.2 to 96.1 |
294 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
92.7 |
89.5 to 95.0 |
929 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
94.3 |
89.9 to 96.9 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
92.5 |
88.9 to 95.0 |
599 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
82.5 |
76.7 to 87.1 |
350 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
92.2 |
91.2 to 93.1 |
18002 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
96.2 |
94.0 to 97.7 |
1923 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
92.0 |
89.1 to 94.3 |
873 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
92.6 |
90.7 to 94.0 |
3338 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
94.8 |
93.0 to 96.1 |
2263 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
93.9 |
92.2 to 95.2 |
2060 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
87.8 |
84.7 to 90.4 |
2184 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
92.8 |
90.3 to 94.7 |
1154 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
94.5 |
92.6 to 95.9 |
1789 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
89.3 |
84.0 to 93.0 |
1173 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
94.8 |
89.1 to 97.6 |
254 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
95.4 |
92.0 to 97.4 |
263 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
98.1 |
96.3 to 99.1 |
445 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
95.3 |
91.6 to 97.4 |
315 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
85.8 |
81.4 to 89.3 |
990 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
85.5 |
79.2 to 90.1 |
296 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
81.6 |
71.5 to 88.7 |
167 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
86.2 |
81.1 to 90.0 |
527 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
84.9 |
76.7 to 90.5 |
245 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
91.1 |
88.1 to 93.5 |
1245 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
93.2 |
88.6 to 96.0 |
304 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
95.4 |
92.9 to 97.1 |
488 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
93.7 |
88.9 to 96.5 |
566 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
90.4 |
84.8 to 94.1 |
349 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
85.3 |
78.9 to 90.0 |
267 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
94.9 |
90.8 to 97.2 |
306 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
91.6 |
86.5 to 94.9 |
261 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
93.5 |
88.7 to 96.4 |
269 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
93.3 |
88.1 to 96.3 |
240 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
92.7 |
88.4 to 95.4 |
273 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
93.2 |
89.2 to 95.8 |
332 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
85.5 |
79.4 to 90.1 |
321 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
93.1 |
89.4 to 95.5 |
342 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
95.8 |
91.9 to 97.9 |
258 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
93.3 |
87.9 to 96.4 |
250 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
76.8 |
68.1 to 83.6 |
237 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
98.0 |
96.0 to 99.0 |
307 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
94.0 |
89.1 to 96.8 |
333 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
72.3 |
63.8 to 79.4 |
240 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
92.7 |
87.6 to 95.8 |
237 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
94.1 |
89.9 to 96.6 |
251 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
93.8 |
90.9 to 95.9 |
630 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
90.4 |
84.9 to 94.1 |
256 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
94.6 |
91.0 to 96.8 |
374 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
95.4 |
91.5 to 97.6 |
258 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
96.1 |
91.6 to 98.2 |
207 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
91.1 |
86.4 to 94.3 |
310 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
94.4 |
89.5 to 97.1 |
276 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
96.1 |
92.9 to 97.9 |
330 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
95.1 |
90.6 to 97.5 |
268 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
94.2 |
89.0 to 97.0 |
346 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
97.6 |
95.1 to 98.8 |
268 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
92.6 |
86.5 to 96.1 |
257 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
96.4 |
92.9 to 98.2 |
331 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
90.0 |
84.5 to 93.7 |
232 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
91.3 |
86.1 to 94.6 |
284 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
95.3 |
91.9 to 97.3 |
297 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
89.5 |
83.9 to 93.3 |
247 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
89.1 |
83.5 to 92.9 |
259 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
97.5 |
94.5 to 98.9 |
225 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
91.5 |
86.8 to 94.6 |
289 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
89.4 |
83.4 to 93.4 |
276 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
96.0 |
93.6 to 97.6 |
536 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
94.0 |
88.4 to 97.0 |
222 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
97.4 |
95.0 to 98.6 |
314 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
95.7 |
92.0 to 97.8 |
361 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
97.1 |
93.3 to 98.7 |
280 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
90.6 |
83.9 to 94.7 |
269 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
86.9 |
80.5 to 91.4 |
249 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
92.8 |
88.3 to 95.6 |
263 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
92.7 |
89.3 to 95.1 |
752 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
96.5 |
93.3 to 98.2 |
267 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
92.2 |
88.3 to 94.9 |
485 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
86.8 |
83.2 to 89.8 |
671 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
91.5 |
90.5 to 92.4 |
16043 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
96.6 |
95.2 to 97.6 |
1595 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
94.5 |
92.3 to 96.0 |
825 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
92.0 |
90.1 to 93.5 |
2424 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
95.1 |
93.8 to 96.1 |
2291 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
93.4 |
91.5 to 94.9 |
2019 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
85.2 |
81.3 to 88.4 |
1981 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
92.1 |
89.6 to 94.0 |
1048 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
92.6 |
90.3 to 94.5 |
1736 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
87.0 |
82.3 to 90.6 |
1090 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
95.7 |
91.5 to 97.8 |
285 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
93.3 |
88.0 to 96.3 |
269 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
95.0 |
91.2 to 97.2 |
252 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
92.8 |
87.9 to 95.9 |
244 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
82.4 |
76.8 to 86.9 |
794 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
91.1 |
86.3 to 94.4 |
253 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
90.5 |
82.3 to 95.1 |
157 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
81.1 |
74.7 to 86.2 |
384 |
| Varicella |
>=2 Doses or history of disease |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
91.3 |
88.0 to 93.7 |
1034 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
90.0 |
83.9 to 93.9 |
271 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
92.7 |
87.5 to 95.8 |
291 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
89.8 |
86.1 to 92.5 |
595 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
89.4 |
83.3 to 93.5 |
280 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
92.8 |
87.7 to 95.9 |
244 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
93.8 |
88.7 to 96.6 |
274 |
| Varicella |
>=2 Doses or history of disease |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
94.0 |
89.7 to 96.5 |
294 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2006 |
Age |
13-15 Years |
4.6 |
3.0 to 6.9 |
648 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2007 |
Age |
13-15 Years |
20.6 |
17.1 to 24.6 |
761 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-15 Years |
23.5 |
13.1 to 38.5 |
52 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-15 Years |
28.2 |
18.5 to 40.6 |
101 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-15 Years |
17.3 |
10.4 to 27.5 |
126 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-15 Years |
32.0 |
22.0 to 43.9 |
145 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-15 Years |
18.2 |
11.1 to 28.3 |
124 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2008 |
Age |
13-15 Years |
18.0 |
12.0 to 26.1 |
135 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2008 |
Age |
13-15 Years |
28.4 |
18.7 to 40.5 |
70 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2008 |
Age |
13-15 Years |
41.1 |
28.5 to 55.0 |
68 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2008 |
Age |
13-15 Years |
20.2 |
12.8 to 30.4 |
111 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2008 |
Age |
13-15 Years |
46.7 |
34.7 to 59.1 |
108 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2008 |
Age |
13-15 Years |
54.2 |
41.7 to 66.2 |
101 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2008 |
Age |
13-15 Years |
62.3 |
50.0 to 73.1 |
95 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2008 |
Age |
13-15 Years |
40.9 |
30.2 to 52.5 |
102 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-15 Years |
48.6 |
38.4 to 58.9 |
124 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2008 |
Age |
13-15 Years |
20.4 |
12.7 to 31.3 |
87 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2008 |
Age |
13-15 Years |
49.4 |
38.1 to 60.8 |
104 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2008 |
Age |
13-15 Years |
49.1 |
38.8 to 59.5 |
115 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2008 |
Age |
13-15 Years |
32.3 |
23.5 to 42.7 |
210 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-15 Years |
23.4 |
15.6 to 33.6 |
101 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-15 Years |
35.1 |
23.8 to 48.3 |
109 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2008 |
Age |
13-15 Years |
27.8 |
19.0 to 38.6 |
92 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2008 |
Age |
13-15 Years |
30.7 |
18.9 to 45.7 |
58 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2008 |
Age |
13-15 Years |
26.9 |
16.2 to 41.1 |
63 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2008 |
Age |
13-15 Years |
23.9 |
14.5 to 36.8 |
64 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2008 |
Age |
13-15 Years |
36.6 |
24.5 to 50.7 |
89 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2008 |
Age |
13-15 Years |
43.9 |
32.1 to 56.5 |
80 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2008 |
Age |
13-15 Years |
37.1 |
27.5 to 47.7 |
147 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-15 Years |
34.8 |
24.2 to 47.0 |
104 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2008 |
Age |
13-15 Years |
41.0 |
28.7 to 54.5 |
76 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2008 |
Age |
13-15 Years |
42.7 |
32.1 to 54.0 |
93 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2008 |
Age |
13-15 Years |
32.8 |
20.5 to 48.0 |
81 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2008 |
Age |
13-15 Years |
39.6 |
29.7 to 50.3 |
109 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2008 |
Age |
13-15 Years |
24.1 |
15.5 to 35.5 |
77 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-15 Years |
40.9 |
28.7 to 54.4 |
87 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2008 |
Age |
13-15 Years |
33.9 |
24.2 to 45.1 |
134 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2008 |
Age |
13-15 Years |
30.5 |
20.4 to 43.0 |
95 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2008 |
Age |
13-15 Years |
44.7 |
36.7 to 52.9 |
214 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-15 Years |
56.7 |
45.2 to 67.6 |
114 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-15 Years |
34.0 |
24.3 to 45.3 |
100 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2008 |
Age |
13-15 Years |
25.3 |
17.2 to 35.6 |
95 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2008 |
Age |
13-15 Years |
36.8 |
26.1 to 48.9 |
80 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2008 |
Age |
13-15 Years |
38.2 |
26.4 to 51.5 |
83 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-15 Years |
19.0 |
11.4 to 29.9 |
90 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2008 |
Age |
13-15 Years |
29.0 |
18.9 to 41.8 |
70 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-15 Years |
50.9 |
42.1 to 59.6 |
261 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-15 Years |
49.4 |
39.7 to 59.2 |
133 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-15 Years |
51.1 |
41.2 to 61.0 |
128 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2008 |
Age |
13-15 Years |
36.7 |
34.1 to 39.5 |
5093 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-15 Years |
46.2 |
39.8 to 52.7 |
552 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-15 Years |
41.2 |
34.9 to 47.8 |
348 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-15 Years |
43.0 |
37.5 to 48.7 |
808 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-15 Years |
25.5 |
21.4 to 30.1 |
787 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-15 Years |
36.8 |
31.9 to 42.0 |
614 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-15 Years |
31.4 |
23.5 to 40.6 |
618 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-15 Years |
32.4 |
25.4 to 40.2 |
311 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-15 Years |
38.7 |
31.1 to 46.9 |
427 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-15 Years |
45.0 |
35.1 to 55.2 |
368 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-15 Years |
63.6 |
51.1 to 74.5 |
113 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2008 |
Age |
13-15 Years |
25.4 |
17.5 to 35.4 |
93 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2008 |
Age |
13-15 Years |
34.0 |
22.3 to 48.0 |
233 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-15 Years |
26.8 |
16.2 to 40.9 |
70 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-15 Years |
50.8 |
33.9 to 67.5 |
73 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-15 Years |
32.4 |
18.9 to 49.6 |
90 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-15 Years |
26.7 |
19.6 to 35.1 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2008 |
Age |
13-15 Years |
26.4 |
14.4 to 43.4 |
53 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2008 |
Age |
13-15 Years |
36.2 |
24.7 to 49.4 |
73 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2008 |
Age |
13-15 Years |
36.1 |
25.1 to 48.8 |
90 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2008 |
Age |
13-15 Years |
27.4 |
16.2 to 42.6 |
66 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2008 |
Age |
13-15 Years |
20.2 |
12.2 to 31.6 |
84 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-15 Years |
41.2 |
28.5 to 55.1 |
60 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2008 |
Age |
13-15 Years |
16.7 |
9.8 to 27.1 |
71 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2009 |
Age |
13-15 Years |
37.9 |
28.2 to 48.6 |
108 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2009 |
Age |
13-15 Years |
53.1 |
41.6 to 64.3 |
88 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2009 |
Age |
13-15 Years |
60.4 |
49.2 to 70.6 |
119 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2009 |
Age |
13-15 Years |
25.3 |
16.2 to 37.2 |
120 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2009 |
Age |
13-15 Years |
62.6 |
52.6 to 71.6 |
153 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2009 |
Age |
13-15 Years |
54.6 |
44.7 to 64.2 |
147 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2009 |
Age |
13-15 Years |
64.3 |
53.1 to 74.1 |
130 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2009 |
Age |
13-15 Years |
55.9 |
44.7 to 66.6 |
123 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-15 Years |
76.1 |
67.3 to 83.2 |
196 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2009 |
Age |
13-15 Years |
43.9 |
35.0 to 53.2 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2009 |
Age |
13-15 Years |
73.8 |
63.2 to 82.2 |
141 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2009 |
Age |
13-15 Years |
55.2 |
44.5 to 65.4 |
102 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2009 |
Age |
13-15 Years |
22.3 |
13.5 to 34.6 |
59 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2009 |
Age |
13-15 Years |
42.7 |
34.4 to 51.4 |
246 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-15 Years |
42.4 |
32.8 to 52.7 |
142 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-15 Years |
42.7 |
32.3 to 53.8 |
104 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2009 |
Age |
13-15 Years |
36.3 |
26.9 to 46.9 |
234 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2009 |
Age |
13-15 Years |
37.5 |
26.5 to 50.0 |
82 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2009 |
Age |
13-15 Years |
47.3 |
33.6 to 61.4 |
63 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2009 |
Age |
13-15 Years |
25.5 |
18.3 to 34.3 |
136 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2009 |
Age |
13-15 Years |
50.9 |
38.7 to 63.0 |
95 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2009 |
Age |
13-15 Years |
51.1 |
39.1 to 63.0 |
89 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2009 |
Age |
13-15 Years |
53.1 |
40.8 to 65.1 |
97 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-15 Years |
56.0 |
46.1 to 65.4 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2009 |
Age |
13-15 Years |
49.8 |
40.7 to 58.8 |
170 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2009 |
Age |
13-15 Years |
66.7 |
56.1 to 75.8 |
106 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2009 |
Age |
13-15 Years |
14.8 |
8.8 to 23.9 |
125 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2009 |
Age |
13-15 Years |
44.6 |
34.4 to 55.3 |
107 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2009 |
Age |
13-15 Years |
36.9 |
25.0 to 50.6 |
70 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2009 |
Age |
13-15 Years |
47.0 |
36.0 to 58.4 |
89 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2009 |
Age |
13-15 Years |
39.2 |
29.7 to 49.5 |
131 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-15 Years |
65.8 |
54.6 to 75.5 |
103 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2009 |
Age |
13-15 Years |
50.7 |
41.4 to 60.0 |
153 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2009 |
Age |
13-15 Years |
46.3 |
37.2 to 55.6 |
147 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2009 |
Age |
13-15 Years |
48.9 |
40.0 to 57.8 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-15 Years |
42.7 |
31.0 to 55.2 |
101 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-15 Years |
54.0 |
41.6 to 65.9 |
86 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2009 |
Age |
13-15 Years |
57.6 |
45.2 to 69.1 |
92 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2009 |
Age |
13-15 Years |
60.2 |
47.8 to 71.4 |
73 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2009 |
Age |
13-15 Years |
45.0 |
33.8 to 56.7 |
106 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-15 Years |
25.2 |
18.4 to 33.5 |
127 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2009 |
Age |
13-15 Years |
55.6 |
46.6 to 64.2 |
151 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-15 Years |
65.3 |
54.9 to 74.4 |
268 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-15 Years |
65.3 |
56.8 to 73.0 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-15 Years |
65.3 |
53.0 to 75.9 |
102 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2009 |
Age |
13-15 Years |
51.5 |
49.3 to 53.8 |
6835 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-15 Years |
60.9 |
55.3 to 66.2 |
778 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-15 Years |
49.5 |
42.7 to 56.2 |
340 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-15 Years |
55.7 |
49.8 to 61.3 |
890 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-15 Years |
46.4 |
42.3 to 50.7 |
1002 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-15 Years |
50.4 |
46.0 to 54.8 |
971 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-15 Years |
44.5 |
38.3 to 50.9 |
1030 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-15 Years |
44.0 |
37.7 to 50.4 |
341 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-15 Years |
45.4 |
39.6 to 51.3 |
581 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-15 Years |
61.0 |
52.8 to 68.6 |
505 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-15 Years |
73.0 |
64.1 to 80.3 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2009 |
Age |
13-15 Years |
26.4 |
17.9 to 37.0 |
106 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2009 |
Age |
13-15 Years |
40.9 |
31.0 to 51.7 |
129 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2009 |
Age |
13-15 Years |
47.7 |
39.1 to 56.5 |
541 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-15 Years |
36.0 |
25.9 to 47.5 |
123 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-15 Years |
53.8 |
40.6 to 66.5 |
90 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-15 Years |
47.7 |
36.1 to 59.6 |
103 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-15 Years |
56.6 |
46.1 to 66.5 |
109 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-15 Years |
47.8 |
36.3 to 59.5 |
116 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-15 Years |
32.3 |
24.6 to 41.0 |
167 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-15 Years |
49.8 |
43.4 to 56.2 |
397 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2009 |
Age |
13-15 Years |
38.9 |
28.7 to 50.2 |
104 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2009 |
Age |
13-15 Years |
75.0 |
66.3 to 82.1 |
137 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2009 |
Age |
13-15 Years |
41.2 |
31.8 to 51.3 |
132 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2009 |
Age |
13-15 Years |
51.7 |
40.8 to 62.4 |
99 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2009 |
Age |
13-15 Years |
40.0 |
28.9 to 52.3 |
74 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-15 Years |
74.8 |
65.2 to 82.5 |
109 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2009 |
Age |
13-15 Years |
40.3 |
30.7 to 50.7 |
122 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2010 |
Age |
13-15 Years |
45.6 |
36.0 to 55.5 |
126 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2010 |
Age |
13-15 Years |
54.1 |
43.0 to 64.7 |
98 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2010 |
Age |
13-15 Years |
63.9 |
53.5 to 73.1 |
135 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2010 |
Age |
13-15 Years |
27.1 |
19.5 to 36.4 |
134 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2010 |
Age |
13-15 Years |
68.1 |
58.9 to 76.0 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2010 |
Age |
13-15 Years |
68.5 |
58.9 to 76.7 |
134 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2010 |
Age |
13-15 Years |
80.0 |
70.9 to 86.8 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2010 |
Age |
13-15 Years |
75.8 |
66.2 to 83.3 |
131 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-15 Years |
86.5 |
78.6 to 91.8 |
180 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2010 |
Age |
13-15 Years |
51.7 |
41.4 to 61.9 |
130 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2010 |
Age |
13-15 Years |
81.4 |
73.3 to 87.5 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2010 |
Age |
13-15 Years |
65.9 |
56.7 to 74.1 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2010 |
Age |
13-15 Years |
42.8 |
31.9 to 54.4 |
90 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2010 |
Age |
13-15 Years |
54.3 |
46.3 to 62.2 |
283 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-15 Years |
64.0 |
54.1 to 72.8 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-15 Years |
51.7 |
42.0 to 61.3 |
138 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2010 |
Age |
13-15 Years |
57.4 |
45.5 to 68.5 |
95 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2010 |
Age |
13-15 Years |
43.8 |
32.4 to 55.9 |
78 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2010 |
Age |
13-15 Years |
71.0 |
61.5 to 79.1 |
125 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2010 |
Age |
13-15 Years |
40.2 |
31.3 to 49.9 |
129 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2010 |
Age |
13-15 Years |
67.4 |
56.9 to 76.4 |
131 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2010 |
Age |
13-15 Years |
62.7 |
52.7 to 71.8 |
124 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2010 |
Age |
13-15 Years |
60.7 |
50.7 to 69.9 |
147 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-15 Years |
75.2 |
65.3 to 83.1 |
138 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2010 |
Age |
13-15 Years |
69.3 |
58.6 to 78.3 |
125 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2010 |
Age |
13-15 Years |
74.3 |
64.5 to 82.1 |
109 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2010 |
Age |
13-15 Years |
26.4 |
18.3 to 36.4 |
122 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2010 |
Age |
13-15 Years |
47.7 |
38.4 to 57.1 |
131 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2010 |
Age |
13-15 Years |
46.5 |
35.8 to 57.6 |
98 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2010 |
Age |
13-15 Years |
67.3 |
56.2 to 76.7 |
104 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2010 |
Age |
13-15 Years |
58.4 |
48.7 to 67.5 |
131 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-15 Years |
80.9 |
71.8 to 87.5 |
129 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2010 |
Age |
13-15 Years |
62.9 |
52.5 to 72.2 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2010 |
Age |
13-15 Years |
56.3 |
46.0 to 66.2 |
128 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2010 |
Age |
13-15 Years |
62.5 |
55.2 to 69.3 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-15 Years |
67.8 |
58.4 to 76.0 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-15 Years |
58.8 |
48.3 to 68.5 |
139 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2010 |
Age |
13-15 Years |
55.5 |
46.2 to 64.3 |
151 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2010 |
Age |
13-15 Years |
69.9 |
58.0 to 79.5 |
83 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2010 |
Age |
13-15 Years |
50.8 |
40.8 to 60.8 |
114 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-15 Years |
47.9 |
37.6 to 58.3 |
107 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2010 |
Age |
13-15 Years |
65.5 |
55.1 to 74.6 |
118 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-15 Years |
83.2 |
77.1 to 87.9 |
360 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-15 Years |
79.6 |
71.8 to 85.7 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-15 Years |
83.7 |
76.7 to 89.0 |
175 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2010 |
Age |
13-15 Years |
62.4 |
60.5 to 64.3 |
7507 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-15 Years |
77.5 |
72.2 to 82.0 |
833 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-15 Years |
62.6 |
56.6 to 68.2 |
479 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-15 Years |
68.1 |
63.6 to 72.3 |
1054 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-15 Years |
54.8 |
50.8 to 58.7 |
1075 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-15 Years |
62.1 |
57.8 to 66.2 |
829 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-15 Years |
59.4 |
54.2 to 64.3 |
1230 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-15 Years |
54.7 |
49.0 to 60.3 |
438 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-15 Years |
61.6 |
55.5 to 67.3 |
595 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-15 Years |
67.0 |
59.7 to 73.6 |
558 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-15 Years |
89.0 |
81.7 to 93.6 |
153 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2010 |
Age |
13-15 Years |
37.9 |
28.8 to 48.0 |
129 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2010 |
Age |
13-15 Years |
20.4 |
11.8 to 32.8 |
86 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2010 |
Age |
13-15 Years |
59.4 |
49.4 to 68.7 |
130 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2010 |
Age |
13-15 Years |
63.2 |
56.0 to 69.8 |
730 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-15 Years |
64.0 |
55.2 to 72.0 |
164 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-15 Years |
72.8 |
63.7 to 80.3 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-15 Years |
60.1 |
49.5 to 69.8 |
139 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-15 Years |
69.3 |
59.7 to 77.5 |
116 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-15 Years |
62.2 |
52.4 to 71.1 |
126 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-15 Years |
69.3 |
59.5 to 77.7 |
134 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-15 Years |
64.4 |
58.1 to 70.2 |
416 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2010 |
Age |
13-15 Years |
60.3 |
48.5 to 70.9 |
110 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2010 |
Age |
13-15 Years |
86.8 |
76.7 to 93.0 |
107 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2010 |
Age |
13-15 Years |
49.5 |
39.3 to 59.8 |
138 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2010 |
Age |
13-15 Years |
69.8 |
59.2 to 78.6 |
110 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2010 |
Age |
13-15 Years |
45.5 |
35.2 to 56.3 |
98 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-15 Years |
83.8 |
74.9 to 89.9 |
103 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2010 |
Age |
13-15 Years |
56.2 |
44.4 to 67.3 |
84 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2011 |
Age |
13-15 Years |
63.0 |
53.6 to 71.5 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2011 |
Age |
13-15 Years |
64.6 |
52.2 to 75.3 |
125 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2011 |
Age |
13-15 Years |
75.3 |
65.6 to 83.0 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2011 |
Age |
13-15 Years |
54.1 |
41.7 to 66.1 |
147 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2011 |
Age |
13-15 Years |
69.4 |
61.9 to 76.0 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2011 |
Age |
13-15 Years |
81.8 |
71.1 to 89.2 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2011 |
Age |
13-15 Years |
87.2 |
79.9 to 92.1 |
217 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2011 |
Age |
13-15 Years |
83.4 |
76.0 to 88.8 |
201 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-15 Years |
95.0 |
90.1 to 97.6 |
203 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2011 |
Age |
13-15 Years |
69.0 |
59.9 to 76.7 |
206 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2011 |
Age |
13-15 Years |
92.3 |
86.3 to 95.8 |
184 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2011 |
Age |
13-15 Years |
73.8 |
65.3 to 80.8 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2011 |
Age |
13-15 Years |
52.4 |
40.2 to 64.3 |
137 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2011 |
Age |
13-15 Years |
66.2 |
58.5 to 73.0 |
369 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-15 Years |
72.1 |
62.9 to 79.8 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-15 Years |
64.6 |
55.3 to 73.0 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2011 |
Age |
13-15 Years |
92.5 |
86.4 to 96.0 |
148 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2011 |
Age |
13-15 Years |
52.1 |
40.8 to 63.1 |
125 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2011 |
Age |
13-15 Years |
64.3 |
51.4 to 75.4 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2011 |
Age |
13-15 Years |
48.8 |
38.7 to 59.0 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2011 |
Age |
13-15 Years |
87.7 |
79.6 to 92.9 |
214 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2011 |
Age |
13-15 Years |
71.4 |
62.8 to 78.7 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2011 |
Age |
13-15 Years |
67.5 |
58.9 to 75.1 |
234 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-15 Years |
87.4 |
79.8 to 92.4 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2011 |
Age |
13-15 Years |
85.0 |
77.4 to 90.3 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2011 |
Age |
13-15 Years |
90.4 |
80.2 to 95.6 |
134 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2011 |
Age |
13-15 Years |
35.8 |
25.1 to 48.1 |
133 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2011 |
Age |
13-15 Years |
48.2 |
37.9 to 58.7 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2011 |
Age |
13-15 Years |
58.6 |
43.3 to 72.5 |
128 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2011 |
Age |
13-15 Years |
80.3 |
70.4 to 87.4 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2011 |
Age |
13-15 Years |
56.1 |
45.4 to 66.4 |
194 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-15 Years |
92.3 |
86.5 to 95.8 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2011 |
Age |
13-15 Years |
76.7 |
68.9 to 83.0 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2011 |
Age |
13-15 Years |
73.9 |
64.2 to 81.7 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2011 |
Age |
13-15 Years |
72.2 |
66.5 to 77.3 |
380 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-15 Years |
74.9 |
67.4 to 81.2 |
204 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-15 Years |
70.2 |
61.7 to 77.5 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2011 |
Age |
13-15 Years |
66.1 |
55.2 to 75.5 |
149 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2011 |
Age |
13-15 Years |
62.5 |
47.8 to 75.2 |
107 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2011 |
Age |
13-15 Years |
59.9 |
50.6 to 68.6 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-15 Years |
47.1 |
37.5 to 57.0 |
180 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2011 |
Age |
13-15 Years |
65.3 |
55.8 to 73.7 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-15 Years |
86.3 |
79.0 to 91.3 |
431 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-15 Years |
81.7 |
73.3 to 87.9 |
199 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-15 Years |
86.9 |
78.5 to 92.4 |
232 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2011 |
Age |
13-15 Years |
71.8 |
70.1 to 73.4 |
10201 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-15 Years |
86.3 |
82.5 to 89.3 |
1111 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-15 Years |
73.6 |
69.1 to 77.7 |
563 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-15 Years |
73.3 |
68.9 to 77.3 |
1428 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-15 Years |
67.5 |
63.8 to 71.0 |
1356 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-15 Years |
76.1 |
72.3 to 79.4 |
1193 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-15 Years |
73.6 |
68.7 to 78.0 |
1734 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-15 Years |
56.9 |
50.8 to 62.8 |
599 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-15 Years |
70.3 |
64.2 to 75.7 |
846 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-15 Years |
69.5 |
63.4 to 75.0 |
824 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-15 Years |
83.9 |
74.7 to 90.2 |
229 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2011 |
Age |
13-15 Years |
53.8 |
43.1 to 64.2 |
164 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2011 |
Age |
13-15 Years |
42.0 |
25.0 to 61.1 |
114 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2011 |
Age |
13-15 Years |
68.1 |
57.0 to 77.5 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2011 |
Age |
13-15 Years |
77.5 |
70.0 to 83.5 |
1012 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-15 Years |
78.1 |
69.4 to 84.8 |
206 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-15 Years |
78.6 |
69.5 to 85.6 |
238 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-15 Years |
77.4 |
67.9 to 84.7 |
204 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-15 Years |
79.2 |
69.3 to 86.5 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-15 Years |
77.2 |
66.9 to 85.0 |
212 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-15 Years |
72.5 |
65.8 to 78.2 |
260 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-15 Years |
67.6 |
61.4 to 73.2 |
547 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2011 |
Age |
13-15 Years |
58.8 |
47.7 to 69.2 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2011 |
Age |
13-15 Years |
89.9 |
82.4 to 94.4 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2011 |
Age |
13-15 Years |
57.6 |
48.1 to 66.5 |
199 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2011 |
Age |
13-15 Years |
73.3 |
62.6 to 81.8 |
122 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2011 |
Age |
13-15 Years |
54.9 |
45.1 to 64.3 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-15 Years |
86.8 |
73.9 to 93.8 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2011 |
Age |
13-15 Years |
80.4 |
68.5 to 88.6 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2012 |
Age |
13-15 Years |
70.0 |
59.4 to 78.9 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2012 |
Age |
13-15 Years |
84.7 |
77.0 to 90.2 |
143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2012 |
Age |
13-15 Years |
73.6 |
64.8 to 80.9 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2012 |
Age |
13-15 Years |
56.1 |
46.1 to 65.7 |
159 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2012 |
Age |
13-15 Years |
72.1 |
63.7 to 79.2 |
220 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2012 |
Age |
13-15 Years |
81.3 |
71.0 to 88.6 |
148 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2012 |
Age |
13-15 Years |
94.1 |
86.3 to 97.6 |
164 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2012 |
Age |
13-15 Years |
90.5 |
83.2 to 94.8 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-15 Years |
94.0 |
85.9 to 97.6 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2012 |
Age |
13-15 Years |
76.5 |
65.6 to 84.8 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2012 |
Age |
13-15 Years |
92.7 |
84.2 to 96.8 |
148 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2012 |
Age |
13-15 Years |
74.9 |
65.7 to 82.4 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2012 |
Age |
13-15 Years |
63.0 |
52.5 to 72.4 |
131 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2012 |
Age |
13-15 Years |
68.4 |
59.1 to 76.4 |
291 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-15 Years |
73.2 |
62.0 to 82.0 |
144 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-15 Years |
67.0 |
55.4 to 76.8 |
147 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2012 |
Age |
13-15 Years |
88.7 |
79.1 to 94.2 |
144 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2012 |
Age |
13-15 Years |
60.7 |
49.5 to 70.9 |
120 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2012 |
Age |
13-15 Years |
79.2 |
68.5 to 87.0 |
134 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2012 |
Age |
13-15 Years |
62.9 |
52.7 to 72.1 |
154 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2012 |
Age |
13-15 Years |
86.1 |
79.2 to 91.0 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2012 |
Age |
13-15 Years |
78.1 |
69.4 to 84.8 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2012 |
Age |
13-15 Years |
82.2 |
73.3 to 88.7 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-15 Years |
89.7 |
82.1 to 94.3 |
180 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2012 |
Age |
13-15 Years |
90.2 |
83.0 to 94.6 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2012 |
Age |
13-15 Years |
92.5 |
86.7 to 95.9 |
144 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2012 |
Age |
13-15 Years |
52.3 |
40.4 to 64.0 |
124 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2012 |
Age |
13-15 Years |
61.4 |
50.6 to 71.1 |
141 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2012 |
Age |
13-15 Years |
66.4 |
55.7 to 75.6 |
125 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2012 |
Age |
13-15 Years |
81.4 |
71.8 to 88.2 |
144 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2012 |
Age |
13-15 Years |
73.1 |
63.4 to 81.0 |
159 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-15 Years |
95.6 |
90.8 to 97.9 |
116 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2012 |
Age |
13-15 Years |
74.4 |
64.4 to 82.3 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2012 |
Age |
13-15 Years |
64.8 |
54.8 to 73.6 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2012 |
Age |
13-15 Years |
73.5 |
66.3 to 79.7 |
301 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-15 Years |
71.5 |
61.3 to 79.9 |
159 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-15 Years |
75.0 |
64.5 to 83.2 |
142 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2012 |
Age |
13-15 Years |
72.9 |
62.9 to 81.0 |
157 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2012 |
Age |
13-15 Years |
70.2 |
59.2 to 79.3 |
137 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2012 |
Age |
13-15 Years |
62.8 |
51.9 to 72.5 |
143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-15 Years |
73.1 |
64.0 to 80.7 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2012 |
Age |
13-15 Years |
77.9 |
69.0 to 84.8 |
180 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-15 Years |
92.7 |
88.2 to 95.6 |
392 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-15 Years |
89.3 |
81.7 to 93.9 |
199 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-15 Years |
93.1 |
87.9 to 96.2 |
193 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2012 |
Age |
13-15 Years |
76.8 |
75.1 to 78.4 |
8868 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-15 Years |
90.9 |
87.1 to 93.6 |
884 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-15 Years |
73.8 |
68.1 to 78.8 |
472 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-15 Years |
82.7 |
78.8 to 86.1 |
1201 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-15 Years |
75.5 |
71.5 to 79.1 |
1193 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-15 Years |
78.8 |
74.7 to 82.3 |
1040 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-15 Years |
79.0 |
75.4 to 82.1 |
1434 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-15 Years |
67.3 |
61.2 to 72.9 |
539 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-15 Years |
73.0 |
67.1 to 78.2 |
796 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-15 Years |
72.4 |
65.6 to 78.3 |
717 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-15 Years |
94.8 |
88.9 to 97.6 |
153 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2012 |
Age |
13-15 Years |
59.8 |
48.9 to 69.8 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2012 |
Age |
13-15 Years |
41.3 |
31.5 to 51.9 |
115 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2012 |
Age |
13-15 Years |
84.8 |
75.5 to 91.0 |
147 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2012 |
Age |
13-15 Years |
82.5 |
77.4 to 86.6 |
784 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-15 Years |
77.8 |
66.0 to 86.3 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-15 Years |
76.4 |
65.5 to 84.6 |
194 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-15 Years |
83.4 |
77.5 to 88.0 |
417 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-15 Years |
77.9 |
72.2 to 82.7 |
296 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-15 Years |
75.1 |
69.0 to 80.4 |
592 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2012 |
Age |
13-15 Years |
64.9 |
53.7 to 74.8 |
143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2012 |
Age |
13-15 Years |
94.2 |
88.6 to 97.1 |
116 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2012 |
Age |
13-15 Years |
69.6 |
59.3 to 78.2 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2012 |
Age |
13-15 Years |
75.5 |
64.4 to 84.0 |
138 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2012 |
Age |
13-15 Years |
65.6 |
53.7 to 75.8 |
112 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-15 Years |
88.2 |
79.2 to 93.6 |
135 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2012 |
Age |
13-15 Years |
87.1 |
77.8 to 92.9 |
128 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2013 |
Age |
13-15 Years |
80.3 |
71.4 to 86.9 |
148 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2013 |
Age |
13-15 Years |
89.2 |
82.3 to 93.7 |
154 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2013 |
Age |
13-15 Years |
70.7 |
61.6 to 78.4 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2013 |
Age |
13-15 Years |
61.6 |
51.9 to 70.5 |
142 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2013 |
Age |
13-15 Years |
84.8 |
77.0 to 90.3 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2013 |
Age |
13-15 Years |
81.4 |
73.8 to 87.2 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2013 |
Age |
13-15 Years |
97.1 |
90.3 to 99.2 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2013 |
Age |
13-15 Years |
84.5 |
76.4 to 90.2 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-15 Years |
83.5 |
67.4 to 92.6 |
110 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2013 |
Age |
13-15 Years |
75.2 |
65.3 to 83.0 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2013 |
Age |
13-15 Years |
96.2 |
87.1 to 99.0 |
130 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2013 |
Age |
13-15 Years |
40.6 |
30.8 to 51.1 |
121 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2013 |
Age |
13-15 Years |
83.2 |
75.2 to 89.0 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2013 |
Age |
13-15 Years |
63.0 |
51.7 to 73.0 |
123 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2013 |
Age |
13-15 Years |
83.9 |
77.6 to 88.7 |
264 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-15 Years |
82.2 |
69.7 to 90.2 |
104 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-15 Years |
84.4 |
76.8 to 89.9 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2013 |
Age |
13-15 Years |
92.8 |
85.6 to 96.5 |
161 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2013 |
Age |
13-15 Years |
63.1 |
54.2 to 71.1 |
197 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2013 |
Age |
13-15 Years |
83.9 |
76.1 to 89.5 |
126 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2013 |
Age |
13-15 Years |
71.6 |
61.9 to 79.7 |
132 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2013 |
Age |
13-15 Years |
91.5 |
85.5 to 95.2 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2013 |
Age |
13-15 Years |
69.1 |
59.5 to 77.3 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2013 |
Age |
13-15 Years |
82.1 |
72.8 to 88.8 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-15 Years |
91.0 |
83.4 to 95.3 |
202 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2013 |
Age |
13-15 Years |
91.5 |
85.1 to 95.3 |
142 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2013 |
Age |
13-15 Years |
88.3 |
79.7 to 93.5 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2013 |
Age |
13-15 Years |
56.0 |
45.7 to 65.8 |
132 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2013 |
Age |
13-15 Years |
57.5 |
46.6 to 67.8 |
131 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2013 |
Age |
13-15 Years |
62.1 |
51.1 to 71.9 |
124 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2013 |
Age |
13-15 Years |
87.1 |
79.3 to 92.2 |
136 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2013 |
Age |
13-15 Years |
82.2 |
74.3 to 88.1 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-15 Years |
93.6 |
86.4 to 97.1 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2013 |
Age |
13-15 Years |
77.6 |
68.1 to 85.0 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2013 |
Age |
13-15 Years |
72.8 |
64.3 to 80.0 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2013 |
Age |
13-15 Years |
80.0 |
74.0 to 84.9 |
339 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-15 Years |
80.5 |
71.2 to 87.3 |
144 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-15 Years |
79.7 |
71.5 to 86.0 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2013 |
Age |
13-15 Years |
78.5 |
70.1 to 85.0 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2013 |
Age |
13-15 Years |
87.6 |
80.8 to 92.2 |
154 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2013 |
Age |
13-15 Years |
63.6 |
54.2 to 72.1 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-15 Years |
67.9 |
60.0 to 74.9 |
223 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2013 |
Age |
13-15 Years |
87.0 |
81.0 to 91.3 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-15 Years |
92.8 |
87.0 to 96.1 |
385 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-15 Years |
95.2 |
89.2 to 97.9 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-15 Years |
92.5 |
86.0 to 96.1 |
233 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2013 |
Age |
13-15 Years |
80.7 |
79.2 to 82.1 |
8843 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-15 Years |
91.4 |
87.9 to 93.9 |
967 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-15 Years |
79.2 |
74.2 to 83.4 |
512 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-15 Years |
81.4 |
76.7 to 85.3 |
1145 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-15 Years |
78.8 |
75.2 to 82.0 |
1175 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-15 Years |
83.4 |
80.2 to 86.1 |
1060 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-15 Years |
81.5 |
77.4 to 85.0 |
1229 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-15 Years |
67.5 |
61.6 to 72.9 |
590 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-15 Years |
74.2 |
69.4 to 78.4 |
857 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-15 Years |
82.7 |
76.7 to 87.4 |
699 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-15 Years |
95.1 |
88.7 to 97.9 |
148 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2013 |
Age |
13-15 Years |
62.5 |
52.2 to 71.8 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2013 |
Age |
13-15 Years |
54.1 |
43.6 to 64.2 |
121 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2013 |
Age |
13-15 Years |
86.1 |
78.3 to 91.4 |
149 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2013 |
Age |
13-15 Years |
84.2 |
78.2 to 88.8 |
546 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-15 Years |
83.5 |
74.9 to 89.5 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-15 Years |
83.6 |
72.7 to 90.6 |
134 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-15 Years |
84.3 |
77.4 to 89.4 |
267 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-15 Years |
78.4 |
70.8 to 84.4 |
183 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-15 Years |
79.1 |
73.3 to 83.9 |
609 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2013 |
Age |
13-15 Years |
64.5 |
54.1 to 73.7 |
139 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2013 |
Age |
13-15 Years |
89.6 |
81.0 to 94.6 |
136 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2013 |
Age |
13-15 Years |
66.5 |
54.2 to 76.9 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2013 |
Age |
13-15 Years |
77.0 |
66.3 to 85.1 |
153 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2013 |
Age |
13-15 Years |
64.0 |
54.1 to 72.9 |
146 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-15 Years |
94.8 |
89.1 to 97.6 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2013 |
Age |
13-15 Years |
91.3 |
84.2 to 95.4 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2014 |
Age |
13-15 Years |
82.7 |
75.0 to 88.5 |
167 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2014 |
Age |
13-15 Years |
81.0 |
72.9 to 87.0 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2014 |
Age |
13-15 Years |
73.9 |
65.3 to 81.0 |
221 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2014 |
Age |
13-15 Years |
71.2 |
61.8 to 79.1 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2014 |
Age |
13-15 Years |
82.1 |
74.1 to 88.0 |
196 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2014 |
Age |
13-15 Years |
86.2 |
79.1 to 91.1 |
193 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2014 |
Age |
13-15 Years |
97.1 |
93.8 to 98.7 |
214 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2014 |
Age |
13-15 Years |
91.7 |
84.9 to 95.6 |
202 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-15 Years |
92.1 |
85.2 to 96.0 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2014 |
Age |
13-15 Years |
79.3 |
69.8 to 86.3 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2014 |
Age |
13-15 Years |
95.6 |
91.3 to 97.8 |
198 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2014 |
Age |
13-15 Years |
78.1 |
70.2 to 84.3 |
214 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2014 |
Age |
13-15 Years |
69.6 |
59.6 to 78.0 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2014 |
Age |
13-15 Years |
83.0 |
77.3 to 87.6 |
398 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-15 Years |
86.2 |
77.9 to 91.8 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-15 Years |
82.3 |
75.3 to 87.6 |
240 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2014 |
Age |
13-15 Years |
93.1 |
86.7 to 96.5 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2014 |
Age |
13-15 Years |
79.2 |
70.2 to 86.1 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2014 |
Age |
13-15 Years |
78.6 |
69.0 to 85.9 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2014 |
Age |
13-15 Years |
82.5 |
74.7 to 88.2 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2014 |
Age |
13-15 Years |
92.6 |
85.7 to 96.3 |
162 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2014 |
Age |
13-15 Years |
85.3 |
77.3 to 90.7 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2014 |
Age |
13-15 Years |
79.6 |
70.8 to 86.2 |
218 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-15 Years |
93.3 |
85.9 to 96.9 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2014 |
Age |
13-15 Years |
90.2 |
82.9 to 94.6 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2014 |
Age |
13-15 Years |
84.3 |
75.0 to 90.6 |
136 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2014 |
Age |
13-15 Years |
59.8 |
50.4 to 68.5 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2014 |
Age |
13-15 Years |
70.9 |
61.8 to 78.5 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2014 |
Age |
13-15 Years |
67.2 |
57.4 to 75.7 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2014 |
Age |
13-15 Years |
85.1 |
76.3 to 91.0 |
150 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2014 |
Age |
13-15 Years |
73.7 |
65.8 to 80.4 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-15 Years |
97.3 |
94.1 to 98.8 |
216 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2014 |
Age |
13-15 Years |
84.2 |
77.1 to 89.3 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2014 |
Age |
13-15 Years |
78.9 |
70.1 to 85.7 |
184 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2014 |
Age |
13-15 Years |
78.8 |
72.4 to 84.0 |
295 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-15 Years |
84.4 |
75.7 to 90.4 |
139 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-15 Years |
75.7 |
66.8 to 82.9 |
156 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2014 |
Age |
13-15 Years |
73.6 |
65.4 to 80.4 |
205 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2014 |
Age |
13-15 Years |
86.3 |
77.4 to 92.1 |
154 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2014 |
Age |
13-15 Years |
77.1 |
68.2 to 84.1 |
214 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-15 Years |
86.2 |
79.4 to 91.1 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2014 |
Age |
13-15 Years |
78.7 |
70.2 to 85.3 |
217 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-15 Years |
93.5 |
87.5 to 96.7 |
392 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-15 Years |
89.6 |
80.1 to 94.8 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-15 Years |
93.9 |
87.0 to 97.3 |
232 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-15 Years |
80.6 |
68.5 to 88.8 |
124 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2014 |
Age |
13-15 Years |
82.1 |
80.6 to 83.4 |
10555 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-15 Years |
94.3 |
91.3 to 96.3 |
1160 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-15 Years |
80.5 |
75.7 to 84.6 |
477 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-15 Years |
84.6 |
80.8 to 87.8 |
1341 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-15 Years |
80.5 |
77.4 to 83.3 |
1503 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-15 Years |
84.8 |
81.8 to 87.3 |
1276 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-15 Years |
81.9 |
77.4 to 85.7 |
1514 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-15 Years |
76.1 |
71.2 to 80.4 |
634 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-15 Years |
79.6 |
75.4 to 83.2 |
1087 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-15 Years |
80.4 |
74.2 to 85.3 |
816 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-15 Years |
97.0 |
91.6 to 99.0 |
211 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2014 |
Age |
13-15 Years |
61.9 |
52.7 to 70.3 |
201 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2014 |
Age |
13-15 Years |
63.6 |
53.9 to 72.4 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2014 |
Age |
13-15 Years |
90.1 |
81.6 to 94.9 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2014 |
Age |
13-15 Years |
81.0 |
74.4 to 86.3 |
816 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-15 Years |
83.6 |
75.4 to 89.4 |
190 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-15 Years |
80.6 |
71.7 to 87.3 |
194 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-15 Years |
80.8 |
70.6 to 88.1 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-15 Years |
80.9 |
72.9 to 87.0 |
240 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-15 Years |
77.9 |
72.8 to 82.3 |
747 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2014 |
Age |
13-15 Years |
73.5 |
64.4 to 81.0 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2014 |
Age |
13-15 Years |
95.0 |
89.9 to 97.6 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2014 |
Age |
13-15 Years |
79.8 |
70.5 to 86.8 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2014 |
Age |
13-15 Years |
79.6 |
70.7 to 86.4 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2014 |
Age |
13-15 Years |
60.4 |
51.0 to 69.2 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-15 Years |
86.1 |
77.3 to 91.8 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2014 |
Age |
13-15 Years |
90.4 |
84.7 to 94.1 |
219 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2015 |
Age |
13-15 Years |
88.8 |
82.4 to 93.1 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2015 |
Age |
13-15 Years |
85.5 |
78.9 to 90.3 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2015 |
Age |
13-15 Years |
81.5 |
74.9 to 86.7 |
230 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2015 |
Age |
13-15 Years |
88.0 |
81.4 to 92.5 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2015 |
Age |
13-15 Years |
80.5 |
71.7 to 87.0 |
190 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2015 |
Age |
13-15 Years |
91.7 |
86.5 to 95.0 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2015 |
Age |
13-15 Years |
95.0 |
90.0 to 97.6 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2015 |
Age |
13-15 Years |
92.6 |
87.1 to 95.9 |
198 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-15 Years |
89.1 |
83.1 to 93.2 |
240 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2015 |
Age |
13-15 Years |
85.0 |
76.2 to 91.0 |
167 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2015 |
Age |
13-15 Years |
93.1 |
87.2 to 96.4 |
212 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2015 |
Age |
13-15 Years |
54.8 |
45.1 to 64.1 |
147 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2015 |
Age |
13-15 Years |
84.1 |
77.0 to 89.3 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2015 |
Age |
13-15 Years |
69.3 |
59.8 to 77.4 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2015 |
Age |
13-15 Years |
85.0 |
79.9 to 88.9 |
434 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-15 Years |
88.5 |
82.2 to 92.8 |
162 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-15 Years |
84.2 |
78.0 to 88.8 |
272 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2015 |
Age |
13-15 Years |
92.8 |
86.6 to 96.2 |
156 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2015 |
Age |
13-15 Years |
81.8 |
74.8 to 87.2 |
219 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2015 |
Age |
13-15 Years |
80.8 |
72.2 to 87.2 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2015 |
Age |
13-15 Years |
84.3 |
76.8 to 89.7 |
167 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2015 |
Age |
13-15 Years |
92.6 |
87.6 to 95.8 |
210 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2015 |
Age |
13-15 Years |
88.5 |
81.8 to 93.0 |
190 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2015 |
Age |
13-15 Years |
83.2 |
74.6 to 89.3 |
223 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-15 Years |
97.1 |
92.2 to 98.9 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2015 |
Age |
13-15 Years |
93.8 |
89.0 to 96.6 |
221 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2015 |
Age |
13-15 Years |
88.6 |
81.4 to 93.3 |
205 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2015 |
Age |
13-15 Years |
76.1 |
68.2 to 82.5 |
189 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2015 |
Age |
13-15 Years |
67.0 |
57.6 to 75.1 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2015 |
Age |
13-15 Years |
75.3 |
67.3 to 81.8 |
189 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2015 |
Age |
13-15 Years |
89.7 |
83.3 to 93.8 |
207 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2015 |
Age |
13-15 Years |
85.3 |
77.5 to 90.7 |
210 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-15 Years |
94.8 |
88.5 to 97.7 |
150 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2015 |
Age |
13-15 Years |
85.6 |
78.2 to 90.8 |
186 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2015 |
Age |
13-15 Years |
82.5 |
75.2 to 88.0 |
201 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2015 |
Age |
13-15 Years |
88.2 |
83.3 to 91.8 |
339 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-15 Years |
86.3 |
78.3 to 91.7 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-15 Years |
89.4 |
82.7 to 93.7 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2015 |
Age |
13-15 Years |
84.2 |
77.0 to 89.4 |
202 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2015 |
Age |
13-15 Years |
92.7 |
84.3 to 96.8 |
151 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2015 |
Age |
13-15 Years |
79.4 |
69.8 to 86.5 |
170 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-15 Years |
83.5 |
75.4 to 89.3 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2015 |
Age |
13-15 Years |
86.5 |
80.1 to 91.1 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-15 Years |
92.8 |
87.7 to 95.9 |
442 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-15 Years |
90.0 |
84.3 to 93.8 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-15 Years |
93.2 |
87.2 to 96.4 |
263 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-15 Years |
86.0 |
78.4 to 91.2 |
193 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2015 |
Age |
13-15 Years |
84.6 |
83.2 to 85.9 |
11494 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-15 Years |
95.5 |
93.3 to 96.9 |
1137 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-15 Years |
87.3 |
83.4 to 90.4 |
525 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-15 Years |
83.8 |
79.7 to 87.3 |
1477 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-15 Years |
85.2 |
82.4 to 87.7 |
1481 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-15 Years |
87.8 |
85.1 to 90.1 |
1384 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-15 Years |
84.5 |
81.7 to 86.9 |
2129 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-15 Years |
76.3 |
71.5 to 80.4 |
784 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-15 Years |
80.5 |
76.7 to 83.8 |
1041 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-15 Years |
81.0 |
74.0 to 86.4 |
809 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-15 Years |
95.0 |
90.6 to 97.3 |
221 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2015 |
Age |
13-15 Years |
70.9 |
62.8 to 77.8 |
193 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2015 |
Age |
13-15 Years |
72.5 |
64.5 to 79.3 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2015 |
Age |
13-15 Years |
86.8 |
79.2 to 91.9 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2015 |
Age |
13-15 Years |
83.0 |
79.1 to 86.3 |
1378 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-15 Years |
78.6 |
70.8 to 84.8 |
211 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-15 Years |
79.2 |
69.9 to 86.1 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-15 Years |
80.8 |
73.9 to 86.2 |
280 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-15 Years |
84.0 |
79.1 to 88.0 |
488 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-15 Years |
82.6 |
77.0 to 87.0 |
287 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-15 Years |
80.4 |
75.7 to 84.4 |
727 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2015 |
Age |
13-15 Years |
65.8 |
56.8 to 73.7 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2015 |
Age |
13-15 Years |
96.8 |
93.0 to 98.6 |
211 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2015 |
Age |
13-15 Years |
71.6 |
60.5 to 80.6 |
211 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2015 |
Age |
13-15 Years |
78.9 |
70.5 to 85.4 |
190 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2015 |
Age |
13-15 Years |
72.6 |
63.8 to 79.9 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-15 Years |
94.1 |
89.2 to 96.9 |
198 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2015 |
Age |
13-15 Years |
86.6 |
78.6 to 91.9 |
159 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2016 |
Age |
13-15 Years |
92.9 |
88.5 to 95.7 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2016 |
Age |
13-15 Years |
88.7 |
81.3 to 93.4 |
203 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2016 |
Age |
13-15 Years |
77.3 |
68.1 to 84.4 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2016 |
Age |
13-15 Years |
92.2 |
86.9 to 95.4 |
180 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2016 |
Age |
13-15 Years |
79.1 |
70.4 to 85.8 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2016 |
Age |
13-15 Years |
88.9 |
80.9 to 93.8 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2016 |
Age |
13-15 Years |
98.4 |
94.4 to 99.6 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2016 |
Age |
13-15 Years |
93.2 |
87.4 to 96.5 |
200 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-15 Years |
94.4 |
90.5 to 96.7 |
220 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2016 |
Age |
13-15 Years |
92.4 |
85.4 to 96.2 |
200 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2016 |
Age |
13-15 Years |
96.5 |
90.4 to 98.8 |
230 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2016 |
Age |
13-15 Years |
55.5 |
47.2 to 63.5 |
216 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2016 |
Age |
13-15 Years |
85.9 |
78.5 to 91.0 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2016 |
Age |
13-15 Years |
78.6 |
71.0 to 84.6 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2016 |
Age |
13-15 Years |
93.2 |
89.4 to 95.6 |
308 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-15 Years |
89.6 |
80.5 to 94.8 |
93 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-15 Years |
94.1 |
89.6 to 96.7 |
215 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2016 |
Age |
13-15 Years |
89.2 |
82.8 to 93.5 |
193 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2016 |
Age |
13-15 Years |
85.6 |
79.0 to 90.4 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2016 |
Age |
13-15 Years |
90.9 |
85.3 to 94.5 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2016 |
Age |
13-15 Years |
90.2 |
83.2 to 94.4 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2016 |
Age |
13-15 Years |
96.0 |
91.4 to 98.2 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2016 |
Age |
13-15 Years |
91.7 |
86.2 to 95.1 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2016 |
Age |
13-15 Years |
84.1 |
76.0 to 89.9 |
275 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-15 Years |
96.2 |
92.6 to 98.1 |
203 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2016 |
Age |
13-15 Years |
96.0 |
91.1 to 98.2 |
141 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2016 |
Age |
13-15 Years |
88.0 |
80.4 to 92.9 |
198 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2016 |
Age |
13-15 Years |
88.0 |
81.5 to 92.4 |
189 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2016 |
Age |
13-15 Years |
75.9 |
67.1 to 83.0 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2016 |
Age |
13-15 Years |
81.3 |
72.0 to 88.1 |
188 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2016 |
Age |
13-15 Years |
90.1 |
83.5 to 94.2 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2016 |
Age |
13-15 Years |
87.3 |
80.2 to 92.1 |
193 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-15 Years |
94.3 |
86.8 to 97.7 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2016 |
Age |
13-15 Years |
88.0 |
81.7 to 92.4 |
232 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2016 |
Age |
13-15 Years |
87.7 |
81.8 to 91.8 |
204 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2016 |
Age |
13-15 Years |
90.0 |
85.2 to 93.3 |
357 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-15 Years |
86.6 |
77.4 to 92.4 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-15 Years |
91.9 |
85.9 to 95.4 |
205 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2016 |
Age |
13-15 Years |
78.5 |
69.7 to 85.2 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2016 |
Age |
13-15 Years |
92.7 |
85.5 to 96.5 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2016 |
Age |
13-15 Years |
84.4 |
76.1 to 90.2 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-15 Years |
79.8 |
71.2 to 86.4 |
164 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2016 |
Age |
13-15 Years |
86.2 |
78.7 to 91.3 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-15 Years |
93.7 |
89.9 to 96.1 |
474 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-15 Years |
91.3 |
85.1 to 95.1 |
186 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-15 Years |
94.0 |
89.7 to 96.6 |
288 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-15 Years |
91.4 |
85.2 to 95.2 |
217 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2016 |
Age |
13-15 Years |
87.0 |
85.6 to 88.3 |
10938 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-15 Years |
96.0 |
94.2 to 97.3 |
1083 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-15 Years |
89.3 |
85.7 to 92.1 |
589 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-15 Years |
87.3 |
83.8 to 90.1 |
1591 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-15 Years |
89.9 |
87.4 to 91.9 |
1449 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-15 Years |
90.5 |
88.1 to 92.5 |
1192 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-15 Years |
86.5 |
84.0 to 88.7 |
1757 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-15 Years |
83.1 |
78.7 to 86.7 |
743 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-15 Years |
84.1 |
79.8 to 87.6 |
1041 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-15 Years |
79.5 |
72.6 to 85.0 |
722 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-15 Years |
94.4 |
89.4 to 97.1 |
180 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2016 |
Age |
13-15 Years |
78.8 |
69.6 to 85.9 |
149 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2016 |
Age |
13-15 Years |
85.0 |
76.0 to 91.0 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2016 |
Age |
13-15 Years |
92.3 |
83.3 to 96.6 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2016 |
Age |
13-15 Years |
85.3 |
81.8 to 88.2 |
1028 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-15 Years |
84.3 |
76.6 to 89.8 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-15 Years |
79.2 |
66.5 to 88.0 |
120 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-15 Years |
79.0 |
69.7 to 86.0 |
162 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-15 Years |
81.5 |
72.0 to 88.3 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-15 Years |
87.0 |
82.4 to 90.6 |
390 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-15 Years |
75.1 |
68.2 to 80.9 |
261 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-15 Years |
85.2 |
80.6 to 88.9 |
771 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2016 |
Age |
13-15 Years |
75.2 |
66.7 to 82.1 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2016 |
Age |
13-15 Years |
95.4 |
89.4 to 98.1 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2016 |
Age |
13-15 Years |
80.3 |
70.8 to 87.3 |
262 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2016 |
Age |
13-15 Years |
86.2 |
77.4 to 91.9 |
194 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2016 |
Age |
13-15 Years |
81.3 |
73.3 to 87.3 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-15 Years |
92.7 |
87.0 to 96.0 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2016 |
Age |
13-15 Years |
90.4 |
85.0 to 94.0 |
196 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2017 |
Age |
13-15 Years |
90.3 |
85.2 to 93.7 |
210 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2017 |
Age |
13-15 Years |
90.6 |
85.1 to 94.2 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2017 |
Age |
13-15 Years |
84.3 |
76.3 to 89.9 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2017 |
Age |
13-15 Years |
91.0 |
85.3 to 94.6 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2017 |
Age |
13-15 Years |
84.9 |
76.5 to 90.7 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2017 |
Age |
13-15 Years |
88.7 |
82.8 to 92.7 |
215 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2017 |
Age |
13-15 Years |
97.4 |
89.4 to 99.4 |
170 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2017 |
Age |
13-15 Years |
88.8 |
81.1 to 93.6 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-15 Years |
87.2 |
77.9 to 92.9 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2017 |
Age |
13-15 Years |
94.6 |
90.0 to 97.2 |
218 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2017 |
Age |
13-15 Years |
97.0 |
91.9 to 98.9 |
209 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2017 |
Age |
13-15 Years |
58.0 |
48.3 to 67.1 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2017 |
Age |
13-15 Years |
88.6 |
80.8 to 93.5 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2017 |
Age |
13-15 Years |
85.9 |
78.0 to 91.3 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2017 |
Age |
13-15 Years |
92.9 |
89.3 to 95.3 |
361 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-15 Years |
87.9 |
76.2 to 94.3 |
101 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-15 Years |
93.8 |
89.9 to 96.2 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2017 |
Age |
13-15 Years |
97.6 |
94.2 to 99.0 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2017 |
Age |
13-15 Years |
94.3 |
88.5 to 97.3 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2017 |
Age |
13-15 Years |
90.8 |
84.6 to 94.6 |
196 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2017 |
Age |
13-15 Years |
94.2 |
89.1 to 97.0 |
207 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2017 |
Age |
13-15 Years |
96.4 |
92.4 to 98.4 |
199 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2017 |
Age |
13-15 Years |
94.0 |
89.0 to 96.8 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2017 |
Age |
13-15 Years |
86.4 |
77.0 to 92.3 |
287 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-15 Years |
94.9 |
89.5 to 97.6 |
230 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2017 |
Age |
13-15 Years |
95.1 |
88.6 to 98.0 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2017 |
Age |
13-15 Years |
95.0 |
89.9 to 97.6 |
198 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2017 |
Age |
13-15 Years |
96.0 |
92.2 to 98.0 |
177 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2017 |
Age |
13-15 Years |
80.1 |
72.0 to 86.3 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2017 |
Age |
13-15 Years |
92.4 |
85.3 to 96.2 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2017 |
Age |
13-15 Years |
90.6 |
82.3 to 95.3 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2017 |
Age |
13-15 Years |
88.4 |
81.4 to 93.0 |
210 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-15 Years |
94.7 |
88.1 to 97.7 |
177 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2017 |
Age |
13-15 Years |
85.7 |
78.2 to 91.0 |
193 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2017 |
Age |
13-15 Years |
84.8 |
77.4 to 90.1 |
202 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2017 |
Age |
13-15 Years |
95.4 |
92.3 to 97.3 |
357 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-15 Years |
91.6 |
85.1 to 95.5 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-15 Years |
98.0 |
94.4 to 99.3 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2017 |
Age |
13-15 Years |
94.0 |
89.6 to 96.7 |
204 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2017 |
Age |
13-15 Years |
93.8 |
88.7 to 96.7 |
203 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2017 |
Age |
13-15 Years |
92.4 |
87.8 to 95.4 |
209 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-15 Years |
84.6 |
77.7 to 89.6 |
186 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2017 |
Age |
13-15 Years |
86.1 |
78.9 to 91.0 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-15 Years |
95.9 |
92.4 to 97.8 |
471 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-15 Years |
94.5 |
89.9 to 97.0 |
198 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-15 Years |
96.1 |
92.0 to 98.1 |
273 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2017 |
Age |
13-15 Years |
90.3 |
89.2 to 91.4 |
11464 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-15 Years |
95.6 |
93.0 to 97.3 |
1138 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-15 Years |
92.3 |
89.3 to 94.6 |
550 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-15 Years |
92.2 |
89.5 to 94.2 |
1577 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-15 Years |
93.1 |
91.4 to 94.5 |
1605 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-15 Years |
94.2 |
92.6 to 95.5 |
1289 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-15 Years |
85.7 |
82.9 to 88.1 |
1994 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-15 Years |
87.2 |
83.4 to 90.2 |
726 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-15 Years |
88.6 |
85.2 to 91.3 |
1151 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-15 Years |
85.1 |
78.6 to 89.9 |
726 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-15 Years |
97.7 |
93.7 to 99.2 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2017 |
Age |
13-15 Years |
79.7 |
71.5 to 86.1 |
196 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2017 |
Age |
13-15 Years |
90.1 |
83.2 to 94.3 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2017 |
Age |
13-15 Years |
91.4 |
84.9 to 95.2 |
184 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2017 |
Age |
13-15 Years |
83.8 |
79.9 to 87.0 |
1241 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-15 Years |
85.8 |
78.3 to 91.0 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-15 Years |
88.5 |
80.1 to 93.6 |
91 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-15 Years |
71.6 |
61.3 to 80.1 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-15 Years |
83.8 |
75.6 to 89.6 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-15 Years |
84.1 |
76.6 to 89.5 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-15 Years |
84.7 |
79.3 to 88.9 |
462 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-15 Years |
89.1 |
85.5 to 91.9 |
708 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2017 |
Age |
13-15 Years |
86.1 |
78.8 to 91.2 |
203 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2017 |
Age |
13-15 Years |
94.6 |
89.3 to 97.4 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2017 |
Age |
13-15 Years |
94.2 |
87.9 to 97.4 |
243 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2017 |
Age |
13-15 Years |
91.4 |
85.4 to 95.1 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2017 |
Age |
13-15 Years |
79.6 |
72.2 to 85.5 |
196 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-15 Years |
94.5 |
89.8 to 97.1 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2017 |
Age |
13-15 Years |
91.5 |
85.0 to 95.4 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2018 |
Age |
13-15 Years |
91.9 |
85.6 to 95.6 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2018 |
Age |
13-15 Years |
87.8 |
81.5 to 92.1 |
219 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2018 |
Age |
13-15 Years |
84.2 |
76.3 to 89.9 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2018 |
Age |
13-15 Years |
90.6 |
82.8 to 95.0 |
161 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2018 |
Age |
13-15 Years |
88.4 |
81.0 to 93.2 |
200 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2018 |
Age |
13-15 Years |
89.5 |
80.0 to 94.8 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2018 |
Age |
13-15 Years |
96.9 |
92.8 to 98.7 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2018 |
Age |
13-15 Years |
97.6 |
94.0 to 99.0 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2018 |
Age |
13-15 Years |
97.1 |
91.9 to 99.0 |
194 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2018 |
Age |
13-15 Years |
95.0 |
89.0 to 97.8 |
205 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2018 |
Age |
13-15 Years |
60.7 |
50.6 to 69.9 |
148 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2018 |
Age |
13-15 Years |
93.5 |
88.9 to 96.3 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2018 |
Age |
13-15 Years |
90.2 |
83.5 to 94.4 |
149 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2018 |
Age |
13-15 Years |
95.1 |
91.6 to 97.1 |
408 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-15 Years |
94.6 |
82.0 to 98.5 |
105 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-15 Years |
95.2 |
91.3 to 97.4 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2018 |
Age |
13-15 Years |
97.0 |
92.4 to 98.9 |
170 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2018 |
Age |
13-15 Years |
96.9 |
91.7 to 98.9 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2018 |
Age |
13-15 Years |
85.7 |
77.0 to 91.5 |
167 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2018 |
Age |
13-15 Years |
91.3 |
84.4 to 95.3 |
137 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2018 |
Age |
13-15 Years |
91.9 |
82.9 to 96.4 |
135 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2018 |
Age |
13-15 Years |
93.9 |
86.9 to 97.3 |
170 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2018 |
Age |
13-15 Years |
91.8 |
84.9 to 95.8 |
228 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-15 Years |
98.9 |
95.0 to 99.8 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2018 |
Age |
13-15 Years |
96.3 |
92.6 to 98.2 |
177 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2018 |
Age |
13-15 Years |
97.3 |
94.0 to 98.8 |
150 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2018 |
Age |
13-15 Years |
90.4 |
82.5 to 95.0 |
143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2018 |
Age |
13-15 Years |
89.2 |
82.3 to 93.6 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2018 |
Age |
13-15 Years |
90.4 |
82.8 to 94.8 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2018 |
Age |
13-15 Years |
94.0 |
86.9 to 97.4 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2018 |
Age |
13-15 Years |
87.8 |
80.8 to 92.5 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-15 Years |
95.2 |
88.0 to 98.2 |
164 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2018 |
Age |
13-15 Years |
86.3 |
77.6 to 91.9 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2018 |
Age |
13-15 Years |
91.4 |
84.7 to 95.3 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2018 |
Age |
13-15 Years |
93.5 |
89.3 to 96.1 |
273 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-15 Years |
95.0 |
90.0 to 97.6 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-15 Years |
92.4 |
85.6 to 96.1 |
133 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2018 |
Age |
13-15 Years |
89.3 |
81.7 to 94.0 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2018 |
Age |
13-15 Years |
96.0 |
91.0 to 98.2 |
157 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2018 |
Age |
13-15 Years |
93.8 |
88.5 to 96.8 |
177 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-15 Years |
84.7 |
77.6 to 89.9 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2018 |
Age |
13-15 Years |
93.3 |
86.8 to 96.7 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-15 Years |
96.3 |
92.8 to 98.1 |
368 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-15 Years |
96.8 |
90.3 to 99.0 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-15 Years |
96.2 |
92.2 to 98.2 |
228 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2018 |
Age |
13-15 Years |
91.1 |
90.0 to 92.0 |
10318 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-15 Years |
97.1 |
95.6 to 98.1 |
1043 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-15 Years |
91.0 |
87.2 to 93.8 |
451 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-15 Years |
92.3 |
89.3 to 94.5 |
1319 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-15 Years |
93.3 |
91.4 to 94.9 |
1405 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-15 Years |
95.0 |
93.4 to 96.2 |
1278 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-15 Years |
84.8 |
81.8 to 87.3 |
1805 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-15 Years |
90.8 |
87.3 to 93.3 |
656 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-15 Years |
90.8 |
86.6 to 93.9 |
959 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-15 Years |
87.9 |
82.3 to 91.9 |
711 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-15 Years |
95.1 |
89.7 to 97.7 |
194 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2018 |
Age |
13-15 Years |
88.2 |
81.9 to 92.5 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2018 |
Age |
13-15 Years |
94.3 |
88.3 to 97.3 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2018 |
Age |
13-15 Years |
92.3 |
85.6 to 96.0 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2018 |
Age |
13-15 Years |
83.0 |
79.1 to 86.3 |
1169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-15 Years |
84.3 |
77.0 to 89.6 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-15 Years |
82.1 |
71.4 to 89.3 |
108 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-15 Years |
75.9 |
65.8 to 83.8 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-15 Years |
85.4 |
78.6 to 90.4 |
202 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-15 Years |
83.0 |
77.9 to 87.1 |
519 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-15 Years |
90.0 |
85.6 to 93.1 |
691 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2018 |
Age |
13-15 Years |
91.8 |
85.4 to 95.6 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2018 |
Age |
13-15 Years |
94.0 |
89.1 to 96.8 |
180 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2018 |
Age |
13-15 Years |
88.9 |
79.0 to 94.4 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2018 |
Age |
13-15 Years |
88.6 |
80.7 to 93.5 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2018 |
Age |
13-15 Years |
80.6 |
72.5 to 86.8 |
188 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-15 Years |
90.2 |
84.3 to 94.0 |
196 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2018 |
Age |
13-15 Years |
86.5 |
78.5 to 91.9 |
132 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2019 |
Age |
13-15 Years |
92.5 |
85.7 to 96.2 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2019 |
Age |
13-15 Years |
91.8 |
86.5 to 95.1 |
237 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2019 |
Age |
13-15 Years |
82.1 |
74.0 to 88.0 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2019 |
Age |
13-15 Years |
95.4 |
91.2 to 97.7 |
197 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2019 |
Age |
13-15 Years |
88.6 |
77.5 to 94.6 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2019 |
Age |
13-15 Years |
93.8 |
85.9 to 97.4 |
156 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2019 |
Age |
13-15 Years |
94.9 |
88.4 to 97.9 |
156 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2019 |
Age |
13-15 Years |
94.8 |
88.5 to 97.8 |
177 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-15 Years |
88.9 |
80.5 to 94.0 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2019 |
Age |
13-15 Years |
96.1 |
90.8 to 98.4 |
198 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2019 |
Age |
13-15 Years |
93.5 |
87.1 to 96.8 |
189 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2019 |
Age |
13-15 Years |
69.5 |
60.4 to 77.4 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2019 |
Age |
13-15 Years |
88.2 |
79.9 to 93.4 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2019 |
Age |
13-15 Years |
87.6 |
81.3 to 92.0 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2019 |
Age |
13-15 Years |
91.8 |
87.4 to 94.7 |
352 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-15 Years |
87.5 |
76.4 to 93.8 |
96 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-15 Years |
92.8 |
87.6 to 95.9 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2019 |
Age |
13-15 Years |
93.4 |
87.0 to 96.8 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2019 |
Age |
13-15 Years |
97.0 |
93.6 to 98.6 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2019 |
Age |
13-15 Years |
90.5 |
84.4 to 94.3 |
214 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2019 |
Age |
13-15 Years |
95.8 |
91.4 to 98.0 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2019 |
Age |
13-15 Years |
94.2 |
89.2 to 97.0 |
203 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2019 |
Age |
13-15 Years |
90.2 |
82.0 to 94.9 |
180 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2019 |
Age |
13-15 Years |
93.4 |
88.0 to 96.5 |
311 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-15 Years |
96.1 |
89.3 to 98.6 |
164 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2019 |
Age |
13-15 Years |
95.4 |
89.3 to 98.1 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2019 |
Age |
13-15 Years |
96.7 |
90.3 to 98.9 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2019 |
Age |
13-15 Years |
94.7 |
88.0 to 97.8 |
143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2019 |
Age |
13-15 Years |
90.0 |
82.1 to 94.6 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2019 |
Age |
13-15 Years |
87.5 |
78.9 to 93.0 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2019 |
Age |
13-15 Years |
90.6 |
83.1 to 95.0 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2019 |
Age |
13-15 Years |
88.3 |
80.7 to 93.2 |
190 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-15 Years |
94.5 |
86.3 to 97.9 |
186 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2019 |
Age |
13-15 Years |
87.2 |
79.0 to 92.5 |
207 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2019 |
Age |
13-15 Years |
92.1 |
86.7 to 95.4 |
232 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2019 |
Age |
13-15 Years |
93.7 |
89.7 to 96.2 |
278 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-15 Years |
91.7 |
84.6 to 95.7 |
142 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-15 Years |
95.1 |
89.9 to 97.7 |
136 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2019 |
Age |
13-15 Years |
91.5 |
84.0 to 95.7 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2019 |
Age |
13-15 Years |
96.7 |
91.2 to 98.8 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2019 |
Age |
13-15 Years |
93.7 |
88.4 to 96.7 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-15 Years |
89.5 |
83.1 to 93.6 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2019 |
Age |
13-15 Years |
92.7 |
86.1 to 96.3 |
162 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-15 Years |
96.3 |
93.0 to 98.1 |
406 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-15 Years |
93.6 |
87.4 to 96.8 |
126 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-15 Years |
96.7 |
92.7 to 98.5 |
280 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-15 Years |
92.7 |
80.4 to 97.5 |
119 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2019 |
Age |
13-15 Years |
91.7 |
90.3 to 92.9 |
10708 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-15 Years |
95.3 |
92.3 to 97.1 |
1118 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-15 Years |
91.3 |
87.5 to 94.0 |
485 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-15 Years |
94.1 |
91.7 to 95.8 |
1467 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-15 Years |
94.0 |
91.9 to 95.5 |
1385 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-15 Years |
94.0 |
92.1 to 95.5 |
1176 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-15 Years |
87.7 |
84.8 to 90.0 |
1867 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-15 Years |
91.7 |
88.2 to 94.2 |
731 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-15 Years |
91.7 |
87.8 to 94.3 |
1022 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-15 Years |
87.7 |
79.6 to 92.8 |
688 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-15 Years |
97.7 |
94.3 to 99.1 |
167 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2019 |
Age |
13-15 Years |
92.5 |
87.0 to 95.8 |
186 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2019 |
Age |
13-15 Years |
91.1 |
84.8 to 94.9 |
180 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2019 |
Age |
13-15 Years |
92.9 |
86.0 to 96.6 |
148 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2019 |
Age |
13-15 Years |
85.4 |
81.6 to 88.6 |
1052 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-15 Years |
86.6 |
79.0 to 91.7 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-15 Years |
90.5 |
79.6 to 95.9 |
105 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-15 Years |
80.2 |
70.7 to 87.1 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-15 Years |
90.7 |
84.0 to 94.8 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-15 Years |
85.3 |
80.1 to 89.4 |
460 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-15 Years |
78.6 |
67.3 to 86.7 |
121 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-15 Years |
92.5 |
88.9 to 95.0 |
769 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2019 |
Age |
13-15 Years |
88.3 |
80.2 to 93.4 |
190 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2019 |
Age |
13-15 Years |
95.2 |
90.0 to 97.7 |
265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2019 |
Age |
13-15 Years |
93.0 |
85.5 to 96.8 |
223 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2019 |
Age |
13-15 Years |
93.8 |
87.0 to 97.2 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2019 |
Age |
13-15 Years |
87.1 |
79.5 to 92.1 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-15 Years |
95.2 |
90.8 to 97.6 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2019 |
Age |
13-15 Years |
95.4 |
89.2 to 98.1 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2020 |
Age |
13-15 Years |
93.7 |
88.0 to 96.8 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2020 |
Age |
13-15 Years |
91.5 |
85.4 to 95.2 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2020 |
Age |
13-15 Years |
89.0 |
83.0 to 93.1 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2020 |
Age |
13-15 Years |
96.8 |
89.3 to 99.1 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2020 |
Age |
13-15 Years |
90.0 |
82.8 to 94.3 |
250 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2020 |
Age |
13-15 Years |
92.6 |
86.0 to 96.3 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2020 |
Age |
13-15 Years |
96.6 |
91.5 to 98.7 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2020 |
Age |
13-15 Years |
92.4 |
85.8 to 96.1 |
207 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-15 Years |
88.6 |
82.1 to 93.0 |
226 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2020 |
Age |
13-15 Years |
94.2 |
88.2 to 97.2 |
213 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2020 |
Age |
13-15 Years |
96.8 |
92.4 to 98.7 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2020 |
Age |
13-15 Years |
69.7 |
59.7 to 78.2 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2020 |
Age |
13-15 Years |
92.3 |
87.0 to 95.6 |
162 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2020 |
Age |
13-15 Years |
89.3 |
82.9 to 93.5 |
220 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2020 |
Age |
13-15 Years |
94.5 |
91.2 to 96.7 |
391 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-15 Years |
89.4 |
78.7 to 95.1 |
159 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-15 Years |
95.6 |
91.9 to 97.7 |
232 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2020 |
Age |
13-15 Years |
97.4 |
93.8 to 98.9 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2020 |
Age |
13-15 Years |
96.6 |
93.1 to 98.4 |
151 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2020 |
Age |
13-15 Years |
92.8 |
86.3 to 96.4 |
205 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2020 |
Age |
13-15 Years |
98.2 |
95.2 to 99.3 |
150 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2020 |
Age |
13-15 Years |
94.6 |
89.6 to 97.3 |
207 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2020 |
Age |
13-15 Years |
97.0 |
92.5 to 98.9 |
208 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2020 |
Age |
13-15 Years |
93.9 |
90.4 to 96.2 |
499 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-15 Years |
96.7 |
92.3 to 98.6 |
234 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2020 |
Age |
13-15 Years |
96.2 |
92.1 to 98.2 |
215 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2020 |
Age |
13-15 Years |
98.6 |
96.1 to 99.5 |
193 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2020 |
Age |
13-15 Years |
94.0 |
87.4 to 97.3 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2020 |
Age |
13-15 Years |
92.2 |
86.2 to 95.7 |
231 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2020 |
Age |
13-15 Years |
93.1 |
86.0 to 96.7 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2020 |
Age |
13-15 Years |
86.0 |
79.1 to 90.9 |
220 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2020 |
Age |
13-15 Years |
85.7 |
77.3 to 91.4 |
198 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-15 Years |
99.9 |
99.1 to 100.0 |
204 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2020 |
Age |
13-15 Years |
92.6 |
87.5 to 95.7 |
239 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2020 |
Age |
13-15 Years |
97.0 |
93.9 to 98.5 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2020 |
Age |
13-15 Years |
92.7 |
88.4 to 95.5 |
415 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-15 Years |
89.6 |
83.0 to 93.8 |
218 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-15 Years |
94.8 |
87.7 to 97.9 |
197 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2020 |
Age |
13-15 Years |
97.5 |
93.5 to 99.0 |
194 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2020 |
Age |
13-15 Years |
96.5 |
91.5 to 98.6 |
233 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2020 |
Age |
13-15 Years |
91.4 |
84.9 to 95.3 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-15 Years |
88.1 |
81.4 to 92.5 |
199 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2020 |
Age |
13-15 Years |
93.2 |
87.6 to 96.4 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-15 Years |
93.3 |
87.5 to 96.5 |
430 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-15 Years |
97.0 |
93.2 to 98.7 |
150 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-15 Years |
92.8 |
86.2 to 96.4 |
280 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-15 Years |
70.8 |
54.7 to 83.0 |
91 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2020 |
Age |
13-15 Years |
92.7 |
91.6 to 93.6 |
11544 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-15 Years |
96.8 |
94.8 to 98.1 |
1213 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-15 Years |
92.6 |
89.5 to 94.9 |
654 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-15 Years |
93.3 |
90.8 to 95.2 |
1919 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-15 Years |
95.1 |
93.2 to 96.4 |
1473 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-15 Years |
95.0 |
93.3 to 96.4 |
1319 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-15 Years |
88.8 |
85.1 to 91.6 |
1424 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-15 Years |
92.4 |
89.6 to 94.5 |
807 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-15 Years |
91.4 |
88.1 to 93.8 |
1120 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-15 Years |
89.6 |
84.3 to 93.3 |
797 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-15 Years |
96.7 |
90.2 to 98.9 |
146 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2020 |
Age |
13-15 Years |
93.6 |
86.6 to 97.1 |
196 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2020 |
Age |
13-15 Years |
94.6 |
88.5 to 97.5 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2020 |
Age |
13-15 Years |
91.6 |
85.2 to 95.3 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2020 |
Age |
13-15 Years |
86.6 |
81.3 to 90.6 |
661 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-15 Years |
88.1 |
82.2 to 92.3 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-15 Years |
86.0 |
77.4 to 91.7 |
139 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-15 Years |
86.5 |
80.4 to 91.0 |
348 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-15 Years |
91.8 |
88.1 to 94.4 |
818 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2020 |
Age |
13-15 Years |
87.9 |
81.1 to 92.5 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2020 |
Age |
13-15 Years |
94.2 |
88.9 to 97.0 |
234 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2020 |
Age |
13-15 Years |
93.4 |
87.9 to 96.5 |
396 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2020 |
Age |
13-15 Years |
91.8 |
84.9 to 95.7 |
255 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2020 |
Age |
13-15 Years |
92.7 |
87.4 to 95.9 |
161 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-15 Years |
95.1 |
88.2 to 98.0 |
156 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2020 |
Age |
13-15 Years |
89.5 |
81.5 to 94.3 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2021 |
Age |
13-15 Years |
95.4 |
89.0 to 98.1 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2021 |
Age |
13-15 Years |
88.3 |
80.3 to 93.3 |
156 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2021 |
Age |
13-15 Years |
88.5 |
81.5 to 93.1 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2021 |
Age |
13-15 Years |
93.8 |
87.0 to 97.2 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2021 |
Age |
13-15 Years |
86.3 |
74.7 to 93.1 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2021 |
Age |
13-15 Years |
94.6 |
90.3 to 97.0 |
184 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2021 |
Age |
13-15 Years |
95.3 |
89.1 to 98.1 |
204 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2021 |
Age |
13-15 Years |
91.3 |
83.8 to 95.6 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-15 Years |
86.5 |
79.0 to 91.6 |
248 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2021 |
Age |
13-15 Years |
94.2 |
85.9 to 97.8 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2021 |
Age |
13-15 Years |
91.9 |
79.6 to 97.0 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2021 |
Age |
13-15 Years |
63.5 |
51.4 to 74.1 |
109 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2021 |
Age |
13-15 Years |
91.6 |
85.4 to 95.4 |
133 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2021 |
Age |
13-15 Years |
91.4 |
84.7 to 95.3 |
200 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2021 |
Age |
13-15 Years |
95.9 |
92.3 to 97.9 |
339 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-15 Years |
96.7 |
82.7 to 99.5 |
88 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-15 Years |
95.7 |
91.5 to 97.8 |
251 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2021 |
Age |
13-15 Years |
91.0 |
83.0 to 95.4 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2021 |
Age |
13-15 Years |
96.4 |
91.7 to 98.5 |
120 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2021 |
Age |
13-15 Years |
92.1 |
84.0 to 96.3 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2021 |
Age |
13-15 Years |
96.8 |
91.8 to 98.8 |
128 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2021 |
Age |
13-15 Years |
92.2 |
85.1 to 96.1 |
184 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2021 |
Age |
13-15 Years |
94.3 |
88.8 to 97.1 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2021 |
Age |
13-15 Years |
92.9 |
89.3 to 95.4 |
539 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-15 Years |
96.5 |
88.2 to 99.0 |
153 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2021 |
Age |
13-15 Years |
90.1 |
81.8 to 94.8 |
216 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2021 |
Age |
13-15 Years |
97.0 |
92.7 to 98.8 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2021 |
Age |
13-15 Years |
94.7 |
88.2 to 97.7 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2021 |
Age |
13-15 Years |
88.4 |
80.4 to 93.4 |
203 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2021 |
Age |
13-15 Years |
94.3 |
89.2 to 97.1 |
161 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2021 |
Age |
13-15 Years |
93.1 |
87.7 to 96.2 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2021 |
Age |
13-15 Years |
88.5 |
80.8 to 93.3 |
202 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-15 Years |
98.5 |
95.5 to 99.5 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2021 |
Age |
13-15 Years |
87.8 |
78.6 to 93.4 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2021 |
Age |
13-15 Years |
90.4 |
84.1 to 94.4 |
188 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2021 |
Age |
13-15 Years |
95.9 |
92.2 to 97.9 |
319 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-15 Years |
92.6 |
85.0 to 96.5 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-15 Years |
98.2 |
92.8 to 99.6 |
151 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2021 |
Age |
13-15 Years |
93.5 |
84.8 to 97.4 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2021 |
Age |
13-15 Years |
94.8 |
88.7 to 97.7 |
95 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2021 |
Age |
13-15 Years |
95.0 |
87.1 to 98.2 |
146 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-15 Years |
91.4 |
85.9 to 94.9 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2021 |
Age |
13-15 Years |
91.7 |
84.7 to 95.7 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-15 Years |
92.0 |
87.4 to 95.0 |
535 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-15 Years |
94.4 |
86.4 to 97.8 |
189 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-15 Years |
91.7 |
86.5 to 94.9 |
346 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-15 Years |
82.8 |
75.3 to 88.4 |
201 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2021 |
Age |
13-15 Years |
91.7 |
90.2 to 93.0 |
10456 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-15 Years |
96.0 |
93.1 to 97.8 |
1109 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-15 Years |
93.1 |
89.2 to 95.6 |
492 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-15 Years |
92.2 |
89.7 to 94.1 |
1977 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-15 Years |
94.1 |
91.3 to 96.1 |
1327 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-15 Years |
93.7 |
91.4 to 95.5 |
1188 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-15 Years |
88.7 |
84.5 to 91.8 |
1252 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-15 Years |
91.5 |
87.7 to 94.3 |
671 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-15 Years |
93.9 |
91.2 to 95.8 |
1025 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-15 Years |
86.9 |
78.3 to 92.4 |
675 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-15 Years |
94.8 |
88.6 to 97.8 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2021 |
Age |
13-15 Years |
94.9 |
90.0 to 97.4 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2021 |
Age |
13-15 Years |
97.8 |
94.7 to 99.1 |
259 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2021 |
Age |
13-15 Years |
94.7 |
89.5 to 97.4 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2021 |
Age |
13-15 Years |
87.2 |
81.3 to 91.5 |
557 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-15 Years |
87.5 |
79.5 to 92.6 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-15 Years |
91.4 |
79.7 to 96.6 |
85 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-15 Years |
86.9 |
80.1 to 91.7 |
309 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-15 Years |
82.5 |
71.3 to 90.0 |
160 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-15 Years |
92.6 |
89.5 to 94.9 |
740 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2021 |
Age |
13-15 Years |
92.6 |
85.2 to 96.4 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2021 |
Age |
13-15 Years |
95.6 |
91.9 to 97.7 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2021 |
Age |
13-15 Years |
93.3 |
86.2 to 96.9 |
327 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2021 |
Age |
13-15 Years |
94.1 |
88.7 to 97.0 |
206 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2021 |
Age |
13-15 Years |
86.1 |
78.0 to 91.6 |
146 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-15 Years |
93.3 |
86.1 to 96.9 |
161 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2021 |
Age |
13-15 Years |
89.3 |
81.8 to 93.9 |
151 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2022 |
Age |
13-15 Years |
95.4 |
88.6 to 98.2 |
150 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2022 |
Age |
13-15 Years |
90.6 |
82.2 to 95.2 |
142 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2022 |
Age |
13-15 Years |
92.4 |
85.9 to 96.1 |
149 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2022 |
Age |
13-15 Years |
93.5 |
88.5 to 96.4 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2022 |
Age |
13-15 Years |
83.7 |
74.0 to 90.3 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2022 |
Age |
13-15 Years |
95.6 |
91.8 to 97.6 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2022 |
Age |
13-15 Years |
95.7 |
90.1 to 98.2 |
161 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2022 |
Age |
13-15 Years |
94.2 |
88.4 to 97.1 |
133 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-15 Years |
78.3 |
67.0 to 86.5 |
143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2022 |
Age |
13-15 Years |
98.0 |
95.4 to 99.2 |
177 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2022 |
Age |
13-15 Years |
91.7 |
83.4 to 96.0 |
207 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2022 |
Age |
13-15 Years |
71.9 |
59.9 to 81.5 |
132 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2022 |
Age |
13-15 Years |
90.3 |
81.4 to 95.2 |
125 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2022 |
Age |
13-15 Years |
93.4 |
86.7 to 96.9 |
147 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2022 |
Age |
13-15 Years |
92.1 |
87.3 to 95.2 |
360 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-15 Years |
90.5 |
83.2 to 94.8 |
150 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-15 Years |
92.5 |
86.4 to 96.0 |
210 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2022 |
Age |
13-15 Years |
95.7 |
89.7 to 98.3 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2022 |
Age |
13-15 Years |
96.8 |
91.9 to 98.8 |
120 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2022 |
Age |
13-15 Years |
90.4 |
83.5 to 94.6 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2022 |
Age |
13-15 Years |
95.3 |
87.3 to 98.4 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2022 |
Age |
13-15 Years |
97.0 |
92.5 to 98.9 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2022 |
Age |
13-15 Years |
94.7 |
89.0 to 97.5 |
156 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2022 |
Age |
13-15 Years |
94.7 |
87.7 to 97.8 |
202 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-15 Years |
96.0 |
91.1 to 98.3 |
135 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2022 |
Age |
13-15 Years |
92.7 |
83.3 to 97.0 |
154 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2022 |
Age |
13-15 Years |
98.5 |
95.8 to 99.4 |
180 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2022 |
Age |
13-15 Years |
89.5 |
81.3 to 94.4 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2022 |
Age |
13-15 Years |
92.4 |
84.2 to 96.6 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2022 |
Age |
13-15 Years |
96.4 |
91.9 to 98.5 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2022 |
Age |
13-15 Years |
91.2 |
84.6 to 95.1 |
148 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2022 |
Age |
13-15 Years |
90.6 |
83.3 to 95.0 |
143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-15 Years |
98.5 |
95.3 to 99.5 |
125 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2022 |
Age |
13-15 Years |
89.9 |
82.4 to 94.4 |
153 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2022 |
Age |
13-15 Years |
89.9 |
82.3 to 94.5 |
173 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2022 |
Age |
13-15 Years |
95.6 |
91.5 to 97.7 |
308 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-15 Years |
92.1 |
83.4 to 96.5 |
144 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-15 Years |
98.2 |
94.5 to 99.4 |
164 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2022 |
Age |
13-15 Years |
94.4 |
88.3 to 97.4 |
215 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2022 |
Age |
13-15 Years |
96.2 |
89.9 to 98.6 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2022 |
Age |
13-15 Years |
92.8 |
84.8 to 96.8 |
159 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-15 Years |
86.2 |
77.3 to 92.0 |
142 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2022 |
Age |
13-15 Years |
91.7 |
85.3 to 95.5 |
156 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-15 Years |
94.6 |
90.5 to 97.0 |
449 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-15 Years |
97.8 |
94.9 to 99.1 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-15 Years |
94.1 |
89.4 to 96.8 |
284 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-15 Years |
85.6 |
80.3 to 89.6 |
386 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2022 |
Age |
13-15 Years |
90.8 |
89.4 to 92.1 |
9232 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-15 Years |
95.9 |
93.6 to 97.4 |
899 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-15 Years |
93.7 |
90.3 to 95.9 |
461 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-15 Years |
92.6 |
90.2 to 94.5 |
1410 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-15 Years |
94.3 |
92.4 to 95.8 |
1335 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-15 Years |
93.8 |
91.3 to 95.6 |
1160 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-15 Years |
82.8 |
77.4 to 87.2 |
1153 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-15 Years |
92.8 |
89.4 to 95.2 |
609 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-15 Years |
95.1 |
92.8 to 96.7 |
1008 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-15 Years |
85.6 |
78.2 to 90.8 |
591 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-15 Years |
95.2 |
89.1 to 98.0 |
167 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2022 |
Age |
13-15 Years |
91.6 |
82.5 to 96.1 |
149 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2022 |
Age |
13-15 Years |
95.8 |
90.5 to 98.2 |
153 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2022 |
Age |
13-15 Years |
90.0 |
81.7 to 94.8 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2022 |
Age |
13-15 Years |
79.0 |
71.3 to 85.0 |
456 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-15 Years |
90.7 |
82.5 to 95.3 |
139 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-15 Years |
82.7 |
68.8 to 91.2 |
92 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-15 Years |
78.0 |
69.3 to 84.7 |
225 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-15 Years |
90.8 |
86.3 to 93.9 |
606 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2022 |
Age |
13-15 Years |
93.9 |
87.4 to 97.1 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2022 |
Age |
13-15 Years |
93.7 |
85.8 to 97.3 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2022 |
Age |
13-15 Years |
88.0 |
82.4 to 92.0 |
344 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2022 |
Age |
13-15 Years |
89.4 |
80.5 to 94.5 |
161 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2022 |
Age |
13-15 Years |
97.3 |
94.1 to 98.8 |
139 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-15 Years |
94.8 |
90.0 to 97.3 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2022 |
Age |
13-15 Years |
95.2 |
90.3 to 97.7 |
170 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2006 |
Age |
13-17 Years |
4.1 |
2.8 to 5.9 |
901 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
19.0 |
16.1 to 22.2 |
1047 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
19.3 |
11.2 to 31.1 |
72 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
30.1 |
21.1 to 41.1 |
145 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
15.2 |
9.7 to 22.9 |
188 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
27.1 |
19.2 to 36.9 |
194 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
19.5 |
12.9 to 28.2 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
17.1 |
12.1 to 23.7 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
24.1 |
16.3 to 34.1 |
95 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
35.6 |
25.6 to 47.0 |
95 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
17.8 |
11.6 to 26.4 |
143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
46.0 |
35.0 to 57.4 |
143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
42.2 |
31.7 to 53.4 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
58.7 |
48.1 to 68.5 |
129 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
35.3 |
26.6 to 45.2 |
144 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
43.5 |
35.2 to 52.2 |
177 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
20.3 |
13.4 to 29.4 |
117 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
42.6 |
33.0 to 52.8 |
133 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
41.3 |
32.8 to 50.3 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
26.5 |
19.7 to 34.5 |
308 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
19.8 |
13.6 to 27.8 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
28.4 |
20.0 to 38.7 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
24.0 |
16.7 to 33.3 |
115 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
23.5 |
15.1 to 34.7 |
90 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
26.9 |
16.7 to 40.3 |
87 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
18.4 |
11.6 to 28.0 |
95 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
33.1 |
23.1 to 44.9 |
127 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
40.4 |
30.2 to 51.4 |
105 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
34.6 |
26.5 to 43.7 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
31.6 |
22.7 to 42.2 |
132 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
38.8 |
28.8 to 49.9 |
112 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
38.1 |
29.2 to 47.8 |
138 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
31.0 |
20.7 to 43.6 |
111 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
10.9 |
6.0 to 19.1 |
93 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
36.7 |
27.7 to 46.8 |
126 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
20.2 |
13.3 to 29.5 |
104 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
44.6 |
34.2 to 55.5 |
130 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
37.3 |
28.6 to 46.8 |
182 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
24.3 |
16.5 to 34.3 |
132 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
41.2 |
34.3 to 48.4 |
279 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
50.1 |
39.7 to 60.4 |
144 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
34.4 |
25.8 to 44.3 |
135 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
20.8 |
14.6 to 28.7 |
135 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
30.9 |
22.6 to 40.8 |
118 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
38.4 |
28.1 to 49.8 |
106 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
15.7 |
9.6 to 24.6 |
113 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
24.5 |
16.2 to 35.3 |
90 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
48.4 |
41.1 to 55.7 |
370 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
50.0 |
41.6 to 58.4 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
48.2 |
39.9 to 56.5 |
179 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
34.1 |
31.8 to 36.5 |
6982 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
43.7 |
38.3 to 49.3 |
737 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
40.0 |
34.5 to 45.7 |
461 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
39.5 |
35.0 to 44.2 |
1124 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
22.4 |
19.1 to 26.1 |
1078 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
33.8 |
29.7 to 38.1 |
867 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
28.7 |
22.3 to 36.2 |
830 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
29.4 |
23.5 to 36.0 |
414 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
30.6 |
24.6 to 37.4 |
621 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
43.5 |
34.4 to 53.0 |
505 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
60.3 |
50.0 to 69.8 |
149 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
22.9 |
16.4 to 31.1 |
133 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
31.8 |
22.1 to 43.4 |
315 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
22.4 |
13.9 to 34.1 |
90 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
48.8 |
34.8 to 63.1 |
98 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
30.4 |
19.2 to 44.5 |
127 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
24.4 |
18.4 to 31.5 |
345 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2008 |
Age |
13-17 Years |
22.4 |
12.7 to 36.4 |
71 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
38.4 |
27.5 to 50.7 |
92 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
31.1 |
22.4 to 41.4 |
123 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
26.6 |
17.1 to 39.0 |
89 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
16.6 |
10.6 to 25.2 |
119 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
37.9 |
27.6 to 49.4 |
88 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
18.1 |
11.7 to 27.0 |
103 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
34.0 |
26.3 to 42.7 |
160 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
44.8 |
34.8 to 55.2 |
114 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
57.8 |
48.5 to 66.6 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
21.9 |
14.6 to 31.4 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
56.9 |
48.2 to 65.2 |
214 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
54.4 |
45.4 to 63.2 |
202 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
62.6 |
53.4 to 71.0 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
49.8 |
40.8 to 58.9 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
72.0 |
64.2 to 78.7 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
38.7 |
31.3 to 46.8 |
209 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
68.0 |
59.0 to 75.8 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
55.3 |
46.3 to 64.0 |
143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
25.6 |
16.5 to 37.4 |
81 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
41.6 |
34.6 to 48.9 |
351 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
39.7 |
32.1 to 47.8 |
211 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
42.2 |
33.2 to 51.8 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
35.0 |
27.1 to 43.7 |
352 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
35.4 |
26.4 to 45.6 |
122 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
46.4 |
35.1 to 58.0 |
91 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
23.9 |
17.8 to 31.4 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
42.2 |
32.1 to 53.0 |
124 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
48.7 |
38.7 to 58.9 |
122 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
49.8 |
39.6 to 60.1 |
136 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
53.7 |
45.3 to 61.8 |
196 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
47.7 |
39.9 to 55.7 |
217 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
59.3 |
50.1 to 67.9 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
12.2 |
7.6 to 18.9 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
42.3 |
33.4 to 51.7 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
28.3 |
19.7 to 38.9 |
111 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
47.8 |
38.4 to 57.3 |
124 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
39.7 |
31.1 to 49.0 |
164 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
67.7 |
58.0 to 76.0 |
138 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
51.1 |
43.5 to 58.8 |
232 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
42.4 |
34.8 to 50.4 |
201 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
48.8 |
41.4 to 56.2 |
253 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
39.1 |
29.5 to 49.7 |
131 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
56.2 |
46.0 to 65.8 |
122 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
54.0 |
43.7 to 64.0 |
128 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
54.3 |
44.0 to 64.2 |
107 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
40.3 |
31.1 to 50.2 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
26.3 |
19.9 to 33.8 |
169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
50.3 |
42.6 to 58.0 |
210 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
67.5 |
58.9 to 75.0 |
358 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
66.4 |
58.9 to 73.2 |
217 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
67.6 |
57.6 to 76.3 |
141 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
48.6 |
46.6 to 50.6 |
9391 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
58.9 |
54.2 to 63.5 |
1067 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
49.6 |
44.0 to 55.2 |
485 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
55.0 |
50.0 to 59.9 |
1213 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
41.0 |
37.5 to 44.6 |
1367 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
47.6 |
43.9 to 51.3 |
1368 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
42.3 |
37.0 to 47.8 |
1395 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
42.4 |
37.2 to 47.8 |
477 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
43.8 |
38.6 to 49.1 |
797 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
56.2 |
48.9 to 63.1 |
687 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
70.5 |
63.2 to 76.8 |
249 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
19.9 |
13.6 to 28.1 |
142 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
33.6 |
26.0 to 42.1 |
186 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
46.7 |
39.1 to 54.4 |
736 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
32.8 |
24.2 to 42.7 |
151 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
47.4 |
36.1 to 58.9 |
133 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
46.1 |
36.4 to 56.0 |
154 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
51.8 |
43.3 to 60.3 |
159 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
47.8 |
37.2 to 58.7 |
139 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-17 Years |
29.3 |
23.5 to 36.0 |
261 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
47.0 |
41.5 to 52.5 |
535 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
35.3 |
26.6 to 45.1 |
133 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
67.8 |
59.4 to 75.1 |
179 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
36.7 |
28.6 to 45.8 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
50.1 |
40.4 to 59.7 |
130 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
33.9 |
24.8 to 44.4 |
104 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
71.8 |
63.4 to 78.9 |
158 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
38.1 |
29.8 to 47.1 |
156 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
43.5 |
35.0 to 52.3 |
164 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
44.7 |
35.8 to 54.0 |
140 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
64.5 |
55.8 to 72.3 |
183 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
27.4 |
20.6 to 35.4 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
57.3 |
48.7 to 65.4 |
197 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
65.3 |
57.1 to 72.6 |
190 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
79.5 |
72.0 to 85.5 |
268 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
67.8 |
59.8 to 75.0 |
200 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
84.9 |
78.8 to 89.5 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
44.5 |
36.1 to 53.2 |
194 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
75.0 |
67.2 to 81.5 |
208 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
65.2 |
57.6 to 72.1 |
216 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
42.8 |
33.1 to 53.0 |
120 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
52.5 |
45.7 to 59.3 |
387 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
62.4 |
54.0 to 70.1 |
200 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
49.8 |
41.6 to 58.1 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
58.1 |
48.0 to 67.6 |
129 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
38.5 |
29.1 to 48.9 |
105 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
65.6 |
57.4 to 73.0 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
40.7 |
32.4 to 49.5 |
161 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
63.9 |
55.1 to 71.8 |
184 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
58.0 |
49.2 to 66.3 |
164 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
59.4 |
51.5 to 66.9 |
226 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
74.7 |
66.6 to 81.4 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
64.3 |
55.5 to 72.2 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
68.0 |
59.6 to 75.5 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
24.7 |
17.7 to 33.3 |
162 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
44.3 |
36.7 to 52.1 |
193 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
41.4 |
32.8 to 50.6 |
146 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
59.8 |
49.9 to 68.9 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
53.6 |
45.3 to 61.8 |
176 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
76.8 |
69.1 to 83.1 |
193 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
62.2 |
53.8 to 69.9 |
238 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
55.7 |
47.0 to 64.1 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
61.6 |
55.7 to 67.3 |
457 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
66.7 |
59.1 to 73.5 |
262 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
58.0 |
49.4 to 66.2 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
52.1 |
44.1 to 59.9 |
201 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
63.6 |
54.1 to 72.1 |
127 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
48.0 |
39.5 to 56.6 |
163 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
42.9 |
34.4 to 51.8 |
157 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
60.1 |
51.5 to 68.0 |
177 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
80.5 |
75.0 to 85.0 |
508 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
77.3 |
70.6 to 82.9 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
81.0 |
74.6 to 86.1 |
238 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
58.1 |
56.4 to 59.8 |
10542 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
76.1 |
71.8 to 79.9 |
1192 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
61.8 |
56.9 to 66.4 |
695 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
64.2 |
60.4 to 67.9 |
1538 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
49.8 |
46.3 to 53.3 |
1447 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
58.9 |
55.3 to 62.4 |
1167 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
56.2 |
51.7 to 60.6 |
1674 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
49.8 |
45.0 to 54.5 |
617 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
56.3 |
51.2 to 61.3 |
851 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
58.2 |
51.3 to 64.9 |
772 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
85.3 |
79.2 to 89.9 |
226 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
32.3 |
25.0 to 40.7 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
19.7 |
12.4 to 29.8 |
116 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
54.7 |
46.4 to 62.6 |
185 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
60.2 |
53.7 to 66.3 |
981 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
57.2 |
49.1 to 64.9 |
212 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
68.4 |
60.3 to 75.5 |
254 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
58.8 |
49.9 to 67.2 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
65.2 |
57.0 to 72.5 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
59.4 |
50.3 to 67.8 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
61.3 |
53.2 to 68.8 |
205 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
59.3 |
54.0 to 64.3 |
589 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
50.3 |
40.8 to 59.7 |
148 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
81.2 |
72.4 to 87.7 |
149 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
43.1 |
34.8 to 51.7 |
206 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
64.3 |
55.4 to 72.4 |
152 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
40.2 |
31.8 to 49.2 |
141 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
78.1 |
69.7 to 84.6 |
150 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
47.6 |
38.0 to 57.3 |
124 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
56.4 |
48.6 to 63.8 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
59.5 |
48.8 to 69.4 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
60.5 |
51.6 to 68.7 |
262 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
47.2 |
36.8 to 57.8 |
203 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
66.5 |
60.4 to 72.1 |
410 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
74.0 |
65.1 to 81.3 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
87.2 |
81.7 to 91.3 |
318 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
79.2 |
73.1 to 84.1 |
306 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
92.2 |
87.2 to 95.3 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
66.1 |
58.4 to 73.0 |
313 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
85.8 |
79.6 to 90.4 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
73.6 |
66.4 to 79.8 |
255 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
49.9 |
39.3 to 60.4 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
63.7 |
57.3 to 69.7 |
546 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
66.2 |
58.6 to 73.1 |
272 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
63.1 |
55.4 to 70.3 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
86.2 |
78.6 to 91.5 |
221 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
49.8 |
40.4 to 59.3 |
172 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
60.9 |
51.0 to 69.9 |
212 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
43.8 |
35.7 to 52.3 |
225 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
84.2 |
77.3 to 89.2 |
284 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
69.6 |
62.4 to 76.0 |
253 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
69.7 |
62.9 to 75.8 |
343 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
82.3 |
75.5 to 87.5 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
80.3 |
72.9 to 86.1 |
275 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
81.9 |
72.9 to 88.4 |
197 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
32.9 |
24.3 to 42.8 |
194 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
46.7 |
37.9 to 55.6 |
226 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
51.8 |
39.1 to 64.4 |
193 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
76.4 |
67.8 to 83.3 |
221 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
51.2 |
42.2 to 60.3 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
88.2 |
83.0 to 92.0 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
71.5 |
64.9 to 77.3 |
285 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
70.7 |
62.7 to 77.5 |
266 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
68.9 |
64.0 to 73.4 |
566 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
70.7 |
64.2 to 76.5 |
302 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
67.6 |
60.6 to 74.0 |
264 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
62.7 |
53.7 to 70.8 |
212 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
61.4 |
49.7 to 71.9 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
59.9 |
51.9 to 67.4 |
231 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
48.4 |
40.2 to 56.8 |
235 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
61.5 |
53.0 to 69.3 |
243 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
85.0 |
79.7 to 89.1 |
664 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
80.4 |
73.6 to 85.7 |
307 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
85.7 |
79.5 to 90.2 |
357 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
68.3 |
66.9 to 69.6 |
14882 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
83.2 |
79.8 to 86.1 |
1653 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
69.7 |
65.8 to 73.4 |
851 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
72.3 |
68.8 to 75.5 |
2161 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
63.2 |
60.0 to 66.3 |
1961 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
73.3 |
70.2 to 76.2 |
1731 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
70.2 |
66.2 to 73.9 |
2476 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
54.6 |
49.4 to 59.6 |
831 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
64.2 |
59.2 to 68.9 |
1234 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
65.2 |
60.2 to 69.9 |
1197 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
83.1 |
76.1 to 88.4 |
333 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
49.7 |
40.9 to 58.5 |
230 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
37.1 |
24.6 to 51.6 |
168 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
61.3 |
52.0 to 69.8 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
73.1 |
67.5 to 78.1 |
1488 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
71.5 |
64.4 to 77.7 |
293 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
77.7 |
70.4 to 83.5 |
354 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
70.6 |
62.5 to 77.6 |
296 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
75.1 |
67.0 to 81.7 |
223 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
73.0 |
65.4 to 79.5 |
322 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
66.1 |
60.7 to 71.2 |
418 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
62.2 |
56.7 to 67.3 |
787 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
54.5 |
45.6 to 63.2 |
229 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
81.7 |
73.9 to 87.6 |
229 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
54.9 |
47.3 to 62.3 |
290 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
65.6 |
56.6 to 73.6 |
189 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
46.8 |
38.9 to 54.9 |
237 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
86.6 |
78.4 to 92.0 |
261 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
78.8 |
68.8 to 86.2 |
204 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
68.1 |
59.1 to 76.0 |
221 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
73.6 |
65.4 to 80.4 |
194 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
73.8 |
66.5 to 80.0 |
239 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
53.3 |
44.8 to 61.6 |
228 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
75.3 |
68.7 to 81.0 |
324 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
81.6 |
74.0 to 87.3 |
236 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
93.5 |
87.7 to 96.6 |
241 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
84.9 |
77.5 to 90.2 |
240 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
92.3 |
85.7 to 96.0 |
282 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
73.3 |
63.9 to 80.9 |
242 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
89.3 |
83.0 to 93.5 |
229 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
76.0 |
68.8 to 81.9 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
57.0 |
48.1 to 65.4 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
63.4 |
55.9 to 70.3 |
439 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
72.2 |
63.3 to 79.6 |
216 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
60.9 |
51.6 to 69.4 |
223 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
84.8 |
76.8 to 90.4 |
206 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
62.1 |
53.3 to 70.2 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
78.7 |
71.0 to 84.9 |
211 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
57.3 |
48.8 to 65.3 |
223 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
84.8 |
78.8 to 89.3 |
242 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
75.6 |
67.5 to 82.2 |
217 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
80.4 |
72.6 to 86.4 |
259 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
88.8 |
83.2 to 92.8 |
272 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
87.4 |
81.5 to 91.7 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
82.9 |
75.3 to 88.5 |
205 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
48.1 |
38.6 to 57.8 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
53.6 |
43.9 to 63.0 |
188 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
61.3 |
52.1 to 69.7 |
175 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
82.2 |
74.9 to 87.7 |
224 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
69.4 |
61.1 to 76.6 |
225 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
92.9 |
87.9 to 96.0 |
190 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
73.8 |
66.0 to 80.4 |
252 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
60.5 |
52.1 to 68.3 |
238 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
74.4 |
68.9 to 79.2 |
465 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
70.2 |
62.2 to 77.1 |
235 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
77.1 |
69.5 to 83.3 |
230 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
66.7 |
58.4 to 74.1 |
229 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
68.6 |
59.1 to 76.7 |
206 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
62.0 |
52.8 to 70.3 |
206 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
65.1 |
57.1 to 72.3 |
222 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
75.6 |
68.8 to 81.3 |
284 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
90.4 |
85.1 to 93.9 |
599 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
90.0 |
84.2 to 93.8 |
296 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
90.4 |
84.4 to 94.3 |
303 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
74.9 |
73.5 to 76.3 |
13197 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
89.9 |
87.0 to 92.2 |
1366 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
74.2 |
69.8 to 78.2 |
717 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
81.2 |
77.8 to 84.2 |
1804 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
71.0 |
67.6 to 74.3 |
1779 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
75.3 |
72.0 to 78.4 |
1527 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
75.5 |
72.5 to 78.3 |
2075 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
64.6 |
59.3 to 69.6 |
810 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
71.2 |
66.6 to 75.4 |
1189 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
74.9 |
69.5 to 79.6 |
1048 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
93.3 |
88.4 to 96.3 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
58.3 |
49.5 to 66.5 |
218 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
43.7 |
35.0 to 52.8 |
161 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
70.8 |
61.5 to 78.7 |
225 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
79.1 |
74.9 to 82.8 |
1145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
72.5 |
63.2 to 80.1 |
250 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
77.6 |
69.5 to 84.0 |
297 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
79.8 |
74.9 to 83.9 |
598 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
75.6 |
70.9 to 79.8 |
475 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
72.4 |
67.4 to 76.9 |
882 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
59.2 |
50.3 to 67.5 |
222 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
92.4 |
87.6 to 95.4 |
189 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
69.1 |
60.9 to 76.2 |
258 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
73.9 |
64.8 to 81.4 |
209 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
61.5 |
51.8 to 70.3 |
166 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
87.9 |
81.4 to 92.4 |
211 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
88.8 |
81.9 to 93.3 |
189 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
79.1 |
72.3 to 84.5 |
241 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
80.7 |
73.8 to 86.1 |
220 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
67.8 |
60.3 to 74.5 |
254 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
59.6 |
51.9 to 66.8 |
220 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
79.0 |
71.8 to 84.7 |
242 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
78.5 |
72.2 to 83.6 |
265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
95.8 |
91.2 to 98.1 |
255 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
79.8 |
72.8 to 85.4 |
264 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
82.1 |
69.6 to 90.1 |
157 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
76.0 |
68.3 to 82.2 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
93.7 |
86.0 to 97.3 |
195 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
43.7 |
35.5 to 52.3 |
186 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
83.3 |
76.8 to 88.3 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
63.8 |
54.0 to 72.6 |
162 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
79.9 |
74.3 to 84.6 |
407 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
79.4 |
70.0 to 86.5 |
165 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
80.0 |
73.2 to 85.5 |
242 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
91.8 |
86.6 to 95.2 |
237 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
62.1 |
54.5 to 69.1 |
258 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
80.7 |
73.9 to 86.1 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
66.5 |
58.5 to 73.7 |
210 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
89.1 |
83.9 to 92.8 |
230 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
71.0 |
63.2 to 77.6 |
237 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
78.9 |
71.0 to 85.1 |
265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
91.1 |
85.9 to 94.5 |
316 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
92.2 |
87.5 to 95.2 |
231 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
86.3 |
79.1 to 91.3 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
55.7 |
47.4 to 63.6 |
200 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
58.6 |
49.8 to 66.9 |
198 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
58.6 |
49.9 to 66.8 |
191 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
84.6 |
78.3 to 89.3 |
215 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
74.6 |
67.4 to 80.6 |
251 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
91.6 |
86.5 to 94.9 |
247 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
79.2 |
71.8 to 85.0 |
264 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
72.5 |
65.7 to 78.3 |
272 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
79.1 |
74.4 to 83.1 |
553 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
80.6 |
73.5 to 86.1 |
238 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
78.1 |
71.7 to 83.4 |
315 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
74.0 |
66.9 to 80.1 |
241 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
86.0 |
79.9 to 90.4 |
224 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
66.2 |
58.5 to 73.1 |
227 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
67.3 |
60.9 to 73.2 |
322 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
84.3 |
79.0 to 88.5 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
92.1 |
88.0 to 95.0 |
613 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
91.8 |
86.1 to 95.3 |
259 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
92.2 |
87.4 to 95.3 |
354 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
78.5 |
77.2 to 79.8 |
13428 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
90.9 |
88.4 to 93.0 |
1536 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
79.1 |
75.2 to 82.5 |
817 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
80.4 |
76.7 to 83.6 |
1764 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
76.5 |
73.6 to 79.2 |
1790 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
83.0 |
80.4 to 85.2 |
1604 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
77.8 |
74.1 to 81.1 |
1878 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
67.4 |
62.8 to 71.7 |
858 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
71.8 |
67.8 to 75.4 |
1284 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
77.4 |
71.8 to 82.2 |
1017 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
93.2 |
88.7 to 96.0 |
264 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
58.6 |
50.3 to 66.5 |
226 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
50.6 |
42.3 to 58.9 |
189 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
79.7 |
72.5 to 85.4 |
220 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
79.4 |
74.1 to 83.9 |
834 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
78.9 |
72.0 to 84.4 |
230 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
82.1 |
73.8 to 88.2 |
213 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
79.2 |
73.0 to 84.3 |
391 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
77.9 |
72.1 to 82.8 |
299 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
75.3 |
70.5 to 79.6 |
880 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
62.2 |
53.5 to 70.2 |
192 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
90.9 |
85.3 to 94.5 |
217 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
68.0 |
58.3 to 76.3 |
252 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
71.6 |
62.9 to 78.9 |
228 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
59.4 |
51.1 to 67.2 |
213 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
93.4 |
88.5 to 96.3 |
246 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
90.1 |
84.6 to 93.7 |
223 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
78.4 |
71.9 to 83.7 |
298 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
76.0 |
69.1 to 81.8 |
269 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
71.9 |
64.7 to 78.1 |
329 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
68.7 |
61.5 to 75.0 |
291 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
81.7 |
75.3 to 86.7 |
302 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
83.7 |
78.0 to 88.1 |
322 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
95.0 |
91.0 to 97.3 |
329 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
90.2 |
85.0 to 93.7 |
319 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
91.1 |
85.5 to 94.7 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
81.9 |
74.9 to 87.3 |
292 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
93.9 |
89.4 to 96.6 |
308 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
76.7 |
70.2 to 82.2 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
66.5 |
58.4 to 73.8 |
241 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
82.4 |
77.8 to 86.3 |
576 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
85.4 |
78.4 to 90.4 |
232 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
81.7 |
76.1 to 86.3 |
344 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
89.2 |
84.1 to 92.8 |
269 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
70.4 |
62.4 to 77.2 |
237 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
77.1 |
69.9 to 83.1 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
76.1 |
68.8 to 82.1 |
265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
90.3 |
84.7 to 94.0 |
262 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
84.1 |
78.2 to 88.7 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
82.3 |
75.9 to 87.3 |
361 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
92.4 |
87.2 to 95.6 |
295 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
90.5 |
85.1 to 94.1 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
85.6 |
78.5 to 90.7 |
223 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
56.9 |
49.1 to 64.5 |
265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
63.8 |
56.0 to 70.9 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
62.4 |
54.4 to 69.8 |
252 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
83.5 |
76.8 to 88.5 |
247 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
69.8 |
63.0 to 75.7 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
94.7 |
90.9 to 97.0 |
332 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
83.2 |
77.3 to 87.8 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
75.3 |
68.3 to 81.3 |
291 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
79.6 |
74.9 to 83.7 |
489 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
83.7 |
76.8 to 88.8 |
232 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
77.3 |
70.7 to 82.7 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
72.4 |
65.9 to 78.1 |
306 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
84.7 |
77.4 to 90.0 |
228 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
74.2 |
67.2 to 80.1 |
329 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
82.4 |
76.6 to 87.0 |
272 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
74.7 |
67.7 to 80.5 |
328 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
94.4 |
90.7 to 96.6 |
652 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
91.0 |
84.5 to 94.9 |
281 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
94.8 |
90.6 to 97.2 |
371 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
77.3 |
67.9 to 84.6 |
205 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
81.0 |
79.8 to 82.1 |
16461 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
92.9 |
90.6 to 94.7 |
1862 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
80.8 |
77.2 to 84.0 |
765 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
84.9 |
81.9 to 87.4 |
2147 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
79.4 |
76.9 to 81.6 |
2312 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
84.3 |
81.9 to 86.4 |
1936 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
80.4 |
76.9 to 83.4 |
2416 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
70.7 |
66.5 to 74.5 |
1015 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
76.3 |
72.9 to 79.4 |
1667 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
79.7 |
74.7 to 83.9 |
1210 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
96.3 |
92.9 to 98.1 |
358 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
60.0 |
52.6 to 66.9 |
309 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
63.0 |
55.1 to 70.3 |
253 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
86.0 |
79.8 to 90.5 |
269 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
80.2 |
75.1 to 84.4 |
1300 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
82.2 |
76.0 to 87.0 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
81.8 |
75.0 to 87.1 |
318 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
76.9 |
68.7 to 83.5 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
80.0 |
74.0 to 84.9 |
376 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
75.3 |
71.2 to 79.0 |
1131 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
68.1 |
60.9 to 74.5 |
286 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
92.8 |
87.2 to 96.0 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
76.4 |
68.4 to 82.8 |
299 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
77.8 |
71.0 to 83.3 |
293 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
60.8 |
53.1 to 68.0 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
90.7 |
84.7 to 94.5 |
269 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
87.4 |
82.5 to 91.1 |
326 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
86.6 |
81.2 to 90.6 |
295 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
84.5 |
78.7 to 88.9 |
279 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
78.0 |
72.2 to 82.9 |
357 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
84.1 |
78.3 to 88.6 |
294 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
78.3 |
71.5 to 83.9 |
304 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
91.6 |
87.5 to 94.4 |
293 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
93.6 |
89.6 to 96.1 |
312 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
91.0 |
86.2 to 94.2 |
301 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
88.2 |
83.0 to 91.9 |
388 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
83.8 |
77.1 to 88.9 |
266 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
93.5 |
89.0 to 96.2 |
324 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
51.2 |
43.5 to 58.8 |
234 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
83.5 |
78.1 to 87.8 |
292 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
67.5 |
59.9 to 74.3 |
254 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
84.9 |
80.9 to 88.1 |
645 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
88.7 |
83.5 to 92.4 |
246 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
84.0 |
79.3 to 87.8 |
399 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
92.3 |
87.7 to 95.3 |
254 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
80.4 |
74.5 to 85.1 |
317 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
81.5 |
75.1 to 86.6 |
285 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
78.3 |
71.9 to 83.6 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
93.2 |
89.6 to 95.5 |
326 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
84.6 |
79.0 to 89.0 |
301 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
82.3 |
75.9 to 87.3 |
337 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
95.7 |
91.9 to 97.8 |
295 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
93.2 |
89.4 to 95.7 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
89.9 |
84.3 to 93.7 |
305 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
71.5 |
65.0 to 77.1 |
278 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
68.6 |
61.1 to 75.3 |
247 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
73.3 |
66.7 to 79.0 |
283 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
88.7 |
83.6 to 92.3 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
81.7 |
75.6 to 86.6 |
312 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
95.8 |
91.5 to 98.0 |
246 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
85.1 |
79.4 to 89.4 |
309 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
80.6 |
75.0 to 85.2 |
327 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
84.2 |
80.2 to 87.6 |
565 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
81.9 |
75.6 to 86.8 |
269 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
85.8 |
80.1 to 90.0 |
296 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
83.0 |
77.4 to 87.5 |
297 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
89.8 |
83.7 to 93.7 |
240 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
75.7 |
68.2 to 81.9 |
266 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
77.6 |
70.8 to 83.2 |
249 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
85.6 |
80.3 to 89.6 |
287 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
91.2 |
86.8 to 94.3 |
729 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
90.0 |
85.7 to 93.2 |
298 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
91.4 |
86.3 to 94.7 |
431 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
85.0 |
79.3 to 89.4 |
308 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
83.1 |
82.0 to 84.2 |
17892 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
94.3 |
92.4 to 95.7 |
1827 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
84.5 |
81.3 to 87.2 |
874 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
81.9 |
78.6 to 84.8 |
2339 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
83.9 |
81.6 to 86.0 |
2287 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
86.8 |
84.6 to 88.7 |
2096 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
82.6 |
80.3 to 84.7 |
3296 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
76.8 |
73.1 to 80.1 |
1170 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
80.7 |
77.7 to 83.3 |
1619 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
78.6 |
73.3 to 83.1 |
1265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
96.0 |
92.9 to 97.8 |
361 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
68.6 |
61.9 to 74.6 |
289 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
65.8 |
58.5 to 72.4 |
255 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
86.9 |
80.8 to 91.3 |
268 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
81.6 |
78.3 to 84.5 |
2100 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
79.8 |
73.5 to 85.0 |
309 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
79.5 |
72.3 to 85.3 |
226 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
77.2 |
71.7 to 82.0 |
442 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
82.4 |
78.2 to 85.9 |
742 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
82.6 |
78.1 to 86.3 |
431 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
79.9 |
76.2 to 83.1 |
1119 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
67.4 |
60.5 to 73.7 |
288 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
96.2 |
93.3 to 97.9 |
312 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
67.3 |
58.2 to 75.2 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
79.1 |
72.7 to 84.4 |
299 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
69.8 |
62.8 to 76.0 |
263 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
92.5 |
88.1 to 95.3 |
305 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
85.7 |
79.5 to 90.2 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
86.5 |
81.5 to 90.3 |
295 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
87.9 |
82.5 to 91.8 |
325 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
75.4 |
68.4 to 81.2 |
277 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
89.1 |
84.3 to 92.6 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
81.0 |
74.5 to 86.2 |
284 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
90.3 |
85.0 to 93.9 |
283 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
96.5 |
93.0 to 98.3 |
322 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
92.4 |
88.4 to 95.1 |
335 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
95.4 |
92.6 to 97.2 |
339 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
92.2 |
87.6 to 95.2 |
326 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
96.9 |
92.7 to 98.7 |
319 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
54.5 |
47.8 to 61.0 |
338 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
86.9 |
81.3 to 91.0 |
271 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
74.9 |
68.4 to 80.5 |
290 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
92.1 |
89.1 to 94.3 |
497 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
89.4 |
81.2 to 94.3 |
131 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
92.7 |
89.3 to 95.1 |
366 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
91.3 |
86.3 to 94.6 |
282 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
81.6 |
76.1 to 86.1 |
302 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
89.2 |
83.6 to 93.0 |
262 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
88.0 |
82.7 to 91.8 |
273 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
95.2 |
91.4 to 97.4 |
279 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
90.1 |
85.9 to 93.2 |
296 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
80.8 |
74.4 to 86.0 |
407 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
97.2 |
94.9 to 98.5 |
334 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
96.0 |
92.8 to 97.8 |
241 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
86.8 |
80.6 to 91.3 |
299 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
75.8 |
69.3 to 81.3 |
314 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
71.9 |
64.8 to 78.0 |
299 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
83.1 |
76.3 to 88.2 |
285 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
86.7 |
80.6 to 91.0 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
84.8 |
78.3 to 89.5 |
279 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
94.4 |
89.6 to 97.0 |
269 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
87.7 |
83.0 to 91.3 |
377 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
84.7 |
79.5 to 88.8 |
313 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
88.8 |
85.2 to 91.6 |
573 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
85.8 |
79.5 to 90.4 |
246 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
90.7 |
85.9 to 94.0 |
327 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
77.4 |
70.6 to 83.0 |
305 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
91.7 |
85.9 to 95.2 |
237 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
80.6 |
73.9 to 85.9 |
281 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
78.3 |
71.4 to 83.9 |
249 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
81.3 |
74.7 to 86.5 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
91.8 |
88.4 to 94.3 |
782 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
91.4 |
87.1 to 94.4 |
313 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
91.9 |
87.9 to 94.6 |
469 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
89.1 |
84.6 to 92.4 |
374 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
85.6 |
84.5 to 86.6 |
17328 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
95.9 |
94.6 to 96.9 |
1815 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
88.4 |
85.7 to 90.8 |
950 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
85.0 |
82.2 to 87.5 |
2518 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
87.3 |
85.3 to 89.0 |
2341 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
89.9 |
88.0 to 91.5 |
1887 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
82.6 |
80.1 to 84.8 |
2765 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
79.7 |
76.1 to 82.8 |
1137 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
82.4 |
79.0 to 85.2 |
1620 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
80.6 |
75.5 to 84.8 |
1111 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
93.8 |
89.2 to 96.6 |
289 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
72.9 |
65.6 to 79.1 |
259 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
77.6 |
70.5 to 83.4 |
258 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
87.3 |
80.6 to 91.9 |
250 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
80.4 |
76.9 to 83.5 |
1621 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
82.8 |
76.5 to 87.7 |
271 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
77.2 |
67.4 to 84.7 |
197 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
79.9 |
72.9 to 85.5 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
82.6 |
75.6 to 88.0 |
287 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
80.4 |
75.8 to 84.4 |
606 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
79.8 |
74.7 to 84.0 |
404 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
82.6 |
78.8 to 85.7 |
1184 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
68.9 |
61.7 to 75.3 |
265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
95.2 |
91.4 to 97.3 |
305 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
78.2 |
70.7 to 84.3 |
402 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
84.9 |
78.4 to 89.7 |
295 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
77.2 |
70.7 to 82.6 |
253 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
93.7 |
89.7 to 96.2 |
287 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
88.9 |
83.9 to 92.4 |
292 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
86.1 |
81.3 to 89.8 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
89.3 |
84.8 to 92.6 |
297 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
83.1 |
77.2 to 87.7 |
288 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
91.1 |
86.7 to 94.2 |
299 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
83.4 |
76.8 to 88.5 |
269 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
89.7 |
85.2 to 92.9 |
309 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
97.7 |
93.3 to 99.2 |
279 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
90.3 |
85.1 to 93.9 |
307 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
91.4 |
85.3 to 95.1 |
288 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
89.3 |
84.1 to 93.0 |
358 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
96.2 |
92.3 to 98.2 |
312 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
56.8 |
49.2 to 64.1 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
88.3 |
83.0 to 92.2 |
282 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
81.3 |
74.9 to 86.3 |
282 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
93.2 |
90.7 to 95.1 |
605 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
86.0 |
77.7 to 91.5 |
178 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
94.7 |
92.1 to 96.5 |
427 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
96.3 |
92.3 to 98.3 |
302 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
88.9 |
83.9 to 92.4 |
294 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
87.2 |
81.6 to 91.3 |
288 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
88.7 |
83.7 to 92.4 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
95.2 |
91.1 to 97.4 |
305 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
93.7 |
89.8 to 96.1 |
298 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
87.2 |
80.3 to 92.0 |
415 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
93.2 |
88.8 to 95.9 |
365 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
95.8 |
92.0 to 97.9 |
285 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
90.8 |
85.8 to 94.2 |
307 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
89.2 |
84.5 to 92.6 |
288 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
76.9 |
70.7 to 82.1 |
287 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
92.1 |
87.3 to 95.2 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
93.0 |
87.7 to 96.1 |
271 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
87.1 |
81.7 to 91.1 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
94.8 |
90.4 to 97.2 |
277 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
86.2 |
81.0 to 90.1 |
324 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
81.7 |
76.1 to 86.3 |
324 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
93.6 |
90.6 to 95.7 |
563 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
92.1 |
87.5 to 95.2 |
247 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
94.6 |
90.1 to 97.1 |
316 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
91.3 |
87.0 to 94.2 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
92.4 |
88.5 to 95.1 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
88.8 |
84.7 to 91.9 |
339 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
80.3 |
74.5 to 85.1 |
291 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
86.1 |
81.0 to 90.1 |
301 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
94.5 |
91.5 to 96.5 |
760 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
95.0 |
91.5 to 97.2 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
94.5 |
91.0 to 96.7 |
439 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
88.6 |
87.6 to 89.5 |
18152 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
94.7 |
92.6 to 96.2 |
1816 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
91.1 |
88.6 to 93.1 |
887 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
89.5 |
87.0 to 91.6 |
2437 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
90.0 |
88.2 to 91.5 |
2496 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
93.2 |
91.9 to 94.3 |
2117 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
84.5 |
82.4 to 86.4 |
3164 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
83.9 |
80.9 to 86.6 |
1140 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
87.4 |
84.8 to 89.6 |
1784 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
83.7 |
78.6 to 87.8 |
1142 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
96.1 |
92.1 to 98.2 |
289 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
79.0 |
72.5 to 84.2 |
296 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
83.9 |
78.2 to 88.3 |
284 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
91.3 |
86.5 to 94.5 |
297 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
82.9 |
80.0 to 85.5 |
1945 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
85.8 |
80.0 to 90.1 |
288 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
83.0 |
74.9 to 88.8 |
162 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
70.3 |
62.0 to 77.5 |
235 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
84.4 |
78.0 to 89.2 |
278 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
84.2 |
78.1 to 88.8 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
84.2 |
80.1 to 87.5 |
726 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
88.8 |
86.2 to 90.9 |
1169 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
82.6 |
77.0 to 87.1 |
308 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
93.4 |
89.0 to 96.1 |
308 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
86.2 |
79.1 to 91.2 |
371 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
92.0 |
88.0 to 94.8 |
289 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
75.8 |
69.4 to 81.2 |
296 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
95.4 |
92.2 to 97.3 |
279 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
90.7 |
85.7 to 94.1 |
306 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
89.3 |
84.0 to 92.9 |
295 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
89.0 |
84.5 to 92.3 |
344 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
81.5 |
74.8 to 86.7 |
254 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
90.2 |
84.8 to 93.8 |
273 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
86.7 |
80.8 to 91.0 |
318 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
90.7 |
84.6 to 94.6 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
96.5 |
92.6 to 98.4 |
265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
94.1 |
89.2 to 96.9 |
283 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
94.2 |
89.7 to 96.8 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
96.5 |
92.7 to 98.4 |
315 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
57.3 |
49.0 to 65.2 |
214 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
91.3 |
87.1 to 94.2 |
290 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
84.9 |
78.9 to 89.5 |
243 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
93.7 |
91.0 to 95.6 |
636 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
91.9 |
83.7 to 96.2 |
170 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
94.1 |
91.1 to 96.1 |
466 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
97.3 |
94.1 to 98.8 |
251 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
94.0 |
89.4 to 96.6 |
235 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
83.1 |
76.4 to 88.3 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
90.0 |
84.7 to 93.6 |
230 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
93.2 |
87.4 to 96.5 |
245 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
91.3 |
85.9 to 94.7 |
291 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
92.6 |
88.1 to 95.5 |
356 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
98.6 |
96.4 to 99.4 |
293 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
93.5 |
88.8 to 96.4 |
286 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
93.3 |
87.9 to 96.3 |
249 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
88.8 |
83.3 to 92.6 |
242 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
85.0 |
79.4 to 89.3 |
284 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
90.4 |
85.2 to 93.9 |
245 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
91.8 |
86.5 to 95.2 |
250 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
86.8 |
81.4 to 90.8 |
292 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
96.6 |
92.2 to 98.5 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
85.0 |
78.6 to 89.8 |
306 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
89.7 |
84.5 to 93.4 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
92.5 |
88.9 to 95.0 |
465 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
92.9 |
88.0 to 95.9 |
222 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
92.2 |
86.9 to 95.5 |
243 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
89.7 |
84.6 to 93.3 |
291 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
96.2 |
92.8 to 98.1 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
91.3 |
86.5 to 94.5 |
282 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
79.6 |
73.9 to 84.4 |
325 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
88.6 |
83.3 to 92.4 |
266 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
95.7 |
92.8 to 97.4 |
604 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
93.2 |
87.2 to 96.5 |
222 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
96.0 |
92.7 to 97.9 |
382 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
89.6 |
88.7 to 90.4 |
16483 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
96.9 |
95.6 to 97.8 |
1708 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
90.1 |
87.0 to 92.5 |
771 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
91.1 |
88.6 to 93.2 |
2080 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
92.2 |
90.6 to 93.6 |
2209 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
93.3 |
91.8 to 94.6 |
2001 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
83.8 |
81.5 to 85.9 |
2896 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
87.5 |
84.6 to 89.9 |
1026 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
89.6 |
86.6 to 92.0 |
1536 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
86.1 |
81.5 to 89.6 |
1154 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
96.1 |
92.6 to 98.0 |
307 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
85.4 |
80.2 to 89.4 |
289 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
91.5 |
86.9 to 94.6 |
298 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
93.1 |
88.4 to 95.9 |
244 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
82.0 |
78.9 to 84.8 |
1797 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
81.9 |
75.3 to 87.0 |
253 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
80.9 |
72.8 to 87.0 |
171 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
78.7 |
71.0 to 84.8 |
265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
84.7 |
79.3 to 88.9 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
82.0 |
77.9 to 85.5 |
787 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
86.2 |
82.5 to 89.2 |
1102 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
86.4 |
80.7 to 90.6 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
93.9 |
90.2 to 96.3 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
85.7 |
77.5 to 91.3 |
288 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
85.0 |
78.4 to 89.8 |
249 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
80.7 |
74.8 to 85.5 |
290 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
91.4 |
86.8 to 94.5 |
297 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
88.3 |
82.2 to 92.5 |
207 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
94.7 |
90.4 to 97.1 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
91.9 |
88.0 to 94.6 |
380 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
85.1 |
79.4 to 89.4 |
282 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
95.4 |
92.1 to 97.4 |
292 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
85.8 |
77.3 to 91.5 |
254 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
93.4 |
87.7 to 96.6 |
238 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
94.3 |
89.5 to 96.9 |
278 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
93.9 |
88.8 to 96.8 |
283 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
86.7 |
79.0 to 91.8 |
265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
93.5 |
87.5 to 96.7 |
304 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
94.7 |
90.1 to 97.2 |
281 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
68.2 |
60.6 to 75.0 |
210 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
88.5 |
82.7 to 92.6 |
281 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
85.1 |
79.1 to 89.6 |
296 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
92.3 |
88.7 to 94.8 |
544 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
88.0 |
80.0 to 93.1 |
153 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
93.3 |
89.0 to 96.0 |
391 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
94.2 |
89.5 to 96.8 |
264 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
96.8 |
94.1 to 98.2 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
88.9 |
84.0 to 92.4 |
332 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
94.7 |
90.6 to 97.1 |
265 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
95.5 |
92.1 to 97.4 |
308 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
91.5 |
86.0 to 94.9 |
289 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
92.7 |
88.5 to 95.4 |
479 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
96.6 |
91.9 to 98.6 |
275 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
95.5 |
91.3 to 97.7 |
269 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
95.3 |
90.7 to 97.7 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
90.7 |
85.0 to 94.4 |
242 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
87.9 |
81.1 to 92.4 |
254 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
88.0 |
81.9 to 92.3 |
251 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
89.5 |
83.6 to 93.5 |
260 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
87.6 |
81.6 to 91.8 |
278 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
93.5 |
88.6 to 96.4 |
318 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
89.4 |
83.7 to 93.3 |
309 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
87.5 |
82.1 to 91.5 |
364 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
93.5 |
90.3 to 95.7 |
439 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
89.0 |
82.2 to 93.4 |
228 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
96.5 |
93.4 to 98.2 |
211 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
91.3 |
86.3 to 94.6 |
282 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
95.5 |
91.1 to 97.8 |
292 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
92.3 |
88.0 to 95.2 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
87.8 |
83.1 to 91.3 |
318 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
94.6 |
90.3 to 97.0 |
244 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
96.6 |
94.3 to 97.9 |
684 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
95.6 |
91.8 to 97.7 |
218 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
96.7 |
94.1 to 98.1 |
466 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
91.8 |
82.7 to 96.3 |
206 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
90.6 |
89.5 to 91.7 |
17010 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
95.2 |
93.1 to 96.6 |
1862 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
92.1 |
89.3 to 94.1 |
748 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
93.7 |
91.8 to 95.1 |
2323 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
93.1 |
91.2 to 94.6 |
2186 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
93.9 |
92.3 to 95.1 |
1900 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
84.8 |
82.3 to 86.9 |
2948 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
90.3 |
87.3 to 92.6 |
1116 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
90.5 |
87.6 to 92.8 |
1642 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
85.9 |
79.4 to 90.5 |
1095 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
95.4 |
91.8 to 97.5 |
284 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
91.8 |
87.3 to 94.7 |
300 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
90.9 |
85.8 to 94.3 |
280 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
91.6 |
86.5 to 94.8 |
236 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
81.6 |
78.2 to 84.6 |
1666 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
85.5 |
79.2 to 90.1 |
263 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
85.5 |
76.3 to 91.5 |
155 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
77.8 |
70.4 to 83.8 |
240 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
90.3 |
84.5 to 94.0 |
247 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
81.0 |
76.5 to 84.8 |
761 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
79.7 |
71.7 to 85.9 |
211 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
91.2 |
88.2 to 93.4 |
1190 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
85.9 |
79.7 to 90.5 |
298 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
95.2 |
91.4 to 97.4 |
418 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
91.7 |
85.7 to 95.3 |
330 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
91.0 |
85.5 to 94.5 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
86.8 |
81.3 to 90.8 |
282 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
95.8 |
92.6 to 97.7 |
293 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
94.3 |
89.9 to 96.8 |
283 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
94.9 |
91.1 to 97.1 |
277 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
91.2 |
86.4 to 94.4 |
278 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
84.2 |
78.6 to 88.6 |
312 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
95.9 |
91.9 to 98.0 |
298 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
85.8 |
79.6 to 90.3 |
370 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
93.2 |
89.1 to 95.9 |
327 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
96.7 |
93.5 to 98.4 |
309 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
93.6 |
89.3 to 96.3 |
333 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
86.4 |
80.8 to 90.6 |
372 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
94.8 |
90.9 to 97.1 |
335 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
96.2 |
92.8 to 98.0 |
288 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
67.2 |
59.3 to 74.3 |
233 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
91.2 |
86.2 to 94.5 |
267 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
88.6 |
83.3 to 92.3 |
325 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
94.0 |
91.0 to 96.1 |
642 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
89.7 |
82.0 to 94.4 |
248 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
94.9 |
91.4 to 97.0 |
394 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
97.1 |
94.5 to 98.5 |
275 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
96.1 |
93.0 to 97.9 |
251 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
91.5 |
86.6 to 94.8 |
319 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
96.5 |
93.1 to 98.3 |
236 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
95.7 |
92.5 to 97.6 |
329 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
95.7 |
92.1 to 97.7 |
338 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
93.7 |
91.0 to 95.6 |
754 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
96.0 |
93.0 to 97.7 |
372 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
95.2 |
91.6 to 97.3 |
374 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
97.0 |
94.0 to 98.6 |
300 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
94.9 |
90.3 to 97.4 |
251 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
91.0 |
86.5 to 94.0 |
353 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
93.1 |
88.5 to 95.9 |
278 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
87.7 |
82.6 to 91.4 |
368 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
83.9 |
77.4 to 88.7 |
340 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
98.9 |
97.1 to 99.6 |
349 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
90.4 |
85.3 to 93.9 |
361 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
93.6 |
89.5 to 96.1 |
323 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
93.6 |
90.6 to 95.7 |
673 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
89.6 |
84.3 to 93.2 |
350 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
96.2 |
91.9 to 98.3 |
323 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
96.4 |
91.9 to 98.4 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
97.0 |
93.8 to 98.6 |
368 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
91.8 |
87.3 to 94.8 |
317 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
89.9 |
85.1 to 93.3 |
301 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
93.8 |
89.7 to 96.4 |
280 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
94.5 |
90.9 to 96.7 |
709 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
94.0 |
89.0 to 96.8 |
243 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
94.5 |
90.4 to 97.0 |
466 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
67.0 |
54.8 to 77.2 |
162 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
91.9 |
91.0 to 92.7 |
18513 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
96.4 |
94.9 to 97.5 |
1984 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
92.5 |
90.0 to 94.4 |
1034 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
93.3 |
91.5 to 94.7 |
3077 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
94.9 |
93.5 to 96.0 |
2285 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
94.4 |
93.0 to 95.6 |
2164 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
88.9 |
86.2 to 91.1 |
2291 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
91.7 |
89.6 to 93.5 |
1291 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
92.0 |
89.6 to 93.8 |
1834 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
85.6 |
80.9 to 89.3 |
1289 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
96.1 |
92.1 to 98.1 |
252 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
90.1 |
84.4 to 93.9 |
289 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
95.4 |
91.4 to 97.6 |
290 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
93.3 |
89.0 to 96.0 |
306 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
86.7 |
82.9 to 89.9 |
1040 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
84.5 |
79.0 to 88.8 |
288 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
84.1 |
77.0 to 89.4 |
207 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
87.1 |
82.6 to 90.6 |
545 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
92.2 |
89.6 to 94.2 |
1264 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
88.3 |
82.9 to 92.1 |
275 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
95.3 |
91.9 to 97.4 |
364 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
92.5 |
88.5 to 95.2 |
633 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
92.4 |
87.6 to 95.5 |
381 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
88.8 |
84.0 to 92.3 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
93.5 |
88.6 to 96.4 |
256 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
92.1 |
87.4 to 95.2 |
296 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
95.8 |
91.6 to 98.0 |
282 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
89.6 |
83.9 to 93.5 |
244 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
88.1 |
82.7 to 92.0 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
93.9 |
89.3 to 96.6 |
293 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
88.3 |
80.6 to 93.2 |
267 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
94.5 |
90.8 to 96.8 |
277 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
96.2 |
92.3 to 98.2 |
322 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
93.0 |
88.1 to 96.0 |
287 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
85.8 |
80.0 to 90.1 |
387 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
95.4 |
90.6 to 97.8 |
296 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
93.7 |
86.7 to 97.1 |
244 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
60.3 |
50.9 to 68.9 |
181 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
91.5 |
85.9 to 95.0 |
237 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
89.0 |
83.7 to 92.8 |
305 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
94.0 |
91.0 to 96.1 |
548 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
93.2 |
83.0 to 97.5 |
135 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
94.2 |
90.8 to 96.4 |
413 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
92.1 |
86.3 to 95.5 |
249 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
97.1 |
94.0 to 98.6 |
187 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
92.4 |
86.6 to 95.8 |
278 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
94.6 |
89.5 to 97.3 |
209 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
94.3 |
89.6 to 96.9 |
287 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
94.6 |
90.8 to 96.9 |
270 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
92.5 |
89.5 to 94.6 |
804 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
96.0 |
90.1 to 98.5 |
248 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
89.4 |
83.6 to 93.3 |
338 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
96.8 |
93.6 to 98.4 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
91.3 |
85.6 to 94.8 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
89.1 |
83.3 to 93.0 |
316 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
94.9 |
91.5 to 97.0 |
262 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
94.0 |
90.2 to 96.4 |
292 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
89.2 |
83.8 to 92.9 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
98.0 |
94.7 to 99.2 |
263 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
86.1 |
79.4 to 90.8 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
87.9 |
82.6 to 91.8 |
315 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
94.2 |
90.4 to 96.6 |
535 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
91.4 |
85.0 to 95.2 |
277 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
96.2 |
90.2 to 98.5 |
258 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
92.5 |
85.5 to 96.3 |
247 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
94.9 |
89.7 to 97.5 |
174 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
94.6 |
88.2 to 97.6 |
237 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
90.0 |
85.1 to 93.4 |
220 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
92.7 |
87.5 to 95.9 |
271 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
92.3 |
88.9 to 94.7 |
886 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
94.0 |
89.5 to 96.7 |
315 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
92.0 |
88.2 to 94.7 |
571 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
82.0 |
76.1 to 86.7 |
339 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
91.5 |
90.5 to 92.5 |
16725 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
96.0 |
93.6 to 97.5 |
1785 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
91.4 |
88.2 to 93.8 |
811 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
92.1 |
90.2 to 93.7 |
3141 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
94.4 |
92.5 to 95.8 |
2088 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
93.4 |
91.6 to 94.8 |
1930 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
86.9 |
83.6 to 89.6 |
2039 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
92.3 |
89.6 to 94.3 |
1073 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
93.9 |
91.9 to 95.5 |
1632 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
88.4 |
82.7 to 92.4 |
1083 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
94.5 |
88.5 to 97.4 |
240 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
95.2 |
91.6 to 97.3 |
249 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
98.0 |
95.9 to 99.0 |
413 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
94.7 |
90.7 to 97.1 |
287 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
84.7 |
80.1 to 88.5 |
924 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
84.7 |
78.2 to 89.6 |
276 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
80.6 |
70.1 to 88.0 |
157 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
85.1 |
79.6 to 89.2 |
491 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
84.3 |
75.9 to 90.1 |
240 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
90.4 |
87.2 to 92.9 |
1143 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
92.3 |
87.3 to 95.5 |
274 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
95.0 |
92.2 to 96.8 |
442 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
93.4 |
88.3 to 96.3 |
535 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
89.7 |
83.7 to 93.6 |
323 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
83.6 |
76.6 to 88.9 |
242 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
94.4 |
90.0 to 96.9 |
282 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
90.7 |
85.0 to 94.3 |
232 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
93.0 |
87.8 to 96.0 |
252 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
92.6 |
86.9 to 95.9 |
220 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
92.2 |
87.7 to 95.2 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
92.9 |
88.6 to 95.6 |
313 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
84.9 |
78.6 to 89.6 |
303 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
92.6 |
88.8 to 95.2 |
321 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
95.6 |
91.5 to 97.8 |
246 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
92.7 |
87.0 to 96.1 |
234 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
75.0 |
65.9 to 82.3 |
222 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
97.8 |
95.8 to 98.9 |
292 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
93.6 |
88.5 to 96.6 |
317 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
67.5 |
58.2 to 75.7 |
204 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
92.2 |
86.7 to 95.5 |
221 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
93.3 |
88.6 to 96.2 |
225 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
93.4 |
90.2 to 95.6 |
591 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
89.9 |
84.1 to 93.8 |
241 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
94.1 |
90.3 to 96.5 |
350 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
95.0 |
90.7 to 97.4 |
239 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
95.7 |
91.0 to 98.1 |
190 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
90.4 |
85.4 to 93.9 |
291 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
93.8 |
88.4 to 96.8 |
252 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
95.8 |
92.4 to 97.7 |
302 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
94.7 |
89.9 to 97.3 |
251 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
93.8 |
88.2 to 96.8 |
318 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
97.4 |
94.7 to 98.7 |
244 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
92.0 |
85.5 to 95.8 |
239 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
96.2 |
92.6 to 98.1 |
314 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
89.0 |
83.1 to 93.1 |
218 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
90.7 |
85.2 to 94.3 |
266 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
95.0 |
91.3 to 97.1 |
267 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
89.1 |
83.3 to 93.0 |
232 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
88.1 |
82.2 to 92.3 |
241 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
97.3 |
94.1 to 98.8 |
208 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
90.9 |
85.9 to 94.2 |
272 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
88.7 |
82.4 to 93.0 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
95.8 |
93.1 to 97.4 |
507 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
93.8 |
88.0 to 96.9 |
216 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
97.1 |
94.6 to 98.5 |
291 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
95.4 |
91.3 to 97.6 |
335 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
96.9 |
93.0 to 98.7 |
264 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
90.0 |
82.9 to 94.3 |
254 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
85.4 |
78.4 to 90.4 |
229 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
92.0 |
87.1 to 95.1 |
241 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
92.2 |
88.5 to 94.7 |
709 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
96.4 |
93.0 to 98.1 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
91.6 |
87.4 to 94.5 |
452 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
86.6 |
82.9 to 89.6 |
661 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
90.8 |
89.8 to 91.8 |
14960 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
96.3 |
94.9 to 97.4 |
1490 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
94.1 |
91.8 to 95.8 |
779 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
91.4 |
89.4 to 93.0 |
2266 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
94.7 |
93.4 to 95.8 |
2156 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
92.9 |
90.9 to 94.5 |
1894 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
83.7 |
79.4 to 87.2 |
1834 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
91.5 |
88.9 to 93.5 |
979 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
92.1 |
89.5 to 94.0 |
1600 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
86.3 |
81.4 to 90.1 |
1022 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
95.4 |
91.0 to 97.7 |
273 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
92.9 |
87.3 to 96.1 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
94.5 |
90.4 to 96.9 |
235 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
92.3 |
87.0 to 95.6 |
233 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
80.4 |
74.4 to 85.3 |
733 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
90.2 |
84.8 to 93.8 |
232 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
89.1 |
80.0 to 94.4 |
145 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
79.0 |
72.1 to 84.6 |
356 |
| Varicella |
>=2 Doses with no disease history |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
90.3 |
86.7 to 93.0 |
940 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
89.0 |
82.5 to 93.3 |
254 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
92.1 |
86.4 to 95.5 |
268 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
89.0 |
85.1 to 92.0 |
557 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
88.3 |
81.5 to 92.7 |
254 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
92.2 |
86.8 to 95.5 |
226 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
93.3 |
88.0 to 96.4 |
257 |
| Varicella |
>=2 Doses with no disease history |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
93.0 |
88.1 to 96.0 |
259 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2006 |
Age |
13-17 Years |
81.3 |
79.4 to 83.1 |
2882 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2006 |
Age |
13-17 Years |
92.9 |
87.1 to 96.2 |
170 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2006 |
Age |
13-17 Years |
91.9 |
84.7 to 95.9 |
227 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2006 |
Age |
13-17 Years |
85.2 |
79.9 to 89.3 |
347 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2006 |
Age |
13-17 Years |
76.5 |
72.0 to 80.4 |
608 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2006 |
Age |
13-17 Years |
78.1 |
72.3 to 82.9 |
458 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2006 |
Age |
13-17 Years |
80.9 |
74.4 to 86.1 |
268 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2006 |
Age |
13-17 Years |
70.2 |
61.2 to 77.9 |
165 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2006 |
Age |
13-17 Years |
65.7 |
51.9 to 77.4 |
118 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2006 |
Age |
13-17 Years |
87.4 |
83.0 to 90.9 |
362 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2006 |
Age |
13-17 Years |
77.4 |
68.5 to 84.3 |
159 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
87.6 |
86.0 to 89.0 |
2947 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
95.3 |
90.6 to 97.8 |
190 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-17 Years |
92.1 |
85.4 to 95.9 |
219 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
88.9 |
84.8 to 92.0 |
370 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
86.5 |
82.7 to 89.6 |
501 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
89.7 |
86.5 to 92.2 |
584 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-17 Years |
85.7 |
80.2 to 89.9 |
322 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-17 Years |
84.2 |
76.2 to 89.8 |
165 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-17 Years |
77.5 |
68.2 to 84.7 |
112 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
86.9 |
80.7 to 91.3 |
366 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2007 |
Age |
13-17 Years |
82.9 |
73.7 to 89.3 |
118 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
68.2 |
62.3 to 73.5 |
406 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
86.9 |
82.3 to 90.5 |
304 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
83.9 |
77.9 to 88.5 |
250 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
90.9 |
87.1 to 93.7 |
382 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
89.9 |
83.8 to 93.8 |
316 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
94.6 |
91.0 to 96.8 |
347 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
98.4 |
94.8 to 99.5 |
292 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
95.2 |
91.9 to 97.2 |
334 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
94.8 |
90.7 to 97.2 |
329 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
92.8 |
87.6 to 96.0 |
284 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
91.6 |
87.4 to 94.5 |
345 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
93.1 |
88.9 to 95.8 |
317 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
73.1 |
66.4 to 78.8 |
268 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
93.2 |
89.5 to 95.7 |
783 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
90.2 |
85.5 to 93.5 |
343 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
94.0 |
89.1 to 96.8 |
440 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
86.2 |
81.4 to 90.0 |
345 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
79.2 |
73.9 to 83.6 |
308 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
71.4 |
64.7 to 77.3 |
271 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
93.3 |
89.3 to 95.9 |
296 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
85.1 |
80.3 to 88.9 |
379 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
81.4 |
76.0 to 85.7 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
91.2 |
87.1 to 94.1 |
394 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
97.4 |
95.0 to 98.6 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
92.8 |
89.3 to 95.2 |
320 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
89.7 |
85.4 to 92.9 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2008 |
Age |
13-17 Years |
60.8 |
55.0 to 66.2 |
404 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
87.0 |
82.4 to 90.5 |
351 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
75.2 |
69.4 to 80.1 |
299 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
90.6 |
86.1 to 93.8 |
365 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
82.7 |
76.6 to 87.4 |
235 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
92.7 |
88.2 to 95.5 |
300 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
94.5 |
91.0 to 96.7 |
390 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
83.1 |
76.5 to 88.1 |
310 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
93.0 |
89.7 to 95.3 |
600 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
90.9 |
86.0 to 94.1 |
293 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
94.5 |
89.3 to 97.3 |
307 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
81.4 |
75.2 to 86.4 |
326 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
87.9 |
83.4 to 91.3 |
362 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
76.9 |
71.0 to 82.0 |
311 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
88.9 |
84.0 to 92.4 |
292 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
88.0 |
81.5 to 92.4 |
235 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
95.3 |
91.8 to 97.4 |
682 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
93.3 |
89.4 to 95.8 |
345 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
95.6 |
91.4 to 97.8 |
337 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
87.9 |
86.9 to 88.8 |
17835 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
95.7 |
94.5 to 96.7 |
1838 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
93.5 |
91.1 to 95.3 |
990 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
90.1 |
87.8 to 92.0 |
2306 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
86.0 |
84.1 to 87.8 |
2788 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
87.7 |
85.9 to 89.4 |
2361 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
86.7 |
83.3 to 89.5 |
2203 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
82.5 |
79.8 to 84.9 |
1295 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
82.6 |
80.0 to 84.9 |
1854 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
88.8 |
84.2 to 92.2 |
1118 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
98.4 |
96.7 to 99.3 |
297 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
92.0 |
88.4 to 94.5 |
367 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
65.2 |
59.2 to 70.7 |
344 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
82.4 |
76.1 to 87.2 |
360 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
86.5 |
81.3 to 90.4 |
840 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
83.9 |
76.7 to 89.3 |
269 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
86.4 |
79.3 to 91.3 |
233 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
86.7 |
80.5 to 91.2 |
338 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
82.5 |
79.1 to 85.5 |
1082 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2008 |
Age |
13-17 Years |
70.2 |
63.1 to 76.5 |
222 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
94.8 |
91.4 to 96.9 |
283 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
83.7 |
76.8 to 88.8 |
272 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
81.3 |
75.6 to 85.9 |
275 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
72.4 |
66.2 to 77.8 |
295 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
87.8 |
82.4 to 91.7 |
264 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
80.9 |
75.1 to 85.7 |
280 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
82.9 |
78.1 to 86.7 |
339 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
91.8 |
87.8 to 94.6 |
274 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
84.3 |
79.0 to 88.4 |
349 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
88.0 |
83.3 to 91.6 |
363 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
89.6 |
85.5 to 92.7 |
379 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
91.2 |
87.5 to 93.9 |
411 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
96.3 |
91.7 to 98.4 |
351 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
91.4 |
86.7 to 94.5 |
371 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
97.9 |
94.1 to 99.3 |
412 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
95.9 |
92.6 to 97.7 |
412 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
96.0 |
92.9 to 97.7 |
383 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
93.8 |
89.4 to 96.4 |
256 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
83.5 |
76.6 to 88.7 |
227 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
93.7 |
91.0 to 95.5 |
754 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
86.3 |
81.0 to 90.3 |
389 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
95.5 |
92.2 to 97.5 |
365 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
89.0 |
85.5 to 91.7 |
873 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
79.8 |
74.3 to 84.4 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
76.1 |
69.5 to 81.6 |
252 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
92.3 |
88.4 to 94.9 |
393 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
90.2 |
84.7 to 93.8 |
281 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
84.4 |
78.3 to 89.0 |
299 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
92.2 |
85.8 to 95.8 |
245 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
97.5 |
95.4 to 98.7 |
397 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
91.4 |
86.9 to 94.5 |
446 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
90.9 |
86.8 to 93.7 |
336 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
78.6 |
73.9 to 82.7 |
438 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
89.7 |
84.8 to 93.2 |
374 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
76.2 |
70.1 to 81.4 |
306 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
90.5 |
85.9 to 93.7 |
286 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
86.4 |
80.9 to 90.5 |
336 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
94.7 |
91.6 to 96.7 |
307 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
92.8 |
88.6 to 95.6 |
427 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
89.3 |
85.4 to 92.2 |
406 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
92.3 |
88.5 to 94.9 |
539 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
87.3 |
79.0 to 92.7 |
269 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
95.7 |
92.4 to 97.6 |
270 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
86.9 |
81.7 to 90.8 |
323 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
89.8 |
85.4 to 93.0 |
272 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
91.1 |
87.4 to 93.8 |
351 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
87.1 |
82.4 to 90.7 |
336 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
87.4 |
83.0 to 90.8 |
386 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
95.2 |
92.0 to 97.1 |
579 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
89.1 |
84.5 to 92.4 |
324 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
96.1 |
92.2 to 98.1 |
255 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
89.9 |
89.2 to 90.6 |
20066 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
95.4 |
94.0 to 96.4 |
2189 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
92.5 |
89.6 to 94.6 |
966 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
91.3 |
89.1 to 93.2 |
2214 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
91.1 |
89.7 to 92.3 |
2984 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
91.8 |
90.4 to 93.0 |
3105 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
87.0 |
84.4 to 89.1 |
2856 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
84.8 |
82.1 to 87.2 |
1250 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
84.9 |
82.5 to 87.0 |
1974 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
88.9 |
85.6 to 91.4 |
1320 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
93.8 |
89.3 to 96.5 |
409 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
91.5 |
87.0 to 94.5 |
299 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
73.6 |
67.1 to 79.3 |
271 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
87.4 |
82.4 to 91.1 |
397 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
86.1 |
82.3 to 89.1 |
1470 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
82.0 |
75.3 to 87.2 |
305 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
82.1 |
75.2 to 87.3 |
239 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
82.3 |
75.4 to 87.6 |
296 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
87.0 |
82.0 to 90.8 |
325 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
87.3 |
82.1 to 91.2 |
305 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-17 Years |
89.7 |
84.3 to 93.4 |
333 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
85.6 |
82.6 to 88.2 |
1208 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
80.6 |
74.9 to 85.4 |
339 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
94.7 |
92.0 to 96.6 |
426 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
86.7 |
80.8 to 91.0 |
358 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
84.4 |
79.2 to 88.5 |
321 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
79.4 |
72.7 to 84.8 |
249 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
93.4 |
89.5 to 95.9 |
345 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
79.7 |
74.5 to 84.1 |
375 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
89.3 |
84.5 to 92.7 |
296 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
89.0 |
84.0 to 92.5 |
294 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
85.4 |
79.8 to 89.7 |
331 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
90.6 |
86.1 to 93.7 |
313 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
89.0 |
83.5 to 92.8 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
93.1 |
89.6 to 95.5 |
317 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
97.1 |
93.5 to 98.8 |
408 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
92.1 |
87.7 to 95.0 |
348 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
98.5 |
96.6 to 99.3 |
355 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
96.8 |
93.6 to 98.5 |
344 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
95.1 |
92.1 to 97.0 |
373 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
93.9 |
90.2 to 96.2 |
320 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
90.0 |
85.7 to 93.1 |
318 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
95.3 |
93.2 to 96.8 |
739 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
89.0 |
84.1 to 92.5 |
366 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
97.0 |
94.3 to 98.4 |
373 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
93.9 |
90.1 to 96.3 |
316 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
87.4 |
82.4 to 91.2 |
264 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
88.2 |
84.0 to 91.4 |
373 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
94.4 |
90.4 to 96.8 |
309 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
94.1 |
90.3 to 96.4 |
347 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
89.3 |
84.2 to 92.8 |
312 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
96.9 |
94.4 to 98.4 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
95.7 |
91.9 to 97.8 |
306 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
94.6 |
90.1 to 97.1 |
304 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
92.8 |
88.5 to 95.6 |
310 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
83.2 |
77.9 to 87.4 |
354 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
90.9 |
87.0 to 93.7 |
347 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
84.4 |
79.2 to 88.5 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
92.8 |
88.7 to 95.5 |
307 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
92.2 |
88.6 to 94.7 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
96.9 |
94.1 to 98.4 |
350 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
95.4 |
91.0 to 97.7 |
399 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
86.4 |
81.0 to 90.5 |
332 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
94.9 |
92.2 to 96.7 |
701 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
93.8 |
89.9 to 96.3 |
388 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
95.6 |
91.5 to 97.8 |
313 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
89.2 |
85.1 to 92.3 |
366 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
96.6 |
94.2 to 98.0 |
299 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
90.3 |
85.8 to 93.4 |
302 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
91.7 |
87.6 to 94.6 |
300 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
88.0 |
82.8 to 91.8 |
302 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
93.7 |
89.9 to 96.2 |
742 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
93.2 |
89.5 to 95.6 |
371 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
93.8 |
89.3 to 96.5 |
371 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
91.6 |
90.8 to 92.4 |
19257 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
95.5 |
93.8 to 96.7 |
2026 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
95.1 |
92.9 to 96.6 |
1100 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
92.4 |
90.2 to 94.0 |
2436 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
93.5 |
92.3 to 94.5 |
2679 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
93.0 |
91.6 to 94.3 |
2248 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
88.6 |
86.1 to 90.7 |
3001 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
89.8 |
87.7 to 91.6 |
1291 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
89.8 |
87.8 to 91.5 |
1890 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
88.8 |
84.6 to 92.0 |
1311 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
93.6 |
89.3 to 96.3 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
95.3 |
92.3 to 97.2 |
317 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
78.3 |
71.9 to 83.5 |
321 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
94.6 |
90.9 to 96.8 |
320 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
87.2 |
83.5 to 90.1 |
1709 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
88.7 |
84.4 to 91.9 |
382 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
83.4 |
77.7 to 87.8 |
413 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
83.2 |
75.9 to 88.6 |
304 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
91.1 |
87.1 to 93.9 |
313 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
87.8 |
82.6 to 91.6 |
297 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
92.9 |
87.9 to 96.0 |
231 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
87.3 |
84.6 to 89.7 |
1275 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
87.5 |
82.8 to 91.0 |
325 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
95.8 |
92.5 to 97.7 |
320 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
89.6 |
83.8 to 93.5 |
332 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
86.1 |
81.4 to 89.7 |
361 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
77.4 |
71.8 to 82.2 |
321 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
89.9 |
84.9 to 93.4 |
277 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
92.9 |
89.3 to 95.4 |
295 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
90.0 |
85.4 to 93.3 |
403 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
91.6 |
86.9 to 94.7 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
86.4 |
79.8 to 91.1 |
416 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
88.7 |
82.6 to 92.8 |
350 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
89.9 |
85.9 to 92.8 |
583 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
88.5 |
82.2 to 92.8 |
431 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
98.5 |
95.8 to 99.5 |
453 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
96.3 |
93.8 to 97.8 |
442 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
97.1 |
93.4 to 98.8 |
415 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
95.7 |
92.6 to 97.5 |
483 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
97.6 |
95.9 to 98.7 |
425 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
95.4 |
92.3 to 97.2 |
339 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
86.3 |
80.2 to 90.8 |
385 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
94.7 |
92.4 to 96.3 |
848 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
90.6 |
86.2 to 93.7 |
407 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
95.7 |
92.9 to 97.4 |
441 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
94.4 |
90.2 to 96.8 |
430 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
91.8 |
86.5 to 95.1 |
359 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
86.6 |
80.4 to 91.1 |
399 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
96.4 |
93.0 to 98.2 |
382 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
97.1 |
94.9 to 98.3 |
473 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
91.5 |
87.3 to 94.3 |
411 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
94.8 |
91.9 to 96.7 |
516 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
97.8 |
95.5 to 98.9 |
365 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
95.9 |
93.1 to 97.6 |
398 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
93.3 |
87.4 to 96.5 |
327 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
95.3 |
92.6 to 97.1 |
345 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
88.9 |
83.2 to 92.8 |
402 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
86.7 |
80.4 to 91.2 |
385 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
94.0 |
90.0 to 96.4 |
368 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
88.8 |
82.9 to 92.8 |
412 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
95.7 |
92.8 to 97.5 |
385 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
95.5 |
92.1 to 97.5 |
432 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
90.1 |
85.8 to 93.3 |
431 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
94.6 |
92.4 to 96.2 |
840 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
92.1 |
88.5 to 94.6 |
435 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
96.2 |
92.8 to 98.0 |
405 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
89.3 |
84.5 to 92.8 |
347 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
91.7 |
84.6 to 95.7 |
314 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
90.6 |
85.7 to 93.9 |
381 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
92.7 |
88.5 to 95.4 |
360 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
89.0 |
83.0 to 93.0 |
362 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
93.5 |
89.8 to 95.9 |
880 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
90.2 |
84.9 to 93.7 |
387 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
93.9 |
89.7 to 96.5 |
493 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
92.3 |
91.6 to 92.9 |
23564 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
96.9 |
95.9 to 97.7 |
2467 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
94.9 |
93.1 to 96.2 |
1272 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
93.1 |
91.3 to 94.5 |
3073 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
94.2 |
92.9 to 95.2 |
3171 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
93.4 |
91.9 to 94.6 |
2800 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
90.7 |
88.8 to 92.3 |
3838 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
89.7 |
86.8 to 92.0 |
1528 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
88.5 |
85.2 to 91.1 |
2242 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
89.5 |
86.4 to 92.0 |
1750 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
95.6 |
92.7 to 97.4 |
449 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
95.2 |
91.2 to 97.5 |
362 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
87.3 |
78.0 to 93.1 |
355 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
92.1 |
86.3 to 95.6 |
424 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
89.6 |
86.9 to 91.9 |
2224 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
93.6 |
89.9 to 96.0 |
448 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
87.7 |
82.8 to 91.3 |
490 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
87.8 |
82.0 to 91.9 |
441 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
90.5 |
86.0 to 93.7 |
355 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
89.6 |
85.8 to 92.5 |
490 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
92.8 |
89.6 to 95.0 |
485 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
88.7 |
85.6 to 91.1 |
1423 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
88.2 |
81.7 to 92.5 |
393 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
94.0 |
89.9 to 96.5 |
404 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
93.1 |
89.2 to 95.6 |
417 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
88.8 |
83.7 to 92.4 |
346 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
82.0 |
76.9 to 86.2 |
403 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
90.7 |
84.9 to 94.4 |
416 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
90.9 |
84.2 to 95.0 |
364 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
96.4 |
93.8 to 97.9 |
317 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
91.1 |
87.2 to 93.9 |
340 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
84.5 |
78.2 to 89.2 |
360 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
92.6 |
88.5 to 95.3 |
322 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
92.4 |
88.1 to 95.2 |
430 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
96.4 |
93.7 to 98.0 |
311 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
95.7 |
92.0 to 97.8 |
323 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
94.8 |
90.9 to 97.0 |
341 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
92.7 |
86.8 to 96.1 |
342 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
98.7 |
96.5 to 99.5 |
325 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
97.1 |
92.8 to 98.9 |
328 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
92.3 |
88.0 to 95.2 |
342 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
91.1 |
86.8 to 94.0 |
357 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
90.7 |
85.6 to 94.0 |
632 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
93.8 |
89.3 to 96.5 |
287 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
89.9 |
83.6 to 93.9 |
345 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
94.9 |
90.5 to 97.3 |
341 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
93.8 |
89.4 to 96.4 |
325 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
91.3 |
85.9 to 94.7 |
340 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
95.0 |
91.3 to 97.1 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
95.6 |
92.1 to 97.6 |
370 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
93.6 |
89.7 to 96.1 |
319 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
94.5 |
89.9 to 97.1 |
325 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
95.9 |
91.7 to 98.0 |
347 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
93.3 |
88.6 to 96.2 |
368 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
94.1 |
90.4 to 96.5 |
322 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
93.5 |
87.3 to 96.8 |
321 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
87.9 |
82.1 to 92.0 |
292 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
89.8 |
85.4 to 92.9 |
325 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
90.0 |
84.5 to 93.7 |
328 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
90.5 |
85.8 to 93.8 |
329 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
97.3 |
94.6 to 98.7 |
278 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
96.9 |
93.4 to 98.6 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
89.9 |
85.3 to 93.3 |
331 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
94.6 |
92.0 to 96.4 |
627 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
92.9 |
88.1 to 95.9 |
312 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
95.7 |
92.2 to 97.7 |
315 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
95.6 |
92.0 to 97.6 |
347 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
91.2 |
85.1 to 95.0 |
324 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
88.4 |
81.9 to 92.8 |
327 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
95.0 |
91.9 to 96.9 |
322 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
92.7 |
88.9 to 95.2 |
381 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
94.8 |
91.6 to 96.8 |
741 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
91.0 |
86.0 to 94.3 |
348 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
95.3 |
91.6 to 97.4 |
393 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
92.8 |
92.1 to 93.5 |
19199 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
95.6 |
93.7 to 96.9 |
1916 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
95.4 |
93.4 to 96.8 |
957 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
93.5 |
91.7 to 95.0 |
2365 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
96.5 |
95.5 to 97.3 |
2612 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
92.0 |
89.9 to 93.6 |
2297 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
89.7 |
87.6 to 91.5 |
2939 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
90.2 |
87.4 to 92.4 |
1285 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
91.8 |
89.6 to 93.5 |
1936 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
91.2 |
87.9 to 93.7 |
1461 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
94.3 |
89.5 to 97.0 |
327 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
92.9 |
88.1 to 95.9 |
310 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
90.3 |
85.4 to 93.6 |
298 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
96.2 |
93.2 to 97.9 |
331 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
87.6 |
84.6 to 90.1 |
1594 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
91.8 |
86.9 to 95.0 |
346 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
84.9 |
78.9 to 89.5 |
393 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
87.5 |
84.0 to 90.4 |
855 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
93.0 |
90.4 to 94.9 |
547 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
89.1 |
85.8 to 91.8 |
1431 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
85.5 |
79.6 to 89.9 |
345 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
93.4 |
88.7 to 96.3 |
322 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
92.7 |
88.1 to 95.5 |
334 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
86.5 |
80.2 to 91.0 |
353 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
84.4 |
77.6 to 89.4 |
282 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
94.1 |
91.0 to 96.2 |
307 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
94.5 |
91.0 to 96.7 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
93.9 |
90.3 to 96.3 |
317 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
92.6 |
88.2 to 95.5 |
320 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
85.3 |
79.9 to 89.5 |
359 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
91.2 |
86.6 to 94.3 |
312 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
92.6 |
87.4 to 95.8 |
309 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
92.3 |
88.2 to 95.0 |
331 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
96.4 |
91.8 to 98.4 |
328 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
95.6 |
92.3 to 97.6 |
348 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
83.9 |
73.2 to 90.9 |
192 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
94.3 |
90.2 to 96.7 |
323 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
96.5 |
92.1 to 98.5 |
253 |
| HepB |
>=3 Doses |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
84.5 |
79.2 to 88.6 |
363 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
90.2 |
84.5 to 94.0 |
315 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
91.5 |
86.7 to 94.7 |
272 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
95.7 |
93.2 to 97.3 |
558 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
92.9 |
86.7 to 96.4 |
209 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
96.4 |
93.3 to 98.1 |
349 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
95.6 |
92.3 to 97.5 |
381 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
93.9 |
89.8 to 96.4 |
383 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
89.5 |
84.4 to 93.1 |
287 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
94.7 |
90.8 to 97.1 |
291 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
98.5 |
96.2 to 99.4 |
298 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
88.8 |
83.7 to 92.5 |
343 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
93.8 |
88.7 to 96.7 |
320 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
95.8 |
92.6 to 97.6 |
393 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
94.5 |
90.7 to 96.8 |
307 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
95.8 |
92.3 to 97.8 |
369 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
95.9 |
92.8 to 97.7 |
284 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
88.1 |
81.8 to 92.4 |
280 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
91.6 |
87.4 to 94.5 |
320 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
93.8 |
90.1 to 96.2 |
301 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
95.1 |
91.3 to 97.3 |
335 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
95.7 |
92.1 to 97.7 |
345 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
97.5 |
93.7 to 99.1 |
322 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
93.4 |
89.5 to 96.0 |
357 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
94.4 |
91.4 to 96.3 |
710 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
92.7 |
87.3 to 95.9 |
300 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
95.4 |
91.5 to 97.6 |
410 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
93.6 |
89.3 to 96.2 |
306 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
94.9 |
91.6 to 97.0 |
344 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
93.9 |
89.8 to 96.4 |
319 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
92.6 |
89.0 to 95.1 |
426 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
90.9 |
86.9 to 93.8 |
364 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
92.9 |
88.9 to 95.6 |
751 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
91.8 |
86.8 to 95.0 |
307 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
93.1 |
88.4 to 96.0 |
444 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
93.2 |
92.4 to 93.9 |
18264 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
95.2 |
93.6 to 96.5 |
2050 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
95.4 |
93.2 to 96.9 |
1032 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
93.0 |
90.8 to 94.6 |
2241 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
94.6 |
93.1 to 95.7 |
2374 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
94.8 |
93.4 to 95.8 |
2264 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
91.3 |
88.9 to 93.2 |
2505 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
90.4 |
87.5 to 92.7 |
1251 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
91.4 |
89.2 to 93.2 |
1913 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
91.7 |
87.8 to 94.4 |
1318 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
96.2 |
93.1 to 98.0 |
315 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
94.2 |
90.0 to 96.7 |
296 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
95.7 |
91.9 to 97.8 |
292 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
93.5 |
88.7 to 96.4 |
304 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
89.8 |
86.2 to 92.5 |
1112 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
86.6 |
81.5 to 90.5 |
317 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
86.4 |
79.9 to 91.1 |
278 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
90.3 |
86.1 to 93.3 |
517 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
92.8 |
89.4 to 95.2 |
332 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
90.3 |
87.6 to 92.5 |
1316 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
88.6 |
83.6 to 92.2 |
301 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
93.1 |
89.1 to 95.7 |
326 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
94.3 |
89.1 to 97.1 |
302 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
89.4 |
84.4 to 92.9 |
360 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
84.5 |
79.5 to 88.4 |
328 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
92.8 |
88.5 to 95.5 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
90.8 |
85.8 to 94.1 |
325 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
91.4 |
87.1 to 94.3 |
378 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
88.6 |
83.9 to 92.1 |
377 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
82.8 |
76.7 to 87.5 |
421 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
86.9 |
81.7 to 90.8 |
368 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
92.6 |
88.4 to 95.4 |
356 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
95.1 |
91.8 to 97.1 |
394 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
97.4 |
94.2 to 98.8 |
386 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
93.5 |
88.9 to 96.3 |
374 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
90.6 |
85.1 to 94.2 |
285 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
95.4 |
91.3 to 97.6 |
363 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
96.9 |
93.3 to 98.6 |
373 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
90.5 |
86.0 to 93.6 |
363 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
84.4 |
78.7 to 88.8 |
341 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
94.1 |
91.4 to 96.0 |
709 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
89.0 |
82.8 to 93.2 |
274 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
95.2 |
92.0 to 97.2 |
435 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
94.7 |
90.4 to 97.1 |
370 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
95.5 |
92.7 to 97.2 |
328 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
86.7 |
81.6 to 90.5 |
352 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
94.3 |
89.9 to 96.8 |
335 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
92.9 |
88.7 to 95.7 |
335 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
90.8 |
86.6 to 93.9 |
341 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
91.2 |
86.0 to 94.6 |
409 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
93.3 |
89.1 to 95.9 |
358 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
93.2 |
88.1 to 96.2 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
93.5 |
88.9 to 96.3 |
286 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
91.7 |
87.3 to 94.6 |
356 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
85.4 |
79.4 to 89.9 |
361 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
87.0 |
82.3 to 90.5 |
367 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
93.9 |
89.6 to 96.5 |
321 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
89.4 |
85.0 to 92.6 |
351 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
96.5 |
93.6 to 98.1 |
402 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
95.3 |
91.7 to 97.4 |
328 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
85.6 |
80.0 to 89.8 |
378 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
90.2 |
86.3 to 93.0 |
594 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
90.8 |
85.7 to 94.2 |
288 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
89.8 |
84.0 to 93.6 |
306 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
93.3 |
89.2 to 95.9 |
372 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
92.6 |
87.8 to 95.6 |
327 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
87.7 |
82.7 to 91.4 |
430 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
93.3 |
90.0 to 95.6 |
356 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
88.4 |
83.3 to 92.1 |
399 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
94.6 |
91.4 to 96.6 |
785 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
93.2 |
88.0 to 96.3 |
343 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
94.8 |
91.1 to 97.0 |
442 |
| HepB |
>=3 Doses |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
92.8 |
85.7 to 96.5 |
230 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
91.4 |
90.6 to 92.1 |
20827 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
94.5 |
92.6 to 96.0 |
2268 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
91.8 |
89.1 to 93.9 |
922 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
91.4 |
89.2 to 93.2 |
2553 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
94.4 |
93.0 to 95.5 |
2896 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
92.4 |
90.7 to 93.8 |
2465 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
87.3 |
84.7 to 89.6 |
3089 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
89.0 |
86.2 to 91.3 |
1362 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
90.8 |
88.8 to 92.5 |
2290 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
91.1 |
87.8 to 93.5 |
1491 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
95.2 |
91.4 to 97.3 |
414 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
93.3 |
89.6 to 95.8 |
380 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
93.4 |
88.8 to 96.1 |
358 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
93.3 |
89.6 to 95.8 |
339 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
85.8 |
82.0 to 88.9 |
1652 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
89.4 |
85.4 to 92.4 |
385 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
80.6 |
74.2 to 85.7 |
379 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
81.1 |
74.4 to 86.4 |
397 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
86.3 |
81.7 to 89.8 |
491 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
87.1 |
84.3 to 89.5 |
1491 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
84.7 |
79.6 to 88.6 |
398 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
93.1 |
88.6 to 95.9 |
367 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
88.1 |
82.1 to 92.3 |
350 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
87.0 |
82.3 to 90.6 |
374 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
84.4 |
78.9 to 88.8 |
350 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
92.6 |
87.6 to 95.7 |
340 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
91.2 |
87.2 to 94.0 |
446 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
94.1 |
90.2 to 96.5 |
361 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
90.1 |
86.1 to 93.1 |
350 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
83.5 |
78.3 to 87.7 |
444 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
91.2 |
87.0 to 94.2 |
362 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
84.9 |
78.9 to 89.5 |
350 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
93.2 |
89.6 to 95.6 |
354 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
97.3 |
94.4 to 98.7 |
358 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
94.4 |
90.6 to 96.8 |
360 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
89.3 |
84.5 to 92.8 |
418 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
95.4 |
90.7 to 97.7 |
321 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
97.2 |
94.0 to 98.7 |
374 |
| HepB |
>=3 Doses |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
82.2 |
77.3 to 86.2 |
419 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
93.0 |
89.2 to 95.6 |
340 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
83.1 |
77.7 to 87.5 |
356 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
93.1 |
90.7 to 95.0 |
779 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
91.6 |
87.0 to 94.7 |
283 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
93.4 |
90.5 to 95.5 |
496 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
91.4 |
86.8 to 94.4 |
328 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
93.4 |
89.9 to 95.7 |
383 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
86.8 |
81.6 to 90.7 |
375 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
92.8 |
89.2 to 95.3 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
95.5 |
92.5 to 97.3 |
382 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
94.6 |
91.4 to 96.7 |
374 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
90.6 |
85.4 to 94.1 |
403 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
95.4 |
91.1 to 97.7 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
94.8 |
91.2 to 97.0 |
373 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
93.2 |
88.7 to 96.0 |
366 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
92.1 |
88.1 to 94.8 |
364 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
89.5 |
84.3 to 93.1 |
300 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
88.2 |
84.2 to 91.4 |
406 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
92.5 |
88.9 to 95.0 |
393 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
92.1 |
87.7 to 95.0 |
372 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
97.8 |
94.3 to 99.2 |
295 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
96.0 |
93.0 to 97.7 |
364 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
88.3 |
83.9 to 91.6 |
396 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
95.8 |
93.9 to 97.1 |
665 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
91.8 |
87.5 to 94.7 |
313 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
98.3 |
96.8 to 99.2 |
352 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
93.3 |
88.9 to 96.0 |
358 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
91.7 |
87.1 to 94.8 |
323 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
92.0 |
87.9 to 94.8 |
332 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
95.3 |
92.3 to 97.1 |
291 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
91.6 |
87.4 to 94.5 |
353 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
93.3 |
90.2 to 95.4 |
832 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
88.9 |
84.5 to 92.1 |
340 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
93.8 |
90.2 to 96.2 |
492 |
| HepB |
>=3 Doses |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
96.7 |
92.9 to 98.5 |
339 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
91.1 |
90.2 to 91.9 |
21875 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
96.0 |
94.2 to 97.3 |
2188 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
95.8 |
94.4 to 96.9 |
1029 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
91.2 |
89.0 to 93.0 |
2742 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
94.5 |
93.1 to 95.7 |
2793 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
93.0 |
91.6 to 94.1 |
2543 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
87.9 |
86.0 to 89.5 |
4048 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
90.2 |
87.7 to 92.2 |
1451 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
90.3 |
88.2 to 92.1 |
2120 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
85.3 |
80.7 to 89.0 |
1506 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
95.1 |
92.1 to 96.9 |
419 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
91.8 |
87.8 to 94.6 |
360 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
90.1 |
85.4 to 93.5 |
349 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
94.1 |
90.6 to 96.4 |
325 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
85.3 |
82.6 to 87.7 |
2617 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
83.2 |
77.9 to 87.5 |
368 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
86.3 |
80.8 to 90.5 |
259 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
82.5 |
77.9 to 86.3 |
558 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
85.7 |
82.3 to 88.5 |
946 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
90.8 |
87.7 to 93.2 |
458 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
86.9 |
84.0 to 89.3 |
1455 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
86.2 |
81.2 to 90.0 |
357 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
96.1 |
93.7 to 97.6 |
404 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
89.2 |
83.0 to 93.3 |
385 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
85.0 |
79.9 to 88.9 |
396 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
86.5 |
81.7 to 90.2 |
344 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
93.2 |
89.4 to 95.7 |
365 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
92.8 |
88.8 to 95.5 |
331 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
96.0 |
93.3 to 97.6 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
92.8 |
88.8 to 95.4 |
392 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
83.7 |
78.0 to 88.2 |
329 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
90.7 |
86.6 to 93.6 |
352 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
88.9 |
84.0 to 92.4 |
327 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
91.6 |
86.4 to 94.9 |
322 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
97.3 |
94.2 to 98.7 |
357 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
94.5 |
90.8 to 96.7 |
375 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
94.3 |
90.5 to 96.6 |
377 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
96.2 |
93.2 to 97.9 |
376 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
97.0 |
93.2 to 98.7 |
367 |
| HepB |
>=3 Doses |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
75.7 |
70.6 to 80.1 |
535 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
93.1 |
89.4 to 95.5 |
317 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
86.2 |
81.5 to 89.9 |
358 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
95.3 |
93.3 to 96.8 |
605 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
93.6 |
87.6 to 96.8 |
157 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
95.7 |
93.4 to 97.3 |
448 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
91.3 |
86.7 to 94.4 |
350 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
94.0 |
90.7 to 96.2 |
382 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
90.2 |
85.9 to 93.3 |
322 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
92.7 |
88.4 to 95.5 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
95.9 |
92.7 to 97.7 |
336 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
93.5 |
89.8 to 95.9 |
347 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
91.5 |
86.9 to 94.6 |
451 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
96.2 |
93.0 to 97.9 |
374 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
96.9 |
94.3 to 98.3 |
283 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
92.3 |
87.9 to 95.2 |
375 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
93.5 |
90.2 to 95.7 |
377 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
89.2 |
85.0 to 92.4 |
360 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
88.8 |
84.3 to 92.1 |
375 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
91.2 |
86.7 to 94.3 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
89.4 |
84.1 to 93.1 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
97.7 |
95.4 to 98.9 |
313 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
93.7 |
90.2 to 96.0 |
422 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
89.8 |
85.6 to 92.9 |
374 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
92.8 |
90.0 to 94.8 |
655 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
86.7 |
80.7 to 91.0 |
291 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
96.7 |
93.9 to 98.2 |
364 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
92.5 |
88.2 to 95.3 |
366 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
93.0 |
88.7 to 95.7 |
293 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
92.8 |
88.6 to 95.6 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
90.4 |
85.6 to 93.8 |
281 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
89.1 |
83.5 to 92.9 |
318 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
93.0 |
90.1 to 95.2 |
875 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
89.7 |
85.4 to 92.8 |
349 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
93.5 |
90.1 to 95.8 |
526 |
| HepB |
>=3 Doses |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
93.0 |
89.0 to 95.6 |
405 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
91.4 |
90.7 to 92.1 |
20475 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
96.2 |
94.7 to 97.3 |
2097 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
93.1 |
91.0 to 94.7 |
1077 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
90.8 |
88.6 to 92.6 |
2842 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
94.5 |
93.2 to 95.5 |
2757 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
94.2 |
92.9 to 95.3 |
2284 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
86.9 |
84.8 to 88.7 |
3270 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
90.8 |
88.7 to 92.5 |
1394 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
89.1 |
86.4 to 91.3 |
2022 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
88.3 |
84.5 to 91.2 |
1303 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
95.1 |
91.2 to 97.4 |
326 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
90.8 |
86.0 to 94.1 |
314 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
95.1 |
90.8 to 97.5 |
342 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
91.9 |
87.0 to 95.1 |
291 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
84.5 |
81.6 to 87.0 |
1927 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
85.7 |
80.5 to 89.7 |
334 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
80.7 |
72.4 to 86.9 |
225 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
81.1 |
74.1 to 86.5 |
294 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
85.0 |
79.5 to 89.2 |
345 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
85.1 |
81.3 to 88.2 |
729 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
88.8 |
85.3 to 91.6 |
428 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
88.5 |
85.5 to 90.9 |
1429 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
83.0 |
77.4 to 87.4 |
317 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
94.0 |
90.1 to 96.4 |
380 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
87.2 |
80.9 to 91.6 |
451 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
88.3 |
83.2 to 92.0 |
361 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
87.4 |
82.5 to 91.0 |
313 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
95.1 |
91.4 to 97.3 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
91.9 |
88.0 to 94.6 |
373 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
91.7 |
87.8 to 94.4 |
367 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
91.4 |
87.6 to 94.0 |
349 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
88.6 |
84.0 to 92.0 |
335 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
92.5 |
88.8 to 95.1 |
357 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
89.8 |
84.2 to 93.6 |
306 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
89.2 |
84.3 to 92.6 |
354 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
95.0 |
91.0 to 97.3 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
94.4 |
90.2 to 96.9 |
350 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
87.4 |
81.2 to 91.7 |
318 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
95.9 |
92.6 to 97.8 |
415 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
95.8 |
91.6 to 97.9 |
343 |
| HepB |
>=3 Doses |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
81.2 |
76.1 to 85.5 |
382 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
91.2 |
87.1 to 94.2 |
314 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
89.9 |
84.6 to 93.4 |
353 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
94.1 |
91.8 to 95.8 |
683 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
85.0 |
77.1 to 90.5 |
204 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
96.1 |
93.7 to 97.6 |
479 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
95.7 |
91.1 to 98.0 |
334 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
96.0 |
93.0 to 97.8 |
343 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
89.8 |
85.2 to 93.1 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
93.2 |
89.3 to 95.7 |
372 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
95.0 |
91.6 to 97.1 |
341 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
94.3 |
91.0 to 96.4 |
347 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
90.6 |
85.0 to 94.2 |
470 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
95.3 |
91.8 to 97.3 |
412 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
96.2 |
92.6 to 98.1 |
328 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
95.7 |
93.0 to 97.3 |
356 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
94.6 |
91.2 to 96.7 |
347 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
88.4 |
83.9 to 91.8 |
335 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
93.1 |
88.9 to 95.7 |
326 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
96.4 |
93.4 to 98.1 |
324 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
91.4 |
87.0 to 94.5 |
344 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
95.4 |
91.7 to 97.5 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
90.5 |
85.9 to 93.8 |
366 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
86.4 |
81.6 to 90.2 |
362 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
94.2 |
91.7 to 95.9 |
651 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
92.5 |
88.1 to 95.4 |
281 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
95.2 |
91.8 to 97.2 |
370 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
90.8 |
86.3 to 93.9 |
336 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
92.1 |
88.2 to 94.8 |
379 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
94.6 |
91.7 to 96.5 |
408 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
90.2 |
85.9 to 93.4 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
90.2 |
85.6 to 93.5 |
359 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
95.4 |
92.6 to 97.1 |
851 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
94.3 |
90.5 to 96.6 |
362 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
95.5 |
92.3 to 97.4 |
489 |
| HepB |
>=3 Doses |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
91.9 |
91.1 to 92.6 |
20949 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
95.0 |
93.3 to 96.3 |
2107 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
93.0 |
90.8 to 94.6 |
1017 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
93.4 |
91.4 to 94.9 |
2745 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
93.7 |
92.4 to 94.8 |
2846 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
95.0 |
93.9 to 96.0 |
2433 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
86.9 |
85.1 to 88.6 |
3654 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
91.5 |
89.4 to 93.3 |
1340 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
89.7 |
87.2 to 91.8 |
2108 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
89.8 |
85.5 to 92.8 |
1299 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
96.2 |
92.7 to 98.1 |
319 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
92.3 |
88.1 to 95.1 |
328 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
93.0 |
89.3 to 95.5 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
91.2 |
86.1 to 94.5 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
84.7 |
82.2 to 87.0 |
2256 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
83.8 |
78.1 to 88.3 |
336 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
81.0 |
72.9 to 87.0 |
187 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
76.6 |
69.3 to 82.6 |
263 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
86.8 |
81.1 to 91.0 |
320 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
88.7 |
84.2 to 92.0 |
304 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
85.9 |
82.4 to 88.8 |
846 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
90.1 |
87.7 to 92.2 |
1400 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
88.1 |
83.4 to 91.6 |
356 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
91.8 |
87.7 to 94.6 |
366 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
94.2 |
88.8 to 97.1 |
413 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
90.0 |
85.9 to 93.1 |
339 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
85.1 |
79.9 to 89.1 |
343 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
94.7 |
90.9 to 97.0 |
324 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
92.9 |
88.7 to 95.7 |
360 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
94.2 |
89.7 to 96.8 |
327 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
89.5 |
85.3 to 92.6 |
392 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
89.1 |
83.8 to 92.8 |
288 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
91.4 |
86.9 to 94.5 |
308 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
88.8 |
83.6 to 92.5 |
356 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
93.5 |
88.4 to 96.4 |
278 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
95.9 |
91.4 to 98.0 |
293 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
94.3 |
90.7 to 96.5 |
306 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
97.6 |
94.0 to 99.1 |
337 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
95.4 |
91.6 to 97.6 |
345 |
| HepB |
>=3 Doses |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
77.5 |
70.8 to 83.0 |
309 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
93.4 |
89.9 to 95.7 |
327 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
88.4 |
83.4 to 92.1 |
291 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
94.5 |
92.2 to 96.1 |
721 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
91.9 |
84.4 to 96.0 |
192 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
95.0 |
92.5 to 96.7 |
529 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
95.9 |
92.8 to 97.7 |
296 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
95.5 |
92.1 to 97.5 |
280 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
85.8 |
79.9 to 90.2 |
297 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
91.9 |
87.1 to 95.0 |
270 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
93.4 |
88.2 to 96.4 |
284 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
94.5 |
91.1 to 96.6 |
317 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
93.4 |
88.7 to 96.2 |
393 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
97.9 |
93.9 to 99.3 |
328 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
91.6 |
86.4 to 94.9 |
313 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
93.8 |
88.7 to 96.7 |
285 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
91.9 |
87.3 to 94.9 |
285 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
90.7 |
86.3 to 93.7 |
319 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
88.9 |
83.6 to 92.6 |
290 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
91.9 |
87.1 to 95.0 |
295 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
88.0 |
82.9 to 91.7 |
334 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
97.3 |
94.7 to 98.6 |
303 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
93.4 |
88.4 to 96.3 |
351 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
91.4 |
87.0 to 94.4 |
295 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
95.9 |
93.4 to 97.5 |
535 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
94.5 |
91.1 to 96.6 |
261 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
96.9 |
92.4 to 98.8 |
274 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
93.2 |
88.7 to 96.0 |
341 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
97.5 |
94.1 to 98.9 |
287 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
94.7 |
91.3 to 96.8 |
329 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
88.0 |
83.3 to 91.5 |
360 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
93.5 |
88.8 to 96.3 |
297 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
97.2 |
95.1 to 98.4 |
649 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
91.3 |
85.2 to 95.0 |
237 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
97.9 |
95.5 to 99.1 |
412 |
| HepB |
>=3 Doses |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
92.1 |
91.3 to 92.8 |
18700 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
96.9 |
95.2 to 98.0 |
1902 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
95.1 |
92.9 to 96.7 |
886 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
93.9 |
92.1 to 95.4 |
2295 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
95.0 |
93.7 to 96.0 |
2507 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
94.1 |
92.7 to 95.2 |
2276 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
85.8 |
83.7 to 87.6 |
3326 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
90.9 |
88.6 to 92.7 |
1191 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
92.5 |
90.0 to 94.4 |
1746 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
88.9 |
84.9 to 92.0 |
1305 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
96.9 |
94.4 to 98.3 |
337 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
93.0 |
88.6 to 95.8 |
318 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
95.0 |
91.8 to 97.0 |
340 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
95.1 |
91.0 to 97.4 |
284 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
83.5 |
80.7 to 85.9 |
2079 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
83.0 |
76.8 to 87.8 |
298 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
78.5 |
70.6 to 84.7 |
186 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
77.4 |
70.3 to 83.3 |
314 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
83.6 |
78.1 to 88.0 |
364 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
84.2 |
80.6 to 87.3 |
917 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
90.8 |
87.9 to 93.0 |
1266 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
90.9 |
85.8 to 94.4 |
310 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
96.6 |
94.1 to 98.1 |
324 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
91.7 |
85.7 to 95.3 |
327 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
90.1 |
84.8 to 93.7 |
286 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
88.2 |
83.8 to 91.6 |
337 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
94.3 |
90.6 to 96.6 |
332 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
91.1 |
86.4 to 94.3 |
241 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
95.7 |
91.2 to 98.0 |
296 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
91.7 |
88.3 to 94.2 |
426 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
89.4 |
84.3 to 93.0 |
308 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
95.7 |
92.8 to 97.5 |
329 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
86.0 |
77.9 to 91.5 |
274 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
92.6 |
86.5 to 96.1 |
262 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
96.8 |
93.4 to 98.5 |
294 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
93.2 |
88.7 to 95.9 |
308 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
87.0 |
79.7 to 92.0 |
282 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
95.6 |
90.9 to 97.9 |
329 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
95.2 |
90.9 to 97.5 |
315 |
| HepB |
>=3 Doses |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
81.3 |
75.1 to 86.2 |
278 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
89.4 |
83.9 to 93.2 |
304 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
90.7 |
85.8 to 94.0 |
332 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
95.7 |
93.2 to 97.3 |
602 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
92.8 |
86.7 to 96.2 |
160 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
96.3 |
93.3 to 98.0 |
442 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
96.3 |
93.3 to 98.0 |
289 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
94.0 |
89.6 to 96.6 |
302 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
92.1 |
88.1 to 94.8 |
381 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
95.8 |
92.1 to 97.9 |
292 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
94.5 |
91.0 to 96.7 |
336 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
93.5 |
89.0 to 96.2 |
316 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
90.4 |
85.0 to 93.9 |
524 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
95.6 |
91.1 to 97.9 |
300 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
92.9 |
87.7 to 96.0 |
297 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
95.8 |
91.2 to 98.1 |
276 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
89.1 |
83.4 to 93.1 |
270 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
90.3 |
84.7 to 94.0 |
288 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
87.6 |
81.7 to 91.9 |
297 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
93.8 |
88.9 to 96.7 |
285 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
88.3 |
82.5 to 92.4 |
313 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
94.2 |
89.4 to 96.8 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
94.3 |
89.5 to 97.0 |
331 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
87.0 |
81.9 to 90.8 |
405 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
93.3 |
89.4 to 95.8 |
498 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
91.4 |
85.6 to 95.0 |
257 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
94.4 |
88.3 to 97.4 |
241 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
94.1 |
89.6 to 96.8 |
305 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
94.3 |
89.8 to 96.9 |
319 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
91.8 |
87.5 to 94.8 |
302 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
88.9 |
84.3 to 92.3 |
369 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
95.1 |
90.7 to 97.5 |
270 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
94.5 |
91.1 to 96.7 |
734 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
93.2 |
87.5 to 96.4 |
242 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
94.7 |
90.7 to 97.0 |
492 |
| HepB |
>=3 Doses |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
93.2 |
84.1 to 97.3 |
216 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
91.6 |
90.6 to 92.6 |
18788 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
95.5 |
93.6 to 96.9 |
2034 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
93.6 |
90.7 to 95.6 |
829 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
92.9 |
90.8 to 94.6 |
2520 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
94.9 |
93.4 to 96.1 |
2387 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
94.3 |
92.8 to 95.5 |
2097 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
86.3 |
84.1 to 88.2 |
3289 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
92.0 |
89.4 to 94.0 |
1256 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
91.1 |
88.2 to 93.3 |
1845 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
86.7 |
80.6 to 91.1 |
1199 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
97.0 |
94.4 to 98.4 |
319 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
96.3 |
93.1 to 98.0 |
319 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
93.9 |
89.7 to 96.5 |
313 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
94.2 |
89.6 to 96.8 |
261 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
83.8 |
80.8 to 86.5 |
1850 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
87.6 |
82.1 to 91.6 |
293 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
82.5 |
73.7 to 88.8 |
174 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
80.8 |
74.1 to 86.1 |
271 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
90.9 |
85.9 to 94.2 |
280 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
83.6 |
79.5 to 87.0 |
832 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
88.6 |
82.9 to 92.6 |
218 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
91.7 |
88.9 to 93.8 |
1332 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
88.1 |
82.5 to 92.0 |
325 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
92.2 |
88.3 to 94.8 |
472 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
92.8 |
87.1 to 96.1 |
363 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
90.1 |
85.0 to 93.6 |
304 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
92.3 |
87.2 to 95.5 |
309 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
94.7 |
91.3 to 96.8 |
331 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
94.5 |
90.1 to 97.0 |
329 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
93.5 |
89.5 to 96.1 |
298 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
93.9 |
89.6 to 96.4 |
302 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
84.7 |
79.1 to 89.0 |
340 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
95.8 |
92.0 to 97.8 |
322 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
89.3 |
84.1 to 92.9 |
403 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
91.9 |
87.5 to 94.9 |
354 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
97.9 |
94.8 to 99.2 |
331 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
92.6 |
88.8 to 95.1 |
360 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
86.1 |
80.5 to 90.3 |
404 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
95.1 |
91.6 to 97.1 |
355 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
96.6 |
92.9 to 98.4 |
300 |
| HepB |
>=3 Doses |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
84.9 |
79.5 to 89.1 |
300 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
95.6 |
92.3 to 97.5 |
290 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
89.5 |
84.5 to 93.0 |
376 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
94.2 |
91.3 to 96.1 |
699 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
91.6 |
85.2 to 95.3 |
271 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
94.7 |
91.4 to 96.8 |
428 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
95.6 |
91.8 to 97.6 |
302 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
94.2 |
90.5 to 96.5 |
280 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
92.7 |
89.0 to 95.3 |
364 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
96.1 |
92.9 to 97.9 |
255 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
94.7 |
90.8 to 97.0 |
356 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
94.9 |
91.4 to 97.0 |
372 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
93.2 |
90.2 to 95.3 |
815 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
95.5 |
91.9 to 97.5 |
394 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
96.0 |
92.9 to 97.8 |
398 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
96.4 |
93.6 to 98.0 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
94.5 |
89.6 to 97.2 |
282 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
91.5 |
86.5 to 94.7 |
397 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
92.1 |
88.0 to 94.9 |
307 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
90.6 |
86.1 to 93.7 |
405 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
85.4 |
79.6 to 89.8 |
369 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
96.2 |
93.4 to 97.8 |
381 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
94.6 |
90.5 to 97.0 |
379 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
92.2 |
88.0 to 95.0 |
352 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
95.0 |
92.4 to 96.7 |
729 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
93.3 |
89.7 to 95.7 |
381 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
96.1 |
92.0 to 98.1 |
348 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
97.7 |
93.7 to 99.2 |
327 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
94.6 |
91.6 to 96.6 |
401 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
93.3 |
89.3 to 95.8 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
91.0 |
87.0 to 93.9 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
95.8 |
92.7 to 97.7 |
308 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
95.0 |
91.2 to 97.2 |
765 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
94.3 |
89.7 to 96.9 |
263 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
95.1 |
90.7 to 97.4 |
502 |
| HepB |
>=3 Doses |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
70.8 |
59.0 to 80.4 |
169 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
92.6 |
91.8 to 93.3 |
20163 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
96.0 |
94.3 to 97.1 |
2147 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
94.9 |
92.8 to 96.3 |
1108 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
94.2 |
92.5 to 95.5 |
3331 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
95.6 |
94.3 to 96.5 |
2466 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
94.6 |
93.3 to 95.7 |
2344 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
88.2 |
85.6 to 90.4 |
2509 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
92.2 |
90.0 to 94.0 |
1446 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
91.3 |
88.9 to 93.2 |
2007 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
88.5 |
84.6 to 91.5 |
1402 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
94.3 |
89.7 to 97.0 |
271 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
95.4 |
91.3 to 97.6 |
311 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
96.5 |
93.9 to 98.0 |
317 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
93.5 |
89.3 to 96.2 |
338 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
86.0 |
82.2 to 89.0 |
1141 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
83.7 |
78.3 to 87.9 |
314 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
83.1 |
75.8 to 88.5 |
221 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
86.3 |
82.0 to 89.8 |
606 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
91.5 |
88.6 to 93.7 |
1403 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
88.4 |
83.2 to 92.2 |
304 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
93.3 |
89.4 to 95.8 |
398 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
94.6 |
91.2 to 96.7 |
677 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
89.5 |
84.2 to 93.2 |
417 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
93.3 |
89.6 to 95.7 |
310 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
93.0 |
88.1 to 95.9 |
277 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
92.4 |
87.8 to 95.3 |
324 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
92.4 |
88.3 to 95.1 |
304 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
90.5 |
85.6 to 93.9 |
268 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
86.2 |
80.4 to 90.6 |
296 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
94.1 |
90.0 to 96.6 |
314 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
90.5 |
83.7 to 94.6 |
286 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
93.8 |
89.4 to 96.5 |
298 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
96.4 |
92.9 to 98.2 |
340 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
91.0 |
85.7 to 94.4 |
310 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
85.6 |
80.2 to 89.7 |
409 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
95.7 |
90.9 to 98.1 |
312 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
95.9 |
90.5 to 98.3 |
260 |
| HepB |
>=3 Doses |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
81.8 |
74.4 to 87.4 |
225 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
93.8 |
88.4 to 96.8 |
258 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
90.8 |
86.4 to 93.9 |
334 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
96.1 |
93.9 to 97.6 |
578 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
93.6 |
83.6 to 97.7 |
144 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
96.7 |
94.5 to 98.0 |
434 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
92.9 |
87.4 to 96.1 |
268 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
97.6 |
94.5 to 99.0 |
199 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
93.1 |
88.4 to 96.0 |
300 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
94.9 |
90.7 to 97.3 |
240 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
91.8 |
86.4 to 95.2 |
303 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
92.5 |
87.7 to 95.5 |
293 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
93.2 |
90.4 to 95.2 |
857 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
95.9 |
91.0 to 98.2 |
266 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
90.6 |
85.3 to 94.1 |
358 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
96.1 |
92.8 to 97.9 |
296 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
91.0 |
85.9 to 94.4 |
303 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
90.7 |
85.7 to 94.1 |
340 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
91.2 |
86.6 to 94.4 |
290 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
92.9 |
89.0 to 95.5 |
315 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
89.9 |
84.6 to 93.5 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
96.9 |
93.9 to 98.4 |
282 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
91.5 |
85.4 to 95.2 |
292 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
88.0 |
83.2 to 91.5 |
337 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
96.2 |
93.7 to 97.7 |
581 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
93.2 |
88.3 to 96.2 |
297 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
98.1 |
94.9 to 99.3 |
284 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
95.5 |
88.9 to 98.2 |
266 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
93.1 |
87.0 to 96.4 |
191 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
94.1 |
88.3 to 97.1 |
254 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
90.4 |
85.9 to 93.6 |
240 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
92.7 |
88.0 to 95.7 |
294 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
92.6 |
89.4 to 94.9 |
929 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
95.2 |
92.0 to 97.2 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
92.2 |
88.6 to 94.8 |
599 |
| HepB |
>=3 Doses |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
84.0 |
78.3 to 88.5 |
350 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
92.3 |
91.3 to 93.1 |
18002 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
95.8 |
93.7 to 97.2 |
1923 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
94.6 |
92.1 to 96.3 |
873 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
92.1 |
90.2 to 93.6 |
3338 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
95.1 |
93.4 to 96.3 |
2263 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
94.1 |
92.5 to 95.4 |
2060 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
86.5 |
83.3 to 89.2 |
2184 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
93.1 |
90.8 to 94.9 |
1154 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
93.7 |
91.6 to 95.3 |
1789 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
89.9 |
84.9 to 93.4 |
1173 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
96.3 |
90.8 to 98.5 |
254 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
95.0 |
90.6 to 97.3 |
263 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
97.2 |
94.8 to 98.5 |
445 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
95.1 |
91.4 to 97.2 |
315 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
84.4 |
79.8 to 88.1 |
990 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
85.3 |
79.0 to 90.0 |
296 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
82.7 |
73.1 to 89.3 |
167 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
84.5 |
79.2 to 88.6 |
527 |
| HepB |
>=3 Doses |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
88.1 |
80.4 to 93.0 |
245 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
91.2 |
88.4 to 93.4 |
1245 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
94.3 |
90.3 to 96.7 |
304 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
94.1 |
91.1 to 96.1 |
488 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
92.2 |
87.2 to 95.3 |
566 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
90.6 |
85.5 to 94.1 |
349 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
86.1 |
79.8 to 90.6 |
267 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
95.2 |
90.7 to 97.5 |
306 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
89.1 |
83.0 to 93.2 |
261 |
| HepB |
>=3 Doses |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
93.0 |
88.0 to 96.0 |
269 |
| HepB |
>=3 Doses |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
92.1 |
86.8 to 95.3 |
240 |
| HepB |
>=3 Doses |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
91.1 |
86.6 to 94.2 |
273 |
| HepB |
>=3 Doses |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
94.0 |
90.0 to 96.4 |
332 |
| HepB |
>=3 Doses |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
86.0 |
79.8 to 90.5 |
321 |
| HepB |
>=3 Doses |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
91.9 |
88.3 to 94.4 |
342 |
| HepB |
>=3 Doses |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
96.7 |
93.4 to 98.4 |
258 |
| HepB |
>=3 Doses |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
87.1 |
80.7 to 91.5 |
250 |
| HepB |
>=3 Doses |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
73.0 |
64.3 to 80.3 |
237 |
| HepB |
>=3 Doses |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
97.7 |
94.8 to 99.0 |
307 |
| HepB |
>=3 Doses |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
93.9 |
89.2 to 96.6 |
333 |
| HepB |
>=3 Doses |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
80.3 |
72.0 to 86.6 |
240 |
| HepB |
>=3 Doses |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
92.4 |
87.3 to 95.5 |
237 |
| HepB |
>=3 Doses |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
91.3 |
85.8 to 94.8 |
251 |
| HepB |
>=3 Doses |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
94.2 |
91.0 to 96.3 |
630 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
91.9 |
85.7 to 95.6 |
256 |
| HepB |
>=3 Doses |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
94.7 |
90.8 to 97.0 |
374 |
| HepB |
>=3 Doses |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
96.5 |
92.7 to 98.3 |
258 |
| HepB |
>=3 Doses |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
96.5 |
91.9 to 98.5 |
207 |
| HepB |
>=3 Doses |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
90.8 |
86.0 to 94.1 |
310 |
| HepB |
>=3 Doses |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
88.2 |
81.5 to 92.7 |
276 |
| HepB |
>=3 Doses |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
95.6 |
92.5 to 97.4 |
330 |
| HepB |
>=3 Doses |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
95.3 |
91.5 to 97.5 |
268 |
| HepB |
>=3 Doses |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
89.6 |
83.2 to 93.7 |
346 |
| HepB |
>=3 Doses |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
92.7 |
87.0 to 96.0 |
268 |
| HepB |
>=3 Doses |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
93.5 |
87.9 to 96.6 |
257 |
| HepB |
>=3 Doses |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
95.7 |
92.3 to 97.7 |
331 |
| HepB |
>=3 Doses |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
92.5 |
87.3 to 95.7 |
232 |
| HepB |
>=3 Doses |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
88.1 |
82.4 to 92.2 |
284 |
| HepB |
>=3 Doses |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
90.2 |
85.7 to 93.4 |
297 |
| HepB |
>=3 Doses |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
90.2 |
84.9 to 93.8 |
247 |
| HepB |
>=3 Doses |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
84.7 |
78.4 to 89.4 |
259 |
| HepB |
>=3 Doses |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
93.7 |
89.2 to 96.4 |
225 |
| HepB |
>=3 Doses |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
93.6 |
89.0 to 96.4 |
289 |
| HepB |
>=3 Doses |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
88.4 |
82.3 to 92.6 |
276 |
| HepB |
>=3 Doses |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
96.0 |
93.9 to 97.5 |
536 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
93.2 |
88.4 to 96.1 |
222 |
| HepB |
>=3 Doses |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
97.9 |
95.8 to 99.0 |
314 |
| HepB |
>=3 Doses |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
95.9 |
93.2 to 97.6 |
361 |
| HepB |
>=3 Doses |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
95.8 |
91.7 to 97.9 |
280 |
| HepB |
>=3 Doses |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
91.9 |
85.8 to 95.5 |
269 |
| HepB |
>=3 Doses |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
89.6 |
83.6 to 93.6 |
249 |
| HepB |
>=3 Doses |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
92.7 |
88.8 to 95.4 |
263 |
| HepB |
>=3 Doses |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
95.0 |
92.6 to 96.6 |
752 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
94.7 |
89.9 to 97.3 |
267 |
| HepB |
>=3 Doses |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
95.0 |
92.3 to 96.8 |
485 |
| HepB |
>=3 Doses |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
89.5 |
86.1 to 92.1 |
671 |
| HepB |
>=3 Doses |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
91.2 |
90.2 to 92.1 |
16043 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
94.3 |
91.7 to 96.1 |
1595 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
95.2 |
93.2 to 96.6 |
825 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
91.8 |
90.0 to 93.2 |
2424 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
94.9 |
93.6 to 95.9 |
2291 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
93.9 |
92.1 to 95.3 |
2019 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
84.5 |
80.5 to 87.9 |
1981 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
90.8 |
88.2 to 93.0 |
1048 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
90.5 |
87.9 to 92.5 |
1736 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
86.8 |
82.1 to 90.4 |
1090 |
| HepB |
>=3 Doses |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
96.5 |
93.3 to 98.2 |
285 |
| HepB |
>=3 Doses |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
95.2 |
90.3 to 97.7 |
269 |
| HepB |
>=3 Doses |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
93.0 |
88.2 to 96.0 |
252 |
| HepB |
>=3 Doses |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
93.7 |
87.9 to 96.8 |
244 |
| HepB |
>=3 Doses |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
81.2 |
75.5 to 85.8 |
794 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
86.6 |
80.6 to 91.0 |
253 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
87.2 |
78.4 to 92.8 |
157 |
| HepB |
>=3 Doses |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
80.3 |
73.7 to 85.6 |
384 |
| HepB |
>=3 Doses |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
91.7 |
88.6 to 94.0 |
1034 |
| HepB |
>=3 Doses |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
86.8 |
80.0 to 91.5 |
271 |
| HepB |
>=3 Doses |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
92.4 |
87.4 to 95.5 |
291 |
| HepB |
>=3 Doses |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
89.8 |
86.1 to 92.5 |
595 |
| HepB |
>=3 Doses |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
91.2 |
85.4 to 94.9 |
280 |
| HepB |
>=3 Doses |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
93.9 |
90.0 to 96.3 |
244 |
| HepB |
>=3 Doses |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
93.0 |
88.1 to 96.0 |
274 |
| HepB |
>=3 Doses |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
93.5 |
88.5 to 96.4 |
294 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2007 |
Age |
13-15 Years |
5.9 |
4.1 to 8.3 |
872 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2008 |
Age |
13-15 Years |
15.7 |
9.7 to 24.2 |
119 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2008 |
Age |
13-15 Years |
17.7 |
11.0 to 27.3 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2008 |
Age |
13-15 Years |
22.3 |
13.2 to 35.1 |
75 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2008 |
Age |
13-15 Years |
16.6 |
9.6 to 27.0 |
93 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2008 |
Age |
13-15 Years |
19.5 |
11.8 to 30.4 |
112 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2008 |
Age |
13-15 Years |
25.8 |
16.8 to 37.3 |
87 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2008 |
Age |
13-15 Years |
30.0 |
20.2 to 42.0 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-15 Years |
13.8 |
7.8 to 23.4 |
92 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2008 |
Age |
13-15 Years |
22.0 |
13.3 to 34.2 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2008 |
Age |
13-15 Years |
18.0 |
11.7 to 26.6 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2008 |
Age |
13-15 Years |
14.4 |
7.9 to 24.7 |
73 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2008 |
Age |
13-15 Years |
15.2 |
9.2 to 24.1 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2008 |
Age |
13-15 Years |
27.0 |
15.8 to 42.2 |
63 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2008 |
Age |
13-15 Years |
16.1 |
9.3 to 26.6 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2008 |
Age |
13-15 Years |
21.9 |
14.0 to 32.6 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2008 |
Age |
13-15 Years |
13.5 |
8.4 to 21.0 |
131 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-15 Years |
22.5 |
14.9 to 32.6 |
92 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2008 |
Age |
13-15 Years |
15.2 |
9.4 to 23.6 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2008 |
Age |
13-15 Years |
13.9 |
7.6 to 24.0 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2008 |
Age |
13-15 Years |
19.7 |
13.2 to 28.3 |
122 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-15 Years |
23.8 |
12.9 to 39.7 |
85 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2008 |
Age |
13-15 Years |
24.5 |
15.9 to 35.8 |
107 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2008 |
Age |
13-15 Years |
25.7 |
16.0 to 38.5 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2008 |
Age |
13-15 Years |
28.7 |
20.9 to 38.0 |
174 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-15 Years |
25.8 |
15.7 to 39.5 |
93 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-15 Years |
31.0 |
20.3 to 44.1 |
81 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2008 |
Age |
13-15 Years |
19.8 |
12.4 to 30.0 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2008 |
Age |
13-15 Years |
13.1 |
7.7 to 21.5 |
108 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-15 Years |
17.9 |
11.0 to 28.0 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-15 Years |
28.8 |
20.4 to 39.0 |
211 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-15 Years |
17.8 |
10.8 to 28.1 |
110 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-15 Years |
30.6 |
21.1 to 42.2 |
101 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2008 |
Age |
13-15 Years |
16.6 |
14.9 to 18.4 |
5231 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-15 Years |
24.1 |
19.3 to 29.6 |
543 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-15 Years |
27.4 |
21.2 to 34.7 |
281 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-15 Years |
22.6 |
18.0 to 28.0 |
725 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-15 Years |
15.6 |
12.2 to 19.8 |
821 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-15 Years |
12.9 |
10.0 to 16.5 |
661 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-15 Years |
9.8 |
6.8 to 13.9 |
636 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-15 Years |
15.7 |
11.4 to 21.2 |
360 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-15 Years |
14.8 |
10.6 to 20.3 |
540 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-15 Years |
16.9 |
11.1 to 25.0 |
341 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-15 Years |
31.7 |
21.6 to 43.8 |
89 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2008 |
Age |
13-15 Years |
13.2 |
7.3 to 22.5 |
114 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2008 |
Age |
13-15 Years |
26.4 |
18.2 to 36.6 |
103 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-15 Years |
16.8 |
9.1 to 28.8 |
62 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-15 Years |
13.3 |
9.1 to 19.0 |
323 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2008 |
Age |
13-15 Years |
23.9 |
15.6 to 34.8 |
88 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2008 |
Age |
13-15 Years |
20.1 |
12.9 to 30.0 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2008 |
Age |
13-15 Years |
15.6 |
8.5 to 27.0 |
92 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2008 |
Age |
13-15 Years |
18.8 |
11.2 to 29.7 |
68 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2009 |
Age |
13-15 Years |
24.0 |
16.0 to 34.3 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2009 |
Age |
13-15 Years |
16.2 |
9.4 to 26.6 |
92 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2009 |
Age |
13-15 Years |
28.5 |
18.1 to 41.7 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2009 |
Age |
13-15 Years |
15.4 |
9.9 to 23.1 |
120 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2009 |
Age |
13-15 Years |
30.4 |
20.9 to 42.0 |
123 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2009 |
Age |
13-15 Years |
36.1 |
26.7 to 46.7 |
111 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2009 |
Age |
13-15 Years |
36.8 |
25.4 to 50.0 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-15 Years |
22.4 |
15.3 to 31.4 |
136 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2009 |
Age |
13-15 Years |
22.1 |
14.6 to 32.0 |
143 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2009 |
Age |
13-15 Years |
20.6 |
13.3 to 30.5 |
112 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2009 |
Age |
13-15 Years |
39.3 |
28.4 to 51.5 |
75 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2009 |
Age |
13-15 Years |
19.5 |
13.4 to 27.6 |
210 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-15 Years |
15.4 |
9.4 to 24.2 |
114 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-15 Years |
20.5 |
13.2 to 30.6 |
96 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2009 |
Age |
13-15 Years |
17.4 |
11.3 to 25.8 |
232 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2009 |
Age |
13-15 Years |
32.7 |
23.2 to 43.8 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2009 |
Age |
13-15 Years |
23.5 |
14.0 to 36.6 |
74 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2009 |
Age |
13-15 Years |
20.8 |
14.1 to 29.6 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2009 |
Age |
13-15 Years |
35.4 |
22.9 to 50.3 |
85 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2009 |
Age |
13-15 Years |
22.5 |
14.7 to 33.0 |
91 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2009 |
Age |
13-15 Years |
19.5 |
10.8 to 32.7 |
62 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-15 Years |
40.7 |
30.0 to 52.3 |
106 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2009 |
Age |
13-15 Years |
25.1 |
16.9 to 35.6 |
148 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2009 |
Age |
13-15 Years |
27.2 |
18.5 to 38.2 |
90 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2009 |
Age |
13-15 Years |
14.2 |
8.5 to 22.8 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2009 |
Age |
13-15 Years |
18.9 |
11.3 to 29.9 |
75 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2009 |
Age |
13-15 Years |
33.3 |
22.2 to 46.6 |
78 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2009 |
Age |
13-15 Years |
12.4 |
7.0 to 21.2 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-15 Years |
30.4 |
20.6 to 42.4 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2009 |
Age |
13-15 Years |
22.1 |
14.8 to 31.6 |
107 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2009 |
Age |
13-15 Years |
38.4 |
29.3 to 48.5 |
123 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2009 |
Age |
13-15 Years |
28.2 |
20.5 to 37.5 |
167 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-15 Years |
19.3 |
11.7 to 30.1 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-15 Years |
35.7 |
23.9 to 49.6 |
69 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2009 |
Age |
13-15 Years |
26.9 |
17.4 to 39.1 |
91 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2009 |
Age |
13-15 Years |
31.5 |
21.2 to 44.0 |
77 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2009 |
Age |
13-15 Years |
18.0 |
10.7 to 28.7 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-15 Years |
20.2 |
13.2 to 29.8 |
103 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2009 |
Age |
13-15 Years |
26.9 |
19.1 to 36.3 |
125 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-15 Years |
27.5 |
19.0 to 38.1 |
167 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-15 Years |
31.7 |
22.1 to 43.1 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-15 Years |
26.7 |
17.1 to 39.3 |
68 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2009 |
Age |
13-15 Years |
22.9 |
21.2 to 24.7 |
5871 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-15 Years |
37.2 |
31.5 to 43.2 |
614 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-15 Years |
26.5 |
20.4 to 33.5 |
274 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-15 Years |
25.9 |
20.8 to 31.6 |
647 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-15 Years |
20.9 |
17.5 to 24.7 |
872 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-15 Years |
21.3 |
17.8 to 25.2 |
882 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-15 Years |
23.1 |
18.3 to 28.7 |
859 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-15 Years |
22.6 |
18.0 to 27.9 |
362 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-15 Years |
28.0 |
22.6 to 34.2 |
560 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-15 Years |
17.3 |
12.4 to 23.6 |
409 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-15 Years |
47.8 |
36.3 to 59.6 |
103 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2009 |
Age |
13-15 Years |
10.9 |
6.2 to 18.4 |
91 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2009 |
Age |
13-15 Years |
46.8 |
34.7 to 59.2 |
83 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2009 |
Age |
13-15 Years |
23.6 |
15.7 to 33.9 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2009 |
Age |
13-15 Years |
21.7 |
15.4 to 29.6 |
434 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-15 Years |
16.8 |
10.3 to 26.2 |
96 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-15 Years |
23.1 |
13.8 to 36.2 |
64 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-15 Years |
20.3 |
12.6 to 31.0 |
80 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-15 Years |
32.6 |
22.9 to 44.0 |
85 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-15 Years |
21.7 |
13.8 to 32.4 |
109 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-15 Years |
28.4 |
22.7 to 34.9 |
392 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2009 |
Age |
13-15 Years |
20.9 |
12.5 to 32.8 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2009 |
Age |
13-15 Years |
35.9 |
26.9 to 46.0 |
117 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2009 |
Age |
13-15 Years |
26.8 |
18.2 to 37.6 |
117 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2009 |
Age |
13-15 Years |
33.7 |
24.6 to 44.1 |
110 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2009 |
Age |
13-15 Years |
24.8 |
15.5 to 37.3 |
66 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-15 Years |
23.2 |
14.8 to 34.4 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2009 |
Age |
13-15 Years |
36.0 |
25.8 to 47.6 |
103 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2010 |
Age |
13-15 Years |
24.2 |
16.0 to 34.9 |
91 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2010 |
Age |
13-15 Years |
18.4 |
10.7 to 29.7 |
80 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2010 |
Age |
13-15 Years |
35.4 |
23.9 to 48.8 |
88 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2010 |
Age |
13-15 Years |
18.6 |
11.1 to 29.6 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2010 |
Age |
13-15 Years |
29.0 |
20.2 to 39.6 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2010 |
Age |
13-15 Years |
39.7 |
29.3 to 51.0 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2010 |
Age |
13-15 Years |
37.5 |
26.9 to 49.4 |
103 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2010 |
Age |
13-15 Years |
44.4 |
32.6 to 56.9 |
89 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-15 Years |
31.4 |
22.5 to 41.8 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2010 |
Age |
13-15 Years |
21.9 |
13.0 to 34.4 |
79 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2010 |
Age |
13-15 Years |
22.9 |
16.2 to 31.4 |
129 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2010 |
Age |
13-15 Years |
34.2 |
24.3 to 45.8 |
85 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2010 |
Age |
13-15 Years |
19.2 |
11.9 to 29.5 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2010 |
Age |
13-15 Years |
22.0 |
15.9 to 29.6 |
236 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-15 Years |
27.6 |
18.0 to 39.7 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-15 Years |
20.6 |
13.7 to 29.8 |
123 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2010 |
Age |
13-15 Years |
23.8 |
15.8 to 34.1 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2010 |
Age |
13-15 Years |
33.0 |
23.2 to 44.6 |
83 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2010 |
Age |
13-15 Years |
21.8 |
14.1 to 32.2 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2010 |
Age |
13-15 Years |
29.0 |
20.2 to 39.6 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2010 |
Age |
13-15 Years |
33.1 |
23.5 to 44.3 |
89 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2010 |
Age |
13-15 Years |
31.3 |
22.0 to 42.3 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2010 |
Age |
13-15 Years |
26.6 |
16.5 to 40.1 |
72 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-15 Years |
35.8 |
24.2 to 49.3 |
83 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2010 |
Age |
13-15 Years |
20.3 |
12.9 to 30.5 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2010 |
Age |
13-15 Years |
40.4 |
29.6 to 52.2 |
88 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2010 |
Age |
13-15 Years |
20.5 |
12.8 to 31.1 |
119 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2010 |
Age |
13-15 Years |
24.7 |
16.9 to 34.6 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2010 |
Age |
13-15 Years |
26.0 |
17.0 to 37.7 |
94 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2010 |
Age |
13-15 Years |
42.9 |
31.7 to 54.9 |
89 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2010 |
Age |
13-15 Years |
22.4 |
14.6 to 32.6 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-15 Years |
28.1 |
18.9 to 39.6 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2010 |
Age |
13-15 Years |
20.2 |
12.9 to 30.3 |
114 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2010 |
Age |
13-15 Years |
27.8 |
19.3 to 38.4 |
108 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2010 |
Age |
13-15 Years |
30.0 |
22.9 to 38.1 |
200 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-15 Years |
34.1 |
23.6 to 46.4 |
106 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-15 Years |
27.4 |
18.7 to 38.3 |
94 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2010 |
Age |
13-15 Years |
30.8 |
21.2 to 42.4 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2010 |
Age |
13-15 Years |
24.3 |
16.0 to 35.3 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-15 Years |
28.3 |
18.6 to 40.7 |
85 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2010 |
Age |
13-15 Years |
29.5 |
18.6 to 43.4 |
75 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-15 Years |
39.1 |
30.2 to 48.9 |
227 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-15 Years |
36.1 |
26.1 to 47.5 |
112 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-15 Years |
39.6 |
29.5 to 50.6 |
115 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2010 |
Age |
13-15 Years |
28.6 |
26.6 to 30.7 |
5636 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-15 Years |
36.5 |
30.2 to 43.3 |
566 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-15 Years |
26.7 |
21.2 to 33.0 |
314 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-15 Years |
35.1 |
29.4 to 41.2 |
690 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-15 Years |
24.7 |
21.0 to 28.9 |
808 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-15 Years |
25.9 |
22.2 to 30.0 |
682 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-15 Years |
28.3 |
23.0 to 34.3 |
898 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-15 Years |
28.2 |
23.3 to 33.7 |
379 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-15 Years |
33.7 |
28.1 to 39.7 |
563 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-15 Years |
29.5 |
22.0 to 38.2 |
375 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-15 Years |
57.9 |
46.4 to 68.6 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2010 |
Age |
13-15 Years |
30.4 |
20.6 to 42.4 |
104 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2010 |
Age |
13-15 Years |
57.1 |
45.0 to 68.4 |
92 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2010 |
Age |
13-15 Years |
20.6 |
13.5 to 30.2 |
87 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2010 |
Age |
13-15 Years |
28.6 |
21.5 to 37.0 |
530 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-15 Years |
25.7 |
18.4 to 34.8 |
127 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-15 Years |
31.3 |
21.8 to 42.7 |
126 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-15 Years |
36.8 |
27.0 to 47.7 |
93 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-15 Years |
30.1 |
20.7 to 41.5 |
94 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-15 Years |
33.4 |
27.2 to 40.2 |
361 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2010 |
Age |
13-15 Years |
24.8 |
16.8 to 34.9 |
108 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2010 |
Age |
13-15 Years |
28.9 |
20.1 to 39.8 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2010 |
Age |
13-15 Years |
35.6 |
24.3 to 48.7 |
94 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2010 |
Age |
13-15 Years |
40.7 |
31.0 to 51.2 |
108 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2010 |
Age |
13-15 Years |
22.3 |
14.9 to 31.8 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-15 Years |
39.0 |
27.4 to 52.0 |
76 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2010 |
Age |
13-15 Years |
35.4 |
25.1 to 47.2 |
88 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2011 |
Age |
13-15 Years |
27.1 |
17.5 to 39.4 |
93 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2011 |
Age |
13-15 Years |
34.5 |
24.5 to 46.0 |
111 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2011 |
Age |
13-15 Years |
31.8 |
21.7 to 44.0 |
128 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2011 |
Age |
13-15 Years |
37.8 |
29.0 to 47.4 |
173 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2011 |
Age |
13-15 Years |
17.2 |
10.4 to 27.2 |
129 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2011 |
Age |
13-15 Years |
23.4 |
15.7 to 33.3 |
133 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2011 |
Age |
13-15 Years |
45.0 |
34.7 to 55.8 |
135 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-15 Years |
32.5 |
22.8 to 44.0 |
123 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2011 |
Age |
13-15 Years |
30.5 |
21.3 to 41.6 |
142 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2011 |
Age |
13-15 Years |
25.9 |
17.0 to 37.5 |
121 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2011 |
Age |
13-15 Years |
46.0 |
33.9 to 58.7 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2011 |
Age |
13-15 Years |
38.4 |
26.5 to 51.8 |
116 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2011 |
Age |
13-15 Years |
23.2 |
16.7 to 31.2 |
253 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-15 Years |
25.1 |
15.5 to 38.1 |
111 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-15 Years |
22.7 |
15.2 to 32.4 |
142 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2011 |
Age |
13-15 Years |
26.9 |
17.7 to 38.6 |
122 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2011 |
Age |
13-15 Years |
30.1 |
19.5 to 43.4 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2011 |
Age |
13-15 Years |
19.6 |
12.6 to 29.3 |
114 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2011 |
Age |
13-15 Years |
30.5 |
20.0 to 43.4 |
106 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2011 |
Age |
13-15 Years |
32.5 |
23.0 to 43.7 |
144 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2011 |
Age |
13-15 Years |
38.1 |
27.9 to 49.5 |
127 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2011 |
Age |
13-15 Years |
24.6 |
17.2 to 33.8 |
155 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-15 Years |
35.4 |
24.7 to 47.8 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2011 |
Age |
13-15 Years |
28.5 |
19.0 to 40.5 |
120 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2011 |
Age |
13-15 Years |
32.6 |
22.4 to 44.8 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2011 |
Age |
13-15 Years |
21.4 |
11.5 to 36.4 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2011 |
Age |
13-15 Years |
25.6 |
15.5 to 39.3 |
114 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2011 |
Age |
13-15 Years |
35.6 |
22.2 to 51.8 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2011 |
Age |
13-15 Years |
28.6 |
19.4 to 40.0 |
115 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2011 |
Age |
13-15 Years |
33.6 |
21.8 to 47.9 |
117 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-15 Years |
40.1 |
29.7 to 51.5 |
108 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2011 |
Age |
13-15 Years |
28.5 |
20.3 to 38.3 |
128 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2011 |
Age |
13-15 Years |
32.5 |
23.4 to 43.2 |
130 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2011 |
Age |
13-15 Years |
28.8 |
22.7 to 35.7 |
248 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-15 Years |
36.2 |
27.4 to 46.0 |
133 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-15 Years |
23.8 |
16.3 to 33.4 |
115 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2011 |
Age |
13-15 Years |
34.0 |
24.0 to 45.7 |
107 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2011 |
Age |
13-15 Years |
31.5 |
19.0 to 47.4 |
78 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2011 |
Age |
13-15 Years |
25.5 |
16.9 to 36.5 |
109 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-15 Years |
25.0 |
16.0 to 36.8 |
122 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2011 |
Age |
13-15 Years |
42.7 |
30.9 to 55.4 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-15 Years |
31.0 |
22.7 to 40.7 |
261 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-15 Years |
46.0 |
34.2 to 58.3 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-15 Years |
29.3 |
20.4 to 40.1 |
156 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2011 |
Age |
13-15 Years |
30.0 |
28.0 to 32.1 |
6850 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-15 Years |
34.2 |
28.3 to 40.7 |
697 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-15 Years |
28.7 |
23.7 to 34.3 |
376 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-15 Years |
27.8 |
23.0 to 33.2 |
895 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-15 Years |
28.4 |
24.3 to 32.9 |
903 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-15 Years |
27.7 |
23.8 to 32.1 |
825 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-15 Years |
29.2 |
23.3 to 35.8 |
1134 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-15 Years |
25.7 |
19.9 to 32.4 |
443 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-15 Years |
21.8 |
16.9 to 27.5 |
642 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-15 Years |
37.0 |
29.7 to 44.9 |
504 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-15 Years |
50.2 |
38.1 to 62.3 |
119 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2011 |
Age |
13-15 Years |
24.2 |
15.3 to 36.1 |
108 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2011 |
Age |
13-15 Years |
39.7 |
22.7 to 59.6 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2011 |
Age |
13-15 Years |
24.4 |
15.4 to 36.4 |
125 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2011 |
Age |
13-15 Years |
31.1 |
22.6 to 41.0 |
646 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-15 Years |
27.3 |
18.7 to 37.9 |
140 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-15 Years |
17.5 |
11.4 to 26.0 |
145 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-15 Years |
26.1 |
16.2 to 39.2 |
115 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-15 Years |
45.3 |
33.5 to 57.6 |
109 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-15 Years |
32.7 |
21.6 to 46.0 |
137 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-15 Years |
9.4 |
5.2 to 16.4 |
142 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-15 Years |
37.2 |
30.5 to 44.4 |
431 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2011 |
Age |
13-15 Years |
17.7 |
10.7 to 27.8 |
107 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2011 |
Age |
13-15 Years |
42.2 |
30.9 to 54.3 |
110 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2011 |
Age |
13-15 Years |
23.4 |
14.2 to 36.1 |
111 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2011 |
Age |
13-15 Years |
34.7 |
24.8 to 46.2 |
103 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2011 |
Age |
13-15 Years |
26.4 |
17.5 to 37.8 |
110 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-15 Years |
38.4 |
26.0 to 52.5 |
119 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2011 |
Age |
13-15 Years |
31.5 |
21.1 to 44.1 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2012 |
Age |
13-15 Years |
18.2 |
10.6 to 29.6 |
84 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2012 |
Age |
13-15 Years |
35.0 |
24.3 to 47.4 |
96 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2012 |
Age |
13-15 Years |
33.1 |
22.7 to 45.5 |
116 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2012 |
Age |
13-15 Years |
18.4 |
11.2 to 28.8 |
106 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2012 |
Age |
13-15 Years |
27.5 |
19.1 to 37.8 |
125 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2012 |
Age |
13-15 Years |
26.2 |
15.8 to 40.1 |
92 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2012 |
Age |
13-15 Years |
38.1 |
25.5 to 52.6 |
84 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2012 |
Age |
13-15 Years |
50.4 |
38.0 to 62.8 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-15 Years |
35.5 |
24.5 to 48.1 |
103 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2012 |
Age |
13-15 Years |
26.7 |
16.6 to 39.9 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2012 |
Age |
13-15 Years |
27.9 |
17.7 to 41.0 |
87 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2012 |
Age |
13-15 Years |
27.7 |
18.2 to 39.7 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2012 |
Age |
13-15 Years |
32.6 |
22.3 to 44.9 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2012 |
Age |
13-15 Years |
22.2 |
14.7 to 32.0 |
203 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-15 Years |
38.7 |
26.3 to 52.8 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-15 Years |
17.7 |
9.6 to 30.3 |
106 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2012 |
Age |
13-15 Years |
28.9 |
19.7 to 40.3 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2012 |
Age |
13-15 Years |
22.4 |
13.9 to 34.0 |
88 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2012 |
Age |
13-15 Years |
19.1 |
10.8 to 31.6 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2012 |
Age |
13-15 Years |
36.0 |
24.4 to 49.5 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2012 |
Age |
13-15 Years |
38.3 |
28.3 to 49.5 |
122 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2012 |
Age |
13-15 Years |
37.7 |
27.4 to 49.2 |
114 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2012 |
Age |
13-15 Years |
24.5 |
15.4 to 36.7 |
85 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-15 Years |
35.1 |
24.4 to 47.5 |
92 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2012 |
Age |
13-15 Years |
31.6 |
20.9 to 44.7 |
107 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2012 |
Age |
13-15 Years |
23.6 |
13.8 to 37.3 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2012 |
Age |
13-15 Years |
15.5 |
8.8 to 26.0 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2012 |
Age |
13-15 Years |
29.1 |
18.9 to 41.9 |
92 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2012 |
Age |
13-15 Years |
31.9 |
20.9 to 45.4 |
89 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2012 |
Age |
13-15 Years |
37.9 |
26.1 to 51.2 |
84 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2012 |
Age |
13-15 Years |
32.3 |
20.5 to 46.8 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2012 |
Age |
13-15 Years |
27.1 |
18.0 to 38.6 |
90 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2012 |
Age |
13-15 Years |
24.9 |
15.8 to 36.9 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2012 |
Age |
13-15 Years |
35.3 |
26.8 to 44.9 |
191 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-15 Years |
29.8 |
20.5 to 41.3 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-15 Years |
38.5 |
26.6 to 51.9 |
93 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2012 |
Age |
13-15 Years |
25.1 |
16.2 to 36.8 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2012 |
Age |
13-15 Years |
40.1 |
29.0 to 52.3 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2012 |
Age |
13-15 Years |
25.3 |
16.2 to 37.3 |
103 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-15 Years |
41.1 |
30.0 to 53.3 |
108 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2012 |
Age |
13-15 Years |
32.7 |
21.5 to 46.3 |
90 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-15 Years |
29.4 |
21.3 to 38.9 |
212 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-15 Years |
47.5 |
35.6 to 59.7 |
106 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-15 Years |
27.1 |
18.4 to 37.9 |
106 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2012 |
Age |
13-15 Years |
28.1 |
26.1 to 30.2 |
5573 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-15 Years |
35.4 |
29.1 to 42.2 |
525 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-15 Years |
32.6 |
25.9 to 40.1 |
281 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-15 Years |
26.7 |
21.8 to 32.2 |
674 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-15 Years |
26.2 |
21.8 to 31.2 |
750 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-15 Years |
27.3 |
22.9 to 32.2 |
684 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-15 Years |
28.2 |
24.0 to 33.0 |
943 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-15 Years |
26.3 |
20.6 to 32.9 |
361 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-15 Years |
25.3 |
19.4 to 32.3 |
554 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-15 Years |
28.6 |
21.7 to 36.6 |
427 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-15 Years |
43.3 |
31.0 to 56.5 |
85 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2012 |
Age |
13-15 Years |
28.3 |
17.9 to 41.7 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2012 |
Age |
13-15 Years |
16.9 |
9.8 to 27.7 |
87 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2012 |
Age |
13-15 Years |
26.4 |
15.2 to 41.7 |
82 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2012 |
Age |
13-15 Years |
26.2 |
20.5 to 32.8 |
512 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-15 Years |
19.0 |
10.8 to 31.2 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-15 Years |
33.9 |
22.6 to 47.3 |
116 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-15 Years |
26.1 |
19.7 to 33.8 |
283 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-15 Years |
29.3 |
23.1 to 36.5 |
374 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2012 |
Age |
13-15 Years |
22.3 |
13.7 to 34.2 |
104 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2012 |
Age |
13-15 Years |
39.7 |
28.3 to 52.2 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2012 |
Age |
13-15 Years |
20.6 |
12.4 to 32.2 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2012 |
Age |
13-15 Years |
25.8 |
16.9 to 37.4 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2012 |
Age |
13-15 Years |
30.5 |
19.4 to 44.5 |
76 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-15 Years |
37.2 |
23.9 to 52.7 |
72 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2012 |
Age |
13-15 Years |
22.6 |
14.2 to 33.8 |
87 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2013 |
Age |
13-15 Years |
36.7 |
26.1 to 48.7 |
92 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2013 |
Age |
13-15 Years |
21.2 |
13.5 to 31.7 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2013 |
Age |
13-15 Years |
34.5 |
24.2 to 46.4 |
120 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2013 |
Age |
13-15 Years |
21.1 |
12.6 to 33.1 |
96 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2013 |
Age |
13-15 Years |
49.2 |
35.9 to 62.5 |
85 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2013 |
Age |
13-15 Years |
30.0 |
21.0 to 40.7 |
109 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2013 |
Age |
13-15 Years |
33.6 |
23.7 to 45.2 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2013 |
Age |
13-15 Years |
43.2 |
31.6 to 55.6 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-15 Years |
25.7 |
14.7 to 41.2 |
59 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2013 |
Age |
13-15 Years |
27.2 |
17.1 to 40.3 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2013 |
Age |
13-15 Years |
27.9 |
18.1 to 40.3 |
84 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Guam |
2013 |
Age |
13-15 Years |
34.3 |
24.5 to 45.7 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2013 |
Age |
13-15 Years |
25.2 |
16.3 to 36.9 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2013 |
Age |
13-15 Years |
28.3 |
18.6 to 40.6 |
87 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2013 |
Age |
13-15 Years |
30.4 |
21.8 to 40.7 |
158 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-15 Years |
35.6 |
22.5 to 51.2 |
60 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-15 Years |
28.9 |
18.8 to 41.7 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2013 |
Age |
13-15 Years |
32.0 |
22.9 to 42.7 |
114 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2013 |
Age |
13-15 Years |
33.3 |
24.2 to 43.8 |
122 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2013 |
Age |
13-15 Years |
15.0 |
8.3 to 25.6 |
84 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2013 |
Age |
13-15 Years |
21.5 |
13.5 to 32.6 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2013 |
Age |
13-15 Years |
35.3 |
23.9 to 48.7 |
84 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2013 |
Age |
13-15 Years |
35.7 |
26.1 to 46.7 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2013 |
Age |
13-15 Years |
22.8 |
13.4 to 36.1 |
91 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-15 Years |
28.6 |
20.0 to 39.1 |
111 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2013 |
Age |
13-15 Years |
22.1 |
13.8 to 33.5 |
76 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2013 |
Age |
13-15 Years |
32.7 |
22.9 to 44.4 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2013 |
Age |
13-15 Years |
22.3 |
13.5 to 34.4 |
93 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2013 |
Age |
13-15 Years |
19.1 |
11.6 to 30.0 |
82 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2013 |
Age |
13-15 Years |
23.6 |
15.7 to 33.9 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2013 |
Age |
13-15 Years |
28.6 |
19.4 to 40.0 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2013 |
Age |
13-15 Years |
24.7 |
16.1 to 35.8 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-15 Years |
31.7 |
22.1 to 43.2 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2013 |
Age |
13-15 Years |
30.9 |
20.4 to 43.9 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2013 |
Age |
13-15 Years |
40.2 |
29.0 to 52.5 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2013 |
Age |
13-15 Years |
38.0 |
29.9 to 46.8 |
205 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-15 Years |
37.5 |
26.1 to 50.6 |
90 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-15 Years |
38.3 |
27.7 to 50.0 |
115 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2013 |
Age |
13-15 Years |
31.9 |
22.0 to 43.8 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2013 |
Age |
13-15 Years |
38.5 |
28.0 to 50.3 |
107 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2013 |
Age |
13-15 Years |
25.8 |
17.6 to 36.3 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-15 Years |
30.9 |
22.1 to 41.4 |
118 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2013 |
Age |
13-15 Years |
36.2 |
26.2 to 47.5 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-15 Years |
36.3 |
27.2 to 46.6 |
223 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-15 Years |
47.2 |
35.8 to 58.8 |
96 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-15 Years |
34.9 |
24.8 to 46.5 |
127 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2013 |
Age |
13-15 Years |
32.7 |
30.3 to 35.2 |
5402 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-15 Years |
32.2 |
27.0 to 38.0 |
592 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-15 Years |
35.8 |
29.2 to 43.0 |
302 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-15 Years |
30.2 |
24.5 to 36.5 |
670 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-15 Years |
28.7 |
24.2 to 33.7 |
723 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-15 Years |
27.8 |
23.7 to 32.2 |
650 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-15 Years |
35.1 |
29.0 to 41.8 |
722 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-15 Years |
22.7 |
18.0 to 28.3 |
374 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-15 Years |
27.3 |
22.1 to 33.3 |
579 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-15 Years |
44.5 |
34.4 to 55.0 |
400 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-15 Years |
47.3 |
35.6 to 59.2 |
88 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2013 |
Age |
13-15 Years |
36.2 |
24.3 to 50.1 |
91 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2013 |
Age |
13-15 Years |
38.7 |
27.5 to 51.3 |
85 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2013 |
Age |
13-15 Years |
26.1 |
17.0 to 37.8 |
82 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2013 |
Age |
13-15 Years |
36.8 |
28.4 to 46.1 |
325 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-15 Years |
24.1 |
16.0 to 34.7 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-15 Years |
30.5 |
19.2 to 44.6 |
71 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-15 Years |
38.4 |
28.7 to 49.1 |
155 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-15 Years |
36.1 |
29.0 to 43.9 |
390 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2013 |
Age |
13-15 Years |
19.8 |
11.5 to 31.9 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2013 |
Age |
13-15 Years |
30.6 |
21.0 to 42.2 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2013 |
Age |
13-15 Years |
24.7 |
13.6 to 40.6 |
96 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2013 |
Age |
13-15 Years |
39.9 |
28.1 to 53.0 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2013 |
Age |
13-15 Years |
32.0 |
22.4 to 43.2 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-15 Years |
24.8 |
16.2 to 36.0 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2013 |
Age |
13-15 Years |
30.8 |
20.8 to 43.1 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2014 |
Age |
13-15 Years |
36.8 |
25.7 to 49.4 |
93 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2014 |
Age |
13-15 Years |
22.8 |
15.5 to 32.2 |
123 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2014 |
Age |
13-15 Years |
24.3 |
16.0 to 35.1 |
119 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2014 |
Age |
13-15 Years |
23.7 |
14.7 to 35.8 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2014 |
Age |
13-15 Years |
43.2 |
30.9 to 56.4 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2014 |
Age |
13-15 Years |
41.1 |
30.7 to 52.4 |
114 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2014 |
Age |
13-15 Years |
36.9 |
26.4 to 48.8 |
111 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2014 |
Age |
13-15 Years |
40.3 |
28.7 to 53.2 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-15 Years |
55.9 |
42.0 to 68.9 |
93 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2014 |
Age |
13-15 Years |
21.4 |
12.6 to 33.9 |
111 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2014 |
Age |
13-15 Years |
43.9 |
32.1 to 56.4 |
119 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2014 |
Age |
13-15 Years |
32.0 |
22.9 to 42.8 |
120 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2014 |
Age |
13-15 Years |
39.4 |
28.4 to 51.5 |
112 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2014 |
Age |
13-15 Years |
44.0 |
35.6 to 52.8 |
225 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-15 Years |
42.8 |
30.0 to 56.6 |
88 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-15 Years |
44.3 |
34.6 to 54.4 |
137 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2014 |
Age |
13-15 Years |
39.4 |
28.8 to 51.2 |
118 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2014 |
Age |
13-15 Years |
28.5 |
18.5 to 41.3 |
82 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2014 |
Age |
13-15 Years |
16.9 |
10.2 to 26.6 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2014 |
Age |
13-15 Years |
33.5 |
24.2 to 44.3 |
128 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2014 |
Age |
13-15 Years |
33.6 |
23.3 to 45.8 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2014 |
Age |
13-15 Years |
35.6 |
25.3 to 47.4 |
94 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2014 |
Age |
13-15 Years |
30.3 |
19.7 to 43.4 |
110 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-15 Years |
38.3 |
27.7 to 50.0 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2014 |
Age |
13-15 Years |
35.9 |
25.7 to 47.6 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2014 |
Age |
13-15 Years |
34.8 |
23.2 to 48.6 |
81 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2014 |
Age |
13-15 Years |
26.4 |
16.9 to 38.6 |
107 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2014 |
Age |
13-15 Years |
21.5 |
13.7 to 32.0 |
117 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2014 |
Age |
13-15 Years |
39.1 |
28.3 to 51.1 |
116 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2014 |
Age |
13-15 Years |
41.0 |
29.1 to 54.2 |
85 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2014 |
Age |
13-15 Years |
30.3 |
21.3 to 41.1 |
119 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-15 Years |
41.0 |
30.9 to 51.9 |
115 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2014 |
Age |
13-15 Years |
24.2 |
15.7 to 35.4 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2014 |
Age |
13-15 Years |
36.5 |
26.7 to 47.5 |
130 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2014 |
Age |
13-15 Years |
29.7 |
21.8 to 39.1 |
171 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-15 Years |
29.4 |
19.7 to 41.4 |
91 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-15 Years |
29.9 |
19.2 to 43.4 |
80 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2014 |
Age |
13-15 Years |
49.8 |
38.1 to 61.6 |
110 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2014 |
Age |
13-15 Years |
41.4 |
29.7 to 54.1 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2014 |
Age |
13-15 Years |
29.0 |
20.0 to 40.0 |
123 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-15 Years |
36.9 |
26.5 to 48.6 |
112 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2014 |
Age |
13-15 Years |
44.6 |
33.8 to 56.1 |
126 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-15 Years |
43.9 |
33.4 to 55.0 |
221 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-15 Years |
50.9 |
37.6 to 64.1 |
89 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-15 Years |
43.0 |
31.3 to 55.5 |
132 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-15 Years |
34.3 |
21.7 to 49.5 |
64 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2014 |
Age |
13-15 Years |
34.4 |
32.1 to 36.7 |
6181 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-15 Years |
38.7 |
32.9 to 44.9 |
627 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-15 Years |
28.0 |
21.7 to 35.2 |
266 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-15 Years |
34.2 |
28.4 to 40.4 |
735 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-15 Years |
32.6 |
28.0 to 37.5 |
887 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-15 Years |
36.1 |
31.8 to 40.7 |
754 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-15 Years |
34.0 |
28.0 to 40.4 |
917 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-15 Years |
24.3 |
19.2 to 30.3 |
379 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-15 Years |
34.7 |
28.9 to 40.9 |
695 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-15 Years |
39.2 |
29.8 to 49.6 |
455 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-15 Years |
46.9 |
36.0 to 58.2 |
107 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2014 |
Age |
13-15 Years |
33.4 |
23.4 to 45.3 |
122 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2014 |
Age |
13-15 Years |
29.2 |
19.7 to 41.0 |
109 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2014 |
Age |
13-15 Years |
19.2 |
12.2 to 28.8 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2014 |
Age |
13-15 Years |
34.4 |
26.3 to 43.6 |
473 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-15 Years |
24.2 |
15.1 to 36.5 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-15 Years |
41.2 |
29.5 to 53.9 |
118 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-15 Years |
49.7 |
35.7 to 63.7 |
120 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-15 Years |
33.8 |
24.5 to 44.7 |
140 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-15 Years |
41.2 |
34.3 to 48.5 |
466 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2014 |
Age |
13-15 Years |
25.2 |
17.1 to 35.5 |
120 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2014 |
Age |
13-15 Years |
42.8 |
31.8 to 54.7 |
103 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2014 |
Age |
13-15 Years |
22.6 |
14.2 to 33.9 |
107 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2014 |
Age |
13-15 Years |
41.6 |
30.3 to 53.9 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2014 |
Age |
13-15 Years |
35.7 |
25.7 to 47.2 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-15 Years |
29.4 |
19.5 to 41.8 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2014 |
Age |
13-15 Years |
25.4 |
17.3 to 35.6 |
136 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2015 |
Age |
13-15 Years |
39.0 |
27.5 to 51.9 |
95 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2015 |
Age |
13-15 Years |
39.1 |
29.5 to 49.7 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2015 |
Age |
13-15 Years |
41.2 |
31.1 to 52.2 |
128 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2015 |
Age |
13-15 Years |
31.3 |
21.9 to 42.6 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2015 |
Age |
13-15 Years |
41.5 |
29.1 to 55.2 |
93 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2015 |
Age |
13-15 Years |
34.7 |
24.9 to 45.9 |
108 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2015 |
Age |
13-15 Years |
47.1 |
35.8 to 58.8 |
93 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2015 |
Age |
13-15 Years |
47.1 |
35.9 to 58.6 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-15 Years |
58.9 |
46.9 to 69.9 |
120 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2015 |
Age |
13-15 Years |
30.5 |
20.9 to 42.1 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2015 |
Age |
13-15 Years |
30.6 |
21.4 to 41.6 |
118 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Guam |
2015 |
Age |
13-15 Years |
40.5 |
30.6 to 51.3 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2015 |
Age |
13-15 Years |
44.0 |
33.3 to 55.4 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2015 |
Age |
13-15 Years |
27.9 |
18.6 to 39.6 |
104 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2015 |
Age |
13-15 Years |
37.8 |
30.8 to 45.3 |
261 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-15 Years |
42.6 |
31.0 to 55.0 |
94 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-15 Years |
36.7 |
28.7 to 45.6 |
167 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2015 |
Age |
13-15 Years |
26.3 |
17.5 to 37.4 |
96 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2015 |
Age |
13-15 Years |
39.9 |
30.0 to 50.6 |
121 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2015 |
Age |
13-15 Years |
28.6 |
19.4 to 40.1 |
98 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2015 |
Age |
13-15 Years |
31.0 |
21.3 to 42.7 |
92 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2015 |
Age |
13-15 Years |
37.0 |
26.8 to 48.7 |
103 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2015 |
Age |
13-15 Years |
37.8 |
27.9 to 48.8 |
116 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2015 |
Age |
13-15 Years |
34.4 |
23.7 to 46.9 |
123 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-15 Years |
44.3 |
32.1 to 57.2 |
86 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2015 |
Age |
13-15 Years |
43.5 |
32.9 to 54.7 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2015 |
Age |
13-15 Years |
44.1 |
32.8 to 56.1 |
104 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2015 |
Age |
13-15 Years |
24.0 |
16.8 to 33.1 |
129 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2015 |
Age |
13-15 Years |
22.6 |
13.5 to 35.4 |
91 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2015 |
Age |
13-15 Years |
24.4 |
16.5 to 34.5 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2015 |
Age |
13-15 Years |
41.2 |
31.0 to 52.3 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2015 |
Age |
13-15 Years |
37.4 |
27.3 to 48.7 |
119 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-15 Years |
37.8 |
26.0 to 51.3 |
75 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2015 |
Age |
13-15 Years |
36.4 |
26.4 to 47.7 |
109 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2015 |
Age |
13-15 Years |
36.1 |
27.6 to 45.7 |
139 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2015 |
Age |
13-15 Years |
41.5 |
33.1 to 50.5 |
169 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-15 Years |
39.4 |
28.0 to 52.2 |
80 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-15 Years |
42.8 |
31.5 to 54.9 |
89 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2015 |
Age |
13-15 Years |
37.1 |
26.9 to 48.8 |
107 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2015 |
Age |
13-15 Years |
43.7 |
32.4 to 55.8 |
90 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2015 |
Age |
13-15 Years |
28.0 |
18.6 to 39.9 |
88 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-15 Years |
33.5 |
22.4 to 46.8 |
73 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2015 |
Age |
13-15 Years |
39.4 |
29.1 to 50.8 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-15 Years |
43.6 |
33.7 to 53.9 |
232 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-15 Years |
53.4 |
42.0 to 64.4 |
104 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-15 Years |
42.3 |
31.4 to 53.9 |
128 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-15 Years |
34.7 |
23.8 to 47.4 |
88 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2015 |
Age |
13-15 Years |
37.1 |
34.8 to 39.5 |
6395 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-15 Years |
45.0 |
38.4 to 51.8 |
603 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-15 Years |
39.8 |
33.2 to 46.8 |
278 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-15 Years |
38.4 |
32.3 to 44.9 |
773 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-15 Years |
32.6 |
28.3 to 37.3 |
844 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-15 Years |
36.3 |
32.0 to 40.8 |
767 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-15 Years |
38.8 |
34.2 to 43.7 |
1224 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-15 Years |
30.3 |
24.7 to 36.6 |
423 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-15 Years |
28.6 |
23.3 to 34.7 |
604 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-15 Years |
41.3 |
31.3 to 52.0 |
440 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-15 Years |
58.3 |
48.0 to 67.9 |
123 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2015 |
Age |
13-15 Years |
34.2 |
24.1 to 46.0 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2015 |
Age |
13-15 Years |
32.5 |
22.7 to 44.2 |
101 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2015 |
Age |
13-15 Years |
35.4 |
25.3 to 47.0 |
100 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2015 |
Age |
13-15 Years |
40.7 |
34.4 to 47.3 |
810 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-15 Years |
24.6 |
16.2 to 35.5 |
134 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-15 Years |
36.8 |
25.0 to 50.4 |
80 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-15 Years |
48.3 |
38.7 to 58.0 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-15 Years |
42.5 |
34.6 to 50.8 |
275 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-15 Years |
10.3 |
6.1 to 16.9 |
151 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-15 Years |
40.0 |
33.7 to 46.7 |
439 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2015 |
Age |
13-15 Years |
18.6 |
11.2 to 29.2 |
99 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2015 |
Age |
13-15 Years |
48.0 |
37.2 to 59.0 |
110 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2015 |
Age |
13-15 Years |
32.7 |
20.7 to 47.5 |
102 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2015 |
Age |
13-15 Years |
43.3 |
33.3 to 53.9 |
121 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2015 |
Age |
13-15 Years |
33.9 |
24.1 to 45.3 |
97 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-15 Years |
41.8 |
30.9 to 53.6 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2015 |
Age |
13-15 Years |
21.1 |
12.2 to 33.9 |
93 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
5.9 |
4.4 to 7.8 |
1441 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
7.0 |
4.1 to 11.6 |
183 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
13.2 |
8.8 to 19.3 |
185 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
21.0 |
14.7 to 29.0 |
149 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
20.8 |
13.8 to 30.1 |
120 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
22.1 |
14.2 to 32.8 |
150 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
19.0 |
12.7 to 27.4 |
181 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
23.3 |
16.4 to 32.0 |
143 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
26.1 |
18.8 to 34.9 |
164 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
12.4 |
7.7 to 19.3 |
161 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
20.2 |
13.3 to 29.6 |
149 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
8.1 |
5.0 to 12.9 |
167 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
18.7 |
13.1 to 25.9 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
8.0 |
4.4 to 14.1 |
131 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
12.8 |
8.5 to 18.9 |
373 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
11.2 |
6.5 to 18.6 |
173 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
13.3 |
8.2 to 20.9 |
200 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
11.6 |
7.4 to 17.6 |
173 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
26.8 |
18.7 to 36.7 |
127 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
15.6 |
9.1 to 25.3 |
137 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
12.7 |
8.1 to 19.4 |
133 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
16.5 |
11.0 to 24.1 |
179 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
21.4 |
14.9 to 29.8 |
169 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
14.2 |
9.7 to 20.5 |
198 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
29.1 |
21.7 to 37.8 |
152 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
13.5 |
8.5 to 20.7 |
143 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
14.7 |
10.1 to 20.7 |
167 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
15.1 |
9.8 to 22.6 |
158 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
8.6 |
4.8 to 15.1 |
142 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
17.5 |
12.4 to 24.3 |
186 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
23.2 |
15.3 to 33.5 |
151 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
20.4 |
14.2 to 28.3 |
187 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
23.2 |
15.4 to 33.4 |
143 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
29.2 |
22.9 to 36.4 |
270 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
24.3 |
16.2 to 34.9 |
135 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
32.5 |
23.9 to 42.5 |
135 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
17.8 |
12.2 to 25.3 |
157 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
15.9 |
10.8 to 22.8 |
177 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
15.6 |
10.0 to 23.5 |
154 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
16.6 |
10.9 to 24.4 |
141 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
14.3 |
8.7 to 22.4 |
106 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
25.7 |
19.5 to 33.0 |
346 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
20.7 |
14.1 to 29.3 |
178 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
26.5 |
19.5 to 34.9 |
168 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
17.9 |
16.3 to 19.6 |
8607 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
26.4 |
22.3 to 30.9 |
911 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
26.4 |
21.6 to 32.0 |
457 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
21.5 |
18.0 to 25.5 |
1176 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
14.5 |
12.0 to 17.5 |
1333 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
14.6 |
12.2 to 17.5 |
1123 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
11.6 |
8.6 to 15.5 |
1018 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
18.1 |
14.5 to 22.3 |
608 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
15.3 |
12.0 to 19.3 |
911 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
21.3 |
14.7 to 29.7 |
549 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
31.4 |
23.2 to 40.9 |
152 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
13.8 |
9.0 to 20.7 |
183 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
34.2 |
26.9 to 42.4 |
178 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
13.0 |
7.9 to 20.9 |
172 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
9.7 |
5.8 to 15.6 |
370 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
20.2 |
12.9 to 30.2 |
114 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
13.8 |
7.9 to 22.9 |
102 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
18.8 |
14.2 to 24.5 |
521 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
25.8 |
18.2 to 35.2 |
144 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
21.2 |
14.7 to 29.6 |
151 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
23.8 |
16.1 to 33.7 |
135 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
17.1 |
11.3 to 25.1 |
156 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
22.6 |
14.9 to 32.7 |
113 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
19.8 |
13.5 to 28.2 |
124 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
25.2 |
18.6 to 33.2 |
166 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
19.3 |
12.7 to 28.3 |
136 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
31.2 |
23.0 to 40.7 |
184 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
13.8 |
8.7 to 21.1 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
21.8 |
15.8 to 29.4 |
190 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
32.5 |
24.3 to 41.8 |
198 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
44.7 |
36.4 to 53.3 |
191 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
32.6 |
24.6 to 41.9 |
186 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
22.8 |
16.9 to 30.2 |
198 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
24.6 |
18.1 to 32.5 |
216 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
21.8 |
15.9 to 29.1 |
182 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
38.9 |
29.8 to 48.8 |
115 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
16.9 |
10.0 to 27.2 |
105 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
23.4 |
17.9 to 29.9 |
365 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
15.6 |
11.1 to 21.4 |
199 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
25.4 |
18.7 to 33.6 |
166 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
22.3 |
16.8 to 28.9 |
404 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
32.7 |
25.2 to 41.1 |
174 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
27.7 |
18.6 to 39.2 |
117 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
19.5 |
13.8 to 26.9 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
29.8 |
20.4 to 41.2 |
127 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
28.0 |
20.6 to 37.0 |
140 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
29.5 |
19.8 to 41.7 |
110 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
49.4 |
40.8 to 58.1 |
181 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
22.9 |
16.6 to 30.7 |
220 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
27.0 |
20.3 to 34.9 |
164 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
8.1 |
4.9 to 13.0 |
191 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
19.9 |
14.2 to 27.0 |
173 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
21.9 |
15.3 to 30.2 |
146 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
33.9 |
25.5 to 43.3 |
143 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
17.4 |
11.4 to 25.7 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
39.8 |
31.3 to 48.8 |
150 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
28.0 |
21.6 to 35.5 |
197 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
35.4 |
28.2 to 43.3 |
195 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
33.8 |
27.2 to 41.1 |
262 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
27.3 |
19.1 to 37.4 |
137 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
38.2 |
29.1 to 48.2 |
125 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
30.5 |
22.7 to 39.6 |
157 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
31.7 |
23.6 to 41.1 |
133 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
25.0 |
17.9 to 33.9 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
16.2 |
10.8 to 23.4 |
158 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
32.2 |
25.1 to 40.1 |
200 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
37.5 |
28.9 to 46.9 |
262 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
27.5 |
20.1 to 36.4 |
148 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
39.1 |
29.2 to 49.9 |
114 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
26.7 |
25.2 to 28.2 |
9621 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
45.1 |
40.5 to 49.8 |
1022 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
32.0 |
27.0 to 37.5 |
459 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
31.5 |
26.7 to 36.7 |
1049 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
23.4 |
20.6 to 26.5 |
1416 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
24.5 |
21.6 to 27.6 |
1507 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
23.4 |
19.5 to 27.9 |
1352 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
26.2 |
22.2 to 30.6 |
607 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
28.7 |
24.2 to 33.5 |
962 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
23.2 |
18.1 to 29.3 |
648 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
51.7 |
42.5 to 60.8 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
16.6 |
11.1 to 24.1 |
148 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
45.0 |
36.0 to 54.4 |
142 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
26.5 |
19.9 to 34.3 |
180 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
23.4 |
18.1 to 29.9 |
696 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
20.6 |
13.7 to 29.7 |
145 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
17.6 |
11.3 to 26.2 |
112 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
21.0 |
13.9 to 30.4 |
131 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
28.4 |
21.4 to 36.6 |
153 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
24.4 |
17.3 to 33.3 |
155 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
31.1 |
26.4 to 36.3 |
599 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
19.5 |
13.0 to 28.1 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
39.1 |
31.4 to 47.3 |
184 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
24.6 |
17.8 to 32.9 |
175 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
35.4 |
27.6 to 44.1 |
158 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
27.0 |
19.2 to 36.4 |
118 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
28.9 |
21.9 to 37.2 |
178 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
31.1 |
24.1 to 39.2 |
184 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
20.0 |
13.9 to 27.9 |
143 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
25.0 |
17.8 to 33.9 |
134 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
33.1 |
24.7 to 42.8 |
151 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
19.6 |
13.2 to 28.2 |
135 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
32.0 |
24.5 to 40.6 |
163 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
40.9 |
32.5 to 49.9 |
166 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
45.5 |
37.2 to 54.1 |
182 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
40.4 |
31.7 to 49.7 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
33.8 |
26.2 to 42.5 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
24.9 |
16.9 to 35.1 |
147 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
22.8 |
17.4 to 29.4 |
195 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
39.9 |
31.1 to 49.4 |
133 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
17.6 |
11.8 to 25.4 |
152 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
26.0 |
20.6 to 32.2 |
362 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
28.4 |
20.5 to 38.0 |
175 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
25.3 |
19.0 to 32.9 |
187 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
24.8 |
18.4 to 32.7 |
168 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
36.2 |
27.8 to 45.5 |
128 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
25.1 |
18.6 to 33.0 |
170 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
27.3 |
20.1 to 35.9 |
142 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
39.3 |
30.6 to 48.6 |
142 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
32.9 |
24.8 to 42.2 |
144 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
30.8 |
22.9 to 40.0 |
140 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
46.8 |
37.1 to 56.9 |
140 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
25.2 |
18.1 to 33.9 |
145 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
37.8 |
29.3 to 47.1 |
139 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
20.0 |
13.8 to 28.2 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
25.5 |
19.3 to 33.0 |
170 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
33.2 |
25.1 to 42.3 |
163 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
42.5 |
33.3 to 52.2 |
148 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
25.9 |
19.1 to 34.1 |
165 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
42.2 |
34.4 to 50.4 |
173 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
25.4 |
18.6 to 33.7 |
180 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
31.1 |
23.7 to 39.5 |
174 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
39.7 |
33.3 to 46.5 |
329 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
42.4 |
34.0 to 51.3 |
182 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
37.9 |
29.1 to 47.6 |
147 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
39.3 |
30.6 to 48.6 |
156 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
26.3 |
19.8 to 34.0 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
31.1 |
23.6 to 39.8 |
150 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
31.1 |
23.5 to 39.9 |
163 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
38.2 |
29.2 to 48.0 |
129 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
41.7 |
34.4 to 49.3 |
360 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
38.5 |
30.6 to 47.0 |
185 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
42.2 |
33.9 to 50.9 |
175 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
32.0 |
30.3 to 33.6 |
9220 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
45.0 |
40.0 to 50.2 |
953 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
35.2 |
30.1 to 40.5 |
509 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
38.3 |
33.9 to 43.0 |
1161 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
26.8 |
23.5 to 30.4 |
1272 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
30.0 |
26.8 to 33.3 |
1099 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
28.5 |
24.3 to 33.1 |
1438 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
30.1 |
26.1 to 34.4 |
616 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
35.0 |
30.5 to 39.8 |
970 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
32.0 |
25.9 to 38.9 |
612 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
55.1 |
46.0 to 63.9 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
29.5 |
21.5 to 39.0 |
164 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
54.5 |
45.6 to 63.1 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
26.3 |
19.7 to 34.2 |
149 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
27.0 |
21.3 to 33.6 |
824 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
26.7 |
20.5 to 34.0 |
203 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
31.9 |
24.2 to 40.8 |
197 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
18.6 |
12.0 to 27.7 |
135 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
39.4 |
31.1 to 48.3 |
148 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
27.0 |
19.4 to 36.2 |
141 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
38.4 |
33.3 to 43.8 |
590 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
22.2 |
15.7 to 30.5 |
170 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
38.6 |
30.2 to 47.7 |
155 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
41.5 |
32.1 to 51.5 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
45.5 |
37.3 to 53.9 |
175 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
25.3 |
18.9 to 32.9 |
164 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
44.1 |
34.7 to 54.0 |
135 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
40.3 |
31.9 to 49.3 |
150 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
31.2 |
23.3 to 40.3 |
180 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
40.4 |
31.1 to 50.4 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
36.7 |
27.4 to 47.1 |
191 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
15.5 |
9.1 to 25.1 |
152 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
42.9 |
35.8 to 50.3 |
270 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
25.3 |
18.4 to 33.8 |
220 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
43.0 |
34.6 to 51.9 |
223 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
46.8 |
38.2 to 55.6 |
203 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
36.0 |
28.0 to 44.9 |
210 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
35.3 |
27.3 to 44.1 |
240 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
30.0 |
22.4 to 39.0 |
215 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
50.9 |
41.4 to 60.3 |
154 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
30.0 |
21.1 to 40.6 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
34.0 |
26.5 to 42.3 |
404 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
24.7 |
17.4 to 33.9 |
181 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
36.2 |
27.3 to 46.1 |
223 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
28.4 |
21.0 to 37.1 |
199 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
40.7 |
31.0 to 51.1 |
169 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
21.9 |
16.0 to 29.2 |
198 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
30.5 |
22.7 to 39.7 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
36.3 |
28.3 to 45.2 |
214 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
44.5 |
36.4 to 52.8 |
211 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
29.9 |
23.3 to 37.4 |
255 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
48.5 |
39.5 to 57.6 |
178 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
31.6 |
23.7 to 40.8 |
185 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
35.1 |
26.6 to 44.7 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
19.6 |
11.9 to 30.5 |
167 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
30.8 |
22.6 to 40.4 |
191 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
39.8 |
28.6 to 52.2 |
204 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
32.6 |
24.7 to 41.7 |
174 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
30.9 |
21.7 to 41.9 |
189 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
46.0 |
37.8 to 54.4 |
191 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
38.7 |
30.9 to 47.3 |
219 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
29.7 |
22.6 to 38.0 |
209 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
34.2 |
29.0 to 39.9 |
399 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
38.6 |
31.4 to 46.4 |
209 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
31.5 |
24.5 to 39.3 |
190 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
32.3 |
23.6 to 42.5 |
161 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
27.8 |
18.7 to 39.2 |
142 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
32.6 |
25.0 to 41.3 |
181 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
27.7 |
19.9 to 37.1 |
175 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
38.5 |
29.1 to 48.9 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
41.0 |
33.6 to 48.8 |
435 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
48.8 |
39.7 to 58.0 |
188 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
39.9 |
31.7 to 48.8 |
247 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
35.4 |
33.8 to 37.1 |
11236 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
47.2 |
42.3 to 52.0 |
1211 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
35.7 |
31.2 to 40.4 |
618 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
35.1 |
30.9 to 39.5 |
1458 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
30.7 |
27.2 to 34.3 |
1505 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
33.9 |
30.4 to 37.6 |
1338 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
30.4 |
26.0 to 35.2 |
1807 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
31.3 |
26.6 to 36.4 |
732 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
27.8 |
23.5 to 32.5 |
1090 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
41.6 |
35.8 to 47.7 |
804 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
56.8 |
47.5 to 65.7 |
203 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
23.3 |
15.8 to 32.9 |
161 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
50.1 |
36.7 to 63.4 |
179 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
27.2 |
19.7 to 36.2 |
205 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
31.5 |
25.4 to 38.4 |
1057 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
31.9 |
24.2 to 40.8 |
213 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
26.9 |
19.9 to 35.3 |
250 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
23.4 |
16.2 to 32.5 |
196 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
45.1 |
35.8 to 54.7 |
169 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
32.3 |
24.2 to 41.6 |
229 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
8.3 |
5.2 to 13.0 |
232 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
38.3 |
32.8 to 44.1 |
673 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
20.4 |
14.2 to 28.3 |
170 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
50.1 |
41.4 to 58.9 |
205 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
29.8 |
21.8 to 39.2 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
40.0 |
31.4 to 49.3 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
28.6 |
21.2 to 37.3 |
179 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
46.2 |
36.7 to 56.0 |
210 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
40.9 |
30.7 to 52.1 |
175 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
31.1 |
22.1 to 41.8 |
146 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
31.4 |
23.3 to 40.8 |
145 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
36.9 |
28.2 to 46.6 |
178 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
18.3 |
12.1 to 26.6 |
156 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
35.8 |
28.0 to 44.5 |
202 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
38.0 |
27.6 to 49.6 |
156 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
43.6 |
33.5 to 54.2 |
141 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
50.4 |
40.3 to 60.4 |
157 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
38.5 |
29.4 to 48.5 |
158 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
25.3 |
17.6 to 35.0 |
150 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
29.0 |
20.9 to 38.7 |
156 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
43.4 |
34.1 to 53.2 |
152 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
27.8 |
20.4 to 36.7 |
173 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
21.1 |
15.4 to 28.1 |
308 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
37.8 |
27.8 to 49.1 |
143 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
16.9 |
10.8 to 25.4 |
165 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
35.2 |
26.7 to 44.8 |
154 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
35.6 |
26.9 to 45.3 |
151 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
25.1 |
16.9 to 35.5 |
157 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
34.9 |
25.7 to 45.4 |
154 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
40.5 |
31.9 to 49.7 |
186 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
41.8 |
32.6 to 51.7 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
30.9 |
22.4 to 41.0 |
148 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
43.0 |
34.2 to 52.3 |
165 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
32.2 |
23.7 to 42.1 |
171 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
33.1 |
24.0 to 43.7 |
164 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
12.1 |
7.3 to 19.3 |
160 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
34.5 |
25.5 to 44.7 |
150 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
41.6 |
32.0 to 51.9 |
150 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
37.3 |
27.9 to 47.7 |
146 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
37.2 |
27.6 to 47.8 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
34.5 |
25.5 to 44.7 |
121 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
31.6 |
23.7 to 40.6 |
145 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
30.3 |
22.4 to 39.6 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
39.7 |
32.8 to 47.1 |
303 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
37.3 |
28.8 to 46.5 |
158 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
41.3 |
31.5 to 51.8 |
145 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
35.5 |
26.7 to 45.6 |
163 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
40.9 |
31.7 to 50.7 |
151 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
31.9 |
22.4 to 43.2 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
38.4 |
29.5 to 48.1 |
167 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
38.6 |
29.8 to 48.1 |
160 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
44.6 |
36.5 to 52.9 |
337 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
51.9 |
41.6 to 62.0 |
166 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
43.6 |
34.7 to 52.9 |
171 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
33.4 |
31.7 to 35.2 |
9058 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
43.4 |
38.4 to 48.6 |
900 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
37.1 |
31.6 to 42.9 |
448 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
36.8 |
32.1 to 41.8 |
1089 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
28.5 |
24.9 to 32.4 |
1230 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
30.4 |
26.7 to 34.4 |
1089 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
31.3 |
27.6 to 35.3 |
1466 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
33.1 |
28.0 to 38.5 |
604 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
33.5 |
27.9 to 39.5 |
908 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
36.2 |
29.8 to 43.2 |
691 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
57.7 |
47.6 to 67.3 |
153 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
26.6 |
18.2 to 37.0 |
153 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
31.8 |
23.3 to 41.6 |
135 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
28.6 |
20.2 to 38.8 |
148 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
30.3 |
25.3 to 35.8 |
798 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
26.3 |
18.1 to 36.6 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
36.8 |
27.9 to 46.7 |
189 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
30.1 |
24.3 to 36.5 |
433 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
9.1 |
5.5 to 14.6 |
262 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
39.2 |
33.6 to 45.2 |
633 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
24.1 |
16.8 to 33.4 |
163 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
46.2 |
36.9 to 55.8 |
158 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
27.9 |
19.7 to 38.0 |
155 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
43.5 |
34.1 to 53.4 |
155 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
36.1 |
26.6 to 46.7 |
134 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
37.5 |
27.7 to 48.4 |
133 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
30.3 |
22.4 to 39.6 |
153 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
39.6 |
31.0 to 48.8 |
152 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
27.1 |
19.6 to 36.0 |
158 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
37.4 |
28.7 to 47.0 |
171 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
24.4 |
17.3 to 33.2 |
157 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
45.8 |
35.9 to 56.0 |
148 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
39.1 |
30.9 to 48.1 |
163 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
40.1 |
31.4 to 49.4 |
157 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
51.7 |
42.8 to 60.5 |
183 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
30.2 |
19.5 to 43.7 |
84 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
34.3 |
25.3 to 44.6 |
157 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
33.2 |
24.5 to 43.2 |
132 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
33.6 |
25.9 to 42.4 |
164 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
34.4 |
25.6 to 44.4 |
141 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
31.3 |
22.6 to 41.6 |
124 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
33.8 |
27.0 to 41.3 |
268 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
38.6 |
27.4 to 51.2 |
94 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
32.6 |
24.7 to 41.6 |
174 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
34.6 |
27.3 to 42.7 |
194 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
41.9 |
33.4 to 50.9 |
183 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
21.0 |
13.9 to 30.3 |
133 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
26.8 |
19.2 to 36.1 |
140 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
42.1 |
32.7 to 52.1 |
138 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
45.8 |
37.2 to 54.6 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
33.4 |
23.7 to 44.8 |
148 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
39.3 |
31.3 to 48.0 |
183 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
34.5 |
25.8 to 44.4 |
131 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
37.6 |
29.1 to 46.9 |
167 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
25.2 |
17.6 to 34.8 |
148 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
28.8 |
20.7 to 38.6 |
135 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
28.3 |
21.0 to 37.0 |
149 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
41.5 |
32.7 to 50.8 |
141 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
27.4 |
20.0 to 36.5 |
150 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
43.2 |
34.9 to 51.9 |
168 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
31.4 |
23.0 to 41.2 |
157 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
44.3 |
35.4 to 53.6 |
166 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
45.4 |
38.9 to 52.1 |
344 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
45.2 |
35.9 to 54.8 |
154 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
45.6 |
36.9 to 54.5 |
190 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
32.8 |
24.3 to 42.5 |
149 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
41.1 |
32.3 to 50.4 |
168 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
35.0 |
26.7 to 44.2 |
156 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
35.4 |
27.6 to 44.0 |
184 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
39.5 |
31.2 to 48.6 |
164 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
45.9 |
37.9 to 54.0 |
379 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
54.5 |
45.4 to 63.3 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
44.7 |
35.9 to 53.9 |
220 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
37.6 |
35.7 to 39.6 |
8710 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
41.8 |
37.2 to 46.5 |
978 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
40.8 |
35.5 to 46.3 |
501 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
37.8 |
32.9 to 43.1 |
1101 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
33.9 |
30.1 to 38.0 |
1165 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
35.0 |
31.5 to 38.7 |
1076 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
38.1 |
33.1 to 43.5 |
1159 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
31.7 |
27.0 to 36.8 |
592 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
33.1 |
28.6 to 38.0 |
919 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
43.3 |
35.5 to 51.6 |
610 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
56.5 |
47.1 to 65.5 |
147 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
40.7 |
30.9 to 51.4 |
145 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
42.3 |
33.2 to 52.1 |
141 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
35.9 |
27.4 to 45.5 |
142 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
38.9 |
31.8 to 46.4 |
514 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
32.5 |
24.4 to 41.8 |
155 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
33.9 |
24.2 to 45.2 |
119 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
39.8 |
31.7 to 48.5 |
240 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
9.5 |
5.6 to 15.5 |
156 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
40.7 |
35.0 to 46.7 |
609 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
20.5 |
13.8 to 29.4 |
151 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
42.7 |
33.9 to 52.0 |
161 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
27.6 |
18.4 to 39.3 |
155 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
45.3 |
35.8 to 55.2 |
163 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
38.4 |
29.9 to 47.6 |
152 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
36.8 |
28.3 to 46.2 |
160 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
42.1 |
33.2 to 51.5 |
147 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
35.3 |
27.1 to 44.5 |
172 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
34.4 |
26.7 to 42.9 |
200 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
35.8 |
27.6 to 45.0 |
194 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
23.4 |
16.7 to 31.6 |
183 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
47.7 |
38.1 to 57.5 |
166 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
42.1 |
33.7 to 50.9 |
189 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
48.5 |
39.5 to 57.5 |
185 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
42.3 |
32.9 to 52.2 |
180 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
56.9 |
45.9 to 67.3 |
142 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
28.5 |
20.3 to 38.4 |
173 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
47.1 |
37.7 to 56.8 |
187 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
38.0 |
30.0 to 46.7 |
186 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
38.3 |
29.0 to 48.5 |
156 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
47.7 |
40.8 to 54.6 |
349 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
52.6 |
41.9 to 63.0 |
141 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
46.5 |
38.5 to 54.7 |
208 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
44.4 |
35.6 to 53.5 |
184 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
37.6 |
28.8 to 47.2 |
157 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
24.8 |
17.6 to 33.6 |
158 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
37.5 |
28.8 to 47.0 |
174 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
38.4 |
29.9 to 47.8 |
168 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
43.0 |
34.7 to 51.8 |
165 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
39.4 |
30.2 to 49.5 |
192 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
49.5 |
40.4 to 58.6 |
163 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
40.9 |
32.2 to 50.2 |
172 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
42.5 |
32.7 to 52.9 |
134 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
24.6 |
17.2 to 33.9 |
160 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
28.3 |
20.9 to 37.2 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
42.9 |
34.1 to 52.2 |
197 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
43.3 |
34.1 to 52.8 |
154 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
32.5 |
24.9 to 41.1 |
184 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
50.1 |
41.8 to 58.4 |
181 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
34.5 |
25.8 to 44.3 |
145 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
39.9 |
31.5 to 49.0 |
202 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
40.1 |
33.0 to 47.6 |
283 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
38.3 |
28.9 to 48.6 |
144 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
41.2 |
31.6 to 51.6 |
139 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
54.0 |
44.8 to 63.0 |
173 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
41.7 |
32.7 to 51.3 |
168 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
35.2 |
27.4 to 43.9 |
202 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
36.4 |
27.9 to 46.0 |
170 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
43.1 |
34.4 to 52.3 |
193 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
48.2 |
40.2 to 56.2 |
380 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
59.3 |
49.0 to 68.9 |
157 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
46.7 |
37.9 to 55.8 |
223 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
49.9 |
37.2 to 62.7 |
107 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
39.7 |
37.8 to 41.6 |
10084 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
49.0 |
44.1 to 54.0 |
1070 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
38.3 |
32.7 to 44.2 |
428 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
42.5 |
37.7 to 47.4 |
1222 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
36.5 |
32.7 to 40.4 |
1386 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
41.9 |
38.4 to 45.6 |
1206 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
34.2 |
29.6 to 39.0 |
1516 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
31.6 |
27.2 to 36.4 |
645 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
36.2 |
31.7 to 40.9 |
1153 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
45.0 |
37.4 to 52.8 |
730 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
53.7 |
45.2 to 62.0 |
194 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
35.9 |
27.4 to 45.5 |
193 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
33.1 |
25.0 to 42.4 |
177 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
20.1 |
14.2 to 27.6 |
154 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
33.9 |
27.7 to 40.7 |
793 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
30.8 |
23.0 to 39.9 |
179 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
43.8 |
34.4 to 53.6 |
197 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
45.6 |
35.0 to 56.6 |
189 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
32.8 |
25.6 to 40.9 |
228 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
42.3 |
36.8 to 48.1 |
728 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
26.0 |
19.4 to 33.8 |
199 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
49.8 |
40.7 to 58.9 |
182 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
35.9 |
26.8 to 46.1 |
166 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
43.8 |
34.8 to 53.3 |
179 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
40.0 |
31.4 to 49.3 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
40.9 |
31.5 to 51.0 |
165 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
33.6 |
26.4 to 41.6 |
223 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
40.8 |
32.0 to 50.3 |
165 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
36.9 |
29.0 to 45.6 |
165 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
44.2 |
36.1 to 52.6 |
215 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
34.0 |
26.2 to 42.9 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
48.4 |
38.6 to 58.3 |
174 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
46.0 |
37.5 to 54.7 |
180 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
55.2 |
46.1 to 64.0 |
155 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
52.8 |
43.7 to 61.7 |
161 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
58.8 |
49.4 to 67.6 |
199 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
36.8 |
28.1 to 46.5 |
161 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
32.3 |
24.6 to 41.2 |
172 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
37.0 |
29.5 to 45.1 |
192 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
52.4 |
43.6 to 61.0 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
30.3 |
22.8 to 39.0 |
177 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
40.2 |
34.4 to 46.4 |
401 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
47.7 |
38.4 to 57.3 |
147 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
38.6 |
31.9 to 45.8 |
254 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
30.9 |
23.5 to 39.5 |
167 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
49.8 |
41.3 to 58.3 |
190 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
31.7 |
24.3 to 40.2 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
36.2 |
28.2 to 45.1 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
39.3 |
30.9 to 48.4 |
163 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
44.1 |
35.8 to 52.8 |
186 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
43.7 |
34.7 to 53.2 |
203 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
52.8 |
43.1 to 62.3 |
158 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
47.2 |
38.2 to 56.4 |
168 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
44.5 |
35.9 to 53.4 |
179 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
24.4 |
18.4 to 31.6 |
205 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
31.5 |
22.7 to 41.9 |
141 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
34.8 |
27.2 to 43.1 |
192 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
48.2 |
39.8 to 56.8 |
184 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
42.5 |
33.7 to 51.8 |
176 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
51.4 |
41.5 to 61.3 |
137 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
45.0 |
36.4 to 53.9 |
178 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
40.6 |
33.3 to 48.3 |
214 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
47.3 |
40.7 to 53.9 |
298 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
46.1 |
37.0 to 55.4 |
142 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
48.0 |
39.1 to 57.0 |
156 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
37.8 |
29.6 to 46.7 |
172 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
47.1 |
38.1 to 56.2 |
159 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
37.8 |
28.9 to 47.6 |
146 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
32.2 |
23.8 to 41.9 |
129 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
48.9 |
40.1 to 57.9 |
168 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
47.8 |
40.2 to 55.5 |
397 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
58.6 |
49.9 to 66.8 |
175 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
46.4 |
37.9 to 55.1 |
222 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
42.0 |
32.9 to 51.6 |
158 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
41.9 |
40.1 to 43.7 |
10508 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
53.7 |
48.4 to 58.8 |
1026 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
46.5 |
41.3 to 51.8 |
476 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
44.2 |
39.3 to 49.1 |
1295 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
35.9 |
32.3 to 39.6 |
1375 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
41.0 |
37.5 to 44.6 |
1232 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
39.5 |
35.8 to 43.3 |
1962 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
37.9 |
33.0 to 43.1 |
691 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
36.8 |
32.2 to 41.6 |
1026 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
47.6 |
39.8 to 55.4 |
727 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
68.0 |
60.2 to 75.0 |
201 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
34.3 |
26.4 to 43.3 |
172 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
32.4 |
24.4 to 41.6 |
162 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
38.9 |
30.5 to 48.0 |
166 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
40.9 |
36.0 to 46.0 |
1294 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
32.8 |
25.1 to 41.5 |
198 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
42.8 |
32.5 to 53.8 |
116 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
52.2 |
44.8 to 59.5 |
276 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
41.0 |
34.9 to 47.4 |
453 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
16.4 |
11.3 to 23.2 |
222 |
| HPV |
>=3 Doses, Females |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
43.6 |
38.5 to 48.9 |
698 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
24.6 |
17.7 to 33.1 |
171 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
54.4 |
46.0 to 62.6 |
189 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
38.5 |
28.2 to 49.9 |
171 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
45.1 |
36.9 to 53.5 |
188 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
39.2 |
31.0 to 48.0 |
164 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
47.3 |
38.5 to 56.2 |
171 |
| HPV |
>=3 Doses, Females |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
26.5 |
18.7 to 36.0 |
162 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
United States |
2011 |
Age |
13-15 Years |
1.4 |
1.0 to 2.0 |
7505 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-15 Years |
2.4 |
1.4 to 4.3 |
1265 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
California |
2012 |
Age |
13-15 Years |
11.3 |
6.5 to 18.8 |
146 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Delaware |
2012 |
Age |
13-15 Years |
11.9 |
6.9 to 19.7 |
121 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
United States |
2012 |
Age |
13-15 Years |
6.9 |
5.8 to 8.3 |
6217 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-15 Years |
7.8 |
5.4 to 11.0 |
601 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-15 Years |
7.4 |
4.2 to 12.8 |
321 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-15 Years |
3.3 |
2.0 to 5.3 |
799 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-15 Years |
6.0 |
3.8 to 9.4 |
843 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-15 Years |
6.8 |
4.2 to 10.8 |
735 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-15 Years |
6.7 |
4.9 to 9.1 |
906 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-15 Years |
5.2 |
2.9 to 9.2 |
394 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-15 Years |
10.3 |
6.4 to 16.2 |
483 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-15 Years |
15.8 |
9.6 to 24.8 |
105 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Texas |
2012 |
Age |
13-15 Years |
5.3 |
3.4 to 8.2 |
487 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-15 Years |
4.8 |
2.8 to 8.2 |
256 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-15 Years |
4.1 |
2.3 to 7.0 |
489 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Arizona |
2013 |
Age |
13-15 Years |
12.7 |
7.1 to 21.8 |
104 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
California |
2013 |
Age |
13-15 Years |
19.7 |
11.4 to 32.0 |
110 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Connecticut |
2013 |
Age |
13-15 Years |
20.2 |
12.0 to 32.0 |
98 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Delaware |
2013 |
Age |
13-15 Years |
14.7 |
8.6 to 24.1 |
106 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Hawaii |
2013 |
Age |
13-15 Years |
13.5 |
7.3 to 23.4 |
107 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Illinois |
2013 |
Age |
13-15 Years |
15.3 |
9.2 to 24.4 |
177 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-15 Years |
21.4 |
11.9 to 35.4 |
66 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Iowa |
2013 |
Age |
13-15 Years |
14.4 |
8.8 to 22.6 |
135 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maine |
2013 |
Age |
13-15 Years |
12.4 |
7.2 to 20.5 |
108 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-15 Years |
22.2 |
14.3 to 32.7 |
131 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nebraska |
2013 |
Age |
13-15 Years |
20.6 |
13.0 to 31.0 |
93 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-15 Years |
17.3 |
10.0 to 28.3 |
96 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Mexico |
2013 |
Age |
13-15 Years |
19.7 |
12.7 to 29.2 |
120 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New York |
2013 |
Age |
13-15 Years |
17.5 |
11.7 to 25.2 |
194 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-15 Years |
26.8 |
16.8 to 39.8 |
83 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Carolina |
2013 |
Age |
13-15 Years |
15.0 |
8.2 to 25.7 |
105 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Dakota |
2013 |
Age |
13-15 Years |
26.3 |
16.9 to 38.6 |
106 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-15 Years |
20.4 |
14.0 to 28.8 |
161 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oregon |
2013 |
Age |
13-15 Years |
10.2 |
5.7 to 17.5 |
131 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-15 Years |
15.4 |
9.5 to 24.1 |
236 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-15 Years |
14.4 |
8.2 to 24.2 |
87 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-15 Years |
15.5 |
9.1 to 25.3 |
149 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
United States |
2013 |
Age |
13-15 Years |
13.5 |
11.8 to 15.5 |
5819 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-15 Years |
21.6 |
16.9 to 27.2 |
609 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-15 Years |
15.0 |
10.6 to 20.9 |
298 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-15 Years |
13.9 |
10.0 to 19.1 |
711 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-15 Years |
10.0 |
7.3 to 13.5 |
739 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-15 Years |
10.8 |
8.2 to 14.2 |
732 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-15 Years |
16.3 |
12.5 to 21.0 |
832 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-15 Years |
8.5 |
5.9 to 12.2 |
416 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-15 Years |
8.3 |
5.7 to 11.8 |
587 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-15 Years |
18.2 |
11.2 to 28.1 |
445 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-15 Years |
39.5 |
28.1 to 52.1 |
88 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Texas |
2013 |
Age |
13-15 Years |
17.0 |
11.8 to 23.7 |
371 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-15 Years |
12.2 |
6.6 to 21.2 |
95 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-15 Years |
18.9 |
11.4 to 29.8 |
90 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-15 Years |
17.2 |
11.4 to 25.0 |
186 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-15 Years |
11.0 |
7.5 to 16.0 |
450 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Vermont |
2013 |
Age |
13-15 Years |
23.4 |
14.3 to 36.0 |
88 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Washington |
2013 |
Age |
13-15 Years |
14.1 |
8.2 to 23.1 |
122 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
West Virginia |
2013 |
Age |
13-15 Years |
18.8 |
10.8 to 30.6 |
100 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Arizona |
2014 |
Age |
13-15 Years |
16.8 |
10.7 to 25.4 |
148 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Arkansas |
2014 |
Age |
13-15 Years |
12.4 |
6.8 to 21.5 |
110 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
California |
2014 |
Age |
13-15 Years |
29.5 |
19.7 to 41.7 |
122 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Colorado |
2014 |
Age |
13-15 Years |
23.7 |
15.4 to 34.6 |
119 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Connecticut |
2014 |
Age |
13-15 Years |
19.9 |
12.7 to 29.7 |
127 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Delaware |
2014 |
Age |
13-15 Years |
26.3 |
16.3 to 39.7 |
126 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-15 Years |
37.6 |
23.9 to 53.6 |
86 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Florida |
2014 |
Age |
13-15 Years |
21.5 |
11.8 to 35.8 |
111 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Georgia |
2014 |
Age |
13-15 Years |
18.1 |
11.3 to 27.9 |
113 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Hawaii |
2014 |
Age |
13-15 Years |
28.4 |
19.3 to 39.6 |
117 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Idaho |
2014 |
Age |
13-15 Years |
20.1 |
12.3 to 30.9 |
118 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Illinois |
2014 |
Age |
13-15 Years |
21.6 |
15.4 to 29.5 |
239 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-15 Years |
23.3 |
13.8 to 36.5 |
87 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-15 Years |
21.3 |
14.1 to 30.7 |
152 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Indiana |
2014 |
Age |
13-15 Years |
13.7 |
8.5 to 21.2 |
115 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Iowa |
2014 |
Age |
13-15 Years |
20.0 |
12.1 to 31.2 |
96 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Kansas |
2014 |
Age |
13-15 Years |
18.5 |
11.0 to 29.3 |
126 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Louisiana |
2014 |
Age |
13-15 Years |
20.0 |
12.3 to 30.9 |
99 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maine |
2014 |
Age |
13-15 Years |
25.3 |
17.0 to 35.9 |
107 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maryland |
2014 |
Age |
13-15 Years |
20.8 |
12.5 to 32.6 |
135 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-15 Years |
23.2 |
15.0 to 34.2 |
125 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Michigan |
2014 |
Age |
13-15 Years |
20.5 |
11.9 to 33.1 |
90 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Montana |
2014 |
Age |
13-15 Years |
15.9 |
9.0 to 26.6 |
109 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nebraska |
2014 |
Age |
13-15 Years |
23.0 |
14.5 to 34.4 |
101 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nevada |
2014 |
Age |
13-15 Years |
19.1 |
12.2 to 28.7 |
107 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-15 Years |
23.2 |
15.9 to 32.5 |
130 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Jersey |
2014 |
Age |
13-15 Years |
22.6 |
13.5 to 35.4 |
116 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Mexico |
2014 |
Age |
13-15 Years |
26.7 |
16.8 to 39.6 |
102 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New York |
2014 |
Age |
13-15 Years |
24.0 |
17.1 to 32.5 |
169 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-15 Years |
31.3 |
19.0 to 46.8 |
73 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-15 Years |
20.2 |
12.7 to 30.5 |
96 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Carolina |
2014 |
Age |
13-15 Years |
20.0 |
12.2 to 30.9 |
131 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Dakota |
2014 |
Age |
13-15 Years |
18.1 |
11.1 to 28.0 |
95 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Ohio |
2014 |
Age |
13-15 Years |
21.1 |
13.3 to 31.9 |
142 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-15 Years |
20.8 |
12.8 to 32.1 |
108 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oregon |
2014 |
Age |
13-15 Years |
13.0 |
8.0 to 20.5 |
133 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-15 Years |
20.1 |
13.2 to 29.4 |
234 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-15 Years |
28.9 |
18.9 to 41.6 |
101 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-15 Years |
19.1 |
11.7 to 29.6 |
133 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-15 Years |
28.6 |
15.9 to 45.9 |
68 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
United States |
2014 |
Age |
13-15 Years |
20.6 |
18.6 to 22.8 |
6583 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-15 Years |
23.8 |
19.1 to 29.4 |
730 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-15 Years |
23.5 |
17.7 to 30.4 |
285 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-15 Years |
20.9 |
16.2 to 26.5 |
817 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-15 Years |
16.3 |
12.5 to 20.8 |
920 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-15 Years |
19.9 |
16.4 to 23.9 |
788 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-15 Years |
18.1 |
13.9 to 23.3 |
945 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-15 Years |
16.0 |
12.1 to 20.9 |
436 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-15 Years |
19.4 |
14.9 to 24.9 |
704 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-15 Years |
27.3 |
19.3 to 37.0 |
494 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-15 Years |
38.0 |
28.5 to 48.6 |
128 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
South Dakota |
2014 |
Age |
13-15 Years |
26.8 |
16.9 to 39.7 |
114 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Texas |
2014 |
Age |
13-15 Years |
17.5 |
12.0 to 25.0 |
526 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-15 Years |
16.5 |
9.5 to 27.3 |
130 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-15 Years |
27.7 |
17.8 to 40.5 |
115 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-15 Years |
32.9 |
21.0 to 47.4 |
120 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-15 Years |
16.1 |
9.8 to 25.2 |
161 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-15 Years |
21.4 |
16.0 to 28.2 |
464 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Utah |
2014 |
Age |
13-15 Years |
14.4 |
8.5 to 23.4 |
121 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Vermont |
2014 |
Age |
13-15 Years |
30.9 |
21.4 to 42.2 |
113 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Virginia |
2014 |
Age |
13-15 Years |
20.5 |
11.1 to 34.8 |
111 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Washington |
2014 |
Age |
13-15 Years |
27.6 |
18.0 to 39.7 |
109 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
West Virginia |
2014 |
Age |
13-15 Years |
21.9 |
14.3 to 32.0 |
125 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-15 Years |
24.9 |
15.9 to 36.8 |
114 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Alabama |
2015 |
Age |
13-15 Years |
20.3 |
12.8 to 30.5 |
126 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Alaska |
2015 |
Age |
13-15 Years |
14.3 |
8.5 to 23.0 |
108 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Arizona |
2015 |
Age |
13-15 Years |
29.3 |
20.6 to 39.7 |
144 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Arkansas |
2015 |
Age |
13-15 Years |
14.6 |
9.0 to 22.7 |
118 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
California |
2015 |
Age |
13-15 Years |
29.1 |
19.3 to 41.2 |
122 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Colorado |
2015 |
Age |
13-15 Years |
30.6 |
21.1 to 42.1 |
108 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Connecticut |
2015 |
Age |
13-15 Years |
38.9 |
28.8 to 50.0 |
112 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Delaware |
2015 |
Age |
13-15 Years |
43.5 |
34.1 to 53.4 |
129 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-15 Years |
32.6 |
22.9 to 44.2 |
135 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Florida |
2015 |
Age |
13-15 Years |
23.6 |
15.3 to 34.4 |
99 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Georgia |
2015 |
Age |
13-15 Years |
29.7 |
20.6 to 40.7 |
122 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Guam |
2015 |
Age |
13-15 Years |
25.7 |
18.0 to 35.2 |
129 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Hawaii |
2015 |
Age |
13-15 Years |
29.3 |
20.7 to 39.7 |
107 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Idaho |
2015 |
Age |
13-15 Years |
27.8 |
18.9 to 38.8 |
113 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Illinois |
2015 |
Age |
13-15 Years |
23.3 |
17.6 to 30.1 |
240 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-15 Years |
37.5 |
27.0 to 49.4 |
91 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-15 Years |
20.0 |
13.8 to 28.1 |
149 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Indiana |
2015 |
Age |
13-15 Years |
24.5 |
16.0 to 35.6 |
95 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Iowa |
2015 |
Age |
13-15 Years |
20.8 |
13.6 to 30.3 |
131 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Kansas |
2015 |
Age |
13-15 Years |
14.6 |
9.1 to 22.8 |
129 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Kentucky |
2015 |
Age |
13-15 Years |
19.6 |
12.8 to 28.7 |
106 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Louisiana |
2015 |
Age |
13-15 Years |
34.9 |
25.9 to 45.2 |
134 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maine |
2015 |
Age |
13-15 Years |
40.3 |
30.1 to 51.5 |
108 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maryland |
2015 |
Age |
13-15 Years |
24.0 |
15.5 to 35.2 |
134 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-15 Years |
30.8 |
22.2 to 41.0 |
117 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Michigan |
2015 |
Age |
13-15 Years |
25.9 |
18.2 to 35.6 |
132 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Minnesota |
2015 |
Age |
13-15 Years |
23.5 |
16.4 to 32.4 |
132 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Mississippi |
2015 |
Age |
13-15 Years |
20.5 |
12.6 to 31.6 |
105 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Missouri |
2015 |
Age |
13-15 Years |
19.0 |
11.2 to 30.4 |
108 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Montana |
2015 |
Age |
13-15 Years |
24.1 |
16.5 to 33.9 |
130 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nebraska |
2015 |
Age |
13-15 Years |
33.3 |
24.7 to 43.1 |
134 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nevada |
2015 |
Age |
13-15 Years |
22.9 |
15.6 to 32.4 |
124 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-15 Years |
42.4 |
31.4 to 54.2 |
96 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Jersey |
2015 |
Age |
13-15 Years |
22.9 |
14.5 to 34.1 |
102 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Mexico |
2015 |
Age |
13-15 Years |
40.4 |
30.4 to 51.3 |
108 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New York |
2015 |
Age |
13-15 Years |
40.9 |
33.6 to 48.7 |
221 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-15 Years |
54.9 |
43.6 to 65.7 |
101 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-15 Years |
32.5 |
23.7 to 42.8 |
120 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Carolina |
2015 |
Age |
13-15 Years |
29.8 |
20.8 to 40.6 |
124 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Dakota |
2015 |
Age |
13-15 Years |
45.5 |
34.2 to 57.2 |
96 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Ohio |
2015 |
Age |
13-15 Years |
16.1 |
10.1 to 24.8 |
112 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-15 Years |
34.6 |
24.4 to 46.5 |
104 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oregon |
2015 |
Age |
13-15 Years |
37.3 |
26.9 to 49.1 |
109 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-15 Years |
35.9 |
27.4 to 45.5 |
260 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-15 Years |
36.2 |
25.3 to 48.8 |
96 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-15 Years |
35.9 |
26.4 to 46.5 |
164 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-15 Years |
30.3 |
20.8 to 41.8 |
119 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
United States |
2015 |
Age |
13-15 Years |
27.1 |
25.1 to 29.2 |
7093 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-15 Years |
36.3 |
30.9 to 42.0 |
700 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-15 Years |
35.1 |
29.3 to 41.4 |
323 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-15 Years |
29.8 |
24.5 to 35.7 |
910 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-15 Years |
23.4 |
19.8 to 27.5 |
902 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-15 Years |
23.6 |
20.3 to 27.1 |
838 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-15 Years |
26.5 |
22.8 to 30.4 |
1306 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-15 Years |
20.3 |
15.9 to 25.6 |
502 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-15 Years |
25.9 |
20.7 to 32.0 |
669 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-15 Years |
28.8 |
20.7 to 38.5 |
497 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-15 Years |
50.7 |
41.2 to 60.2 |
131 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
South Carolina |
2015 |
Age |
13-15 Years |
25.4 |
16.8 to 36.4 |
122 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
South Dakota |
2015 |
Age |
13-15 Years |
22.5 |
14.7 to 32.9 |
120 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Texas |
2015 |
Age |
13-15 Years |
24.3 |
19.7 to 29.5 |
842 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-15 Years |
23.1 |
14.5 to 34.6 |
111 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-15 Years |
16.3 |
9.8 to 26.0 |
88 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-15 Years |
32.4 |
24.3 to 41.7 |
168 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-15 Years |
24.1 |
18.6 to 30.5 |
324 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-15 Years |
13.0 |
8.2 to 20.1 |
154 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-15 Years |
31.1 |
25.3 to 37.5 |
446 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Utah |
2015 |
Age |
13-15 Years |
18.7 |
10.9 to 30.3 |
113 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Vermont |
2015 |
Age |
13-15 Years |
37.9 |
29.0 to 47.8 |
136 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Virginia |
2015 |
Age |
13-15 Years |
25.0 |
14.5 to 39.5 |
139 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Washington |
2015 |
Age |
13-15 Years |
30.1 |
21.3 to 40.7 |
116 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
West Virginia |
2015 |
Age |
13-15 Years |
23.7 |
15.3 to 34.7 |
113 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-15 Years |
33.3 |
24.3 to 43.7 |
127 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Wyoming |
2015 |
Age |
13-15 Years |
16.9 |
10.0 to 27.1 |
102 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
1.3 |
1.0 to 1.7 |
12328 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
0.8 |
0.5 to 1.4 |
1666 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
2.2 |
1.4 to 3.4 |
2031 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
2.4 |
1.4 to 4.2 |
1167 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
11.7 |
7.4 to 17.9 |
228 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
8.5 |
4.9 to 14.4 |
182 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
10.7 |
6.7 to 16.7 |
184 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
4.8 |
2.8 to 8.1 |
184 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
15.6 |
9.4 to 24.7 |
190 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
17.0 |
9.6 to 28.3 |
144 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
12.1 |
7.2 to 19.8 |
157 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
7.0 |
4.0 to 11.8 |
182 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
8.6 |
4.7 to 15.1 |
184 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
10.6 |
6.3 to 17.3 |
155 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
5.3 |
3.1 to 9.0 |
404 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
6.8 |
5.9 to 7.8 |
10141 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
8.2 |
6.2 to 11.0 |
1016 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
5.9 |
3.6 to 9.4 |
509 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
4.6 |
3.2 to 6.4 |
1276 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
6.1 |
4.4 to 8.4 |
1382 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
5.5 |
3.7 to 8.0 |
1208 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
7.1 |
5.5 to 9.3 |
1473 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
5.3 |
3.4 to 8.1 |
681 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
10.6 |
7.2 to 15.5 |
770 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
17.7 |
12.3 to 25.0 |
174 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
7.0 |
4.9 to 9.9 |
796 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
15.1 |
8.8 to 24.8 |
204 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
6.5 |
4.2 to 9.8 |
422 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
4.9 |
2.8 to 8.5 |
798 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
10.6 |
6.1 to 17.6 |
164 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
8.5 |
4.8 to 14.6 |
162 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
19.5 |
13.5 to 27.4 |
188 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
16.6 |
10.1 to 26.2 |
161 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
9.9 |
6.0 to 15.7 |
168 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
23.4 |
16.5 to 32.2 |
171 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
18.1 |
12.3 to 26.0 |
165 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
24.5 |
13.8 to 39.6 |
108 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
13.2 |
8.1 to 20.6 |
166 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
15.3 |
8.7 to 25.4 |
121 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
15.1 |
10.0 to 22.1 |
174 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
16.5 |
11.1 to 23.9 |
290 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
19.8 |
12.7 to 29.6 |
115 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
15.8 |
9.6 to 24.9 |
175 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
8.1 |
4.8 to 13.5 |
187 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
13.7 |
9.1 to 20.1 |
200 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
13.5 |
8.1 to 21.5 |
160 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
17.6 |
12.4 to 24.4 |
181 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
21.8 |
15.6 to 29.6 |
210 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
7.7 |
4.3 to 13.6 |
176 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
8.6 |
5.1 to 14.3 |
202 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
9.4 |
5.6 to 15.1 |
171 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
19.7 |
13.4 to 27.9 |
160 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
7.3 |
4.2 to 12.3 |
185 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
17.8 |
12.0 to 25.4 |
177 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
14.2 |
8.5 to 22.7 |
165 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
19.2 |
13.5 to 26.6 |
191 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
19.1 |
14.5 to 24.7 |
366 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
29.6 |
21.4 to 39.3 |
146 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
12.5 |
7.7 to 19.7 |
220 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
12.4 |
7.4 to 20.2 |
157 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
18.4 |
12.1 to 27.1 |
176 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
14.7 |
9.4 to 22.4 |
163 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
17.3 |
12.3 to 23.7 |
242 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
12.2 |
8.0 to 18.2 |
200 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
15.4 |
10.6 to 21.8 |
372 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
15.8 |
10.6 to 23.0 |
148 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
15.4 |
10.1 to 22.6 |
224 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
13.9 |
12.5 to 15.3 |
9554 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
23.0 |
19.3 to 27.1 |
1072 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
17.5 |
13.7 to 22.0 |
531 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
14.6 |
11.2 to 18.7 |
1140 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
11.1 |
8.8 to 14.1 |
1209 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
12.2 |
9.9 to 15.0 |
1188 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
14.5 |
11.5 to 18.1 |
1346 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
9.4 |
7.1 to 12.4 |
659 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
8.6 |
6.4 to 11.4 |
994 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
16.4 |
11.0 to 23.8 |
708 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
43.2 |
34.5 to 52.3 |
168 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
8.4 |
5.0 to 13.6 |
151 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
15.0 |
11.0 to 20.3 |
598 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
9.6 |
5.8 to 15.4 |
162 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
17.5 |
11.6 to 25.6 |
159 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
15.2 |
10.6 to 21.3 |
277 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
11.6 |
8.8 to 15.2 |
707 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
21.7 |
15.0 to 30.4 |
165 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
12.5 |
8.1 to 18.6 |
197 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
15.1 |
9.7 to 22.9 |
176 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
13.7 |
8.2 to 21.8 |
170 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
8.4 |
4.9 to 14.1 |
178 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
9.0 |
5.2 to 15.0 |
206 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
13.3 |
8.2 to 20.9 |
177 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
16.7 |
11.7 to 23.3 |
227 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
11.4 |
6.9 to 18.4 |
185 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
31.1 |
22.9 to 40.6 |
190 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
21.9 |
15.7 to 29.7 |
205 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
27.0 |
19.9 to 35.5 |
201 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
31.0 |
22.2 to 41.5 |
194 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
34.5 |
24.4 to 46.1 |
143 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
17.5 |
10.8 to 27.0 |
190 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
21.0 |
14.7 to 29.1 |
186 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
30.9 |
23.1 to 39.9 |
177 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
17.2 |
11.3 to 25.2 |
185 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
22.6 |
17.5 to 28.8 |
360 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
26.1 |
18.0 to 36.4 |
133 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
21.8 |
15.9 to 29.2 |
227 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
12.8 |
8.5 to 18.8 |
186 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
18.7 |
12.5 to 27.2 |
171 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
19.5 |
13.2 to 27.9 |
194 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
13.3 |
7.9 to 21.3 |
161 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
21.5 |
14.9 to 30.1 |
167 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
27.5 |
20.6 to 35.7 |
176 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
24.5 |
16.9 to 34.0 |
217 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
27.3 |
20.3 to 35.6 |
195 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
22.1 |
15.0 to 31.4 |
158 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
13.6 |
8.0 to 22.1 |
152 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
11.3 |
6.7 to 18.4 |
185 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
13.0 |
7.8 to 20.8 |
170 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
22.8 |
15.9 to 31.5 |
167 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
15.7 |
10.6 to 22.7 |
167 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
33.0 |
25.9 to 41.0 |
221 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
21.2 |
14.0 to 30.8 |
183 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
23.3 |
16.1 to 32.4 |
176 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
28.5 |
22.7 to 35.2 |
311 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
35.0 |
25.8 to 45.5 |
144 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
24.4 |
17.3 to 33.4 |
167 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
20.9 |
14.5 to 29.1 |
199 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
25.3 |
18.3 to 33.9 |
159 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
23.3 |
16.8 to 31.4 |
228 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
19.9 |
13.8 to 27.9 |
186 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
12.3 |
8.2 to 18.0 |
206 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
26.0 |
19.9 to 33.2 |
405 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
34.8 |
26.5 to 44.1 |
186 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
24.9 |
18.2 to 33.0 |
219 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
23.7 |
14.5 to 36.1 |
123 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
21.6 |
20.0 to 23.3 |
10743 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
29.0 |
25.0 to 33.3 |
1198 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
26.1 |
21.4 to 31.5 |
494 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
24.8 |
20.8 to 29.3 |
1331 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
16.7 |
13.9 to 20.0 |
1510 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
20.6 |
17.8 to 23.7 |
1259 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
18.2 |
14.7 to 22.2 |
1573 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
16.3 |
13.0 to 20.1 |
717 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
18.1 |
14.7 to 22.1 |
1137 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
28.2 |
21.7 to 35.8 |
761 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
42.9 |
35.2 to 51.0 |
220 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
16.1 |
10.4 to 24.1 |
187 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
23.5 |
16.1 to 32.9 |
181 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
14.0 |
8.6 to 21.9 |
185 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
17.7 |
13.1 to 23.6 |
859 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
15.0 |
9.5 to 23.0 |
206 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
27.1 |
19.1 to 36.9 |
182 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
31.8 |
23.0 to 42.1 |
208 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
16.5 |
11.2 to 23.6 |
263 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
19.5 |
15.3 to 24.3 |
763 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
12.4 |
7.9 to 19.0 |
199 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
30.5 |
22.7 to 39.5 |
185 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
22.5 |
14.5 to 33.1 |
184 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
24.6 |
17.6 to 33.3 |
195 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
23.5 |
16.7 to 32.0 |
188 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
23.6 |
16.4 to 32.7 |
175 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
12.2 |
7.6 to 18.9 |
223 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
22.6 |
15.7 to 31.4 |
196 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
18.8 |
13.2 to 26.1 |
185 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
27.0 |
20.3 to 34.9 |
229 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
16.4 |
11.4 to 23.0 |
200 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
29.5 |
21.3 to 39.2 |
176 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
37.1 |
28.8 to 46.2 |
174 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
42.0 |
34.0 to 50.4 |
203 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
43.0 |
35.2 to 51.1 |
199 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
40.9 |
32.6 to 49.8 |
219 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
19.8 |
13.7 to 27.6 |
160 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
27.5 |
20.6 to 35.6 |
202 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
22.4 |
16.7 to 29.4 |
227 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
36.2 |
28.6 to 44.6 |
178 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
26.4 |
19.3 to 35.0 |
179 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
26.8 |
21.6 to 32.8 |
378 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
41.6 |
32.3 to 51.5 |
136 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
23.6 |
17.7 to 30.6 |
242 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
27.5 |
20.1 to 36.3 |
161 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
23.9 |
17.5 to 31.9 |
193 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
18.5 |
12.7 to 26.1 |
199 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
17.1 |
11.9 to 24.1 |
168 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
30.5 |
23.6 to 38.4 |
219 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
46.7 |
38.4 to 55.1 |
188 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
31.3 |
23.1 to 40.8 |
200 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
35.2 |
27.2 to 44.1 |
180 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
28.6 |
22.0 to 36.3 |
205 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
22.4 |
16.6 to 29.7 |
187 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
21.4 |
14.5 to 30.4 |
159 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
25.1 |
17.1 to 35.1 |
159 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
21.7 |
15.7 to 29.3 |
214 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
32.2 |
25.4 to 39.8 |
209 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
23.7 |
17.2 to 31.6 |
196 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
47.1 |
38.2 to 56.2 |
158 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
30.9 |
23.3 to 39.7 |
186 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
40.3 |
32.4 to 48.7 |
182 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
38.1 |
32.5 to 44.0 |
367 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
47.9 |
39.4 to 56.5 |
171 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
31.7 |
24.7 to 39.7 |
196 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
29.8 |
22.5 to 38.3 |
186 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
38.4 |
30.3 to 47.3 |
164 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
21.0 |
15.1 to 28.4 |
186 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
35.7 |
27.4 to 45.1 |
162 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
35.7 |
27.7 to 44.6 |
185 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
38.3 |
31.7 to 45.5 |
435 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
43.4 |
34.6 to 52.6 |
165 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
37.7 |
30.2 to 45.7 |
270 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
30.8 |
22.9 to 40.1 |
181 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
28.1 |
26.6 to 29.7 |
11367 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
40.8 |
36.3 to 45.5 |
1162 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
35.7 |
31.1 to 40.6 |
553 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
32.9 |
28.7 to 37.4 |
1447 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
22.5 |
19.7 to 25.7 |
1418 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
26.2 |
23.4 to 29.2 |
1311 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
26.0 |
23.2 to 29.1 |
2086 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
24.4 |
20.1 to 29.2 |
760 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
28.7 |
24.3 to 33.6 |
1094 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
29.0 |
22.4 to 36.5 |
779 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
58.1 |
50.6 to 65.3 |
218 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
21.0 |
14.5 to 29.5 |
188 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
22.0 |
15.7 to 30.0 |
187 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
16.0 |
10.4 to 23.8 |
159 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
24.0 |
20.4 to 28.1 |
1323 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
19.9 |
13.6 to 28.1 |
170 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
22.7 |
15.7 to 31.7 |
143 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
34.4 |
28.1 to 41.3 |
282 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
23.5 |
19.1 to 28.6 |
493 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
11.8 |
7.9 to 17.3 |
236 |
| HPV |
>=3 Doses, Males |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
29.5 |
25.1 to 34.2 |
757 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
19.9 |
13.4 to 28.6 |
186 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
41.1 |
33.6 to 49.0 |
215 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
25.7 |
17.5 to 35.9 |
214 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
28.0 |
21.5 to 35.6 |
208 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
27.1 |
20.2 to 35.3 |
180 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
33.5 |
26.2 to 41.7 |
194 |
| HPV |
>=3 Doses, Males |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
18.8 |
12.8 to 26.7 |
169 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
15.4 |
11.4 to 20.6 |
403 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
20.3 |
15.1 to 26.6 |
330 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
19.5 |
14.5 to 25.8 |
416 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
7.8 |
4.6 to 12.8 |
350 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
21.6 |
17.7 to 26.2 |
583 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
13.9 |
10.1 to 18.8 |
431 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
22.2 |
17.6 to 27.5 |
453 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
24.1 |
19.3 to 29.8 |
442 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
18.2 |
14.1 to 23.3 |
415 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
17.4 |
13.2 to 22.6 |
483 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
15.5 |
11.4 to 20.6 |
425 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
24.9 |
19.6 to 31.0 |
339 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
15.3 |
10.6 to 21.5 |
385 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
17.3 |
13.2 to 22.4 |
848 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
14.0 |
9.8 to 19.7 |
407 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
18.1 |
13.2 to 24.3 |
441 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
14.1 |
10.4 to 18.9 |
430 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
20.4 |
15.1 to 26.9 |
359 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
11.0 |
8.1 to 14.8 |
399 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
15.3 |
11.3 to 20.4 |
382 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
18.8 |
14.7 to 23.9 |
473 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
21.6 |
17.1 to 26.8 |
411 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
15.3 |
11.9 to 19.5 |
516 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
23.7 |
18.6 to 29.6 |
365 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
15.5 |
11.6 to 20.6 |
398 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
17.6 |
13.2 to 23.0 |
327 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
9.8 |
5.9 to 15.9 |
345 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
15.1 |
10.9 to 20.6 |
402 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
19.7 |
13.5 to 27.7 |
385 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
16.6 |
12.6 to 21.5 |
368 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
15.6 |
10.9 to 21.8 |
412 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
23.2 |
18.7 to 28.3 |
385 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
19.4 |
15.1 to 24.7 |
432 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
15.7 |
11.9 to 20.4 |
431 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
17.4 |
14.6 to 20.5 |
840 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
19.9 |
16.0 to 24.6 |
435 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
15.8 |
12.2 to 20.2 |
405 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
16.2 |
11.6 to 22.2 |
347 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
14.5 |
9.9 to 20.8 |
314 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
16.2 |
12.1 to 21.3 |
381 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
14.5 |
10.5 to 19.8 |
360 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
20.1 |
14.9 to 26.4 |
362 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
21.1 |
17.1 to 25.8 |
880 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
25.0 |
20.1 to 30.7 |
387 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
20.6 |
16.2 to 25.9 |
493 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
17.6 |
16.8 to 18.6 |
23564 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
23.5 |
20.7 to 26.5 |
2467 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
18.0 |
15.6 to 20.7 |
1272 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
18.1 |
15.9 to 20.6 |
3073 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
15.4 |
13.5 to 17.4 |
3171 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
17.1 |
15.2 to 19.2 |
2800 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
16.0 |
13.6 to 18.7 |
3838 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
15.6 |
13.1 to 18.4 |
1528 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
14.4 |
12.2 to 17.0 |
2242 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
21.1 |
17.8 to 24.8 |
1750 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
29.1 |
23.9 to 34.9 |
449 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
11.8 |
8.1 to 17.1 |
362 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
25.2 |
17.8 to 34.4 |
355 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
13.5 |
9.7 to 18.7 |
424 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
16.6 |
13.3 to 20.6 |
2224 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
16.9 |
12.7 to 22.1 |
448 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
14.8 |
11.1 to 19.6 |
490 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
12.5 |
8.7 to 17.5 |
441 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
25.4 |
20.1 to 31.6 |
355 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
16.8 |
12.5 to 22.3 |
490 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
19.3 |
16.3 to 22.7 |
1423 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
10.0 |
7.0 to 14.0 |
393 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
24.6 |
19.5 to 30.6 |
404 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
15.6 |
11.4 to 21.0 |
417 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
19.8 |
15.3 to 25.3 |
346 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
14.8 |
11.0 to 19.7 |
403 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
24.2 |
18.9 to 30.4 |
416 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
20.8 |
15.2 to 27.9 |
364 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
18.6 |
13.3 to 25.3 |
317 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
17.0 |
12.8 to 22.4 |
340 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
21.2 |
16.2 to 27.2 |
360 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
10.8 |
7.4 to 15.5 |
322 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
23.5 |
18.8 to 28.9 |
430 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
25.7 |
18.6 to 34.4 |
311 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
25.6 |
19.8 to 32.5 |
323 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
30.1 |
24.3 to 36.6 |
341 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
21.6 |
16.6 to 27.6 |
342 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
16.3 |
11.8 to 22.2 |
325 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
16.5 |
12.2 to 22.1 |
328 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
29.2 |
23.3 to 35.8 |
342 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
15.9 |
11.6 to 21.5 |
357 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
15.5 |
11.5 to 20.5 |
632 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
27.4 |
20.8 to 35.1 |
287 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
12.6 |
8.2 to 18.9 |
345 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
19.7 |
15.0 to 25.5 |
341 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
21.8 |
16.7 to 27.9 |
325 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
14.5 |
9.9 to 20.8 |
340 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
18.0 |
13.1 to 24.0 |
333 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
23.7 |
18.5 to 29.8 |
370 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
26.6 |
21.1 to 33.0 |
319 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
18.4 |
13.8 to 24.0 |
325 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
24.4 |
19.3 to 30.3 |
347 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
17.6 |
12.9 to 23.6 |
368 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
18.1 |
13.1 to 24.4 |
322 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
7.3 |
4.6 to 11.3 |
321 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
18.6 |
13.6 to 24.7 |
292 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
22.3 |
16.9 to 28.9 |
325 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
21.7 |
16.8 to 27.6 |
328 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
20.5 |
15.1 to 27.1 |
329 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
18.7 |
14.0 to 24.6 |
278 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
19.0 |
14.5 to 24.4 |
330 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
18.2 |
13.6 to 23.9 |
331 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
22.2 |
18.1 to 26.9 |
627 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
23.2 |
17.8 to 29.8 |
312 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
21.5 |
16.1 to 28.2 |
315 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
21.7 |
16.6 to 27.9 |
347 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
22.6 |
17.5 to 28.6 |
324 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
16.7 |
11.6 to 23.5 |
327 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
24.2 |
18.9 to 30.4 |
322 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
20.8 |
16.0 to 26.5 |
381 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
24.4 |
19.8 to 29.7 |
741 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
30.7 |
24.4 to 37.8 |
348 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
23.6 |
18.5 to 29.6 |
393 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
19.8 |
18.8 to 20.9 |
19199 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
25.4 |
22.4 to 28.6 |
1916 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
21.1 |
18.0 to 24.7 |
957 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
20.3 |
17.7 to 23.2 |
2365 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
17.0 |
15.0 to 19.3 |
2612 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
17.7 |
15.5 to 20.1 |
2297 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
19.0 |
16.8 to 21.3 |
2939 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
18.8 |
16.0 to 22.0 |
1285 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
20.7 |
17.1 to 25.0 |
1936 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
23.1 |
19.3 to 27.4 |
1461 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
37.2 |
31.2 to 43.7 |
327 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
16.1 |
11.5 to 22.2 |
310 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
18.3 |
13.5 to 24.3 |
298 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
16.2 |
11.7 to 22.1 |
331 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
18.4 |
15.5 to 21.6 |
1594 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
15.5 |
10.8 to 21.7 |
346 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
25.8 |
20.0 to 32.6 |
393 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
18.0 |
14.7 to 21.7 |
855 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
21.6 |
18.4 to 25.2 |
1431 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
14.0 |
9.8 to 19.5 |
345 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
28.0 |
22.3 to 34.5 |
322 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
14.5 |
10.3 to 20.0 |
334 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
24.1 |
18.9 to 30.3 |
353 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
19.4 |
14.3 to 25.8 |
282 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
21.7 |
16.2 to 28.5 |
307 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
16.0 |
11.9 to 21.1 |
333 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
22.7 |
17.8 to 28.5 |
317 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
17.5 |
13.2 to 22.9 |
320 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
28.3 |
22.8 to 34.4 |
359 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
14.3 |
10.4 to 19.4 |
312 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
30.8 |
24.6 to 37.9 |
309 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
24.2 |
19.3 to 29.8 |
331 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
31.6 |
25.8 to 38.0 |
328 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
34.6 |
28.8 to 40.9 |
348 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
27.4 |
19.4 to 37.0 |
192 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
23.5 |
18.0 to 30.0 |
323 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
24.0 |
18.3 to 30.9 |
253 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
18.8 |
14.5 to 23.9 |
363 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
24.5 |
19.2 to 30.6 |
315 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
19.7 |
14.6 to 26.0 |
272 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
25.0 |
20.4 to 30.1 |
558 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
21.1 |
16.9 to 26.1 |
381 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
27.4 |
22.3 to 33.2 |
383 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
14.4 |
10.0 to 20.2 |
287 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
16.6 |
12.3 to 22.0 |
291 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
27.5 |
21.6 to 34.2 |
298 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
31.3 |
26.0 to 37.2 |
343 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
21.6 |
16.0 to 28.6 |
320 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
30.3 |
25.1 to 36.1 |
393 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
20.8 |
15.9 to 26.8 |
307 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
22.7 |
17.9 to 28.4 |
369 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
14.6 |
10.4 to 20.2 |
284 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
16.5 |
12.0 to 22.1 |
280 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
18.5 |
14.3 to 23.6 |
320 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
30.3 |
24.8 to 36.5 |
301 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
17.1 |
12.9 to 22.4 |
335 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
30.1 |
24.8 to 35.9 |
345 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
22.6 |
17.2 to 29.0 |
322 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
31.5 |
26.0 to 37.7 |
357 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
32.0 |
27.8 to 36.4 |
710 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
22.4 |
17.2 to 28.6 |
306 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
29.5 |
23.9 to 35.8 |
344 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
24.6 |
19.5 to 30.6 |
319 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
26.1 |
21.3 to 31.5 |
426 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
25.5 |
20.6 to 31.2 |
364 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
30.2 |
25.4 to 35.6 |
751 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
25.5 |
24.2 to 26.7 |
18264 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
32.1 |
29.1 to 35.3 |
2050 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
28.9 |
25.5 to 32.5 |
1032 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
25.9 |
22.9 to 29.3 |
2241 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
22.3 |
19.9 to 24.8 |
2374 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
23.4 |
21.2 to 25.7 |
2264 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
26.1 |
23.0 to 29.4 |
2505 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
20.2 |
17.6 to 23.2 |
1251 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
20.5 |
17.9 to 23.4 |
1913 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
29.6 |
24.5 to 35.2 |
1318 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
49.7 |
43.2 to 56.2 |
315 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
23.3 |
17.4 to 30.4 |
296 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
24.9 |
19.6 to 31.0 |
292 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
22.4 |
17.3 to 28.5 |
304 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
26.7 |
22.4 to 31.4 |
1112 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
7.0 |
4.5 to 10.7 |
332 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
25.8 |
22.4 to 29.5 |
1316 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
12.4 |
8.7 to 17.5 |
301 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
31.9 |
26.2 to 38.3 |
326 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
21.4 |
15.2 to 29.2 |
302 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
28.4 |
22.8 to 34.8 |
360 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
26.5 |
21.3 to 32.5 |
328 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
25.0 |
19.7 to 31.1 |
330 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
24.7 |
19.6 to 30.6 |
325 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
21.9 |
17.2 to 27.4 |
378 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
23.6 |
18.7 to 29.2 |
377 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
26.1 |
21.1 to 31.7 |
421 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
17.3 |
13.1 to 22.5 |
368 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
39.2 |
32.8 to 46.0 |
356 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
31.8 |
26.4 to 37.7 |
394 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
37.5 |
31.4 to 43.9 |
386 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
36.6 |
30.0 to 43.6 |
374 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
45.6 |
38.0 to 53.5 |
285 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
22.9 |
17.4 to 29.5 |
363 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
33.8 |
27.7 to 40.4 |
373 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
34.4 |
28.7 to 40.6 |
363 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
27.4 |
21.8 to 34.0 |
341 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
34.9 |
30.4 to 39.7 |
709 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
39.1 |
32.0 to 46.7 |
274 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
33.9 |
28.7 to 39.6 |
435 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
28.2 |
22.9 to 34.3 |
370 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
27.9 |
22.4 to 34.2 |
328 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
22.1 |
17.1 to 28.0 |
352 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
25.1 |
19.7 to 31.4 |
335 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
29.8 |
24.2 to 36.1 |
335 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
35.1 |
29.5 to 41.1 |
341 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
31.8 |
25.7 to 38.6 |
409 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
38.2 |
32.3 to 44.4 |
358 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
31.3 |
25.4 to 37.8 |
330 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
27.7 |
21.7 to 34.6 |
286 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
16.1 |
11.7 to 21.6 |
356 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
19.6 |
15.0 to 25.2 |
361 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
27.5 |
22.0 to 33.7 |
367 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
32.8 |
26.8 to 39.4 |
321 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
23.9 |
19.0 to 29.4 |
351 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
41.3 |
35.7 to 47.1 |
402 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
27.7 |
21.9 to 34.4 |
328 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
31.4 |
25.7 to 37.8 |
378 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
34.2 |
29.5 to 39.1 |
594 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
36.6 |
30.0 to 43.8 |
288 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
32.6 |
26.5 to 39.5 |
306 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
37.1 |
31.0 to 43.6 |
372 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
33.3 |
27.4 to 39.8 |
327 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
29.1 |
23.9 to 35.0 |
430 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
28.0 |
22.5 to 34.2 |
356 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
27.4 |
22.2 to 33.2 |
399 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
36.8 |
31.6 to 42.4 |
785 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
46.9 |
40.1 to 53.8 |
343 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
35.5 |
29.7 to 41.7 |
442 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
36.4 |
28.3 to 45.4 |
230 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
30.4 |
29.2 to 31.7 |
20827 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
38.8 |
35.5 to 42.1 |
2268 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
32.1 |
28.4 to 36.0 |
922 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
33.4 |
30.3 to 36.8 |
2553 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
26.4 |
24.0 to 28.9 |
2896 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
31.0 |
28.7 to 33.5 |
2465 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
26.0 |
23.1 to 29.1 |
3089 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
23.8 |
20.9 to 26.8 |
1362 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
26.9 |
24.0 to 30.0 |
2290 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
36.4 |
31.3 to 41.8 |
1491 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
48.2 |
42.4 to 54.0 |
414 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
25.8 |
20.4 to 32.0 |
380 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
28.1 |
22.5 to 34.6 |
358 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
17.0 |
12.8 to 22.1 |
339 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
25.6 |
21.6 to 30.1 |
1652 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
23.0 |
18.0 to 28.9 |
385 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
35.2 |
28.8 to 42.2 |
379 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
38.3 |
31.3 to 45.9 |
397 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
24.4 |
19.8 to 29.7 |
491 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
30.6 |
27.0 to 34.5 |
1491 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
19.0 |
14.9 to 24.0 |
398 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
39.8 |
33.7 to 46.3 |
367 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
29.0 |
22.8 to 36.2 |
350 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
34.0 |
28.1 to 40.5 |
374 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
31.6 |
25.9 to 37.8 |
350 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
32.0 |
25.9 to 38.8 |
340 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
22.6 |
18.2 to 27.7 |
446 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
31.6 |
25.8 to 38.0 |
361 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
27.5 |
22.5 to 33.2 |
350 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
35.4 |
30.0 to 41.3 |
444 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
25.0 |
20.2 to 30.5 |
362 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
38.7 |
32.2 to 45.7 |
350 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
41.4 |
35.4 to 47.8 |
354 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
48.4 |
42.3 to 54.6 |
358 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
47.8 |
41.8 to 53.9 |
360 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
49.8 |
43.4 to 56.2 |
418 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
28.1 |
22.6 to 34.3 |
321 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
29.9 |
24.6 to 35.7 |
374 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
44.1 |
38.2 to 50.2 |
340 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
28.3 |
23.0 to 34.3 |
356 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
33.4 |
29.4 to 37.7 |
779 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
44.6 |
37.9 to 51.5 |
283 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
30.9 |
26.3 to 36.0 |
496 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
29.2 |
23.8 to 35.2 |
328 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
36.6 |
30.9 to 42.7 |
383 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
24.9 |
20.1 to 30.5 |
375 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
26.4 |
21.4 to 32.2 |
330 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
34.8 |
29.3 to 40.8 |
382 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
45.4 |
39.5 to 51.5 |
374 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
37.4 |
31.1 to 44.0 |
403 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
43.8 |
37.3 to 50.5 |
338 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
37.7 |
31.9 to 43.9 |
373 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
33.2 |
27.8 to 39.1 |
366 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
22.9 |
18.1 to 28.5 |
364 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
28.2 |
22.1 to 35.3 |
300 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
28.1 |
23.1 to 33.6 |
406 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
40.0 |
34.5 to 45.9 |
393 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
32.8 |
27.2 to 39.1 |
372 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
49.2 |
42.5 to 55.9 |
295 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
37.8 |
31.9 to 44.1 |
364 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
40.4 |
35.0 to 46.1 |
396 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
42.6 |
38.2 to 47.0 |
665 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
47.0 |
40.8 to 53.4 |
313 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
39.7 |
33.8 to 45.9 |
352 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
33.7 |
28.1 to 39.8 |
358 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
42.7 |
36.5 to 49.1 |
323 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
29.2 |
23.7 to 35.4 |
332 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
34.0 |
27.9 to 40.7 |
291 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
42.2 |
36.1 to 48.5 |
353 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
42.9 |
37.8 to 48.2 |
832 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
50.7 |
44.4 to 57.0 |
340 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
41.9 |
36.2 to 47.8 |
492 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
36.2 |
30.1 to 42.8 |
339 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
34.9 |
33.7 to 36.1 |
21875 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
47.1 |
43.6 to 50.6 |
2188 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
41.0 |
37.5 to 44.6 |
1029 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
38.4 |
35.2 to 41.7 |
2742 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
29.1 |
26.7 to 31.5 |
2793 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
33.5 |
31.2 to 35.8 |
2543 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
32.6 |
30.2 to 35.1 |
4048 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
31.0 |
27.7 to 34.5 |
1451 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
32.7 |
29.4 to 36.0 |
2120 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
38.1 |
32.9 to 43.6 |
1506 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
63.0 |
57.6 to 68.0 |
419 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
27.6 |
22.3 to 33.6 |
360 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
27.1 |
21.8 to 33.1 |
349 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
27.2 |
21.8 to 33.3 |
325 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
32.3 |
29.2 to 35.6 |
2617 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
26.4 |
21.2 to 32.3 |
368 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
32.7 |
26.2 to 40.0 |
259 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
43.0 |
38.0 to 48.1 |
558 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-Hidalgo County |
2015 |
Age |
13-17 Years |
37.3 |
32.6 to 42.3 |
486 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
32.1 |
28.2 to 36.2 |
946 |
| HPV |
>=3 Doses, Males and Females |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
36.4 |
32.9 to 40.0 |
1455 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
22.2 |
17.3 to 28.0 |
357 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
47.6 |
41.9 to 53.3 |
404 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
31.9 |
25.2 to 39.6 |
385 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
36.3 |
30.9 to 42.1 |
396 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
33.0 |
27.5 to 38.9 |
344 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
40.2 |
34.5 to 46.3 |
365 |
| HPV |
>=3 Doses, Males and Females |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
22.5 |
17.4 to 28.6 |
331 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2006 |
Age |
13-17 Years |
69.9 |
67.7 to 72.0 |
2882 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2006 |
Age |
13-17 Years |
76.7 |
68.5 to 83.3 |
170 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2006 |
Age |
13-17 Years |
64.3 |
56.1 to 71.6 |
227 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2006 |
Age |
13-17 Years |
64.5 |
58.2 to 70.4 |
347 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2006 |
Age |
13-17 Years |
69.9 |
65.0 to 74.4 |
608 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2006 |
Age |
13-17 Years |
74.5 |
69.1 to 79.3 |
458 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2006 |
Age |
13-17 Years |
70.4 |
63.5 to 76.5 |
268 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2006 |
Age |
13-17 Years |
74.6 |
65.6 to 82.0 |
165 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2006 |
Age |
13-17 Years |
75.3 |
63.3 to 84.4 |
118 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2006 |
Age |
13-17 Years |
64.9 |
58.5 to 70.8 |
362 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2006 |
Age |
13-17 Years |
73.4 |
64.9 to 80.4 |
159 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
65.8 |
63.5 to 68.0 |
2947 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2007 |
Age |
13-17 Years |
63.4 |
54.9 to 71.2 |
190 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2007 |
Age |
13-17 Years |
69.6 |
61.9 to 76.3 |
219 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2007 |
Age |
13-17 Years |
61.6 |
54.8 to 67.9 |
370 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2007 |
Age |
13-17 Years |
63.1 |
57.6 to 68.2 |
501 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2007 |
Age |
13-17 Years |
69.0 |
64.2 to 73.5 |
584 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2007 |
Age |
13-17 Years |
71.7 |
65.2 to 77.5 |
322 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2007 |
Age |
13-17 Years |
77.5 |
68.4 to 84.6 |
165 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2007 |
Age |
13-17 Years |
67.7 |
54.8 to 78.3 |
112 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
58.0 |
50.6 to 65.1 |
366 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2007 |
Age |
13-17 Years |
68.9 |
58.2 to 77.9 |
118 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2008 |
Age |
13-17 Years |
56.1 |
50.3 to 61.8 |
406 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2008 |
Age |
13-17 Years |
70.3 |
64.5 to 75.5 |
304 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2008 |
Age |
13-17 Years |
62.4 |
55.1 to 69.2 |
250 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2008 |
Age |
13-17 Years |
64.6 |
58.9 to 69.9 |
382 |
| Varicella |
History of disease |
States/Local Areas |
California |
2008 |
Age |
13-17 Years |
51.6 |
44.1 to 59.1 |
316 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2008 |
Age |
13-17 Years |
60.9 |
53.8 to 67.5 |
347 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2008 |
Age |
13-17 Years |
54.9 |
47.7 to 61.9 |
292 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2008 |
Age |
13-17 Years |
56.0 |
49.5 to 62.2 |
334 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2008 |
Age |
13-17 Years |
45.4 |
39.1 to 51.8 |
329 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2008 |
Age |
13-17 Years |
56.3 |
48.2 to 64.1 |
284 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2008 |
Age |
13-17 Years |
63.4 |
57.0 to 69.4 |
345 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2008 |
Age |
13-17 Years |
47.3 |
41.2 to 53.4 |
317 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2008 |
Age |
13-17 Years |
74.2 |
67.9 to 79.7 |
268 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2008 |
Age |
13-17 Years |
65.2 |
59.9 to 70.1 |
783 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2008 |
Age |
13-17 Years |
61.4 |
55.2 to 67.2 |
343 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2008 |
Age |
13-17 Years |
66.2 |
59.6 to 72.1 |
440 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2008 |
Age |
13-17 Years |
66.8 |
60.9 to 72.2 |
345 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2008 |
Age |
13-17 Years |
69.8 |
63.6 to 75.3 |
308 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2008 |
Age |
13-17 Years |
66.6 |
59.5 to 73.0 |
271 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2008 |
Age |
13-17 Years |
68.8 |
62.4 to 74.5 |
296 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2008 |
Age |
13-17 Years |
63.8 |
57.4 to 69.7 |
379 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2008 |
Age |
13-17 Years |
69.4 |
63.5 to 74.7 |
333 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2008 |
Age |
13-17 Years |
53.7 |
47.3 to 59.9 |
394 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2008 |
Age |
13-17 Years |
59.7 |
53.2 to 65.9 |
333 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2008 |
Age |
13-17 Years |
63.0 |
56.7 to 69.0 |
320 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2008 |
Age |
13-17 Years |
59.4 |
53.2 to 65.3 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2008 |
Age |
13-17 Years |
65.3 |
59.6 to 70.5 |
404 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2008 |
Age |
13-17 Years |
67.3 |
61.1 to 72.9 |
351 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2008 |
Age |
13-17 Years |
70.5 |
64.4 to 76.0 |
299 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2008 |
Age |
13-17 Years |
65.7 |
59.9 to 71.0 |
365 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2008 |
Age |
13-17 Years |
56.7 |
49.3 to 63.9 |
235 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2008 |
Age |
13-17 Years |
56.8 |
49.6 to 63.8 |
300 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2008 |
Age |
13-17 Years |
53.1 |
46.9 to 59.3 |
390 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2008 |
Age |
13-17 Years |
58.5 |
51.8 to 64.9 |
310 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2008 |
Age |
13-17 Years |
53.3 |
48.4 to 58.2 |
600 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2008 |
Age |
13-17 Years |
50.1 |
42.9 to 57.2 |
293 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2008 |
Age |
13-17 Years |
55.6 |
48.9 to 62.0 |
307 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2008 |
Age |
13-17 Years |
57.9 |
51.3 to 64.2 |
326 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2008 |
Age |
13-17 Years |
66.3 |
60.7 to 71.5 |
362 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2008 |
Age |
13-17 Years |
66.7 |
60.4 to 72.6 |
311 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2008 |
Age |
13-17 Years |
61.6 |
55.2 to 67.6 |
292 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2008 |
Age |
13-17 Years |
61.3 |
54.0 to 68.1 |
235 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2008 |
Age |
13-17 Years |
46.6 |
41.1 to 52.1 |
682 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2008 |
Age |
13-17 Years |
45.1 |
39.0 to 51.4 |
345 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2008 |
Age |
13-17 Years |
46.8 |
40.6 to 53.1 |
337 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2008 |
Age |
13-17 Years |
59.8 |
58.4 to 61.3 |
17835 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2008 |
Age |
13-17 Years |
58.7 |
55.2 to 62.2 |
1838 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2008 |
Age |
13-17 Years |
53.3 |
49.4 to 57.1 |
990 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2008 |
Age |
13-17 Years |
50.8 |
47.5 to 54.1 |
2306 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2008 |
Age |
13-17 Years |
60.6 |
57.6 to 63.4 |
2788 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2008 |
Age |
13-17 Years |
64.7 |
62.1 to 67.2 |
2361 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2008 |
Age |
13-17 Years |
65.6 |
61.0 to 70.0 |
2203 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2008 |
Age |
13-17 Years |
67.5 |
64.1 to 70.7 |
1295 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2008 |
Age |
13-17 Years |
65.7 |
61.9 to 69.3 |
1854 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2008 |
Age |
13-17 Years |
53.2 |
47.1 to 59.3 |
1118 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2008 |
Age |
13-17 Years |
51.3 |
44.2 to 58.5 |
297 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2008 |
Age |
13-17 Years |
59.7 |
53.8 to 65.4 |
367 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2008 |
Age |
13-17 Years |
70.9 |
65.0 to 76.3 |
344 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2008 |
Age |
13-17 Years |
67.3 |
61.5 to 72.7 |
360 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2008 |
Age |
13-17 Years |
67.2 |
60.3 to 73.4 |
840 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2008 |
Age |
13-17 Years |
66.1 |
58.7 to 72.8 |
269 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2008 |
Age |
13-17 Years |
55.8 |
46.7 to 64.6 |
233 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2008 |
Age |
13-17 Years |
68.4 |
60.3 to 75.5 |
338 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2008 |
Age |
13-17 Years |
66.8 |
62.7 to 70.7 |
1082 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2008 |
Age |
13-17 Years |
70.4 |
63.2 to 76.7 |
222 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2008 |
Age |
13-17 Years |
65.1 |
58.2 to 71.4 |
283 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2008 |
Age |
13-17 Years |
53.3 |
46.2 to 60.2 |
272 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2008 |
Age |
13-17 Years |
67.7 |
61.0 to 73.7 |
275 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2008 |
Age |
13-17 Years |
60.3 |
53.6 to 66.5 |
295 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2008 |
Age |
13-17 Years |
64.9 |
58.2 to 71.1 |
264 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2008 |
Age |
13-17 Years |
64.3 |
57.9 to 70.2 |
280 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2009 |
Age |
13-17 Years |
52.2 |
46.0 to 58.4 |
339 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2009 |
Age |
13-17 Years |
58.6 |
51.8 to 65.0 |
274 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2009 |
Age |
13-17 Years |
55.1 |
48.5 to 61.5 |
349 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2009 |
Age |
13-17 Years |
55.6 |
49.6 to 61.5 |
363 |
| Varicella |
History of disease |
States/Local Areas |
California |
2009 |
Age |
13-17 Years |
40.0 |
34.1 to 46.2 |
379 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2009 |
Age |
13-17 Years |
55.6 |
49.4 to 61.7 |
411 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2009 |
Age |
13-17 Years |
46.1 |
39.9 to 52.5 |
351 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2009 |
Age |
13-17 Years |
52.5 |
46.2 to 58.8 |
371 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2009 |
Age |
13-17 Years |
37.2 |
31.4 to 43.3 |
412 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2009 |
Age |
13-17 Years |
53.1 |
47.0 to 59.1 |
412 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2009 |
Age |
13-17 Years |
54.0 |
47.9 to 60.0 |
383 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2009 |
Age |
13-17 Years |
45.6 |
38.9 to 52.5 |
256 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2009 |
Age |
13-17 Years |
61.7 |
53.8 to 69.1 |
227 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2009 |
Age |
13-17 Years |
60.4 |
55.6 to 65.0 |
754 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2009 |
Age |
13-17 Years |
47.9 |
41.8 to 54.0 |
389 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2009 |
Age |
13-17 Years |
63.5 |
57.7 to 69.0 |
365 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2009 |
Age |
13-17 Years |
64.7 |
59.3 to 69.8 |
873 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2009 |
Age |
13-17 Years |
63.0 |
56.8 to 68.8 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2009 |
Age |
13-17 Years |
65.2 |
58.3 to 71.5 |
252 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2009 |
Age |
13-17 Years |
58.2 |
52.6 to 63.7 |
393 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2009 |
Age |
13-17 Years |
60.5 |
53.3 to 67.3 |
281 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2009 |
Age |
13-17 Years |
61.8 |
55.1 to 68.0 |
299 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2009 |
Age |
13-17 Years |
46.2 |
38.4 to 54.2 |
245 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2009 |
Age |
13-17 Years |
49.9 |
44.1 to 55.8 |
397 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2009 |
Age |
13-17 Years |
51.9 |
46.3 to 57.4 |
446 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2009 |
Age |
13-17 Years |
56.8 |
50.8 to 62.7 |
336 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2009 |
Age |
13-17 Years |
58.8 |
53.2 to 64.1 |
438 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2009 |
Age |
13-17 Years |
63.3 |
57.5 to 68.7 |
374 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2009 |
Age |
13-17 Years |
61.3 |
54.9 to 67.3 |
306 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2009 |
Age |
13-17 Years |
57.8 |
51.3 to 63.9 |
286 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2009 |
Age |
13-17 Years |
49.2 |
42.8 to 55.7 |
336 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2009 |
Age |
13-17 Years |
53.9 |
47.5 to 60.3 |
307 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2009 |
Age |
13-17 Years |
46.3 |
40.6 to 52.0 |
427 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2009 |
Age |
13-17 Years |
50.5 |
44.9 to 56.1 |
406 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2009 |
Age |
13-17 Years |
54.4 |
49.3 to 59.4 |
539 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2009 |
Age |
13-17 Years |
51.1 |
43.5 to 58.7 |
269 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2009 |
Age |
13-17 Years |
56.6 |
49.8 to 63.2 |
270 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2009 |
Age |
13-17 Years |
62.7 |
56.3 to 68.7 |
323 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2009 |
Age |
13-17 Years |
61.2 |
54.7 to 67.4 |
272 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2009 |
Age |
13-17 Years |
57.3 |
50.9 to 63.4 |
351 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2009 |
Age |
13-17 Years |
56.1 |
50.0 to 62.0 |
336 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2009 |
Age |
13-17 Years |
46.9 |
41.3 to 52.5 |
386 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2009 |
Age |
13-17 Years |
41.2 |
35.2 to 47.4 |
579 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2009 |
Age |
13-17 Years |
34.7 |
29.0 to 40.8 |
324 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2009 |
Age |
13-17 Years |
42.2 |
35.3 to 49.4 |
255 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2009 |
Age |
13-17 Years |
52.7 |
51.4 to 54.0 |
20066 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2009 |
Age |
13-17 Years |
50.3 |
47.1 to 53.5 |
2189 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2009 |
Age |
13-17 Years |
51.9 |
47.9 to 55.8 |
966 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2009 |
Age |
13-17 Years |
47.0 |
43.4 to 50.5 |
2214 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2009 |
Age |
13-17 Years |
54.9 |
52.4 to 57.4 |
2984 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2009 |
Age |
13-17 Years |
57.0 |
54.6 to 59.4 |
3105 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2009 |
Age |
13-17 Years |
55.2 |
51.5 to 58.8 |
2856 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2009 |
Age |
13-17 Years |
62.9 |
59.6 to 66.0 |
1250 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2009 |
Age |
13-17 Years |
59.7 |
56.3 to 63.0 |
1974 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2009 |
Age |
13-17 Years |
42.6 |
37.7 to 47.6 |
1320 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2009 |
Age |
13-17 Years |
43.8 |
37.7 to 50.1 |
409 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2009 |
Age |
13-17 Years |
50.4 |
43.6 to 57.2 |
299 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2009 |
Age |
13-17 Years |
67.3 |
60.6 to 73.4 |
271 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2009 |
Age |
13-17 Years |
51.0 |
45.0 to 57.0 |
397 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2009 |
Age |
13-17 Years |
54.4 |
49.1 to 59.5 |
1470 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2009 |
Age |
13-17 Years |
53.1 |
45.9 to 60.2 |
305 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2009 |
Age |
13-17 Years |
42.1 |
34.0 to 50.7 |
239 |
| Varicella |
History of disease |
States/Local Areas |
TX-Dallas County |
2009 |
Age |
13-17 Years |
49.2 |
42.0 to 56.4 |
296 |
| Varicella |
History of disease |
States/Local Areas |
TX-El Paso County |
2009 |
Age |
13-17 Years |
51.2 |
45.3 to 57.1 |
325 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2009 |
Age |
13-17 Years |
56.7 |
49.5 to 63.6 |
305 |
| Varicella |
History of disease |
States/Local Areas |
U.S. Virgin Islands |
2009 |
Age |
13-17 Years |
26.3 |
20.5 to 33.1 |
333 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2009 |
Age |
13-17 Years |
57.1 |
53.3 to 60.8 |
1208 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2009 |
Age |
13-17 Years |
63.0 |
56.9 to 68.8 |
339 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2009 |
Age |
13-17 Years |
57.3 |
51.7 to 62.7 |
426 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2009 |
Age |
13-17 Years |
54.1 |
47.8 to 60.3 |
358 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2009 |
Age |
13-17 Years |
61.5 |
55.3 to 67.3 |
321 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2009 |
Age |
13-17 Years |
60.0 |
53.0 to 66.6 |
249 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2009 |
Age |
13-17 Years |
49.5 |
43.4 to 55.7 |
345 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2009 |
Age |
13-17 Years |
61.2 |
55.5 to 66.6 |
375 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2010 |
Age |
13-17 Years |
44.3 |
38.0 to 50.8 |
296 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2010 |
Age |
13-17 Years |
53.2 |
46.7 to 59.6 |
294 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2010 |
Age |
13-17 Years |
43.6 |
37.3 to 50.0 |
331 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2010 |
Age |
13-17 Years |
45.1 |
38.7 to 51.7 |
313 |
| Varicella |
History of disease |
States/Local Areas |
California |
2010 |
Age |
13-17 Years |
40.1 |
33.9 to 46.6 |
330 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2010 |
Age |
13-17 Years |
38.8 |
32.7 to 45.3 |
317 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2010 |
Age |
13-17 Years |
33.4 |
28.3 to 39.0 |
408 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2010 |
Age |
13-17 Years |
43.6 |
37.3 to 50.0 |
348 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2010 |
Age |
13-17 Years |
30.5 |
25.0 to 36.5 |
355 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2010 |
Age |
13-17 Years |
44.3 |
37.9 to 50.8 |
344 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2010 |
Age |
13-17 Years |
46.0 |
40.1 to 52.0 |
373 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2010 |
Age |
13-17 Years |
31.2 |
25.8 to 37.1 |
320 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2010 |
Age |
13-17 Years |
61.9 |
55.7 to 67.7 |
318 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2010 |
Age |
13-17 Years |
49.0 |
44.1 to 53.9 |
739 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2010 |
Age |
13-17 Years |
46.6 |
40.2 to 53.1 |
366 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2010 |
Age |
13-17 Years |
49.6 |
43.7 to 55.5 |
373 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2010 |
Age |
13-17 Years |
60.1 |
53.7 to 66.3 |
316 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2010 |
Age |
13-17 Years |
62.1 |
55.5 to 68.2 |
264 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2010 |
Age |
13-17 Years |
50.3 |
44.7 to 56.0 |
373 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2010 |
Age |
13-17 Years |
48.0 |
41.8 to 54.3 |
309 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2010 |
Age |
13-17 Years |
46.6 |
40.5 to 52.7 |
347 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2010 |
Age |
13-17 Years |
50.4 |
44.1 to 56.8 |
312 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2010 |
Age |
13-17 Years |
34.3 |
28.3 to 40.8 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2010 |
Age |
13-17 Years |
35.6 |
29.4 to 42.2 |
306 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2010 |
Age |
13-17 Years |
47.2 |
40.3 to 54.2 |
304 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2010 |
Age |
13-17 Years |
46.0 |
39.8 to 52.3 |
310 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2010 |
Age |
13-17 Years |
55.9 |
49.9 to 61.7 |
354 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2010 |
Age |
13-17 Years |
42.9 |
37.2 to 48.7 |
347 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2010 |
Age |
13-17 Years |
55.3 |
49.3 to 61.2 |
333 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2010 |
Age |
13-17 Years |
53.2 |
46.7 to 59.6 |
307 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2010 |
Age |
13-17 Years |
49.0 |
42.9 to 55.2 |
330 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2010 |
Age |
13-17 Years |
46.1 |
40.3 to 51.9 |
350 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2010 |
Age |
13-17 Years |
44.7 |
38.2 to 51.4 |
399 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2010 |
Age |
13-17 Years |
51.2 |
45.0 to 57.4 |
332 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2010 |
Age |
13-17 Years |
35.6 |
31.1 to 40.4 |
701 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2010 |
Age |
13-17 Years |
31.8 |
26.6 to 37.6 |
388 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2010 |
Age |
13-17 Years |
38.1 |
31.7 to 45.0 |
313 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2010 |
Age |
13-17 Years |
49.2 |
43.2 to 55.2 |
366 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2010 |
Age |
13-17 Years |
56.1 |
49.8 to 62.2 |
299 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2010 |
Age |
13-17 Years |
46.4 |
40.2 to 52.8 |
302 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2010 |
Age |
13-17 Years |
46.8 |
40.5 to 53.3 |
300 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2010 |
Age |
13-17 Years |
44.4 |
38.0 to 50.9 |
302 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2010 |
Age |
13-17 Years |
35.1 |
30.3 to 40.3 |
742 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2010 |
Age |
13-17 Years |
31.7 |
26.3 to 37.7 |
371 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2010 |
Age |
13-17 Years |
35.7 |
30.2 to 41.5 |
371 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2010 |
Age |
13-17 Years |
44.7 |
43.5 to 46.0 |
19257 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2010 |
Age |
13-17 Years |
38.0 |
34.7 to 41.3 |
2026 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2010 |
Age |
13-17 Years |
38.5 |
34.8 to 42.4 |
1100 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2010 |
Age |
13-17 Years |
36.6 |
33.6 to 39.7 |
2436 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2010 |
Age |
13-17 Years |
46.5 |
43.9 to 49.1 |
2679 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2010 |
Age |
13-17 Years |
49.0 |
46.3 to 51.6 |
2248 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2010 |
Age |
13-17 Years |
48.0 |
44.6 to 51.5 |
3001 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2010 |
Age |
13-17 Years |
50.1 |
46.8 to 53.3 |
1291 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2010 |
Age |
13-17 Years |
48.6 |
45.1 to 52.1 |
1890 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2010 |
Age |
13-17 Years |
40.8 |
35.8 to 46.0 |
1311 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2010 |
Age |
13-17 Years |
31.8 |
26.3 to 37.9 |
330 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2010 |
Age |
13-17 Years |
46.2 |
39.8 to 52.8 |
317 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2010 |
Age |
13-17 Years |
62.7 |
56.4 to 68.6 |
321 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2010 |
Age |
13-17 Years |
45.6 |
39.4 to 51.8 |
320 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2010 |
Age |
13-17 Years |
48.5 |
43.6 to 53.5 |
1709 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2010 |
Age |
13-17 Years |
44.2 |
38.3 to 50.3 |
382 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2010 |
Age |
13-17 Years |
42.2 |
36.1 to 48.6 |
413 |
| Varicella |
History of disease |
States/Local Areas |
TX-Dallas County |
2010 |
Age |
13-17 Years |
41.4 |
34.1 to 49.1 |
304 |
| Varicella |
History of disease |
States/Local Areas |
TX-El Paso County |
2010 |
Age |
13-17 Years |
48.3 |
42.2 to 54.4 |
313 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2010 |
Age |
13-17 Years |
50.6 |
43.9 to 57.2 |
297 |
| Varicella |
History of disease |
States/Local Areas |
U.S. Virgin Islands |
2010 |
Age |
13-17 Years |
13.9 |
9.2 to 20.6 |
231 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2010 |
Age |
13-17 Years |
53.9 |
50.3 to 57.5 |
1275 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2010 |
Age |
13-17 Years |
54.5 |
48.1 to 60.7 |
325 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2010 |
Age |
13-17 Years |
56.9 |
50.5 to 63.0 |
320 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2010 |
Age |
13-17 Years |
36.0 |
29.7 to 42.8 |
332 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2010 |
Age |
13-17 Years |
57.2 |
51.4 to 62.8 |
361 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2010 |
Age |
13-17 Years |
56.4 |
50.3 to 62.2 |
321 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2010 |
Age |
13-17 Years |
47.0 |
40.3 to 53.9 |
277 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2010 |
Age |
13-17 Years |
59.1 |
52.7 to 65.2 |
295 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2011 |
Age |
13-17 Years |
30.8 |
25.7 to 36.4 |
403 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2011 |
Age |
13-17 Years |
47.3 |
40.2 to 54.4 |
330 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2011 |
Age |
13-17 Years |
39.7 |
32.9 to 47.0 |
416 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2011 |
Age |
13-17 Years |
44.7 |
37.0 to 52.7 |
350 |
| Varicella |
History of disease |
States/Local Areas |
California |
2011 |
Age |
13-17 Years |
32.5 |
27.8 to 37.5 |
583 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2011 |
Age |
13-17 Years |
39.0 |
32.2 to 46.2 |
431 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2011 |
Age |
13-17 Years |
32.8 |
27.1 to 39.1 |
453 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2011 |
Age |
13-17 Years |
31.5 |
26.3 to 37.2 |
442 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2011 |
Age |
13-17 Years |
23.8 |
18.6 to 29.9 |
415 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2011 |
Age |
13-17 Years |
36.4 |
30.7 to 42.6 |
483 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2011 |
Age |
13-17 Years |
40.2 |
34.2 to 46.6 |
425 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2011 |
Age |
13-17 Years |
25.5 |
20.1 to 31.7 |
339 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2011 |
Age |
13-17 Years |
52.2 |
45.0 to 59.3 |
385 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2011 |
Age |
13-17 Years |
36.9 |
32.0 to 42.2 |
848 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2011 |
Age |
13-17 Years |
36.5 |
30.5 to 42.9 |
407 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2011 |
Age |
13-17 Years |
37.0 |
31.1 to 43.4 |
441 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2011 |
Age |
13-17 Years |
46.8 |
40.7 to 53.0 |
430 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2011 |
Age |
13-17 Years |
54.1 |
47.2 to 60.9 |
359 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2011 |
Age |
13-17 Years |
48.7 |
42.1 to 55.4 |
399 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2011 |
Age |
13-17 Years |
45.9 |
39.3 to 52.6 |
382 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2011 |
Age |
13-17 Years |
40.7 |
34.7 to 47.0 |
473 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2011 |
Age |
13-17 Years |
38.0 |
32.4 to 43.9 |
411 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2011 |
Age |
13-17 Years |
30.3 |
25.5 to 35.6 |
516 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2011 |
Age |
13-17 Years |
29.9 |
24.5 to 35.8 |
365 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2011 |
Age |
13-17 Years |
34.5 |
28.3 to 41.1 |
398 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2011 |
Age |
13-17 Years |
39.0 |
32.2 to 46.1 |
327 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2011 |
Age |
13-17 Years |
42.2 |
35.5 to 49.2 |
345 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2011 |
Age |
13-17 Years |
43.1 |
36.9 to 49.5 |
402 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2011 |
Age |
13-17 Years |
52.0 |
43.3 to 60.6 |
385 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2011 |
Age |
13-17 Years |
40.3 |
34.0 to 47.0 |
368 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2011 |
Age |
13-17 Years |
41.4 |
34.0 to 49.2 |
412 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2011 |
Age |
13-17 Years |
30.8 |
25.5 to 36.6 |
385 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2011 |
Age |
13-17 Years |
32.8 |
27.6 to 38.4 |
432 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2011 |
Age |
13-17 Years |
39.5 |
33.4 to 46.0 |
431 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2011 |
Age |
13-17 Years |
31.5 |
27.8 to 35.5 |
840 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2011 |
Age |
13-17 Years |
27.2 |
22.7 to 32.1 |
435 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2011 |
Age |
13-17 Years |
34.2 |
28.9 to 39.9 |
405 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2011 |
Age |
13-17 Years |
37.5 |
31.2 to 44.3 |
347 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2011 |
Age |
13-17 Years |
45.1 |
36.9 to 53.6 |
314 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2011 |
Age |
13-17 Years |
41.7 |
35.7 to 47.9 |
381 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2011 |
Age |
13-17 Years |
37.0 |
30.8 to 43.6 |
360 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2011 |
Age |
13-17 Years |
35.2 |
28.8 to 42.2 |
362 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2011 |
Age |
13-17 Years |
26.6 |
22.2 to 31.6 |
880 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2011 |
Age |
13-17 Years |
21.7 |
16.8 to 27.5 |
387 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2011 |
Age |
13-17 Years |
27.3 |
22.3 to 32.9 |
493 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2011 |
Age |
13-17 Years |
36.6 |
35.5 to 37.7 |
23564 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2011 |
Age |
13-17 Years |
31.8 |
28.7 to 34.9 |
2467 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2011 |
Age |
13-17 Years |
31.9 |
28.9 to 35.1 |
1272 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2011 |
Age |
13-17 Years |
30.7 |
27.9 to 33.6 |
3073 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2011 |
Age |
13-17 Years |
38.0 |
35.4 to 40.5 |
3171 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2011 |
Age |
13-17 Years |
39.0 |
36.5 to 41.6 |
2800 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2011 |
Age |
13-17 Years |
37.0 |
34.1 to 40.1 |
3838 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2011 |
Age |
13-17 Years |
46.4 |
42.8 to 50.0 |
1528 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2011 |
Age |
13-17 Years |
43.6 |
39.6 to 47.6 |
2242 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2011 |
Age |
13-17 Years |
33.8 |
29.9 to 37.9 |
1750 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2011 |
Age |
13-17 Years |
26.1 |
21.1 to 31.7 |
449 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2011 |
Age |
13-17 Years |
36.6 |
30.2 to 43.5 |
362 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2011 |
Age |
13-17 Years |
55.5 |
45.4 to 65.1 |
355 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2011 |
Age |
13-17 Years |
38.1 |
31.9 to 44.7 |
424 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2011 |
Age |
13-17 Years |
35.4 |
31.3 to 39.7 |
2224 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2011 |
Age |
13-17 Years |
35.2 |
29.6 to 41.2 |
448 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2011 |
Age |
13-17 Years |
32.7 |
26.8 to 39.1 |
490 |
| Varicella |
History of disease |
States/Local Areas |
TX-Dallas County |
2011 |
Age |
13-17 Years |
36.3 |
29.8 to 43.3 |
441 |
| Varicella |
History of disease |
States/Local Areas |
TX-El Paso County |
2011 |
Age |
13-17 Years |
37.4 |
31.2 to 44.1 |
355 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2011 |
Age |
13-17 Years |
35.5 |
30.1 to 41.2 |
490 |
| Varicella |
History of disease |
States/Local Areas |
U.S. Virgin Islands |
2011 |
Age |
13-17 Years |
14.5 |
11.1 to 18.7 |
485 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2011 |
Age |
13-17 Years |
42.4 |
38.4 to 46.4 |
1423 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2011 |
Age |
13-17 Years |
44.6 |
37.5 to 51.8 |
393 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2011 |
Age |
13-17 Years |
44.5 |
38.6 to 50.7 |
404 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2011 |
Age |
13-17 Years |
35.6 |
29.7 to 42.1 |
417 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2011 |
Age |
13-17 Years |
43.2 |
36.9 to 49.8 |
346 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2011 |
Age |
13-17 Years |
39.0 |
33.4 to 44.9 |
403 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2011 |
Age |
13-17 Years |
37.3 |
31.1 to 43.8 |
416 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2011 |
Age |
13-17 Years |
44.8 |
36.8 to 53.0 |
364 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2012 |
Age |
13-17 Years |
27.6 |
21.9 to 34.3 |
317 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2012 |
Age |
13-17 Years |
43.8 |
37.7 to 50.1 |
340 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2012 |
Age |
13-17 Years |
35.6 |
29.4 to 42.2 |
360 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2012 |
Age |
13-17 Years |
31.0 |
24.6 to 38.1 |
322 |
| Varicella |
History of disease |
States/Local Areas |
California |
2012 |
Age |
13-17 Years |
24.1 |
19.4 to 29.5 |
430 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2012 |
Age |
13-17 Years |
26.6 |
19.5 to 35.1 |
311 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2012 |
Age |
13-17 Years |
24.9 |
19.6 to 31.1 |
323 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2012 |
Age |
13-17 Years |
32.0 |
26.0 to 38.7 |
341 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2012 |
Age |
13-17 Years |
16.4 |
11.8 to 22.2 |
342 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2012 |
Age |
13-17 Years |
29.2 |
22.7 to 36.7 |
325 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2012 |
Age |
13-17 Years |
30.6 |
24.1 to 38.1 |
328 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2012 |
Age |
13-17 Years |
28.9 |
22.8 to 35.8 |
342 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2012 |
Age |
13-17 Years |
41.6 |
35.4 to 48.1 |
357 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2012 |
Age |
13-17 Years |
36.2 |
30.4 to 42.3 |
632 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2012 |
Age |
13-17 Years |
26.6 |
20.6 to 33.6 |
287 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2012 |
Age |
13-17 Years |
38.5 |
31.6 to 45.9 |
345 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2012 |
Age |
13-17 Years |
38.5 |
32.1 to 45.3 |
341 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2012 |
Age |
13-17 Years |
43.9 |
37.1 to 50.9 |
325 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2012 |
Age |
13-17 Years |
40.3 |
33.3 to 47.7 |
340 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2012 |
Age |
13-17 Years |
33.9 |
27.4 to 41.0 |
333 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2012 |
Age |
13-17 Years |
32.5 |
26.8 to 38.8 |
370 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2012 |
Age |
13-17 Years |
34.8 |
28.6 to 41.5 |
319 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2012 |
Age |
13-17 Years |
22.6 |
16.8 to 29.7 |
325 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2012 |
Age |
13-17 Years |
21.4 |
16.6 to 27.1 |
347 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2012 |
Age |
13-17 Years |
30.2 |
24.3 to 36.9 |
368 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2012 |
Age |
13-17 Years |
40.2 |
33.2 to 47.6 |
322 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2012 |
Age |
13-17 Years |
37.9 |
31.2 to 45.0 |
321 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2012 |
Age |
13-17 Years |
35.9 |
28.9 to 43.6 |
292 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2012 |
Age |
13-17 Years |
48.1 |
41.5 to 54.8 |
325 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2012 |
Age |
13-17 Years |
33.7 |
27.1 to 40.9 |
328 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2012 |
Age |
13-17 Years |
29.8 |
24.3 to 36.1 |
329 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2012 |
Age |
13-17 Years |
31.6 |
25.4 to 38.5 |
278 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2012 |
Age |
13-17 Years |
25.1 |
19.6 to 31.4 |
330 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2012 |
Age |
13-17 Years |
30.6 |
24.4 to 37.7 |
331 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2012 |
Age |
13-17 Years |
24.9 |
21.1 to 29.2 |
627 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2012 |
Age |
13-17 Years |
23.5 |
18.6 to 29.2 |
312 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2012 |
Age |
13-17 Years |
25.8 |
20.6 to 31.9 |
315 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2012 |
Age |
13-17 Years |
37.1 |
30.8 to 43.8 |
347 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2012 |
Age |
13-17 Years |
40.4 |
33.7 to 47.5 |
324 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2012 |
Age |
13-17 Years |
38.1 |
31.3 to 45.5 |
327 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2012 |
Age |
13-17 Years |
28.5 |
23.0 to 34.7 |
322 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2012 |
Age |
13-17 Years |
24.9 |
20.0 to 30.5 |
381 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2012 |
Age |
13-17 Years |
23.0 |
18.6 to 28.2 |
741 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2012 |
Age |
13-17 Years |
17.3 |
12.4 to 23.4 |
348 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2012 |
Age |
13-17 Years |
23.7 |
18.8 to 29.5 |
393 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2012 |
Age |
13-17 Years |
30.6 |
29.4 to 31.8 |
19199 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2012 |
Age |
13-17 Years |
25.2 |
22.3 to 28.2 |
1916 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2012 |
Age |
13-17 Years |
25.0 |
21.8 to 28.5 |
957 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2012 |
Age |
13-17 Years |
25.6 |
22.6 to 28.8 |
2365 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2012 |
Age |
13-17 Years |
31.9 |
29.1 to 34.8 |
2612 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2012 |
Age |
13-17 Years |
36.1 |
33.3 to 39.0 |
2297 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2012 |
Age |
13-17 Years |
31.2 |
28.5 to 34.0 |
2939 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2012 |
Age |
13-17 Years |
38.3 |
34.4 to 42.4 |
1285 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2012 |
Age |
13-17 Years |
33.9 |
30.0 to 38.1 |
1936 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2012 |
Age |
13-17 Years |
26.1 |
22.2 to 30.4 |
1461 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2012 |
Age |
13-17 Years |
22.3 |
17.1 to 28.4 |
327 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2012 |
Age |
13-17 Years |
31.9 |
25.3 to 39.2 |
310 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2012 |
Age |
13-17 Years |
50.2 |
43.3 to 57.1 |
298 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2012 |
Age |
13-17 Years |
32.8 |
26.3 to 39.9 |
331 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2012 |
Age |
13-17 Years |
31.4 |
27.7 to 35.3 |
1594 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2012 |
Age |
13-17 Years |
27.3 |
20.9 to 34.7 |
346 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2012 |
Age |
13-17 Years |
27.4 |
21.8 to 33.8 |
393 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2012 |
Age |
13-17 Years |
32.1 |
27.8 to 36.6 |
855 |
| Varicella |
History of disease |
States/Local Areas |
U.S. Virgin Islands |
2012 |
Age |
13-17 Years |
12.7 |
9.8 to 16.3 |
547 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2012 |
Age |
13-17 Years |
35.4 |
31.6 to 39.5 |
1431 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2012 |
Age |
13-17 Years |
34.4 |
28.2 to 41.2 |
345 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2012 |
Age |
13-17 Years |
38.3 |
32.1 to 44.9 |
322 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2012 |
Age |
13-17 Years |
28.5 |
22.2 to 35.9 |
334 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2012 |
Age |
13-17 Years |
38.7 |
32.2 to 45.6 |
353 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2012 |
Age |
13-17 Years |
39.5 |
32.5 to 46.9 |
282 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2012 |
Age |
13-17 Years |
35.3 |
28.5 to 42.9 |
307 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2012 |
Age |
13-17 Years |
43.1 |
36.7 to 49.8 |
333 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2013 |
Age |
13-17 Years |
26.6 |
21.2 to 32.8 |
317 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2013 |
Age |
13-17 Years |
33.4 |
27.5 to 39.9 |
320 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2013 |
Age |
13-17 Years |
27.6 |
22.3 to 33.6 |
359 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2013 |
Age |
13-17 Years |
31.4 |
25.5 to 38.1 |
312 |
| Varicella |
History of disease |
States/Local Areas |
California |
2013 |
Age |
13-17 Years |
23.1 |
17.8 to 29.6 |
309 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2013 |
Age |
13-17 Years |
18.7 |
14.5 to 23.9 |
331 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2013 |
Age |
13-17 Years |
27.1 |
21.3 to 33.8 |
328 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2013 |
Age |
13-17 Years |
25.0 |
19.8 to 30.9 |
348 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2013 |
Age |
13-17 Years |
23.1 |
15.2 to 33.6 |
192 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2013 |
Age |
13-17 Years |
21.7 |
16.3 to 28.1 |
323 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2013 |
Age |
13-17 Years |
21.5 |
16.0 to 28.2 |
253 |
| Varicella |
History of disease |
States/Local Areas |
Guam |
2013 |
Age |
13-17 Years |
51.4 |
45.3 to 57.5 |
363 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2013 |
Age |
13-17 Years |
17.5 |
12.7 to 23.7 |
315 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2013 |
Age |
13-17 Years |
46.2 |
38.9 to 53.7 |
272 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2013 |
Age |
13-17 Years |
31.0 |
26.1 to 36.5 |
558 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2013 |
Age |
13-17 Years |
21.8 |
15.3 to 30.2 |
209 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2013 |
Age |
13-17 Years |
33.2 |
27.3 to 39.7 |
349 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2013 |
Age |
13-17 Years |
37.9 |
32.4 to 43.8 |
381 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2013 |
Age |
13-17 Years |
33.6 |
28.0 to 39.6 |
383 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2013 |
Age |
13-17 Years |
36.3 |
29.9 to 43.2 |
287 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2013 |
Age |
13-17 Years |
28.2 |
22.4 to 34.9 |
291 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2013 |
Age |
13-17 Years |
22.8 |
17.6 to 29.0 |
298 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2013 |
Age |
13-17 Years |
30.8 |
25.4 to 36.8 |
343 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2013 |
Age |
13-17 Years |
15.3 |
10.6 to 21.7 |
320 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2013 |
Age |
13-17 Years |
20.1 |
15.8 to 25.4 |
393 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2013 |
Age |
13-17 Years |
25.3 |
19.9 to 31.4 |
307 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2013 |
Age |
13-17 Years |
29.4 |
24.0 to 35.4 |
369 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2013 |
Age |
13-17 Years |
29.0 |
23.2 to 35.5 |
284 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2013 |
Age |
13-17 Years |
28.3 |
22.3 to 35.2 |
280 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2013 |
Age |
13-17 Years |
40.0 |
33.7 to 46.5 |
320 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2013 |
Age |
13-17 Years |
28.2 |
22.7 to 34.5 |
301 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2013 |
Age |
13-17 Years |
27.1 |
21.6 to 33.4 |
335 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2013 |
Age |
13-17 Years |
26.9 |
21.9 to 32.5 |
345 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2013 |
Age |
13-17 Years |
20.5 |
15.4 to 26.7 |
322 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2013 |
Age |
13-17 Years |
24.1 |
19.1 to 29.8 |
357 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2013 |
Age |
13-17 Years |
21.1 |
17.7 to 24.8 |
710 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2013 |
Age |
13-17 Years |
20.5 |
15.6 to 26.4 |
300 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2013 |
Age |
13-17 Years |
21.4 |
17.1 to 26.5 |
410 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2013 |
Age |
13-17 Years |
20.5 |
15.7 to 26.3 |
306 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2013 |
Age |
13-17 Years |
37.4 |
31.2 to 44.1 |
344 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2013 |
Age |
13-17 Years |
30.6 |
24.9 to 37.0 |
319 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2013 |
Age |
13-17 Years |
25.5 |
20.8 to 30.8 |
426 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2013 |
Age |
13-17 Years |
27.0 |
21.9 to 32.8 |
364 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2013 |
Age |
13-17 Years |
22.2 |
17.7 to 27.5 |
751 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2013 |
Age |
13-17 Years |
17.1 |
12.5 to 23.0 |
307 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2013 |
Age |
13-17 Years |
22.9 |
17.8 to 28.8 |
444 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2013 |
Age |
13-17 Years |
25.4 |
24.2 to 26.6 |
18264 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2013 |
Age |
13-17 Years |
24.0 |
21.3 to 27.0 |
2050 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2013 |
Age |
13-17 Years |
20.9 |
18.0 to 24.0 |
1032 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2013 |
Age |
13-17 Years |
20.5 |
17.6 to 23.8 |
2241 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2013 |
Age |
13-17 Years |
23.5 |
21.1 to 26.0 |
2374 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2013 |
Age |
13-17 Years |
30.1 |
27.7 to 32.6 |
2264 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2013 |
Age |
13-17 Years |
24.9 |
21.9 to 28.1 |
2505 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2013 |
Age |
13-17 Years |
31.2 |
27.8 to 34.8 |
1251 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2013 |
Age |
13-17 Years |
28.6 |
25.7 to 31.7 |
1913 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2013 |
Age |
13-17 Years |
23.8 |
19.4 to 28.9 |
1318 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2013 |
Age |
13-17 Years |
18.4 |
13.7 to 24.2 |
315 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2013 |
Age |
13-17 Years |
23.9 |
18.0 to 30.9 |
296 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2013 |
Age |
13-17 Years |
33.0 |
27.1 to 39.5 |
292 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2013 |
Age |
13-17 Years |
27.7 |
22.3 to 33.8 |
304 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2013 |
Age |
13-17 Years |
24.5 |
20.4 to 29.1 |
1112 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2013 |
Age |
13-17 Years |
30.4 |
24.7 to 36.9 |
317 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2013 |
Age |
13-17 Years |
23.6 |
17.9 to 30.5 |
278 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2013 |
Age |
13-17 Years |
24.1 |
19.4 to 29.5 |
517 |
| Varicella |
History of disease |
States/Local Areas |
U.S. Virgin Islands |
2013 |
Age |
13-17 Years |
9.6 |
6.7 to 13.6 |
332 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2013 |
Age |
13-17 Years |
35.1 |
31.4 to 39.1 |
1316 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2013 |
Age |
13-17 Years |
36.9 |
30.6 to 43.7 |
301 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2013 |
Age |
13-17 Years |
36.1 |
30.0 to 42.6 |
326 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2013 |
Age |
13-17 Years |
18.2 |
12.3 to 26.1 |
302 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2013 |
Age |
13-17 Years |
36.9 |
30.6 to 43.6 |
360 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2013 |
Age |
13-17 Years |
34.7 |
28.8 to 41.1 |
328 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2013 |
Age |
13-17 Years |
27.1 |
21.7 to 33.3 |
330 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2013 |
Age |
13-17 Years |
31.4 |
25.8 to 37.6 |
325 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2014 |
Age |
13-17 Years |
22.9 |
17.9 to 28.7 |
378 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2014 |
Age |
13-17 Years |
30.9 |
25.4 to 37.0 |
377 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2014 |
Age |
13-17 Years |
22.4 |
17.6 to 28.2 |
421 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2014 |
Age |
13-17 Years |
18.1 |
13.9 to 23.2 |
368 |
| Varicella |
History of disease |
States/Local Areas |
California |
2014 |
Age |
13-17 Years |
17.5 |
12.8 to 23.5 |
356 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2014 |
Age |
13-17 Years |
21.5 |
16.6 to 27.3 |
394 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2014 |
Age |
13-17 Years |
16.6 |
12.2 to 22.3 |
386 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2014 |
Age |
13-17 Years |
16.0 |
11.5 to 21.9 |
374 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2014 |
Age |
13-17 Years |
9.1 |
5.3 to 15.0 |
285 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2014 |
Age |
13-17 Years |
24.0 |
18.0 to 31.2 |
363 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2014 |
Age |
13-17 Years |
18.9 |
14.2 to 24.9 |
373 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2014 |
Age |
13-17 Years |
17.4 |
13.2 to 22.6 |
363 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2014 |
Age |
13-17 Years |
30.5 |
24.4 to 37.2 |
341 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2014 |
Age |
13-17 Years |
21.8 |
17.9 to 26.2 |
709 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2014 |
Age |
13-17 Years |
16.4 |
11.3 to 23.2 |
274 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2014 |
Age |
13-17 Years |
23.0 |
18.5 to 28.2 |
435 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2014 |
Age |
13-17 Years |
30.3 |
24.6 to 36.6 |
370 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2014 |
Age |
13-17 Years |
29.5 |
23.4 to 36.4 |
328 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2014 |
Age |
13-17 Years |
30.4 |
24.4 to 37.1 |
352 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2014 |
Age |
13-17 Years |
20.6 |
15.6 to 26.7 |
335 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2014 |
Age |
13-17 Years |
21.9 |
16.9 to 27.9 |
335 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2014 |
Age |
13-17 Years |
20.1 |
15.6 to 25.5 |
341 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2014 |
Age |
13-17 Years |
8.2 |
5.3 to 12.4 |
409 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2014 |
Age |
13-17 Years |
21.4 |
16.3 to 27.5 |
358 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2014 |
Age |
13-17 Years |
17.6 |
13.1 to 23.4 |
330 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2014 |
Age |
13-17 Years |
21.4 |
16.1 to 27.9 |
286 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2014 |
Age |
13-17 Years |
28.3 |
22.6 to 34.7 |
356 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2014 |
Age |
13-17 Years |
25.0 |
19.6 to 31.3 |
361 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2014 |
Age |
13-17 Years |
33.6 |
27.6 to 40.1 |
367 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2014 |
Age |
13-17 Years |
24.5 |
19.1 to 30.8 |
321 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2014 |
Age |
13-17 Years |
25.4 |
20.1 to 31.6 |
351 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2014 |
Age |
13-17 Years |
17.2 |
13.3 to 22.0 |
402 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2014 |
Age |
13-17 Years |
16.8 |
12.2 to 22.8 |
328 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2014 |
Age |
13-17 Years |
24.7 |
19.5 to 30.8 |
378 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2014 |
Age |
13-17 Years |
18.9 |
15.2 to 23.1 |
594 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2014 |
Age |
13-17 Years |
22.5 |
16.9 to 29.3 |
288 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2014 |
Age |
13-17 Years |
16.6 |
12.1 to 22.3 |
306 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2014 |
Age |
13-17 Years |
19.7 |
14.9 to 25.6 |
372 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2014 |
Age |
13-17 Years |
31.1 |
25.1 to 37.7 |
327 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2014 |
Age |
13-17 Years |
22.8 |
18.1 to 28.3 |
430 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2014 |
Age |
13-17 Years |
23.4 |
18.4 to 29.3 |
356 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2014 |
Age |
13-17 Years |
18.8 |
14.3 to 24.4 |
399 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2014 |
Age |
13-17 Years |
16.4 |
12.8 to 20.8 |
785 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2014 |
Age |
13-17 Years |
18.9 |
14.1 to 25.0 |
343 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2014 |
Age |
13-17 Years |
16.1 |
12.2 to 21.0 |
442 |
| Varicella |
History of disease |
States/Local Areas |
Puerto Rico |
2014 |
Age |
13-17 Years |
9.7 |
5.5 to 16.3 |
230 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2014 |
Age |
13-17 Years |
21.0 |
19.9 to 22.1 |
20827 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2014 |
Age |
13-17 Years |
19.5 |
16.7 to 22.6 |
2268 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2014 |
Age |
13-17 Years |
18.2 |
15.2 to 21.6 |
922 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2014 |
Age |
13-17 Years |
14.3 |
12.3 to 16.7 |
2553 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2014 |
Age |
13-17 Years |
21.4 |
19.0 to 24.0 |
2896 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2014 |
Age |
13-17 Years |
22.5 |
20.4 to 24.8 |
2465 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2014 |
Age |
13-17 Years |
23.8 |
20.8 to 27.0 |
3089 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2014 |
Age |
13-17 Years |
27.1 |
23.9 to 30.5 |
1362 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2014 |
Age |
13-17 Years |
25.4 |
22.6 to 28.5 |
2290 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2014 |
Age |
13-17 Years |
18.6 |
14.8 to 23.3 |
1491 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2014 |
Age |
13-17 Years |
15.4 |
11.5 to 20.4 |
414 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2014 |
Age |
13-17 Years |
16.9 |
12.7 to 22.3 |
380 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2014 |
Age |
13-17 Years |
29.9 |
24.2 to 36.3 |
358 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2014 |
Age |
13-17 Years |
20.2 |
15.4 to 26.1 |
339 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2014 |
Age |
13-17 Years |
24.7 |
20.6 to 29.3 |
1652 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2014 |
Age |
13-17 Years |
27.2 |
21.5 to 33.7 |
385 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2014 |
Age |
13-17 Years |
18.9 |
13.9 to 25.1 |
379 |
| Varicella |
History of disease |
States/Local Areas |
TX-El Paso County |
2014 |
Age |
13-17 Years |
24.2 |
18.3 to 31.2 |
397 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2014 |
Age |
13-17 Years |
25.0 |
20.2 to 30.4 |
491 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2014 |
Age |
13-17 Years |
24.2 |
20.9 to 27.8 |
1491 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2014 |
Age |
13-17 Years |
26.5 |
21.6 to 32.1 |
398 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2014 |
Age |
13-17 Years |
27.7 |
22.1 to 34.2 |
367 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2014 |
Age |
13-17 Years |
13.3 |
9.4 to 18.5 |
350 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2014 |
Age |
13-17 Years |
24.8 |
19.5 to 30.9 |
374 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2014 |
Age |
13-17 Years |
26.3 |
21.0 to 32.4 |
350 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2014 |
Age |
13-17 Years |
24.2 |
18.7 to 30.6 |
340 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2014 |
Age |
13-17 Years |
28.4 |
23.5 to 33.9 |
446 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2015 |
Age |
13-17 Years |
19.7 |
15.1 to 25.2 |
361 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2015 |
Age |
13-17 Years |
21.5 |
16.7 to 27.1 |
350 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2015 |
Age |
13-17 Years |
18.4 |
14.4 to 23.2 |
444 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2015 |
Age |
13-17 Years |
19.2 |
14.7 to 24.6 |
362 |
| Varicella |
History of disease |
States/Local Areas |
California |
2015 |
Age |
13-17 Years |
15.3 |
10.5 to 21.8 |
350 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2015 |
Age |
13-17 Years |
18.0 |
13.7 to 23.3 |
354 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2015 |
Age |
13-17 Years |
12.8 |
9.3 to 17.4 |
358 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2015 |
Age |
13-17 Years |
18.6 |
14.2 to 24.0 |
360 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2015 |
Age |
13-17 Years |
9.8 |
6.4 to 14.8 |
418 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2015 |
Age |
13-17 Years |
20.1 |
14.8 to 26.7 |
321 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2015 |
Age |
13-17 Years |
13.3 |
9.6 to 18.2 |
374 |
| Varicella |
History of disease |
States/Local Areas |
Guam |
2015 |
Age |
13-17 Years |
45.9 |
40.3 to 51.6 |
419 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2015 |
Age |
13-17 Years |
14.6 |
10.8 to 19.4 |
340 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2015 |
Age |
13-17 Years |
31.4 |
25.7 to 37.8 |
356 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2015 |
Age |
13-17 Years |
17.4 |
14.3 to 20.9 |
779 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2015 |
Age |
13-17 Years |
14.5 |
10.4 to 19.9 |
283 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2015 |
Age |
13-17 Years |
18.0 |
14.4 to 22.1 |
496 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2015 |
Age |
13-17 Years |
21.6 |
16.8 to 27.4 |
328 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2015 |
Age |
13-17 Years |
15.8 |
11.9 to 20.6 |
383 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2015 |
Age |
13-17 Years |
23.2 |
18.5 to 28.6 |
375 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2015 |
Age |
13-17 Years |
19.1 |
14.5 to 24.7 |
330 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2015 |
Age |
13-17 Years |
14.5 |
10.7 to 19.3 |
382 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2015 |
Age |
13-17 Years |
18.8 |
14.6 to 24.0 |
374 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2015 |
Age |
13-17 Years |
18.5 |
13.6 to 24.5 |
403 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2015 |
Age |
13-17 Years |
13.8 |
9.6 to 19.4 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2015 |
Age |
13-17 Years |
14.0 |
10.2 to 18.9 |
373 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2015 |
Age |
13-17 Years |
18.2 |
13.8 to 23.6 |
366 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2015 |
Age |
13-17 Years |
24.2 |
19.5 to 29.8 |
364 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2015 |
Age |
13-17 Years |
20.9 |
15.6 to 27.5 |
300 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2015 |
Age |
13-17 Years |
27.7 |
23.0 to 32.9 |
406 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2015 |
Age |
13-17 Years |
18.3 |
14.3 to 23.1 |
393 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2015 |
Age |
13-17 Years |
18.6 |
13.8 to 24.4 |
372 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2015 |
Age |
13-17 Years |
15.6 |
11.4 to 20.9 |
295 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2015 |
Age |
13-17 Years |
15.7 |
11.6 to 20.9 |
364 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2015 |
Age |
13-17 Years |
16.2 |
12.5 to 20.7 |
396 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2015 |
Age |
13-17 Years |
16.0 |
12.9 to 19.7 |
665 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2015 |
Age |
13-17 Years |
13.7 |
10.0 to 18.6 |
313 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2015 |
Age |
13-17 Years |
17.5 |
13.1 to 22.8 |
352 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2015 |
Age |
13-17 Years |
16.7 |
12.8 to 21.7 |
358 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2015 |
Age |
13-17 Years |
27.2 |
21.7 to 33.4 |
323 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2015 |
Age |
13-17 Years |
19.3 |
14.6 to 25.2 |
332 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2015 |
Age |
13-17 Years |
14.5 |
10.3 to 19.9 |
291 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2015 |
Age |
13-17 Years |
21.1 |
16.3 to 26.8 |
353 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2015 |
Age |
13-17 Years |
11.2 |
8.5 to 14.6 |
832 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2015 |
Age |
13-17 Years |
12.7 |
9.0 to 17.5 |
340 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2015 |
Age |
13-17 Years |
11.0 |
8.0 to 14.9 |
492 |
| Varicella |
History of disease |
States/Local Areas |
Puerto Rico |
2015 |
Age |
13-17 Years |
7.8 |
5.2 to 11.5 |
339 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2015 |
Age |
13-17 Years |
17.8 |
16.8 to 18.9 |
21875 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2015 |
Age |
13-17 Years |
14.6 |
12.2 to 17.3 |
2188 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2015 |
Age |
13-17 Years |
15.9 |
13.3 to 18.8 |
1029 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2015 |
Age |
13-17 Years |
15.9 |
13.6 to 18.6 |
2742 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2015 |
Age |
13-17 Years |
18.4 |
16.3 to 20.7 |
2793 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2015 |
Age |
13-17 Years |
17.8 |
16.0 to 19.8 |
2543 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2015 |
Age |
13-17 Years |
19.1 |
17.1 to 21.4 |
4048 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2015 |
Age |
13-17 Years |
19.9 |
17.1 to 23.1 |
1451 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2015 |
Age |
13-17 Years |
20.3 |
17.8 to 23.2 |
2120 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2015 |
Age |
13-17 Years |
15.9 |
12.0 to 20.9 |
1506 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2015 |
Age |
13-17 Years |
15.4 |
11.6 to 20.1 |
419 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2015 |
Age |
13-17 Years |
18.9 |
14.4 to 24.4 |
360 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2015 |
Age |
13-17 Years |
27.3 |
22.0 to 33.3 |
349 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2015 |
Age |
13-17 Years |
19.7 |
14.9 to 25.7 |
325 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2015 |
Age |
13-17 Years |
20.7 |
17.9 to 23.8 |
2617 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2015 |
Age |
13-17 Years |
17.5 |
13.2 to 22.9 |
368 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2015 |
Age |
13-17 Years |
14.5 |
9.7 to 21.1 |
259 |
| Varicella |
History of disease |
States/Local Areas |
TX-El Paso County |
2015 |
Age |
13-17 Years |
20.6 |
16.8 to 25.0 |
558 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2015 |
Age |
13-17 Years |
21.4 |
18.0 to 25.3 |
946 |
| Varicella |
History of disease |
States/Local Areas |
U.S. Virgin Islands |
2015 |
Age |
13-17 Years |
6.1 |
4.0 to 9.3 |
458 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2015 |
Age |
13-17 Years |
25.4 |
22.3 to 28.8 |
1455 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2015 |
Age |
13-17 Years |
18.7 |
14.2 to 24.2 |
357 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2015 |
Age |
13-17 Years |
22.5 |
18.1 to 27.7 |
404 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2015 |
Age |
13-17 Years |
19.6 |
14.0 to 26.8 |
385 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2015 |
Age |
13-17 Years |
26.6 |
21.7 to 32.1 |
396 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2015 |
Age |
13-17 Years |
23.2 |
18.5 to 28.7 |
344 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2015 |
Age |
13-17 Years |
17.4 |
13.1 to 22.7 |
365 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2015 |
Age |
13-17 Years |
21.8 |
16.9 to 27.7 |
331 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
11.1 |
7.7 to 15.7 |
333 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
19.9 |
15.3 to 25.6 |
392 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
16.6 |
12.2 to 22.2 |
329 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
12.9 |
9.4 to 17.4 |
352 |
| Varicella |
History of disease |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
12.6 |
8.7 to 17.8 |
327 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
11.8 |
8.0 to 17.1 |
322 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
10.6 |
7.2 to 15.4 |
357 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
11.7 |
8.2 to 16.6 |
375 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
10.2 |
6.9 to 14.9 |
377 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
13.6 |
9.6 to 19.0 |
376 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
11.5 |
8.0 to 16.2 |
367 |
| Varicella |
History of disease |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
36.0 |
31.1 to 41.2 |
535 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
17.1 |
12.5 to 22.8 |
317 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
20.3 |
15.6 to 25.9 |
358 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
18.5 |
14.9 to 22.9 |
605 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
17.5 |
11.0 to 26.5 |
157 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
18.8 |
14.6 to 23.8 |
448 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
20.0 |
15.3 to 25.7 |
350 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
21.5 |
17.0 to 26.9 |
382 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
19.8 |
14.9 to 25.7 |
322 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
18.4 |
14.0 to 23.9 |
333 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
17.2 |
13.0 to 22.6 |
336 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
15.4 |
11.4 to 20.6 |
347 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
11.3 |
7.7 to 16.3 |
451 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
11.4 |
8.2 to 15.6 |
374 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
14.8 |
10.5 to 20.3 |
283 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
20.6 |
16.1 to 26.0 |
375 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
17.0 |
13.0 to 22.0 |
377 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
16.2 |
12.2 to 21.1 |
360 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
26.7 |
21.3 to 33.0 |
375 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
17.6 |
13.1 to 23.2 |
330 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
19.0 |
14.1 to 25.1 |
330 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
14.5 |
10.5 to 19.6 |
313 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
10.3 |
7.4 to 14.2 |
422 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
16.3 |
12.3 to 21.2 |
374 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
12.0 |
9.3 to 15.3 |
655 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
13.4 |
9.6 to 18.4 |
291 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
11.1 |
7.6 to 15.8 |
364 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
17.4 |
12.9 to 22.9 |
366 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
20.4 |
15.3 to 26.5 |
293 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
20.2 |
15.3 to 26.4 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
9.4 |
6.2 to 13.9 |
281 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
12.9 |
9.2 to 17.7 |
318 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
13.0 |
9.6 to 17.2 |
875 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
11.5 |
7.9 to 16.4 |
349 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
13.2 |
9.5 to 18.0 |
526 |
| Varicella |
History of disease |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
8.2 |
5.3 to 12.5 |
405 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
15.2 |
14.3 to 16.1 |
20475 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
12.2 |
10.2 to 14.4 |
2097 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
11.4 |
9.3 to 13.9 |
1077 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
12.9 |
10.8 to 15.4 |
2842 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
14.6 |
12.8 to 16.6 |
2757 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
18.2 |
16.2 to 20.3 |
2284 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
16.6 |
14.5 to 18.9 |
3270 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
18.3 |
15.9 to 21.0 |
1394 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
15.7 |
13.4 to 18.4 |
2022 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
13.6 |
10.4 to 17.6 |
1303 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
13.0 |
9.0 to 18.4 |
326 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
15.2 |
10.9 to 20.6 |
314 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
26.0 |
20.5 to 32.3 |
342 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
16.4 |
11.7 to 22.5 |
291 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
17.9 |
15.0 to 21.1 |
1927 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
23.1 |
17.7 to 29.7 |
334 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
11.9 |
7.3 to 18.8 |
225 |
| Varicella |
History of disease |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
11.9 |
7.8 to 17.9 |
294 |
| Varicella |
History of disease |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
17.3 |
12.5 to 23.6 |
345 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
18.6 |
15.0 to 22.9 |
729 |
| Varicella |
History of disease |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
5.9 |
3.6 to 9.4 |
428 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
18.7 |
15.7 to 22.2 |
1429 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
14.6 |
10.8 to 19.5 |
317 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
18.3 |
14.4 to 22.9 |
380 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
13.2 |
8.8 to 19.3 |
451 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
21.4 |
16.3 to 27.5 |
361 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
18.0 |
13.5 to 23.6 |
313 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
14.4 |
10.3 to 19.7 |
333 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
21.6 |
17.1 to 26.9 |
373 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
12.6 |
9.1 to 17.2 |
367 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
15.2 |
11.3 to 20.1 |
349 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
11.9 |
8.3 to 16.9 |
335 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
13.6 |
10.2 to 18.0 |
357 |
| Varicella |
History of disease |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
13.4 |
9.0 to 19.6 |
306 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
13.6 |
9.6 to 19.0 |
354 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
17.7 |
13.0 to 23.7 |
330 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
12.6 |
8.8 to 17.8 |
350 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
10.3 |
6.5 to 16.0 |
318 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
13.3 |
9.6 to 18.2 |
415 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
10.9 |
7.1 to 16.4 |
343 |
| Varicella |
History of disease |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
36.0 |
30.3 to 42.1 |
382 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
11.7 |
8.0 to 16.9 |
314 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
20.0 |
15.2 to 25.7 |
353 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
11.8 |
9.1 to 15.2 |
683 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
14.8 |
9.4 to 22.7 |
204 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
11.1 |
8.2 to 15.1 |
479 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
11.0 |
7.2 to 16.4 |
334 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
14.6 |
10.9 to 19.4 |
343 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
15.0 |
11.1 to 20.0 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
12.1 |
8.8 to 16.3 |
372 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
11.2 |
7.8 to 15.9 |
341 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
13.5 |
10.1 to 17.9 |
347 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
12.7 |
8.5 to 18.7 |
470 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
13.1 |
9.3 to 18.0 |
412 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
12.9 |
9.2 to 17.8 |
328 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
15.5 |
11.3 to 20.9 |
356 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
17.6 |
13.2 to 23.0 |
347 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
12.9 |
9.3 to 17.7 |
335 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
21.4 |
16.5 to 27.2 |
326 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
15.8 |
11.7 to 21.0 |
324 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
12.0 |
8.4 to 16.9 |
344 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
17.5 |
13.1 to 22.9 |
333 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
11.8 |
8.2 to 16.6 |
366 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
13.4 |
9.4 to 18.8 |
362 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
14.4 |
11.4 to 18.2 |
651 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
10.0 |
6.8 to 14.4 |
281 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
17.3 |
12.9 to 22.8 |
370 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
8.7 |
5.7 to 13.0 |
336 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
14.7 |
11.1 to 19.2 |
379 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
19.3 |
15.0 to 24.3 |
408 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
15.7 |
11.4 to 21.2 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
15.5 |
11.6 to 20.2 |
359 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
9.9 |
7.2 to 13.6 |
851 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
12.0 |
8.4 to 16.7 |
362 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
9.6 |
6.6 to 13.8 |
489 |
| Varicella |
History of disease |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
13.2 |
12.3 to 14.2 |
20949 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
14.7 |
12.4 to 17.4 |
2107 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
13.6 |
11.1 to 16.4 |
1017 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
11.2 |
9.1 to 13.6 |
2745 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
11.7 |
10.1 to 13.5 |
2846 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
14.2 |
12.6 to 16.1 |
2433 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
13.8 |
12.1 to 15.7 |
3654 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
14.2 |
12.0 to 16.6 |
1340 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
14.1 |
11.7 to 16.7 |
2108 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
13.1 |
9.5 to 17.8 |
1299 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
10.7 |
7.1 to 15.9 |
319 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
10.6 |
7.0 to 15.9 |
328 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
13.2 |
9.4 to 18.2 |
333 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
10.3 |
7.1 to 14.8 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
14.0 |
11.8 to 16.5 |
2256 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
13.3 |
9.7 to 18.0 |
336 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
12.1 |
7.3 to 19.6 |
187 |
| Varicella |
History of disease |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
11.5 |
7.5 to 17.3 |
263 |
| Varicella |
History of disease |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
13.8 |
9.7 to 19.2 |
320 |
| Varicella |
History of disease |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
16.4 |
11.9 to 22.1 |
304 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
14.4 |
11.5 to 18.0 |
846 |
| Varicella |
History of disease |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
15.4 |
13.0 to 18.3 |
1400 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
12.6 |
9.1 to 17.2 |
356 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
18.0 |
13.5 to 23.6 |
366 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
10.9 |
6.7 to 17.4 |
413 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
14.2 |
10.4 to 19.0 |
339 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
15.6 |
11.4 to 20.9 |
343 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
14.6 |
10.6 to 19.9 |
324 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
16.5 |
12.2 to 22.0 |
360 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
9.4 |
6.1 to 14.3 |
327 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
11.5 |
8.3 to 15.7 |
392 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
12.5 |
8.5 to 17.9 |
288 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
13.1 |
8.9 to 18.7 |
308 |
| Varicella |
History of disease |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
10.2 |
6.6 to 15.5 |
356 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
10.4 |
6.4 to 16.6 |
278 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
8.9 |
5.8 to 13.4 |
293 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
6.0 |
3.6 to 9.7 |
306 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
10.3 |
6.9 to 15.1 |
337 |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
8.3 |
5.3 to 12.6 |
345 |
| Varicella |
History of disease |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
33.4 |
27.3 to 40.1 |
309 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
9.5 |
6.5 to 13.5 |
327 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
17.4 |
12.6 to 23.5 |
291 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
12.5 |
9.8 to 15.9 |
721 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
12.1 |
6.9 to 20.4 |
192 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
12.6 |
9.6 to 16.4 |
529 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
15.8 |
11.4 to 21.5 |
296 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
14.9 |
10.7 to 20.3 |
280 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
12.1 |
8.5 to 16.9 |
297 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
16.3 |
11.7 to 22.4 |
270 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
13.2 |
9.2 to 18.6 |
284 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
6.6 |
4.3 to 10.0 |
317 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
10.4 |
6.8 to 15.7 |
393 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
13.9 |
9.3 to 20.3 |
328 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
8.2 |
5.1 to 12.9 |
313 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
13.7 |
9.0 to 20.4 |
285 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
15.0 |
10.7 to 20.5 |
285 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
12.9 |
8.7 to 18.7 |
319 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
16.9 |
12.2 to 22.8 |
290 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
13.7 |
9.5 to 19.2 |
295 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
13.7 |
9.7 to 19.1 |
334 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
9.4 |
5.8 to 14.7 |
303 |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
13.8 |
9.7 to 19.3 |
351 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
11.8 |
8.0 to 17.0 |
295 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
11.8 |
8.6 to 15.8 |
535 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
12.5 |
8.3 to 18.4 |
261 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
11.3 |
7.2 to 17.2 |
274 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
14.7 |
10.5 to 20.1 |
341 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
11.9 |
7.9 to 17.5 |
287 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
16.6 |
11.9 to 22.6 |
329 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
7.0 |
4.7 to 10.2 |
360 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
11.5 |
7.7 to 16.8 |
297 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
8.1 |
4.9 to 13.0 |
649 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
5.3 |
3.0 to 9.2 |
237 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
8.5 |
5.0 to 14.0 |
412 |
| Varicella |
History of disease |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
11.9 |
11.0 to 12.7 |
18700 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
11.4 |
8.9 to 14.4 |
1902 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
12.4 |
9.9 to 15.6 |
886 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
9.7 |
7.4 to 12.5 |
2295 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
11.9 |
10.3 to 13.8 |
2507 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
12.9 |
11.2 to 14.9 |
2276 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
12.5 |
10.9 to 14.4 |
3326 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
13.3 |
10.9 to 16.1 |
1191 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
11.9 |
9.4 to 14.8 |
1746 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
10.7 |
7.7 to 14.7 |
1305 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
9.2 |
6.0 to 13.7 |
337 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
10.9 |
7.1 to 16.4 |
318 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
13.1 |
9.4 to 18.1 |
340 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
16.8 |
11.7 to 23.4 |
284 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
13.1 |
11.0 to 15.6 |
2079 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
16.1 |
11.5 to 22.1 |
298 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
7.9 |
4.4 to 13.7 |
186 |
| Varicella |
History of disease |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
19.9 |
14.1 to 27.3 |
314 |
| Varicella |
History of disease |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
12.6 |
8.9 to 17.4 |
364 |
| Varicella |
History of disease |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
13.0 |
10.3 to 16.2 |
917 |
| Varicella |
History of disease |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
11.8 |
9.3 to 14.8 |
1266 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
11.8 |
8.1 to 17.0 |
310 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
17.0 |
12.6 to 22.4 |
324 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
11.2 |
6.4 to 19.0 |
327 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
10.4 |
6.7 to 15.7 |
286 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
13.1 |
9.6 to 17.6 |
337 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
10.6 |
7.4 to 14.9 |
332 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
15.1 |
10.3 to 21.5 |
241 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
7.6 |
4.4 to 12.9 |
296 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
10.4 |
7.4 to 14.3 |
426 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
10.4 |
6.4 to 16.5 |
308 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
11.4 |
7.9 to 16.2 |
329 |
| Varicella |
History of disease |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
6.0 |
3.4 to 10.4 |
274 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
12.3 |
7.6 to 19.3 |
262 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
7.2 |
4.1 to 12.3 |
294 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
6.4 |
3.9 to 10.3 |
308 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
8.6 |
5.6 to 13.0 |
315 |
| Varicella |
History of disease |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
25.2 |
19.3 to 32.2 |
278 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
8.6 |
5.3 to 13.7 |
304 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
9.9 |
6.3 to 15.2 |
332 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
11.0 |
8.1 to 14.8 |
602 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
12.9 |
9.4 to 17.4 |
442 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
10.3 |
6.5 to 15.9 |
289 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
10.3 |
6.8 to 15.2 |
302 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
9.3 |
6.4 to 13.3 |
381 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
8.5 |
5.6 to 12.6 |
292 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
9.4 |
5.7 to 15.1 |
336 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
10.1 |
6.5 to 15.3 |
316 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
7.5 |
4.8 to 11.6 |
524 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
8.6 |
5.2 to 14.0 |
300 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
7.8 |
5.1 to 11.7 |
297 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
8.9 |
5.8 to 13.5 |
270 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
10.4 |
6.8 to 15.6 |
288 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
19.2 |
14.1 to 25.7 |
297 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
7.7 |
5.0 to 11.9 |
285 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
12.4 |
8.4 to 18.1 |
313 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
6.9 |
4.1 to 11.3 |
331 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
10.8 |
7.3 to 15.8 |
405 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
12.8 |
9.5 to 17.2 |
498 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
10.3 |
6.8 to 15.2 |
257 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
14.5 |
9.7 to 21.1 |
241 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
9.0 |
5.3 to 14.8 |
305 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
7.9 |
5.0 to 12.4 |
319 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
7.6 |
5.0 to 11.4 |
302 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
13.3 |
9.6 to 18.2 |
369 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
10.5 |
6.6 to 16.2 |
270 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
7.5 |
4.8 to 11.5 |
734 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
10.9 |
6.6 to 17.6 |
242 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
7.1 |
4.2 to 11.7 |
492 |
| Varicella |
History of disease |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
9.1 |
8.4 to 9.9 |
18788 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
8.4 |
6.4 to 11.0 |
2034 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
10.8 |
8.3 to 14.0 |
829 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
8.9 |
6.9 to 11.4 |
2520 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
7.9 |
6.4 to 9.7 |
2387 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
9.2 |
7.8 to 10.8 |
2097 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
11.0 |
9.4 to 13.0 |
3289 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
9.8 |
7.8 to 12.2 |
1256 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
10.6 |
8.2 to 13.7 |
1845 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
7.1 |
4.8 to 10.4 |
1199 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
10.3 |
6.8 to 15.4 |
319 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
6.0 |
3.5 to 10.3 |
319 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
11.4 |
7.8 to 16.4 |
313 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
10.1 |
6.4 to 15.7 |
261 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
11.0 |
8.8 to 13.6 |
1850 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
11.7 |
7.6 to 17.4 |
293 |
| Varicella |
History of disease |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
10.3 |
5.8 to 17.5 |
174 |
| Varicella |
History of disease |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
11.9 |
7.8 to 17.8 |
271 |
| Varicella |
History of disease |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
10.0 |
6.7 to 14.5 |
280 |
| Varicella |
History of disease |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
10.9 |
8.2 to 14.4 |
832 |
| Varicella |
History of disease |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
10.8 |
8.2 to 14.2 |
1332 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
6.1 |
3.7 to 9.8 |
325 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
13.9 |
10.1 to 18.8 |
472 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
12.6 |
7.9 to 19.6 |
363 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
11.4 |
7.3 to 17.3 |
304 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
8.2 |
5.2 to 12.7 |
309 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
11.1 |
7.8 to 15.7 |
331 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
14.1 |
10.1 to 19.2 |
329 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
7.1 |
4.4 to 11.2 |
298 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
8.9 |
5.5 to 14.1 |
302 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
8.4 |
5.5 to 12.8 |
340 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
6.4 |
3.9 to 10.2 |
322 |
| Varicella |
History of disease |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
9.2 |
5.8 to 14.3 |
403 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
8.9 |
5.7 to 13.6 |
354 |
| Varicella |
History of disease |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
5.5 |
3.2 to 9.4 |
331 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
10.3 |
6.6 to 15.6 |
360 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
4.7 |
2.6 to 8.2 |
404 |
| Varicella |
History of disease |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
7.7 |
4.6 to 12.6 |
355 |
| Varicella |
History of disease |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
23.1 |
17.9 to 29.4 |
300 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
8.3 |
5.2 to 13.1 |
290 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
15.1 |
10.8 to 20.6 |
376 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
6.0 |
4.2 to 8.6 |
699 |
| Varicella |
History of disease |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
8.7 |
4.9 to 15.0 |
271 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
5.5 |
3.5 to 8.4 |
428 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
10.6 |
6.9 to 16.1 |
302 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
11.2 |
7.3 to 16.6 |
280 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
10.3 |
7.3 to 14.5 |
364 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
7.2 |
4.4 to 11.6 |
255 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
8.4 |
5.3 to 13.2 |
356 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
9.8 |
6.8 to 14.1 |
372 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
7.5 |
5.2 to 10.8 |
815 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
6.2 |
3.8 to 10.0 |
394 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
7.9 |
5.0 to 12.3 |
398 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
8.1 |
5.2 to 12.5 |
330 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
11.1 |
7.4 to 16.3 |
282 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
10.4 |
7.1 to 14.9 |
397 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
10.4 |
6.9 to 15.3 |
307 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
8.6 |
5.8 to 12.5 |
405 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
7.5 |
4.6 to 12.0 |
369 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
9.7 |
6.5 to 14.2 |
381 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
7.9 |
5.2 to 11.8 |
352 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
7.4 |
5.3 to 10.4 |
729 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
6.7 |
4.2 to 10.5 |
381 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
7.9 |
5.0 to 12.4 |
348 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
5.7 |
3.3 to 9.8 |
327 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
8.0 |
5.2 to 12.3 |
401 |
| Varicella |
History of disease |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
6.7 |
3.7 to 11.6 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
9.5 |
6.4 to 13.8 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
10.2 |
6.7 to 15.2 |
308 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
8.8 |
5.9 to 13.0 |
765 |
| Varicella |
History of disease |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
6.2 |
3.5 to 10.8 |
263 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
9.1 |
5.9 to 13.9 |
502 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
8.4 |
7.6 to 9.2 |
20163 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
6.9 |
5.4 to 8.7 |
2147 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
6.6 |
4.9 to 8.9 |
1108 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
8.6 |
6.9 to 10.7 |
3331 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
6.8 |
5.5 to 8.4 |
2466 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
7.7 |
6.3 to 9.3 |
2344 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
10.1 |
8.0 to 12.7 |
2509 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
10.3 |
8.3 to 12.6 |
1446 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
9.4 |
7.4 to 11.9 |
2007 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
9.0 |
6.2 to 12.8 |
1402 |
| Varicella |
History of disease |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
7.8 |
4.7 to 12.6 |
271 |
| Varicella |
History of disease |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
6.6 |
4.0 to 10.6 |
311 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
9.9 |
6.3 to 15.2 |
317 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
8.9 |
6.0 to 13.1 |
338 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
10.9 |
8.0 to 14.6 |
1141 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
8.1 |
5.0 to 12.9 |
314 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
11.5 |
8.3 to 15.7 |
606 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
11.4 |
8.8 to 14.6 |
1403 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
9.9 |
6.4 to 15.2 |
304 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
9.0 |
6.0 to 13.1 |
398 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
8.6 |
5.6 to 13.1 |
677 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
11.2 |
7.2 to 17.0 |
417 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
11.2 |
7.6 to 16.2 |
310 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
8.7 |
5.4 to 13.7 |
277 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
10.1 |
6.6 to 15.1 |
324 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
7.1 |
4.3 to 11.4 |
304 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
8.3 |
5.1 to 13.2 |
268 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
8.5 |
5.1 to 14.0 |
296 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
6.6 |
4.1 to 10.4 |
314 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
8.1 |
4.7 to 13.9 |
298 |
| Varicella |
History of disease |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
8.1 |
5.0 to 12.9 |
310 |
| Varicella |
History of disease |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
7.7 |
4.6 to 12.7 |
409 |
| Varicella |
History of disease |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
21.8 |
15.8 to 29.4 |
225 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
9.2 |
5.7 to 14.3 |
258 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
10.1 |
6.6 to 15.4 |
334 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
5.9 |
3.8 to 9.2 |
578 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
6.0 |
3.5 to 9.8 |
434 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
8.1 |
4.8 to 13.4 |
268 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
7.1 |
4.0 to 12.3 |
300 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
13.2 |
8.7 to 19.6 |
240 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
3.9 |
2.3 to 6.7 |
303 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
7.4 |
4.5 to 11.9 |
293 |
| Varicella |
History of disease |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
5.0 |
3.4 to 7.2 |
857 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
5.9 |
3.4 to 10.2 |
296 |
| Varicella |
History of disease |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
7.6 |
4.9 to 11.6 |
303 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
7.2 |
4.4 to 11.4 |
340 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
11.6 |
7.6 to 17.3 |
290 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
7.3 |
4.4 to 11.9 |
315 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
7.7 |
4.7 to 12.3 |
333 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
9.0 |
5.4 to 14.7 |
282 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
8.2 |
5.0 to 13.1 |
337 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
8.5 |
6.0 to 11.9 |
581 |
| Varicella |
History of disease |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
7.8 |
4.6 to 13.0 |
297 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
9.0 |
5.7 to 13.8 |
284 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
10.2 |
5.8 to 17.2 |
266 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
8.1 |
5.0 to 13.1 |
240 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
6.5 |
4.0 to 10.5 |
294 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
5.4 |
3.5 to 8.2 |
929 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
5.5 |
3.4 to 8.6 |
599 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
7.3 |
6.5 to 8.2 |
18002 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
6.5 |
4.6 to 9.1 |
1923 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
7.4 |
5.5 to 9.9 |
873 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
5.7 |
4.5 to 7.3 |
3338 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
7.7 |
6.1 to 9.6 |
2263 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
7.4 |
5.8 to 9.3 |
2060 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
6.8 |
5.0 to 9.2 |
2184 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
7.1 |
5.4 to 9.4 |
1154 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
9.2 |
7.0 to 12.1 |
1789 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
7.8 |
4.6 to 13.0 |
1173 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
7.8 |
5.0 to 11.8 |
445 |
| Varicella |
History of disease |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
10.0 |
6.3 to 15.4 |
315 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
7.0 |
4.6 to 10.5 |
990 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
7.3 |
4.6 to 11.4 |
527 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
7.5 |
5.5 to 10.0 |
1245 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
10.8 |
6.9 to 16.5 |
304 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
8.5 |
6.2 to 11.6 |
488 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
7.1 |
4.1 to 11.9 |
349 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
10.0 |
6.3 to 15.6 |
267 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
9.1 |
5.9 to 13.9 |
306 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
9.8 |
6.4 to 14.9 |
261 |
| Varicella |
History of disease |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
7.7 |
4.5 to 12.9 |
269 |
| Varicella |
History of disease |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
10.0 |
5.9 to 16.5 |
240 |
| Varicella |
History of disease |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
5.4 |
3.0 to 9.3 |
273 |
| Varicella |
History of disease |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
5.4 |
3.1 to 9.3 |
332 |
| Varicella |
History of disease |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
4.3 |
2.5 to 7.4 |
321 |
| Varicella |
History of disease |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
5.9 |
3.7 to 9.4 |
342 |
| Varicella |
History of disease |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
14.6 |
9.6 to 21.5 |
240 |
| Varicella |
History of disease |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
7.2 |
4.2 to 12.2 |
237 |
| Varicella |
History of disease |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
12.1 |
7.6 to 18.7 |
251 |
| Varicella |
History of disease |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
6.9 |
4.4 to 10.7 |
630 |
| Varicella |
History of disease |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
7.3 |
4.4 to 12.0 |
374 |
| Varicella |
History of disease |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
8.5 |
5.0 to 14.0 |
258 |
| Varicella |
History of disease |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
7.2 |
4.2 to 12.1 |
207 |
| Varicella |
History of disease |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
7.2 |
4.2 to 12.1 |
310 |
| Varicella |
History of disease |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
9.8 |
6.1 to 15.2 |
276 |
| Varicella |
History of disease |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
7.7 |
4.7 to 12.2 |
330 |
| Varicella |
History of disease |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
6.8 |
3.9 to 11.6 |
268 |
| Varicella |
History of disease |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
8.6 |
5.1 to 14.0 |
268 |
| Varicella |
History of disease |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
7.1 |
4.2 to 11.7 |
257 |
| Varicella |
History of disease |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
5.3 |
3.0 to 9.2 |
331 |
| Varicella |
History of disease |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
6.4 |
3.8 to 10.5 |
284 |
| Varicella |
History of disease |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
7.3 |
4.6 to 11.4 |
297 |
| Varicella |
History of disease |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
4.2 |
2.4 to 7.3 |
247 |
| Varicella |
History of disease |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
7.9 |
4.5 to 13.3 |
259 |
| Varicella |
History of disease |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
7.4 |
4.4 to 12.3 |
225 |
| Varicella |
History of disease |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
6.3 |
3.5 to 11.2 |
276 |
| Varicella |
History of disease |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
6.2 |
4.1 to 9.4 |
536 |
| Varicella |
History of disease |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
8.1 |
5.0 to 12.8 |
314 |
| Varicella |
History of disease |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
7.7 |
4.6 to 12.7 |
361 |
| Varicella |
History of disease |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
5.1 |
3.0 to 8.7 |
280 |
| Varicella |
History of disease |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
10.6 |
6.4 to 17.0 |
249 |
| Varicella |
History of disease |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
9.7 |
6.1 to 15.1 |
263 |
| Varicella |
History of disease |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
7.1 |
4.7 to 10.5 |
752 |
| Varicella |
History of disease |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
7.6 |
5.0 to 11.4 |
485 |
| Varicella |
History of disease |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
7.0 |
6.3 to 7.8 |
16043 |
| Varicella |
History of disease |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
7.0 |
5.1 to 9.5 |
1595 |
| Varicella |
History of disease |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
6.3 |
4.4 to 8.9 |
825 |
| Varicella |
History of disease |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
7.0 |
5.6 to 8.8 |
2424 |
| Varicella |
History of disease |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
6.7 |
5.3 to 8.4 |
2291 |
| Varicella |
History of disease |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
6.8 |
5.3 to 8.5 |
2019 |
| Varicella |
History of disease |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
9.4 |
6.7 to 13.1 |
1981 |
| Varicella |
History of disease |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
6.4 |
4.8 to 8.5 |
1048 |
| Varicella |
History of disease |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
7.5 |
5.7 to 9.7 |
1736 |
| Varicella |
History of disease |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
4.8 |
3.2 to 7.1 |
1090 |
| Varicella |
History of disease |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
9.1 |
5.2 to 15.5 |
252 |
| Varicella |
History of disease |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
10.1 |
6.5 to 15.4 |
794 |
| Varicella |
History of disease |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
9.8 |
5.8 to 16.1 |
253 |
| Varicella |
History of disease |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
10.0 |
6.0 to 16.2 |
384 |
| Varicella |
History of disease |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
10.3 |
7.8 to 13.6 |
1034 |
| Varicella |
History of disease |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
8.6 |
4.9 to 14.7 |
271 |
| Varicella |
History of disease |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
7.8 |
4.7 to 12.7 |
291 |
| Varicella |
History of disease |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
7.0 |
4.7 to 10.2 |
595 |
| Varicella |
History of disease |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
10.2 |
6.3 to 16.1 |
280 |
| Varicella |
History of disease |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
7.1 |
4.2 to 11.9 |
244 |
| Varicella |
History of disease |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
6.5 |
3.7 to 11.2 |
274 |
| Varicella |
History of disease |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
14.1 |
9.5 to 20.4 |
294 |
| HPV |
Series Completion (3 Dose) Among HPV Vaccination
Initiators, Females |
HHS Regions/National |
United States |
2007 |
Age |
13-17 Years |
45.2 |
35.9 to 54.9 |
188 |
| HPV |
Series Completion (3 Dose) Among HPV Vaccination
Initiators, Females |
HHS Regions/National |
Region 9 |
2007 |
Age |
13-17 Years |
54.5 |
32.3 to 75.0 |
37 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2018 |
Age |
13-15 Years |
45.6 |
33.6 to 58.2 |
96 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2018 |
Age |
13-15 Years |
39.8 |
30.2 to 50.3 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2018 |
Age |
13-15 Years |
54.0 |
41.8 to 65.6 |
94 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2018 |
Age |
13-15 Years |
36.4 |
25.5 to 48.8 |
92 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2018 |
Age |
13-15 Years |
43.4 |
31.8 to 55.6 |
119 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2018 |
Age |
13-15 Years |
54.9 |
41.3 to 67.8 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2018 |
Age |
13-15 Years |
48.8 |
37.2 to 60.5 |
96 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2018 |
Age |
13-15 Years |
61.3 |
48.6 to 72.7 |
102 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-15 Years |
75.2 |
61.3 to 85.4 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2018 |
Age |
13-15 Years |
43.4 |
31.5 to 56.1 |
101 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2018 |
Age |
13-15 Years |
47.9 |
36.6 to 59.4 |
113 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2018 |
Age |
13-15 Years |
46.7 |
35.2 to 58.6 |
103 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2018 |
Age |
13-15 Years |
58.9 |
47.1 to 69.9 |
98 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2018 |
Age |
13-15 Years |
45.2 |
32.7 to 58.2 |
74 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2018 |
Age |
13-15 Years |
54.3 |
46.2 to 62.2 |
226 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-15 Years |
63.0 |
43.2 to 79.3 |
55 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-15 Years |
52.7 |
43.9 to 61.4 |
171 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2018 |
Age |
13-15 Years |
47.7 |
35.6 to 60.0 |
91 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2018 |
Age |
13-15 Years |
60.1 |
47.7 to 71.4 |
80 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2018 |
Age |
13-15 Years |
32.8 |
22.8 to 44.7 |
93 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2018 |
Age |
13-15 Years |
46.2 |
33.3 to 59.8 |
73 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2018 |
Age |
13-15 Years |
41.4 |
28.0 to 56.1 |
68 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2018 |
Age |
13-15 Years |
44.8 |
33.2 to 57.0 |
100 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2018 |
Age |
13-15 Years |
50.0 |
38.0 to 62.1 |
122 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-15 Years |
61.3 |
47.7 to 73.4 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2018 |
Age |
13-15 Years |
57.6 |
44.9 to 69.4 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2018 |
Age |
13-15 Years |
54.6 |
39.8 to 68.7 |
74 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2018 |
Age |
13-15 Years |
35.1 |
23.5 to 48.9 |
77 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2018 |
Age |
13-15 Years |
46.0 |
34.1 to 58.3 |
84 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2018 |
Age |
13-15 Years |
46.3 |
34.9 to 58.1 |
97 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2018 |
Age |
13-15 Years |
65.5 |
52.5 to 76.5 |
88 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2018 |
Age |
13-15 Years |
47.9 |
36.5 to 59.5 |
101 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-15 Years |
62.7 |
49.8 to 74.1 |
90 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2018 |
Age |
13-15 Years |
43.2 |
32.0 to 55.2 |
105 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2018 |
Age |
13-15 Years |
49.7 |
37.2 to 62.2 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2018 |
Age |
13-15 Years |
51.3 |
40.9 to 61.7 |
141 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-15 Years |
48.7 |
34.7 to 62.8 |
71 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-15 Years |
53.0 |
38.6 to 66.9 |
70 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2018 |
Age |
13-15 Years |
45.9 |
35.0 to 57.3 |
114 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2018 |
Age |
13-15 Years |
71.4 |
58.3 to 81.7 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2018 |
Age |
13-15 Years |
54.3 |
43.0 to 65.3 |
110 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-15 Years |
34.5 |
23.9 to 46.8 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2018 |
Age |
13-15 Years |
59.4 |
46.2 to 71.4 |
80 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-15 Years |
65.1 |
54.0 to 74.8 |
196 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-15 Years |
69.1 |
55.1 to 80.2 |
77 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-15 Years |
64.6 |
52.0 to 75.4 |
119 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2018 |
Age |
13-15 Years |
48.9 |
46.5 to 51.3 |
5582 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-15 Years |
56.9 |
49.8 to 63.8 |
564 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-15 Years |
48.4 |
40.5 to 56.4 |
246 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-15 Years |
57.0 |
49.8 to 63.9 |
717 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-15 Years |
44.1 |
39.0 to 49.4 |
763 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-15 Years |
54.3 |
49.5 to 59.0 |
688 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-15 Years |
44.0 |
39.3 to 48.9 |
939 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-15 Years |
48.6 |
42.0 to 55.3 |
345 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-15 Years |
50.1 |
42.5 to 57.7 |
520 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-15 Years |
45.5 |
36.2 to 55.2 |
412 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-15 Years |
71.8 |
60.3 to 81.1 |
97 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2018 |
Age |
13-15 Years |
33.0 |
22.3 to 45.8 |
97 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2018 |
Age |
13-15 Years |
41.1 |
30.5 to 52.5 |
98 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2018 |
Age |
13-15 Years |
45.4 |
33.1 to 58.3 |
92 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2018 |
Age |
13-15 Years |
46.0 |
39.7 to 52.4 |
605 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-15 Years |
49.8 |
38.6 to 61.0 |
104 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-15 Years |
57.5 |
41.3 to 72.3 |
53 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-15 Years |
44.3 |
30.7 to 58.7 |
92 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-15 Years |
50.7 |
38.9 to 62.4 |
103 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-15 Years |
44.1 |
36.1 to 52.5 |
253 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-15 Years |
52.6 |
44.9 to 60.3 |
388 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2018 |
Age |
13-15 Years |
40.2 |
28.0 to 53.8 |
92 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2018 |
Age |
13-15 Years |
53.5 |
42.2 to 64.5 |
98 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2018 |
Age |
13-15 Years |
51.5 |
35.4 to 67.3 |
110 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2018 |
Age |
13-15 Years |
52.9 |
40.9 to 64.6 |
108 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2018 |
Age |
13-15 Years |
45.9 |
35.3 to 56.9 |
104 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-15 Years |
56.6 |
45.4 to 67.2 |
100 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2018 |
Age |
13-15 Years |
54.4 |
40.0 to 68.1 |
63 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2019 |
Age |
13-15 Years |
47.9 |
36.1 to 60.0 |
95 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2019 |
Age |
13-15 Years |
54.6 |
44.0 to 64.8 |
122 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2019 |
Age |
13-15 Years |
51.9 |
38.8 to 64.7 |
90 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2019 |
Age |
13-15 Years |
47.9 |
36.0 to 60.0 |
96 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2019 |
Age |
13-15 Years |
65.6 |
49.3 to 78.9 |
80 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2019 |
Age |
13-15 Years |
70.2 |
55.3 to 81.7 |
70 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2019 |
Age |
13-15 Years |
45.6 |
31.2 to 60.7 |
67 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2019 |
Age |
13-15 Years |
58.3 |
44.9 to 70.5 |
82 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-15 Years |
70.5 |
54.0 to 83.0 |
73 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2019 |
Age |
13-15 Years |
53.7 |
39.0 to 67.7 |
104 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2019 |
Age |
13-15 Years |
51.5 |
39.5 to 63.4 |
105 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2019 |
Age |
13-15 Years |
47.6 |
35.5 to 60.0 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2019 |
Age |
13-15 Years |
64.5 |
50.2 to 76.7 |
82 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2019 |
Age |
13-15 Years |
42.5 |
30.6 to 55.3 |
101 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2019 |
Age |
13-15 Years |
52.7 |
43.4 to 61.9 |
173 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-15 Years |
68.5 |
49.5 to 82.8 |
47 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-15 Years |
49.5 |
39.1 to 60.0 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2019 |
Age |
13-15 Years |
33.2 |
23.0 to 45.1 |
89 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2019 |
Age |
13-15 Years |
59.6 |
48.5 to 69.8 |
103 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2019 |
Age |
13-15 Years |
43.1 |
31.1 to 56.0 |
107 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2019 |
Age |
13-15 Years |
59.0 |
46.6 to 70.4 |
84 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2019 |
Age |
13-15 Years |
64.2 |
51.0 to 75.5 |
111 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2019 |
Age |
13-15 Years |
42.1 |
30.3 to 55.0 |
95 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2019 |
Age |
13-15 Years |
62.7 |
50.9 to 73.2 |
169 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-15 Years |
65.4 |
50.7 to 77.7 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2019 |
Age |
13-15 Years |
59.5 |
46.4 to 71.4 |
95 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2019 |
Age |
13-15 Years |
71.3 |
55.8 to 83.1 |
71 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2019 |
Age |
13-15 Years |
62.7 |
50.3 to 73.6 |
95 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2019 |
Age |
13-15 Years |
49.8 |
37.2 to 62.4 |
85 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2019 |
Age |
13-15 Years |
63.1 |
49.6 to 74.9 |
81 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2019 |
Age |
13-15 Years |
57.9 |
45.1 to 69.7 |
103 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-15 Years |
55.9 |
42.5 to 68.5 |
88 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2019 |
Age |
13-15 Years |
42.3 |
30.2 to 55.5 |
99 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2019 |
Age |
13-15 Years |
49.4 |
38.8 to 60.1 |
136 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2019 |
Age |
13-15 Years |
60.0 |
49.7 to 69.5 |
155 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-15 Years |
60.9 |
47.6 to 72.7 |
84 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-15 Years |
59.3 |
43.9 to 73.1 |
71 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2019 |
Age |
13-15 Years |
42.6 |
30.5 to 55.6 |
86 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2019 |
Age |
13-15 Years |
70.4 |
58.7 to 79.9 |
93 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2019 |
Age |
13-15 Years |
45.4 |
32.5 to 58.8 |
74 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-15 Years |
35.5 |
25.0 to 47.5 |
98 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2019 |
Age |
13-15 Years |
63.3 |
49.2 to 75.4 |
88 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-15 Years |
56.1 |
45.8 to 65.9 |
212 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-15 Years |
77.3 |
63.0 to 87.2 |
62 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-15 Years |
53.3 |
42.0 to 64.3 |
150 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-15 Years |
61.7 |
41.8 to 78.3 |
64 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2019 |
Age |
13-15 Years |
54.6 |
51.8 to 57.4 |
5500 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-15 Years |
58.2 |
50.2 to 65.9 |
540 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-15 Years |
54.2 |
46.1 to 62.0 |
254 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-15 Years |
52.3 |
45.8 to 58.7 |
745 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-15 Years |
50.4 |
44.6 to 56.3 |
719 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-15 Years |
52.3 |
47.2 to 57.4 |
594 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-15 Years |
50.7 |
45.7 to 55.7 |
998 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-15 Years |
58.2 |
51.4 to 64.7 |
386 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-15 Years |
58.4 |
50.7 to 65.7 |
507 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-15 Years |
63.3 |
50.6 to 74.4 |
355 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-15 Years |
77.8 |
62.9 to 87.8 |
77 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2019 |
Age |
13-15 Years |
57.9 |
45.3 to 69.6 |
96 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2019 |
Age |
13-15 Years |
55.3 |
42.6 to 67.4 |
78 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2019 |
Age |
13-15 Years |
53.4 |
40.0 to 66.3 |
78 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2019 |
Age |
13-15 Years |
51.0 |
44.4 to 57.4 |
557 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-15 Years |
47.4 |
34.8 to 60.3 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-15 Years |
59.0 |
40.6 to 75.2 |
56 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-15 Years |
51.9 |
39.2 to 64.4 |
85 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-15 Years |
71.6 |
59.8 to 81.1 |
88 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-15 Years |
49.4 |
41.0 to 57.9 |
245 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-15 Years |
30.8 |
17.9 to 47.7 |
66 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-15 Years |
58.5 |
49.9 to 66.7 |
402 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2019 |
Age |
13-15 Years |
44.4 |
32.6 to 57.0 |
102 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2019 |
Age |
13-15 Years |
58.0 |
46.6 to 68.6 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2019 |
Age |
13-15 Years |
40.5 |
28.2 to 54.2 |
129 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2019 |
Age |
13-15 Years |
60.9 |
46.6 to 73.7 |
91 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2019 |
Age |
13-15 Years |
46.1 |
33.6 to 59.1 |
80 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-15 Years |
63.4 |
51.4 to 73.9 |
92 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2019 |
Age |
13-15 Years |
35.5 |
24.4 to 48.3 |
79 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2020 |
Age |
13-15 Years |
58.7 |
46.3 to 70.0 |
85 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2020 |
Age |
13-15 Years |
59.5 |
46.6 to 71.2 |
84 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2020 |
Age |
13-15 Years |
49.0 |
37.3 to 60.7 |
99 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2020 |
Age |
13-15 Years |
46.2 |
34.3 to 58.7 |
96 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2020 |
Age |
13-15 Years |
64.2 |
51.2 to 75.4 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2020 |
Age |
13-15 Years |
65.6 |
52.7 to 76.6 |
95 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2020 |
Age |
13-15 Years |
61.9 |
50.3 to 72.3 |
99 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2020 |
Age |
13-15 Years |
55.1 |
43.1 to 66.6 |
103 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-15 Years |
74.1 |
61.8 to 83.5 |
116 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2020 |
Age |
13-15 Years |
50.4 |
37.6 to 63.1 |
103 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2020 |
Age |
13-15 Years |
53.6 |
40.2 to 66.5 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2020 |
Age |
13-15 Years |
52.3 |
39.6 to 64.7 |
84 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2020 |
Age |
13-15 Years |
60.5 |
46.9 to 72.5 |
73 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2020 |
Age |
13-15 Years |
57.6 |
45.7 to 68.7 |
121 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2020 |
Age |
13-15 Years |
56.4 |
46.2 to 66.1 |
200 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-15 Years |
71.0 |
56.6 to 82.2 |
93 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-15 Years |
53.1 |
41.1 to 64.7 |
107 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2020 |
Age |
13-15 Years |
50.3 |
38.3 to 62.3 |
90 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2020 |
Age |
13-15 Years |
70.2 |
57.0 to 80.7 |
75 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2020 |
Age |
13-15 Years |
55.0 |
42.9 to 66.6 |
102 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2020 |
Age |
13-15 Years |
61.9 |
48.5 to 73.8 |
79 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2020 |
Age |
13-15 Years |
61.9 |
49.3 to 73.1 |
107 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2020 |
Age |
13-15 Years |
60.0 |
48.9 to 70.2 |
108 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2020 |
Age |
13-15 Years |
69.6 |
61.2 to 76.9 |
252 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-15 Years |
66.3 |
54.8 to 76.2 |
121 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2020 |
Age |
13-15 Years |
50.2 |
38.2 to 62.1 |
101 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2020 |
Age |
13-15 Years |
73.1 |
60.8 to 82.6 |
97 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2020 |
Age |
13-15 Years |
30.4 |
20.7 to 42.3 |
89 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2020 |
Age |
13-15 Years |
43.4 |
31.8 to 55.7 |
117 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2020 |
Age |
13-15 Years |
55.1 |
42.5 to 67.1 |
90 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2020 |
Age |
13-15 Years |
59.9 |
48.7 to 70.2 |
113 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2020 |
Age |
13-15 Years |
44.3 |
32.8 to 56.5 |
111 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-15 Years |
65.3 |
54.6 to 74.7 |
113 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2020 |
Age |
13-15 Years |
47.4 |
34.9 to 60.3 |
109 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2020 |
Age |
13-15 Years |
58.5 |
46.8 to 69.3 |
91 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2020 |
Age |
13-15 Years |
64.6 |
55.4 to 72.8 |
207 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-15 Years |
72.1 |
60.0 to 81.6 |
108 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-15 Years |
59.9 |
47.0 to 71.5 |
99 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2020 |
Age |
13-15 Years |
68.3 |
55.5 to 78.8 |
107 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2020 |
Age |
13-15 Years |
69.9 |
58.5 to 79.3 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2020 |
Age |
13-15 Years |
40.2 |
28.7 to 52.9 |
97 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-15 Years |
37.2 |
27.1 to 48.4 |
110 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2020 |
Age |
13-15 Years |
53.4 |
40.7 to 65.7 |
85 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-15 Years |
55.6 |
44.8 to 66.0 |
236 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-15 Years |
75.3 |
62.6 to 84.8 |
80 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-15 Years |
52.9 |
40.9 to 64.6 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-15 Years |
51.7 |
31.5 to 71.3 |
38 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2020 |
Age |
13-15 Years |
56.4 |
53.9 to 58.8 |
5937 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-15 Years |
65.3 |
59.2 to 70.9 |
636 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-15 Years |
59.1 |
51.7 to 66.2 |
316 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-15 Years |
59.2 |
53.3 to 65.0 |
1002 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-15 Years |
53.4 |
47.9 to 58.8 |
758 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-15 Years |
52.4 |
47.3 to 57.5 |
651 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-15 Years |
53.2 |
46.7 to 59.7 |
750 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-15 Years |
54.1 |
47.4 to 60.8 |
407 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-15 Years |
60.0 |
53.0 to 66.6 |
576 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-15 Years |
60.8 |
50.8 to 70.0 |
409 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-15 Years |
73.6 |
59.7 to 84.0 |
69 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2020 |
Age |
13-15 Years |
50.0 |
38.0 to 62.0 |
99 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2020 |
Age |
13-15 Years |
74.7 |
63.4 to 83.5 |
95 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2020 |
Age |
13-15 Years |
46.0 |
35.0 to 57.4 |
109 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2020 |
Age |
13-15 Years |
54.7 |
45.6 to 63.5 |
346 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-15 Years |
61.3 |
49.1 to 72.2 |
90 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-15 Years |
67.6 |
52.1 to 80.0 |
68 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-15 Years |
53.3 |
43.0 to 63.3 |
188 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-15 Years |
57.9 |
50.4 to 65.1 |
432 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2020 |
Age |
13-15 Years |
48.1 |
35.5 to 61.0 |
92 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2020 |
Age |
13-15 Years |
74.6 |
64.4 to 82.7 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2020 |
Age |
13-15 Years |
59.9 |
48.1 to 70.7 |
216 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2020 |
Age |
13-15 Years |
59.8 |
48.2 to 70.4 |
142 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2020 |
Age |
13-15 Years |
41.0 |
29.5 to 53.6 |
79 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-15 Years |
56.4 |
41.6 to 70.2 |
66 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2020 |
Age |
13-15 Years |
53.9 |
40.3 to 67.0 |
78 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2021 |
Age |
13-15 Years |
62.5 |
49.9 to 73.7 |
86 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2021 |
Age |
13-15 Years |
49.9 |
36.3 to 63.5 |
73 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2021 |
Age |
13-15 Years |
53.9 |
40.5 to 66.8 |
72 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2021 |
Age |
13-15 Years |
54.5 |
42.5 to 66.0 |
96 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2021 |
Age |
13-15 Years |
64.5 |
48.4 to 77.9 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2021 |
Age |
13-15 Years |
65.6 |
52.2 to 76.9 |
95 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2021 |
Age |
13-15 Years |
56.8 |
44.1 to 68.6 |
101 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2021 |
Age |
13-15 Years |
66.3 |
53.9 to 76.8 |
94 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-15 Years |
76.1 |
64.9 to 84.6 |
125 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2021 |
Age |
13-15 Years |
43.2 |
28.0 to 59.8 |
78 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2021 |
Age |
13-15 Years |
63.9 |
48.7 to 76.7 |
66 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2021 |
Age |
13-15 Years |
46.4 |
30.6 to 62.9 |
51 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2021 |
Age |
13-15 Years |
63.0 |
49.1 to 75.0 |
68 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2021 |
Age |
13-15 Years |
62.2 |
49.6 to 73.4 |
99 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2021 |
Age |
13-15 Years |
61.3 |
52.0 to 69.9 |
176 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-15 Years |
72.5 |
51.4 to 86.8 |
47 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-15 Years |
58.2 |
47.7 to 68.1 |
129 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2021 |
Age |
13-15 Years |
55.3 |
42.0 to 67.8 |
76 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2021 |
Age |
13-15 Years |
71.7 |
54.1 to 84.5 |
61 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2021 |
Age |
13-15 Years |
72.6 |
60.0 to 82.5 |
85 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2021 |
Age |
13-15 Years |
38.8 |
24.6 to 55.1 |
61 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2021 |
Age |
13-15 Years |
57.4 |
44.7 to 69.3 |
88 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2021 |
Age |
13-15 Years |
64.1 |
51.3 to 75.1 |
90 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2021 |
Age |
13-15 Years |
70.1 |
61.9 to 77.2 |
261 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-15 Years |
77.2 |
60.8 to 88.0 |
67 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2021 |
Age |
13-15 Years |
61.4 |
48.5 to 72.9 |
108 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2021 |
Age |
13-15 Years |
68.9 |
54.1 to 80.7 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2021 |
Age |
13-15 Years |
38.8 |
26.7 to 52.6 |
86 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2021 |
Age |
13-15 Years |
64.5 |
52.7 to 74.7 |
102 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2021 |
Age |
13-15 Years |
49.0 |
36.8 to 61.4 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2021 |
Age |
13-15 Years |
52.9 |
39.0 to 66.3 |
85 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2021 |
Age |
13-15 Years |
47.6 |
35.5 to 59.9 |
122 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-15 Years |
74.9 |
62.8 to 84.1 |
82 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2021 |
Age |
13-15 Years |
64.9 |
51.0 to 76.7 |
85 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2021 |
Age |
13-15 Years |
58.4 |
46.3 to 69.6 |
103 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2021 |
Age |
13-15 Years |
62.5 |
52.9 to 71.3 |
171 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-15 Years |
66.9 |
54.2 to 77.5 |
93 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-15 Years |
59.5 |
45.7 to 71.9 |
78 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2021 |
Age |
13-15 Years |
72.3 |
54.3 to 85.2 |
68 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2021 |
Age |
13-15 Years |
46.7 |
31.5 to 62.5 |
48 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2021 |
Age |
13-15 Years |
63.7 |
48.5 to 76.6 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-15 Years |
48.8 |
35.9 to 61.8 |
77 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2021 |
Age |
13-15 Years |
54.5 |
41.6 to 66.7 |
89 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-15 Years |
68.6 |
59.9 to 76.2 |
261 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-15 Years |
71.8 |
59.0 to 81.8 |
95 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-15 Years |
68.2 |
58.5 to 76.5 |
166 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-15 Years |
65.4 |
53.1 to 75.9 |
105 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2021 |
Age |
13-15 Years |
60.0 |
57.1 to 62.7 |
5217 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-15 Years |
69.9 |
62.4 to 76.6 |
550 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-15 Years |
63.4 |
55.5 to 70.6 |
256 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-15 Years |
70.3 |
65.0 to 75.1 |
966 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-15 Years |
55.4 |
48.7 to 61.9 |
618 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-15 Years |
61.7 |
56.3 to 66.9 |
603 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-15 Years |
49.1 |
41.7 to 56.5 |
632 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-15 Years |
66.1 |
59.0 to 72.5 |
333 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-15 Years |
62.1 |
54.6 to 69.0 |
527 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-15 Years |
61.6 |
49.5 to 72.5 |
349 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-15 Years |
81.8 |
67.4 to 90.7 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2021 |
Age |
13-15 Years |
59.9 |
46.5 to 72.0 |
86 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2021 |
Age |
13-15 Years |
80.3 |
70.0 to 87.7 |
122 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2021 |
Age |
13-15 Years |
63.3 |
49.9 to 74.9 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2021 |
Age |
13-15 Years |
46.5 |
36.3 to 57.1 |
268 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-15 Years |
65.6 |
52.0 to 77.0 |
89 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-15 Years |
52.2 |
34.5 to 69.4 |
40 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-15 Years |
44.4 |
32.9 to 56.6 |
139 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-15 Years |
58.6 |
41.2 to 74.0 |
62 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-15 Years |
57.0 |
49.5 to 64.2 |
383 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2021 |
Age |
13-15 Years |
60.7 |
47.0 to 72.8 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2021 |
Age |
13-15 Years |
56.5 |
45.8 to 66.7 |
123 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2021 |
Age |
13-15 Years |
73.5 |
60.6 to 83.3 |
150 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2021 |
Age |
13-15 Years |
57.7 |
45.6 to 69.0 |
122 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2021 |
Age |
13-15 Years |
66.6 |
53.6 to 77.5 |
75 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-15 Years |
59.8 |
46.6 to 71.8 |
77 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2021 |
Age |
13-15 Years |
49.8 |
37.0 to 62.7 |
92 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2022 |
Age |
13-15 Years |
57.2 |
44.4 to 69.2 |
84 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2022 |
Age |
13-15 Years |
59.1 |
44.2 to 72.5 |
68 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2022 |
Age |
13-15 Years |
54.5 |
40.3 to 68.0 |
76 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2022 |
Age |
13-15 Years |
51.4 |
39.3 to 63.2 |
99 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2022 |
Age |
13-15 Years |
54.8 |
40.7 to 68.2 |
81 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2022 |
Age |
13-15 Years |
69.0 |
56.9 to 78.9 |
91 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2022 |
Age |
13-15 Years |
69.8 |
57.0 to 80.1 |
80 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2022 |
Age |
13-15 Years |
71.9 |
57.7 to 82.7 |
78 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-15 Years |
72.5 |
56.5 to 84.2 |
72 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2022 |
Age |
13-15 Years |
60.0 |
46.1 to 72.4 |
91 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2022 |
Age |
13-15 Years |
64.2 |
50.7 to 75.8 |
91 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2022 |
Age |
13-15 Years |
45.0 |
31.0 to 59.9 |
74 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2022 |
Age |
13-15 Years |
73.7 |
58.8 to 84.7 |
53 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2022 |
Age |
13-15 Years |
73.2 |
59.1 to 83.8 |
69 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2022 |
Age |
13-15 Years |
67.2 |
57.3 to 75.8 |
180 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-15 Years |
65.8 |
50.4 to 78.5 |
80 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-15 Years |
67.6 |
55.7 to 77.6 |
100 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2022 |
Age |
13-15 Years |
53.1 |
39.2 to 66.5 |
74 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2022 |
Age |
13-15 Years |
68.3 |
51.6 to 81.3 |
55 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2022 |
Age |
13-15 Years |
59.5 |
46.7 to 71.2 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2022 |
Age |
13-15 Years |
51.8 |
38.3 to 64.9 |
75 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2022 |
Age |
13-15 Years |
63.0 |
49.6 to 74.7 |
101 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2022 |
Age |
13-15 Years |
57.5 |
44.3 to 69.7 |
78 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2022 |
Age |
13-15 Years |
73.0 |
57.8 to 84.3 |
102 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-15 Years |
69.3 |
54.0 to 81.2 |
77 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2022 |
Age |
13-15 Years |
74.2 |
62.5 to 83.2 |
85 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2022 |
Age |
13-15 Years |
56.7 |
44.5 to 68.2 |
93 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2022 |
Age |
13-15 Years |
34.0 |
21.6 to 49.0 |
72 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2022 |
Age |
13-15 Years |
60.5 |
48.5 to 71.3 |
97 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2022 |
Age |
13-15 Years |
58.7 |
45.6 to 70.7 |
89 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2022 |
Age |
13-15 Years |
49.7 |
37.6 to 61.9 |
91 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2022 |
Age |
13-15 Years |
58.2 |
43.8 to 71.4 |
69 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-15 Years |
73.6 |
58.9 to 84.5 |
58 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2022 |
Age |
13-15 Years |
58.2 |
43.1 to 72.0 |
70 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2022 |
Age |
13-15 Years |
61.8 |
48.7 to 73.3 |
97 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2022 |
Age |
13-15 Years |
68.4 |
59.5 to 76.1 |
161 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-15 Years |
68.9 |
55.8 to 79.5 |
78 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-15 Years |
68.0 |
55.5 to 78.3 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2022 |
Age |
13-15 Years |
54.5 |
42.1 to 66.4 |
111 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2022 |
Age |
13-15 Years |
73.9 |
60.2 to 84.1 |
77 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2022 |
Age |
13-15 Years |
63.2 |
47.6 to 76.4 |
77 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-15 Years |
41.9 |
28.2 to 57.0 |
65 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2022 |
Age |
13-15 Years |
61.1 |
47.2 to 73.4 |
72 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-15 Years |
67.3 |
58.2 to 75.3 |
220 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-15 Years |
72.2 |
56.3 to 84.0 |
74 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-15 Years |
66.7 |
56.6 to 75.5 |
146 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-15 Years |
69.5 |
60.7 to 77.1 |
198 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2022 |
Age |
13-15 Years |
60.7 |
57.9 to 63.4 |
4644 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-15 Years |
69.5 |
61.9 to 76.2 |
456 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-15 Years |
65.0 |
57.2 to 72.1 |
231 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-15 Years |
65.0 |
59.3 to 70.3 |
696 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-15 Years |
57.2 |
51.4 to 62.8 |
672 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-15 Years |
64.1 |
58.6 to 69.2 |
592 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-15 Years |
57.3 |
48.7 to 65.5 |
596 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-15 Years |
60.4 |
53.4 to 66.9 |
326 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-15 Years |
65.9 |
59.3 to 72.0 |
501 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-15 Years |
55.4 |
44.2 to 66.0 |
279 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-15 Years |
81.9 |
67.4 to 90.8 |
80 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2022 |
Age |
13-15 Years |
57.1 |
43.5 to 69.7 |
80 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2022 |
Age |
13-15 Years |
57.8 |
44.0 to 70.5 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2022 |
Age |
13-15 Years |
56.5 |
41.3 to 70.6 |
68 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2022 |
Age |
13-15 Years |
58.7 |
47.0 to 69.5 |
234 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-15 Years |
69.1 |
53.5 to 81.3 |
71 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-15 Years |
53.3 |
36.0 to 69.9 |
60 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-15 Years |
58.3 |
45.2 to 70.3 |
103 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-15 Years |
65.6 |
56.9 to 73.4 |
295 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2022 |
Age |
13-15 Years |
68.4 |
54.6 to 79.6 |
82 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2022 |
Age |
13-15 Years |
66.4 |
52.6 to 77.9 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2022 |
Age |
13-15 Years |
56.6 |
46.3 to 66.3 |
163 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2022 |
Age |
13-15 Years |
66.5 |
52.1 to 78.3 |
86 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2022 |
Age |
13-15 Years |
50.4 |
36.3 to 64.5 |
61 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-15 Years |
62.4 |
49.3 to 73.8 |
83 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2022 |
Age |
13-15 Years |
35.9 |
23.2 to 50.9 |
79 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
46.5 |
37.4 to 55.7 |
153 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
47.8 |
39.0 to 56.8 |
183 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
46.6 |
37.2 to 56.2 |
154 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
35.5 |
27.1 to 45.0 |
149 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
58.3 |
47.6 to 68.2 |
143 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
52.1 |
41.9 to 62.2 |
154 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
56.9 |
48.1 to 65.3 |
191 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
66.8 |
58.4 to 74.3 |
180 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
65.1 |
55.4 to 73.7 |
181 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
46.4 |
36.9 to 56.2 |
181 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
55.4 |
46.2 to 64.2 |
193 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
55.8 |
48.0 to 63.4 |
242 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
61.5 |
52.0 to 70.2 |
149 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
43.4 |
34.9 to 52.3 |
166 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
52.6 |
45.6 to 59.5 |
293 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
65.3 |
51.5 to 76.9 |
76 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
49.8 |
41.8 to 57.7 |
217 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
43.5 |
34.3 to 53.0 |
157 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
47.4 |
39.0 to 55.9 |
183 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
45.6 |
36.6 to 54.9 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
39.7 |
30.9 to 49.3 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
50.8 |
41.7 to 59.8 |
154 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
64.3 |
55.5 to 72.3 |
170 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
51.8 |
42.6 to 60.9 |
213 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
62.0 |
53.3 to 70.1 |
175 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
55.4 |
45.5 to 65.0 |
144 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
46.4 |
37.7 to 55.3 |
174 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
33.9 |
25.6 to 43.3 |
168 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
38.5 |
29.8 to 48.0 |
174 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
52.5 |
43.6 to 61.2 |
189 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
50.6 |
41.1 to 60.0 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
43.0 |
34.2 to 52.3 |
169 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
56.5 |
47.3 to 65.2 |
161 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
50.1 |
41.8 to 58.5 |
221 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
49.0 |
40.4 to 57.7 |
171 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
61.3 |
54.6 to 67.6 |
299 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
69.9 |
60.5 to 77.8 |
136 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
55.8 |
46.7 to 64.5 |
163 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
46.9 |
38.1 to 56.0 |
192 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
60.2 |
50.1 to 69.5 |
130 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
42.5 |
33.7 to 51.9 |
178 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
43.6 |
33.6 to 54.1 |
127 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
50.3 |
40.7 to 59.9 |
148 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
58.0 |
50.6 to 65.1 |
390 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
76.2 |
67.8 to 83.0 |
150 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
55.6 |
47.4 to 63.6 |
240 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
61.9 |
52.8 to 70.3 |
197 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
49.5 |
47.6 to 51.4 |
9661 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
61.0 |
56.2 to 65.5 |
1017 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
57.6 |
52.3 to 62.8 |
520 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
51.9 |
47.1 to 56.6 |
1320 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
44.8 |
40.9 to 48.7 |
1319 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
49.2 |
45.4 to 53.0 |
1096 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
41.3 |
37.4 to 45.4 |
1492 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
43.7 |
38.8 to 48.7 |
664 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
48.1 |
42.6 to 53.7 |
953 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
55.8 |
47.5 to 63.8 |
615 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
73.0 |
63.5 to 80.8 |
149 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
30.8 |
22.5 to 40.6 |
145 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
47.3 |
37.8 to 57.1 |
158 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
36.9 |
28.1 to 46.6 |
136 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
39.7 |
34.4 to 45.1 |
891 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
45.2 |
35.8 to 55.0 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
44.2 |
31.8 to 57.3 |
94 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
24.3 |
16.8 to 33.6 |
141 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
69.0 |
58.9 to 77.6 |
172 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
39.2 |
32.5 to 46.4 |
328 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
26.6 |
19.5 to 35.0 |
201 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
51.7 |
46.0 to 57.4 |
665 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
41.3 |
32.4 to 50.7 |
154 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
58.4 |
49.7 to 66.7 |
171 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
41.1 |
30.8 to 52.3 |
209 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
55.2 |
45.8 to 64.2 |
168 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
49.7 |
40.2 to 59.3 |
147 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
53.6 |
44.1 to 63.0 |
150 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
33.9 |
26.1 to 42.7 |
168 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
47.2 |
38.9 to 55.7 |
193 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
45.7 |
37.3 to 54.3 |
175 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
57.9 |
48.0 to 67.1 |
162 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
46.6 |
37.4 to 56.2 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
60.9 |
49.9 to 70.8 |
135 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
53.1 |
44.1 to 62.0 |
169 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
63.5 |
54.0 to 72.1 |
143 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
59.6 |
50.1 to 68.4 |
161 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
79.4 |
69.4 to 86.7 |
165 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
45.3 |
36.2 to 54.7 |
193 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
45.0 |
35.8 to 54.5 |
170 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
48.2 |
39.5 to 56.9 |
185 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
62.7 |
53.3 to 71.2 |
154 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
52.1 |
42.3 to 61.7 |
162 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
48.9 |
42.2 to 55.6 |
310 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
73.0 |
61.3 to 82.2 |
95 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
43.6 |
36.1 to 51.4 |
215 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
48.4 |
38.6 to 58.3 |
155 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
65.5 |
56.4 to 73.5 |
159 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
38.5 |
29.7 to 48.2 |
150 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
44.7 |
36.2 to 53.5 |
169 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
64.3 |
55.3 to 72.3 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
61.5 |
52.8 to 69.6 |
163 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
57.5 |
46.8 to 67.6 |
221 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
67.4 |
58.7 to 75.1 |
191 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
60.4 |
51.4 to 68.7 |
167 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
48.6 |
39.7 to 57.5 |
174 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
34.4 |
26.4 to 43.5 |
159 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
45.2 |
36.7 to 54.1 |
170 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
50.1 |
40.6 to 59.6 |
150 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
61.4 |
51.8 to 70.3 |
145 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
52.9 |
43.6 to 62.0 |
164 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
63.0 |
54.5 to 70.8 |
173 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
53.8 |
44.8 to 62.5 |
169 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
55.0 |
45.8 to 63.9 |
160 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
58.2 |
51.3 to 64.8 |
292 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
69.9 |
60.0 to 78.3 |
133 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
50.7 |
41.6 to 59.7 |
159 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
50.0 |
40.2 to 59.7 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
62.6 |
54.1 to 70.3 |
175 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
54.9 |
46.7 to 62.9 |
206 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
45.6 |
36.5 to 54.9 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
55.1 |
46.6 to 63.4 |
183 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
56.1 |
48.2 to 63.7 |
393 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
69.2 |
60.3 to 76.9 |
174 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
54.4 |
45.6 to 62.9 |
219 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
53.1 |
51.2 to 55.0 |
9845 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
66.2 |
61.4 to 70.6 |
989 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
56.8 |
51.3 to 62.1 |
461 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
59.8 |
54.6 to 64.7 |
1274 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
46.0 |
42.1 to 49.9 |
1357 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
53.1 |
49.5 to 56.6 |
1159 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
46.6 |
42.9 to 50.3 |
1686 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
50.5 |
45.6 to 55.4 |
624 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
48.8 |
43.8 to 53.8 |
982 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
60.0 |
51.4 to 68.0 |
615 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
76.8 |
67.5 to 84.1 |
145 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
47.4 |
38.0 to 57.0 |
154 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
48.8 |
39.5 to 58.2 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
47.7 |
38.3 to 57.2 |
168 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
43.5 |
38.7 to 48.5 |
1063 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
55.6 |
46.7 to 64.3 |
160 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
50.6 |
37.0 to 64.1 |
82 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
41.7 |
31.5 to 52.6 |
123 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
65.4 |
55.4 to 74.2 |
155 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
57.0 |
47.3 to 66.2 |
149 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
40.2 |
33.9 to 46.8 |
394 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
55.0 |
49.6 to 60.3 |
698 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
42.1 |
33.4 to 51.3 |
163 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
68.5 |
59.5 to 76.3 |
174 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
68.0 |
56.5 to 77.6 |
181 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
56.8 |
47.9 to 65.3 |
178 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
48.6 |
39.4 to 57.9 |
153 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
56.0 |
46.3 to 65.1 |
147 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
33.6 |
25.9 to 42.3 |
169 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
52.0 |
42.4 to 61.4 |
155 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
45.3 |
37.0 to 53.9 |
193 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
51.0 |
41.0 to 60.9 |
135 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
46.4 |
37.0 to 56.1 |
155 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
50.1 |
40.1 to 60.0 |
179 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
59.0 |
48.0 to 69.2 |
131 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
54.7 |
44.9 to 64.2 |
139 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
63.9 |
53.7 to 73.0 |
157 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
73.5 |
62.8 to 82.0 |
134 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
52.9 |
42.8 to 62.7 |
160 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
53.7 |
44.4 to 62.7 |
167 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
47.9 |
38.8 to 57.2 |
159 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
62.5 |
53.5 to 70.8 |
168 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
47.9 |
38.1 to 57.7 |
136 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
55.9 |
49.5 to 62.2 |
359 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
63.6 |
48.8 to 76.2 |
98 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
54.3 |
47.1 to 61.2 |
261 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
55.7 |
45.7 to 65.2 |
137 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
61.9 |
52.2 to 70.8 |
132 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
38.1 |
29.2 to 48.0 |
138 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
45.4 |
35.7 to 55.4 |
130 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
52.9 |
42.2 to 63.3 |
124 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
52.0 |
42.2 to 61.5 |
160 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
60.9 |
51.0 to 70.0 |
185 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
66.6 |
56.1 to 75.7 |
143 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
56.9 |
46.8 to 66.4 |
137 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
62.2 |
51.0 to 72.2 |
131 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
38.1 |
28.9 to 48.3 |
136 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
51.1 |
41.6 to 60.5 |
144 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
53.0 |
43.3 to 62.5 |
146 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
66.6 |
56.3 to 75.5 |
134 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
49.4 |
40.3 to 58.5 |
162 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
66.4 |
56.3 to 75.1 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
51.5 |
42.0 to 60.8 |
177 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
58.4 |
48.2 to 67.9 |
139 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
56.4 |
48.2 to 64.3 |
236 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
54.9 |
43.5 to 65.7 |
122 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
57.5 |
46.1 to 68.1 |
114 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
53.7 |
44.2 to 62.9 |
161 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
72.2 |
62.1 to 80.4 |
132 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
59.1 |
49.9 to 67.7 |
168 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
43.9 |
35.2 to 53.1 |
157 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
59.0 |
49.3 to 68.0 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
62.3 |
53.2 to 70.6 |
314 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
67.1 |
55.6 to 76.9 |
115 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
61.6 |
51.4 to 70.9 |
199 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
53.7 |
51.8 to 55.6 |
8928 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
62.7 |
57.1 to 67.9 |
895 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
54.8 |
48.5 to 61.0 |
413 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
60.8 |
55.1 to 66.2 |
1113 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
50.7 |
46.6 to 54.7 |
1205 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
58.0 |
54.2 to 61.7 |
1088 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
48.4 |
44.5 to 52.2 |
1544 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
52.9 |
47.7 to 58.1 |
548 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
54.9 |
49.0 to 60.6 |
845 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
50.5 |
42.6 to 58.3 |
644 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
76.1 |
67.6 to 83.0 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
44.8 |
35.6 to 54.3 |
159 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
46.3 |
37.8 to 55.0 |
169 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
47.5 |
37.4 to 57.8 |
137 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
47.8 |
42.7 to 52.8 |
969 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
52.5 |
42.9 to 62.0 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
54.2 |
41.7 to 66.1 |
85 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
49.7 |
38.3 to 61.1 |
144 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
45.5 |
36.4 to 54.9 |
170 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
46.9 |
40.5 to 53.4 |
419 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
55.2 |
49.1 to 61.1 |
633 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
48.6 |
38.7 to 58.7 |
150 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
59.6 |
50.3 to 68.2 |
146 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
59.1 |
45.6 to 71.4 |
167 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
56.3 |
46.2 to 65.9 |
153 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
52.9 |
44.0 to 61.6 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
61.0 |
52.0 to 69.3 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
54.4 |
43.6 to 64.9 |
117 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
52.2 |
42.5 to 61.8 |
143 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
57.8 |
49.6 to 65.6 |
208 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
57.4 |
47.7 to 66.6 |
162 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
55.2 |
45.5 to 64.5 |
150 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
61.5 |
48.2 to 73.3 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
70.4 |
58.3 to 80.2 |
109 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
56.3 |
45.4 to 66.7 |
128 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
60.7 |
50.9 to 69.7 |
145 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
73.0 |
60.3 to 82.8 |
121 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
55.5 |
43.4 to 66.9 |
158 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
56.1 |
46.2 to 65.6 |
161 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
45.2 |
35.5 to 55.2 |
139 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
66.2 |
55.8 to 75.3 |
147 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
47.6 |
37.6 to 57.9 |
155 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
55.2 |
47.8 to 62.4 |
274 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
64.1 |
48.5 to 77.2 |
74 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
53.4 |
45.0 to 61.5 |
200 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
41.5 |
31.6 to 52.1 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
60.4 |
51.3 to 68.9 |
154 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
46.6 |
37.2 to 56.2 |
182 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
61.8 |
52.2 to 70.5 |
144 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
58.2 |
46.9 to 68.7 |
162 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
56.6 |
46.5 to 66.1 |
154 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
68.6 |
59.1 to 76.8 |
261 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
74.0 |
63.4 to 82.3 |
146 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
57.7 |
47.3 to 67.4 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
64.0 |
52.4 to 74.1 |
129 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
32.1 |
22.1 to 44.0 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
55.2 |
44.2 to 65.6 |
140 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
51.3 |
41.4 to 61.2 |
138 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
62.1 |
51.4 to 71.7 |
132 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
55.6 |
45.4 to 65.4 |
157 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
67.4 |
57.8 to 75.7 |
154 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
52.5 |
42.8 to 62.1 |
166 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
53.8 |
44.9 to 62.5 |
200 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
59.7 |
51.0 to 67.8 |
239 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
60.6 |
49.8 to 70.5 |
123 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
59.1 |
46.6 to 70.5 |
116 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
53.4 |
43.2 to 63.4 |
143 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
76.6 |
68.1 to 83.4 |
152 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
52.4 |
42.4 to 62.2 |
137 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
42.4 |
33.6 to 51.7 |
168 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
63.7 |
52.7 to 73.3 |
134 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
61.2 |
53.2 to 68.7 |
351 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
78.8 |
67.7 to 86.9 |
108 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
58.9 |
50.0 to 67.3 |
243 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
59.7 |
44.3 to 73.4 |
107 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
56.8 |
54.6 to 59.0 |
8916 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
67.4 |
61.7 to 72.6 |
950 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
57.3 |
50.7 to 63.6 |
405 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
59.8 |
54.6 to 64.8 |
1176 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
54.1 |
49.5 to 58.6 |
1152 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
55.5 |
51.5 to 59.5 |
972 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
51.1 |
47.2 to 55.0 |
1577 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
55.5 |
49.9 to 61.0 |
608 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
60.2 |
54.0 to 66.1 |
840 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
60.7 |
50.4 to 70.1 |
592 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
77.8 |
67.1 to 85.7 |
140 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
59.2 |
49.1 to 68.5 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
59.2 |
48.9 to 68.8 |
124 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
50.5 |
40.1 to 60.8 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
50.6 |
45.5 to 55.7 |
897 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
47.7 |
37.7 to 57.9 |
138 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
61.6 |
47.5 to 74.1 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
52.7 |
42.1 to 63.1 |
128 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
71.4 |
62.0 to 79.3 |
142 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
48.6 |
42.0 to 55.3 |
402 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
33.3 |
22.7 to 46.0 |
111 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
59.3 |
52.7 to 65.6 |
644 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
48.0 |
38.0 to 58.2 |
166 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
67.0 |
58.9 to 74.3 |
228 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
52.5 |
40.7 to 64.0 |
175 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
60.4 |
49.5 to 70.4 |
147 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
51.3 |
41.1 to 61.3 |
123 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
67.2 |
58.0 to 75.2 |
155 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
42.6 |
33.7 to 52.1 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
57.0 |
47.2 to 66.2 |
135 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
56.5 |
46.5 to 66.0 |
145 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
51.6 |
42.3 to 60.8 |
160 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
53.5 |
43.5 to 63.2 |
162 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
68.7 |
58.5 to 77.5 |
184 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
69.4 |
60.0 to 77.4 |
167 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
70.0 |
61.1 to 77.7 |
159 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
62.2 |
52.8 to 70.7 |
162 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
73.4 |
63.3 to 81.6 |
189 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
52.7 |
42.4 to 62.9 |
162 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
58.8 |
48.0 to 68.8 |
134 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
53.6 |
43.7 to 63.3 |
143 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
68.2 |
58.4 to 76.7 |
131 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
57.4 |
48.4 to 66.0 |
197 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
64.3 |
56.5 to 71.4 |
332 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
74.6 |
63.5 to 83.3 |
142 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
62.1 |
52.9 to 70.5 |
190 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
60.0 |
49.9 to 69.4 |
141 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
72.4 |
62.5 to 80.4 |
129 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
57.6 |
48.0 to 66.7 |
163 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
65.5 |
55.2 to 74.6 |
128 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
62.9 |
52.9 to 71.9 |
171 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
62.4 |
53.4 to 70.7 |
165 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
71.3 |
64.5 to 77.2 |
386 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
74.7 |
66.3 to 81.6 |
201 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
61.6 |
52.4 to 70.1 |
179 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
73.2 |
63.0 to 81.4 |
146 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
32.6 |
24.3 to 42.2 |
140 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
53.2 |
43.4 to 62.8 |
175 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
60.3 |
50.5 to 69.3 |
155 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
62.2 |
53.4 to 70.3 |
184 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
51.6 |
42.0 to 61.1 |
186 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
71.8 |
63.9 to 78.6 |
183 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
60.3 |
50.7 to 69.2 |
171 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
64.8 |
56.1 to 72.6 |
166 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
69.4 |
62.6 to 75.5 |
342 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
72.5 |
63.2 to 80.2 |
180 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
67.4 |
57.7 to 75.8 |
162 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
65.8 |
55.3 to 74.9 |
158 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
77.8 |
69.5 to 84.3 |
198 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
49.7 |
40.0 to 59.5 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
47.0 |
38.1 to 56.2 |
165 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
64.5 |
54.3 to 73.5 |
129 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
66.8 |
58.5 to 74.1 |
394 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
76.1 |
66.1 to 83.8 |
125 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
65.6 |
56.4 to 73.8 |
269 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
47.5 |
32.1 to 63.3 |
67 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
61.4 |
59.5 to 63.3 |
9576 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
72.6 |
68.1 to 76.7 |
1015 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
66.3 |
60.8 to 71.4 |
513 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
66.1 |
61.7 to 70.2 |
1632 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
55.3 |
51.0 to 59.5 |
1171 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
60.9 |
57.0 to 64.7 |
1076 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
56.9 |
51.7 to 61.9 |
1227 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
59.7 |
54.4 to 64.8 |
651 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
62.6 |
57.3 to 67.6 |
957 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
65.2 |
57.3 to 72.3 |
661 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
79.9 |
69.9 to 87.2 |
112 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
47.1 |
37.4 to 57.0 |
144 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
74.7 |
65.9 to 81.8 |
146 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
49.4 |
40.4 to 58.5 |
170 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
57.0 |
49.9 to 63.9 |
563 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
62.1 |
52.8 to 70.5 |
153 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
72.5 |
61.5 to 81.3 |
111 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
55.5 |
47.4 to 63.3 |
299 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
63.5 |
57.6 to 68.9 |
673 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
49.8 |
39.7 to 59.9 |
148 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
75.3 |
66.8 to 82.3 |
195 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
64.8 |
56.0 to 72.8 |
353 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
65.4 |
55.7 to 73.9 |
202 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
48.2 |
39.1 to 57.4 |
148 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
63.4 |
52.8 to 72.9 |
122 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
52.7 |
42.7 to 62.5 |
143 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
58.2 |
47.9 to 67.8 |
135 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
60.5 |
49.5 to 70.6 |
121 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
63.1 |
52.7 to 72.4 |
127 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
58.9 |
49.4 to 67.7 |
149 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
67.0 |
54.8 to 77.3 |
146 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
68.6 |
57.5 to 77.9 |
135 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
67.1 |
57.0 to 75.8 |
159 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
68.8 |
59.0 to 77.1 |
144 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
81.2 |
73.3 to 87.2 |
197 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
49.1 |
36.9 to 61.5 |
127 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
66.6 |
55.6 to 76.0 |
118 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
52.9 |
40.8 to 64.7 |
94 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
69.0 |
59.0 to 77.5 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
63.7 |
53.6 to 72.7 |
153 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
64.8 |
57.3 to 71.7 |
282 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
76.5 |
60.2 to 87.5 |
72 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
62.3 |
53.7 to 70.1 |
210 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
62.0 |
51.4 to 71.6 |
122 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
70.3 |
56.4 to 81.3 |
92 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
70.6 |
60.0 to 79.4 |
140 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
48.9 |
37.2 to 60.7 |
111 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
60.7 |
50.0 to 70.4 |
129 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
67.8 |
57.9 to 76.4 |
137 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
73.8 |
67.4 to 79.4 |
389 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
78.1 |
66.8 to 86.4 |
115 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
68.9 |
58.9 to 77.4 |
179 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
69.5 |
58.0 to 78.9 |
135 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
32.6 |
23.9 to 42.6 |
146 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
62.7 |
53.1 to 71.5 |
156 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
49.5 |
39.6 to 59.3 |
135 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
63.2 |
52.5 to 72.7 |
147 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
54.9 |
44.6 to 64.8 |
175 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
77.0 |
67.6 to 84.4 |
133 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
63.0 |
51.3 to 73.4 |
122 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
62.9 |
53.5 to 71.3 |
168 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
67.5 |
59.9 to 74.3 |
278 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
72.8 |
63.1 to 80.7 |
150 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
64.0 |
53.1 to 73.7 |
128 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
72.8 |
60.0 to 82.7 |
122 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
68.6 |
56.0 to 78.9 |
87 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
69.0 |
57.2 to 78.8 |
129 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
55.1 |
44.5 to 65.4 |
114 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
63.3 |
52.6 to 72.8 |
129 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
68.2 |
61.4 to 74.3 |
434 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
74.0 |
64.2 to 81.8 |
157 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
67.5 |
59.9 to 74.3 |
277 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
68.6 |
59.3 to 76.6 |
175 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
63.8 |
61.5 to 65.9 |
8423 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
73.9 |
68.2 to 78.8 |
898 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
66.0 |
59.6 to 71.8 |
400 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
71.0 |
66.9 to 74.9 |
1546 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
58.3 |
53.3 to 63.3 |
1023 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
66.9 |
62.7 to 70.7 |
991 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
56.0 |
50.1 to 61.8 |
1022 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
66.2 |
60.5 to 71.4 |
535 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
65.0 |
59.2 to 70.3 |
840 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
65.7 |
56.3 to 74.1 |
574 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
80.1 |
68.4 to 88.2 |
138 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
61.0 |
50.1 to 71.0 |
123 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
78.3 |
70.7 to 84.4 |
202 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
64.4 |
54.2 to 73.5 |
141 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
54.8 |
46.6 to 62.7 |
462 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
60.9 |
50.6 to 70.4 |
150 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
55.7 |
41.7 to 68.9 |
73 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
54.2 |
44.8 to 63.2 |
239 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
45.7 |
33.0 to 58.9 |
113 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
64.3 |
58.4 to 69.9 |
594 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
62.5 |
52.1 to 71.9 |
144 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
63.8 |
55.8 to 71.1 |
216 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
73.5 |
63.4 to 81.6 |
259 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
65.5 |
55.8 to 74.0 |
191 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
67.3 |
57.2 to 76.0 |
123 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
66.9 |
57.3 to 75.3 |
144 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
48.7 |
38.2 to 59.3 |
137 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
59.8 |
50.0 to 68.8 |
139 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
61.9 |
49.6 to 72.8 |
99 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
59.2 |
48.5 to 69.2 |
129 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
56.9 |
47.2 to 66.2 |
159 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
60.8 |
50.1 to 70.6 |
140 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
69.4 |
60.4 to 77.1 |
160 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
74.3 |
64.2 to 82.3 |
125 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
67.5 |
56.5 to 77.0 |
127 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
75.1 |
62.7 to 84.3 |
113 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
64.4 |
53.6 to 73.9 |
149 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
65.9 |
56.0 to 74.6 |
159 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
42.7 |
31.6 to 54.5 |
120 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
79.4 |
69.6 to 86.7 |
109 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
75.0 |
65.0 to 82.9 |
121 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
67.1 |
59.4 to 74.1 |
294 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
69.6 |
57.1 to 79.7 |
119 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
66.6 |
57.5 to 74.6 |
175 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
63.5 |
52.5 to 73.3 |
116 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
74.4 |
61.8 to 84.0 |
88 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
61.9 |
51.6 to 71.3 |
137 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
57.5 |
47.5 to 67.0 |
139 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
69.3 |
59.3 to 77.8 |
169 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
65.6 |
55.2 to 74.6 |
126 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
78.6 |
67.9 to 86.5 |
161 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
76.3 |
65.4 to 84.6 |
136 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
72.6 |
62.3 to 80.9 |
127 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
65.6 |
55.8 to 74.1 |
152 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
37.0 |
26.6 to 48.9 |
116 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
63.8 |
54.0 to 72.6 |
144 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
59.5 |
49.2 to 69.0 |
142 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
56.5 |
46.1 to 66.2 |
134 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
63.8 |
52.8 to 73.5 |
117 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
76.6 |
66.4 to 84.4 |
109 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
61.3 |
50.5 to 71.1 |
133 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
63.8 |
53.3 to 73.2 |
148 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
69.0 |
62.0 to 75.3 |
263 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
67.3 |
55.9 to 76.9 |
112 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
70.2 |
60.9 to 78.1 |
151 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
53.5 |
43.6 to 63.2 |
175 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
74.4 |
63.7 to 82.8 |
128 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
65.1 |
53.2 to 75.4 |
123 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
46.5 |
35.4 to 58.0 |
109 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
67.0 |
56.3 to 76.2 |
116 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
67.2 |
59.8 to 73.9 |
339 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
77.2 |
65.5 to 85.8 |
116 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
65.9 |
57.6 to 73.3 |
223 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
68.9 |
61.8 to 75.2 |
323 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
64.6 |
62.5 to 66.6 |
7623 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
75.4 |
69.9 to 80.2 |
778 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
66.4 |
60.5 to 71.8 |
396 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
68.6 |
64.3 to 72.6 |
1131 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
61.0 |
56.7 to 65.2 |
1118 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
67.1 |
62.9 to 71.0 |
949 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
62.1 |
55.3 to 68.5 |
952 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
64.7 |
59.2 to 69.9 |
503 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
65.5 |
60.3 to 70.4 |
834 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
61.2 |
52.9 to 69.0 |
495 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
85.2 |
75.5 to 91.5 |
139 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
64.7 |
53.7 to 74.4 |
135 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
64.3 |
52.8 to 74.2 |
129 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
65.9 |
54.4 to 75.9 |
106 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
63.5 |
53.9 to 72.1 |
367 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
71.6 |
59.9 to 80.9 |
121 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
57.8 |
43.2 to 71.2 |
90 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
63.3 |
52.2 to 73.1 |
156 |
| HPV |
Up-to-Date, Females |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
70.1 |
63.5 to 75.9 |
467 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
62.5 |
51.8 to 72.2 |
141 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
73.7 |
63.7 to 81.7 |
143 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
64.4 |
56.7 to 71.4 |
281 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
71.0 |
59.8 to 80.2 |
131 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
62.4 |
51.7 to 72.0 |
110 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
67.6 |
57.2 to 76.6 |
137 |
| HPV |
Up-to-Date, Females |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
52.4 |
41.5 to 63.1 |
134 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2018 |
Age |
13-15 Years |
49.8 |
38.1 to 61.6 |
101 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2018 |
Age |
13-15 Years |
43.0 |
32.9 to 53.7 |
117 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2018 |
Age |
13-15 Years |
43.1 |
31.6 to 55.4 |
93 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2018 |
Age |
13-15 Years |
36.5 |
25.2 to 49.4 |
89 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2018 |
Age |
13-15 Years |
58.8 |
45.7 to 70.8 |
107 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2018 |
Age |
13-15 Years |
66.8 |
52.5 to 78.6 |
80 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2018 |
Age |
13-15 Years |
52.6 |
40.0 to 64.9 |
88 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2018 |
Age |
13-15 Years |
50.6 |
38.8 to 62.4 |
93 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-15 Years |
67.2 |
52.8 to 79.0 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2018 |
Age |
13-15 Years |
38.6 |
27.7 to 50.8 |
107 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2018 |
Age |
13-15 Years |
44.3 |
33.4 to 55.8 |
113 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2018 |
Age |
13-15 Years |
45.0 |
34.1 to 56.5 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2018 |
Age |
13-15 Years |
61.3 |
49.5 to 72.0 |
97 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2018 |
Age |
13-15 Years |
46.7 |
35.5 to 58.3 |
95 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2018 |
Age |
13-15 Years |
53.9 |
45.9 to 61.7 |
226 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-15 Years |
69.8 |
52.8 to 82.7 |
63 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-15 Years |
50.4 |
41.4 to 59.4 |
163 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2018 |
Age |
13-15 Years |
39.3 |
28.9 to 50.8 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2018 |
Age |
13-15 Years |
48.1 |
36.2 to 60.2 |
95 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2018 |
Age |
13-15 Years |
48.7 |
36.8 to 60.7 |
93 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2018 |
Age |
13-15 Years |
34.9 |
24.3 to 47.3 |
77 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2018 |
Age |
13-15 Years |
39.7 |
27.5 to 53.4 |
85 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2018 |
Age |
13-15 Years |
42.8 |
30.3 to 56.2 |
79 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2018 |
Age |
13-15 Years |
50.5 |
38.4 to 62.6 |
130 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-15 Years |
69.3 |
56.6 to 79.6 |
103 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2018 |
Age |
13-15 Years |
53.5 |
42.0 to 64.6 |
105 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2018 |
Age |
13-15 Years |
54.3 |
40.8 to 67.3 |
94 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2018 |
Age |
13-15 Years |
28.9 |
18.8 to 41.7 |
88 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2018 |
Age |
13-15 Years |
30.2 |
20.4 to 42.3 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2018 |
Age |
13-15 Years |
43.6 |
31.2 to 56.8 |
79 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2018 |
Age |
13-15 Years |
55.1 |
42.2 to 67.4 |
93 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2018 |
Age |
13-15 Years |
52.1 |
40.7 to 63.3 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-15 Years |
65.6 |
52.8 to 76.4 |
92 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2018 |
Age |
13-15 Years |
44.6 |
33.0 to 56.9 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2018 |
Age |
13-15 Years |
51.8 |
39.6 to 63.9 |
90 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2018 |
Age |
13-15 Years |
50.3 |
40.9 to 59.7 |
173 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-15 Years |
59.0 |
46.5 to 70.4 |
91 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-15 Years |
44.4 |
31.7 to 57.8 |
82 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2018 |
Age |
13-15 Years |
47.0 |
35.2 to 59.2 |
110 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2018 |
Age |
13-15 Years |
53.5 |
41.2 to 65.5 |
90 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2018 |
Age |
13-15 Years |
64.1 |
51.8 to 74.8 |
90 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-15 Years |
27.6 |
19.3 to 37.9 |
112 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2018 |
Age |
13-15 Years |
57.9 |
45.1 to 69.7 |
91 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-15 Years |
40.6 |
29.5 to 52.8 |
196 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-15 Years |
73.0 |
60.2 to 82.8 |
75 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-15 Years |
36.4 |
24.5 to 50.3 |
121 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2018 |
Age |
13-15 Years |
47.1 |
44.7 to 49.6 |
5886 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-15 Years |
63.0 |
56.3 to 69.2 |
576 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-15 Years |
48.5 |
41.0 to 56.1 |
271 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-15 Years |
41.9 |
34.8 to 49.4 |
722 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-15 Years |
40.7 |
36.0 to 45.6 |
799 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-15 Years |
53.5 |
48.9 to 58.1 |
729 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-15 Years |
36.8 |
32.6 to 41.3 |
1086 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-15 Years |
41.8 |
35.7 to 48.3 |
381 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-15 Years |
51.8 |
44.6 to 59.0 |
538 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-15 Years |
56.2 |
45.9 to 66.0 |
397 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-15 Years |
81.1 |
70.4 to 88.5 |
112 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2018 |
Age |
13-15 Years |
32.8 |
23.3 to 43.8 |
107 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2018 |
Age |
13-15 Years |
52.9 |
41.7 to 63.7 |
107 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2018 |
Age |
13-15 Years |
39.4 |
28.3 to 51.7 |
96 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2018 |
Age |
13-15 Years |
36.7 |
31.3 to 42.4 |
710 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-15 Years |
38.4 |
27.8 to 50.3 |
97 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-15 Years |
46.8 |
32.7 to 61.5 |
61 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-15 Years |
46.3 |
33.9 to 59.2 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-15 Years |
48.0 |
37.3 to 59.0 |
120 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-15 Years |
34.1 |
27.5 to 41.4 |
334 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-15 Years |
49.1 |
41.0 to 57.3 |
387 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2018 |
Age |
13-15 Years |
37.2 |
26.2 to 49.7 |
102 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2018 |
Age |
13-15 Years |
57.3 |
46.1 to 67.8 |
102 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2018 |
Age |
13-15 Years |
37.6 |
22.3 to 55.8 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2018 |
Age |
13-15 Years |
45.4 |
32.3 to 59.2 |
84 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2018 |
Age |
13-15 Years |
28.8 |
19.8 to 39.7 |
105 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-15 Years |
49.7 |
39.1 to 60.3 |
114 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2018 |
Age |
13-15 Years |
35.3 |
24.2 to 48.2 |
80 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2019 |
Age |
13-15 Years |
43.6 |
32.0 to 56.1 |
91 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2019 |
Age |
13-15 Years |
48.1 |
38.4 to 57.9 |
140 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2019 |
Age |
13-15 Years |
48.8 |
36.7 to 61.0 |
101 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2019 |
Age |
13-15 Years |
37.0 |
26.7 to 48.6 |
114 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2019 |
Age |
13-15 Years |
55.6 |
38.8 to 71.1 |
90 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2019 |
Age |
13-15 Years |
55.3 |
41.5 to 68.3 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2019 |
Age |
13-15 Years |
45.9 |
33.4 to 59.0 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2019 |
Age |
13-15 Years |
54.9 |
43.7 to 65.6 |
112 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-15 Years |
78.2 |
65.1 to 87.3 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2019 |
Age |
13-15 Years |
53.4 |
38.1 to 68.0 |
111 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2019 |
Age |
13-15 Years |
38.0 |
27.2 to 50.1 |
105 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2019 |
Age |
13-15 Years |
35.3 |
24.8 to 47.4 |
92 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2019 |
Age |
13-15 Years |
56.9 |
44.4 to 68.6 |
93 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2019 |
Age |
13-15 Years |
34.1 |
24.3 to 45.5 |
116 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2019 |
Age |
13-15 Years |
47.6 |
38.9 to 56.4 |
209 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-15 Years |
56.0 |
37.0 to 73.5 |
53 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-15 Years |
45.9 |
36.3 to 55.8 |
156 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2019 |
Age |
13-15 Years |
41.6 |
31.0 to 53.2 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2019 |
Age |
13-15 Years |
55.6 |
43.6 to 67.0 |
91 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2019 |
Age |
13-15 Years |
50.3 |
39.2 to 61.4 |
131 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2019 |
Age |
13-15 Years |
47.8 |
36.6 to 59.1 |
103 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2019 |
Age |
13-15 Years |
63.3 |
49.8 to 75.1 |
109 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2019 |
Age |
13-15 Years |
38.1 |
27.4 to 50.1 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2019 |
Age |
13-15 Years |
66.4 |
54.7 to 76.4 |
166 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-15 Years |
67.5 |
53.1 to 79.3 |
90 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2019 |
Age |
13-15 Years |
67.8 |
54.8 to 78.5 |
83 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2019 |
Age |
13-15 Years |
50.0 |
36.0 to 63.9 |
94 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2019 |
Age |
13-15 Years |
27.7 |
17.4 to 41.1 |
89 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2019 |
Age |
13-15 Years |
46.1 |
33.3 to 59.5 |
91 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2019 |
Age |
13-15 Years |
36.1 |
25.9 to 47.9 |
94 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2019 |
Age |
13-15 Years |
60.0 |
47.0 to 71.7 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2019 |
Age |
13-15 Years |
48.0 |
35.6 to 60.6 |
102 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-15 Years |
47.5 |
35.2 to 60.1 |
108 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2019 |
Age |
13-15 Years |
46.9 |
35.6 to 58.5 |
120 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2019 |
Age |
13-15 Years |
54.8 |
43.8 to 65.3 |
121 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2019 |
Age |
13-15 Years |
47.9 |
38.3 to 57.7 |
162 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-15 Years |
57.9 |
43.3 to 71.2 |
79 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-15 Years |
41.5 |
29.5 to 54.6 |
83 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2019 |
Age |
13-15 Years |
43.4 |
31.8 to 55.7 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2019 |
Age |
13-15 Years |
69.9 |
57.1 to 80.2 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2019 |
Age |
13-15 Years |
49.6 |
37.0 to 62.2 |
92 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-15 Years |
41.4 |
30.8 to 52.8 |
116 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2019 |
Age |
13-15 Years |
56.2 |
43.2 to 68.4 |
89 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-15 Years |
56.9 |
46.5 to 66.7 |
224 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-15 Years |
76.2 |
64.1 to 85.2 |
81 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-15 Years |
54.0 |
42.4 to 65.2 |
143 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-15 Years |
50.4 |
32.0 to 68.7 |
60 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2019 |
Age |
13-15 Years |
50.0 |
47.3 to 52.6 |
6187 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-15 Years |
58.8 |
51.3 to 65.9 |
669 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-15 Years |
47.5 |
40.1 to 55.1 |
282 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-15 Years |
57.8 |
51.3 to 63.9 |
844 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-15 Years |
44.1 |
38.5 to 49.8 |
782 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-15 Years |
51.2 |
46.2 to 56.1 |
677 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-15 Years |
46.7 |
41.9 to 51.5 |
1060 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-15 Years |
51.1 |
44.3 to 58.0 |
413 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-15 Years |
51.1 |
43.5 to 58.6 |
622 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-15 Years |
54.0 |
41.3 to 66.2 |
386 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-15 Years |
83.2 |
72.7 to 90.2 |
109 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2019 |
Age |
13-15 Years |
39.4 |
27.9 to 52.3 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2019 |
Age |
13-15 Years |
62.0 |
51.2 to 71.7 |
122 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2019 |
Age |
13-15 Years |
40.7 |
29.1 to 53.6 |
85 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2019 |
Age |
13-15 Years |
45.4 |
39.1 to 51.8 |
600 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-15 Years |
43.2 |
31.9 to 55.2 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-15 Years |
61.0 |
44.6 to 75.2 |
64 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-15 Years |
51.9 |
39.1 to 64.4 |
93 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-15 Years |
51.6 |
39.1 to 63.9 |
90 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-15 Years |
42.7 |
34.4 to 51.3 |
255 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-15 Years |
34.6 |
20.7 to 51.7 |
58 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-15 Years |
46.9 |
38.8 to 55.1 |
452 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2019 |
Age |
13-15 Years |
44.2 |
31.9 to 57.2 |
107 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2019 |
Age |
13-15 Years |
56.8 |
47.1 to 66.1 |
165 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2019 |
Age |
13-15 Years |
55.4 |
40.7 to 69.3 |
118 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2019 |
Age |
13-15 Years |
45.7 |
32.8 to 59.2 |
107 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2019 |
Age |
13-15 Years |
43.8 |
33.8 to 54.3 |
126 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-15 Years |
48.9 |
37.5 to 60.4 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2019 |
Age |
13-15 Years |
42.3 |
31.3 to 54.0 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2020 |
Age |
13-15 Years |
51.3 |
39.9 to 62.7 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2020 |
Age |
13-15 Years |
51.6 |
39.2 to 63.8 |
97 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2020 |
Age |
13-15 Years |
49.9 |
38.6 to 61.1 |
104 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2020 |
Age |
13-15 Years |
45.3 |
33.7 to 57.6 |
95 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2020 |
Age |
13-15 Years |
51.6 |
39.7 to 63.3 |
146 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2020 |
Age |
13-15 Years |
64.0 |
51.7 to 74.7 |
111 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2020 |
Age |
13-15 Years |
61.0 |
48.7 to 72.0 |
101 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2020 |
Age |
13-15 Years |
60.1 |
47.3 to 71.7 |
119 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-15 Years |
65.5 |
52.1 to 76.8 |
129 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2020 |
Age |
13-15 Years |
49.4 |
36.6 to 62.2 |
122 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2020 |
Age |
13-15 Years |
45.6 |
34.0 to 57.8 |
111 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2020 |
Age |
13-15 Years |
47.9 |
36.4 to 59.6 |
95 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2020 |
Age |
13-15 Years |
77.3 |
66.4 to 85.5 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2020 |
Age |
13-15 Years |
50.1 |
38.6 to 61.6 |
132 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2020 |
Age |
13-15 Years |
59.4 |
49.8 to 68.3 |
220 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-15 Years |
66.6 |
50.6 to 79.5 |
78 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-15 Years |
57.9 |
46.8 to 68.2 |
142 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2020 |
Age |
13-15 Years |
39.8 |
28.2 to 52.5 |
89 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2020 |
Age |
13-15 Years |
49.9 |
37.9 to 62.0 |
91 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2020 |
Age |
13-15 Years |
49.8 |
39.4 to 60.3 |
130 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2020 |
Age |
13-15 Years |
44.9 |
33.1 to 57.2 |
85 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2020 |
Age |
13-15 Years |
57.3 |
45.3 to 68.4 |
116 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2020 |
Age |
13-15 Years |
61.9 |
51.4 to 71.4 |
117 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2020 |
Age |
13-15 Years |
61.1 |
52.4 to 69.2 |
281 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-15 Years |
65.2 |
54.0 to 74.9 |
125 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2020 |
Age |
13-15 Years |
56.7 |
45.5 to 67.2 |
129 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2020 |
Age |
13-15 Years |
63.0 |
51.3 to 73.4 |
116 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2020 |
Age |
13-15 Years |
32.9 |
22.3 to 45.6 |
88 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2020 |
Age |
13-15 Years |
45.6 |
34.8 to 56.9 |
141 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2020 |
Age |
13-15 Years |
45.5 |
33.8 to 57.7 |
92 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2020 |
Age |
13-15 Years |
65.8 |
54.7 to 75.4 |
125 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2020 |
Age |
13-15 Years |
44.5 |
33.2 to 56.5 |
105 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-15 Years |
62.4 |
51.2 to 72.4 |
106 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2020 |
Age |
13-15 Years |
58.0 |
46.1 to 69.0 |
139 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2020 |
Age |
13-15 Years |
48.6 |
37.2 to 60.1 |
106 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2020 |
Age |
13-15 Years |
65.6 |
57.5 to 72.9 |
237 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-15 Years |
58.5 |
46.3 to 69.7 |
125 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-15 Years |
70.7 |
60.0 to 79.5 |
112 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2020 |
Age |
13-15 Years |
52.2 |
39.2 to 64.9 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2020 |
Age |
13-15 Years |
54.7 |
43.2 to 65.8 |
130 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2020 |
Age |
13-15 Years |
51.7 |
39.6 to 63.6 |
108 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-15 Years |
42.1 |
31.1 to 53.9 |
105 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2020 |
Age |
13-15 Years |
54.2 |
42.9 to 65.1 |
103 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-15 Years |
59.3 |
48.0 to 69.6 |
232 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-15 Years |
73.5 |
60.1 to 83.7 |
84 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-15 Years |
57.3 |
44.8 to 69.0 |
148 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-15 Years |
57.3 |
35.9 to 76.3 |
56 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2020 |
Age |
13-15 Years |
52.6 |
50.2 to 54.9 |
6510 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-15 Years |
64.6 |
58.2 to 70.4 |
661 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-15 Years |
63.0 |
56.3 to 69.2 |
376 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-15 Years |
52.1 |
46.2 to 57.9 |
1065 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-15 Years |
48.2 |
42.9 to 53.5 |
812 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-15 Years |
55.1 |
50.4 to 59.7 |
764 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-15 Years |
49.5 |
43.1 to 55.9 |
791 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-15 Years |
50.2 |
44.1 to 56.3 |
487 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-15 Years |
51.9 |
45.2 to 58.5 |
635 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-15 Years |
51.6 |
42.2 to 60.9 |
453 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-15 Years |
80.2 |
69.5 to 87.9 |
91 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2020 |
Age |
13-15 Years |
37.3 |
27.3 to 48.6 |
112 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2020 |
Age |
13-15 Years |
66.1 |
54.2 to 76.3 |
97 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2020 |
Age |
13-15 Years |
59.7 |
47.3 to 71.0 |
96 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2020 |
Age |
13-15 Years |
49.7 |
40.9 to 58.4 |
369 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-15 Years |
59.3 |
47.4 to 70.2 |
96 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-15 Years |
50.6 |
36.4 to 64.6 |
75 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-15 Years |
48.9 |
39.1 to 58.8 |
198 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-15 Years |
51.5 |
44.5 to 58.5 |
466 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2020 |
Age |
13-15 Years |
36.7 |
26.1 to 48.7 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2020 |
Age |
13-15 Years |
62.4 |
51.3 to 72.4 |
121 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2020 |
Age |
13-15 Years |
37.2 |
27.2 to 48.6 |
202 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2020 |
Age |
13-15 Years |
50.6 |
38.8 to 62.4 |
134 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2020 |
Age |
13-15 Years |
33.3 |
23.9 to 44.2 |
102 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-15 Years |
55.7 |
44.3 to 66.5 |
102 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2020 |
Age |
13-15 Years |
40.0 |
29.7 to 51.3 |
106 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2021 |
Age |
13-15 Years |
63.5 |
51.7 to 73.8 |
102 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2021 |
Age |
13-15 Years |
46.6 |
35.0 to 58.7 |
97 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2021 |
Age |
13-15 Years |
53.6 |
41.8 to 65.1 |
107 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2021 |
Age |
13-15 Years |
49.0 |
37.0 to 61.1 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2021 |
Age |
13-15 Years |
72.1 |
55.9 to 84.0 |
95 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2021 |
Age |
13-15 Years |
61.3 |
48.2 to 73.0 |
101 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2021 |
Age |
13-15 Years |
58.4 |
46.5 to 69.4 |
111 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2021 |
Age |
13-15 Years |
60.7 |
48.8 to 71.4 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-15 Years |
82.8 |
71.6 to 90.2 |
136 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2021 |
Age |
13-15 Years |
53.1 |
39.1 to 66.6 |
123 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2021 |
Age |
13-15 Years |
54.5 |
40.0 to 68.3 |
95 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2021 |
Age |
13-15 Years |
50.6 |
37.2 to 63.8 |
79 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2021 |
Age |
13-15 Years |
69.1 |
55.9 to 79.7 |
77 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2021 |
Age |
13-15 Years |
59.9 |
48.4 to 70.4 |
119 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2021 |
Age |
13-15 Years |
56.5 |
47.0 to 65.6 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-15 Years |
56.7 |
36.7 to 74.7 |
47 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-15 Years |
56.5 |
45.7 to 66.7 |
132 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2021 |
Age |
13-15 Years |
48.0 |
35.7 to 60.6 |
87 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2021 |
Age |
13-15 Years |
63.0 |
47.3 to 76.3 |
66 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2021 |
Age |
13-15 Years |
52.2 |
39.2 to 64.9 |
95 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2021 |
Age |
13-15 Years |
62.1 |
48.9 to 73.7 |
83 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2021 |
Age |
13-15 Years |
58.9 |
46.4 to 70.3 |
105 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2021 |
Age |
13-15 Years |
48.6 |
36.6 to 60.7 |
93 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2021 |
Age |
13-15 Years |
65.6 |
57.4 to 72.9 |
311 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-15 Years |
70.2 |
55.8 to 81.4 |
96 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2021 |
Age |
13-15 Years |
59.0 |
46.1 to 70.7 |
117 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2021 |
Age |
13-15 Years |
55.1 |
42.7 to 66.8 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2021 |
Age |
13-15 Years |
33.4 |
22.9 to 45.7 |
103 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2021 |
Age |
13-15 Years |
48.0 |
36.4 to 59.9 |
110 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2021 |
Age |
13-15 Years |
56.4 |
44.3 to 67.7 |
93 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2021 |
Age |
13-15 Years |
57.8 |
45.8 to 68.9 |
111 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2021 |
Age |
13-15 Years |
57.0 |
44.0 to 69.1 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-15 Years |
68.7 |
56.6 to 78.7 |
96 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2021 |
Age |
13-15 Years |
39.9 |
28.0 to 53.2 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2021 |
Age |
13-15 Years |
49.3 |
37.5 to 61.1 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2021 |
Age |
13-15 Years |
59.6 |
49.8 to 68.7 |
173 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-15 Years |
70.1 |
57.4 to 80.3 |
86 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-15 Years |
52.9 |
39.7 to 65.7 |
87 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2021 |
Age |
13-15 Years |
60.4 |
47.5 to 72.0 |
99 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2021 |
Age |
13-15 Years |
72.5 |
55.7 to 84.6 |
56 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2021 |
Age |
13-15 Years |
46.3 |
31.5 to 61.9 |
73 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-15 Years |
51.9 |
38.5 to 65.0 |
74 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2021 |
Age |
13-15 Years |
65.5 |
53.0 to 76.1 |
103 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-15 Years |
62.9 |
54.6 to 70.5 |
300 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-15 Years |
68.7 |
56.1 to 79.0 |
103 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-15 Years |
62.1 |
52.9 to 70.6 |
197 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-15 Years |
62.7 |
49.9 to 73.9 |
100 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2021 |
Age |
13-15 Years |
57.1 |
54.3 to 59.9 |
5944 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-15 Years |
66.4 |
59.4 to 72.8 |
636 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-15 Years |
53.1 |
45.3 to 60.8 |
271 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-15 Years |
59.2 |
53.7 to 64.4 |
1129 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-15 Years |
55.3 |
49.8 to 60.8 |
794 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-15 Years |
53.3 |
47.8 to 58.7 |
653 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-15 Years |
48.1 |
41.2 to 55.1 |
701 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-15 Years |
53.8 |
46.8 to 60.5 |
382 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-15 Years |
58.7 |
51.6 to 65.5 |
585 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-15 Years |
68.4 |
56.3 to 78.5 |
378 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-15 Years |
88.8 |
78.9 to 94.4 |
80 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2021 |
Age |
13-15 Years |
62.7 |
49.8 to 74.0 |
88 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2021 |
Age |
13-15 Years |
68.1 |
57.5 to 77.0 |
154 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2021 |
Age |
13-15 Years |
48.1 |
35.9 to 60.5 |
101 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2021 |
Age |
13-15 Years |
46.3 |
37.3 to 55.4 |
324 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-15 Years |
58.3 |
44.7 to 70.7 |
85 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-15 Years |
70.1 |
49.1 to 85.0 |
53 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-15 Years |
44.2 |
34.5 to 54.4 |
186 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-15 Years |
42.4 |
29.0 to 57.1 |
101 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-15 Years |
63.6 |
55.8 to 70.6 |
415 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2021 |
Age |
13-15 Years |
55.0 |
42.1 to 67.4 |
104 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2021 |
Age |
13-15 Years |
67.8 |
58.7 to 75.7 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2021 |
Age |
13-15 Years |
52.5 |
39.5 to 65.1 |
195 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2021 |
Age |
13-15 Years |
65.9 |
52.2 to 77.4 |
96 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2021 |
Age |
13-15 Years |
38.3 |
27.1 to 50.9 |
87 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-15 Years |
54.3 |
42.4 to 65.7 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2021 |
Age |
13-15 Years |
37.6 |
25.6 to 51.3 |
77 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2022 |
Age |
13-15 Years |
66.4 |
52.9 to 77.7 |
73 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2022 |
Age |
13-15 Years |
45.2 |
32.6 to 58.4 |
88 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2022 |
Age |
13-15 Years |
60.9 |
48.0 to 72.4 |
83 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2022 |
Age |
13-15 Years |
51.6 |
39.4 to 63.5 |
94 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2022 |
Age |
13-15 Years |
55.8 |
42.5 to 68.3 |
107 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2022 |
Age |
13-15 Years |
58.6 |
48.0 to 68.5 |
114 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2022 |
Age |
13-15 Years |
62.6 |
49.2 to 74.3 |
87 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2022 |
Age |
13-15 Years |
66.0 |
51.4 to 78.1 |
67 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-15 Years |
81.4 |
67.6 to 90.2 |
80 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2022 |
Age |
13-15 Years |
38.0 |
25.7 to 52.1 |
92 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2022 |
Age |
13-15 Years |
55.0 |
43.3 to 66.1 |
125 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2022 |
Age |
13-15 Years |
37.2 |
25.1 to 51.3 |
73 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2022 |
Age |
13-15 Years |
65.7 |
53.0 to 76.5 |
84 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2022 |
Age |
13-15 Years |
53.6 |
40.3 to 66.3 |
89 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2022 |
Age |
13-15 Years |
65.4 |
55.4 to 74.3 |
203 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-15 Years |
60.8 |
45.9 to 73.8 |
81 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-15 Years |
66.5 |
54.5 to 76.8 |
122 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2022 |
Age |
13-15 Years |
55.8 |
43.6 to 67.4 |
93 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2022 |
Age |
13-15 Years |
77.6 |
65.2 to 86.5 |
76 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2022 |
Age |
13-15 Years |
58.3 |
46.6 to 69.2 |
105 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2022 |
Age |
13-15 Years |
51.0 |
38.5 to 63.3 |
84 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2022 |
Age |
13-15 Years |
65.0 |
53.4 to 75.1 |
109 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2022 |
Age |
13-15 Years |
59.8 |
47.5 to 71.1 |
85 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2022 |
Age |
13-15 Years |
64.6 |
49.8 to 77.0 |
111 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-15 Years |
74.8 |
61.8 to 84.4 |
74 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2022 |
Age |
13-15 Years |
56.6 |
42.1 to 70.0 |
80 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2022 |
Age |
13-15 Years |
63.6 |
51.1 to 74.5 |
95 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2022 |
Age |
13-15 Years |
32.3 |
20.2 to 47.4 |
75 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2022 |
Age |
13-15 Years |
53.1 |
39.6 to 66.1 |
82 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2022 |
Age |
13-15 Years |
63.5 |
51.8 to 73.7 |
102 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2022 |
Age |
13-15 Years |
70.5 |
56.7 to 81.4 |
65 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2022 |
Age |
13-15 Years |
46.5 |
34.5 to 58.9 |
86 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-15 Years |
70.7 |
57.6 to 81.1 |
76 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2022 |
Age |
13-15 Years |
64.5 |
50.8 to 76.1 |
88 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2022 |
Age |
13-15 Years |
55.4 |
42.7 to 67.4 |
88 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2022 |
Age |
13-15 Years |
64.9 |
55.5 to 73.3 |
159 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-15 Years |
75.4 |
62.1 to 85.2 |
68 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-15 Years |
57.6 |
45.0 to 69.3 |
91 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2022 |
Age |
13-15 Years |
50.2 |
38.4 to 61.9 |
118 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2022 |
Age |
13-15 Years |
76.8 |
64.3 to 85.9 |
100 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2022 |
Age |
13-15 Years |
59.7 |
45.9 to 72.1 |
86 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-15 Years |
40.7 |
29.0 to 53.4 |
88 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2022 |
Age |
13-15 Years |
59.0 |
46.8 to 70.2 |
98 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-15 Years |
66.9 |
58.0 to 74.7 |
251 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-15 Years |
66.3 |
53.0 to 77.3 |
95 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-15 Years |
67.0 |
56.9 to 75.7 |
156 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-15 Years |
70.3 |
61.1 to 78.1 |
195 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2022 |
Age |
13-15 Years |
56.6 |
53.9 to 59.2 |
5172 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-15 Years |
69.4 |
62.6 to 75.5 |
491 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-15 Years |
64.7 |
57.1 to 71.7 |
247 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-15 Years |
62.7 |
57.3 to 67.7 |
798 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-15 Years |
48.0 |
42.6 to 53.5 |
734 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-15 Years |
61.1 |
55.6 to 66.2 |
634 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-15 Years |
50.2 |
42.2 to 58.2 |
633 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-15 Years |
62.5 |
55.4 to 69.1 |
328 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-15 Years |
55.5 |
49.1 to 61.8 |
584 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-15 Years |
56.3 |
45.9 to 66.1 |
360 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-15 Years |
80.8 |
66.7 to 89.8 |
88 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2022 |
Age |
13-15 Years |
34.5 |
23.4 to 47.6 |
75 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2022 |
Age |
13-15 Years |
73.4 |
60.8 to 83.1 |
75 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2022 |
Age |
13-15 Years |
62.2 |
47.9 to 74.7 |
92 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2022 |
Age |
13-15 Years |
48.9 |
37.8 to 60.1 |
254 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-15 Years |
50.3 |
35.5 to 65.2 |
80 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-15 Years |
63.9 |
44.1 to 79.9 |
38 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-15 Years |
47.8 |
35.4 to 60.5 |
136 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-15 Years |
59.9 |
52.6 to 66.8 |
363 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2022 |
Age |
13-15 Years |
43.6 |
31.5 to 56.6 |
84 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2022 |
Age |
13-15 Years |
57.6 |
44.2 to 69.9 |
81 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2022 |
Age |
13-15 Years |
59.6 |
50.2 to 68.3 |
202 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2022 |
Age |
13-15 Years |
65.2 |
52.4 to 76.1 |
88 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2022 |
Age |
13-15 Years |
37.6 |
27.0 to 49.6 |
87 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-15 Years |
66.6 |
52.6 to 78.1 |
77 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2022 |
Age |
13-15 Years |
48.9 |
37.2 to 60.7 |
109 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
24.7 |
17.9 to 32.9 |
180 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
39.1 |
30.9 to 48.0 |
209 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
41.7 |
32.7 to 51.3 |
175 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
33.6 |
26.3 to 41.7 |
203 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
40.3 |
31.8 to 49.4 |
184 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
44.0 |
34.7 to 53.7 |
168 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
41.5 |
32.8 to 50.7 |
166 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
47.3 |
38.8 to 55.9 |
195 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
58.8 |
49.4 to 67.6 |
196 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
34.5 |
26.3 to 43.8 |
195 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
36.2 |
27.8 to 45.6 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
33.2 |
27.0 to 40.1 |
293 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
46.9 |
38.2 to 55.7 |
168 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
30.0 |
22.7 to 38.4 |
192 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
43.2 |
36.6 to 50.1 |
312 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
46.4 |
32.8 to 60.6 |
81 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
42.6 |
35.2 to 50.3 |
231 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
24.7 |
18.1 to 32.8 |
193 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
43.8 |
35.8 to 52.0 |
199 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
26.0 |
18.7 to 35.0 |
166 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
28.5 |
21.0 to 37.3 |
182 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
33.2 |
25.7 to 41.7 |
182 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
48.2 |
39.6 to 56.9 |
177 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
44.5 |
35.6 to 53.7 |
238 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
51.4 |
43.1 to 59.6 |
199 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
34.6 |
26.1 to 44.3 |
139 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
42.0 |
33.9 to 50.6 |
201 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
24.5 |
17.8 to 32.7 |
209 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
33.3 |
25.2 to 42.5 |
186 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
27.9 |
20.8 to 36.4 |
186 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
41.3 |
32.6 to 50.6 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
37.0 |
28.4 to 46.5 |
161 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
46.3 |
36.9 to 55.9 |
152 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
35.8 |
28.2 to 44.1 |
201 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
37.0 |
29.3 to 45.3 |
203 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
50.3 |
43.9 to 56.7 |
356 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
53.9 |
44.2 to 63.2 |
155 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
48.0 |
39.7 to 56.4 |
201 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
35.7 |
27.3 to 45.1 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
45.5 |
36.6 to 54.6 |
163 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
41.1 |
31.9 to 51.0 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
35.0 |
26.1 to 45.2 |
154 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
44.7 |
36.1 to 53.7 |
170 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
44.4 |
37.5 to 51.5 |
485 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
61.1 |
52.8 to 68.9 |
199 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
42.1 |
34.5 to 50.2 |
286 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
44.1 |
35.7 to 53.0 |
208 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
37.5 |
35.8 to 39.2 |
10814 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
49.3 |
44.7 to 54.0 |
1080 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
45.5 |
40.5 to 50.7 |
557 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
42.1 |
37.7 to 46.6 |
1522 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
32.9 |
29.3 to 36.6 |
1438 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
38.0 |
34.4 to 41.7 |
1188 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
28.9 |
25.8 to 32.3 |
1778 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
35.2 |
30.6 to 40.0 |
730 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
33.5 |
28.6 to 38.7 |
1069 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
40.5 |
33.6 to 47.7 |
688 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
68.7 |
59.8 to 76.4 |
177 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
27.4 |
20.0 to 36.4 |
169 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
30.5 |
23.0 to 39.2 |
184 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
35.2 |
26.5 to 44.9 |
155 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
26.5 |
22.5 to 30.9 |
1036 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
33.3 |
25.6 to 42.1 |
178 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
48.6 |
36.8 to 60.5 |
131 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
23.6 |
16.9 to 32.0 |
153 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
63.2 |
53.2 to 72.1 |
173 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
22.5 |
17.7 to 28.3 |
401 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
19.0 |
13.2 to 26.4 |
227 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
41.9 |
36.6 to 47.4 |
764 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
20.3 |
13.9 to 28.7 |
163 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
53.1 |
45.2 to 60.7 |
209 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
37.4 |
28.0 to 47.9 |
242 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
44.0 |
35.4 to 52.9 |
193 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
33.0 |
24.9 to 42.2 |
166 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
37.8 |
29.7 to 46.5 |
183 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
19.9 |
14.1 to 27.3 |
205 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
33.7 |
25.7 to 42.7 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
39.8 |
31.6 to 48.7 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
48.4 |
39.3 to 57.5 |
173 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
24.3 |
18.3 to 31.6 |
206 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
46.3 |
37.1 to 55.7 |
171 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
54.4 |
45.6 to 62.9 |
185 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
52.7 |
43.7 to 61.5 |
187 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
56.7 |
47.6 to 65.4 |
189 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
76.6 |
66.4 to 84.4 |
153 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
39.4 |
30.8 to 48.8 |
222 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
46.4 |
37.0 to 56.1 |
173 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
37.5 |
29.9 to 45.9 |
197 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
47.2 |
38.5 to 56.0 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
36.5 |
28.3 to 45.4 |
191 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
51.8 |
45.6 to 58.1 |
373 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
60.2 |
47.2 to 72.0 |
109 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
50.1 |
43.0 to 57.2 |
264 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
33.5 |
25.5 to 42.5 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
42.6 |
34.6 to 51.0 |
184 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
30.4 |
23.2 to 38.8 |
188 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
31.1 |
24.0 to 39.2 |
203 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
41.9 |
33.5 to 50.8 |
185 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
57.0 |
48.6 to 65.0 |
184 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
48.4 |
38.2 to 58.8 |
249 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
63.7 |
55.9 to 70.8 |
221 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
48.5 |
39.5 to 57.7 |
161 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
45.4 |
36.7 to 54.4 |
182 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
23.4 |
16.9 to 31.6 |
188 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
34.2 |
26.2 to 43.2 |
165 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
48.1 |
39.1 to 57.3 |
176 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
55.3 |
46.7 to 63.6 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
45.3 |
36.5 to 54.4 |
180 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
56.9 |
47.8 to 65.6 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
45.5 |
37.2 to 54.2 |
197 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
41.9 |
34.1 to 50.2 |
202 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
49.1 |
42.7 to 55.5 |
359 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
52.4 |
42.8 to 61.9 |
148 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
47.0 |
38.7 to 55.4 |
211 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
53.7 |
44.9 to 62.3 |
185 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
53.2 |
45.0 to 61.2 |
204 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
39.3 |
31.6 to 47.6 |
202 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
37.5 |
29.5 to 46.3 |
182 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
54.4 |
45.6 to 63.0 |
176 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
49.1 |
42.3 to 56.0 |
458 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
69.8 |
61.3 to 77.2 |
188 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
46.4 |
38.9 to 54.0 |
270 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
44.3 |
42.6 to 46.0 |
11104 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
60.5 |
56.1 to 64.8 |
1118 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
47.9 |
42.8 to 53.1 |
556 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
49.4 |
44.6 to 54.1 |
1471 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
40.2 |
36.5 to 44.0 |
1489 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
45.0 |
41.6 to 48.5 |
1274 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
36.2 |
33.0 to 39.6 |
1968 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
38.2 |
33.7 to 42.9 |
716 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
45.0 |
40.2 to 49.9 |
1126 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
46.5 |
39.2 to 54.0 |
684 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
78.4 |
70.0 to 85.0 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
38.0 |
29.2 to 47.8 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
40.9 |
32.7 to 49.7 |
177 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
31.1 |
23.0 to 40.6 |
170 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
36.0 |
31.8 to 40.5 |
1193 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
37.2 |
29.3 to 45.9 |
176 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
59.7 |
47.2 to 71.0 |
105 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
29.9 |
21.5 to 40.0 |
140 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
54.6 |
44.8 to 64.2 |
165 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
46.9 |
38.1 to 55.9 |
155 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
33.1 |
27.6 to 39.2 |
452 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
50.6 |
45.1 to 56.1 |
702 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
32.9 |
25.3 to 41.5 |
193 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
60.8 |
52.3 to 68.7 |
192 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
50.4 |
39.5 to 61.3 |
232 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
53.7 |
44.6 to 62.6 |
161 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
39.3 |
31.4 to 47.9 |
190 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
48.8 |
40.1 to 57.6 |
177 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
28.4 |
21.2 to 36.8 |
191 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
48.4 |
39.1 to 57.8 |
172 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
42.9 |
35.1 to 51.1 |
199 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
50.4 |
40.9 to 59.8 |
153 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
39.0 |
30.0 to 48.8 |
153 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
55.1 |
44.7 to 65.0 |
177 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
65.8 |
55.6 to 74.8 |
147 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
51.6 |
41.9 to 61.1 |
154 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
53.1 |
43.3 to 62.7 |
149 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
69.2 |
57.7 to 78.6 |
149 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
40.5 |
31.7 to 49.9 |
177 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
45.6 |
36.7 to 54.8 |
178 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
43.5 |
34.6 to 52.9 |
150 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
58.9 |
49.6 to 67.7 |
159 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
39.2 |
30.7 to 48.4 |
155 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
51.0 |
44.7 to 57.3 |
362 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
66.3 |
52.2 to 78.1 |
94 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
47.9 |
40.8 to 55.0 |
268 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
42.5 |
34.0 to 51.6 |
159 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
48.6 |
39.1 to 58.2 |
148 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
43.2 |
34.3 to 52.6 |
159 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
39.9 |
31.1 to 49.4 |
140 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
40.8 |
31.5 to 50.8 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
49.5 |
40.0 to 59.0 |
157 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
55.4 |
45.8 to 64.7 |
208 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
70.6 |
60.9 to 78.8 |
185 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
53.3 |
44.3 to 62.1 |
176 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
55.6 |
45.2 to 65.5 |
154 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
27.3 |
19.6 to 36.7 |
149 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
33.5 |
25.4 to 42.7 |
175 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
43.9 |
34.7 to 53.6 |
144 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
59.0 |
49.1 to 68.2 |
161 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
52.7 |
43.9 to 61.3 |
172 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
68.5 |
58.4 to 77.1 |
152 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
45.7 |
36.6 to 55.1 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
55.6 |
46.4 to 64.4 |
156 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
58.1 |
50.9 to 65.0 |
299 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
61.6 |
51.5 to 70.8 |
139 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
55.9 |
46.0 to 65.4 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
50.5 |
41.1 to 59.9 |
180 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
55.5 |
45.7 to 64.8 |
155 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
57.3 |
48.0 to 66.1 |
161 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
32.1 |
25.2 to 39.9 |
203 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
57.5 |
47.5 to 67.0 |
146 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
46.3 |
37.0 to 55.9 |
335 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
75.7 |
66.3 to 83.2 |
122 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
42.5 |
32.4 to 53.3 |
213 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
48.7 |
46.8 to 50.6 |
9772 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
64.1 |
58.9 to 69.0 |
1007 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
54.0 |
48.3 to 59.7 |
473 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
49.2 |
43.4 to 55.0 |
1182 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
42.8 |
39.0 to 46.7 |
1302 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
52.2 |
48.6 to 55.7 |
1188 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
39.6 |
36.1 to 43.2 |
1782 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
42.5 |
37.7 to 47.5 |
643 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
52.3 |
46.8 to 57.7 |
901 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
54.4 |
46.2 to 62.3 |
661 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
80.0 |
71.7 to 86.3 |
181 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
37.7 |
28.9 to 47.3 |
159 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
52.5 |
43.8 to 61.0 |
171 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
41.5 |
32.2 to 51.4 |
147 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
39.4 |
34.8 to 44.1 |
1110 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
43.6 |
34.2 to 53.5 |
147 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
47.8 |
36.5 to 59.4 |
101 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
49.2 |
39.1 to 59.4 |
170 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
46.4 |
37.7 to 55.2 |
194 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
37.0 |
31.3 to 43.1 |
498 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
48.6 |
42.2 to 55.0 |
633 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
38.1 |
29.2 to 47.9 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
64.3 |
55.8 to 71.9 |
178 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
50.8 |
37.7 to 63.8 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
47.0 |
36.5 to 57.8 |
133 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
33.5 |
26.2 to 41.7 |
181 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
50.7 |
42.2 to 59.1 |
176 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
30.3 |
21.6 to 40.7 |
124 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
42.5 |
33.2 to 52.5 |
153 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
47.5 |
39.7 to 55.5 |
218 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
56.3 |
46.0 to 66.1 |
146 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
46.1 |
37.2 to 55.2 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
51.4 |
39.2 to 63.4 |
148 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
56.9 |
45.8 to 67.4 |
153 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
51.3 |
41.3 to 61.2 |
166 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
57.7 |
48.3 to 66.6 |
163 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
78.0 |
67.1 to 86.1 |
161 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
56.4 |
44.3 to 67.8 |
171 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
43.5 |
33.9 to 53.6 |
154 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
42.6 |
33.0 to 52.8 |
139 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
65.8 |
56.3 to 74.1 |
157 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
40.7 |
31.7 to 50.4 |
177 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
54.5 |
47.6 to 61.3 |
328 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
64.3 |
49.5 to 76.8 |
86 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
52.5 |
44.7 to 60.2 |
242 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
40.9 |
32.5 to 49.8 |
163 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
61.4 |
52.0 to 70.0 |
148 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
52.3 |
43.3 to 61.1 |
199 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
48.3 |
39.0 to 57.7 |
148 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
60.7 |
50.0 to 70.4 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
48.9 |
39.6 to 58.3 |
162 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
69.1 |
60.2 to 76.8 |
263 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
74.6 |
64.1 to 82.9 |
154 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
61.1 |
51.3 to 70.1 |
146 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
50.0 |
39.1 to 60.9 |
147 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
29.0 |
20.4 to 39.4 |
144 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
53.5 |
43.2 to 63.6 |
148 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
42.3 |
33.5 to 51.6 |
159 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
59.0 |
48.7 to 68.5 |
153 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
50.3 |
40.2 to 60.4 |
156 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
59.1 |
49.1 to 68.4 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
50.3 |
40.5 to 60.1 |
165 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
65.7 |
57.4 to 73.1 |
205 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
54.5 |
46.5 to 62.3 |
259 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
65.4 |
54.5 to 75.0 |
134 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
47.6 |
37.0 to 58.3 |
125 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
45.8 |
36.5 to 55.3 |
162 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
77.2 |
68.3 to 84.2 |
167 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
46.8 |
37.7 to 56.2 |
165 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
41.2 |
33.1 to 49.9 |
201 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
58.0 |
47.7 to 67.7 |
136 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
59.1 |
51.2 to 66.6 |
383 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
76.2 |
65.5 to 84.4 |
134 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
56.9 |
48.1 to 65.3 |
249 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
57.1 |
42.7 to 70.4 |
109 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
51.8 |
49.7 to 53.9 |
9872 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
64.8 |
59.3 to 70.0 |
1084 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
53.1 |
46.9 to 59.2 |
424 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
60.1 |
55.1 to 64.9 |
1344 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
46.7 |
42.1 to 51.3 |
1235 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
51.7 |
48.0 to 55.5 |
1125 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
48.2 |
44.4 to 52.0 |
1712 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
55.8 |
50.4 to 61.1 |
648 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
51.7 |
45.8 to 57.5 |
1005 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
52.4 |
42.8 to 61.8 |
607 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
80.0 |
71.9 to 86.3 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
47.0 |
37.4 to 56.7 |
168 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
63.0 |
54.5 to 70.8 |
189 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
35.8 |
26.7 to 46.0 |
135 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
46.3 |
41.4 to 51.4 |
953 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
47.3 |
38.1 to 56.7 |
155 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
54.2 |
40.6 to 67.3 |
87 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
48.3 |
38.3 to 58.5 |
143 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
56.3 |
46.2 to 65.8 |
138 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
44.8 |
38.4 to 51.4 |
430 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
35.9 |
24.9 to 48.6 |
107 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
48.9 |
42.4 to 55.5 |
688 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
41.4 |
31.9 to 51.7 |
159 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
60.3 |
52.3 to 67.7 |
244 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
57.8 |
46.3 to 68.6 |
188 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
46.5 |
35.7 to 57.7 |
157 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
43.8 |
35.7 to 52.3 |
186 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
54.1 |
45.4 to 62.6 |
176 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
40.4 |
32.0 to 49.5 |
178 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
49.1 |
40.3 to 57.9 |
163 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
53.4 |
43.3 to 63.2 |
157 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
51.2 |
42.4 to 59.9 |
180 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
45.9 |
36.5 to 55.6 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
56.2 |
46.6 to 65.4 |
219 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
63.6 |
54.3 to 72.0 |
187 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
63.9 |
54.6 to 72.2 |
172 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
64.1 |
54.9 to 72.4 |
198 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
71.2 |
60.4 to 79.9 |
215 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
50.5 |
40.7 to 60.3 |
193 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
51.2 |
41.5 to 60.8 |
166 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
41.7 |
33.0 to 51.0 |
157 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
79.3 |
70.7 to 85.8 |
159 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
51.8 |
42.2 to 61.2 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
62.0 |
54.8 to 68.7 |
367 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
70.0 |
57.8 to 79.9 |
129 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
60.4 |
52.0 to 68.1 |
238 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
47.1 |
37.7 to 56.7 |
161 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
48.8 |
39.5 to 58.1 |
151 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
49.2 |
40.7 to 57.6 |
201 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
46.4 |
36.4 to 56.6 |
127 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
58.0 |
48.6 to 66.7 |
185 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
64.6 |
56.5 to 71.9 |
207 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
62.5 |
55.5 to 69.0 |
429 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
72.1 |
63.7 to 79.2 |
193 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
61.1 |
52.7 to 68.8 |
219 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
65.3 |
56.3 to 73.4 |
184 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
31.2 |
23.1 to 40.7 |
142 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
53.9 |
44.9 to 62.7 |
222 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
48.8 |
39.4 to 58.2 |
152 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
67.3 |
59.2 to 74.4 |
221 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
48.6 |
39.4 to 57.9 |
183 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
65.8 |
57.6 to 73.2 |
198 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
59.2 |
50.0 to 67.8 |
208 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
53.7 |
45.0 to 62.2 |
186 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
66.8 |
60.5 to 72.6 |
387 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
63.7 |
54.1 to 72.4 |
201 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
68.8 |
60.4 to 76.2 |
186 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
55.8 |
45.7 to 65.4 |
169 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
63.2 |
53.8 to 71.6 |
203 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
56.5 |
47.2 to 65.3 |
182 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
44.6 |
35.8 to 53.8 |
173 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
58.9 |
50.3 to 67.0 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
67.3 |
58.7 to 74.9 |
371 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
74.5 |
64.0 to 82.7 |
138 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
66.3 |
56.7 to 74.8 |
233 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
52.1 |
36.2 to 67.6 |
102 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
56.0 |
54.1 to 57.8 |
10587 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
69.5 |
64.9 to 73.7 |
1132 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
64.3 |
59.1 to 69.2 |
595 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
59.2 |
54.6 to 63.7 |
1699 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
50.5 |
46.4 to 54.5 |
1295 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
58.7 |
55.1 to 62.3 |
1268 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
52.2 |
47.1 to 57.3 |
1282 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
53.7 |
48.9 to 58.5 |
795 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
54.2 |
49.0 to 59.3 |
1050 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
55.6 |
48.0 to 62.9 |
741 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
86.0 |
78.0 to 91.4 |
159 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
46.9 |
37.7 to 56.3 |
167 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
68.5 |
59.7 to 76.2 |
171 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
56.3 |
46.9 to 65.3 |
168 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
52.9 |
45.8 to 59.9 |
578 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
59.4 |
50.1 to 68.0 |
161 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
49.8 |
38.5 to 61.2 |
110 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
52.6 |
44.6 to 60.5 |
307 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
54.5 |
48.8 to 60.0 |
730 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
40.5 |
31.5 to 50.2 |
156 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
65.9 |
57.4 to 73.4 |
203 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
48.2 |
39.4 to 57.1 |
324 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
53.0 |
43.6 to 62.1 |
215 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
38.9 |
30.5 to 47.9 |
162 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
59.6 |
50.2 to 68.3 |
155 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
37.3 |
29.4 to 46.0 |
181 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
66.6 |
57.7 to 74.5 |
169 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
52.1 |
42.2 to 61.8 |
147 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
60.3 |
50.6 to 69.2 |
169 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
54.7 |
45.5 to 63.7 |
165 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
70.9 |
58.7 to 80.7 |
140 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
69.8 |
60.3 to 77.8 |
163 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
65.8 |
56.8 to 73.8 |
181 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
68.9 |
59.7 to 76.9 |
166 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
77.7 |
68.3 to 84.9 |
212 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
48.8 |
38.1 to 59.6 |
185 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
55.4 |
43.9 to 66.3 |
142 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
54.9 |
44.1 to 65.2 |
131 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
69.6 |
59.4 to 78.2 |
132 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
59.5 |
50.4 to 68.0 |
181 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
59.6 |
52.3 to 66.6 |
296 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
64.4 |
48.2 to 77.9 |
72 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
58.6 |
50.3 to 66.4 |
224 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
48.7 |
39.1 to 58.5 |
146 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
62.0 |
49.5 to 73.0 |
107 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
58.3 |
47.9 to 67.9 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
64.8 |
54.2 to 74.2 |
129 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
67.1 |
57.9 to 75.1 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
55.5 |
45.9 to 64.8 |
156 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
70.2 |
63.9 to 75.8 |
468 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
72.0 |
61.0 to 80.9 |
151 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
60.7 |
50.4 to 70.2 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
62.0 |
52.4 to 70.8 |
161 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
32.8 |
24.3 to 42.6 |
157 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
56.0 |
46.6 to 65.0 |
184 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
55.5 |
46.2 to 64.5 |
155 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
60.7 |
50.9 to 69.7 |
168 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
58.0 |
47.6 to 67.8 |
158 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
67.8 |
58.2 to 76.1 |
149 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
47.0 |
37.2 to 57.0 |
170 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
53.1 |
44.2 to 61.9 |
169 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
61.5 |
53.9 to 68.5 |
303 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
68.0 |
57.6 to 76.9 |
147 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
57.0 |
46.7 to 66.8 |
156 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
62.9 |
52.2 to 72.5 |
144 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
75.6 |
63.8 to 84.4 |
104 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
55.6 |
43.4 to 67.2 |
125 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
58.2 |
47.9 to 67.8 |
126 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
70.6 |
61.2 to 78.5 |
165 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
69.2 |
62.9 to 74.9 |
495 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
74.5 |
65.4 to 81.9 |
173 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
68.5 |
61.5 to 74.8 |
322 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
65.9 |
56.5 to 74.1 |
175 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
59.8 |
57.6 to 61.8 |
9579 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
69.5 |
64.0 to 74.5 |
1025 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
56.6 |
50.6 to 62.4 |
473 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
64.6 |
60.5 to 68.6 |
1792 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
55.0 |
50.5 to 59.4 |
1240 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
57.8 |
53.5 to 61.9 |
1069 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
51.7 |
46.3 to 57.0 |
1162 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
58.5 |
53.0 to 63.7 |
619 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
65.0 |
59.7 to 70.0 |
949 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
68.5 |
59.2 to 76.6 |
599 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
86.3 |
77.1 to 92.2 |
116 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
63.2 |
52.9 to 72.3 |
140 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
71.3 |
63.1 to 78.4 |
243 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
48.8 |
39.3 to 58.4 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
48.3 |
41.0 to 55.6 |
528 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
58.4 |
48.0 to 68.1 |
146 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
68.7 |
54.2 to 80.3 |
94 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
46.0 |
37.9 to 54.3 |
288 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
45.3 |
33.3 to 57.8 |
132 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
67.7 |
61.9 to 73.0 |
651 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
60.2 |
49.9 to 69.7 |
160 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
69.5 |
62.6 to 75.6 |
272 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
56.7 |
46.4 to 66.4 |
307 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
70.1 |
60.1 to 78.5 |
158 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
46.1 |
36.6 to 55.9 |
144 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
59.9 |
50.7 to 68.4 |
162 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
47.4 |
36.8 to 58.4 |
124 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
58.7 |
48.4 to 68.3 |
130 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
54.1 |
43.7 to 64.1 |
141 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
64.8 |
54.8 to 73.5 |
144 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
54.5 |
45.4 to 63.3 |
173 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
60.4 |
50.6 to 69.4 |
181 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
62.3 |
54.0 to 69.9 |
182 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
69.5 |
58.9 to 78.4 |
133 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
68.8 |
57.9 to 78.0 |
123 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
80.6 |
69.3 to 88.4 |
124 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
53.5 |
42.6 to 64.1 |
158 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
57.2 |
47.4 to 66.4 |
174 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
46.2 |
35.4 to 57.3 |
120 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
69.3 |
59.3 to 77.8 |
128 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
59.2 |
48.3 to 69.3 |
130 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
64.3 |
56.6 to 71.4 |
336 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
68.9 |
57.3 to 78.4 |
137 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
63.3 |
54.2 to 71.6 |
199 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
55.8 |
45.9 to 65.3 |
142 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
75.4 |
65.3 to 83.4 |
119 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
59.5 |
50.2 to 68.1 |
173 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
52.6 |
42.4 to 62.5 |
137 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
65.5 |
56.0 to 73.8 |
161 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
66.8 |
57.6 to 74.8 |
142 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
65.7 |
54.2 to 75.6 |
185 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
77.8 |
68.4 to 85.1 |
132 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
52.4 |
41.3 to 63.3 |
130 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
71.5 |
62.7 to 79.0 |
179 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
39.8 |
28.8 to 52.0 |
116 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
55.9 |
45.5 to 65.9 |
140 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
61.0 |
51.6 to 69.7 |
155 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
73.9 |
63.9 to 82.0 |
113 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
55.4 |
45.5 to 64.8 |
142 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
75.9 |
66.1 to 83.6 |
116 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
66.0 |
55.8 to 74.8 |
156 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
57.8 |
47.3 to 67.7 |
128 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
72.3 |
65.5 to 78.2 |
273 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
79.0 |
69.2 to 86.4 |
110 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
67.8 |
58.5 to 75.9 |
163 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
56.0 |
46.4 to 65.2 |
186 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
74.4 |
64.4 to 82.4 |
152 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
60.5 |
49.5 to 70.5 |
146 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
45.8 |
36.0 to 56.0 |
140 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
64.2 |
54.5 to 72.8 |
147 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
66.3 |
59.3 to 72.6 |
413 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
72.9 |
62.9 to 81.1 |
151 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
65.4 |
57.7 to 72.4 |
262 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
71.6 |
65.0 to 77.4 |
348 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
60.6 |
58.6 to 62.6 |
8420 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
74.8 |
69.7 to 79.3 |
817 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
70.2 |
64.6 to 75.2 |
429 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
63.5 |
59.3 to 67.6 |
1293 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
54.5 |
50.2 to 58.8 |
1173 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
61.6 |
57.4 to 65.6 |
1070 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
54.4 |
48.2 to 60.5 |
1029 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
63.6 |
58.0 to 68.9 |
545 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
58.3 |
53.3 to 63.2 |
902 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
60.9 |
53.3 to 68.1 |
595 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
85.2 |
75.7 to 91.4 |
146 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
44.3 |
34.7 to 54.4 |
134 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
72.1 |
62.3 to 80.2 |
123 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
62.9 |
52.0 to 72.7 |
138 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
53.7 |
45.2 to 62.1 |
427 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
55.6 |
44.1 to 66.6 |
132 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
68.9 |
53.5 to 81.0 |
67 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
52.5 |
42.8 to 62.0 |
228 |
| HPV |
Up-to-Date, Males |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
66.5 |
60.7 to 71.8 |
567 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
48.3 |
38.2 to 58.6 |
130 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
70.3 |
60.6 to 78.5 |
148 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
61.0 |
53.6 to 68.0 |
314 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
71.1 |
61.6 to 79.0 |
149 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
41.2 |
32.1 to 51.0 |
134 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
70.4 |
60.2 to 78.8 |
137 |
| HPV |
Up-to-Date, Males |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
46.2 |
36.7 to 56.0 |
160 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2019 |
Age |
13-15 Years |
45.8 |
37.2 to 54.5 |
186 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2019 |
Age |
13-15 Years |
51.2 |
44.0 to 58.4 |
262 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2019 |
Age |
13-15 Years |
50.2 |
41.2 to 59.1 |
191 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2019 |
Age |
13-15 Years |
42.1 |
34.1 to 50.5 |
210 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2019 |
Age |
13-15 Years |
60.8 |
49.0 to 71.5 |
170 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2019 |
Age |
13-15 Years |
62.4 |
52.3 to 71.5 |
170 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2019 |
Age |
13-15 Years |
45.8 |
36.1 to 55.7 |
165 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2019 |
Age |
13-15 Years |
56.3 |
47.7 to 64.5 |
194 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-15 Years |
74.2 |
63.8 to 82.5 |
171 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2019 |
Age |
13-15 Years |
53.5 |
42.9 to 63.9 |
215 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2019 |
Age |
13-15 Years |
45.0 |
36.7 to 53.7 |
210 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2019 |
Age |
13-15 Years |
40.9 |
32.7 to 49.7 |
179 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2019 |
Age |
13-15 Years |
60.7 |
51.2 to 69.4 |
175 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2019 |
Age |
13-15 Years |
38.2 |
30.3 to 46.8 |
217 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2019 |
Age |
13-15 Years |
50.1 |
43.7 to 56.5 |
382 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-15 Years |
62.2 |
48.4 to 74.2 |
100 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-15 Years |
47.7 |
40.5 to 54.9 |
282 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2019 |
Age |
13-15 Years |
37.2 |
29.6 to 45.5 |
188 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2019 |
Age |
13-15 Years |
57.7 |
49.6 to 65.4 |
194 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2019 |
Age |
13-15 Years |
46.9 |
38.6 to 55.4 |
238 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2019 |
Age |
13-15 Years |
52.8 |
44.4 to 61.1 |
187 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2019 |
Age |
13-15 Years |
63.8 |
54.4 to 72.2 |
220 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2019 |
Age |
13-15 Years |
40.0 |
31.8 to 48.7 |
194 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2019 |
Age |
13-15 Years |
64.5 |
56.3 to 72.0 |
335 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-15 Years |
66.6 |
56.4 to 75.4 |
177 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2019 |
Age |
13-15 Years |
63.6 |
54.3 to 71.9 |
178 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2019 |
Age |
13-15 Years |
59.6 |
48.8 to 69.5 |
165 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2019 |
Age |
13-15 Years |
24.5 |
16.7 to 34.3 |
160 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2019 |
Age |
13-15 Years |
54.8 |
45.5 to 63.8 |
186 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2019 |
Age |
13-15 Years |
43.3 |
34.8 to 52.2 |
179 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2019 |
Age |
13-15 Years |
61.5 |
52.2 to 70.1 |
181 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2019 |
Age |
13-15 Years |
53.1 |
44.2 to 61.9 |
205 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-15 Years |
51.5 |
42.3 to 60.6 |
196 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2019 |
Age |
13-15 Years |
44.9 |
36.5 to 53.6 |
219 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2019 |
Age |
13-15 Years |
51.8 |
44.1 to 59.4 |
257 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2019 |
Age |
13-15 Years |
53.8 |
46.5 to 60.8 |
317 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-15 Years |
59.5 |
49.6 to 68.6 |
163 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-15 Years |
49.6 |
39.5 to 59.7 |
154 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2019 |
Age |
13-15 Years |
43.0 |
34.4 to 52.0 |
185 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2019 |
Age |
13-15 Years |
70.1 |
61.7 to 77.4 |
192 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2019 |
Age |
13-15 Years |
47.4 |
38.3 to 56.7 |
166 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-15 Years |
38.5 |
30.9 to 46.8 |
214 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2019 |
Age |
13-15 Years |
59.7 |
50.2 to 68.6 |
177 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-15 Years |
56.5 |
49.2 to 63.5 |
436 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-15 Years |
76.7 |
67.8 to 83.8 |
143 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-15 Years |
53.7 |
45.5 to 61.6 |
293 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-15 Years |
56.1 |
42.3 to 68.9 |
124 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2019 |
Age |
13-15 Years |
52.3 |
50.3 to 54.2 |
11687 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-15 Years |
58.5 |
53.1 to 63.8 |
1209 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-15 Years |
50.6 |
45.1 to 56.2 |
536 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-15 Years |
55.0 |
50.4 to 59.5 |
1589 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-15 Years |
47.3 |
43.2 to 51.4 |
1501 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-15 Years |
51.7 |
48.2 to 55.3 |
1271 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-15 Years |
48.7 |
45.2 to 52.1 |
2058 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-15 Years |
54.7 |
49.8 to 59.5 |
799 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-15 Years |
54.6 |
49.1 to 59.9 |
1129 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-15 Years |
58.7 |
49.7 to 67.3 |
741 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-15 Years |
80.8 |
72.3 to 87.2 |
186 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2019 |
Age |
13-15 Years |
49.1 |
40.3 to 58.0 |
195 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2019 |
Age |
13-15 Years |
58.8 |
50.4 to 66.7 |
200 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2019 |
Age |
13-15 Years |
46.6 |
37.6 to 55.9 |
163 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2019 |
Age |
13-15 Years |
48.2 |
43.6 to 52.7 |
1157 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-15 Years |
45.2 |
36.6 to 54.1 |
181 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-15 Years |
60.1 |
47.9 to 71.2 |
120 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-15 Years |
51.9 |
42.8 to 60.9 |
178 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-15 Years |
61.6 |
52.8 to 69.7 |
178 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-15 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-15 Years |
46.1 |
40.2 to 52.1 |
500 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-15 Years |
32.6 |
22.7 to 44.4 |
124 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-15 Years |
52.5 |
46.6 to 58.5 |
854 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2019 |
Age |
13-15 Years |
44.3 |
35.5 to 53.5 |
209 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2019 |
Age |
13-15 Years |
57.3 |
49.9 to 64.4 |
291 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2019 |
Age |
13-15 Years |
47.6 |
37.7 to 57.8 |
247 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2019 |
Age |
13-15 Years |
53.0 |
43.1 to 62.7 |
198 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2019 |
Age |
13-15 Years |
44.8 |
36.8 to 53.1 |
206 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-15 Years |
56.2 |
47.8 to 64.2 |
192 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2019 |
Age |
13-15 Years |
39.3 |
31.2 to 47.9 |
179 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2020 |
Age |
13-15 Years |
55.0 |
46.5 to 63.1 |
184 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2020 |
Age |
13-15 Years |
55.2 |
46.2 to 63.9 |
181 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2020 |
Age |
13-15 Years |
49.4 |
41.3 to 57.6 |
203 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2020 |
Age |
13-15 Years |
45.8 |
37.3 to 54.5 |
191 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2020 |
Age |
13-15 Years |
58.1 |
49.3 to 66.4 |
272 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2020 |
Age |
13-15 Years |
64.8 |
56.0 to 72.7 |
206 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2020 |
Age |
13-15 Years |
61.5 |
53.1 to 69.2 |
200 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2020 |
Age |
13-15 Years |
57.5 |
48.7 to 65.8 |
222 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-15 Years |
69.3 |
60.1 to 77.2 |
245 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2020 |
Age |
13-15 Years |
49.9 |
40.7 to 59.1 |
225 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2020 |
Age |
13-15 Years |
49.5 |
40.6 to 58.5 |
198 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2020 |
Age |
13-15 Years |
50.1 |
41.4 to 58.7 |
179 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2020 |
Age |
13-15 Years |
69.5 |
60.9 to 76.9 |
171 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2020 |
Age |
13-15 Years |
53.4 |
45.1 to 61.6 |
253 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2020 |
Age |
13-15 Years |
58.0 |
51.0 to 64.7 |
420 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-15 Years |
68.8 |
58.1 to 77.7 |
171 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-15 Years |
55.6 |
47.4 to 63.5 |
249 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2020 |
Age |
13-15 Years |
45.8 |
37.1 to 54.8 |
179 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2020 |
Age |
13-15 Years |
59.6 |
50.6 to 68.0 |
166 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2020 |
Age |
13-15 Years |
52.3 |
44.3 to 60.2 |
232 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2020 |
Age |
13-15 Years |
52.8 |
43.7 to 61.8 |
164 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2020 |
Age |
13-15 Years |
59.4 |
50.7 to 67.5 |
223 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2020 |
Age |
13-15 Years |
60.9 |
53.2 to 68.1 |
225 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2020 |
Age |
13-15 Years |
65.3 |
59.2 to 70.9 |
533 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-15 Years |
65.7 |
57.8 to 72.8 |
246 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2020 |
Age |
13-15 Years |
53.7 |
45.4 to 61.8 |
230 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2020 |
Age |
13-15 Years |
67.9 |
59.5 to 75.2 |
213 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2020 |
Age |
13-15 Years |
31.7 |
24.2 to 40.2 |
177 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2020 |
Age |
13-15 Years |
44.6 |
36.5 to 52.9 |
258 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2020 |
Age |
13-15 Years |
49.9 |
41.2 to 58.6 |
182 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2020 |
Age |
13-15 Years |
62.9 |
55.1 to 70.1 |
238 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2020 |
Age |
13-15 Years |
44.4 |
36.2 to 53.0 |
216 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-15 Years |
63.9 |
56.3 to 71.0 |
219 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2020 |
Age |
13-15 Years |
52.9 |
44.2 to 61.4 |
248 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2020 |
Age |
13-15 Years |
53.3 |
45.0 to 61.4 |
197 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2020 |
Age |
13-15 Years |
65.1 |
59.0 to 70.7 |
444 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-15 Years |
65.2 |
56.5 to 73.0 |
233 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-15 Years |
65.0 |
56.5 to 72.6 |
211 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2020 |
Age |
13-15 Years |
60.2 |
51.0 to 68.8 |
206 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2020 |
Age |
13-15 Years |
62.0 |
53.7 to 69.6 |
256 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2020 |
Age |
13-15 Years |
45.3 |
36.8 to 54.2 |
205 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-15 Years |
39.5 |
32.0 to 47.6 |
215 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2020 |
Age |
13-15 Years |
53.8 |
45.2 to 62.2 |
188 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-15 Years |
57.4 |
49.6 to 64.9 |
468 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-15 Years |
74.4 |
65.5 to 81.7 |
164 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-15 Years |
55.1 |
46.4 to 63.5 |
304 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-15 Years |
54.6 |
39.5 to 68.8 |
94 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2020 |
Age |
13-15 Years |
54.5 |
52.8 to 56.2 |
12447 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-15 Years |
64.9 |
60.6 to 69.0 |
1297 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-15 Years |
61.0 |
56.1 to 65.8 |
692 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-15 Years |
55.6 |
51.4 to 59.7 |
2067 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-15 Years |
50.8 |
47.0 to 54.6 |
1570 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-15 Years |
53.8 |
50.3 to 57.2 |
1415 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-15 Years |
51.3 |
46.7 to 55.9 |
1541 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-15 Years |
52.1 |
47.5 to 56.6 |
894 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-15 Years |
55.8 |
50.9 to 60.5 |
1211 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-15 Years |
56.3 |
49.4 to 63.0 |
862 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-15 Years |
77.0 |
68.5 to 83.8 |
160 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2020 |
Age |
13-15 Years |
44.0 |
35.9 to 52.5 |
211 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2020 |
Age |
13-15 Years |
70.5 |
62.4 to 77.4 |
192 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2020 |
Age |
13-15 Years |
52.4 |
44.0 to 60.7 |
205 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2020 |
Age |
13-15 Years |
52.0 |
45.7 to 58.3 |
715 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-15 Years |
60.3 |
51.8 to 68.2 |
186 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-15 Years |
58.3 |
47.5 to 68.3 |
143 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-15 Years |
51.0 |
43.8 to 58.1 |
386 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-15 Years |
54.8 |
49.6 to 59.9 |
898 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2020 |
Age |
13-15 Years |
41.9 |
33.4 to 50.9 |
191 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2020 |
Age |
13-15 Years |
68.5 |
61.0 to 75.2 |
247 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2020 |
Age |
13-15 Years |
48.5 |
40.3 to 56.7 |
418 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2020 |
Age |
13-15 Years |
55.7 |
47.3 to 63.7 |
276 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2020 |
Age |
13-15 Years |
36.7 |
29.1 to 44.9 |
181 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-15 Years |
56.0 |
46.9 to 64.7 |
168 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2020 |
Age |
13-15 Years |
46.5 |
37.9 to 55.4 |
184 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2021 |
Age |
13-15 Years |
63.0 |
54.5 to 70.8 |
188 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2021 |
Age |
13-15 Years |
48.1 |
39.1 to 57.3 |
170 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2021 |
Age |
13-15 Years |
53.8 |
44.8 to 62.5 |
179 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2021 |
Age |
13-15 Years |
52.0 |
43.4 to 60.4 |
196 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2021 |
Age |
13-15 Years |
68.6 |
57.4 to 78.0 |
182 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2021 |
Age |
13-15 Years |
63.6 |
54.3 to 72.0 |
196 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2021 |
Age |
13-15 Years |
57.6 |
48.9 to 65.9 |
212 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2021 |
Age |
13-15 Years |
63.6 |
55.1 to 71.3 |
194 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-15 Years |
79.3 |
71.7 to 85.3 |
261 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2021 |
Age |
13-15 Years |
48.0 |
37.3 to 58.9 |
201 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2021 |
Age |
13-15 Years |
58.7 |
48.0 to 68.6 |
161 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2021 |
Age |
13-15 Years |
48.8 |
38.4 to 59.3 |
130 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2021 |
Age |
13-15 Years |
66.2 |
56.8 to 74.5 |
145 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2021 |
Age |
13-15 Years |
61.0 |
52.6 to 68.9 |
218 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2021 |
Age |
13-15 Years |
58.9 |
52.3 to 65.3 |
355 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-15 Years |
64.9 |
50.2 to 77.2 |
94 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-15 Years |
57.4 |
49.8 to 64.6 |
261 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2021 |
Age |
13-15 Years |
51.5 |
42.4 to 60.6 |
163 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2021 |
Age |
13-15 Years |
67.1 |
55.6 to 76.9 |
127 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2021 |
Age |
13-15 Years |
62.2 |
52.7 to 70.8 |
180 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2021 |
Age |
13-15 Years |
50.6 |
40.3 to 60.9 |
144 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2021 |
Age |
13-15 Years |
58.1 |
49.2 to 66.6 |
193 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2021 |
Age |
13-15 Years |
56.1 |
47.2 to 64.7 |
183 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2021 |
Age |
13-15 Years |
67.9 |
62.2 to 73.1 |
572 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-15 Years |
73.5 |
63.0 to 81.8 |
163 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2021 |
Age |
13-15 Years |
60.1 |
51.0 to 68.5 |
225 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2021 |
Age |
13-15 Years |
61.9 |
52.4 to 70.5 |
182 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2021 |
Age |
13-15 Years |
35.9 |
27.7 to 45.0 |
189 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2021 |
Age |
13-15 Years |
56.6 |
48.1 to 64.8 |
212 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2021 |
Age |
13-15 Years |
52.7 |
44.0 to 61.2 |
176 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2021 |
Age |
13-15 Years |
55.6 |
46.4 to 64.4 |
196 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2021 |
Age |
13-15 Years |
52.1 |
43.1 to 60.9 |
221 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-15 Years |
71.7 |
63.3 to 78.8 |
178 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2021 |
Age |
13-15 Years |
53.4 |
43.6 to 62.9 |
183 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2021 |
Age |
13-15 Years |
54.0 |
45.5 to 62.2 |
201 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2021 |
Age |
13-15 Years |
61.1 |
54.3 to 67.5 |
344 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-15 Years |
68.4 |
59.6 to 76.1 |
179 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-15 Years |
56.2 |
46.6 to 65.3 |
165 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2021 |
Age |
13-15 Years |
65.6 |
55.2 to 74.7 |
167 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2021 |
Age |
13-15 Years |
59.9 |
48.2 to 70.7 |
104 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2021 |
Age |
13-15 Years |
55.2 |
44.2 to 65.7 |
156 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-15 Years |
50.3 |
40.9 to 59.7 |
151 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2021 |
Age |
13-15 Years |
59.6 |
50.5 to 68.0 |
192 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-15 Years |
65.8 |
59.9 to 71.3 |
561 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-15 Years |
70.3 |
61.5 to 77.8 |
198 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-15 Years |
65.3 |
58.6 to 71.4 |
363 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-15 Years |
64.1 |
55.3 to 72.0 |
205 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2021 |
Age |
13-15 Years |
58.5 |
56.5 to 60.5 |
11161 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-15 Years |
68.1 |
63.0 to 72.8 |
1186 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-15 Years |
58.4 |
52.8 to 63.8 |
527 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-15 Years |
64.8 |
61.0 to 68.5 |
2095 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-15 Years |
55.4 |
51.0 to 59.6 |
1412 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-15 Years |
57.4 |
53.6 to 61.2 |
1256 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-15 Years |
48.6 |
43.5 to 53.7 |
1333 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-15 Years |
59.9 |
54.9 to 64.7 |
715 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-15 Years |
60.4 |
55.3 to 65.4 |
1112 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-15 Years |
65.3 |
56.8 to 72.9 |
727 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-15 Years |
85.4 |
77.0 to 91.1 |
167 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2021 |
Age |
13-15 Years |
61.2 |
51.9 to 69.8 |
174 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2021 |
Age |
13-15 Years |
73.8 |
66.5 to 80.0 |
276 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2021 |
Age |
13-15 Years |
55.8 |
46.6 to 64.7 |
188 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2021 |
Age |
13-15 Years |
46.4 |
39.6 to 53.3 |
592 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-15 Years |
62.0 |
52.5 to 70.7 |
174 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-15 Years |
60.5 |
46.8 to 72.7 |
93 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-15 Years |
44.3 |
36.7 to 52.1 |
325 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-15 Years |
49.0 |
37.9 to 60.3 |
163 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-15 Years |
60.2 |
54.8 to 65.3 |
798 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2021 |
Age |
13-15 Years |
57.6 |
48.2 to 66.6 |
191 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2021 |
Age |
13-15 Years |
62.4 |
55.3 to 69.0 |
283 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2021 |
Age |
13-15 Years |
63.1 |
53.8 to 71.5 |
345 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2021 |
Age |
13-15 Years |
61.6 |
52.6 to 70.0 |
218 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2021 |
Age |
13-15 Years |
51.8 |
42.7 to 60.8 |
162 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-15 Years |
57.0 |
48.1 to 65.4 |
175 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2021 |
Age |
13-15 Years |
44.0 |
34.9 to 53.5 |
169 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2022 |
Age |
13-15 Years |
61.8 |
52.5 to 70.4 |
157 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2022 |
Age |
13-15 Years |
52.5 |
42.5 to 62.2 |
156 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2022 |
Age |
13-15 Years |
57.7 |
48.1 to 66.8 |
159 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2022 |
Age |
13-15 Years |
51.4 |
42.8 to 60.0 |
193 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2022 |
Age |
13-15 Years |
55.3 |
45.6 to 64.7 |
188 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2022 |
Age |
13-15 Years |
63.4 |
55.5 to 70.6 |
205 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2022 |
Age |
13-15 Years |
65.9 |
56.6 to 74.2 |
167 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2022 |
Age |
13-15 Years |
69.2 |
59.2 to 77.7 |
145 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-15 Years |
77.2 |
67.0 to 85.0 |
152 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2022 |
Age |
13-15 Years |
49.3 |
39.5 to 59.2 |
183 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2022 |
Age |
13-15 Years |
59.0 |
50.1 to 67.3 |
216 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2022 |
Age |
13-15 Years |
40.5 |
31.0 to 50.8 |
147 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2022 |
Age |
13-15 Years |
69.1 |
59.5 to 77.2 |
137 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2022 |
Age |
13-15 Years |
61.9 |
52.0 to 70.9 |
158 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2022 |
Age |
13-15 Years |
66.3 |
59.3 to 72.6 |
383 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-15 Years |
63.3 |
52.7 to 72.7 |
161 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-15 Years |
67.0 |
58.7 to 74.4 |
222 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2022 |
Age |
13-15 Years |
54.4 |
45.1 to 63.5 |
167 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2022 |
Age |
13-15 Years |
72.9 |
62.5 to 81.3 |
131 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2022 |
Age |
13-15 Years |
58.9 |
50.3 to 67.0 |
188 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2022 |
Age |
13-15 Years |
51.4 |
42.1 to 60.5 |
159 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2022 |
Age |
13-15 Years |
64.1 |
55.4 to 72.0 |
210 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2022 |
Age |
13-15 Years |
58.7 |
49.7 to 67.2 |
163 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2022 |
Age |
13-15 Years |
68.8 |
58.3 to 77.7 |
213 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-15 Years |
72.1 |
62.3 to 80.2 |
151 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2022 |
Age |
13-15 Years |
65.4 |
55.6 to 74.1 |
165 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2022 |
Age |
13-15 Years |
59.9 |
51.1 to 68.1 |
188 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2022 |
Age |
13-15 Years |
33.1 |
24.0 to 43.6 |
147 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2022 |
Age |
13-15 Years |
57.2 |
48.1 to 65.8 |
179 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2022 |
Age |
13-15 Years |
61.2 |
52.5 to 69.3 |
191 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2022 |
Age |
13-15 Years |
59.2 |
49.8 to 68.0 |
156 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2022 |
Age |
13-15 Years |
52.2 |
42.8 to 61.5 |
155 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-15 Years |
72.0 |
62.5 to 79.9 |
134 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2022 |
Age |
13-15 Years |
61.5 |
51.3 to 70.7 |
158 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2022 |
Age |
13-15 Years |
58.5 |
49.4 to 67.1 |
185 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2022 |
Age |
13-15 Years |
66.5 |
60.1 to 72.4 |
320 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-15 Years |
72.2 |
63.1 to 79.9 |
146 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-15 Years |
62.4 |
53.5 to 70.5 |
174 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2022 |
Age |
13-15 Years |
52.3 |
43.7 to 60.8 |
229 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2022 |
Age |
13-15 Years |
75.4 |
66.4 to 82.6 |
177 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2022 |
Age |
13-15 Years |
61.5 |
51.1 to 70.9 |
163 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-15 Years |
41.2 |
32.1 to 51.1 |
153 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2022 |
Age |
13-15 Years |
60.0 |
50.8 to 68.5 |
170 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-15 Years |
67.1 |
60.8 to 72.8 |
471 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-15 Years |
69.1 |
59.1 to 77.6 |
169 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-15 Years |
66.8 |
59.8 to 73.2 |
302 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-15 Years |
69.9 |
63.6 to 75.5 |
393 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2022 |
Age |
13-15 Years |
58.6 |
56.7 to 60.5 |
9816 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-15 Years |
69.5 |
64.4 to 74.1 |
947 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-15 Years |
64.9 |
59.4 to 69.9 |
478 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-15 Years |
63.8 |
60.0 to 67.5 |
1494 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-15 Years |
52.5 |
48.4 to 56.5 |
1406 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-15 Years |
62.6 |
58.8 to 66.3 |
1226 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-15 Years |
53.8 |
47.9 to 59.6 |
1229 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-15 Years |
61.4 |
56.4 to 66.1 |
654 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-15 Years |
60.3 |
55.6 to 64.8 |
1085 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-15 Years |
55.8 |
48.2 to 63.2 |
639 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-15 Years |
81.3 |
71.8 to 88.2 |
168 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2022 |
Age |
13-15 Years |
45.1 |
35.8 to 54.6 |
155 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2022 |
Age |
13-15 Years |
65.5 |
55.9 to 74.1 |
158 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2022 |
Age |
13-15 Years |
59.5 |
49.1 to 69.0 |
160 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2022 |
Age |
13-15 Years |
54.0 |
45.9 to 61.9 |
488 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-15 Years |
59.5 |
48.5 to 69.7 |
151 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-15 Years |
58.4 |
44.9 to 70.7 |
98 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-15 Years |
53.3 |
44.2 to 62.2 |
239 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-15 Years |
62.8 |
57.2 to 68.1 |
658 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2022 |
Age |
13-15 Years |
54.7 |
45.1 to 64.0 |
166 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2022 |
Age |
13-15 Years |
61.9 |
52.4 to 70.7 |
164 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2022 |
Age |
13-15 Years |
58.2 |
51.3 to 64.8 |
365 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2022 |
Age |
13-15 Years |
65.9 |
56.2 to 74.4 |
174 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2022 |
Age |
13-15 Years |
43.6 |
34.6 to 52.9 |
148 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-15 Years |
64.3 |
54.9 to 72.8 |
160 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2022 |
Age |
13-15 Years |
43.1 |
34.2 to 52.5 |
188 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2016 |
Age |
13-17 Years |
35.4 |
29.5 to 41.7 |
333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2016 |
Age |
13-17 Years |
43.3 |
37.2 to 49.6 |
392 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2016 |
Age |
13-17 Years |
44.1 |
37.5 to 51.0 |
329 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2016 |
Age |
13-17 Years |
34.5 |
28.9 to 40.7 |
352 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2016 |
Age |
13-17 Years |
49.1 |
42.2 to 56.0 |
327 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2016 |
Age |
13-17 Years |
48.0 |
41.0 to 55.0 |
322 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2016 |
Age |
13-17 Years |
49.0 |
42.7 to 55.3 |
357 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2016 |
Age |
13-17 Years |
56.9 |
50.7 to 62.8 |
375 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2016 |
Age |
13-17 Years |
62.0 |
55.3 to 68.2 |
377 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2016 |
Age |
13-17 Years |
40.4 |
34.0 to 47.1 |
376 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2016 |
Age |
13-17 Years |
45.6 |
39.2 to 52.2 |
367 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2016 |
Age |
13-17 Years |
44.2 |
39.0 to 49.5 |
535 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2016 |
Age |
13-17 Years |
54.0 |
47.5 to 60.3 |
317 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2016 |
Age |
13-17 Years |
36.5 |
30.8 to 42.6 |
358 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2016 |
Age |
13-17 Years |
47.8 |
42.9 to 52.7 |
605 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2016 |
Age |
13-17 Years |
55.7 |
45.6 to 65.3 |
157 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2016 |
Age |
13-17 Years |
46.1 |
40.6 to 51.7 |
448 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2016 |
Age |
13-17 Years |
33.9 |
28.0 to 40.2 |
350 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2016 |
Age |
13-17 Years |
45.5 |
39.7 to 51.5 |
382 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2016 |
Age |
13-17 Years |
35.6 |
29.6 to 42.1 |
322 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2016 |
Age |
13-17 Years |
34.0 |
28.0 to 40.5 |
333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2016 |
Age |
13-17 Years |
41.8 |
35.8 to 48.1 |
336 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2016 |
Age |
13-17 Years |
56.0 |
49.8 to 62.1 |
347 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2016 |
Age |
13-17 Years |
48.1 |
41.6 to 54.6 |
451 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2016 |
Age |
13-17 Years |
56.6 |
50.6 to 62.5 |
374 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2016 |
Age |
13-17 Years |
44.8 |
37.9 to 51.9 |
283 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2016 |
Age |
13-17 Years |
44.1 |
38.1 to 50.3 |
375 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2016 |
Age |
13-17 Years |
29.1 |
23.6 to 35.2 |
377 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2016 |
Age |
13-17 Years |
35.8 |
29.8 to 42.4 |
360 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2016 |
Age |
13-17 Years |
39.9 |
33.8 to 46.4 |
375 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2016 |
Age |
13-17 Years |
45.9 |
39.4 to 52.5 |
330 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2016 |
Age |
13-17 Years |
39.9 |
33.7 to 46.5 |
330 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2016 |
Age |
13-17 Years |
51.2 |
44.6 to 57.8 |
313 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2016 |
Age |
13-17 Years |
42.8 |
37.0 to 48.8 |
422 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2016 |
Age |
13-17 Years |
42.9 |
37.0 to 49.0 |
374 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2016 |
Age |
13-17 Years |
55.7 |
51.0 to 60.2 |
655 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2016 |
Age |
13-17 Years |
61.7 |
54.9 to 68.1 |
291 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2016 |
Age |
13-17 Years |
51.8 |
45.6 to 58.0 |
364 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2016 |
Age |
13-17 Years |
41.2 |
35.0 to 47.7 |
366 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2016 |
Age |
13-17 Years |
52.7 |
46.0 to 59.3 |
293 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2016 |
Age |
13-17 Years |
41.8 |
35.3 to 48.6 |
338 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2016 |
Age |
13-17 Years |
39.2 |
32.4 to 46.4 |
281 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2016 |
Age |
13-17 Years |
47.5 |
41.0 to 54.0 |
318 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2016 |
Age |
13-17 Years |
51.0 |
45.9 to 56.1 |
875 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2016 |
Age |
13-17 Years |
68.4 |
62.5 to 73.8 |
349 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2016 |
Age |
13-17 Years |
48.7 |
43.0 to 54.5 |
526 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2016 |
Age |
13-17 Years |
52.8 |
46.4 to 59.0 |
405 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2016 |
Age |
13-17 Years |
43.4 |
42.1 to 44.7 |
20475 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2016 |
Age |
13-17 Years |
55.0 |
51.7 to 58.3 |
2097 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2016 |
Age |
13-17 Years |
51.4 |
47.7 to 55.1 |
1077 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2016 |
Age |
13-17 Years |
46.9 |
43.6 to 50.2 |
2842 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2016 |
Age |
13-17 Years |
38.7 |
36.1 to 41.4 |
2757 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2016 |
Age |
13-17 Years |
43.4 |
40.8 to 46.1 |
2284 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2016 |
Age |
13-17 Years |
35.0 |
32.5 to 37.7 |
3270 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2016 |
Age |
13-17 Years |
39.3 |
36.0 to 42.8 |
1394 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2016 |
Age |
13-17 Years |
40.6 |
36.9 to 44.4 |
2022 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2016 |
Age |
13-17 Years |
48.0 |
42.5 to 53.5 |
1303 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2016 |
Age |
13-17 Years |
70.8 |
64.4 to 76.4 |
326 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2016 |
Age |
13-17 Years |
29.1 |
23.3 to 35.6 |
314 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2016 |
Age |
13-17 Years |
38.6 |
32.4 to 45.2 |
342 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2016 |
Age |
13-17 Years |
36.0 |
29.7 to 42.8 |
291 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2016 |
Age |
13-17 Years |
32.9 |
29.6 to 36.5 |
1927 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2016 |
Age |
13-17 Years |
39.2 |
33.0 to 45.8 |
334 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2016 |
Age |
13-17 Years |
46.4 |
37.6 to 55.3 |
225 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Dallas County |
2016 |
Age |
13-17 Years |
23.9 |
18.8 to 30.0 |
294 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-El Paso County |
2016 |
Age |
13-17 Years |
66.0 |
59.0 to 72.4 |
345 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2016 |
Age |
13-17 Years |
30.7 |
26.4 to 35.4 |
729 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2016 |
Age |
13-17 Years |
22.6 |
17.9 to 28.1 |
428 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2016 |
Age |
13-17 Years |
46.7 |
42.8 to 50.7 |
1429 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2016 |
Age |
13-17 Years |
30.5 |
24.9 to 36.9 |
317 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2016 |
Age |
13-17 Years |
55.7 |
49.9 to 61.3 |
380 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2016 |
Age |
13-17 Years |
39.2 |
32.1 to 46.8 |
451 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2016 |
Age |
13-17 Years |
49.5 |
43.0 to 55.9 |
361 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2016 |
Age |
13-17 Years |
41.2 |
34.7 to 47.9 |
313 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2016 |
Age |
13-17 Years |
45.5 |
39.2 to 52.0 |
333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2016 |
Age |
13-17 Years |
26.7 |
21.7 to 32.3 |
373 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2017 |
Age |
13-17 Years |
40.3 |
34.4 to 46.5 |
367 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2017 |
Age |
13-17 Years |
42.6 |
36.7 to 48.8 |
349 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2017 |
Age |
13-17 Years |
53.0 |
46.3 to 59.6 |
335 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2017 |
Age |
13-17 Years |
35.2 |
29.4 to 41.5 |
357 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2017 |
Age |
13-17 Years |
53.4 |
46.3 to 60.4 |
306 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2017 |
Age |
13-17 Years |
53.8 |
47.4 to 60.0 |
354 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2017 |
Age |
13-17 Years |
58.0 |
51.4 to 64.3 |
330 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2017 |
Age |
13-17 Years |
58.1 |
51.6 to 64.4 |
350 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2017 |
Age |
13-17 Years |
78.0 |
71.1 to 83.6 |
318 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2017 |
Age |
13-17 Years |
42.3 |
35.9 to 49.0 |
415 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2017 |
Age |
13-17 Years |
45.7 |
39.1 to 52.5 |
343 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2017 |
Age |
13-17 Years |
42.7 |
36.9 to 48.8 |
382 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2017 |
Age |
13-17 Years |
54.7 |
48.2 to 61.0 |
314 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2017 |
Age |
13-17 Years |
44.1 |
37.6 to 50.7 |
353 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2017 |
Age |
13-17 Years |
50.4 |
45.8 to 55.0 |
683 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2017 |
Age |
13-17 Years |
66.6 |
57.7 to 74.4 |
204 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2017 |
Age |
13-17 Years |
46.9 |
41.7 to 52.2 |
479 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2017 |
Age |
13-17 Years |
40.8 |
34.4 to 47.5 |
334 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2017 |
Age |
13-17 Years |
53.7 |
47.6 to 59.8 |
343 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2017 |
Age |
13-17 Years |
34.4 |
28.6 to 40.7 |
338 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2017 |
Age |
13-17 Years |
37.7 |
32.1 to 43.7 |
372 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2017 |
Age |
13-17 Years |
52.9 |
46.5 to 59.1 |
341 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2017 |
Age |
13-17 Years |
59.2 |
53.2 to 65.0 |
347 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2017 |
Age |
13-17 Years |
52.9 |
45.4 to 60.2 |
470 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2017 |
Age |
13-17 Years |
65.5 |
59.7 to 70.8 |
412 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2017 |
Age |
13-17 Years |
54.3 |
47.9 to 60.6 |
328 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2017 |
Age |
13-17 Years |
46.9 |
40.7 to 53.3 |
356 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2017 |
Age |
13-17 Years |
28.8 |
23.5 to 34.8 |
347 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2017 |
Age |
13-17 Years |
39.6 |
33.6 to 45.9 |
335 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2017 |
Age |
13-17 Years |
49.1 |
42.5 to 55.7 |
326 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2017 |
Age |
13-17 Years |
58.3 |
51.9 to 64.5 |
324 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2017 |
Age |
13-17 Years |
49.0 |
42.6 to 55.5 |
344 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2017 |
Age |
13-17 Years |
59.9 |
53.7 to 65.8 |
333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2017 |
Age |
13-17 Years |
49.6 |
43.4 to 55.8 |
366 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2017 |
Age |
13-17 Years |
48.3 |
42.2 to 54.5 |
362 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2017 |
Age |
13-17 Years |
53.6 |
48.9 to 58.2 |
651 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2017 |
Age |
13-17 Years |
61.0 |
54.1 to 67.5 |
281 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2017 |
Age |
13-17 Years |
48.8 |
42.6 to 55.0 |
370 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2017 |
Age |
13-17 Years |
51.9 |
45.3 to 58.4 |
336 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2017 |
Age |
13-17 Years |
57.8 |
51.9 to 63.5 |
379 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2017 |
Age |
13-17 Years |
47.0 |
41.2 to 52.8 |
408 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2017 |
Age |
13-17 Years |
41.4 |
35.3 to 47.8 |
338 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2017 |
Age |
13-17 Years |
54.8 |
48.6 to 60.8 |
359 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2017 |
Age |
13-17 Years |
52.5 |
47.3 to 57.7 |
851 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2017 |
Age |
13-17 Years |
69.5 |
63.5 to 75.0 |
362 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2017 |
Age |
13-17 Years |
50.3 |
44.5 to 56.0 |
489 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2017 |
Age |
13-17 Years |
48.6 |
47.3 to 49.9 |
20949 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2017 |
Age |
13-17 Years |
63.3 |
60.1 to 66.4 |
2107 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2017 |
Age |
13-17 Years |
52.3 |
48.5 to 56.0 |
1017 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2017 |
Age |
13-17 Years |
54.5 |
51.0 to 57.9 |
2745 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2017 |
Age |
13-17 Years |
43.0 |
40.3 to 45.7 |
2846 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2017 |
Age |
13-17 Years |
49.0 |
46.5 to 51.4 |
2433 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2017 |
Age |
13-17 Years |
41.3 |
38.9 to 43.8 |
3654 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2017 |
Age |
13-17 Years |
44.2 |
40.9 to 47.6 |
1340 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2017 |
Age |
13-17 Years |
46.8 |
43.4 to 50.3 |
2108 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2017 |
Age |
13-17 Years |
53.1 |
47.5 to 58.7 |
1299 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2017 |
Age |
13-17 Years |
77.7 |
71.6 to 82.8 |
319 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2017 |
Age |
13-17 Years |
42.7 |
36.1 to 49.5 |
328 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2017 |
Age |
13-17 Years |
44.8 |
38.5 to 51.2 |
333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2017 |
Age |
13-17 Years |
39.2 |
32.8 to 46.1 |
338 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2017 |
Age |
13-17 Years |
39.7 |
36.5 to 43.0 |
2256 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2017 |
Age |
13-17 Years |
46.4 |
40.2 to 52.7 |
336 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2017 |
Age |
13-17 Years |
55.2 |
45.9 to 64.2 |
187 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Dallas County |
2017 |
Age |
13-17 Years |
35.7 |
28.8 to 43.1 |
263 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-El Paso County |
2017 |
Age |
13-17 Years |
60.0 |
52.9 to 66.6 |
320 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Hidalgo County |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Travis County |
2017 |
Age |
13-17 Years |
52.0 |
45.4 to 58.5 |
304 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2017 |
Age |
13-17 Years |
36.6 |
32.4 to 41.0 |
846 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2017 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2017 |
Age |
13-17 Years |
52.8 |
48.9 to 56.6 |
1400 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2017 |
Age |
13-17 Years |
37.4 |
31.5 to 43.7 |
356 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2017 |
Age |
13-17 Years |
64.5 |
58.4 to 70.2 |
366 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2017 |
Age |
13-17 Years |
59.0 |
51.1 to 66.6 |
413 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2017 |
Age |
13-17 Years |
55.2 |
48.8 to 61.5 |
339 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2017 |
Age |
13-17 Years |
43.9 |
37.7 to 50.2 |
343 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2017 |
Age |
13-17 Years |
52.3 |
45.8 to 58.7 |
324 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2017 |
Age |
13-17 Years |
30.9 |
25.5 to 36.8 |
360 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018 |
Age |
13-17 Years |
50.2 |
43.4 to 56.9 |
327 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018 |
Age |
13-17 Years |
44.1 |
38.3 to 50.0 |
392 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018 |
Age |
13-17 Years |
50.7 |
43.8 to 57.6 |
288 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018 |
Age |
13-17 Years |
42.6 |
36.0 to 49.5 |
308 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018 |
Age |
13-17 Years |
52.6 |
45.4 to 59.8 |
356 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018 |
Age |
13-17 Years |
62.5 |
55.0 to 69.4 |
278 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018 |
Age |
13-17 Years |
53.1 |
46.2 to 59.9 |
293 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018 |
Age |
13-17 Years |
58.4 |
51.3 to 65.2 |
306 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018 |
Age |
13-17 Years |
71.3 |
63.6 to 78.0 |
283 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018 |
Age |
13-17 Years |
46.5 |
39.7 to 53.5 |
337 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018 |
Age |
13-17 Years |
49.6 |
43.1 to 56.1 |
345 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2018 |
Age |
13-17 Years |
45.6 |
39.2 to 52.3 |
309 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018 |
Age |
13-17 Years |
60.7 |
54.2 to 66.8 |
327 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018 |
Age |
13-17 Years |
43.4 |
36.9 to 50.2 |
291 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018 |
Age |
13-17 Years |
53.4 |
48.9 to 57.9 |
721 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018 |
Age |
13-17 Years |
65.0 |
54.8 to 73.9 |
192 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018 |
Age |
13-17 Years |
51.0 |
45.9 to 56.0 |
529 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018 |
Age |
13-17 Years |
48.9 |
42.3 to 55.7 |
296 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018 |
Age |
13-17 Years |
55.1 |
48.2 to 61.8 |
280 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018 |
Age |
13-17 Years |
40.7 |
34.3 to 47.5 |
297 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018 |
Age |
13-17 Years |
42.6 |
35.9 to 49.5 |
270 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018 |
Age |
13-17 Years |
46.7 |
39.5 to 54.1 |
284 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018 |
Age |
13-17 Years |
50.7 |
43.9 to 57.5 |
317 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018 |
Age |
13-17 Years |
58.1 |
51.2 to 64.7 |
393 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018 |
Age |
13-17 Years |
68.7 |
61.6 to 75.0 |
328 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018 |
Age |
13-17 Years |
55.0 |
48.3 to 61.6 |
313 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018 |
Age |
13-17 Years |
58.8 |
51.2 to 66.0 |
285 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018 |
Age |
13-17 Years |
32.6 |
26.4 to 39.5 |
285 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018 |
Age |
13-17 Years |
42.1 |
35.7 to 48.8 |
319 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018 |
Age |
13-17 Years |
48.4 |
41.6 to 55.2 |
290 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018 |
Age |
13-17 Years |
62.7 |
55.6 to 69.3 |
295 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018 |
Age |
13-17 Years |
51.1 |
44.7 to 57.4 |
334 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018 |
Age |
13-17 Years |
67.4 |
60.4 to 73.8 |
303 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018 |
Age |
13-17 Years |
48.5 |
41.9 to 55.2 |
351 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018 |
Age |
13-17 Years |
57.0 |
50.1 to 63.5 |
295 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018 |
Age |
13-17 Years |
57.3 |
51.8 to 62.6 |
535 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018 |
Age |
13-17 Years |
58.3 |
50.6 to 65.6 |
261 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018 |
Age |
13-17 Years |
56.7 |
49.2 to 63.9 |
274 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018 |
Age |
13-17 Years |
52.1 |
45.4 to 58.7 |
341 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018 |
Age |
13-17 Years |
63.6 |
56.5 to 70.2 |
287 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018 |
Age |
13-17 Years |
58.2 |
51.6 to 64.4 |
329 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018 |
Age |
13-17 Years |
37.9 |
32.2 to 43.9 |
360 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018 |
Age |
13-17 Years |
58.2 |
51.2 to 64.9 |
297 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018 |
Age |
13-17 Years |
54.1 |
47.4 to 60.7 |
649 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018 |
Age |
13-17 Years |
71.5 |
64.1 to 77.9 |
237 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018 |
Age |
13-17 Years |
51.8 |
44.3 to 59.2 |
412 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018 |
Age |
13-17 Years |
51.1 |
49.8 to 52.5 |
18700 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2018 |
Age |
13-17 Years |
63.4 |
59.6 to 67.0 |
1902 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2018 |
Age |
13-17 Years |
54.4 |
50.1 to 58.6 |
886 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2018 |
Age |
13-17 Years |
54.9 |
50.8 to 58.9 |
2295 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2018 |
Age |
13-17 Years |
46.7 |
43.9 to 49.5 |
2507 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2018 |
Age |
13-17 Years |
55.0 |
52.4 to 57.6 |
2276 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2018 |
Age |
13-17 Years |
43.9 |
41.3 to 46.5 |
3326 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2018 |
Age |
13-17 Years |
47.6 |
44.0 to 51.2 |
1191 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2018 |
Age |
13-17 Years |
53.6 |
49.6 to 57.5 |
1746 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2018 |
Age |
13-17 Years |
52.5 |
46.7 to 58.1 |
1305 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018 |
Age |
13-17 Years |
78.1 |
72.3 to 82.9 |
337 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018 |
Age |
13-17 Years |
41.2 |
34.7 to 47.9 |
318 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018 |
Age |
13-17 Years |
49.5 |
43.3 to 55.6 |
340 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018 |
Age |
13-17 Years |
44.4 |
37.4 to 51.6 |
284 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018 |
Age |
13-17 Years |
43.5 |
40.1 to 47.0 |
2079 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018 |
Age |
13-17 Years |
48.0 |
41.2 to 54.9 |
298 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018 |
Age |
13-17 Years |
50.9 |
42.4 to 59.3 |
186 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Dallas County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-El Paso County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Hidalgo County |
2018 |
Age |
13-17 Years |
49.4 |
41.8 to 57.1 |
314 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Tarrant County |
2018 |
Age |
13-17 Years |
45.9 |
39.6 to 52.4 |
364 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Travis County |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018 |
Age |
13-17 Years |
41.9 |
37.5 to 46.4 |
917 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2018 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2018 |
Age |
13-17 Years |
51.8 |
47.4 to 56.2 |
1266 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018 |
Age |
13-17 Years |
43.2 |
36.4 to 50.2 |
310 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018 |
Age |
13-17 Years |
62.0 |
55.8 to 67.9 |
324 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018 |
Age |
13-17 Years |
54.9 |
45.4 to 64.0 |
327 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018 |
Age |
13-17 Years |
51.6 |
44.2 to 58.9 |
286 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018 |
Age |
13-17 Years |
42.9 |
37.0 to 49.1 |
337 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018 |
Age |
13-17 Years |
55.7 |
49.6 to 61.7 |
332 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018 |
Age |
13-17 Years |
42.0 |
34.7 to 49.7 |
241 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2019 |
Age |
13-17 Years |
47.3 |
40.4 to 54.3 |
296 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2019 |
Age |
13-17 Years |
52.6 |
46.9 to 58.2 |
426 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2019 |
Age |
13-17 Years |
56.9 |
49.8 to 63.7 |
308 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2019 |
Age |
13-17 Years |
50.5 |
43.9 to 57.2 |
329 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2019 |
Age |
13-17 Years |
56.4 |
47.3 to 65.0 |
274 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2019 |
Age |
13-17 Years |
63.5 |
55.3 to 71.0 |
262 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2019 |
Age |
13-17 Years |
53.8 |
46.4 to 61.0 |
294 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2019 |
Age |
13-17 Years |
59.2 |
52.4 to 65.6 |
308 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2019 |
Age |
13-17 Years |
75.5 |
67.4 to 82.2 |
282 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2019 |
Age |
13-17 Years |
56.0 |
47.4 to 64.2 |
329 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2019 |
Age |
13-17 Years |
49.7 |
42.7 to 56.8 |
315 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2019 |
Age |
13-17 Years |
43.8 |
36.9 to 51.0 |
278 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2019 |
Age |
13-17 Years |
66.0 |
59.0 to 72.3 |
304 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2019 |
Age |
13-17 Years |
44.1 |
37.2 to 51.2 |
332 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2019 |
Age |
13-17 Years |
54.9 |
49.8 to 59.8 |
602 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2019 |
Age |
13-17 Years |
64.2 |
53.6 to 73.6 |
160 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2019 |
Age |
13-17 Years |
52.9 |
47.2 to 58.5 |
442 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2019 |
Age |
13-17 Years |
41.2 |
34.6 to 48.1 |
289 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2019 |
Age |
13-17 Years |
60.9 |
54.4 to 67.1 |
302 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2019 |
Age |
13-17 Years |
49.5 |
43.0 to 56.1 |
381 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2019 |
Age |
13-17 Years |
54.9 |
48.2 to 61.4 |
292 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2019 |
Age |
13-17 Years |
59.5 |
51.7 to 66.8 |
336 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2019 |
Age |
13-17 Years |
52.6 |
45.7 to 59.4 |
316 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2019 |
Age |
13-17 Years |
68.9 |
62.5 to 74.6 |
524 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2019 |
Age |
13-17 Years |
74.3 |
67.0 to 80.4 |
300 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2019 |
Age |
13-17 Years |
59.4 |
52.3 to 66.2 |
297 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2019 |
Age |
13-17 Years |
56.8 |
48.8 to 64.6 |
276 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2019 |
Age |
13-17 Years |
30.5 |
23.7 to 38.3 |
270 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2019 |
Age |
13-17 Years |
54.3 |
46.8 to 61.7 |
288 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2019 |
Age |
13-17 Years |
46.7 |
40.0 to 53.5 |
297 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2019 |
Age |
13-17 Years |
60.5 |
53.1 to 67.4 |
285 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2019 |
Age |
13-17 Years |
52.9 |
45.7 to 60.0 |
313 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2019 |
Age |
13-17 Years |
63.2 |
56.2 to 69.6 |
333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2019 |
Age |
13-17 Years |
51.4 |
44.5 to 58.3 |
331 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2019 |
Age |
13-17 Years |
59.8 |
53.7 to 65.7 |
405 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2019 |
Age |
13-17 Years |
57.0 |
51.1 to 62.7 |
498 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2019 |
Age |
13-17 Years |
63.0 |
55.4 to 70.1 |
257 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2019 |
Age |
13-17 Years |
53.2 |
44.9 to 61.2 |
241 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2019 |
Age |
13-17 Years |
49.5 |
42.6 to 56.5 |
305 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2019 |
Age |
13-17 Years |
76.9 |
70.9 to 82.0 |
319 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2019 |
Age |
13-17 Years |
49.6 |
42.7 to 56.4 |
302 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2019 |
Age |
13-17 Years |
41.8 |
35.7 to 48.1 |
369 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2019 |
Age |
13-17 Years |
60.8 |
53.3 to 67.7 |
270 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2019 |
Age |
13-17 Years |
60.1 |
54.5 to 65.5 |
734 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2019 |
Age |
13-17 Years |
77.5 |
70.0 to 83.5 |
242 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2019 |
Age |
13-17 Years |
57.9 |
51.6 to 63.9 |
492 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2019 |
Age |
13-17 Years |
58.4 |
47.9 to 68.2 |
216 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2019 |
Age |
13-17 Years |
54.2 |
52.7 to 55.8 |
18788 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2019 |
Age |
13-17 Years |
66.1 |
62.2 to 69.8 |
2034 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2019 |
Age |
13-17 Years |
55.2 |
50.6 to 59.6 |
829 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2019 |
Age |
13-17 Years |
60.0 |
56.4 to 63.4 |
2520 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2019 |
Age |
13-17 Years |
50.3 |
47.1 to 53.5 |
2387 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2019 |
Age |
13-17 Years |
53.6 |
50.8 to 56.3 |
2097 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2019 |
Age |
13-17 Years |
49.6 |
46.9 to 52.4 |
3289 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2019 |
Age |
13-17 Years |
55.6 |
51.7 to 59.5 |
1256 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2019 |
Age |
13-17 Years |
55.8 |
51.5 to 60.0 |
1845 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2019 |
Age |
13-17 Years |
56.5 |
49.4 to 63.3 |
1199 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2019 |
Age |
13-17 Years |
78.9 |
72.5 to 84.2 |
319 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2019 |
Age |
13-17 Years |
53.0 |
46.0 to 59.9 |
319 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2019 |
Age |
13-17 Years |
61.2 |
54.5 to 67.4 |
313 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2019 |
Age |
13-17 Years |
43.0 |
35.9 to 50.4 |
261 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2019 |
Age |
13-17 Years |
48.4 |
44.9 to 52.0 |
1850 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2019 |
Age |
13-17 Years |
47.5 |
40.7 to 54.5 |
293 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2019 |
Age |
13-17 Years |
57.8 |
47.9 to 67.1 |
174 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Dallas County |
2019 |
Age |
13-17 Years |
50.5 |
43.1 to 57.8 |
271 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-El Paso County |
2019 |
Age |
13-17 Years |
63.7 |
56.8 to 70.1 |
280 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Hidalgo County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Tarrant County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Travis County |
2019 |
Age |
13-17 Years |
NA |
NA |
NA |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2019 |
Age |
13-17 Years |
46.7 |
42.1 to 51.3 |
832 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2019 |
Age |
13-17 Years |
34.6 |
26.7 to 43.5 |
218 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2019 |
Age |
13-17 Years |
54.0 |
49.3 to 58.6 |
1332 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2019 |
Age |
13-17 Years |
44.6 |
37.6 to 51.9 |
325 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2019 |
Age |
13-17 Years |
63.6 |
57.9 to 68.9 |
472 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2019 |
Age |
13-17 Years |
55.2 |
46.9 to 63.2 |
363 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2019 |
Age |
13-17 Years |
53.3 |
45.4 to 61.1 |
304 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2019 |
Age |
13-17 Years |
47.4 |
40.9 to 54.0 |
309 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2019 |
Age |
13-17 Years |
60.5 |
54.1 to 66.5 |
331 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2019 |
Age |
13-17 Years |
41.5 |
35.3 to 48.0 |
329 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2020 |
Age |
13-17 Years |
52.9 |
46.3 to 59.4 |
298 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2020 |
Age |
13-17 Years |
54.9 |
47.8 to 61.8 |
302 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2020 |
Age |
13-17 Years |
51.4 |
45.0 to 57.7 |
340 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2020 |
Age |
13-17 Years |
49.6 |
42.6 to 56.5 |
322 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2020 |
Age |
13-17 Years |
62.3 |
55.4 to 68.8 |
403 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2020 |
Age |
13-17 Years |
66.4 |
59.9 to 72.4 |
354 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2020 |
Age |
13-17 Years |
66.9 |
60.5 to 72.7 |
331 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2020 |
Age |
13-17 Years |
63.2 |
56.6 to 69.2 |
360 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2020 |
Age |
13-17 Years |
72.3 |
65.1 to 78.5 |
404 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2020 |
Age |
13-17 Years |
51.6 |
44.4 to 58.7 |
355 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2020 |
Age |
13-17 Years |
54.9 |
47.7 to 62.0 |
300 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2020 |
Age |
13-17 Years |
47.4 |
40.7 to 54.2 |
300 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2020 |
Age |
13-17 Years |
73.9 |
67.6 to 79.4 |
290 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2020 |
Age |
13-17 Years |
54.5 |
47.9 to 61.0 |
376 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2020 |
Age |
13-17 Years |
63.1 |
57.9 to 68.1 |
699 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2020 |
Age |
13-17 Years |
72.3 |
64.2 to 79.1 |
271 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2020 |
Age |
13-17 Years |
61.2 |
55.1 to 67.0 |
428 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2020 |
Age |
13-17 Years |
53.4 |
46.4 to 60.2 |
302 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2020 |
Age |
13-17 Years |
60.3 |
53.4 to 66.8 |
280 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2020 |
Age |
13-17 Years |
53.3 |
46.9 to 59.6 |
364 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2020 |
Age |
13-17 Years |
55.7 |
48.3 to 62.9 |
255 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2020 |
Age |
13-17 Years |
60.4 |
53.6 to 66.8 |
356 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2020 |
Age |
13-17 Years |
63.5 |
57.5 to 69.1 |
372 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2020 |
Age |
13-17 Years |
66.8 |
61.9 to 71.3 |
815 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2020 |
Age |
13-17 Years |
73.4 |
67.6 to 78.5 |
394 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2020 |
Age |
13-17 Years |
61.3 |
55.1 to 67.2 |
398 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2020 |
Age |
13-17 Years |
69.2 |
62.5 to 75.1 |
330 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2020 |
Age |
13-17 Years |
31.9 |
25.9 to 38.5 |
282 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2020 |
Age |
13-17 Years |
53.6 |
46.9 to 60.1 |
397 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2020 |
Age |
13-17 Years |
54.4 |
47.6 to 61.0 |
307 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2020 |
Age |
13-17 Years |
64.8 |
58.9 to 70.3 |
405 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2020 |
Age |
13-17 Years |
50.1 |
43.4 to 56.8 |
369 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2020 |
Age |
13-17 Years |
68.8 |
63.1 to 73.9 |
381 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2020 |
Age |
13-17 Years |
59.7 |
53.1 to 66.0 |
379 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2020 |
Age |
13-17 Years |
59.2 |
53.0 to 65.1 |
352 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2020 |
Age |
13-17 Years |
68.1 |
63.5 to 72.4 |
729 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2020 |
Age |
13-17 Years |
68.1 |
61.4 to 74.1 |
381 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2020 |
Age |
13-17 Years |
68.1 |
61.8 to 73.8 |
348 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2020 |
Age |
13-17 Years |
60.7 |
53.4 to 67.5 |
327 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2020 |
Age |
13-17 Years |
70.3 |
64.0 to 76.0 |
401 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2020 |
Age |
13-17 Years |
53.2 |
46.4 to 59.8 |
338 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2020 |
Age |
13-17 Years |
45.8 |
39.4 to 52.3 |
338 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2020 |
Age |
13-17 Years |
61.6 |
55.0 to 67.8 |
308 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2020 |
Age |
13-17 Years |
67.1 |
61.2 to 72.5 |
765 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2020 |
Age |
13-17 Years |
75.3 |
68.2 to 81.2 |
263 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2020 |
Age |
13-17 Years |
66.0 |
59.4 to 72.0 |
502 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2020 |
Age |
13-17 Years |
49.8 |
38.6 to 61.1 |
169 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2020 |
Age |
13-17 Years |
58.6 |
57.3 to 60.0 |
20163 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2020 |
Age |
13-17 Years |
71.0 |
67.8 to 74.0 |
2147 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2020 |
Age |
13-17 Years |
65.3 |
61.5 to 68.9 |
1108 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2020 |
Age |
13-17 Years |
62.6 |
59.4 to 65.7 |
3331 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2020 |
Age |
13-17 Years |
52.8 |
49.9 to 55.8 |
2466 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2020 |
Age |
13-17 Years |
59.8 |
57.1 to 62.4 |
2344 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2020 |
Age |
13-17 Years |
54.5 |
50.8 to 58.1 |
2509 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2020 |
Age |
13-17 Years |
56.6 |
53.0 to 60.1 |
1446 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2020 |
Age |
13-17 Years |
58.3 |
54.6 to 61.9 |
2007 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2020 |
Age |
13-17 Years |
60.3 |
54.9 to 65.5 |
1402 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2020 |
Age |
13-17 Years |
83.0 |
76.9 to 87.7 |
271 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2020 |
Age |
13-17 Years |
47.0 |
40.2 to 53.8 |
311 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2020 |
Age |
13-17 Years |
71.5 |
65.4 to 76.9 |
317 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2020 |
Age |
13-17 Years |
52.9 |
46.3 to 59.4 |
338 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2020 |
Age |
13-17 Years |
54.9 |
49.9 to 59.9 |
1141 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2020 |
Age |
13-17 Years |
60.7 |
54.2 to 66.9 |
314 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2020 |
Age |
13-17 Years |
61.0 |
52.7 to 68.6 |
221 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2020 |
Age |
13-17 Years |
54.0 |
48.3 to 59.7 |
606 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2020 |
Age |
13-17 Years |
58.9 |
54.8 to 62.8 |
1403 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2020 |
Age |
13-17 Years |
45.0 |
38.1 to 52.1 |
304 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2020 |
Age |
13-17 Years |
70.5 |
64.5 to 75.8 |
398 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2020 |
Age |
13-17 Years |
56.4 |
50.0 to 62.5 |
677 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2020 |
Age |
13-17 Years |
59.0 |
52.2 to 65.5 |
417 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2020 |
Age |
13-17 Years |
43.4 |
37.1 to 49.8 |
310 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2020 |
Age |
13-17 Years |
61.5 |
54.4 to 68.0 |
277 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2020 |
Age |
13-17 Years |
44.8 |
38.3 to 51.4 |
324 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2021 |
Age |
13-17 Years |
62.5 |
55.6 to 68.8 |
304 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2021 |
Age |
13-17 Years |
56.2 |
48.8 to 63.3 |
268 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2021 |
Age |
13-17 Years |
61.7 |
54.6 to 68.3 |
296 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2021 |
Age |
13-17 Years |
56.8 |
50.2 to 63.1 |
314 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2021 |
Age |
13-17 Years |
69.0 |
60.5 to 76.4 |
286 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2021 |
Age |
13-17 Years |
69.2 |
62.1 to 75.5 |
298 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2021 |
Age |
13-17 Years |
66.4 |
59.8 to 72.5 |
340 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2021 |
Age |
13-17 Years |
68.9 |
62.3 to 74.8 |
310 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2021 |
Age |
13-17 Years |
79.4 |
73.5 to 84.4 |
409 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2021 |
Age |
13-17 Years |
49.0 |
40.7 to 57.2 |
312 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2021 |
Age |
13-17 Years |
60.9 |
52.8 to 68.4 |
260 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2021 |
Age |
13-17 Years |
54.0 |
45.9 to 61.8 |
225 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2021 |
Age |
13-17 Years |
69.3 |
62.3 to 75.5 |
258 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2021 |
Age |
13-17 Years |
61.6 |
54.8 to 67.9 |
334 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2021 |
Age |
13-17 Years |
62.2 |
56.9 to 67.1 |
578 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2021 |
Age |
13-17 Years |
70.4 |
59.0 to 79.7 |
144 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2021 |
Age |
13-17 Years |
60.4 |
54.5 to 66.0 |
434 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2021 |
Age |
13-17 Years |
55.2 |
48.0 to 62.2 |
268 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2021 |
Age |
13-17 Years |
66.1 |
56.9 to 74.1 |
199 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2021 |
Age |
13-17 Years |
64.3 |
56.8 to 71.1 |
300 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2021 |
Age |
13-17 Years |
57.0 |
49.0 to 64.8 |
240 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2021 |
Age |
13-17 Years |
63.9 |
56.9 to 70.4 |
303 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2021 |
Age |
13-17 Years |
61.5 |
54.5 to 68.0 |
293 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2021 |
Age |
13-17 Years |
71.9 |
67.5 to 76.0 |
857 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2021 |
Age |
13-17 Years |
75.0 |
67.3 to 81.4 |
266 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2021 |
Age |
13-17 Years |
64.7 |
57.6 to 71.2 |
358 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2021 |
Age |
13-17 Years |
65.7 |
58.4 to 72.3 |
296 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2021 |
Age |
13-17 Years |
32.7 |
26.5 to 39.6 |
303 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2021 |
Age |
13-17 Years |
59.3 |
52.5 to 65.7 |
340 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2021 |
Age |
13-17 Years |
52.6 |
45.8 to 59.3 |
290 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2021 |
Age |
13-17 Years |
61.9 |
54.8 to 68.6 |
315 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2021 |
Age |
13-17 Years |
56.5 |
49.1 to 63.5 |
333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2021 |
Age |
13-17 Years |
72.3 |
65.7 to 78.1 |
282 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2021 |
Age |
13-17 Years |
54.8 |
47.1 to 62.4 |
292 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2021 |
Age |
13-17 Years |
57.9 |
51.5 to 64.1 |
337 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2021 |
Age |
13-17 Years |
64.4 |
59.1 to 69.4 |
581 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2021 |
Age |
13-17 Years |
70.3 |
63.3 to 76.5 |
297 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2021 |
Age |
13-17 Years |
60.5 |
53.0 to 67.5 |
284 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2021 |
Age |
13-17 Years |
67.8 |
59.6 to 75.0 |
266 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2021 |
Age |
13-17 Years |
72.2 |
63.7 to 79.3 |
191 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2021 |
Age |
13-17 Years |
62.2 |
53.5 to 70.1 |
254 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2021 |
Age |
13-17 Years |
56.7 |
49.3 to 63.8 |
240 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2021 |
Age |
13-17 Years |
67.0 |
60.0 to 73.4 |
294 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2021 |
Age |
13-17 Years |
68.7 |
64.2 to 73.0 |
929 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2021 |
Age |
13-17 Years |
74.2 |
67.8 to 79.8 |
330 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2021 |
Age |
13-17 Years |
68.0 |
62.9 to 72.7 |
599 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2021 |
Age |
13-17 Years |
67.2 |
60.7 to 73.1 |
350 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2021 |
Age |
13-17 Years |
61.7 |
60.2 to 63.2 |
18002 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2021 |
Age |
13-17 Years |
71.6 |
67.7 to 75.2 |
1923 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2021 |
Age |
13-17 Years |
61.2 |
56.8 to 65.4 |
873 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2021 |
Age |
13-17 Years |
67.8 |
64.8 to 70.6 |
3338 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2021 |
Age |
13-17 Years |
56.6 |
53.3 to 59.9 |
2263 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2021 |
Age |
13-17 Years |
62.2 |
59.3 to 65.1 |
2060 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2021 |
Age |
13-17 Years |
53.8 |
49.8 to 57.8 |
2184 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2021 |
Age |
13-17 Years |
62.2 |
58.3 to 66.0 |
1154 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2021 |
Age |
13-17 Years |
65.0 |
61.1 to 68.7 |
1789 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2021 |
Age |
13-17 Years |
67.2 |
60.6 to 73.1 |
1173 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2021 |
Age |
13-17 Years |
83.2 |
76.1 to 88.6 |
254 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2021 |
Age |
13-17 Years |
62.1 |
54.7 to 69.0 |
263 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2021 |
Age |
13-17 Years |
74.7 |
69.2 to 79.6 |
445 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2021 |
Age |
13-17 Years |
56.5 |
49.4 to 63.3 |
315 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2021 |
Age |
13-17 Years |
51.5 |
46.0 to 56.9 |
990 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2021 |
Age |
13-17 Years |
59.7 |
52.4 to 66.6 |
296 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2021 |
Age |
13-17 Years |
62.2 |
52.0 to 71.4 |
167 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2021 |
Age |
13-17 Years |
50.0 |
43.8 to 56.2 |
527 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
U.S. Virgin Islands |
2021 |
Age |
13-17 Years |
45.5 |
36.6 to 54.6 |
245 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2021 |
Age |
13-17 Years |
66.0 |
61.9 to 69.9 |
1245 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2021 |
Age |
13-17 Years |
61.4 |
54.1 to 68.2 |
304 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2021 |
Age |
13-17 Years |
66.7 |
61.5 to 71.6 |
488 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2021 |
Age |
13-17 Years |
64.9 |
57.6 to 71.5 |
566 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2021 |
Age |
13-17 Years |
67.8 |
61.0 to 74.0 |
349 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2021 |
Age |
13-17 Years |
56.4 |
49.2 to 63.3 |
267 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2021 |
Age |
13-17 Years |
63.3 |
56.7 to 69.4 |
306 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2021 |
Age |
13-17 Years |
48.0 |
40.5 to 55.7 |
261 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2022 |
Age |
13-17 Years |
59.2 |
52.2 to 65.9 |
269 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2022 |
Age |
13-17 Years |
57.8 |
49.9 to 65.4 |
240 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2022 |
Age |
13-17 Years |
62.1 |
54.8 to 68.8 |
273 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2022 |
Age |
13-17 Years |
55.7 |
49.1 to 62.1 |
332 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2022 |
Age |
13-17 Years |
60.6 |
53.4 to 67.4 |
321 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2022 |
Age |
13-17 Years |
65.7 |
59.7 to 71.3 |
342 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2022 |
Age |
13-17 Years |
71.9 |
64.6 to 78.1 |
258 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2022 |
Age |
13-17 Years |
68.2 |
60.5 to 74.9 |
250 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2022 |
Age |
13-17 Years |
77.8 |
69.8 to 84.2 |
237 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2022 |
Age |
13-17 Years |
58.9 |
51.2 to 66.2 |
307 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2022 |
Age |
13-17 Years |
61.5 |
54.5 to 67.9 |
333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Guam |
2022 |
Age |
13-17 Years |
44.6 |
36.7 to 52.7 |
240 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2022 |
Age |
13-17 Years |
74.2 |
67.3 to 80.1 |
237 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2022 |
Age |
13-17 Years |
66.9 |
59.4 to 73.6 |
251 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2022 |
Age |
13-17 Years |
65.7 |
60.3 to 70.7 |
630 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2022 |
Age |
13-17 Years |
69.2 |
60.9 to 76.4 |
256 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2022 |
Age |
13-17 Years |
64.9 |
58.5 to 70.8 |
374 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2022 |
Age |
13-17 Years |
59.6 |
52.2 to 66.6 |
258 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2022 |
Age |
13-17 Years |
74.9 |
67.1 to 81.4 |
207 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2022 |
Age |
13-17 Years |
60.7 |
53.8 to 67.1 |
310 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2022 |
Age |
13-17 Years |
55.0 |
47.9 to 61.9 |
276 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2022 |
Age |
13-17 Years |
67.3 |
60.6 to 73.5 |
330 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2022 |
Age |
13-17 Years |
66.2 |
59.4 to 72.4 |
268 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2022 |
Age |
13-17 Years |
72.0 |
64.2 to 78.7 |
346 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2022 |
Age |
13-17 Years |
77.1 |
70.1 to 82.9 |
268 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2022 |
Age |
13-17 Years |
62.2 |
54.3 to 69.6 |
257 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2022 |
Age |
13-17 Years |
68.6 |
62.1 to 74.5 |
331 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2022 |
Age |
13-17 Years |
38.5 |
30.7 to 46.9 |
232 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2022 |
Age |
13-17 Years |
59.8 |
52.6 to 66.6 |
284 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2022 |
Age |
13-17 Years |
60.3 |
53.4 to 66.8 |
297 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2022 |
Age |
13-17 Years |
65.4 |
58.1 to 72.1 |
247 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2022 |
Age |
13-17 Years |
59.5 |
52.2 to 66.4 |
259 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2022 |
Age |
13-17 Years |
76.2 |
69.4 to 82.0 |
225 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2022 |
Age |
13-17 Years |
63.7 |
56.3 to 70.4 |
289 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2022 |
Age |
13-17 Years |
60.8 |
53.3 to 67.7 |
276 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2022 |
Age |
13-17 Years |
70.7 |
65.9 to 75.1 |
536 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2022 |
Age |
13-17 Years |
73.3 |
65.9 to 79.7 |
222 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2022 |
Age |
13-17 Years |
69.0 |
62.5 to 74.8 |
314 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2022 |
Age |
13-17 Years |
54.8 |
47.9 to 61.5 |
361 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2022 |
Age |
13-17 Years |
74.4 |
67.3 to 80.5 |
280 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2022 |
Age |
13-17 Years |
62.7 |
54.7 to 70.1 |
269 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2022 |
Age |
13-17 Years |
46.2 |
38.7 to 53.8 |
249 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2022 |
Age |
13-17 Years |
65.6 |
58.5 to 72.0 |
263 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2022 |
Age |
13-17 Years |
66.7 |
61.7 to 71.4 |
752 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2022 |
Age |
13-17 Years |
75.0 |
67.6 to 81.2 |
267 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2022 |
Age |
13-17 Years |
65.6 |
60.1 to 70.8 |
485 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Puerto Rico |
2022 |
Age |
13-17 Years |
70.3 |
65.5 to 74.7 |
671 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2022 |
Age |
13-17 Years |
62.6 |
61.1 to 64.0 |
16043 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 1 |
2022 |
Age |
13-17 Years |
75.1 |
71.4 to 78.4 |
1595 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 2 |
2022 |
Age |
13-17 Years |
68.3 |
64.3 to 72.1 |
825 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 3 |
2022 |
Age |
13-17 Years |
66.0 |
63.0 to 68.9 |
2424 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 4 |
2022 |
Age |
13-17 Years |
57.7 |
54.6 to 60.7 |
2291 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 5 |
2022 |
Age |
13-17 Years |
64.3 |
61.3 to 67.1 |
2019 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 6 |
2022 |
Age |
13-17 Years |
58.2 |
53.6 to 62.7 |
1981 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 7 |
2022 |
Age |
13-17 Years |
64.2 |
60.3 to 67.9 |
1048 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 8 |
2022 |
Age |
13-17 Years |
61.8 |
58.2 to 65.3 |
1736 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 9 |
2022 |
Age |
13-17 Years |
61.1 |
55.5 to 66.4 |
1090 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2022 |
Age |
13-17 Years |
85.2 |
78.8 to 89.9 |
285 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2022 |
Age |
13-17 Years |
54.4 |
46.8 to 61.7 |
269 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2022 |
Age |
13-17 Years |
68.3 |
60.8 to 74.9 |
252 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2022 |
Age |
13-17 Years |
64.4 |
56.5 to 71.6 |
244 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2022 |
Age |
13-17 Years |
58.5 |
52.1 to 64.6 |
794 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2022 |
Age |
13-17 Years |
63.6 |
55.3 to 71.1 |
253 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2022 |
Age |
13-17 Years |
63.2 |
52.6 to 72.8 |
157 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2022 |
Age |
13-17 Years |
57.8 |
50.5 to 64.7 |
384 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
Region 10 |
2022 |
Age |
13-17 Years |
68.2 |
63.9 to 72.2 |
1034 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2022 |
Age |
13-17 Years |
55.2 |
47.7 to 62.5 |
271 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2022 |
Age |
13-17 Years |
71.9 |
65.1 to 77.9 |
291 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2022 |
Age |
13-17 Years |
62.7 |
57.4 to 67.7 |
595 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2022 |
Age |
13-17 Years |
71.1 |
63.9 to 77.3 |
280 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2022 |
Age |
13-17 Years |
51.5 |
44.2 to 58.7 |
244 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2022 |
Age |
13-17 Years |
69.0 |
61.9 to 75.4 |
274 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2022 |
Age |
13-17 Years |
49.2 |
41.9 to 56.6 |
294 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Other |
46.9 |
37.0 to 57.1 |
138 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Other |
55.8 |
48.8 to 62.6 |
316 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Other |
51.9 |
40.2 to 63.4 |
119 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Other |
51.6 |
43.6 to 59.5 |
223 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Other |
53.3 |
36.9 to 69.1 |
132 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Other |
56.8 |
44.8 to 68.1 |
133 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Other |
61.3 |
52.6 to 69.3 |
211 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Other |
61.2 |
46.2 to 74.4 |
72 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Other |
78.1 |
59.2 to 89.7 |
44 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Other |
44.2 |
31.6 to 57.6 |
147 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Other |
59.1 |
48.5 to 68.9 |
158 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Other |
58.6 |
49.1 to 67.4 |
157 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Other |
37.9 |
26.1 to 51.2 |
94 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Other |
41.2 |
28.7 to 54.9 |
101 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
37.2 |
24.0 to 52.7 |
73 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Other |
49.9 |
31.3 to 68.5 |
41 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Other |
68.9 |
58.2 to 77.9 |
103 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Other |
54.4 |
47.5 to 61.2 |
316 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Other |
41.0 |
28.0 to 55.4 |
78 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Other |
44.0 |
29.7 to 59.3 |
67 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Other |
55.1 |
42.3 to 67.2 |
83 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Other |
58.7 |
47.4 to 69.1 |
180 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Other |
75.1 |
59.2 to 86.3 |
67 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Other |
47.8 |
33.2 to 62.7 |
72 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Other |
44.8 |
27.6 to 63.2 |
49 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Other |
25.0 |
16.4 to 36.3 |
105 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Other |
48.3 |
34.8 to 62.1 |
85 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Other |
45.7 |
36.6 to 55.2 |
150 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Other |
62.1 |
48.9 to 73.7 |
89 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Other |
57.9 |
47.2 to 67.9 |
124 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Other |
56.1 |
41.8 to 69.4 |
72 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Other |
57.4 |
36.7 to 75.8 |
47 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Other |
60.3 |
48.7 to 70.8 |
103 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Other |
58.8 |
52.1 to 65.2 |
365 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Other |
59.2 |
49.7 to 68.2 |
176 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
58.6 |
49.5 to 67.2 |
189 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Other |
53.8 |
42.8 to 64.5 |
153 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Other |
67.2 |
57.1 to 76.0 |
148 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Other |
52.8 |
36.5 to 68.6 |
65 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Other |
35.1 |
27.9 to 43.0 |
217 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Other |
56.7 |
45.7 to 67.2 |
122 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Other |
57.3 |
47.8 to 66.3 |
305 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Other |
81.2 |
72.9 to 87.4 |
143 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
52.6 |
41.8 to 63.3 |
162 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Other |
52.4 |
50.2 to 54.7 |
7253 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Other |
83.2 |
68.1 to 91.9 |
54 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Other |
41.2 |
29.5 to 53.9 |
98 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Other |
61.2 |
50.9 to 70.6 |
135 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Other |
40.0 |
29.7 to 51.3 |
123 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Other |
48.5 |
41.5 to 55.5 |
705 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Other |
49.0 |
40.6 to 57.5 |
211 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Other |
48.4 |
34.8 to 62.2 |
72 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Other |
48.5 |
40.1 to 56.9 |
422 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Other |
54.5 |
41.9 to 66.5 |
103 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Other |
64.1 |
50.2 to 75.9 |
78 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Other |
53.5 |
44.2 to 62.7 |
296 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Other |
62.3 |
50.8 to 72.5 |
143 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Other |
50.0 |
38.8 to 61.2 |
99 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Other |
37.5 |
24.0 to 53.3 |
55 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Other |
45.7 |
34.3 to 57.6 |
113 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
50.2 |
46.0 to 54.4 |
806 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
51.8 |
47.4 to 56.1 |
794 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
52.3 |
48.1 to 56.5 |
826 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
49.3 |
44.9 to 53.7 |
752 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
59.5 |
54.8 to 63.9 |
951 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
67.9 |
64.0 to 71.5 |
950 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
61.0 |
57.2 to 64.6 |
1000 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
63.8 |
59.8 to 67.6 |
915 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
75.8 |
71.6 to 79.6 |
1006 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
52.4 |
47.7 to 57.2 |
892 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
54.3 |
50.0 to 58.5 |
886 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
74.0 |
70.3 to 77.3 |
797 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
52.3 |
48.2 to 56.5 |
911 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
61.3 |
58.4 to 64.1 |
1944 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
69.0 |
62.3 to 75.0 |
470 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
60.2 |
57.0 to 63.2 |
1474 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
53.0 |
49.0 to 57.0 |
847 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
65.5 |
61.2 to 69.5 |
769 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
52.0 |
48.1 to 55.9 |
970 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
56.6 |
52.3 to 60.8 |
743 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
48.5 |
43.9 to 53.2 |
756 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
59.4 |
55.5 to 63.1 |
943 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
68.9 |
65.6 to 72.1 |
2139 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
73.8 |
70.3 to 77.1 |
1143 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
62.6 |
58.8 to 66.2 |
1070 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
66.4 |
62.7 to 69.9 |
1092 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
30.9 |
26.5 to 35.8 |
617 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
55.8 |
51.9 to 59.6 |
1032 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
55.6 |
51.5 to 59.6 |
823 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
63.9 |
60.1 to 67.6 |
1027 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
51.0 |
46.8 to 55.3 |
889 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
72.5 |
69.2 to 75.6 |
1058 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
55.0 |
51.3 to 58.7 |
1192 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
57.9 |
53.4 to 62.3 |
721 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
61.1 |
57.9 to 64.2 |
1581 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
62.6 |
57.6 to 67.3 |
640 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
60.4 |
56.3 to 64.4 |
941 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
57.5 |
53.2 to 61.7 |
906 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
72.5 |
68.7 to 76.0 |
1015 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
57.3 |
53.2 to 61.3 |
951 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
38.1 |
33.6 to 42.7 |
632 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
64.6 |
60.7 to 68.3 |
858 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
63.7 |
60.5 to 66.8 |
2218 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
78.8 |
74.1 to 83.0 |
532 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
62.6 |
59.2 to 65.9 |
1686 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
57.7 |
56.9 to 58.6 |
54111 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
85.4 |
82.2 to 88.1 |
867 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
51.3 |
47.0 to 55.5 |
805 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
66.8 |
63.3 to 70.1 |
1100 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
52.0 |
47.7 to 56.3 |
814 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
48.6 |
45.6 to 51.6 |
3327 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
51.2 |
46.4 to 56.0 |
678 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
64.8 |
58.3 to 70.7 |
397 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
47.5 |
44.2 to 50.8 |
2252 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
49.4 |
45.6 to 53.1 |
1130 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
70.7 |
67.5 to 73.8 |
1194 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
61.9 |
57.9 to 65.8 |
1860 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
60.8 |
56.5 to 65.0 |
930 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
45.6 |
41.4 to 49.8 |
735 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
63.1 |
59.5 to 66.6 |
986 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Private Insurance Only |
43.3 |
39.4 to 47.3 |
941 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Insurance Coverage |
Any Medicaid |
61.8 |
56.8 to 66.5 |
521 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Any Medicaid |
54.1 |
48.6 to 59.5 |
474 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Any Medicaid |
64.4 |
59.1 to 69.4 |
476 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
54.1 |
49.1 to 59.0 |
567 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Insurance Coverage |
Any Medicaid |
62.5 |
56.9 to 67.8 |
528 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Any Medicaid |
64.2 |
58.3 to 69.7 |
414 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Any Medicaid |
69.4 |
62.1 to 75.8 |
273 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Any Medicaid |
64.0 |
58.7 to 68.9 |
497 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
75.7 |
70.7 to 80.1 |
549 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Any Medicaid |
58.4 |
52.6 to 64.0 |
503 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
60.4 |
54.6 to 65.9 |
430 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Insurance Coverage |
Any Medicaid |
66.1 |
60.6 to 71.2 |
443 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Any Medicaid |
61.3 |
56.0 to 66.4 |
521 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Any Medicaid |
59.8 |
55.9 to 63.6 |
1112 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Insurance Coverage |
Any Medicaid |
68.8 |
62.9 to 74.1 |
496 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
56.8 |
51.9 to 61.5 |
616 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
53.4 |
48.1 to 58.7 |
467 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Insurance Coverage |
Any Medicaid |
60.1 |
53.9 to 65.9 |
373 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
63.5 |
56.3 to 70.1 |
290 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Any Medicaid |
52.1 |
46.7 to 57.4 |
473 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
69.0 |
64.6 to 73.0 |
748 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Any Medicaid |
58.8 |
53.4 to 64.0 |
496 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Any Medicaid |
67.9 |
62.3 to 73.0 |
569 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Insurance Coverage |
Any Medicaid |
72.8 |
66.3 to 78.4 |
332 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Insurance Coverage |
Any Medicaid |
61.7 |
55.7 to 67.3 |
449 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
61.6 |
54.7 to 68.0 |
348 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Any Medicaid |
37.1 |
32.4 to 42.0 |
589 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Any Medicaid |
53.2 |
47.3 to 58.9 |
445 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Insurance Coverage |
Any Medicaid |
51.6 |
46.3 to 56.8 |
481 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Any Medicaid |
62.5 |
56.2 to 68.3 |
364 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Any Medicaid |
58.5 |
52.9 to 63.9 |
497 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Any Medicaid |
66.0 |
59.8 to 71.7 |
361 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Any Medicaid |
57.6 |
51.0 to 63.9 |
362 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Any Medicaid |
60.0 |
55.8 to 64.1 |
794 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Any Medicaid |
69.9 |
65.9 to 73.7 |
897 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Insurance Coverage |
Any Medicaid |
72.4 |
67.6 to 76.8 |
580 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
67.2 |
60.5 to 73.3 |
317 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Any Medicaid |
59.9 |
54.2 to 65.3 |
471 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
72.4 |
65.3 to 78.6 |
267 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Insurance Coverage |
Any Medicaid |
58.5 |
52.8 to 64.1 |
451 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Any Medicaid |
54.8 |
50.1 to 59.4 |
659 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Insurance Coverage |
Any Medicaid |
62.6 |
56.9 to 67.9 |
430 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Any Medicaid |
66.3 |
61.9 to 70.4 |
1213 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
73.1 |
68.4 to 77.3 |
606 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
64.8 |
59.5 to 69.7 |
607 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Any Medicaid |
60.8 |
59.6 to 61.9 |
27403 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Any Medicaid |
76.9 |
71.8 to 81.3 |
508 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Any Medicaid |
54.8 |
49.6 to 59.9 |
523 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Any Medicaid |
65.0 |
59.1 to 70.6 |
381 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Any Medicaid |
58.2 |
52.3 to 63.9 |
439 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Any Medicaid |
59.2 |
55.1 to 63.2 |
2274 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Any Medicaid |
64.4 |
59.2 to 69.4 |
487 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Any Medicaid |
59.9 |
53.0 to 66.4 |
343 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Any Medicaid |
58.7 |
53.9 to 63.3 |
1444 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Any Medicaid |
55.4 |
47.3 to 63.3 |
218 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Insurance Coverage |
Any Medicaid |
62.6 |
58.0 to 66.9 |
690 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
56.2 |
48.6 to 63.5 |
319 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Insurance Coverage |
Any Medicaid |
61.8 |
56.4 to 67.0 |
544 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Any Medicaid |
51.3 |
46.6 to 55.9 |
603 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Insurance Coverage |
Any Medicaid |
64.4 |
59.1 to 69.4 |
454 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Any Medicaid |
50.3 |
43.5 to 57.0 |
316 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Insurance Coverage |
Uninsured |
42.9 |
25.2 to 62.6 |
44 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Insurance Coverage |
Uninsured |
48.6 |
36.1 to 61.4 |
84 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Insurance Coverage |
Uninsured |
36.4 |
23.7 to 51.5 |
63 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Insurance Coverage |
Uninsured |
56.3 |
37.9 to 73.1 |
37 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Insurance Coverage |
Uninsured |
42.6 |
23.9 to 63.8 |
32 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Insurance Coverage |
Uninsured |
59.5 |
42.7 to 74.4 |
50 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Insurance Coverage |
Uninsured |
31.7 |
20.7 to 45.2 |
98 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Insurance Coverage |
Uninsured |
24.5 |
14.9 to 37.5 |
79 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Insurance Coverage |
Uninsured |
43.4 |
29.4 to 58.6 |
58 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Insurance Coverage |
Uninsured |
43.1 |
29.7 to 57.6 |
73 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
40.6 |
24.8 to 58.7 |
44 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Insurance Coverage |
Uninsured |
26.9 |
15.6 to 42.1 |
58 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Insurance Coverage |
Uninsured |
33.4 |
21.9 to 47.3 |
76 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Insurance Coverage |
Uninsured |
29.5 |
16.3 to 47.5 |
39 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Insurance Coverage |
Uninsured |
38.5 |
22.4 to 57.7 |
38 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Insurance Coverage |
Uninsured |
59.6 |
42.1 to 75.0 |
44 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Insurance Coverage |
Uninsured |
51.9 |
31.5 to 71.7 |
47 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Insurance Coverage |
Uninsured |
25.2 |
13.8 to 41.5 |
61 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Insurance Coverage |
Uninsured |
34.9 |
21.4 to 51.5 |
66 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Insurance Coverage |
Uninsured |
57.7 |
43.2 to 71.0 |
67 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Insurance Coverage |
Uninsured |
50.2 |
38.0 to 62.4 |
98 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Insurance Coverage |
Uninsured |
61.0 |
38.7 to 79.4 |
33 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Insurance Coverage |
Uninsured |
50.9 |
31.8 to 69.8 |
41 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Insurance Coverage |
Uninsured |
50.2 |
32.1 to 68.2 |
47 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Insurance Coverage |
Uninsured |
40.1 |
23.3 to 59.6 |
36 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Insurance Coverage |
Uninsured |
35.5 |
21.4 to 52.6 |
70 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Insurance Coverage |
Uninsured |
62.8 |
44.8 to 77.7 |
48 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Insurance Coverage |
Uninsured |
42.3 |
26.0 to 60.5 |
48 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Insurance Coverage |
Uninsured |
34.4 |
20.1 to 52.2 |
93 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Insurance Coverage |
Uninsured |
46.7 |
31.1 to 63.0 |
58 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Insurance Coverage |
Uninsured |
38.4 |
35.1 to 41.8 |
2929 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Insurance Coverage |
Uninsured |
68.9 |
49.9 to 83.1 |
37 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Insurance Coverage |
Uninsured |
33.6 |
20.9 to 49.3 |
54 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Insurance Coverage |
Uninsured |
51.5 |
34.7 to 68.0 |
51 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Insurance Coverage |
Uninsured |
37.7 |
24.5 to 53.1 |
66 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Insurance Coverage |
Uninsured |
38.9 |
31.7 to 46.5 |
548 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Insurance Coverage |
Uninsured |
45.7 |
32.4 to 59.7 |
78 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Insurance Coverage |
Uninsured |
45.2 |
33.3 to 57.8 |
93 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Insurance Coverage |
Uninsured |
37.9 |
29.8 to 46.6 |
377 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Insurance Coverage |
Uninsured |
34.7 |
22.0 to 50.0 |
63 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Insurance Coverage |
Uninsured |
44.1 |
26.5 to 63.3 |
53 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Insurance Coverage |
Uninsured |
34.2 |
18.1 to 54.9 |
30 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Insurance Coverage |
Uninsured |
42.7 |
29.9 to 56.5 |
79 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Poverty |
Below Poverty Level |
62.6 |
55.4 to 69.3 |
258 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Poverty |
Below Poverty Level |
53.3 |
43.4 to 62.9 |
139 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Poverty |
Below Poverty Level |
70.1 |
62.9 to 76.5 |
230 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Poverty |
Below Poverty Level |
50.1 |
43.5 to 56.7 |
312 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Poverty |
Below Poverty Level |
65.3 |
57.5 to 72.4 |
251 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Poverty |
Below Poverty Level |
64.2 |
54.6 to 72.7 |
157 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Poverty |
Below Poverty Level |
71.2 |
61.7 to 79.1 |
146 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Poverty |
Below Poverty Level |
61.8 |
53.9 to 69.1 |
239 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Poverty |
Below Poverty Level |
74.1 |
66.2 to 80.7 |
268 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Poverty |
Below Poverty Level |
56.7 |
48.2 to 64.8 |
237 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Poverty |
Below Poverty Level |
62.0 |
54.0 to 69.4 |
215 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Poverty |
Below Poverty Level |
60.3 |
50.2 to 69.6 |
138 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Poverty |
Below Poverty Level |
56.9 |
47.6 to 65.9 |
173 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Poverty |
Below Poverty Level |
60.9 |
55.3 to 66.2 |
607 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Poverty |
Below Poverty Level |
71.2 |
63.8 to 77.6 |
313 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
56.8 |
49.7 to 63.7 |
294 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Poverty |
Below Poverty Level |
51.3 |
43.9 to 58.7 |
232 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Poverty |
Below Poverty Level |
59.3 |
49.3 to 68.6 |
147 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Poverty |
Below Poverty Level |
62.8 |
54.8 to 70.1 |
229 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Poverty |
Below Poverty Level |
49.6 |
41.6 to 57.6 |
209 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Poverty |
Below Poverty Level |
71.3 |
64.8 to 77.1 |
315 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Poverty |
Below Poverty Level |
57.1 |
47.6 to 66.1 |
158 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Poverty |
Below Poverty Level |
63.5 |
54.9 to 71.3 |
243 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Poverty |
Below Poverty Level |
72.4 |
62.7 to 80.4 |
158 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Poverty |
Below Poverty Level |
59.8 |
51.2 to 67.8 |
204 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Poverty |
Below Poverty Level |
61.8 |
49.2 to 73.0 |
96 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Poverty |
Below Poverty Level |
38.0 |
31.6 to 44.9 |
297 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Poverty |
Below Poverty Level |
58.0 |
49.5 to 66.0 |
206 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Poverty |
Below Poverty Level |
52.4 |
43.5 to 61.2 |
165 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Poverty |
Below Poverty Level |
61.0 |
52.5 to 68.9 |
202 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Poverty |
Below Poverty Level |
62.0 |
54.4 to 69.0 |
261 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Poverty |
Below Poverty Level |
66.5 |
55.1 to 76.2 |
105 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Poverty |
Below Poverty Level |
65.6 |
56.2 to 74.0 |
167 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Poverty |
Below Poverty Level |
60.3 |
54.4 to 66.0 |
411 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Poverty |
Below Poverty Level |
67.8 |
62.4 to 72.7 |
533 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Poverty |
Below Poverty Level |
68.3 |
61.9 to 74.0 |
377 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
67.1 |
57.7 to 75.3 |
156 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Poverty |
Below Poverty Level |
55.5 |
47.2 to 63.6 |
223 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Poverty |
Below Poverty Level |
67.6 |
55.5 to 77.8 |
109 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Poverty |
Below Poverty Level |
60.4 |
51.9 to 68.3 |
209 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Poverty |
Below Poverty Level |
49.0 |
41.8 to 56.1 |
276 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Poverty |
Below Poverty Level |
56.9 |
48.0 to 65.4 |
173 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Poverty |
Below Poverty Level |
69.8 |
63.1 to 75.8 |
580 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Poverty |
Below Poverty Level |
74.6 |
68.7 to 79.7 |
361 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
68.4 |
59.8 to 75.9 |
219 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Poverty |
Below Poverty Level |
61.6 |
59.9 to 63.2 |
12976 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Poverty |
Below Poverty Level |
72.5 |
64.4 to 79.3 |
221 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Poverty |
Below Poverty Level |
57.1 |
49.2 to 64.6 |
221 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Poverty |
Below Poverty Level |
66.3 |
57.2 to 74.3 |
157 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Poverty |
Below Poverty Level |
50.5 |
42.9 to 58.2 |
253 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Poverty |
Below Poverty Level |
63.5 |
58.7 to 68.1 |
1639 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Poverty |
Below Poverty Level |
64.3 |
57.8 to 70.4 |
322 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Poverty |
Below Poverty Level |
55.2 |
47.9 to 62.3 |
285 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Poverty |
Below Poverty Level |
64.5 |
58.6 to 70.0 |
1032 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Poverty |
Below Poverty Level |
53.6 |
42.6 to 64.2 |
118 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Poverty |
Below Poverty Level |
58.8 |
49.1 to 67.9 |
149 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Poverty |
Below Poverty Level |
57.9 |
46.7 to 68.3 |
136 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Poverty |
Below Poverty Level |
63.4 |
54.5 to 71.6 |
193 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Poverty |
Below Poverty Level |
57.2 |
50.5 to 63.6 |
296 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Poverty |
Below Poverty Level |
64.2 |
55.5 to 72.0 |
168 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Poverty |
Below Poverty Level |
47.6 |
38.1 to 57.3 |
147 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
51.6 |
48.2 to 55.1 |
1182 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
53.2 |
50.0 to 56.4 |
1449 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
53.7 |
50.2 to 57.1 |
1217 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
50.8 |
47.4 to 54.2 |
1242 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
59.2 |
55.3 to 63.1 |
1338 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
65.7 |
62.4 to 68.9 |
1331 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
61.2 |
57.9 to 64.4 |
1306 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
64.3 |
61.0 to 67.6 |
1248 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
75.5 |
71.8 to 78.8 |
1290 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
52.9 |
49.0 to 56.8 |
1339 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
53.2 |
49.7 to 56.7 |
1292 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
70.1 |
66.9 to 73.0 |
1240 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
53.7 |
50.4 to 57.1 |
1378 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
59.8 |
57.3 to 62.3 |
2501 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
70.0 |
64.6 to 74.9 |
667 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
58.0 |
55.2 to 60.8 |
1834 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
51.8 |
48.3 to 55.2 |
1138 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
64.1 |
60.6 to 67.5 |
1087 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
51.8 |
48.5 to 55.1 |
1380 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
53.3 |
49.7 to 56.9 |
1077 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
55.7 |
52.0 to 59.4 |
1221 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
59.2 |
56.0 to 62.4 |
1360 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
67.8 |
64.8 to 70.6 |
2603 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
74.1 |
70.8 to 77.1 |
1335 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
60.3 |
56.9 to 63.7 |
1363 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
63.3 |
59.9 to 66.5 |
1373 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
32.0 |
28.5 to 35.7 |
1025 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
52.9 |
49.6 to 56.2 |
1385 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
53.3 |
50.0 to 56.5 |
1284 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
63.5 |
60.2 to 66.8 |
1308 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
51.6 |
48.1 to 55.1 |
1294 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
69.9 |
66.9 to 72.8 |
1375 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
54.6 |
51.1 to 58.0 |
1395 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
59.1 |
55.7 to 62.5 |
1199 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
63.0 |
60.3 to 65.6 |
2180 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
66.8 |
62.9 to 70.5 |
939 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
61.0 |
57.4 to 64.4 |
1241 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
57.3 |
53.7 to 60.8 |
1329 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
71.7 |
68.5 to 74.8 |
1322 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
55.9 |
52.2 to 59.4 |
1244 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
44.6 |
41.2 to 48.1 |
1240 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
63.9 |
60.5 to 67.1 |
1223 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
61.7 |
58.9 to 64.4 |
3096 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
75.6 |
71.8 to 79.0 |
916 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
60.3 |
57.3 to 63.2 |
2180 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
56.9 |
56.2 to 57.6 |
75678 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
83.5 |
80.6 to 86.1 |
1187 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
49.8 |
46.3 to 53.3 |
1214 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
65.0 |
61.9 to 67.9 |
1467 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
52.1 |
48.4 to 55.7 |
1143 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
48.4 |
45.9 to 51.0 |
4915 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
52.8 |
49.0 to 56.5 |
1090 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
63.5 |
58.1 to 68.6 |
562 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
47.3 |
44.4 to 50.1 |
3263 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
50.7 |
47.3 to 54.1 |
1362 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
68.2 |
65.5 to 70.8 |
1780 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
58.7 |
55.2 to 62.2 |
2323 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
59.4 |
55.9 to 62.9 |
1392 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
44.6 |
41.2 to 48.0 |
1129 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
63.1 |
57.9 to 64.2 |
1306 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Poverty |
Living At or Above Poverty Level |
43.3 |
41.9 to 48.7 |
1271 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
62.5 |
55.7 to 68.8 |
273 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
75.8 |
55.4 to 88.8 |
37 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
43.6 |
28.2 to 60.4 |
48 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
61.4 |
52.2 to 69.8 |
143 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
72.5 |
55.2 to 85.0 |
72 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
71.2 |
60.7 to 79.9 |
120 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
62.5 |
55.2 to 69.2 |
232 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
73.0 |
68.3 to 77.3 |
534 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
54.6 |
45.3 to 63.5 |
178 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
53.8 |
47.6 to 59.9 |
376 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
59.7 |
53.4 to 65.7 |
389 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
61.4 |
53.0 to 69.2 |
218 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
58.5 |
49.5 to 67.0 |
171 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
52.6 |
41.6 to 63.3 |
107 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
57.5 |
39.4 to 73.8 |
37 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
57.7 |
41.4 to 72.4 |
48 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
67.5 |
54.4 to 78.2 |
78 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
70.6 |
64.7 to 75.8 |
318 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
66.1 |
60.6 to 71.1 |
638 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
83.5 |
72.0 to 90.9 |
96 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
63.6 |
53.6 to 72.5 |
139 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
63.6 |
49.6 to 75.6 |
73 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
37.3 |
31.9 to 43.1 |
376 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
68.2 |
57.8 to 77.1 |
106 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
48.5 |
33.7 to 63.5 |
54 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
38.1 |
28.1 to 49.3 |
116 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
55.1 |
44.4 to 65.3 |
122 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
61.8 |
55.0 to 68.2 |
322 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
64.3 |
56.7 to 71.3 |
232 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
57.9 |
45.2 to 69.6 |
90 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
52.4 |
44.1 to 60.6 |
196 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
71.7 |
53.3 to 84.9 |
40 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
71.2 |
61.4 to 79.4 |
127 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
52.5 |
39.3 to 65.4 |
67 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
69.9 |
63.5 to 75.5 |
667 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
76.6 |
72.0 to 80.7 |
490 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
64.6 |
54.0 to 73.9 |
177 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
59.8 |
57.9 to 61.6 |
7808 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
79.9 |
68.3 to 88.0 |
82 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
55.3 |
48.4 to 62.1 |
249 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
63.4 |
54.1 to 71.8 |
150 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
49.9 |
43.1 to 56.7 |
532 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
42.8 |
30.2 to 56.5 |
67 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
58.8 |
48.5 to 68.3 |
131 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
49.2 |
41.4 to 57.0 |
334 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
62.1 |
53.6 to 70.0 |
240 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
80.7 |
64.2 to 90.6 |
48 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
48.8 |
30.7 to 67.1 |
35 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Black, Non-Hispanic |
63.0 |
50.9 to 73.7 |
87 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Hispanic |
56.2 |
44.5 to 67.3 |
101 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Hispanic |
56.8 |
46.4 to 66.8 |
134 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Hispanic |
64.1 |
59.1 to 68.9 |
511 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Hispanic |
49.6 |
40.5 to 58.6 |
163 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Hispanic |
61.0 |
55.8 to 66.0 |
604 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.2 |
64.3 to 75.5 |
365 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Hispanic |
67.5 |
60.7 to 73.8 |
286 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Hispanic |
68.0 |
60.3 to 74.9 |
238 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Hispanic |
80.2 |
73.2 to 85.7 |
325 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Hispanic |
55.7 |
49.3 to 61.9 |
465 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Hispanic |
63.2 |
54.5 to 71.2 |
218 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
Hispanic |
65.3 |
57.6 to 72.3 |
223 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
Hispanic |
59.8 |
51.4 to 67.6 |
207 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Hispanic |
64.1 |
59.5 to 68.4 |
865 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Hispanic |
71.6 |
65.6 to 76.9 |
460 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
60.7 |
54.7 to 66.4 |
405 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Hispanic |
49.6 |
40.6 to 58.7 |
175 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Hispanic |
66.6 |
55.9 to 75.9 |
119 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Hispanic |
66.4 |
59.0 to 73.0 |
258 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Hispanic |
44.5 |
33.4 to 56.3 |
104 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Hispanic |
64.8 |
54.2 to 74.1 |
133 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
Hispanic |
54.8 |
40.1 to 68.8 |
64 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Hispanic |
69.5 |
61.8 to 76.3 |
440 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Hispanic |
73.8 |
65.4 to 80.8 |
214 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Hispanic |
66.4 |
55.4 to 75.9 |
119 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Hispanic |
54.1 |
42.6 to 65.2 |
113 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Hispanic |
47.3 |
32.4 to 62.7 |
76 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Hispanic |
52.1 |
39.9 to 64.0 |
107 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
Hispanic |
60.9 |
48.9 to 71.7 |
100 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.1 |
62.8 to 76.5 |
237 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Hispanic |
61.3 |
56.2 to 66.3 |
532 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
Hispanic |
69.9 |
57.0 to 80.3 |
87 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Hispanic |
63.3 |
56.6 to 69.5 |
336 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
Hispanic |
62.1 |
58.1 to 65.9 |
921 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.1 |
65.7 to 74.2 |
789 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Hispanic |
74.5 |
69.7 to 78.8 |
552 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
63.3 |
55.1 to 70.9 |
237 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Hispanic |
56.9 |
48.6 to 64.9 |
223 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.0 |
56.1 to 81.0 |
67 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Hispanic |
60.6 |
47.9 to 72.0 |
117 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Hispanic |
49.0 |
41.4 to 56.8 |
222 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
Hispanic |
65.6 |
58.3 to 72.2 |
239 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Hispanic |
67.2 |
60.2 to 73.5 |
534 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.4 |
63.0 to 76.8 |
290 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
66.3 |
57.5 to 74.1 |
244 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Hispanic |
60.9 |
59.3 to 62.6 |
16518 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Hispanic |
79.7 |
73.8 to 84.6 |
335 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Hispanic |
58.1 |
48.0 to 67.6 |
150 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
Hispanic |
61.4 |
48.0 to 73.2 |
78 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Hispanic |
58.3 |
48.0 to 68.0 |
148 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Hispanic |
55.8 |
52.5 to 59.0 |
3535 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Hispanic |
58.9 |
55.0 to 62.8 |
907 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Hispanic |
57.0 |
51.3 to 62.5 |
479 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Hispanic |
55.3 |
51.4 to 59.1 |
2149 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
Hispanic |
53.1 |
44.5 to 61.5 |
193 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.7 |
54.9 to 82.7 |
63 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Hispanic |
65.3 |
55.8 to 73.7 |
289 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Hispanic |
70.5 |
63.4 to 76.7 |
294 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Hispanic |
42.1 |
28.3 to 57.3 |
60 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Hispanic |
62.2 |
52.9 to 70.6 |
165 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
Hispanic |
48.9 |
39.7 to 58.1 |
177 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
60.9 |
49.9 to 70.9 |
108 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
58.9 |
53.3 to 64.3 |
477 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
61.0 |
52.0 to 69.3 |
187 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
51.4 |
41.2 to 61.6 |
132 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
65.8 |
58.1 to 72.8 |
333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
65.6 |
56.0 to 74.1 |
145 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
61.2 |
50.8 to 70.6 |
155 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
62.7 |
53.5 to 71.1 |
167 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
72.8 |
61.3 to 82.0 |
133 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
52.2 |
41.2 to 63.0 |
149 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
57.1 |
46.6 to 67.1 |
159 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
72.4 |
68.8 to 75.7 |
902 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
57.1 |
45.3 to 68.1 |
113 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
63.7 |
56.4 to 70.4 |
340 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
77.5 |
62.7 to 87.6 |
84 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
62.3 |
54.3 to 69.6 |
256 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
60.7 |
50.0 to 70.5 |
118 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
73.5 |
61.7 to 82.7 |
88 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
52.4 |
42.9 to 61.8 |
166 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
51.3 |
40.7 to 61.9 |
118 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
71.8 |
62.2 to 79.7 |
152 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
59.3 |
48.3 to 69.5 |
117 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
65.9 |
57.9 to 73.2 |
376 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
74.2 |
65.7 to 81.3 |
183 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
55.5 |
45.7 to 64.9 |
155 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
72.0 |
62.3 to 80.1 |
167 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
38.4 |
27.3 to 50.9 |
98 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
49.5 |
39.3 to 59.7 |
143 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
53.9 |
45.3 to 62.2 |
185 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
58.8 |
47.1 to 69.7 |
107 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
51.8 |
43.2 to 60.3 |
217 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
77.9 |
68.3 to 85.2 |
133 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
54.1 |
46.5 to 61.6 |
284 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
62.6 |
53.0 to 71.3 |
148 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
68.8 |
62.6 to 74.3 |
435 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
71.5 |
63.6 to 78.3 |
256 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
66.4 |
57.1 to 74.6 |
179 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
64.4 |
55.1 to 72.6 |
187 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
73.6 |
64.7 to 80.8 |
187 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
61.2 |
50.9 to 70.6 |
138 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
50.1 |
44.2 to 56.0 |
426 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
60.9 |
51.6 to 69.5 |
182 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
61.5 |
53.3 to 69.1 |
420 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
72.7 |
63.2 to 80.5 |
165 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
60.1 |
51.0 to 68.5 |
255 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
60.9 |
59.0 to 62.8 |
10891 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
78.1 |
68.2 to 85.6 |
131 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
55.1 |
43.0 to 66.6 |
94 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
70.9 |
63.9 to 76.9 |
262 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
52.8 |
41.8 to 63.5 |
123 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
52.1 |
45.2 to 59.0 |
546 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
55.3 |
42.7 to 67.3 |
96 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
59.0 |
43.1 to 73.2 |
82 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
51.5 |
43.9 to 59.1 |
368 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
61.2 |
47.7 to 73.2 |
91 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
69.9 |
60.2 to 78.2 |
134 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
51.2 |
42.8 to 59.6 |
445 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
61.3 |
53.4 to 68.7 |
291 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
52.0 |
41.0 to 62.7 |
102 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
69.6 |
60.1 to 77.7 |
139 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
Other or Multiple Races, Non-Hispanic |
42.4 |
31.7 to 53.8 |
103 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
49.5 |
45.8 to 53.2 |
1012 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
48.0 |
44.1 to 52.0 |
980 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
48.7 |
44.3 to 53.0 |
759 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
48.5 |
45.1 to 52.0 |
1167 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
51.9 |
45.9 to 57.8 |
631 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
62.9 |
58.9 to 66.7 |
999 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
58.6 |
54.7 to 62.4 |
955 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
62.9 |
58.9 to 66.7 |
897 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
79.5 |
75.1 to 83.4 |
623 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
49.0 |
44.2 to 53.9 |
848 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
53.8 |
49.4 to 58.1 |
800 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
59.2 |
52.1 to 65.9 |
279 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
52.6 |
49.1 to 56.1 |
1245 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
57.0 |
53.8 to 60.1 |
1636 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
70.3 |
60.8 to 78.4 |
261 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
56.2 |
52.9 to 59.4 |
1375 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
50.9 |
47.2 to 54.5 |
1013 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
62.7 |
58.9 to 66.2 |
1024 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
50.2 |
46.6 to 53.7 |
1180 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
52.4 |
48.8 to 56.1 |
1033 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
49.2 |
45.3 to 53.2 |
1006 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
59.2 |
56.0 to 62.3 |
1356 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
68.6 |
64.7 to 72.2 |
1481 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
72.2 |
68.5 to 75.7 |
1063 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
59.9 |
56.3 to 63.4 |
1210 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
63.7 |
60.1 to 67.2 |
1165 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
27.7 |
24.1 to 31.7 |
822 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
52.1 |
48.6 to 55.5 |
1272 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
52.0 |
48.5 to 55.3 |
1181 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
63.1 |
59.4 to 66.5 |
1149 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
50.9 |
46.2 to 55.5 |
743 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
68.4 |
65.2 to 71.5 |
1287 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
52.2 |
47.9 to 56.5 |
900 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
50.9 |
45.9 to 55.9 |
567 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
59.3 |
55.9 to 62.7 |
1333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
54.0 |
47.5 to 60.3 |
378 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
60.7 |
56.7 to 64.5 |
955 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
57.5 |
53.5 to 61.4 |
994 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
71.3 |
67.8 to 74.6 |
1184 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
53.5 |
49.6 to 57.3 |
1110 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
40.9 |
36.9 to 45.0 |
841 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
61.6 |
57.9 to 65.2 |
988 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
61.7 |
58.5 to 64.8 |
2208 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
76.1 |
70.5 to 80.9 |
394 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
61.2 |
57.9 to 64.4 |
1814 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
54.8 |
54.1 to 55.6 |
56479 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
83.3 |
79.9 to 86.2 |
918 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
48.1 |
44.3 to 52.0 |
987 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
64.0 |
60.7 to 67.2 |
1302 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
48.7 |
44.9 to 52.6 |
1021 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
45.0 |
41.3 to 48.8 |
2241 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
50.2 |
43.5 to 56.8 |
384 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
67.7 |
58.6 to 75.6 |
213 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
44.0 |
40.0 to 48.1 |
1644 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
48.0 |
44.5 to 51.7 |
1210 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
66.7 |
63.9 to 69.4 |
1750 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
58.0 |
53.6 to 62.2 |
1554 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
55.7 |
51.4 to 59.8 |
1003 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
48.2 |
45.0 to 51.5 |
1270 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
60.9 |
57.5 to 64.2 |
1129 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Race/Ethnicity |
White, Non-Hispanic |
44.5 |
41.0 to 48.1 |
1153 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
60.9 |
56.2 to 65.3 |
628 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
56.8 |
52.7 to 60.9 |
896 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
57.8 |
53.6 to 61.8 |
835 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
58.0 |
53.0 to 62.9 |
557 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
59.3 |
54.4 to 64.1 |
806 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
68.1 |
63.9 to 72.1 |
778 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
67.2 |
61.0 to 72.8 |
350 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
66.5 |
61.2 to 71.4 |
506 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
75.4 |
72.2 to 78.3 |
1615 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
51.6 |
46.9 to 56.2 |
914 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
63.5 |
57.7 to 68.8 |
475 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
69.1 |
63.8 to 73.9 |
471 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
56.6 |
51.5 to 61.7 |
581 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
65.5 |
61.9 to 68.9 |
1398 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
68.2 |
64.0 to 72.2 |
1023 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
61.7 |
55.3 to 67.7 |
375 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
53.5 |
48.7 to 58.2 |
604 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
64.9 |
58.9 to 70.5 |
393 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
60.5 |
55.8 to 65.1 |
625 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
59.9 |
54.8 to 64.8 |
502 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
59.9 |
55.0 to 64.7 |
646 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
63.9 |
56.5 to 70.8 |
250 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
69.8 |
64.7 to 74.5 |
884 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
79.1 |
72.3 to 84.5 |
268 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
64.0 |
58.1 to 69.5 |
450 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
67.2 |
62.5 to 71.6 |
659 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
42.5 |
34.6 to 50.8 |
214 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
64.4 |
59.5 to 69.1 |
619 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
60.2 |
55.1 to 65.1 |
511 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
69.1 |
64.8 to 73.0 |
753 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
55.9 |
52.1 to 59.6 |
1123 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
68.6 |
60.5 to 75.8 |
200 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
63.5 |
54.1 to 71.9 |
176 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
61.6 |
57.6 to 65.5 |
861 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
68.8 |
65.8 to 71.5 |
1728 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
66.6 |
63.4 to 69.7 |
1418 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
74.9 |
68.1 to 80.6 |
310 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
56.7 |
51.7 to 61.5 |
690 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
73.8 |
68.3 to 78.6 |
468 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
63.5 |
58.1 to 68.5 |
513 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
49.1 |
43.4 to 54.8 |
408 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
66.6 |
62.5 to 70.4 |
794 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
71.4 |
67.1 to 75.3 |
1606 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
74.7 |
71.6 to 77.6 |
1339 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
68.7 |
61.3 to 75.3 |
267 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
60.7 |
59.6 to 61.7 |
36713 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
84.5 |
79.6 to 88.4 |
416 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
55.5 |
50.0 to 60.8 |
512 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
69.7 |
64.9 to 74.2 |
512 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
57.4 |
52.4 to 62.1 |
612 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
54.7 |
51.4 to 58.0 |
4042 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
57.1 |
53.7 to 60.4 |
1302 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
59.1 |
54.9 to 63.2 |
905 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
53.4 |
48.8 to 57.8 |
1835 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
55.3 |
49.6 to 61.0 |
467 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
65.5 |
57.6 to 72.7 |
222 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
62.2 |
56.1 to 67.9 |
860 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
64.5 |
60.1 to 68.7 |
859 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
52.0 |
46.5 to 57.4 |
450 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
67.2 |
62.5 to 71.6 |
581 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a MSA Principal City |
48.9 |
43.2 to 54.6 |
425 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
51.3 |
46.3 to 56.3 |
555 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
40.4 |
33.6 to 47.7 |
272 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
54.2 |
49.3 to 59.0 |
582 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
50.1 |
44.7 to 55.5 |
502 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
60.9 |
55.8 to 65.6 |
801 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
64.0 |
58.8 to 68.8 |
592 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
61.0 |
57.3 to 64.6 |
1107 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
62.1 |
58.3 to 65.7 |
1028 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
52.9 |
47.6 to 58.2 |
694 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
51.6 |
47.3 to 55.8 |
886 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
71.2 |
66.9 to 75.1 |
649 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
55.9 |
50.6 to 61.1 |
548 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
59.4 |
56.3 to 62.4 |
1608 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
59.4 |
56.3 to 62.4 |
1608 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
52.4 |
47.4 to 57.4 |
556 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
66.8 |
61.2 to 72.0 |
431 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
51.4 |
46.2 to 56.7 |
529 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
55.2 |
49.2 to 61.1 |
387 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
59.5 |
54.8 to 64.1 |
737 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
58.9 |
54.4 to 63.2 |
696 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
66.1 |
62.7 to 69.2 |
2006 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
72.7 |
69.3 to 75.9 |
1275 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
59.7 |
55.5 to 63.8 |
896 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
63.0 |
57.6 to 68.1 |
543 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
34.7 |
29.7 to 40.1 |
496 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
54.5 |
49.8 to 59.1 |
696 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
52.8 |
39.8 to 65.5 |
75 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
65.1 |
58.1 to 71.5 |
316 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
51.0 |
44.1 to 57.9 |
300 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
72.6 |
68.6 to 76.2 |
716 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
54.4 |
51.0 to 57.8 |
1466 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
60.9 |
54.0 to 67.3 |
323 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
58.3 |
54.4 to 62.1 |
1005 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
58.3 |
54.4 to 62.1 |
1005 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
55.7 |
50.7 to 60.5 |
672 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
72.1 |
63.5 to 79.4 |
215 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
56.9 |
52.2 to 61.5 |
747 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
44.4 |
39.5 to 49.4 |
582 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
57.8 |
52.3 to 63.2 |
450 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
61.3 |
58.2 to 64.3 |
2130 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
61.3 |
58.2 to 64.3 |
2130 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
56.9 |
56.0 to 57.8 |
38031 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
80.6 |
77.3 to 83.5 |
1050 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
50.2 |
45.9 to 54.5 |
805 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
68.8 |
61.6 to 75.1 |
276 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
49.3 |
44.2 to 54.5 |
573 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
48.8 |
45.7 to 52.0 |
2486 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
46.4 |
36.9 to 56.3 |
152 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
48.9 |
45.7 to 52.1 |
2334 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
49.4 |
45.2 to 53.6 |
898 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
65.8 |
60.6 to 70.6 |
567 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
58.2 |
54.0 to 62.3 |
1551 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
56.9 |
51.5 to 62.1 |
625 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
47.9 |
42.7 to 53.1 |
489 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
59.8 |
55.2 to 64.3 |
608 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a MSA Non-Principal City |
34.6 |
18.9 to 54.6 |
34 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
45.9 |
39.0 to 53.1 |
311 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
53.0 |
47.3 to 58.6 |
460 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
62.5 |
49.6 to 73.8 |
88 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
44.1 |
39.1 to 49.3 |
546 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
67.2 |
40.8 to 85.9 |
33 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
55.5 |
45.3 to 65.3 |
164 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
53.4 |
37.1 to 69.0 |
59 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
67.8 |
45.0 to 84.4 |
32 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
53.6 |
44.3 to 62.6 |
192 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
62.4 |
55.6 to 68.7 |
296 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
49.9 |
43.9 to 55.9 |
455 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
42.7 |
34.8 to 51.0 |
224 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
42.7 |
34.8 to 51.0 |
224 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
45.6 |
38.4 to 53.0 |
253 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
58.0 |
52.5 to 63.4 |
444 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
45.6 |
39.9 to 51.5 |
498 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
41.4 |
35.9 to 47.1 |
444 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
59.2 |
50.6 to 67.2 |
226 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
56.9 |
52.0 to 61.6 |
620 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
86.0 |
72.4 to 93.5 |
45 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
55.8 |
48.2 to 63.2 |
277 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
56.2 |
48.5 to 63.7 |
316 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
28.5 |
24.3 to 33.2 |
662 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
29.4 |
23.4 to 36.3 |
313 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
47.2 |
43.3 to 51.2 |
895 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
51.9 |
46.3 to 57.5 |
478 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
46.0 |
36.8 to 55.5 |
185 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
65.6 |
60.5 to 70.3 |
608 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
51.7 |
46.2 to 57.1 |
481 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
51.8 |
41.2 to 62.3 |
146 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
51.8 |
41.2 to 62.3 |
146 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
61.8 |
53.5 to 69.5 |
238 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
70.0 |
65.7 to 74.0 |
795 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
43.9 |
35.9 to 52.3 |
232 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
43.9 |
38.8 to 49.1 |
566 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
58.0 |
49.0 to 66.4 |
188 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
51.3 |
39.3 to 63.2 |
93 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
51.3 |
39.3 to 63.2 |
93 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
49.9 |
48.5 to 51.3 |
16952 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
44.8 |
35.2 to 54.8 |
163 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
60.7 |
56.5 to 64.6 |
879 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
45.7 |
38.0 to 53.6 |
257 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
49.7 |
40.4 to 59.0 |
326 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
49.7 |
40.4 to 59.0 |
326 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
32.8 |
23.1 to 44.3 |
149 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
67.9 |
64.5 to 71.0 |
1184 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
50.4 |
38.3 to 62.4 |
117 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
55.5 |
44.8 to 65.8 |
152 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
45.5 |
40.6 to 50.6 |
528 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
56.4 |
49.8 to 62.7 |
331 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Urbanicity |
Living In a Non-MSA |
43.4 |
39.6 to 47.3 |
990 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alabama |
2018-2022 |
Overall |
Overall |
54.5 |
51.4 to 57.5 |
1494 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Alaska |
2018-2022 |
Overall |
Overall |
53.1 |
50.1 to 56.1 |
1628 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arizona |
2018-2022 |
Overall |
Overall |
56.6 |
53.5 to 59.7 |
1505 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Arkansas |
2018-2022 |
Overall |
Overall |
51.1 |
48.1 to 54.1 |
1605 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
California |
2018-2022 |
Overall |
Overall |
60.2 |
56.7 to 63.6 |
1640 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Colorado |
2018-2022 |
Overall |
Overall |
65.5 |
62.4 to 68.5 |
1534 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Connecticut |
2018-2022 |
Overall |
Overall |
62.4 |
59.3 to 65.3 |
1516 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Delaware |
2018-2022 |
Overall |
Overall |
63.6 |
60.5 to 66.5 |
1534 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
District of Columbia |
2018-2022 |
Overall |
Overall |
75.4 |
72.2 to 78.3 |
1615 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Florida |
2018-2022 |
Overall |
Overall |
52.5 |
49.0 to 55.9 |
1640 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Georgia |
2018-2022 |
Overall |
Overall |
55.4 |
52.2 to 58.6 |
1553 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Hawaii |
2018-2022 |
Overall |
Overall |
68.9 |
65.9 to 71.7 |
1416 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Idaho |
2018-2022 |
Overall |
Overall |
54.5 |
51.4 to 57.6 |
1584 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Illinois |
2018-2022 |
Overall |
Overall |
59.9 |
57.6 to 62.1 |
3230 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-City of Chicago |
2018-2022 |
Overall |
Overall |
68.2 |
64.0 to 72.2 |
1023 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
IL-Rest of state |
2018-2022 |
Overall |
Overall |
58.1 |
55.5 to 60.6 |
2207 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Indiana |
2018-2022 |
Overall |
Overall |
51.8 |
48.6 to 54.9 |
1413 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Iowa |
2018-2022 |
Overall |
Overall |
63.6 |
60.3 to 66.8 |
1268 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kansas |
2018-2022 |
Overall |
Overall |
53.8 |
50.8 to 56.8 |
1652 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Kentucky |
2018-2022 |
Overall |
Overall |
53.1 |
49.9 to 56.3 |
1333 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Louisiana |
2018-2022 |
Overall |
Overall |
59.7 |
56.5 to 62.7 |
1609 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maine |
2018-2022 |
Overall |
Overall |
59.0 |
56.0 to 61.9 |
1566 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Maryland |
2018-2022 |
Overall |
Overall |
67.6 |
64.9 to 70.2 |
2935 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Massachusetts |
2018-2022 |
Overall |
Overall |
73.7 |
70.7 to 76.5 |
1556 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Michigan |
2018-2022 |
Overall |
Overall |
60.5 |
57.4 to 63.6 |
1623 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Minnesota |
2018-2022 |
Overall |
Overall |
63.9 |
60.7 to 67.0 |
1518 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Mississippi |
2018-2022 |
Overall |
Overall |
33.3 |
30.2 to 36.5 |
1372 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Missouri |
2018-2022 |
Overall |
Overall |
53.9 |
50.8 to 57.0 |
1628 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Montana |
2018-2022 |
Overall |
Overall |
52.6 |
49.6 to 55.6 |
1481 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nebraska |
2018-2022 |
Overall |
Overall |
63.1 |
60.0 to 66.1 |
1547 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Nevada |
2018-2022 |
Overall |
Overall |
54.1 |
51.0 to 57.2 |
1608 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Hampshire |
2018-2022 |
Overall |
Overall |
69.6 |
66.7 to 72.3 |
1524 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Jersey |
2018-2022 |
Overall |
Overall |
55.7 |
52.5 to 58.9 |
1642 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New Mexico |
2018-2022 |
Overall |
Overall |
58.9 |
56.0 to 61.8 |
1665 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
New York |
2018-2022 |
Overall |
Overall |
63.5 |
61.2 to 65.8 |
2879 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-City of New York |
2018-2022 |
Overall |
Overall |
66.6 |
63.4 to 69.7 |
1418 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
NY-Rest of state |
2018-2022 |
Overall |
Overall |
61.5 |
58.2 to 64.6 |
1461 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Carolina |
2018-2022 |
Overall |
Overall |
57.0 |
53.8 to 60.2 |
1600 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
North Dakota |
2018-2022 |
Overall |
Overall |
71.6 |
68.5 to 74.5 |
1478 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Ohio |
2018-2022 |
Overall |
Overall |
57.2 |
53.9 to 60.4 |
1492 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oklahoma |
2018-2022 |
Overall |
Overall |
45.7 |
42.7 to 48.8 |
1556 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Oregon |
2018-2022 |
Overall |
Overall |
62.7 |
59.6 to 65.7 |
1432 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Pennsylvania |
2018-2022 |
Overall |
Overall |
63.4 |
60.9 to 65.8 |
3829 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Philadelphia |
2018-2022 |
Overall |
Overall |
74.7 |
71.6 to 77.6 |
1339 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
PA-Rest of state |
2018-2022 |
Overall |
Overall |
61.9 |
59.1 to 64.6 |
2490 |
| HPV |
Up-to-Date, Males and Females |
HHS Regions/National |
United States |
2018-2022 |
Overall |
Overall |
57.7 |
57.1 to 58.4 |
91696 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Rhode Island |
2018-2022 |
Overall |
Overall |
81.7 |
79.0 to 84.1 |
1466 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Carolina |
2018-2022 |
Overall |
Overall |
51.7 |
48.5 to 54.8 |
1480 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
South Dakota |
2018-2022 |
Overall |
Overall |
65.2 |
62.4 to 67.9 |
1667 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Tennessee |
2018-2022 |
Overall |
Overall |
52.4 |
49.2 to 55.7 |
1442 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Texas |
2018-2022 |
Overall |
Overall |
51.5 |
49.3 to 53.7 |
6854 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Bexar County |
2018-2022 |
Overall |
Overall |
56.0 |
52.8 to 59.2 |
1454 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-City of Houston |
2018-2022 |
Overall |
Overall |
59.1 |
54.9 to 63.2 |
905 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
TX-Rest of state |
2018-2022 |
Overall |
Overall |
50.6 |
48.0 to 53.1 |
4495 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Utah |
2018-2022 |
Overall |
Overall |
50.0 |
46.8 to 53.3 |
1514 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Vermont |
2018-2022 |
Overall |
Overall |
67.0 |
64.3 to 69.5 |
1973 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Virginia |
2018-2022 |
Overall |
Overall |
58.9 |
55.5 to 62.1 |
2528 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Washington |
2018-2022 |
Overall |
Overall |
60.7 |
57.5 to 63.9 |
1636 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
West Virginia |
2018-2022 |
Overall |
Overall |
48.3 |
45.3 to 51.3 |
1467 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wisconsin |
2018-2022 |
Overall |
Overall |
62.1 |
59.1 to 64.9 |
1520 |
| HPV |
Up-to-Date, Males and Females |
States/Local Areas |
Wyoming |
2018-2022 |
Overall |
Overall |
45.2 |
42.1 to 48.5 |
1449 |